data_2fws_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fws _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 96.5 mttt . . . . . 0 N--CA 1.415 -2.223 0 N-CA-C 109.195 -0.668 . . . . 74.22 109.195 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 30.9 mm -94.71 136.31 26.3 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 105.374 -2.084 . . . . 75.31 105.374 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -165.6 160.53 17.65 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 118.278 0.49 . . . . 73.23 111.697 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -79.22 141.01 37.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.674 -0.491 . . . . 75.44 109.674 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -65.18 -44.99 86.68 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.592 -0.892 . . . . 74.31 108.592 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -114.44 161.68 17.66 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.401 -0.818 . . . . 74.33 111.053 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.93 -19.11 18.16 Favored Glycine 0 C--N 1.278 -2.67 0 CA-C-N 114.425 -1.261 . . . . 73.14 110.406 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.7 m -138.6 134.21 33.47 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.992 -0.744 . . . . 75.02 108.992 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 72.5 m-85 -124.5 140.38 53.0 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.704 -1.221 . . . . 75.1 107.704 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.44 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 19.2 mt-30 -129.82 140.4 51.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.576 -0.898 . . . . 63.31 108.576 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . 0.626 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.8 p -151.88 159.86 43.71 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.737 -0.838 . . . . 62.33 108.737 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.45 HD11 ' OD1' ' A' ' 386' ' ' ASN . 2.1 mm? -74.98 148.72 39.69 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.45 0.469 . . . . 74.54 109.906 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.83 -36.83 84.5 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.697 0.761 . . . . 74.51 109.425 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.45 ' OD1' HD11 ' A' ' 384' ' ' LEU . 2.7 p-10 -81.15 6.21 14.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.461 -0.791 . . . . 74.21 112.283 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 54.1 t -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.395 0.617 . . . . 73.12 110.402 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.17 -61.42 0.53 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.769 -0.932 . . . . 60.5 110.769 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 6.2 p -137.71 152.57 49.39 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.708 0.29 . . . . 75.34 111.143 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.626 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 7.7 p -109.97 127.43 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 107.976 -1.12 . . . . 74.31 107.976 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.71 120.64 38.46 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.141 0.496 . . . . 54.51 110.482 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.485 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -111.1 152.86 26.47 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.269 -1.382 . . . . 63.43 107.269 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.0 m -123.93 128.47 49.48 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.27 0.557 . . . . 71.45 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.89 125.56 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.796 -1.187 . . . . 75.24 107.796 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.54 144.95 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.645 -1.243 . . . . 74.43 107.645 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.497 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 55.8 ttt180 -127.28 121.06 30.1 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 116.068 -0.515 . . . . 73.43 109.94 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 . . . . . 0 C--N 1.309 -1.163 0 CA-C-N 115.761 -0.654 . . . . 72.54 111.028 178.426 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 14.0 m . . . . . 0 N--CA 1.429 -1.525 0 CA-C-O 121.616 0.722 . . . . 65.25 111.75 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.38 133.89 43.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.231 -0.895 . . . . 70.23 108.737 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -115.94 126.97 54.59 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.75 0.42 . . . . 71.44 109.948 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.29 135.36 64.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.294 -1.743 . . . . 72.43 106.294 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 140.45 35.05 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.24 -0.652 . . . . 70.41 109.24 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -135.25 160.59 37.9 Favored 'General case' 0 C--O 1.254 1.305 0 C-N-CA 120.676 -0.41 . . . . 65.22 110.646 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 30.6 ttt180 -164.03 158.02 19.02 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.263 -1.754 . . . . 74.41 106.263 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.71 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 43.2 p -96.3 150.39 20.62 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.863 -0.791 . . . . 72.51 108.863 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.9 tp10 -105.64 139.8 39.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.735 -1.209 . . . . 74.41 107.735 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 3.7 m-20 -52.39 -39.03 60.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.512 1.125 . . . . 74.04 112.651 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 57.96 -94.99 0.05 OUTLIER Glycine 0 C--N 1.295 -1.708 0 CA-C-N 114.755 -1.111 . . . . 72.13 113.717 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -124.18 17.83 9.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.498 1.142 . . . . 63.43 108.889 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -148.27 -160.52 1.18 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.678 -1.23 . . . . 62.01 107.678 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 417' ' ' ASN . 2.8 m120 -132.71 126.71 33.16 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 113.028 0.751 . . . . 72.31 113.028 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.43 124.37 28.85 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.914 -1.143 . . . . 65.12 107.914 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.48 -5.69 54.99 Favored Glycine 0 C--N 1.3 -1.465 0 N-CA-C 110.69 -0.964 . . . . 74.35 110.69 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 19.9 m -126.13 -51.83 1.53 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.877 0.37 . . . . 74.55 110.114 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 7.6 m-20 -86.46 -57.14 3.11 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 122.205 1.002 . . . . 75.12 109.726 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.689 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.47 165.03 28.61 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 115.116 -0.947 . . . . 71.02 109.683 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.69 162.15 28.3 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.936 0.773 . . . . 71.44 111.788 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.71 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 2.4 p90 -97.93 -17.87 18.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.124 -0.943 . . . . 74.2 111.875 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.436 ' CG2' HG23 ' A' ' 442' ' ' VAL . 6.9 t 32.93 56.37 0.44 Allowed 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.594 1.558 . . . . 63.24 113.844 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.492 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.3 pt-20 -79.89 119.28 22.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.624 0.726 . . . . 73.13 111.614 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.51 -167.51 23.04 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.617 -0.993 . . . . 65.14 110.617 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.8 m -127.78 137.51 52.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 74.43 108.514 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.23 118.49 42.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.532 -0.914 . . . . 74.14 108.532 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.36 107.42 19.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.854 -1.066 . . . . 72.24 109.324 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 404' ' ' THR . 71.1 m-85 -90.38 94.35 9.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.255 0.55 . . . . 74.54 110.784 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 67.3 mttm -84.54 175.71 4.39 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.637 -1.165 . . . . 74.01 111.022 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 34.3 Cg_exo -60.87 117.75 4.55 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.324 2.016 . . . . 73.51 110.27 172.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.93 -11.4 41.16 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.454 -0.658 . . . . 43.33 111.454 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -90.58 63.45 5.48 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.714 0.768 . . . . 72.2 110.765 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 16.9 m -67.52 -22.46 65.43 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.23 -1.35 . . . . 63.35 108.474 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -136.15 149.2 48.54 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 107.284 -1.376 . . . . 75.51 107.284 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -133.07 151.72 52.01 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 120.778 0.323 . . . . 74.41 111.078 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -121.46 132.93 55.01 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.725 -0.67 . . . . 74.5 109.509 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.7 150.46 26.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.513 -0.921 . . . . 65.42 108.513 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 23.1 mtm180 -131.53 134.69 46.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.141 0.496 . . . . 72.13 111.663 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.559 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -107.66 125.56 64.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.437 -0.949 . . . . 74.34 108.437 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -74.82 138.35 23.65 Favored Glycine 0 N--CA 1.439 -1.127 0 O-C-N 123.667 0.604 . . . . 75.14 112.06 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.37 130.71 45.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.597 -1.26 . . . . 72.42 107.597 176.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 84.4 mt -92.03 151.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 108.202 -1.036 . . . . 75.53 108.202 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.03 86.67 6.09 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.708 0.289 . . . . 74.34 110.822 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.8 129.57 54.51 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.521 -2.4 . . . . 65.44 104.521 171.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.256 8.2 t0 -125.61 89.45 3.04 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 116.577 -2.049 . . . . 73.24 111.518 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.611 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.6 mm -115.21 156.4 16.21 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.034 0 CA-C-N 111.058 -2.792 . . . . 75.02 105.587 -174.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -59.79 115.1 3.13 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.76 -1.941 . . . . 73.54 105.76 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.611 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 34.9 mt-10 -122.22 110.78 16.15 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.044 0.926 . . . . 75.34 110.338 -169.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.44 111.93 21.53 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.146 -1.388 . . . . 73.44 108.713 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 49.34 30.38 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.914 1.686 . . . . 72.15 112.548 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.525 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.5 tt0 -60.8 112.55 2.08 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.538 -1.21 . . . . 74.24 108.809 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.84 168.51 19.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.472 -0.786 . . . . 74.12 110.168 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.585 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 31.3 p90 -139.07 175.1 9.84 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.956 -0.566 . . . . 72.23 109.552 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 27.1 mt -120.36 136.79 54.59 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.976 -1.12 . . . . 70.05 107.976 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.0 t -106.43 123.55 61.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.934 -1.136 . . . . 73.52 107.934 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -114.54 150.87 34.26 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 123.852 0.72 . . . . 75.53 109.917 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 65.5 mt -116.36 140.01 49.79 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.414 -0.958 . . . . 75.34 108.414 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 11.8 p -153.37 -179.97 8.23 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.749 -0.834 . . . . 64.44 108.749 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 49.6 86.91 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.307 1.043 . . . . 74.04 112.505 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 83.8 t -102.03 125.87 56.13 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.89 -0.782 . . . . 75.24 108.89 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt . . . . . 0 C--N 1.29 -2.002 0 N-CA-C 106.977 -1.49 . . . . 74.34 106.977 -178.528 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.412 -2.34 0 CA-C-O 120.727 0.298 . . . . 71.44 110.458 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.82 102.72 14.24 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.394 -1.706 . . . . 74.45 106.394 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 29.5 m -80.29 121.28 25.46 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.754 -0.657 . . . . 73.42 109.747 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.413 HG11 HG12 ' A' ' 390' ' ' VAL . 99.5 t -105.68 103.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 108.391 -0.966 . . . . 72.24 108.391 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 19.7 m -93.17 108.42 20.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.137 -1.06 . . . . 73.53 108.137 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.689 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -85.87 121.66 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-O 122.015 0.912 . . . . 74.44 110.992 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.447 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -83.55 95.91 8.46 Favored 'General case' 0 N--CA 1.388 -3.541 0 CA-C-N 114.896 -1.047 . . . . 71.3 110.498 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.06 -54.04 28.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 113.149 -1.841 . . . . 73.4 108.344 170.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.482 1.158 0 C-N-CA 126.141 1.776 . . . . 74.11 111.683 176.092 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp . . . . . 0 N--CA 1.438 -1.038 0 N-CA-C 109.312 -0.625 . . . . 74.04 109.312 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 28.4 mm -110.4 124.61 67.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.28 -1.378 . . . . 73.21 107.28 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -154.82 169.54 23.74 Favored 'General case' 0 C--O 1.201 -1.458 0 CA-C-N 118.335 0.516 . . . . 74.53 111.633 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -85.12 148.13 26.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.3 -0.63 . . . . 74.43 109.3 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -64.51 -46.19 84.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.367 0.604 . . . . 74.53 109.459 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -109.29 -173.89 2.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.334 -0.848 . . . . 74.31 110.414 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.43 -37.22 1.02 Allowed Glycine 0 C--N 1.285 -2.297 0 N-CA-C 109.769 -1.333 . . . . 75.31 109.769 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 35.2 m -121.19 134.36 55.21 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.456 -0.942 . . . . 71.41 108.456 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 58.3 m-85 -122.19 136.62 54.93 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.814 -1.18 . . . . 71.13 107.814 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -130.43 134.76 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.867 -1.16 . . . . 73.33 107.867 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 21.2 t -154.42 164.09 39.17 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.992 -1.114 . . . . 73.05 107.992 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 497' ' ' PHE . 1.8 mm? -79.96 142.88 34.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.279 0.562 . . . . 75.24 111.826 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -57.45 -41.61 80.86 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.438 1.095 . . . . 72.25 109.745 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -70.38 -7.76 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.424 -0.807 . . . . 74.11 113.169 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 49.7 t -68.11 -35.61 78.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.903 0.382 . . . . 72.42 110.837 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.54 -47.5 1.13 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.725 -0.75 . . . . 72.11 111.474 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 16.6 p -142.58 152.6 42.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.692 0.246 . . . . 74.1 110.636 175.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.2 p -111.42 133.15 57.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.471 -1.307 . . . . 72.4 107.471 174.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.49 120.57 41.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.114 0.483 . . . . 72.11 110.833 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 392' ' ' LEU . 3.2 mp -111.45 146.64 36.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.374 -0.973 . . . . 75.0 108.374 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.3 m -107.73 123.81 49.09 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.607 -0.516 . . . . 64.52 109.607 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 61.0 mt -98.83 124.42 52.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.869 -1.16 . . . . 70.3 107.869 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 52.2 mm -99.46 127.8 51.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.409 -0.96 . . . . 75.22 108.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -113.56 114.58 26.68 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.541 -0.911 . . . . 75.24 108.541 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 . . . . . 0 C--N 1.304 -1.391 0 CA-C-N 116.367 -0.379 . . . . 74.22 110.092 -179.605 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 7.5 m . . . . . 0 N--CA 1.416 -2.153 0 N-CA-C 108.783 -0.821 . . . . 74.35 108.783 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.79 143.83 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.257 -0.883 . . . . 74.13 110.074 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.496 ' CE1' HG11 ' A' ' 430' ' ' VAL . 3.5 m-85 -118.43 125.18 49.41 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.422 0.689 . . . . 74.41 109.317 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.62 135.62 63.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.63 -1.248 . . . . 73.24 107.63 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.45 145.43 27.44 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.099 -0.704 . . . . 72.12 109.099 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -142.89 157.78 44.25 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.06 -0.4 . . . . 73.41 110.461 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -161.28 163.92 30.59 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.843 -1.169 . . . . 75.21 107.843 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.664 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.5 p -95.66 172.58 7.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.003 -0.74 . . . . 65.4 109.003 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -115.42 157.72 23.53 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 120.991 0.424 . . . . 71.1 111.995 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -85.95 4.01 39.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.184 1.794 . . . . 72.22 110.571 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -23.36 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.48 1.593 0 C-N-CA 125.912 1.72 . . . . 73.35 116.579 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 455' ' ' ASN . 11.3 t -99.66 -16.48 18.18 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.564 0.697 . . . . 74.32 109.653 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -140.22 170.32 16.05 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 108.583 -0.895 . . . . 74.11 108.583 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -110.83 113.99 26.99 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 112.93 0.715 . . . . 72.1 112.93 -167.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -68.27 124.09 22.51 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.986 -1.116 . . . . 63.44 107.986 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.14 -26.79 8.52 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.391 -1.084 . . . . 63.42 110.391 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 43.2 m -116.38 -47.78 2.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.685 0.279 . . . . 63.24 111.338 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.543 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.0 m-20 -80.39 -57.77 3.44 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 122.174 0.987 . . . . 73.24 109.403 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.736 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.647 -1.161 . . . . 73.41 108.716 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -75.12 160.38 30.53 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.748 0.785 . . . . 74.3 110.702 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.664 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.3 p90 -94.69 -17.95 21.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.402 -0.817 . . . . 75.33 112.268 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.41 ' CG2' HG21 ' A' ' 442' ' ' VAL . 10.1 t 37.08 58.12 1.19 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.413 1.485 . . . . 73.3 113.688 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.92 111.86 17.77 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.997 0.903 . . . . 72.13 110.399 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.6 -173.61 22.96 Favored Glycine 0 N--CA 1.415 -2.76 0 CA-C-N 114.799 -1.091 . . . . 71.5 111.446 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.8 m -126.52 133.19 51.2 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.781 -0.822 . . . . 74.34 108.781 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 17.8 t -96.91 123.55 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.527 -0.916 . . . . 75.34 108.527 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . 0.496 HG11 ' CE1' ' A' ' 406' ' ' PHE . 44.2 t -99.29 109.96 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.051 -0.722 . . . . 63.32 109.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 404' ' ' THR . 65.6 m-85 -86.07 114.94 23.34 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.693 -0.685 . . . . 63.51 109.731 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -108.73 171.56 4.4 Favored Pre-proline 0 C--N 1.291 -1.935 0 CA-C-N 114.944 -1.025 . . . . 75.11 110.296 -175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.26 121.6 10.35 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.784 2.322 . . . . 72.33 111.205 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.81 -16.8 60.38 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.711 -0.677 . . . . 65.25 111.938 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -87.99 62.25 6.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.217 0.532 . . . . 53.11 110.143 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.4 t -70.48 -17.26 62.97 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.643 -0.708 . . . . 74.51 109.561 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -130.86 141.89 50.34 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.245 -1.391 . . . . 72.34 107.245 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -128.94 147.86 50.88 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 120.612 0.244 . . . . 71.13 111.235 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.74 127.7 54.79 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.724 -0.671 . . . . 71.43 109.599 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.95 149.29 21.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.037 -1.098 . . . . 75.13 108.037 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 62.2 mtt180 -130.6 140.12 50.42 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 120.63 -0.428 . . . . 72.52 111.418 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.1 t -108.09 127.65 64.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.11 -0.95 . . . . 73.34 108.442 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -70.82 138.82 28.99 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 124.002 0.814 . . . . 73.31 111.857 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.4 mm -104.16 128.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.298 -1.371 . . . . 75.13 107.298 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 77.5 mt -94.65 151.14 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 106.705 -1.591 . . . . 74.23 106.705 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -81.51 86.29 6.36 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.489 0.662 . . . . 75.41 110.652 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.99 124.67 52.71 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 103.338 -2.838 . . . . 75.31 103.338 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -125.89 98.45 5.53 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 117.297 -1.761 . . . . 75.02 110.027 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.658 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -122.0 156.37 26.54 Favored 'Isoleucine or valine' 1 C--N 1.237 -4.304 0 CA-C-N 111.411 -2.631 . . . . 73.25 104.669 -174.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -56.19 113.48 1.57 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.174 -2.158 . . . . 72.12 105.174 168.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.658 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.2 mt-10 -119.37 107.91 13.93 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-O 121.963 0.887 . . . . 72.22 110.568 -169.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -113.6 107.98 16.53 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 114.432 -1.258 . . . . 72.41 108.059 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 35.3 t70 51.88 61.03 3.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.097 0.873 . . . . 73.12 110.69 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.437 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 32.9 tt0 -89.52 112.68 23.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.52 -1.659 . . . . 72.33 106.52 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 415' ' ' THR . 3.2 p-10 -143.98 164.93 29.18 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.179 0.514 . . . . 72.51 110.77 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.592 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.7 p90 -136.68 178.48 7.04 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.948 -0.76 . . . . 74.33 108.948 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.08 136.71 54.92 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.149 -1.426 . . . . 73.43 107.149 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 492' ' ' ALA . 25.9 t -103.49 122.88 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.333 -1.358 . . . . 75.4 107.333 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -119.96 148.58 43.35 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.862 -0.608 . . . . 74.42 109.849 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.96 147.29 28.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.912 -0.585 . . . . 73.31 109.559 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.8 m -156.11 179.82 8.86 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.514 0.726 . . . . 72.53 109.527 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.0 t30 47.75 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.335 1.454 . . . . 61.22 114.267 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 98.5 t -91.67 127.36 44.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 C-N-CA 119.713 -0.795 . . . . 74.44 109.091 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt . . . . . 0 C--N 1.295 -1.797 0 N-CA-C 107.232 -1.395 . . . . 71.42 107.232 178.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.413 -2.302 0 N-CA-C 109.885 -0.413 . . . . 74.52 109.885 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 458' ' ' VAL . . . -109.39 108.39 18.91 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.435 -1.32 . . . . 73.05 107.435 170.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 74.4 m -83.2 111.71 19.19 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.282 -0.636 . . . . 75.4 109.282 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.413 ' HB ' ' CE1' ' A' ' 456' ' ' PHE . 71.4 t -100.62 106.62 19.64 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 108.262 -1.014 . . . . 70.14 108.262 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 25.1 m -93.47 112.16 24.0 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 107.158 -1.423 . . . . 63.15 107.158 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -86.56 119.66 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 CA-C-O 121.831 0.824 . . . . 74.2 109.616 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.477 ' O ' HD12 ' A' ' 384' ' ' LEU . 5.5 m-85 -82.79 98.08 8.94 Favored 'General case' 1 N--CA 1.378 -4.068 0 CA-C-N 115.041 -0.981 . . . . 73.33 112.34 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 451' ' ' GLU . 2.9 t70 -50.09 -60.52 2.87 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 112.019 -2.355 . . . . 71.01 108.518 170.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 CA--C 1.547 0.838 0 CA-C-N 113.767 -1.56 . . . . 70.14 112.363 179.271 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 N--CA 1.407 -2.576 0 N-CA-C 107.873 -1.158 . . . . 74.33 107.873 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.434 HG23 HG11 ' A' ' 407' ' ' VAL . 37.4 mm -110.08 112.73 41.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.092 -1.448 . . . . 74.3 107.092 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -145.76 161.41 39.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.471 -0.492 . . . . 73.13 111.87 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -79.51 150.46 31.16 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.86 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.14 -50.0 62.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.741 -1.207 . . . . 73.31 107.741 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 27.6 mm-40 -103.57 -177.69 3.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.609 -0.723 . . . . 73.11 111.494 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.44 -38.4 0.93 Allowed Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.836 -1.306 . . . . 74.45 109.836 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.8 m -123.55 131.86 53.74 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 107.582 -1.266 . . . . 73.52 107.582 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 86.1 m-85 -119.78 140.87 50.08 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.483 -1.303 . . . . 75.43 107.483 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 495' ' ' THR . 21.3 mt-30 -130.14 127.39 39.66 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.312 -0.625 . . . . 73.54 109.312 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . 0.646 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.5 p -133.83 165.06 25.85 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.488 -0.93 . . . . 64.42 108.488 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.79 146.09 24.72 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.023 0.439 . . . . 75.05 111.125 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.72 -28.94 70.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.84 0.828 . . . . 65.4 109.138 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -86.45 2.4 47.91 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.868 -1.06 . . . . 71.24 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.76 -32.24 31.54 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 112.611 0.597 . . . . 35.05 112.611 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.71 -65.47 0.4 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.284 -0.96 . . . . 61.12 111.21 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 30.3 p -133.01 159.45 39.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.478 0.639 . . . . 73.3 111.01 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.646 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 3.6 p -111.87 129.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 107.431 -1.322 . . . . 75.51 107.431 171.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.39 128.24 44.69 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.661 -0.866 . . . . 74.34 108.661 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.28 142.82 47.74 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.456 -1.313 . . . . 74.12 107.456 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.4 m -105.64 131.43 53.03 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.188 0.518 . . . . 72.53 110.371 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.456 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 84.4 mt -106.54 128.79 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.915 -1.143 . . . . 74.45 107.915 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 46.4 mm -105.52 127.71 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 N-CA-C 108.198 -1.038 . . . . 74.41 108.198 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -110.41 112.06 23.73 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 116.118 -0.492 . . . . 71.41 109.792 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . 0.497 ' HA ' ' HE ' ' A' ' 397' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 108.874 -0.788 . . . . 74.41 108.874 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 10.0 m . . . . . 0 N--CA 1.414 -2.248 0 CA-C-O 121.621 0.724 . . . . 71.34 109.253 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.71 140.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.813 -1.085 . . . . 74.22 108.207 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -123.09 128.01 49.52 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.756 -0.831 . . . . 75.42 108.756 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.434 HG11 HG23 ' A' ' 374' ' ' ILE . 7.4 p -128.92 134.57 64.01 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 106.339 -1.726 . . . . 73.14 106.339 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.47 122.43 42.54 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.497 -0.481 . . . . 70.44 110.01 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -109.57 154.17 23.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.695 -0.483 . . . . 75.31 109.695 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . 0.405 ' HE ' ' HB2' ' A' ' 410' ' ' ARG . 11.5 ttm180 -163.78 164.73 23.56 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.078 -1.452 . . . . 71.3 107.078 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.444 ' HG1' ' HA ' ' A' ' 424' ' ' PHE . 80.0 p -95.89 172.51 7.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.801 0.334 . . . . 72.53 110.268 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 8.7 tp10 -118.6 147.97 43.17 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.286 0.565 . . . . 75.41 110.257 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.72 4.02 26.77 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 127.039 2.136 . . . . 75.34 109.514 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . 0.465 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -20.35 -74.26 0.01 OUTLIER Glycine 0 N--CA 1.482 1.744 0 C-N-CA 126.113 1.816 . . . . 52.52 115.686 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.7 t -118.47 -5.46 10.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.347 0.594 . . . . 70.42 110.63 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -134.23 -179.65 5.7 Favored 'General case' 0 C--O 1.195 -1.774 0 CA-C-N 116.357 -0.383 . . . . 74.41 110.223 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.16 118.96 28.86 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.409 0.623 . . . . 74.3 110.065 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.23 137.89 49.02 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.177 -0.675 . . . . 74.33 109.177 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.24 -4.92 81.09 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 110.721 -0.952 . . . . 72.33 110.721 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.1 t -123.73 -57.83 1.61 Allowed 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.25 -1.018 . . . . 63.12 108.25 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.527 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 17.6 m-20 -82.45 -59.39 2.55 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-O 122.19 0.995 . . . . 61.53 109.097 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.704 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.23 158.92 43.32 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.267 -0.879 . . . . 74.15 109.99 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.4 142.87 46.95 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.106 -0.701 . . . . 73.13 109.106 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.444 ' HA ' ' HG1' ' A' ' 411' ' ' THR . 8.7 p90 -73.68 -24.13 59.92 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 123.304 0.642 . . . . 65.12 112.632 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.473 HG22 HG21 ' A' ' 442' ' ' VAL 0.291 10.9 t 41.6 62.42 1.56 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.37 1.868 . . . . 75.43 113.185 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.44 107.38 12.16 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.691 -1.141 . . . . 73.15 108.854 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -144.42 168.38 26.72 Favored Glycine 0 CA--C 1.46 -3.385 0 C-N-CA 120.073 -1.06 . . . . 64.32 111.49 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.6 m -112.7 138.1 50.01 Favored 'General case' 0 N--CA 1.393 -3.292 0 N-CA-C 107.652 -1.24 . . . . 64.54 107.652 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.4 117.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.759 -1.201 . . . . 74.33 107.759 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.74 105.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.496 -0.774 . . . . 70.05 109.755 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 404' ' ' THR . 57.7 m-85 -89.25 94.53 9.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.054 -0.521 . . . . 74.33 110.786 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.28 167.51 16.63 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.234 -0.894 . . . . 74.14 110.568 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.01 119.65 7.05 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 122.742 2.295 . . . . 64.53 110.881 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.24 -14.75 60.93 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.073 -0.584 . . . . 72.3 112.457 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -93.91 61.16 2.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.748 0.785 . . . . 70.0 109.381 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 8.0 m -66.09 -25.77 67.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.624 -1.171 . . . . 71.32 109.625 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.41 132.36 54.32 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.415 -1.328 . . . . 72.43 107.415 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -120.73 149.69 42.13 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.93 0.395 . . . . 74.22 111.994 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.73 131.91 56.02 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.223 -0.899 . . . . 63.5 109.435 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.57 149.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.929 -1.137 . . . . 64.13 107.929 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 51.4 mtt180 -131.62 144.01 50.74 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.253 0.549 . . . . 63.53 111.972 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.503 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 49.2 t -117.51 121.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.708 -1.219 . . . . 72.41 107.708 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -78.45 134.1 13.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.07 -0.586 . . . . 75.23 111.985 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . 0.433 HD11 HG12 ' A' ' 496' ' ' ILE . 28.9 mm -90.42 139.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.693 -1.225 . . . . 73.45 107.693 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 81.3 mt -99.29 150.98 4.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.236 -1.394 . . . . 73.55 107.236 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 88.03 3.05 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.113 0.482 . . . . 63.42 111.344 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.95 113.4 20.94 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.029 -2.211 . . . . 64.43 105.029 171.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -115.88 96.2 5.48 Favored 'General case' 0 CA--C 1.457 -2.629 0 C-N-CA 116.802 -1.959 . . . . 73.54 110.054 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.627 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 31.7 mm -121.68 155.63 25.93 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.097 0 N-CA-C 103.589 -2.745 . . . . 74.41 103.589 -175.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -58.49 114.65 2.56 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.602 -1.639 . . . . 74.4 107.55 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.627 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 24.4 mt-10 -128.65 130.32 47.08 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-N 115.518 -0.764 . . . . 71.31 109.693 -169.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.69 108.04 8.78 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.057 -0.974 . . . . 74.21 108.508 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.81 49.72 15.57 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 124.537 1.148 . . . . 73.32 110.238 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.54 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 37.2 tt0 -72.15 116.75 12.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.548 -1.649 . . . . 63.04 106.548 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 36.5 p30 -141.29 166.05 25.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.938 0.718 . . . . 74.32 112.938 -172.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.571 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 23.5 p90 -144.39 175.75 9.88 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.241 -0.891 . . . . 74.13 108.665 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.13 136.64 52.84 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.558 -1.275 . . . . 73.44 107.558 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.84 123.52 52.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.865 -1.532 . . . . 75.13 106.865 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -112.66 135.03 53.86 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 123.803 0.689 . . . . 75.12 111.492 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.9 129.15 45.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.967 -1.494 . . . . 72.22 106.967 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.1 t -154.69 -176.82 6.1 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.982 -1.488 . . . . 60.1 106.982 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 50.86 81.77 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 O-C-N 124.488 1.118 . . . . 74.34 112.216 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 41.2 t -82.05 131.55 33.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 114.916 -1.038 . . . . 71.42 109.026 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 107.18 -1.415 . . . . 74.11 107.18 178.599 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.428 -1.553 0 N-CA-C 110.171 -0.307 . . . . 65.34 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -129.15 122.39 29.71 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.397 -1.334 . . . . 74.35 107.397 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.9 m -89.43 121.46 31.69 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.7 -0.4 . . . . 75.14 110.394 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 74.5 t -109.54 110.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.918 -0.771 . . . . 70.33 108.918 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 91.1 m -101.49 121.61 42.29 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 108.882 -0.784 . . . . 72.51 108.882 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.704 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -95.36 117.1 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.099 0 CA-C-N 115.336 -0.847 . . . . 75.04 109.218 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.42 104.21 5.07 Favored 'General case' 0 N--CA 1.389 -3.507 0 CA-C-N 114.693 -1.14 . . . . 73.11 110.499 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 499' ' ' ASP . 4.0 t70 -55.01 -40.92 70.67 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 112.811 -1.995 . . . . 75.35 110.803 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 498' ' ' ASP . 8.8 t70 . . . . . 0 N--CA 1.484 1.237 0 C-N-CA 124.953 1.301 . . . . 75.54 112.117 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp . . . . . 0 N--CA 1.418 -2.047 0 N-CA-C 107.255 -1.387 . . . . 74.03 107.255 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 44.6 mm -106.9 129.36 60.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 108.065 -1.087 . . . . 74.22 108.065 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -159.27 167.8 28.04 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 117.907 0.321 . . . . 74.42 110.924 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -82.52 153.4 25.59 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.828 -0.349 . . . . 72.51 110.124 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.29 -38.72 81.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.333 0.587 . . . . 73.12 109.816 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -130.5 174.21 10.11 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.59 -0.732 . . . . 72.54 112.304 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -104.12 -25.66 7.0 Favored Glycine 0 C--N 1.304 -1.245 0 CA-C-N 115.37 -0.832 . . . . 70.01 111.857 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.6 m -129.38 133.33 47.33 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.252 -0.648 . . . . 72.12 109.252 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 66.2 m-85 -124.62 136.35 53.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.996 -1.113 . . . . 74.23 107.996 176.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.449 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 87.4 mt-30 -129.46 135.34 48.53 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.221 -1.029 . . . . 73.24 108.221 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 37.8 t -148.81 165.0 32.79 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.446 -0.946 . . . . 72.25 108.446 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -79.23 141.17 37.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.417 0.448 . . . . 75.35 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.93 -50.34 72.89 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.755 0.822 . . . . 75.44 110.764 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -77.25 2.56 15.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.519 0.563 . . . . 72.11 112.519 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.14 -20.6 59.31 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.236 0.541 . . . . 71.2 111.017 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.28 -57.14 0.63 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.258 -0.972 . . . . 70.35 113.105 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 14.8 p -139.33 165.35 27.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 117.189 0.495 . . . . 72.52 111.566 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.8 p -122.51 125.72 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 169.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.39 129.29 43.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.197 0.522 . . . . 73.25 110.4 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 392' ' ' LEU . 3.0 mp -121.21 140.91 51.39 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 107.876 -1.157 . . . . 73.33 107.876 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.2 m -108.33 131.52 54.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.92 -0.582 . . . . 72.2 109.511 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.09 125.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.923 -1.139 . . . . 74.31 107.923 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.8 mm -99.73 133.63 41.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.766 -0.828 . . . . 73.21 108.766 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 436' ' ' THR . 58.4 ttt180 -117.53 120.17 37.28 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.316 -0.856 . . . . 75.21 108.773 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 107.732 -1.211 . . . . 75.52 107.732 179.211 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 41.9 m . . . . . 0 N--CA 1.421 -1.885 0 CA-C-O 121.001 0.429 . . . . 73.31 111.517 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.64 146.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.578 -0.737 . . . . 75.4 109.351 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -122.12 125.53 46.38 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.074 0.549 . . . . 73.32 110.292 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.49 130.83 70.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.208 -1.404 . . . . 71.41 107.208 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 15.1 t70 -100.25 135.0 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.688 -0.486 . . . . 71.14 109.688 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.02 153.99 48.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.45 -0.5 . . . . 74.35 110.363 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -163.43 154.57 16.67 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.752 -1.573 . . . . 71.24 106.752 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 30.8 p -96.46 162.55 13.43 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.279 0.562 . . . . 72.23 110.4 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 3.6 mm-40 -105.11 160.58 14.95 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.586 -0.734 . . . . 75.23 109.378 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.31 -37.65 63.56 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.131 -0.94 . . . . 75.2 110.035 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 48.57 -107.74 0.3 Allowed Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.228 -1.351 . . . . 65.0 114.215 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -101.53 5.03 41.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.739 0.781 . . . . 75.55 110.237 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -135.57 -159.53 0.97 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.942 0.897 . . . . 65.21 109.067 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -136.17 126.2 26.06 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.089 0.471 . . . . 73.03 111.616 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . . . -82.18 124.52 29.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.513 -0.921 . . . . 75.42 108.513 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.44 -19.42 36.79 Favored Glycine 0 C--N 1.296 -1.659 0 N-CA-C 110.123 -1.191 . . . . 60.13 110.123 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.6 m -106.94 -56.88 2.14 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.66 -0.496 . . . . 64.21 109.66 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.46 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 2.2 m-20 -84.68 -57.34 3.17 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 122.106 0.955 . . . . 74.44 110.205 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.685 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -140.01 159.78 41.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.24 -0.891 . . . . 74.52 109.002 -178.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.4 tm-20 -76.26 157.88 32.14 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 123.873 0.733 . . . . 72.02 109.794 -173.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.599 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 13.7 p90 -94.21 -16.68 23.44 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.288 0.635 . . . . 72.34 112.669 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.441 HG22 HG23 ' A' ' 442' ' ' VAL 0.303 9.9 t 37.59 67.12 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.66 1.984 . . . . 72.12 114.303 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -79.1 121.16 24.65 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.003 -0.998 . . . . 65.31 109.481 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -163.0 176.73 39.23 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 120.372 -0.918 . . . . 72.15 111.386 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 32.4 m -120.52 136.73 54.69 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.881 -1.155 . . . . 72.15 107.881 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.9 t -95.57 119.17 43.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.902 -1.147 . . . . 75.15 107.902 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 99.6 t -95.83 107.04 19.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 114.704 -1.134 . . . . 75.13 108.798 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 404' ' ' THR . 51.1 m-85 -84.55 95.08 8.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.971 -0.559 . . . . 73.54 110.586 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.49 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 10.4 mtmp? -80.52 167.83 29.94 Favored Pre-proline 0 N--CA 1.432 -1.373 0 CA-C-N 115.487 -0.778 . . . . 71.53 110.156 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -52.66 131.61 42.2 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.371 2.047 . . . . 75.33 111.803 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.66 -21.49 32.67 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.851 -0.613 . . . . 62.32 113.37 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 38.0 mt-10 -81.17 63.9 5.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.171 0.986 . . . . 72.22 112.647 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 21.4 m -67.49 -11.33 57.68 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.2 -1.364 . . . . 73.1 110.069 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -139.14 136.55 35.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.497 -0.927 . . . . 73.44 108.497 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -126.14 155.12 42.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.294 0.092 . . . . 72.02 111.05 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.22 138.04 54.12 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.807 -0.357 . . . . 71.33 110.801 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 39.9 pt -125.68 153.97 34.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.635 -0.876 . . . . 72.45 108.635 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 56.5 mtm180 -130.4 138.32 50.29 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.911 0.386 . . . . 74.42 110.865 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.49 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 58.6 t -106.54 122.25 60.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.838 -1.171 . . . . 70.41 107.838 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.88 130.7 10.71 Favored Glycine 0 N--CA 1.434 -1.453 0 O-C-N 123.583 0.552 . . . . 71.1 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 496' ' ' ILE . 38.0 mm -88.98 143.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.527 -1.657 . . . . 74.54 106.527 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.2 mt -102.04 145.94 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 N-CA-C 107.368 -1.345 . . . . 73.04 107.368 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.26 85.99 1.43 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.508 0.67 . . . . 73.5 111.497 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.55 120.22 36.1 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 105.175 -2.158 . . . . 72.54 105.175 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -122.57 95.3 4.58 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 116.951 -1.9 . . . . 74.35 110.554 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.649 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 34.3 mm -118.62 155.9 20.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.348 0 N-CA-C 103.61 -2.737 . . . . 71.11 103.61 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -56.89 114.6 2.16 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.058 -1.457 . . . . 74.12 107.119 171.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.649 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 29.0 mt-10 -127.19 133.94 50.22 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-N 116.06 -0.518 . . . . 73.54 109.7 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.48 112.48 7.66 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.475 -0.935 . . . . 74.22 108.475 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 33.5 t70 50.56 61.53 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.855 0.862 . . . . 64.24 112.8 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.32 123.47 41.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 118.729 -1.188 . . . . 71.4 110.932 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.28 174.36 10.64 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.87 -1.059 . . . . 73.31 110.54 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.549 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 26.0 p90 -148.0 -178.54 6.34 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.746 -1.115 . . . . 71.41 108.042 172.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -123.79 136.72 54.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.284 -1.006 . . . . 75.51 108.284 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.4 122.03 59.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.903 -1.517 . . . . 70.13 106.903 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.82 152.86 31.43 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.712 0.632 . . . . 75.14 110.005 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.48 121.43 44.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.893 -0.78 . . . . 74.02 108.893 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 46.8 m -131.1 -178.11 4.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.429 -0.952 . . . . 70.41 108.429 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 39.45 82.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.143 1.377 . . . . 74.02 112.348 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.75 123.02 44.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 119.168 -1.013 . . . . 73.41 108.911 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 C--N 1.286 -2.167 0 CA-C-N 114.926 -1.034 . . . . 75.21 109.453 -177.1 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.412 -2.36 0 N-CA-C 109.174 -0.676 . . . . 74.13 109.174 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -102.22 115.06 29.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.944 -1.132 . . . . 64.51 107.944 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 20.7 m -89.2 121.08 31.16 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.1 -0.704 . . . . 75.11 109.1 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 92.6 t -108.81 106.03 19.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.987 -0.551 . . . . 61.13 109.727 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 88.2 m -92.9 118.85 31.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.348 -0.982 . . . . 74.2 108.348 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.685 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -95.17 120.36 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 N-CA-C 108.946 -0.761 . . . . 74.23 108.946 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . 0.316 26.1 m-85 -84.37 102.7 12.94 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-O 122.233 1.016 . . . . 74.14 113.624 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.02 -54.11 27.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 111.779 -2.464 . . . . 61.44 109.435 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.478 0.955 0 CA-C-N 114.578 -1.192 . . . . 72.34 111.507 174.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 97.0 mttt . . . . . 0 N--CA 1.425 -1.702 0 N-CA-C 112.046 0.387 . . . . 74.25 112.046 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 18.6 mm -104.36 121.12 55.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.027 -1.101 . . . . 72.14 108.027 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -150.49 168.34 24.5 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.153 -0.619 . . . . 72.15 112.235 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -80.91 145.72 31.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.588 -0.523 . . . . 75.1 109.588 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.532 ' HB3' ' OH ' ' A' ' 381' ' ' TYR . 37.2 tt0 -58.4 -59.03 5.99 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.847 0.859 . . . . 72.4 109.746 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.514 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.8 mm100 -104.87 179.98 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.343 -0.844 . . . . 65.44 110.332 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -109.13 -22.2 6.98 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 109.687 -1.365 . . . . 65.34 109.687 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' THR . 38.5 m -143.23 132.16 22.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 115.059 -0.571 . . . . 60.13 109.607 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.532 ' OH ' ' HB3' ' A' ' 377' ' ' GLU . 48.7 m-85 -118.98 147.83 43.64 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.159 -1.052 . . . . 74.41 108.159 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 495' ' ' THR . 40.1 mt-30 -130.74 133.55 46.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.041 -1.096 . . . . 71.13 108.041 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.6 p -140.06 157.39 45.72 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 109.123 -0.695 . . . . 72.12 109.123 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -81.15 143.7 32.2 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.02 -0.733 . . . . 74.02 109.02 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.88 -31.18 70.67 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.355 0.662 . . . . 75.23 110.833 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.452 ' C ' HD21 ' A' ' 386' ' ' ASN . 0.2 OUTLIER -80.94 -2.26 46.98 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.831 -0.622 . . . . 72.24 112.496 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.7 t -68.9 -33.2 73.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.808 0.337 . . . . 72.32 111.685 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 100.78 -58.04 0.71 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.886 -0.886 . . . . 61.13 110.886 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 13.8 p -137.79 154.35 49.57 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.003 -0.369 . . . . 73.43 110.003 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.9 p -110.22 130.52 63.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.042 -1.096 . . . . 62.33 108.042 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -100.54 119.34 38.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.997 0.427 . . . . 75.34 110.26 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.432 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.7 mp -113.14 157.14 22.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.862 -1.532 . . . . 71.33 106.862 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.1 m -120.54 137.01 54.61 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.232 -0.587 . . . . 73.25 110.5 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.8 mt -101.56 121.43 52.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.386 -1.338 . . . . 74.34 107.386 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.55 115.38 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 108.248 -1.019 . . . . 74.12 108.248 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 436' ' ' THR . 52.7 ttt-85 -105.84 129.27 54.05 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.726 -1.212 . . . . 74.4 107.726 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 109.084 -0.709 . . . . 75.15 109.084 179.189 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.423 -1.794 0 CA-C-O 121.373 0.606 . . . . 74.34 110.967 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 52.6 t -106.68 148.89 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.062 -0.972 . . . . 71.43 108.67 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.594 ' CE2' HG21 ' A' ' 430' ' ' VAL . 25.8 m-85 -131.41 142.55 50.05 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.037 0.446 . . . . 73.23 110.706 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.89 137.82 24.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.017 -1.475 . . . . 65.34 107.017 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -101.36 138.5 38.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.189 -0.671 . . . . 72.22 109.189 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.42 150.5 45.56 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.325 -0.991 . . . . 72.33 108.325 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . 0.436 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 10.0 ttm180 -157.85 150.42 22.63 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.446 -0.946 . . . . 73.44 108.446 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 31.9 p -96.75 156.86 16.17 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.183 -0.607 . . . . 72.2 110.319 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 11.5 tp10 -114.36 150.19 34.96 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.475 -1.676 . . . . 71.21 106.475 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 24.4 m-20 -53.86 -44.77 70.66 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.829 0.823 . . . . 71.44 112.2 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.97 3.55 Favored Glycine 0 N--CA 1.42 -2.408 0 CA-C-N 114.299 -1.319 . . . . 71.22 110.351 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 455' ' ' ASN . 9.9 t -104.99 -9.32 17.98 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.83 -0.804 . . . . 75.34 108.83 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -117.72 -159.22 0.74 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.302 -0.999 . . . . 72.22 108.302 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.416 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 3.4 m120 -131.38 127.68 38.06 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 112.878 0.696 . . . . 70.43 112.878 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.105 -1.072 . . . . 74.34 108.105 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.75 56.95 Favored Glycine 0 C--N 1.295 -1.728 0 N-CA-C 110.513 -1.035 . . . . 70.34 110.513 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.1 m -128.88 -54.79 1.21 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.155 -0.313 . . . . 74.21 110.155 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.503 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 18.2 m-20 -84.25 -53.05 5.76 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.814 0.816 . . . . 72.53 108.977 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.637 ' CE2' HD12 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -139.93 166.09 25.57 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.54 159.68 30.13 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.662 -0.866 . . . . 72.14 108.662 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.531 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -97.44 -17.69 19.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.01 0.524 . . . . 75.1 111.853 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.421 HG21 HG21 ' A' ' 442' ' ' VAL . 6.4 t 40.92 56.44 2.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.576 1.95 . . . . 73.24 113.24 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 9.4 pt-20 -77.55 108.96 11.1 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.225 1.012 . . . . 73.21 109.213 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.6 163.71 28.49 Favored Glycine 0 N--CA 1.411 -2.998 0 CA-C-N 114.905 -1.043 . . . . 71.05 110.904 -176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 11.0 m -108.71 134.23 51.71 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 108.049 -1.093 . . . . 74.21 108.049 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 48.8 t -94.78 125.24 47.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.399 -0.963 . . . . 64.44 108.399 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . 0.594 HG21 ' CE2' ' A' ' 406' ' ' PHE . 37.2 t -99.42 112.28 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 CA-C-N 114.761 -1.109 . . . . 75.44 108.392 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -83.48 105.54 14.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.3 -1.0 . . . . 71.32 108.3 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 1.0 OUTLIER -79.58 163.94 56.26 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.913 -1.039 . . . . 73.13 111.465 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.0 Cg_exo -51.41 118.1 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 123.247 2.631 . . . . 73.43 111.303 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.87 -15.96 49.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.924 -0.58 . . . . 75.23 113.88 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.8 63.65 7.56 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.393 0.886 . . . . 64.43 113.393 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 19.3 m -53.86 -24.78 16.93 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 114.496 -1.229 . . . . 74.1 112.092 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -116.23 145.27 43.26 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.763 -0.828 . . . . 62.52 108.763 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -134.48 147.55 50.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.02 0.378 . . . . 70.43 112.02 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.29 141.01 37.56 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.683 -0.689 . . . . 74.51 109.543 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.1 pt -128.42 148.44 32.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.709 -0.849 . . . . 74.12 108.709 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 73.9 mtm180 -129.02 142.66 50.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.361 0.601 . . . . 73.34 111.191 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.533 HG13 ' CZ ' ' A' ' 456' ' ' PHE . 46.1 t -116.42 124.37 72.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.503 -1.295 . . . . 74.1 107.503 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -75.71 141.67 27.77 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.989 -0.624 . . . . 71.41 112.368 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 36.6 mm -99.47 136.91 28.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.892 -1.151 . . . . 73.45 107.892 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.3 mt -98.19 148.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.48 -1.674 . . . . 74.35 106.48 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.47 86.59 5.77 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.287 -0.565 . . . . 73.03 110.707 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.0 118.66 37.03 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 103.936 -2.616 . . . . 63.51 103.936 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.258 10.7 t70 -121.21 92.5 3.77 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.493 -2.083 . . . . 75.22 110.966 176.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.6 mm -120.23 156.62 23.1 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.357 0 CA-C-N 111.018 -2.81 . . . . 71.54 103.825 -175.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -53.62 114.0 1.38 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.625 -1.62 . . . . 73.0 106.625 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.714 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 35.5 mt-10 -121.18 113.04 19.42 Favored 'General case' 0 CA--C 1.468 -2.208 0 CA-C-O 121.56 0.695 . . . . 60.52 110.532 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -117.81 100.55 7.66 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.691 -1.14 . . . . 75.11 109.767 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 51.75 40.89 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.447 -1.251 . . . . 74.33 113.393 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.449 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.7 pt-20 -70.12 131.84 44.91 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 119.945 -0.702 . . . . 62.55 109.81 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.2 OUTLIER -150.13 161.22 42.8 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.446 0.535 . . . . 73.44 112.446 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.533 ' CZ ' HG13 ' A' ' 442' ' ' VAL . 35.3 p90 -131.96 -179.56 5.48 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.377 -0.374 . . . . 75.42 110.611 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 47.4 mt -121.34 138.49 54.23 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.457 -0.942 . . . . 75.41 108.457 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . 0.406 ' HB ' ' HB1' ' A' ' 492' ' ' ALA . 23.0 t -111.06 129.59 66.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.34 -1.356 . . . . 72.21 107.34 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -122.67 165.75 16.01 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 123.574 0.546 . . . . 64.24 109.712 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.52 139.36 51.58 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.198 0.523 . . . . 74.53 110.536 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 37.3 m -150.57 -179.28 7.1 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.271 -1.011 . . . . 74.03 108.271 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.8 t30 45.7 88.39 0.02 OUTLIER 'General case' 0 C--O 1.248 1.02 0 C-N-CA 124.815 1.246 . . . . 73.22 113.856 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.3 123.8 42.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.219 -0.992 . . . . 75.2 108.779 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.6 mttm . . . . . 0 C--N 1.29 -1.978 0 CA-C-O 121.501 0.667 . . . . 73.45 110.421 179.581 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.41 -2.44 0 N-CA-C 109.166 -0.679 . . . . 73.33 109.166 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . 0.406 ' HB1' ' HB ' ' A' ' 458' ' ' VAL . . . -112.06 106.78 15.51 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.714 -1.217 . . . . 62.13 107.714 170.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 380' ' ' THR . 27.0 m -82.0 121.9 27.11 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.69 -0.485 . . . . 74.4 109.69 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 86.6 t -107.75 107.89 23.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.492 -0.929 . . . . 72.1 108.492 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 66.9 m -98.39 113.44 25.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.895 -0.779 . . . . 74.24 108.895 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.637 HD12 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -91.3 120.5 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.556 0.693 . . . . 75.11 110.767 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.01 101.63 13.09 Favored 'General case' 0 N--CA 1.394 -3.273 0 CA-C-N 115.013 -0.994 . . . . 72.4 110.999 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.6 -53.42 52.05 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.547 -2.115 . . . . 72.43 108.974 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 125.571 1.548 . . . . 74.12 112.1 177.311 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 95.6 mttt . . . . . 0 N--CA 1.435 -1.221 0 CA-C-O 120.861 0.363 . . . . 74.25 111.445 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.23 121.41 67.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.143 -1.058 . . . . 71.45 108.143 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -154.1 172.12 18.04 Favored 'General case' 0 C--O 1.193 -1.894 0 N-CA-C 112.195 0.443 . . . . 64.45 112.195 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -85.49 153.36 22.51 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.594 -0.442 . . . . 71.24 110.491 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.46 -36.79 81.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.46 0.648 . . . . 74.42 109.582 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -128.59 172.3 11.32 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.227 -0.897 . . . . 72.13 111.792 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.41 -32.3 4.93 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 114.881 -1.054 . . . . 63.25 110.966 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.3 m -130.39 125.5 34.7 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.389 -0.597 . . . . 72.43 109.389 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.17 140.69 48.33 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.449 -0.945 . . . . 75.43 108.449 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 495' ' ' THR . 37.9 mt-30 -123.96 135.52 53.71 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.404 -1.332 . . . . 75.11 107.404 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 29.7 t -146.48 165.86 28.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.279 -1.008 . . . . 74.12 108.279 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -91.14 145.54 24.59 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.634 -0.506 . . . . 71.31 109.634 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 498' ' ' ASP . 18.1 tt0 -55.66 -54.86 39.05 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.778 0.831 . . . . 75.44 110.723 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.37 8.34 2.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.765 1.024 . . . . 73.03 113.765 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.89 -31.05 68.64 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.538 -0.541 . . . . 74.52 109.538 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.64 -60.38 0.52 Allowed Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.425 -0.893 . . . . 63.22 111.245 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 12.7 p -138.02 152.1 48.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 110.348 -0.242 . . . . 74.04 110.348 176.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.6 p -108.15 124.22 64.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.559 -1.274 . . . . 74.53 107.559 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.16 118.92 34.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.309 0.576 . . . . 71.35 110.815 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.421 HD11 ' N ' ' A' ' 392' ' ' LEU . 3.2 mp -110.93 149.99 29.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.511 -1.292 . . . . 72.24 107.511 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.4 m -116.37 125.45 52.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.235 0.54 . . . . 71.54 110.462 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 77.6 mt -97.24 123.98 49.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.346 -1.353 . . . . 73.43 107.346 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.7 mm -102.16 129.93 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-N 115.205 -0.907 . . . . 75.42 108.775 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 35.9 ttt180 -112.06 108.62 17.99 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.424 -0.807 . . . . 75.0 108.873 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 . . . . . 0 CA--C 1.487 -1.462 0 CA-C-N 116.135 -0.484 . . . . 74.33 109.755 -178.809 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 7.0 m . . . . . 0 N--CA 1.416 -2.129 0 CA-C-O 121.623 0.725 . . . . 72.21 109.832 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.87 137.25 56.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.307 -0.86 . . . . 72.11 109.132 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' A' ' 430' ' ' VAL . 17.9 m-85 -119.93 137.1 54.24 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.582 -0.896 . . . . 75.01 108.582 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.18 128.76 49.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 107.619 -1.252 . . . . 73.35 107.619 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.5 153.68 20.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.714 -0.476 . . . . 63.11 109.714 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -146.95 161.54 40.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.232 -0.293 . . . . 65.31 110.435 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -161.03 163.0 31.91 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 107.311 -1.366 . . . . 75.23 107.311 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.605 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 49.4 p -95.71 172.54 7.98 Favored 'General case' 0 C--O 1.26 1.656 0 N-CA-C 108.34 -0.985 . . . . 64.51 108.34 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -121.72 151.61 40.32 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 120.218 -0.593 . . . . 63.02 111.339 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 3.49 8.68 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 125.734 1.613 . . . . 71.33 113.045 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.85 -92.02 0.01 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 116.917 1.527 . . . . 71.43 116.917 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.3 t -101.85 9.58 40.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.212 1.006 . . . . 73.42 111.096 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -147.03 -157.58 0.82 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.492 -0.929 . . . . 41.32 108.492 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -145.17 124.37 12.94 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.95 -1.1 . . . . 63.1 111.768 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.28 124.65 25.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.255 -0.884 . . . . 74.1 108.889 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.48 -16.02 41.53 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.963 -1.255 . . . . 73.33 109.963 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 48.1 t -110.48 -58.71 2.04 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.379 -0.6 . . . . 64.14 109.379 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.563 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 15.4 m-20 -86.28 -58.39 2.65 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-O 122.261 1.029 . . . . 74.43 109.418 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.695 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.11 163.43 32.45 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.086 -0.961 . . . . 75.22 109.48 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -72.94 151.94 41.63 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 123.879 0.737 . . . . 74.31 110.735 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.605 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.1 p90 -80.54 -21.62 41.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.747 -0.661 . . . . 70.32 112.654 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 442' ' ' VAL 0.255 13.8 t 36.69 67.16 0.35 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.647 1.579 . . . . 74.13 113.754 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -87.86 113.15 23.24 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.098 -0.956 . . . . 65.42 108.756 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.65 -173.86 23.26 Favored Glycine 0 CA--C 1.482 -2.025 0 C-N-CA 120.492 -0.861 . . . . 70.43 111.365 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.7 m -120.51 137.16 54.52 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.501 -0.926 . . . . 71.1 108.501 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.56 123.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.929 -1.137 . . . . 72.42 107.929 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . 0.445 HG21 ' CE2' ' A' ' 406' ' ' PHE . 16.2 t -103.66 109.6 27.58 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-O 121.389 0.614 . . . . 74.44 111.047 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 404' ' ' THR . 55.7 m-85 -94.14 100.02 12.19 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.699 -0.682 . . . . 74.22 111.064 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.8 mttt -94.53 172.1 5.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 114.263 -1.335 . . . . 75.21 110.343 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 44.5 Cg_exo -58.73 126.17 20.44 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.868 2.379 . . . . 75.32 112.173 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.84 -2.04 87.07 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.601 -0.809 . . . . 61.33 114.359 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 437' ' ' GLN . 19.6 mm-40 -73.24 -70.16 0.38 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 117.654 0.727 . . . . 72.01 110.447 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 54.5 m 71.26 -35.33 0.33 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.686 0.795 . . . . 63.51 112.122 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 435' ' ' GLU . 35.8 mt-30 -125.95 140.1 52.9 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.515 -1.291 . . . . 74.12 107.515 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -132.93 143.67 49.64 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.417 -0.356 . . . . 75.52 110.322 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -106.0 134.64 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.495 -0.928 . . . . 65.22 108.495 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.4 pt -123.14 148.54 26.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.437 -1.32 . . . . 73.14 107.437 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 75.5 mtt180 -129.0 138.18 51.78 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.363 0.602 . . . . 75.41 111.93 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.658 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 52.1 t -109.62 119.0 58.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.732 -1.122 . . . . 72.21 108.628 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -66.03 132.55 33.83 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 124.192 0.933 . . . . 61.02 112.236 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . 0.4 HG21 HD12 ' A' ' 444' ' ' ILE . 31.8 mm -97.71 135.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.169 -1.419 . . . . 70.2 107.169 175.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 76.0 mt -101.72 150.57 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 106.948 -1.501 . . . . 73.4 106.948 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.23 95.47 6.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.365 -0.534 . . . . 75.03 111.317 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -122.61 128.1 50.25 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 103.539 -2.763 . . . . 72.42 103.539 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -126.54 99.85 5.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 C-N-CA 116.999 -1.881 . . . . 75.04 110.149 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.746 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -131.04 158.27 43.3 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.118 0 CA-C-N 111.077 -2.783 . . . . 72.22 105.03 -171.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -53.16 114.82 1.6 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 116.721 -1.992 . . . . 70.24 106.397 166.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.746 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.6 mt-10 -125.23 97.17 5.11 Favored 'General case' 0 CA--C 1.458 -2.571 0 N-CA-C 107.856 -1.164 . . . . 74.13 107.856 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -117.84 113.47 21.83 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 108.192 -1.04 . . . . 75.23 108.192 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 31.38 20.41 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.114 0.884 . . . . 71.23 111.366 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.477 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.0 tt0 -65.32 106.57 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.27 -1.381 . . . . 71.4 107.27 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -141.2 169.68 17.15 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.65 -0.704 . . . . 63.22 109.846 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.658 ' CZ ' HG12 ' A' ' 442' ' ' VAL . 22.5 p90 -143.35 170.44 15.76 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.749 -0.834 . . . . 74.14 108.749 173.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.74 136.5 50.92 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.058 -1.46 . . . . 73.23 107.058 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.58 124.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 106.806 -1.553 . . . . 71.11 106.806 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -120.37 142.8 48.84 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.652 -0.704 . . . . 74.11 109.242 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.5 138.13 33.61 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.931 -1.878 . . . . 73.22 105.931 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 26.0 m -148.09 155.1 41.06 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.89 -0.781 . . . . 72.31 108.89 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.5 t30 57.56 92.38 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 O-C-N 124.543 1.152 . . . . 62.43 111.95 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.75 142.46 14.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.391 -0.966 . . . . 74.1 108.391 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 464' ' ' LYS . 32.6 ttmt . . . . . 0 N--CA 1.429 -1.52 0 N-CA-C 109.3 -0.63 . . . . 73.51 109.3 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.425 -1.687 0 N-CA-C 109.25 -0.648 . . . . 62.52 109.25 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -107.59 118.66 37.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.331 -0.989 . . . . 73.15 108.331 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 23.6 m -88.25 119.51 28.73 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.814 0.34 . . . . 65.34 110.47 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.406 HG12 HG13 ' A' ' 390' ' ' VAL . 68.4 t -104.61 106.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.424 -0.954 . . . . 75.35 108.424 176.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 27.6 m -95.53 114.23 25.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.131 -1.063 . . . . 72.14 108.131 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.695 HD11 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -92.21 117.59 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 C-N-CA 120.326 -0.55 . . . . 72.22 110.411 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.446 ' O ' HD11 ' A' ' 384' ' ' LEU . 18.3 m-85 -78.42 103.06 8.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 107.621 -1.252 . . . . 73.55 107.621 170.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 385' ' ' GLU . 0.0 OUTLIER -63.06 -30.81 71.89 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.283 -1.781 . . . . 74.21 109.459 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 125.521 1.528 . . . . 74.52 110.849 174.808 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 120.798 0.333 . . . . 74.33 110.216 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 44.7 mm -109.38 112.62 41.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.162 -1.421 . . . . 62.24 107.162 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -145.53 160.44 41.62 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.836 -0.746 . . . . 73.53 112.609 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.06 142.76 39.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.31 -0.626 . . . . 75.13 109.31 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.21 -48.69 80.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.806 0.842 . . . . 74.52 110.093 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.546 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 16.2 mm100 -106.25 172.4 6.83 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.816 0.817 . . . . 65.15 110.649 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.11 -34.04 4.99 Favored Glycine 0 C--N 1.284 -2.327 0 CA-C-N 114.129 -1.396 . . . . 70.44 110.167 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 42.2 m -132.93 128.43 36.47 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.226 -1.028 . . . . 54.43 108.226 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 37.3 m-85 -112.06 136.84 50.91 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.761 -0.829 . . . . 63.51 108.761 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -126.61 142.49 51.52 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 19.5 t -153.68 165.1 37.01 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.278 -1.378 . . . . 73.22 107.278 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -86.18 141.99 28.94 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.584 -0.525 . . . . 75.22 109.584 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -55.55 -38.2 69.0 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.378 1.071 . . . . 75.21 110.128 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -84.83 7.03 22.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.04 -0.982 . . . . 71.23 111.999 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.5 t -90.45 -1.03 57.89 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 122.02 -0.425 . . . . 75.14 111.213 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.27 4.5 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 64.33 113.117 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 22.1 p -142.91 174.26 10.82 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.314 0.578 . . . . 73.1 110.843 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.6 p -125.61 125.9 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 106.802 -1.555 . . . . 74.23 106.802 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.33 122.69 41.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.996 0.427 . . . . 73.0 110.118 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.522 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.3 mp -112.45 146.42 38.43 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.05 -1.092 . . . . 74.24 108.05 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.2 m -112.46 128.53 56.35 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.448 0.467 . . . . 74.55 109.748 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 62.2 mt -100.45 121.74 51.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.17 -1.419 . . . . 74.41 107.17 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.2 mm -99.2 132.3 44.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.754 -0.832 . . . . 73.41 108.754 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -107.52 122.83 47.44 Favored 'General case' 0 N--CA 1.406 -2.666 0 C-N-CA 119.702 -0.799 . . . . 75.02 110.549 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 . . . . . 0 C--N 1.284 -2.266 0 CA-C-N 115.363 -0.835 . . . . 74.44 108.965 176.262 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 50.7 m . . . . . 0 N--CA 1.439 -0.998 0 CA-C-O 121.492 0.663 . . . . 74.31 111.512 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.6 t -112.26 146.92 16.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.047 -0.524 . . . . 74.31 109.83 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.608 ' CE1' HG12 ' A' ' 430' ' ' VAL . 3.7 m-85 -120.59 129.14 53.63 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.11 0.564 . . . . 73.24 110.66 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.81 135.95 52.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.589 -1.263 . . . . 74.41 107.589 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 18.2 t70 -102.52 148.73 25.18 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.061 -0.718 . . . . 73.53 109.061 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -143.94 159.36 42.71 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.038 -0.665 . . . . 74.44 110.868 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -163.17 160.91 24.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.37 -1.715 . . . . 75.3 106.37 173.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.621 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 34.9 p -96.95 164.81 12.38 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.426 0.631 . . . . 73.12 110.581 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.4 tp10 -106.53 152.59 23.48 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.214 -1.402 . . . . 64.2 107.214 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 4.8 m-20 -60.01 -40.51 89.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.915 0.864 . . . . 71.52 110.493 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 67.69 -86.51 0.16 Allowed Glycine 0 C--N 1.299 -1.495 0 CA-C-N 114.355 -1.293 . . . . 73.21 112.964 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.1 t -135.71 11.5 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.657 -0.868 . . . . 74.12 108.657 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -141.3 -162.87 1.45 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.698 -1.593 . . . . 65.33 106.698 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 7.3 m120 -129.29 116.35 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.583 0.706 . . . . 74.02 112.141 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -78.03 124.5 28.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.903 -1.044 . . . . 71.43 108.898 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.35 -12.25 30.94 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 109.668 -1.373 . . . . 74.3 109.668 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 16.3 t -126.87 -54.84 1.4 Allowed 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.917 -0.313 . . . . 74.21 110.993 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.605 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -73.06 -58.46 3.3 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 122.4 1.095 . . . . 70.43 108.074 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.21 161.78 36.58 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.126 -1.397 . . . . 74.25 107.631 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.6 157.33 32.04 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.566 0.541 . . . . 75.1 109.649 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.621 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 15.6 p90 -90.6 -9.69 46.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.215 0.45 . . . . 74.41 112.215 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 425' ' ' THR . 12.7 t 37.34 68.67 0.27 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.052 1.741 . . . . 72.5 113.728 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -80.3 134.79 36.11 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.023 -1.071 . . . . 75.33 109.128 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -175.03 -178.54 44.97 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.677 -0.969 . . . . 72.32 110.677 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 18.3 m -125.73 139.97 53.08 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.789 -1.189 . . . . 74.24 107.789 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.1 t -99.42 119.43 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.922 -0.769 . . . . 74.14 108.922 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . 0.608 HG12 ' CE1' ' A' ' 406' ' ' PHE . 53.6 t -100.71 106.65 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.575 -0.898 . . . . 64.01 108.575 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 404' ' ' THR . 58.9 m-85 -79.17 95.0 5.49 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.736 -0.665 . . . . 74.35 110.075 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -69.46 164.58 48.36 Favored Pre-proline 0 C--N 1.316 -0.852 0 O-C-N 123.58 0.55 . . . . 75.22 111.549 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.41 113.51 1.16 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.739 2.293 . . . . 75.35 111.797 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.1 67.5 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.742 -0.742 . . . . 73.51 113.399 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -88.25 62.02 6.51 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.558 0.694 . . . . 74.03 110.691 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 m -61.47 -23.31 65.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.813 -1.085 . . . . 72.13 110.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -131.38 132.26 44.28 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.58 -1.267 . . . . 75.35 107.58 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 25.8 mmmt -122.32 149.8 43.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.484 0.55 . . . . 74.22 112.484 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -114.51 125.59 53.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.381 -0.827 . . . . 74.05 111.122 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.8 pt -116.84 146.57 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.043 -1.095 . . . . 72.31 108.043 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 71.2 mtt180 -126.01 141.45 51.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.374 -0.53 . . . . 74.01 110.8 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.572 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -106.22 121.2 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.442 -0.947 . . . . 64.42 108.442 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -62.07 125.01 35.31 Favored Glycine 0 N--CA 1.435 -1.423 0 O-C-N 124.134 0.896 . . . . 70.11 112.068 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.92 135.27 29.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.988 -1.486 . . . . 74.33 106.988 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.9 mt -103.19 151.08 6.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.169 -1.419 . . . . 74.32 107.169 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.98 101.31 8.57 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 121.3 0.571 . . . . 75.33 110.536 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 123.15 29.57 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 103.771 -2.677 . . . . 65.35 103.771 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.256 19.6 t70 -119.78 97.58 5.7 Favored 'General case' 0 CA--C 1.459 -2.553 0 C-N-CA 116.393 -2.123 . . . . 74.02 111.932 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -121.45 156.49 25.36 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.439 0 CA-C-N 111.282 -2.69 . . . . 75.23 104.727 -174.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -53.87 115.32 1.95 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.862 -1.903 . . . . 75.45 105.862 168.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 33.1 mt-10 -123.38 90.71 3.33 Favored 'General case' 0 CA--C 1.483 -1.605 0 CA-C-O 122.069 0.937 . . . . 61.41 111.104 -170.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -93.58 104.94 17.03 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.005 -1.452 . . . . 72.33 107.738 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.308 7.9 p-10 42.28 60.34 2.35 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 125.095 1.497 . . . . 61.34 112.9 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.549 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 33.1 tt0 -74.45 113.96 12.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.683 -1.599 . . . . 64.42 106.683 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -137.13 171.35 14.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.57 0.7 . . . . 74.41 112.729 -174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.581 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 28.5 p90 -146.62 -177.78 5.82 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.861 -1.063 . . . . 72.43 109.665 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 26.6 mt -123.32 141.57 51.85 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.015 -1.106 . . . . 64.32 108.015 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.56 130.85 63.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.199 -1.408 . . . . 72.43 107.199 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -124.17 134.2 53.37 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.498 0.499 . . . . 64.52 110.76 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.412 ' C ' ' HG ' ' A' ' 461' ' ' SER . 91.0 mt -95.86 140.62 30.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.048 -1.093 . . . . 73.02 108.048 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 460' ' ' LEU . 49.1 m -155.3 -177.79 6.8 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.693 -0.854 . . . . 72.04 108.693 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 51.11 83.84 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.651 1.18 . . . . 74.25 111.599 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.61 126.4 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.581 -0.848 . . . . 74.04 109.178 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 116.049 -0.523 . . . . 71.15 110.123 -178.547 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 63.4 m . . . . . 0 N--CA 1.423 -1.776 0 CA-C-O 120.832 0.348 . . . . 71.01 110.554 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -126.82 135.4 50.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.118 -1.438 . . . . 75.23 107.118 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 88.1 m -96.12 129.99 43.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.656 -0.498 . . . . 75.53 109.656 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 390' ' ' VAL . 69.0 t -115.31 109.37 28.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.587 -0.894 . . . . 75.51 108.587 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 35.6 m -101.55 117.12 34.27 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.457 -0.942 . . . . 74.54 108.457 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.725 HD11 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.4 125.08 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.267 0 CA-C-N 115.957 -0.565 . . . . 70.11 109.693 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.498 ' O ' HD11 ' A' ' 384' ' ' LEU . 12.0 m-85 -84.69 104.26 14.51 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-O 121.799 0.809 . . . . 74.31 111.693 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 451' ' ' GLU . 6.2 t70 -49.01 -58.52 4.76 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.721 -2.491 . . . . 73.35 109.475 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.8 t0 . . . . . 0 C--N 1.311 -1.068 0 C-N-CA 125.852 1.661 . . . . 73.53 111.043 177.077 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 94.3 mttt . . . . . 0 N--CA 1.418 -2.036 0 CA-C-O 121.545 0.688 . . . . 72.11 111.293 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 21.8 mm -104.73 121.45 56.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.725 -1.58 . . . . 74.01 108.41 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -157.51 155.16 29.83 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 117.612 0.187 . . . . 75.11 110.658 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -73.87 152.44 40.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.841 0.353 . . . . 72.44 110.981 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.02 -30.1 70.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.649 -0.705 . . . . 74.02 110.768 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -127.71 176.93 7.15 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.76 -0.654 . . . . 73.04 111.464 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.94 -36.38 3.96 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.941 -0.863 . . . . 74.53 110.941 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 49.9 m -129.46 131.81 46.8 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.338 -0.615 . . . . 73.34 109.338 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 49.9 m-85 -114.48 135.97 53.53 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.316 -0.994 . . . . 73.44 108.316 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -125.54 138.91 53.97 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.919 -0.771 . . . . 72.41 108.919 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . 0.639 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.2 p -145.82 155.37 42.87 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.525 -0.546 . . . . 75.24 109.525 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -74.67 141.98 44.52 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.243 -0.651 . . . . 75.41 109.243 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -55.41 -45.76 76.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.927 0.87 . . . . 72.21 109.165 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.405 ' OD1' HD13 ' A' ' 384' ' ' LEU . 2.6 p-10 -82.37 21.54 0.93 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.968 -1.015 . . . . 71.44 112.813 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.28 0.64 46.03 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 121.621 -0.674 . . . . 74.12 112.035 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.82 -71.63 2.57 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.497 -0.859 . . . . 71.24 112.794 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 17.6 p -137.25 159.4 42.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.766 0.283 . . . . 70.42 110.784 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.639 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 5.4 p -112.59 125.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.524 -1.287 . . . . 61.34 107.524 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.55 127.8 43.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.149 -0.478 . . . . 73.2 110.074 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.437 HD11 ' N ' ' A' ' 392' ' ' LEU . 2.3 mp -121.22 138.38 54.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.922 -1.51 . . . . 74.53 106.922 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.4 m -109.8 127.29 54.56 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.408 0.443 . . . . 71.43 110.27 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.22 125.5 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.908 -1.145 . . . . 72.43 107.908 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.38 140.95 19.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 107.68 -1.23 . . . . 73.43 107.68 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 47.5 ttp85 -120.89 109.29 14.94 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.789 -0.449 . . . . 75.33 109.789 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 . . . . . 0 CA--C 1.511 -0.529 0 CA-C-N 115.861 -0.608 . . . . 73.21 110.528 -175.357 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.398 -3.049 0 CA-C-O 121.408 0.623 . . . . 64.31 111.443 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.66 139.55 21.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.12 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 3.0 m-85 -121.81 123.23 41.3 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 123.667 0.787 . . . . 73.53 110.048 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.78 128.69 72.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.292 -1.373 . . . . 74.52 107.292 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 15.7 t70 -98.73 140.33 33.09 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.092 -0.38 . . . . 74.42 110.434 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -134.85 162.73 31.57 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.683 0.278 . . . . 74.24 110.514 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 42.9 ttt180 -166.82 162.71 16.18 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.591 -1.633 . . . . 73.34 106.591 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.597 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 59.8 p -95.6 172.12 8.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.65 -0.87 . . . . 71.23 108.65 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.34 145.92 50.63 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.7 -0.482 . . . . 74.43 109.7 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.1 4.2 5.9 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.124 1.37 . . . . 74.21 113.697 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -17.97 -88.92 0.01 OUTLIER Glycine 0 N--CA 1.479 1.541 0 C-N-CA 126.141 1.829 . . . . 71.21 117.113 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 13.9 t -109.79 5.31 22.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 117.89 0.845 . . . . 71.41 110.532 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.11 28.15 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.204 -1.776 . . . . 75.42 106.204 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.08 127.98 53.97 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.202 -1.399 . . . . 71.1 113.205 -164.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.32 126.36 29.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.289 -0.869 . . . . 61.24 110.181 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.62 -25.03 29.85 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.769 -0.932 . . . . 72.42 110.769 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.4 m -100.27 -57.04 2.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.98 -0.748 . . . . 64.21 108.98 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.568 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.2 m-20 -84.91 -58.45 2.7 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-O 121.364 0.602 . . . . 55.35 110.499 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.521 ' CZ ' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -136.19 166.59 23.05 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 108.915 -0.772 . . . . 74.42 108.915 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.43 155.69 39.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.987 0.805 . . . . 73.34 109.716 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.597 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 3.2 p90 -91.04 -17.9 25.47 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.971 -0.559 . . . . 73.34 111.709 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.448 HG22 HG22 ' A' ' 442' ' ' VAL . 9.2 t 34.07 59.2 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 125.144 1.527 . . . . 75.31 113.024 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.43 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.1 pt-20 -79.88 119.3 22.56 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.421 -0.809 . . . . 72.54 109.656 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.74 -174.13 34.95 Favored Glycine 0 N--CA 1.419 -2.455 0 C-N-CA 120.552 -0.832 . . . . 75.43 111.426 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 4.6 m -128.8 138.56 52.14 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.321 -0.992 . . . . 74.41 108.321 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 49.1 t -95.64 123.37 47.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.971 -0.752 . . . . 62.53 108.971 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 87.9 t -100.58 107.33 20.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.874 -1.057 . . . . 73.33 109.147 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -82.52 94.37 7.46 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.071 -0.513 . . . . 71.32 110.463 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.62 160.49 58.78 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.172 -0.922 . . . . 73.14 110.476 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.799 2.333 . . . . 72.54 111.183 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.34 -0.86 57.16 Favored Glycine 0 C--N 1.31 -0.875 0 C-N-CA 120.972 -0.632 . . . . 72.04 113.831 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.01 -66.66 0.9 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.172 0.486 . . . . 74.31 110.756 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 m 71.64 -49.58 0.69 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.123 0.969 . . . . 70.54 110.571 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -107.85 136.05 48.22 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.235 -1.394 . . . . 74.43 107.235 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -129.32 140.17 51.49 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.979 0.419 . . . . 74.41 110.993 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.58 139.6 44.39 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.564 -0.743 . . . . 73.41 110.739 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.4 pt -121.71 150.44 24.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.887 -1.153 . . . . 72.22 107.887 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.2 mtt180 -131.27 139.37 49.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 110.106 -0.331 . . . . 75.43 110.106 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.486 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 52.2 t -110.77 122.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.579 -1.267 . . . . 75.22 107.579 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -72.19 138.7 26.99 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 63.3 111.507 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.8 mm -96.6 132.61 40.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 107.089 -1.449 . . . . 74.14 107.089 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -95.7 147.08 6.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.358 -1.719 . . . . 65.04 106.358 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.18 88.0 3.05 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.312 0.577 . . . . 75.41 111.694 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.75 113.29 22.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.587 -2.375 . . . . 72.03 104.587 172.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -120.29 94.85 4.51 Favored 'General case' 0 C--N 1.274 -2.717 0 C-N-CA 116.917 -1.913 . . . . 54.31 110.547 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.673 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.4 mm -121.34 156.64 25.12 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.042 0 CA-C-N 111.172 -2.74 . . . . 73.13 105.109 -174.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -53.13 114.78 1.58 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.139 -1.424 . . . . 71.31 107.578 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.673 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 37.1 mt-10 -129.19 123.85 33.09 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-N 115.691 -0.686 . . . . 74.3 110.202 -170.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -134.06 105.95 6.97 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.893 -1.049 . . . . 65.0 109.302 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.03 61.6 3.13 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 124.376 1.048 . . . . 65.33 113.316 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.85 124.27 39.79 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.509 -0.876 . . . . 75.05 111.125 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.6 171.85 8.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.822 -1.081 . . . . 72.41 108.37 -175.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 496' ' ' ILE . 13.8 p90 -147.73 171.98 14.81 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.972 -1.122 . . . . 75.11 107.972 168.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.9 mt -117.56 142.85 46.71 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.908 -0.775 . . . . 75.44 108.908 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.28 122.23 66.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.753 -1.573 . . . . 63.53 106.753 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -111.37 139.55 46.69 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.349 0.405 . . . . 75.23 110.322 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.9 mt -101.25 128.19 47.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.869 -1.16 . . . . 71.45 107.869 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.2 m -151.05 -175.3 5.1 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.668 -0.864 . . . . 75.33 108.668 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.2 t30 50.86 83.41 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.694 1.198 . . . . 71.12 111.248 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.27 119.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.774 -0.825 . . . . 72.03 108.774 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? . . . . . 0 C--N 1.291 -1.971 0 N-CA-C 108.794 -0.817 . . . . 74.24 108.794 -179.075 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 65.4 m . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 120.841 0.353 . . . . 75.45 111.939 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.45 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.848 -1.167 . . . . 64.13 107.848 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 30.7 m -103.37 128.62 50.42 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.57 -0.452 . . . . 73.31 110.298 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 69.9 t -113.36 119.19 60.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.255 -1.017 . . . . 74.34 108.255 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 7.3 m -107.75 118.2 36.11 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.366 -0.976 . . . . 71.13 108.366 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.585 HD12 ' CE2' ' A' ' 456' ' ' PHE . 4.9 mp -97.74 120.75 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.596 0.712 . . . . 75.42 110.067 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.436 ' O ' HD12 ' A' ' 384' ' ' LEU 0.265 29.3 m-85 -88.0 104.46 16.67 Favored 'General case' 0 N--CA 1.388 -3.537 0 CA-C-O 122.355 1.074 . . . . 73.02 113.262 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.5 -55.89 16.43 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 111.748 -2.478 . . . . 71.13 109.064 172.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 C--N 1.313 -0.995 0 C-N-CA 125.633 1.573 . . . . 71.22 111.135 177.627 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 N--CA 1.415 -2.203 0 CA-C-O 121.275 0.559 . . . . 74.12 111.12 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 31.8 mm -114.93 119.14 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.282 -1.747 . . . . 73.24 106.282 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -155.85 164.42 38.54 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.934 -0.306 . . . . 74.44 111.024 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -82.35 153.9 25.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.616 -0.513 . . . . 75.12 109.616 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -62.57 -38.95 92.08 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.226 -0.657 . . . . 75.51 109.226 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -125.37 175.66 7.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.967 -1.015 . . . . 64.03 112.089 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.02 -21.58 10.86 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 115.05 -0.977 . . . . 71.42 111.657 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 30.1 m -135.85 132.4 36.56 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.67 -0.493 . . . . 74.41 109.67 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 46.1 m-85 -122.92 136.79 54.99 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.25 -1.019 . . . . 72.21 108.25 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 495' ' ' THR . 75.1 mt-30 -130.02 143.32 50.73 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.241 -1.022 . . . . 74.44 108.241 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 33.9 t -153.34 165.27 36.28 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.428 -0.952 . . . . 71.1 108.428 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.24 143.0 30.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 122.589 0.356 . . . . 74.11 111.23 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -59.72 -37.27 78.43 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.876 -0.602 . . . . 72.02 109.672 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -83.44 8.31 14.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.968 -0.56 . . . . 73.12 112.371 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 32.2 t -89.91 -11.96 40.29 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 119.962 -0.695 . . . . 51.24 110.924 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.38 -53.61 2.43 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.628 -0.796 . . . . 75.14 113.708 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 7.8 p -141.37 164.93 28.91 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.803 0.301 . . . . 72.54 110.697 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.8 p -120.1 127.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.103 -1.073 . . . . 72.11 108.103 172.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.99 124.2 42.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 71.33 110.799 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.436 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.1 mp -116.54 146.74 42.41 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.142 -1.429 . . . . 75.31 107.142 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.6 m -116.59 129.22 56.04 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.309 -0.556 . . . . 52.33 110.624 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.411 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 73.1 mt -98.41 120.54 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 107.675 -1.232 . . . . 74.42 107.675 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.411 HG22 ' HG3' ' A' ' 397' ' ' ARG . 49.3 mm -98.62 129.01 49.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 107.436 -1.32 . . . . 73.43 107.436 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -108.64 107.7 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.464 -0.939 . . . . 74.45 108.464 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . 0.411 ' HG3' HG22 ' A' ' 395' ' ' ILE . 59.2 mtt180 . . . . . 0 CA--C 1.501 -0.917 0 CA-C-O 121.041 0.448 . . . . 74.05 111.997 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.693 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 19.3 m . . . . . 0 N--CA 1.41 -2.428 0 CA-C-O 121.767 0.794 . . . . 74.03 110.102 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.61 146.29 16.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.198 -1.365 . . . . 73.54 107.857 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 33.6 m-85 -126.4 127.32 45.29 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.125 -0.694 . . . . 75.42 109.125 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.55 129.75 68.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.695 -1.224 . . . . 72.13 107.695 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.99 140.6 31.28 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.606 0.241 . . . . 60.41 110.588 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.401 ' C ' ' HD3' ' A' ' 410' ' ' ARG . 20.7 p90 -137.1 152.34 49.9 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.751 -0.379 . . . . 74.2 111.645 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . 0.401 ' HD3' ' C ' ' A' ' 409' ' ' PHE . 0.7 OUTLIER -150.89 172.86 14.98 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.265 1.426 . . . . 74.03 108.078 174.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.627 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.9 p -106.44 161.03 14.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.971 -0.381 . . . . 65.43 109.971 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.2 tp10 -107.65 155.29 20.31 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 122.704 0.401 . . . . 73.02 110.151 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.415 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 6.8 m-20 -84.63 1.87 44.21 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 124.021 0.928 . . . . 72.22 112.333 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . 0.457 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -11.06 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.499 2.836 0 N-CA-C 117.413 1.725 . . . . 73.25 117.413 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 14.8 t -126.93 17.71 7.28 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 117.73 0.765 . . . . 71.42 110.445 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.88 -162.81 1.63 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.155 -0.475 . . . . 60.2 110.164 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.415 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 3.6 m120 -135.73 119.72 17.52 Favored 'General case' 0 CA--C 1.485 -1.546 0 CA-C-O 121.344 0.592 . . . . 74.3 111.215 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.91 124.48 27.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.447 -0.946 . . . . 75.21 108.447 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.25 -15.28 43.2 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 110.663 -0.975 . . . . 53.11 110.663 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 18.3 t -114.31 -50.55 2.8 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.17 -0.678 . . . . 63.41 109.17 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 20.6 m-20 -85.66 -59.66 2.25 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 122.307 1.051 . . . . 63.43 110.354 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.676 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -138.83 162.83 33.82 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.826 -1.079 . . . . 74.0 108.894 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.9 tt0 -73.82 156.87 37.33 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 124.165 0.915 . . . . 73.14 110.788 -173.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.627 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.2 p90 -89.97 -14.33 34.28 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.175 -0.92 . . . . 75.21 111.448 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.485 ' H ' ' HG2' ' A' ' 423' ' ' GLU . 15.2 t 33.24 66.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.455 1.902 . . . . 74.04 113.127 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.23 111.77 15.79 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.049 0.928 . . . . 74.12 109.592 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -151.76 173.93 30.94 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 120.061 -1.066 . . . . 64.42 111.61 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.2 m -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 106.913 -1.514 . . . . 50.23 106.913 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 32.7 t -95.74 120.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.24 -1.022 . . . . 73.05 108.24 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.68 106.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 115.255 -0.884 . . . . 75.4 109.037 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.693 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.3 m-85 -82.03 94.21 7.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.153 -0.684 . . . . 74.25 109.153 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.05 167.34 30.03 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 115.048 -0.978 . . . . 74.44 110.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.79 110.52 0.64 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.497 2.131 . . . . 64.13 111.569 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 113.56 -18.7 19.95 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.716 -0.675 . . . . 72.42 112.078 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -83.92 62.37 6.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.305 0.574 . . . . 75.42 111.974 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 m -65.64 -20.94 66.5 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.857 0.836 . . . . 72.44 109.486 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -132.01 135.07 46.26 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.066 -1.457 . . . . 64.3 107.066 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -122.99 147.8 46.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 111.565 0.209 . . . . 74.43 111.565 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -118.41 131.4 56.28 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.299 -0.63 . . . . 74.4 109.299 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.7 pt -120.96 149.4 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.099 -1.074 . . . . 74.31 108.099 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.1 mtt180 -129.49 138.53 51.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-O 120.899 0.381 . . . . 74.02 110.854 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.59 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 63.7 t -104.92 126.57 59.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.667 -0.864 . . . . 74.13 108.667 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -68.29 127.31 23.79 Favored Glycine 0 N--CA 1.433 -1.542 0 O-C-N 124.115 0.884 . . . . 73.25 111.953 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.5 mm -94.6 134.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 106.07 -1.826 . . . . 72.14 106.07 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.3 mt -98.57 144.99 10.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 106.982 -1.488 . . . . 74.4 106.982 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.2 88.3 4.28 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.667 -0.813 . . . . 72.52 111.632 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.74 97.83 5.82 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.875 -2.269 . . . . 52.21 104.875 169.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.59 87.05 2.61 Favored 'General case' 0 CA--C 1.46 -2.511 0 CA-C-O 122.905 1.336 . . . . 74.55 109.856 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.441 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 26.5 mm -116.1 154.48 17.61 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.948 0 CA-C-N 111.688 -2.506 . . . . 75.32 104.575 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -63.97 114.82 4.35 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.386 -1.726 . . . . 74.2 108.62 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 19.5 mt-10 -135.49 151.93 50.85 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.646 -1.161 . . . . 72.22 108.485 -170.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -131.55 102.1 5.78 Favored 'General case' 0 N--CA 1.411 -2.393 0 C-N-CA 119.583 -0.847 . . . . 73.43 111.165 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 14.3 t70 63.86 61.55 0.95 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 124.704 1.252 . . . . 71.45 111.018 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.41 130.77 40.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.965 -0.562 . . . . 74.2 109.576 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.94 161.86 39.11 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.885 -0.726 . . . . 73.13 109.831 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.59 ' CZ ' HG12 ' A' ' 442' ' ' VAL . 25.1 p90 -140.91 -178.99 5.81 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.98 -0.555 . . . . 70.31 109.711 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.3 mt -120.92 138.9 53.88 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.359 -1.349 . . . . 75.24 107.359 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 491' ' ' THR . 61.1 t -106.33 121.95 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.069 -1.456 . . . . 75.31 107.069 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 412' ' ' GLU . 63.5 m-70 -110.68 128.36 55.67 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.503 0.502 . . . . 73.4 111.023 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.99 131.7 42.09 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.031 -1.1 . . . . 74.24 108.031 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 12.4 p -155.7 -176.81 6.15 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.843 -0.799 . . . . 51.51 108.843 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 49.67 81.96 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.176 0.922 . . . . 70.13 112.694 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.12 128.36 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 115.332 -0.849 . . . . 64.13 108.772 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 72.0 tttt . . . . . 0 N--CA 1.403 -2.776 0 N-CA-C 106.381 -1.711 . . . . 65.21 106.381 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 36.0 m . . . . . 0 N--CA 1.42 -1.955 0 CA-C-O 120.672 0.272 . . . . 63.03 111.057 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -125.27 136.68 53.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.441 -1.318 . . . . 75.54 107.441 172.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 28.0 m -89.94 125.82 35.51 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.715 -0.476 . . . . 75.51 109.715 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 79.2 t -111.83 109.35 28.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.065 -0.717 . . . . 63.44 109.065 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 29.5 m -99.99 122.27 42.63 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.126 -1.064 . . . . 75.55 108.126 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.676 HD11 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -101.79 124.23 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 N-CA-C 108.561 -0.903 . . . . 71.34 108.561 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . 0.277 42.0 m-85 -87.8 111.3 21.22 Favored 'General case' 0 N--CA 1.393 -3.3 0 CA-C-O 122.124 0.964 . . . . 72.45 112.514 178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 451' ' ' GLU . 7.6 m-20 -51.8 -52.41 49.27 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-N 111.882 -2.417 . . . . 72.25 112.364 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 N--CA 1.472 0.641 0 O-C-N 125.171 1.544 . . . . 74.41 107.956 -173.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp . . . . . 0 C--O 1.24 0.576 0 N-CA-C 108.986 -0.746 . . . . 74.25 108.986 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.44 115.75 50.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.695 -1.594 . . . . 75.41 106.695 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -146.54 158.58 43.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 119.012 0.824 . . . . 71.25 112.752 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -70.47 143.1 51.84 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.542 -0.54 . . . . 73.43 109.542 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.71 -39.44 80.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.533 0.683 . . . . 74.5 109.171 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 12.7 mt-30 -122.58 153.71 38.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.432 -0.804 . . . . 71.2 111.34 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.2 -22.82 26.31 Favored Glycine 0 C--N 1.304 -1.24 0 C-N-CA 120.98 -0.629 . . . . 41.4 111.644 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 85.7 m -137.0 135.72 37.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.144 -0.687 . . . . 73.42 109.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 72.0 m-85 -124.96 138.85 54.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.264 -1.013 . . . . 74.51 108.264 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 495' ' ' THR . 39.3 mt-30 -128.93 124.86 36.21 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.888 -0.782 . . . . 73.34 108.888 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -136.49 156.73 48.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.509 -0.552 . . . . 72.4 109.509 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.581 HD11 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -75.24 144.63 42.48 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 110.174 -0.306 . . . . 74.2 110.174 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -61.66 -31.56 71.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.831 0.824 . . . . 70.24 109.92 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.513 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.9 p-10 -84.52 1.74 44.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.891 -1.049 . . . . 73.54 112.698 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 45.8 t -77.0 -19.09 57.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.133 -0.354 . . . . 62.31 111.476 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.13 -61.86 2.19 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.748 -0.739 . . . . 75.11 112.208 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.3 p -136.96 148.97 47.25 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.54 0.17 . . . . 61.3 110.566 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.2 p -106.35 134.06 49.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.1 -1.445 . . . . 71.13 107.1 174.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.13 112.32 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.547 0.689 . . . . 65.34 110.835 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.473 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.9 mp -101.87 153.88 19.44 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.485 -1.302 . . . . 73.54 107.485 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -116.52 132.35 56.7 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.513 -0.475 . . . . 74.34 110.025 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 79.2 mt -104.91 122.86 58.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.186 -1.042 . . . . 73.22 108.186 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.72 127.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.54 -0.911 . . . . 72.43 108.54 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 54.7 ttt180 -113.75 110.1 19.63 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.3 -0.864 . . . . 72.41 109.157 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 . . . . . 0 C--N 1.304 -1.412 0 N-CA-C 109.439 -0.578 . . . . 72.13 109.439 -178.846 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.9 m . . . . . 0 N--CA 1.437 -1.107 0 CA-C-O 121.629 0.728 . . . . 74.42 110.749 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.09 149.68 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.085 -0.961 . . . . 72.14 108.663 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.446 ' CZ ' HG13 ' A' ' 430' ' ' VAL . 22.1 m-85 -127.31 129.38 47.55 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.942 0.497 . . . . 73.15 110.19 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.66 131.1 62.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.897 -0.779 . . . . 75.22 108.897 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -99.91 135.43 41.34 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 110.066 -0.346 . . . . 75.11 110.066 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -134.98 165.66 24.82 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 122.093 -0.379 . . . . 73.14 111.158 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 21.6 ttm180 -166.02 160.19 16.28 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.115 -1.068 . . . . 74.24 108.115 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 72.5 p -96.71 154.96 16.98 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.905 -0.776 . . . . 74.03 108.905 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 414' ' ' GLY . 28.5 tt0 -115.65 148.49 39.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.734 1.013 . . . . 72.45 113.734 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.79 2.61 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.885 0 C-N-CA 130.722 3.609 . . . . 72.33 114.102 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 412' ' ' GLU . . . -20.19 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 125.741 1.638 . . . . 73.42 117.156 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.1 t -136.24 16.19 3.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.117 0.958 . . . . 75.44 109.857 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.32 -164.14 1.52 Allowed 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.103 -1.073 . . . . 71.21 108.103 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -138.98 121.84 16.57 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.212 -0.995 . . . . 74.15 111.527 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.82 124.71 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.232 -0.655 . . . . 72.44 109.232 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.18 -27.8 7.56 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.552 -1.819 . . . . 73.11 108.552 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.3 t -106.78 -55.71 2.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.945 -0.627 . . . . 74.21 109.518 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.604 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -80.98 -60.28 2.35 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-O 121.608 0.718 . . . . 75.11 111.112 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.689 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -136.75 166.95 22.39 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.545 -0.909 . . . . 74.2 108.545 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -77.72 154.42 32.07 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.638 -0.875 . . . . 74.42 108.638 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.498 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.9 p90 -95.52 -13.23 24.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.97 0.73 . . . . 75.23 112.97 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.447 ' CG2' HG21 ' A' ' 442' ' ' VAL . 10.1 t 36.01 57.77 0.97 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.364 1.866 . . . . 74.23 113.791 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 10.5 pt-20 -78.51 116.44 18.9 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.741 0.781 . . . . 74.21 108.945 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -157.08 -173.61 25.73 Favored Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 115.313 -0.858 . . . . 71.13 111.194 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 17.9 m -128.54 136.59 50.97 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.327 -1.36 . . . . 72.13 107.327 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.42 127.64 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.745 -1.205 . . . . 72.02 107.745 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . 0.446 HG13 ' CZ ' ' A' ' 406' ' ' PHE . 22.7 t -105.04 106.69 20.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.831 -0.803 . . . . 73.12 108.831 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.9 m-85 -85.3 95.64 9.27 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.707 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 175.08 4.46 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 114.818 -1.083 . . . . 74.12 110.238 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.83 135.2 50.69 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.444 1.43 . . . . 73.42 109.603 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 91.85 -20.09 44.5 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.084 -0.579 . . . . 53.21 112.506 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.45 63.45 4.91 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.294 0.637 . . . . 75.45 110.821 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 m -70.69 -24.92 62.75 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.972 -1.013 . . . . 74.24 108.441 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.68 135.39 42.0 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.18 -0.674 . . . . 74.1 109.18 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -123.05 153.62 39.62 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.945 0.402 . . . . 74.34 111.864 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -113.08 129.82 56.38 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.058 -0.974 . . . . 74.35 109.49 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 40.7 pt -117.37 137.28 51.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.294 -1.002 . . . . 74.53 108.294 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 47.0 mtt180 -121.97 136.37 54.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.28 0.562 . . . . 72.22 112.134 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.609 HG13 ' CZ ' ' A' ' 456' ' ' PHE . 48.6 t -111.12 123.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.299 -1.371 . . . . 74.44 107.299 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -78.68 135.79 16.42 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.856 -0.688 . . . . 62.13 111.996 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.4 mm -94.75 131.29 42.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.602 -1.258 . . . . 73.41 107.602 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.6 mt -93.52 143.17 12.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.322 -2.103 . . . . 75.41 105.322 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.47 86.22 7.31 Favored 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 119.036 -1.065 . . . . 62.31 111.314 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.85 98.44 8.13 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 103.25 -2.87 . . . . 74.22 103.25 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.84 89.29 3.61 Favored 'General case' 0 C--N 1.271 -2.841 0 C-N-CA 117.2 -1.8 . . . . 72.32 110.911 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.422 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -123.2 153.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.449 0 N-CA-C 104.265 -2.494 . . . . 74.52 104.265 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -60.12 114.64 2.97 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.658 -1.217 . . . . 73.23 108.845 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 21.3 mt-10 -128.46 140.99 51.53 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.717 -0.674 . . . . 74.41 109.555 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -121.15 99.67 6.62 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.313 -0.858 . . . . 75.42 109.546 -173.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.303 4.3 p-10 47.28 61.15 3.03 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.413 1.485 . . . . 73.25 112.794 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.542 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.7 tt0 -74.56 127.93 34.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.817 -1.083 . . . . 63.33 108.684 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.422 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.2 p-10 -145.56 169.09 19.08 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.811 -0.555 . . . . 73.14 111.905 -173.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.609 ' CZ ' HG13 ' A' ' 442' ' ' VAL . 26.2 p90 -143.83 179.48 7.14 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.269 -0.423 . . . . 65.53 110.582 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 37.9 mt -118.08 138.68 52.08 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.724 -1.213 . . . . 74.51 107.724 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.43 126.47 69.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.216 -1.402 . . . . 72.54 107.216 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -119.66 157.07 29.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.407 0.442 . . . . 72.33 110.662 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.73 138.63 50.49 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.456 -0.572 . . . . 72.35 109.456 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.9 p -153.44 -174.3 4.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.023 0.529 . . . . 75.42 109.691 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.7 t30 34.79 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 126.201 1.8 . . . . 73.54 112.85 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.33 127.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 C-N-CA 119.9 -0.72 . . . . 71.04 109.692 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 108.993 -0.743 . . . . 74.24 108.993 -177.553 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.414 -2.265 0 N-CA-C 109.686 -0.487 . . . . 64.43 109.686 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -122.75 117.39 25.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.525 -1.657 . . . . 74.22 106.525 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 89.8 m -86.09 119.77 26.75 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.237 0.542 . . . . 61.23 110.573 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 390' ' ' VAL . 80.2 t -104.08 108.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.603 -0.888 . . . . 72.41 108.603 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 90.2 m -96.58 121.01 37.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.629 -0.878 . . . . 73.42 108.629 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.689 HD11 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.94 126.88 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.179 0 CA-C-O 121.502 0.668 . . . . 73.34 109.535 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.581 ' O ' HD11 ' A' ' 384' ' ' LEU . 9.3 m-85 -93.0 104.16 16.4 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-O 121.854 0.835 . . . . 74.44 110.433 173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -56.01 -54.02 49.9 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 112.882 -1.963 . . . . 73.42 113.283 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 N--CA 1.48 1.039 0 C-N-CA 126.174 1.79 . . . . 71.24 107.863 -170.129 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp . . . . . 0 N--CA 1.444 -0.766 0 N-CA-C 109.569 -0.53 . . . . 74.43 109.569 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 39.0 mm -107.16 115.87 49.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.909 -1.886 . . . . 73.25 105.909 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.46 167.11 23.76 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 118.794 0.725 . . . . 74.14 112.487 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -78.68 147.61 33.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.107 -0.701 . . . . 73.0 109.107 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.13 -53.3 39.51 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.569 -0.9 . . . . 72.43 108.569 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -109.8 174.15 6.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.074 -0.512 . . . . 73.2 110.751 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.48 -35.49 2.85 Favored Glycine 0 C--N 1.298 -1.559 0 CA-C-N 115.264 -0.88 . . . . 62.45 111.148 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 23.1 m -121.05 134.74 55.29 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.915 -1.142 . . . . 74.33 107.915 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 61.6 m-85 -124.19 136.34 54.11 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.673 -1.232 . . . . 71.35 107.673 175.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.39 123.59 36.56 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.507 -0.923 . . . . 71.24 108.507 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.2 p -134.33 152.9 52.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.667 -0.494 . . . . 71.14 109.667 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -75.02 152.74 38.68 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.256 -0.646 . . . . 75.4 109.256 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 498' ' ' ASP . 29.1 tt0 -65.52 -38.73 90.51 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.06 0.933 . . . . 64.53 109.5 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.46 ' OD1' HD13 ' A' ' 384' ' ' LEU . 2.5 p-10 -83.89 16.36 2.85 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.875 -1.057 . . . . 72.2 111.661 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.9 t -84.63 -20.59 31.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.188 0.518 . . . . 72.53 109.632 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.85 -60.37 3.15 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.913 -0.66 . . . . 72.11 111.883 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 9.0 p -143.57 155.97 44.45 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 122.662 0.385 . . . . 72.44 110.209 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -112.82 132.43 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.522 -1.288 . . . . 75.03 107.522 173.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.52 120.14 40.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.197 0.522 . . . . 71.32 110.141 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.8 mp -112.2 142.25 44.9 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.588 -1.264 . . . . 65.02 107.588 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.2 m -106.8 131.14 54.25 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.565 -0.531 . . . . 74.43 109.565 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.3 122.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.869 -1.16 . . . . 72.34 107.869 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.6 mm -98.02 123.95 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.319 -0.993 . . . . 72.43 108.319 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.492 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 51.4 ttt180 -111.02 110.89 21.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.383 -0.826 . . . . 71.32 109.639 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 . . . . . 0 C--N 1.308 -1.215 0 CA-C-N 115.968 -0.56 . . . . 73.21 109.578 -179.327 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 4.3 m . . . . . 0 N--CA 1.42 -1.959 0 CA-C-O 121.47 0.652 . . . . 74.2 111.687 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.65 142.96 22.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.042 -1.095 . . . . 72.25 108.042 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 464' ' ' LYS . 26.0 m-85 -127.24 129.91 48.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.349 -0.612 . . . . 72.23 109.349 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.27 132.39 66.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.006 -1.109 . . . . 73.42 108.006 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 19.2 t70 -93.3 134.53 35.41 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.75 -0.833 . . . . 75.34 108.75 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -123.06 148.12 45.95 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.923 -0.769 . . . . 74.15 108.923 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -162.93 163.9 26.05 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.292 -1.003 . . . . 74.5 108.292 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 22.1 p -96.69 172.89 7.62 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.903 0.382 . . . . 73.31 111.035 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 4.8 tp10 -133.93 153.96 51.4 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.092 -2.188 . . . . 71.41 105.092 173.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -58.18 -45.02 88.28 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.185 0.809 . . . . 72.41 113.185 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.95 -93.73 0.16 Allowed Glycine 0 C--N 1.293 -1.857 0 CA-C-N 115.667 -0.697 . . . . 61.43 112.03 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.0 t -132.28 9.62 4.42 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.137 0.97 . . . . 72.35 109.007 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -132.14 -159.75 0.99 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.185 -1.783 . . . . 72.2 106.185 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -150.34 113.84 4.95 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.465 -0.894 . . . . 75.33 112.255 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.91 128.82 37.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.265 -0.643 . . . . 63.02 109.265 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.03 -31.63 6.18 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 109.102 -1.599 . . . . 60.05 109.102 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.2 m -110.18 -51.89 2.83 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.106 0.479 . . . . 70.23 109.859 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.608 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.1 m-20 -82.9 -61.43 1.87 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.531 0.682 . . . . 74.32 110.927 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.549 ' CZ ' HD12 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -132.31 173.42 11.28 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 107.228 -1.397 . . . . 75.21 107.228 -178.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -79.11 148.0 32.54 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.361 -0.607 . . . . 74.32 109.361 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -82.36 -16.93 47.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 113.133 0.79 . . . . 71.24 113.133 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.45 HG21 HG21 ' A' ' 442' ' ' VAL 0.251 14.0 t 35.95 73.11 0.09 Allowed 'General case' 0 CA--C 1.556 1.198 0 O-C-N 125.513 1.758 . . . . 73.34 113.279 -178.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.5 130.93 35.76 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.591 -1.186 . . . . 75.34 109.273 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.78 48.53 Favored Glycine 0 CA--C 1.476 -2.35 0 C-N-CA 119.784 -1.198 . . . . 75.03 111.86 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 60.6 m -123.68 138.63 54.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.524 -0.917 . . . . 71.03 108.524 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.39 124.8 49.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.927 -0.768 . . . . 74.3 108.927 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 23.4 t -95.3 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 75.52 109.232 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.492 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 60.5 m-85 -88.78 95.67 10.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.095 0.474 . . . . 73.41 111.236 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.466 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 57.3 mtmt -92.7 176.81 2.36 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 114.918 -1.037 . . . . 75.21 110.456 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.5 Cg_exo -56.62 131.71 47.3 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 122.479 2.119 . . . . 72.21 112.353 175.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 98.34 -33.08 6.27 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.845 -0.616 . . . . 70.11 111.985 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 33.4 mt-10 -82.54 64.15 7.04 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.803 1.241 . . . . 74.34 113.086 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 9.2 t -75.81 -13.01 60.28 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.49 -1.232 . . . . 71.44 109.816 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -135.79 137.12 41.28 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.867 -1.16 . . . . 71.25 107.867 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -130.81 157.87 41.69 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.572 0.225 . . . . 74.4 111.367 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -122.59 137.29 54.94 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.912 -0.585 . . . . 74.34 110.498 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -121.35 145.72 27.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 75.23 108.772 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 60.2 mtm180 -120.42 141.64 49.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.032 0.444 . . . . 72.42 111.097 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.476 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 42.0 t -110.72 121.54 63.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.392 -1.336 . . . . 55.22 107.392 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -72.15 140.67 30.17 Favored Glycine 0 N--CA 1.433 -1.544 0 O-C-N 123.895 0.747 . . . . 63.24 112.113 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 37.8 mm -101.15 132.56 46.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 106.74 -1.578 . . . . 75.41 106.74 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.9 mt -99.22 151.49 4.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 106.536 -1.653 . . . . 71.44 106.536 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -82.38 86.23 6.76 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.223 -0.991 . . . . 71.04 112.136 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.41 107.59 18.55 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.76 -2.682 . . . . 71.33 103.76 169.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -109.69 84.86 2.0 Allowed 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 117.864 -1.534 . . . . 71.34 109.921 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 47.6 mm -124.37 154.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 111.966 -2.379 . . . . 74.32 105.81 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.19 115.38 4.45 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.428 -1.309 . . . . 71.25 109.018 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 24.0 mt-10 -126.98 135.75 51.29 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 114.371 -1.286 . . . . 75.01 109.516 -170.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -138.0 117.16 12.61 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.972 -1.013 . . . . 70.25 108.903 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 56.8 29.99 16.98 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.227 1.011 . . . . 73.25 110.97 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -75.38 118.24 18.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.906 -1.146 . . . . 75.32 107.906 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 2.7 p-10 -144.03 167.72 21.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.313 0.578 . . . . 70.5 110.775 -174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.516 ' CE2' HD11 ' A' ' 496' ' ' ILE . 23.9 p90 -139.12 -177.49 4.92 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.443 -0.799 . . . . 72.51 109.242 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 30.1 mt -122.13 139.64 53.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.401 -0.963 . . . . 75.32 108.401 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.81 126.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.821 -1.548 . . . . 71.51 106.821 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.62 149.62 41.66 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.672 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.08 124.84 50.25 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.275 -1.75 . . . . 75.42 106.275 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.8 m -144.25 170.91 15.08 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.212 -0.662 . . . . 74.11 109.212 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.13 86.53 0.04 OUTLIER 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.708 1.203 . . . . 73.04 112.525 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 61.9 t -80.14 128.82 38.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 119.698 -0.801 . . . . 73.32 108.897 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 406' ' ' PHE . 39.9 ttmt . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 107.088 -1.449 . . . . 73.04 107.088 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.413 -2.324 0 N-CA-C 108.381 -0.97 . . . . 73.44 108.381 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -104.78 131.82 51.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.618 -1.252 . . . . 72.23 107.618 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.7 m -98.86 121.86 41.35 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 120.481 -0.488 . . . . 73.04 110.338 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 86.9 t -109.01 106.06 19.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.798 -0.816 . . . . 74.32 108.798 177.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 93.9 m -95.83 115.3 27.22 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.861 -1.162 . . . . 72.33 107.861 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.549 HD12 ' CZ ' ' A' ' 422' ' ' TYR . 4.9 mp -88.6 107.88 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 C-N-CA 119.896 -0.722 . . . . 72.01 109.867 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 38.2 m-85 -78.01 92.4 4.34 Favored 'General case' 0 CA--C 1.446 -3.044 0 N-CA-C 106.37 -1.715 . . . . 75.44 106.37 169.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . 0.441 ' HB2' ' CD ' ' A' ' 385' ' ' GLU . 1.1 p-10 -82.79 -19.87 36.91 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 114.241 -1.345 . . . . 71.22 108.905 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 N--CA 1.428 -1.552 0 CA-C-N 112.985 -1.916 . . . . 74.21 110.565 179.288 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.0 mmtp . . . . . 0 CA--C 1.505 -0.783 0 N-CA-C 109.899 -0.408 . . . . 73.41 109.899 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 35.6 mm -110.04 119.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.313 -1.366 . . . . 63.3 107.313 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -156.43 161.68 40.06 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 118.443 0.565 . . . . 74.31 112.305 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.17 145.04 40.17 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.133 -0.321 . . . . 74.44 110.133 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.89 -44.28 90.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.395 0.617 . . . . 72.3 109.359 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 14.4 mm100 -107.17 171.11 7.56 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.412 -0.813 . . . . 55.55 111.236 177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -105.62 -25.66 6.49 Favored Glycine 0 C--N 1.289 -2.063 0 N-CA-C 109.63 -1.388 . . . . 73.32 109.63 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 493' ' ' THR . 24.0 m -135.94 140.22 43.84 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.694 -1.225 . . . . 72.15 107.694 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 91.7 m-85 -129.13 136.69 50.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.31 -0.996 . . . . 74.43 108.31 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.66 134.45 53.74 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.131 -0.692 . . . . 74.31 109.131 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 31.7 t -148.69 165.03 32.57 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.486 -1.301 . . . . 72.35 107.486 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -84.4 143.54 29.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.627 0.603 . . . . 73.44 112.627 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.182 -0.917 . . . . 73.21 109.975 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -90.64 14.19 13.98 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.351 0.5 . . . . 71.31 112.351 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.78 -16.32 34.49 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.994 -0.441 . . . . 64.05 111.268 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.21 -68.77 0.37 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.527 -0.844 . . . . 74.33 112.405 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 16.7 p -135.18 161.68 34.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.094 0.473 . . . . 65.31 110.714 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 442' ' ' VAL . 5.7 p -112.5 129.13 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 107.842 -1.17 . . . . 71.04 107.842 172.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.78 120.85 40.39 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.603 0.564 . . . . 74.22 110.306 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.1 mp -112.09 141.8 45.32 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.647 -1.242 . . . . 73.01 107.647 176.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -105.3 129.01 53.74 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.81 -0.441 . . . . 70.35 109.81 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.8 122.64 55.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.164 -1.05 . . . . 73.44 108.164 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.2 mm -94.43 132.36 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 C-N-CA 124.259 1.024 . . . . 74.42 108.456 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 60.6 ttt180 -115.6 111.23 20.36 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.293 -0.867 . . . . 74.14 109.788 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 . . . . . 0 C--N 1.299 -1.616 0 CA-C-N 115.129 -0.941 . . . . 72.01 109.044 179.473 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 25.3 m . . . . . 0 N--CA 1.403 -2.812 0 CA-C-O 121.561 0.696 . . . . 74.43 110.684 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 55.8 t -104.68 143.2 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 114.428 -1.26 . . . . 74.24 108.618 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -126.22 112.77 16.14 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.544 -0.909 . . . . 74.21 108.544 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.6 124.66 71.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.1 -0.704 . . . . 73.54 109.1 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -87.41 140.49 29.48 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.094 -0.706 . . . . 73.53 109.094 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -142.83 154.66 44.38 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.44 -0.788 . . . . 75.44 111.69 -175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 56.0 mtt85 -154.6 165.58 36.05 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 125.144 1.378 . . . . 73.23 109.27 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.6 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 58.5 p -100.97 158.05 16.29 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.647 -0.706 . . . . 72.43 109.262 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 8.2 tp10 -106.02 163.92 12.38 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.006 -1.85 . . . . 75.53 106.006 176.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.8 p-10 -60.29 -40.1 89.25 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.626 0.726 . . . . 70.15 110.559 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.76 -89.26 0.3 Allowed Glycine 0 C--N 1.299 -1.514 0 CA-C-N 114.737 -1.119 . . . . 73.44 110.456 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 455' ' ' ASN . 9.6 t -131.57 -1.09 3.9 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 122.093 0.949 . . . . 71.03 109.212 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.56 ' HB1' ' OH ' ' A' ' 422' ' ' TYR . . . -129.5 -154.84 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.254 -1.017 . . . . 73.12 108.254 -173.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.41 125.6 20.06 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.101 0.477 . . . . 73.41 110.822 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -73.32 128.45 35.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.237 -0.653 . . . . 71.43 109.237 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.27 -13.08 48.34 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 110.522 -1.031 . . . . 53.4 110.522 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.4 m -117.64 -56.49 2.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.17 0.51 . . . . 72.34 109.67 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 38.1 m-20 -85.23 -57.64 3.0 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 122.174 0.988 . . . . 74.41 109.663 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.637 ' CE2' HD12 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -139.95 165.01 28.47 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.275 -0.875 . . . . 74.05 110.638 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.3 tt0 -73.82 149.16 41.82 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 124.057 0.848 . . . . 64.23 110.836 -173.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.6 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.3 OUTLIER -79.85 -16.29 55.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 73.5 111.818 176.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.519 HG21 HG21 ' A' ' 442' ' ' VAL 0.259 8.9 t 35.05 63.91 0.46 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 126.412 1.885 . . . . 72.24 113.622 -177.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -79.2 126.36 30.65 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.427 -0.806 . . . . 74.15 109.084 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -170.14 -173.2 37.32 Favored Glycine 0 N--CA 1.41 -3.065 0 N-CA-C 110.672 -0.971 . . . . 60.52 110.672 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 40.8 m -127.22 139.98 52.55 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.382 -0.97 . . . . 74.01 108.382 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.76 117.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.051 -1.092 . . . . 71.42 108.051 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.0 t -92.75 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.525 -0.761 . . . . 74.4 110.009 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.9 m-85 -91.82 94.46 9.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.129 -0.487 . . . . 74.33 110.053 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.2 mttm -82.79 174.93 5.31 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.073 -0.967 . . . . 71.42 110.296 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.2 Cg_exo -59.75 133.45 51.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 70.14 109.639 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.8 -18.8 48.88 Favored Glycine 0 C--N 1.305 -1.175 0 C-N-CA 120.564 -0.827 . . . . 64.22 113.199 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.83 63.99 7.22 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.24 0.616 . . . . 63.54 112.275 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 7.6 m -68.46 -19.27 64.55 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.182 -0.917 . . . . 73.43 109.113 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -138.28 137.78 37.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.294 -1.002 . . . . 72.33 108.294 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -124.48 151.66 44.32 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.485 -0.325 . . . . 74.02 111.028 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.76 138.99 48.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.964 -0.562 . . . . 75.21 109.946 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.51 133.9 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.445 -0.576 . . . . 74.3 109.445 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 24.5 mmt180 -104.55 133.02 50.12 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.636 -0.711 . . . . 73.04 111.123 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.65 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -110.55 124.21 67.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.14 -1.43 . . . . 75.21 107.14 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -72.7 133.86 19.77 Favored Glycine 0 N--CA 1.428 -1.841 0 O-C-N 123.903 0.752 . . . . 63.4 112.343 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . 0.401 HD11 HG12 ' A' ' 496' ' ' ILE . 34.7 mm -95.19 134.31 33.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 105.966 -1.865 . . . . 74.34 105.966 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 78.2 mt -97.03 143.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 107.732 -1.21 . . . . 73.43 107.732 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.87 95.03 0.66 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.544 0.688 . . . . 72.23 110.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.06 102.84 7.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 104.774 -2.306 . . . . 64.33 104.774 169.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -106.55 89.85 3.16 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.116 -1.434 . . . . 71.23 109.697 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.2 mm -129.63 155.57 41.43 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.28 0 CA-C-N 112.108 -2.315 . . . . 72.43 105.244 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.25 115.22 4.34 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 117.713 -1.595 . . . . 75.02 106.963 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 20.5 mt-10 -126.1 136.55 53.04 Favored 'General case' 0 CA--C 1.468 -2.178 0 CA-C-N 114.843 -1.071 . . . . 73.13 108.653 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -128.94 106.56 8.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.31 0.576 . . . . 75.12 110.35 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 54.74 60.67 3.36 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 125.316 1.446 . . . . 62.1 114.004 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.47 117.44 17.27 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.7 -0.852 . . . . 71.42 108.7 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.42 ' O ' HG23 ' A' ' 415' ' ' THR . 8.5 p30 -140.48 145.48 36.97 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.665 0.745 . . . . 74.34 110.115 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.65 ' CZ ' HG12 ' A' ' 442' ' ' VAL . 22.3 p90 -123.81 174.3 7.61 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.612 -1.176 . . . . 74.52 109.124 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.3 mt -120.7 136.14 54.94 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 107.072 -1.455 . . . . 75.35 107.072 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.65 126.17 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.625 -1.25 . . . . 75.3 107.625 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -121.56 140.98 51.53 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.617 0.573 . . . . 74.23 110.007 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.92 138.8 33.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.973 -1.121 . . . . 74.43 107.973 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 14.9 m -146.55 177.16 9.27 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.16 -1.052 . . . . 72.11 108.16 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 40.8 83.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.727 0 C-N-CA 125.112 1.365 . . . . 64.01 113.42 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.37 134.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.16 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 108.016 -1.105 . . . . 74.44 108.016 -178.4 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 110.002 -0.37 . . . . 74.04 110.002 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.37 27.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.244 -1.021 . . . . 71.12 108.244 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 380' ' ' THR . 30.8 m -86.0 121.26 28.37 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.876 0.37 . . . . 74.43 110.486 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 390' ' ' VAL . 73.6 t -107.25 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.411 -0.959 . . . . 74.32 108.411 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 24.5 m -98.14 112.85 24.67 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.815 -1.18 . . . . 75.21 107.815 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.637 HD12 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.59 121.63 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 N-CA-C 109.212 -0.662 . . . . 72.24 109.212 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.425 ' O ' HD13 ' A' ' 384' ' ' LEU 0.29 23.3 m-85 -81.87 99.95 9.33 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-O 122.652 1.215 . . . . 73.51 112.459 177.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -49.89 -52.11 35.46 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 111.042 -2.799 . . . . 73.23 109.862 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 N--CA 1.479 0.983 0 C-N-CA 126.018 1.727 . . . . 61.15 111.317 177.561 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 51.7 mttm . . . . . 0 N--CA 1.427 -1.621 0 CA-C-O 120.533 0.206 . . . . 73.1 110.509 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 25.5 mm -115.36 124.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 107.421 -1.325 . . . . 74.31 107.421 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -155.64 -177.8 6.82 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 110.025 -0.361 . . . . 71.32 110.025 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -94.33 162.37 13.86 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.146 0.498 . . . . 73.44 112.054 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.11 -35.47 56.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.239 -0.891 . . . . 70.11 109.854 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 23.1 mm-40 -122.38 172.31 8.42 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.386 -0.825 . . . . 70.35 111.966 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -103.01 -37.18 3.21 Favored Glycine 0 C--N 1.293 -1.845 0 CA-C-N 114.465 -1.243 . . . . 72.3 110.025 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.0 m -133.02 130.98 40.15 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.452 0.644 . . . . 74.32 109.439 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 74.7 m-85 -113.43 143.9 43.71 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.112 -1.07 . . . . 71.13 108.112 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 495' ' ' THR . 15.7 mp0 -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.705 -0.85 . . . . 71.43 108.705 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 30.3 t -148.13 165.11 31.84 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.686 -0.857 . . . . 75.21 108.686 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.7 mm? -89.07 141.46 28.48 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 122.457 0.303 . . . . 75.01 110.617 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -56.88 -35.73 69.27 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 122.163 0.982 . . . . 74.52 109.605 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -74.26 -7.83 54.12 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.897 -1.502 . . . . 73.3 111.4 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.57 -22.85 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.011 0.434 . . . . 54.25 111.239 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.14 -51.48 2.48 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.177 -1.011 . . . . 52.13 112.493 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 17.2 p -138.12 160.75 38.58 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.073 0.463 . . . . 70.31 111.175 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.6 p -116.5 132.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.126 -1.435 . . . . 71.35 107.126 172.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -104.06 115.54 30.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.405 0.621 . . . . 72.22 110.36 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.1 mp -105.65 147.43 28.49 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.825 -1.176 . . . . 71.55 107.825 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.7 m -108.76 129.45 55.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.489 -0.559 . . . . 75.23 109.489 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.1 mt -97.98 119.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.465 -1.309 . . . . 74.32 107.465 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.17 121.6 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.473 -0.785 . . . . 73.5 109.324 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.44 129.93 55.87 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.222 -1.399 . . . . 73.54 107.222 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 . . . . . 0 C--N 1.285 -2.209 0 N-CA-C 109.389 -0.597 . . . . 75.44 109.389 177.661 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 33.4 m . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 121.336 0.588 . . . . 73.43 110.14 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.98 148.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.675 -0.693 . . . . 74.11 109.501 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.46 ' CE1' HG13 ' A' ' 430' ' ' VAL . 4.1 m-85 -123.55 132.62 53.95 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.821 0.849 . . . . 72.14 110.137 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.23 134.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.563 -1.273 . . . . 73.43 107.563 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . 0.485 ' CB ' ' HB3' ' A' ' 462' ' ' ASN . 11.6 t70 -105.58 146.21 29.94 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.924 -0.485 . . . . 74.03 109.998 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -143.35 164.0 31.48 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.748 0.309 . . . . 62.34 110.257 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -166.42 169.28 14.12 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.693 -1.965 . . . . 73.13 105.693 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 68.5 p -96.72 145.9 25.37 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.303 0.573 . . . . 72.42 110.537 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 12.1 tp10 -108.67 133.75 52.33 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.929 -1.878 . . . . 73.13 105.929 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 64.2 m-20 -42.69 -52.66 4.82 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.112 1.365 . . . . 73.3 114.24 -173.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 74.57 -90.9 0.75 Allowed Glycine 0 C--N 1.285 -2.28 0 CA-C-N 114.975 -1.011 . . . . 74.3 110.918 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 455' ' ' ASN . 9.4 t -124.86 -13.86 6.82 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.703 -0.851 . . . . 72.01 108.703 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -105.86 -165.98 1.16 Allowed 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.288 -1.375 . . . . 74.51 107.288 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.52 115.87 10.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.116 -0.634 . . . . 62.43 110.62 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.56 138.51 46.92 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.809 -0.812 . . . . 73.12 108.809 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 97.85 -10.84 64.38 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.252 -1.139 . . . . 75.34 110.252 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 35.0 t -126.45 -56.09 1.42 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.792 -0.447 . . . . 64.41 109.792 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.582 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 13.6 m-20 -78.61 -54.88 5.66 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-O 121.541 0.686 . . . . 65.31 109.406 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -138.61 171.55 14.18 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 108.41 -0.959 . . . . 75.25 108.41 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.83 161.41 27.66 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.88 -1.156 . . . . 65.52 107.88 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.466 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 8.0 p90 -99.49 -12.98 19.69 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 112.451 0.538 . . . . 73.24 112.451 -174.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.42 ' CG2' HG21 ' A' ' 442' ' ' VAL 0.273 11.5 t 37.27 73.84 0.09 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.227 1.811 . . . . 75.04 113.449 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.71 138.31 37.29 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.397 -1.274 . . . . 70.1 108.755 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 179.66 169.31 39.81 Favored Glycine 0 N--CA 1.413 -2.863 0 C-N-CA 118.777 -1.678 . . . . 70.13 112.205 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 5.9 m -117.41 133.67 55.71 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 106.69 -1.596 . . . . 74.44 106.69 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.2 t -96.14 119.85 44.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.745 -0.835 . . . . 74.44 108.745 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.0 t -95.73 117.44 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 73.24 108.941 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.9 m-85 -89.77 110.32 21.24 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 116.056 -0.52 . . . . 73.23 111.291 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 164.82 23.31 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.476 -0.784 . . . . 71.42 110.359 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -52.28 113.57 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.664 2.243 . . . . 72.15 112.236 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.58 25.29 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 111.134 -0.787 . . . . 73.11 111.134 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -81.85 63.23 6.01 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 123.533 0.733 . . . . 74.44 110.514 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 11.3 t -79.19 -7.69 58.43 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.874 -1.158 . . . . 72.34 107.874 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -136.92 137.09 39.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.905 -1.517 . . . . 75.54 106.905 172.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -125.98 153.23 44.62 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 111.596 0.221 . . . . 74.34 111.596 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -112.48 132.5 55.04 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.475 -0.565 . . . . 53.22 109.475 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 41.1 pt -127.07 146.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.255 -1.017 . . . . 74.44 108.255 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 52.5 mtt180 -125.8 145.56 50.16 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.133 0.492 . . . . 73.03 111.886 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 389' ' ' THR . 48.9 t -113.42 124.05 69.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.269 -1.382 . . . . 74.21 107.269 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.05 137.05 20.78 Favored Glycine 0 N--CA 1.435 -1.428 0 O-C-N 123.816 0.698 . . . . 73.52 111.866 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 36.8 mm -96.8 132.28 41.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.014 -0.735 . . . . 65.33 109.014 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.5 mt -94.53 149.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.541 -1.651 . . . . 72.21 106.541 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 86.9 5.38 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.471 -0.491 . . . . 75.11 111.868 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.64 120.99 43.43 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 104.717 -2.327 . . . . 73.01 104.717 172.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.289 4.0 t70 -118.35 90.2 3.28 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 116.046 -2.262 . . . . 72.32 112.398 178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.715 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.2 mm -120.21 155.62 23.24 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 110.747 -2.933 . . . . 74.52 104.041 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -54.26 114.84 1.78 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.602 -1.629 . . . . 73.31 106.602 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.715 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 47.4 mt-10 -107.42 98.34 7.97 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.564 1.173 . . . . 74.3 112.676 -171.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -112.58 108.47 17.57 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.673 -2.058 . . . . 71.03 107.681 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 42.07 60.56 2.23 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.99 1.431 . . . . 74.42 111.256 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.415 ' OE2' ' HG2' ' A' ' 451' ' ' GLU . 12.0 tt0 -89.15 107.22 18.93 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.914 -1.513 . . . . 74.24 106.914 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.3 OUTLIER -136.92 159.98 40.27 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 114.684 1.364 . . . . 55.02 114.684 -175.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.522 ' HB2' ' O ' ' A' ' 412' ' ' GLU . 34.0 p90 -132.97 177.61 7.52 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.359 -1.291 . . . . 74.44 108.613 174.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.47 136.99 54.58 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.82 -0.808 . . . . 75.42 108.82 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . 0.423 ' HB ' ' HB1' ' A' ' 492' ' ' ALA . 41.0 t -108.84 125.87 65.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.277 -1.009 . . . . 73.41 108.277 176.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -120.68 152.98 37.54 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.923 -0.581 . . . . 72.32 109.561 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 72.9 mt -109.19 140.61 42.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.465 -0.569 . . . . 70.33 109.465 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.7 m -152.54 -173.13 4.45 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.592 0.757 . . . . 63.43 108.961 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . 0.485 ' HB3' ' CB ' ' A' ' 408' ' ' ASP . 3.0 t30 48.89 81.28 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.95 1.3 . . . . 65.43 111.267 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.09 128.0 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.879 -1.156 . . . . 73.41 107.879 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.42 -1.956 0 CA-C-O 121.163 0.506 . . . . 75.14 111.185 -174.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 25.7 m . . . . . 0 N--CA 1.419 -1.998 0 CA-C-O 120.588 0.232 . . . . 73.54 110.704 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 458' ' ' VAL . . . -104.22 100.46 10.19 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.277 -1.379 . . . . 70.11 107.277 171.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 29.9 m -78.06 129.6 35.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.948 -0.76 . . . . 74.1 108.948 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.25 109.23 27.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.398 -0.593 . . . . 73.01 109.398 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.491 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 26.8 m -98.28 115.67 28.89 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.987 -0.746 . . . . 73.21 108.987 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -95.81 124.46 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 CA-C-O 122.075 0.941 . . . . 73.33 110.002 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 71.7 m-85 -108.04 126.05 52.28 Favored 'General case' 0 N--CA 1.396 -3.156 0 CA-C-N 114.588 -1.187 . . . . 74.45 109.06 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -91.28 -19.7 22.7 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 104.431 -2.433 . . . . 73.43 104.431 166.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 111.795 -2.457 . . . . 73.34 111.677 178.443 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 53.0 mttp . . . . . 0 CA--C 1.477 -1.846 0 CA-C-O 121.242 0.544 . . . . 75.24 112.026 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 37.9 mm -114.49 106.86 21.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.252 -1.34 . . . . 74.24 108.728 -170.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.55 155.84 43.86 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 119.81 -0.756 . . . . 71.33 111.515 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -76.49 150.88 36.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.407 -0.361 . . . . 74.32 110.132 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.8 -42.27 86.21 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.532 -0.914 . . . . 73.23 108.532 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.527 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.4 mm100 -106.29 -171.75 1.96 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.869 -1.059 . . . . 71.31 110.221 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -123.02 -32.67 0.9 Allowed Glycine 0 C--N 1.289 -2.04 0 N-CA-C 109.233 -1.547 . . . . 71.24 109.233 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.2 m -127.84 141.4 51.58 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.907 -1.145 . . . . 72.31 107.907 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 64.5 m-85 -127.88 136.27 51.16 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.361 -0.978 . . . . 75.3 108.361 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.24 129.35 54.89 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.537 -1.283 . . . . 72.32 107.537 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 48.6 t -146.16 163.11 36.41 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.243 -0.651 . . . . 71.05 109.243 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -81.64 146.5 30.03 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.219 0.608 . . . . 72.04 111.917 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -58.12 -49.63 76.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.283 -1.006 . . . . 72.21 108.283 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.478 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.8 p-10 -73.55 16.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.911 -1.041 . . . . 73.33 113.706 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.1 t -86.71 -26.65 24.15 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.184 0.516 . . . . 64.2 109.725 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 96.78 -49.92 1.57 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.762 -0.732 . . . . 75.24 111.486 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 11.4 p -143.31 152.36 41.57 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.855 0.462 . . . . 71.13 109.943 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 442' ' ' VAL . 5.7 p -107.42 133.88 50.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.146 -1.427 . . . . 73.2 107.146 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.18 126.43 50.35 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 123.299 0.375 . . . . 73.43 110.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.41 ' N ' HD11 ' A' ' 392' ' ' LEU . 3.4 mp -119.59 145.94 45.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.961 -1.496 . . . . 72.43 106.961 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 56.7 m -113.14 127.65 56.26 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.438 -0.505 . . . . 74.41 110.831 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 70.1 mt -98.43 126.22 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 107.828 -1.175 . . . . 75.21 107.828 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 397' ' ' ARG . 43.7 mm -102.24 125.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.398 -1.334 . . . . 75.01 107.398 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 16.8 ttp180 -109.38 108.49 19.06 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.464 -0.335 . . . . 74.32 110.373 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . 0.431 ' HG3' HG21 ' A' ' 395' ' ' ILE . 80.2 mtp180 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 116.281 -0.418 . . . . 70.11 111.495 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.7 m . . . . . 0 N--CA 1.419 -2.016 0 CA-C-O 121.625 0.726 . . . . 75.51 109.739 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.49 133.82 51.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.599 -1.182 . . . . 65.51 109.259 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 21.8 m-85 -113.62 123.61 50.36 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.599 -0.728 . . . . 74.22 109.234 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.56 128.94 74.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.721 -0.844 . . . . 73.32 108.721 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.4 139.38 31.18 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.848 0.356 . . . . 64.13 110.725 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -132.56 153.98 50.46 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.858 -0.526 . . . . 71.13 111.108 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -159.39 163.64 35.33 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.433 -0.951 . . . . 75.43 108.433 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 77.2 p -101.01 171.85 7.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.667 0.27 . . . . 73.53 111.139 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.3 151.1 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.06 -0.719 . . . . 73.22 109.06 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.11 1.63 35.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 118.345 -0.836 . . . . 62.25 113.054 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -4.49 -97.08 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 C-N-CA 125.842 1.687 . . . . 71.44 115.185 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.9 t -105.47 -18.66 14.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.296 -0.631 . . . . 74.22 109.296 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -118.52 143.56 46.66 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.955 -0.758 . . . . 74.0 108.955 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -108.02 113.83 27.29 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 121.487 0.66 . . . . 71.54 111.59 -166.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -74.78 124.39 26.72 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.335 -0.848 . . . . 74.12 109.685 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.35 -28.35 6.05 Favored Glycine 0 C--N 1.294 -1.756 0 N-CA-C 109.19 -1.564 . . . . 65.4 109.19 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 32.6 t -117.03 -52.64 2.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.474 -0.363 . . . . 73.12 110.205 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.608 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 6.4 m-20 -75.63 -59.94 2.53 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.865 0.84 . . . . 74.01 110.24 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 444' ' ' ILE . 0.1 OUTLIER -136.93 176.48 8.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.714 -1.587 . . . . 72.41 106.714 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -83.76 157.67 22.03 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.014 -0.736 . . . . 70.43 109.014 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -91.52 -8.93 46.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.068 -0.515 . . . . 74.14 112.337 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.442 HG23 HG21 ' A' ' 442' ' ' VAL . 15.1 t 37.9 63.73 0.76 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.681 1.593 . . . . 74.44 113.252 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.56 110.98 15.39 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.216 -0.902 . . . . 63.52 109.576 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.0 174.24 33.24 Favored Glycine 0 N--CA 1.41 -3.046 0 CA-C-N 115.079 -0.964 . . . . 61.04 111.119 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 69.6 m -125.49 133.45 52.38 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 107.139 -1.43 . . . . 74.25 107.139 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.44 129.47 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.358 -0.978 . . . . 71.21 108.358 -176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.11 104.87 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.342 -0.845 . . . . 74.01 108.873 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.7 m-85 -84.8 108.39 17.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.867 -0.606 . . . . 74.42 111.325 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -90.1 165.04 25.63 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.773 -0.649 . . . . 72.34 110.093 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -50.92 127.73 22.4 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.991 2.461 . . . . 71.43 112.184 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 93.66 -17.65 58.13 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 115.839 -0.619 . . . . 73.44 113.426 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.436 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 71.2 mt-10 -84.24 63.88 7.97 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.866 0.841 . . . . 72.1 112.957 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 39.2 m -60.36 -24.06 64.77 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.009 -1.45 . . . . 74.44 110.707 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -128.57 138.88 52.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.7 -0.625 . . . . 75.24 110.36 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -134.87 145.65 48.48 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 120.941 0.401 . . . . 74.24 111.498 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -109.04 134.43 51.68 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.522 -0.763 . . . . 73.12 110.259 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.7 pt -116.34 137.05 51.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.826 -0.625 . . . . 72.42 109.514 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 17.5 mmt180 -109.05 132.84 53.73 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.297 -0.865 . . . . 74.12 111.286 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.445 ' HB ' ' CG1' ' A' ' 390' ' ' VAL . 47.9 t -108.23 116.79 52.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.674 -1.232 . . . . 73.5 107.674 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -61.2 130.79 47.52 Favored Glycine 0 N--CA 1.44 -1.096 0 O-C-N 124.482 1.114 . . . . 71.43 113.083 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 422' ' ' TYR . 33.3 mm -101.45 130.66 50.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.393 -1.336 . . . . 74.41 107.393 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 68.7 mt -98.38 150.04 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 105.485 -2.042 . . . . 75.14 105.485 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -84.64 86.13 7.35 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.405 -0.918 . . . . 72.24 111.564 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.39 124.27 51.4 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 103.269 -2.863 . . . . 73.42 103.269 169.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -119.38 94.73 4.52 Favored 'General case' 0 CA--C 1.456 -2.658 0 C-N-CA 116.836 -1.945 . . . . 62.12 110.841 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . . . . . . . . . 39.9 mm -118.29 155.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.816 0 CA-C-N 111.752 -2.476 . . . . 74.15 105.379 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.43 115.06 2.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.114 -1.81 . . . . 73.33 106.114 170.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 498' ' ' ASP . 29.5 mt-10 -129.37 94.28 3.75 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.847 1.308 . . . . 74.23 110.442 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.74 106.29 18.56 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 113.703 -1.59 . . . . 72.42 108.747 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.28 4.4 p30 42.39 60.16 2.44 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.86 1.35 . . . . 73.22 112.971 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -87.29 135.22 33.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.252 -1.388 . . . . 72.43 107.252 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -149.55 161.45 42.13 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.238 0.542 . . . . 75.55 111.941 -172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.402 ' CZ ' HG13 ' A' ' 442' ' ' VAL . 17.4 p90 -137.91 -177.98 5.05 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.71 -0.677 . . . . 74.3 110.225 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -119.82 145.04 47.0 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.274 -1.01 . . . . 72.5 108.274 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.24 132.16 67.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 106.828 -1.545 . . . . 73.24 106.828 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -123.06 139.43 54.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.423 0.452 . . . . 60.04 111.033 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.2 mt -100.07 136.69 39.59 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 44.5 m -157.77 174.3 15.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.425 -0.583 . . . . 73.22 109.425 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.4 t30 54.18 90.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.858 1.263 . . . . 73.33 112.596 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.2 123.19 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.644 -0.707 . . . . 72.51 109.688 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 37.2 ttmt . . . . . 0 C--N 1.281 -2.392 0 N-CA-C 107.362 -1.347 . . . . 74.2 107.362 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 109.413 -0.588 . . . . 64.14 109.413 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.18 130.4 53.35 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.845 -1.168 . . . . 72.22 107.845 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 123.37 41.19 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.523 -0.471 . . . . 74.33 109.9 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 76.5 t -108.3 107.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.248 -0.649 . . . . 73.44 109.248 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 10.2 m -91.03 116.54 28.88 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.069 -1.086 . . . . 73.21 108.069 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 50.1 mt -101.97 114.64 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.218 1.009 . . . . 73.4 110.902 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.492 ' O ' HD11 ' A' ' 384' ' ' LEU . 5.3 m-85 -84.05 102.36 12.46 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.24 -1.346 . . . . 74.01 110.777 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 451' ' ' GLU . 23.5 t70 -52.28 -54.87 25.86 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 112.418 -2.174 . . . . 71.21 108.518 172.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.474 0.769 0 CA-C-N 113.23 -1.804 . . . . 65.21 112.003 176.519 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 32.9 mmtp . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 108.199 -1.037 . . . . 74.22 108.199 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 42.7 mm -105.67 114.6 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.52 -0.919 . . . . 73.35 108.52 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -149.33 174.61 12.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.488 0.585 . . . . 74.42 111.319 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.28 146.76 26.89 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.01 -0.366 . . . . 74.24 110.01 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.668 -1.604 . . . . 73.31 106.668 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 4.8 mt-30 -102.31 144.14 31.19 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.288 -0.869 . . . . 74.43 110.201 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 492' ' ' ALA . . . -93.13 -12.4 57.59 Favored Glycine 0 C--N 1.284 -2.341 0 CA-C-N 115.699 -0.682 . . . . 72.03 111.553 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 25.6 m -140.37 131.37 26.18 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.644 -0.873 . . . . 74.53 108.644 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 72.5 m-85 -127.42 136.59 52.04 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.709 -0.848 . . . . 75.32 108.709 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -121.84 123.15 41.08 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.549 -1.278 . . . . 71.14 107.549 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 43.9 t -134.9 165.38 25.45 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.512 -0.551 . . . . 74.03 109.512 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 3.3 mm? -95.38 141.64 28.7 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.478 -0.783 . . . . 73.43 109.722 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.9 -36.93 78.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.822 -0.807 . . . . 74.44 108.822 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -65.53 -14.26 60.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.621 -1.172 . . . . 73.53 112.689 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 76.6 m -72.52 -19.22 61.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.769 0.285 . . . . 75.13 111.769 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.83 -48.48 3.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.309 -0.716 . . . . 73.22 111.309 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.1 p -141.51 161.34 38.16 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.605 0.762 . . . . 75.33 109.807 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.4 p -114.14 130.0 69.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.832 -1.173 . . . . 71.14 107.832 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.98 128.3 46.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 123.558 0.536 . . . . 72.42 110.174 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.52 151.04 41.76 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.677 -1.231 . . . . 64.44 107.677 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -112.03 128.83 56.3 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.336 0.588 . . . . 73.12 111.656 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 73.3 mt -101.53 126.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 107.913 -1.143 . . . . 64.1 107.913 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.2 mm -100.0 128.23 52.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.56 -0.904 . . . . 73.14 108.56 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.488 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 59.9 ttt180 -112.58 107.65 16.45 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.527 -0.916 . . . . 65.54 108.527 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 . . . . . 0 C--N 1.293 -1.874 0 CA-C-N 115.708 -0.678 . . . . 72.11 111.405 -178.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.437 -1.112 0 CA-C-O 121.798 0.808 . . . . 65.53 111.085 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 67.2 t -115.49 149.1 17.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.702 -1.136 . . . . 75.24 109.18 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 11.8 m-85 -126.69 147.42 49.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.338 0.59 . . . . 74.45 110.015 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.1 p -143.82 130.49 16.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.557 -0.535 . . . . 75.32 109.557 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -93.41 128.56 39.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.476 -0.565 . . . . 72.33 109.476 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -123.77 153.11 41.41 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.536 -0.912 . . . . 73.22 108.536 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -161.23 161.1 30.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.6 -1.259 . . . . 72.41 107.6 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 71.2 p -96.62 172.03 8.17 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.36 0.6 . . . . 65.33 109.859 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 6.8 tp10 -127.37 153.95 45.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.517 -2.031 . . . . 75.31 105.517 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.3 p-10 -58.2 -41.94 85.05 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.626 0.579 . . . . 73.41 112.425 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.62 -94.43 0.16 Allowed Glycine 0 C--N 1.294 -1.77 0 CA-C-N 115.478 -0.783 . . . . 60.25 111.696 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.9 t -127.74 7.83 6.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.655 0.741 . . . . 62.35 109.495 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -130.94 -159.48 0.97 Allowed 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.043 -1.466 . . . . 55.41 107.043 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -141.68 116.67 9.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.072 0.463 . . . . 75.11 110.546 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.44 128.72 36.78 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.905 -0.589 . . . . 75.33 109.557 178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.45 -24.38 15.78 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.445 -1.462 . . . . 71.34 109.445 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 21.2 t -111.93 -55.76 2.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 109.632 -0.507 . . . . 71.33 109.632 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.6 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 11.1 m-20 -80.09 -56.72 4.03 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.844 0.83 . . . . 62.31 110.055 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.466 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -136.95 167.78 20.84 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.191 -1.411 . . . . 74.13 107.191 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -74.96 152.05 38.81 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.308 -0.627 . . . . 74.02 109.308 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -85.76 -13.17 49.1 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.93 -0.577 . . . . 75.44 111.547 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.476 HG21 HG23 ' A' ' 442' ' ' VAL 0.253 14.7 t 35.5 63.11 0.55 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 126.1 1.76 . . . . 73.02 113.152 179.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.35 107.55 12.2 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.981 -1.008 . . . . 73.44 109.097 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -147.49 171.51 28.08 Favored Glycine 1 N--CA 1.394 -4.126 0 C-N-CA 119.125 -1.512 . . . . 71.5 112.07 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 25.5 m -124.27 136.13 53.91 Favored 'General case' 0 N--CA 1.388 -3.558 0 N-CA-C 106.652 -1.61 . . . . 73.01 106.652 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.7 t -95.77 126.89 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.371 -0.974 . . . . 73.21 108.371 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' A' ' 406' ' ' PHE . 19.3 t -100.52 100.59 10.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.188 -1.041 . . . . 73.2 108.188 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.488 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 54.6 m-85 -80.91 104.51 11.46 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.32 -0.4 . . . . 75.05 111.006 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.472 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -84.53 169.47 16.6 Favored Pre-proline 0 C--O 1.256 1.432 0 CA-C-N 115.785 -0.643 . . . . 75.31 110.169 177.746 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.08 132.74 49.17 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.79 2.327 . . . . 75.13 111.868 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.44 -25.57 17.63 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.851 -0.613 . . . . 75.11 113.224 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 44.9 mt-10 -75.57 64.47 1.66 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.86 0.864 . . . . 73.12 113.168 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 22.4 m -61.42 -23.64 65.96 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.437 -1.256 . . . . 73.45 109.149 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -132.8 143.25 49.44 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.192 -0.67 . . . . 73.05 109.192 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -131.31 149.82 52.4 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.049 -0.523 . . . . 73.4 110.457 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.1 135.51 51.51 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.798 -0.816 . . . . 75.33 108.798 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.8 pt -120.77 146.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.999 -1.111 . . . . 75.11 107.999 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 87.8 mtt180 -125.41 146.18 49.73 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.207 0.527 . . . . 75.52 110.651 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.537 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 51.1 t -113.37 120.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.863 -1.162 . . . . 73.41 107.863 178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -64.3 131.36 38.59 Favored Glycine 0 N--CA 1.439 -1.153 0 O-C-N 124.072 0.858 . . . . 74.34 111.897 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.51 133.52 39.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.563 -1.273 . . . . 75.03 107.563 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 75.6 mt -98.77 150.43 4.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.049 -1.093 . . . . 74.43 108.049 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.9 86.8 5.39 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.224 0.535 . . . . 70.14 111.421 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -112.9 101.66 9.71 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 104.579 -2.378 . . . . 75.42 104.579 171.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.285 11.3 t70 -106.61 84.44 2.01 Favored 'General case' 0 CA--C 1.458 -2.572 0 C-N-CA 115.613 -2.435 . . . . 70.15 112.025 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.657 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 46.1 mm -117.06 154.0 18.77 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.75 0 N-CA-C 103.388 -2.819 . . . . 75.35 103.388 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -52.09 116.15 2.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.32 0.964 . . . . 73.01 110.158 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 27.2 mt-10 -122.48 119.0 29.66 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.436 1.113 . . . . 72.54 113.258 -171.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.07 110.92 11.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.563 -1.653 . . . . 74.03 106.847 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 48.63 60.52 3.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.72 1.378 . . . . 63.34 114.72 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.404 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.2 pt-20 -99.5 134.6 42.14 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.781 -1.168 . . . . 75.11 108.253 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.7 p-10 -149.25 166.19 29.65 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.372 0.606 . . . . 71.32 111.534 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.537 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 30.7 p90 -137.35 -177.73 4.91 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.248 -0.887 . . . . 73.41 109.404 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.95 137.05 54.68 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.621 -1.251 . . . . 74.45 107.621 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 42.3 t -108.79 128.23 64.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.482 -1.303 . . . . 71.11 107.482 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -122.68 163.07 20.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.075 -0.511 . . . . 72.1 109.718 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 82.4 mt -118.2 134.04 55.36 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.252 -1.388 . . . . 75.3 107.252 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.0 m -150.43 161.46 42.46 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 109.222 -0.659 . . . . 60.22 109.222 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.73 87.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.257 0.973 . . . . 72.3 110.918 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.16 137.94 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.681 -1.229 . . . . 65.42 107.681 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 C--N 1.301 -1.51 0 N-CA-C 109.114 -0.698 . . . . 73.02 109.114 -176.65 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 110.024 -0.361 . . . . 74.03 110.024 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -102.93 103.02 13.12 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.383 -1.339 . . . . 72.05 107.383 172.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 53.3 m -83.26 118.74 23.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.133 0.492 . . . . 71.35 110.986 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.426 HG13 HG12 ' A' ' 390' ' ' VAL . 80.4 t -106.21 110.68 32.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.782 -0.822 . . . . 73.22 108.782 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 46.9 m -98.85 121.57 40.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.36 -0.978 . . . . 65.4 108.36 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.525 HD13 ' CE2' ' A' ' 456' ' ' PHE . 5.2 mp -97.9 117.52 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 121.835 0.826 . . . . 75.3 110.764 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.698 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 55.6 m-85 -98.07 122.98 41.87 Favored 'General case' 0 N--CA 1.399 -3.005 0 N-CA-C 105.709 -1.96 . . . . 74.51 105.709 170.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.12 -3.0 23.58 Favored 'General case' 0 C--N 1.258 -3.402 0 C-N-CA 119.33 -0.948 . . . . 74.43 109.114 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.312 -1.058 0 C-N-CA 126.754 2.021 . . . . 74.51 113.191 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 93.0 mttt . . . . . 0 CA--C 1.494 -1.183 0 N-CA-C 112.917 0.71 . . . . 71.14 112.917 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 31.5 mm -102.19 127.86 55.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.054 -1.462 . . . . 75.13 107.054 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 397' ' ' ARG . 39.3 p90 -159.85 168.73 25.13 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 117.994 0.361 . . . . 74.44 111.655 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -88.55 142.31 27.81 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 110.021 -0.363 . . . . 73.04 110.021 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . 0.416 ' HB2' HG12 ' A' ' 395' ' ' ILE . 41.4 tt0 -62.87 -51.08 68.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.518 0.675 . . . . 73.32 109.444 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -108.94 146.61 33.53 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 114.972 -1.013 . . . . 72.02 110.425 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.47 -25.43 33.19 Favored Glycine 0 C--N 1.294 -1.801 0 N-CA-C 110.686 -0.965 . . . . 73.31 110.686 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 12.9 m -127.34 136.04 51.36 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.406 -0.961 . . . . 74.22 108.406 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -127.13 137.32 52.96 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.355 -0.98 . . . . 73.43 108.355 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -127.34 129.66 48.05 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.83 -1.544 . . . . 72.45 106.83 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 11.9 t -148.72 160.3 43.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.054 -1.091 . . . . 71.03 108.054 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.546 HD11 ' OD1' ' A' ' 386' ' ' ASN . 2.6 mm? -78.43 144.76 35.55 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.294 0.569 . . . . 73.44 112.202 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -59.48 -41.82 90.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.315 -0.857 . . . . 63.44 108.742 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.546 ' OD1' HD11 ' A' ' 384' ' ' LEU . 2.4 p-10 -78.25 9.81 3.52 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.436 -0.802 . . . . 74.11 113.065 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.3 t -83.97 -28.5 27.74 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.728 -0.608 . . . . 72.03 110.524 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.81 -58.39 0.56 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.175 -0.536 . . . . 72.31 112.209 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 5.6 p -141.95 151.41 42.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.024 0.412 . . . . 71.14 110.447 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.7 p -109.14 133.41 54.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 107.755 -1.202 . . . . 74.22 107.755 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.98 128.83 48.24 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.153 0.501 . . . . 73.33 110.39 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -120.62 145.28 47.56 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.311 -1.366 . . . . 75.21 107.311 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 29.4 m -113.67 127.06 55.9 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 121.43 0.633 . . . . 74.43 111.298 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 76.5 mt -95.05 121.34 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 N-CA-C 108.02 -1.104 . . . . 73.54 108.02 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 377' ' ' GLU . 42.8 mm -99.14 119.4 47.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.48 -1.304 . . . . 75.31 107.48 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.404 ' NH1' HG23 ' A' ' 405' ' ' VAL . 23.6 ttt85 -100.48 121.36 41.42 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-O 121.482 0.658 . . . . 73.5 110.576 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 375' ' ' PHE . 22.0 mmm180 . . . . . 0 C--N 1.295 -1.788 0 CA-C-N 115.449 -0.796 . . . . 75.43 109.094 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.434 -1.251 0 CA-C-O 121.183 0.516 . . . . 75.31 111.681 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 66.6 t -103.44 136.5 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.046 -0.524 . . . . 75.55 109.707 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.95 121.41 34.37 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.601 0.361 . . . . 73.2 110.582 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 5.9 p -120.8 127.62 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.354 -0.98 . . . . 74.12 108.354 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.6 143.53 27.61 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.539 -0.912 . . . . 74.23 108.539 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -142.42 158.39 43.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.941 -0.474 . . . . 75.44 110.124 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -165.68 158.01 15.0 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.548 -1.279 . . . . 75.43 107.548 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.633 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 36.5 p -96.73 156.13 16.48 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.373 -0.603 . . . . 75.21 109.373 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.2 tp10 -106.35 151.26 25.1 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.96 -1.496 . . . . 75.32 106.96 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.591 ' OD1' ' HA ' ' A' ' 417' ' ' ASN . 11.2 m-20 -55.96 -39.02 71.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.698 0.799 . . . . 61.41 112.38 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 62.93 -95.56 0.13 Allowed Glycine 0 C--N 1.297 -1.614 0 CA-C-N 114.938 -1.028 . . . . 75.55 112.63 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.9 t -121.37 8.92 10.26 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.296 -0.631 . . . . 64.31 109.296 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -137.9 -160.49 1.06 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.537 -0.912 . . . . 73.51 108.537 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.591 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 6.5 m120 -137.25 122.55 19.37 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.708 0.766 . . . . 72.53 112.021 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -68.62 129.31 39.56 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.561 -1.199 . . . . 72.52 109.394 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.95 -32.66 6.87 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 111.305 -0.718 . . . . 72.33 111.305 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 t -102.24 -44.52 5.4 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.695 -0.483 . . . . 64.44 109.695 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.544 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 23.7 m-20 -87.3 -64.27 1.17 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.049 0.928 . . . . 73.11 109.659 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.717 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.16 167.0 23.24 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.147 -0.933 . . . . 65.22 110.217 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -75.47 153.52 37.53 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.632 0.583 . . . . 73.23 110.333 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.633 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.2 p90 -88.93 -15.34 34.56 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.717 -0.674 . . . . 72.45 112.126 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 442' ' ' VAL 0.296 13.5 t 32.49 66.87 0.18 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.897 1.679 . . . . 74.53 114.414 -176.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.76 131.12 34.94 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.592 -0.892 . . . . 75.25 108.592 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -173.38 -175.74 41.36 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 120.099 -1.048 . . . . 72.43 110.957 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.3 m -116.89 138.35 51.59 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 108.159 -1.052 . . . . 75.24 108.159 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.2 t -96.12 116.42 37.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.085 -1.45 . . . . 73.12 107.085 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.17 105.69 17.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.533 -0.758 . . . . 65.31 109.749 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.436 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 78.7 m-85 -82.57 98.36 8.94 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.226 -1.028 . . . . 71.34 108.226 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.1 mttm -80.58 170.18 16.66 Favored Pre-proline 0 C--N 1.296 -1.747 0 CA-C-N 114.065 -1.425 . . . . 71.54 109.948 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.7 Cg_exo -52.24 109.91 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.55 2.167 . . . . 54.04 113.339 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.47 -0.34 61.47 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.126 -0.943 . . . . 44.12 114.825 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.406 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 34.6 mm-40 -76.59 64.23 2.2 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.852 0.826 . . . . 74.21 113.062 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.9 m -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 121.374 0.607 . . . . 74.34 110.381 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -131.4 139.81 49.52 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.08 -0.711 . . . . 75.52 109.08 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -130.63 151.41 51.12 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.594 -0.275 . . . . 74.02 111.65 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.85 137.3 52.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.849 -0.614 . . . . 74.41 109.644 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.28 147.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.936 -1.135 . . . . 74.21 107.936 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 49.4 mtt180 -129.57 135.07 48.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 120.996 0.426 . . . . 73.43 111.215 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.576 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 61.9 t -105.34 127.3 60.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.431 -0.804 . . . . 63.32 109.409 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -70.97 130.31 19.45 Favored Glycine 0 N--CA 1.439 -1.115 0 O-C-N 124.192 0.933 . . . . 62.23 112.37 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.7 mm -94.9 134.78 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 106.916 -1.512 . . . . 75.02 106.916 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 66.6 mt -101.7 151.19 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 108.063 -1.088 . . . . 72.44 108.063 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.96 97.6 2.33 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.995 0.426 . . . . 53.43 110.234 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.45 124.75 27.63 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 103.63 -2.73 . . . . 73.1 103.63 170.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.2 97.13 4.81 Favored 'General case' 0 CA--C 1.462 -2.436 0 C-N-CA 117.733 -1.587 . . . . 72.24 110.042 174.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.722 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 28.9 mm -123.35 156.64 29.53 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.55 0 CA-C-N 111.308 -2.678 . . . . 75.5 104.171 -173.15 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -56.86 113.49 1.69 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 116.652 -2.019 . . . . 72.34 105.777 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.722 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.7 mt-10 -120.93 121.86 38.96 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 108.986 -0.746 . . . . 75.12 108.986 -170.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -132.34 109.48 9.9 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 115.176 -0.92 . . . . 74.0 108.691 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.37 35.72 26.34 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.469 1.106 . . . . 70.32 111.18 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.3 tt0 -64.02 106.63 1.08 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.318 -1.364 . . . . 63.41 107.318 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.411 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 35.2 p30 -138.57 166.15 25.07 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.449 0.643 . . . . 75.42 112.078 -175.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.604 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 21.2 p90 -140.2 -179.24 5.87 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.182 -0.917 . . . . 73.14 109.764 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 31.9 mt -123.79 136.74 54.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.134 -1.062 . . . . 74.15 108.134 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.3 124.9 60.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.418 -1.327 . . . . 75.22 107.418 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -117.71 156.34 28.4 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.572 0.545 . . . . 74.11 109.839 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 86.5 mt -113.42 140.61 47.93 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.563 -0.903 . . . . 73.3 108.563 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.7 m -146.84 173.56 12.29 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.787 -0.449 . . . . 71.04 109.787 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.4 t30 34.65 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 126.145 1.778 . . . . 75.41 113.854 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.77 132.54 43.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.142 -1.023 . . . . 73.01 108.564 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.2 tptp . . . . . 0 C--N 1.296 -1.74 0 N-CA-C 108.237 -1.023 . . . . 73.33 108.237 -179.55 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 N--CA 1.409 -2.51 0 N-CA-C 108.024 -1.102 . . . . 73.24 108.024 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -101.84 120.6 40.64 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.131 -1.063 . . . . 73.35 108.131 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 40.8 m -89.38 119.19 29.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.235 -0.586 . . . . 50.21 109.834 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.418 HG11 HG12 ' A' ' 390' ' ' VAL . 76.6 t -106.89 107.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 108.177 -1.046 . . . . 73.45 108.177 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.411 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 85.2 m -97.45 114.32 26.15 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.72 -0.844 . . . . 74.12 108.72 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.717 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.09 116.96 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.367 -0.833 . . . . 75.42 109.169 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.544 ' O ' HD13 ' A' ' 384' ' ' LEU . 24.2 m-85 -80.26 97.79 7.11 Favored 'General case' 0 N--CA 1.382 -3.868 0 CA-C-O 122.324 1.059 . . . . 74.54 112.366 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . 0.42 ' CG ' ' HB2' ' A' ' 451' ' ' GLU . 3.3 t70 -50.17 -54.87 17.85 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 111.749 -2.478 . . . . 55.41 108.493 170.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.476 0.853 0 CA-C-N 113.797 -1.547 . . . . 53.21 110.965 176.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 107.411 -1.329 . . . . 71.41 107.411 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.0 120.74 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 71.23 107.98 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -152.95 173.32 15.54 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 118.455 0.57 . . . . 73.13 110.361 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -87.41 154.68 20.47 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.21 110.873 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.12 -40.68 86.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.958 -0.756 . . . . 73.33 108.958 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -126.36 162.74 24.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.492 -0.777 . . . . 72.11 111.835 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -94.46 -19.69 31.8 Favored Glycine 0 C--N 1.3 -1.436 0 CA-C-N 115.045 -0.979 . . . . 60.33 111.712 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 62.6 m -141.86 128.51 20.33 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 39.8 m-85 -114.56 136.82 52.61 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 124.261 1.024 . . . . 75.33 108.792 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 495' ' ' THR . 43.7 mt-30 -129.51 123.92 32.68 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.429 -1.323 . . . . 74.54 107.429 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 46.6 t -139.96 165.18 28.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.356 -0.979 . . . . 72.43 108.356 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.656 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 3.8 mm? -87.13 140.56 29.43 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 123.32 0.388 . . . . 73.42 111.552 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -58.76 -42.28 88.54 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.009 -0.737 . . . . 73.12 109.009 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -73.19 -5.42 39.17 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.354 0.872 . . . . 53.41 113.354 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 57.7 m -80.73 -7.28 59.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.8 -0.562 . . . . 72.14 111.91 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.78 -56.01 3.38 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.467 -0.873 . . . . 74.35 112.819 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 21.6 p -137.58 166.77 23.09 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.979 0.419 . . . . 74.32 111.203 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.8 p -116.93 128.84 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 106.932 -1.507 . . . . 64.01 106.932 170.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.95 118.48 37.0 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.307 0.575 . . . . 71.12 110.418 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.434 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.0 mp -109.82 139.89 44.37 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.52 -1.289 . . . . 71.21 107.52 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.9 m -109.55 127.92 54.82 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 109.391 -0.596 . . . . 71.04 109.391 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 64.1 mt -99.37 125.6 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.52 -1.289 . . . . 75.53 107.52 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.6 mm -101.48 129.04 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 115.09 -0.959 . . . . 64.22 108.421 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -115.92 108.88 16.84 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.928 -1.033 . . . . 74.41 109.226 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 . . . . . 0 C--N 1.301 -1.53 0 CA-C-N 115.72 -0.673 . . . . 72.22 110.292 -177.897 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 9.4 m . . . . . 0 N--CA 1.411 -2.382 0 N-CA-C 109.38 -0.6 . . . . 70.11 109.38 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.5 t -100.37 141.86 16.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.404 -0.962 . . . . 73.24 108.404 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 54.2 m-85 -128.38 119.77 25.67 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 122.735 0.414 . . . . 64.23 109.948 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.07 124.45 72.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.532 -0.914 . . . . 73.45 108.532 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 461' ' ' SER . 14.7 t70 -90.05 140.46 29.62 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 110.1 -0.333 . . . . 72.53 110.1 -177.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.95 169.1 18.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.179 -0.304 . . . . 74.54 110.179 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 411' ' ' THR . 63.5 ttt-85 -167.52 167.22 13.77 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 105.825 -1.917 . . . . 73.53 105.825 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.617 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 62.2 p -95.55 168.2 10.84 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.692 -0.855 . . . . 75.12 108.692 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.7 tp10 -106.51 150.74 25.81 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.613 0.721 . . . . 71.32 109.29 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.53 5.39 51.01 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 125.915 1.686 . . . . 55.42 110.679 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -28.73 -93.39 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.74 2.114 . . . . 61.14 116.953 -174.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 455' ' ' ASN . 5.2 t -93.74 -7.06 44.68 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.848 0.832 . . . . 74.03 110.56 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.734 ' HB2' ' OH ' ' A' ' 422' ' ' TYR . . . -151.89 153.22 33.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.409 -1.7 . . . . 71.24 106.409 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.19 145.86 33.61 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.617 0.722 . . . . 73.22 112.138 -164.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -82.93 148.71 27.48 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.072 -0.967 . . . . 71.42 108.534 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.94 79.05 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.454 -1.058 . . . . 60.12 110.454 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 38.3 m -149.44 -58.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.697 -0.483 . . . . 71.12 109.697 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.497 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 8.0 m-20 -86.23 -55.0 4.12 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.408 1.099 . . . . 71.24 108.934 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.734 ' OH ' ' HB2' ' A' ' 416' ' ' ALA . 0.1 OUTLIER -141.67 164.79 29.26 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.948 -1.024 . . . . 75.42 111.07 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.07 160.56 31.08 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.352 -0.84 . . . . 73.32 108.842 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.617 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -100.07 -20.14 16.17 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 122.936 0.495 . . . . 72.42 112.152 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.479 ' CG2' HG23 ' A' ' 442' ' ' VAL 0.323 10.1 t 39.04 64.55 0.78 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.351 1.861 . . . . 72.5 114.239 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.67 112.33 15.67 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.589 -1.187 . . . . 71.33 109.274 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -158.25 -178.62 32.46 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 110.443 -1.063 . . . . 73.14 110.443 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 17.5 m -122.63 139.72 53.62 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.358 -1.349 . . . . 73.1 107.358 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 45.0 t -95.56 118.8 42.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.8 -0.815 . . . . 74.1 108.8 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 406' ' ' PHE . 26.0 t -91.11 112.18 24.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.654 -1.157 . . . . 71.25 108.511 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 404' ' ' THR . 60.5 m-85 -97.61 101.75 13.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.69 -0.485 . . . . 71.51 109.69 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.3 mttm -85.21 172.5 8.68 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.071 -0.513 . . . . 74.43 109.979 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.9 Cg_exo -56.09 131.83 48.3 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.467 2.111 . . . . 74.35 111.649 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 87.33 -14.89 56.66 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 116.027 -0.533 . . . . 73.3 113.77 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -81.07 63.57 5.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.607 0.717 . . . . 74.0 112.391 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.1 m -60.9 -22.22 64.12 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.273 -1.33 . . . . 75.01 110.366 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -131.17 139.64 49.79 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.951 -1.129 . . . . 74.52 107.951 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -131.46 154.35 48.8 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 122.793 0.437 . . . . 73.14 110.068 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.27 132.48 50.33 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.787 -0.765 . . . . 75.15 111.076 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.5 pt -119.39 146.72 23.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.594 -0.891 . . . . 74.32 108.594 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 90.2 mtt180 -130.27 132.88 46.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.343 -0.543 . . . . 75.24 111.788 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.479 HG23 ' CG2' ' A' ' 425' ' ' THR . 62.1 t -104.71 120.56 55.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.041 -0.981 . . . . 74.41 108.451 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -71.98 136.52 24.2 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 121.134 -0.555 . . . . 71.42 112.241 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 35.5 mm -97.93 132.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.83 -1.174 . . . . 72.34 107.83 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 92.4 mt -91.57 151.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.477 -0.934 . . . . 75.35 108.477 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.29 92.54 5.15 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 120.981 0.419 . . . . 73.22 110.015 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.07 96.49 6.35 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.498 -2.778 . . . . 60.43 103.498 166.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -99.59 81.3 2.48 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 116.687 -2.005 . . . . 73.42 110.454 -173.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.6 mm -127.37 155.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.09 0 CA-C-N 110.383 -3.099 . . . . 74.45 103.993 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -56.36 114.36 1.96 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.925 -1.509 . . . . 73.14 106.925 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.7 mt-10 -111.89 128.12 56.05 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 108.259 -1.015 . . . . 73.11 108.259 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -124.27 103.85 8.47 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 115.599 -0.728 . . . . 72.45 110.086 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.82 60.38 3.58 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 125.076 1.485 . . . . 75.04 113.078 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.21 114.55 20.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.693 0.758 . . . . 75.1 109.516 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 415' ' ' THR . 3.4 p-10 -136.74 153.44 50.86 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 114.949 -1.023 . . . . 73.11 109.799 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.6 ' HD2' ' CZ ' ' A' ' 422' ' ' TYR . 20.9 p90 -136.78 -177.94 4.96 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.861 -0.609 . . . . 74.3 110.195 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 57.2 mt -121.17 139.71 52.98 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.983 -1.117 . . . . 74.52 107.983 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 491' ' ' THR . 47.5 t -107.65 110.77 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.579 -1.267 . . . . 73.22 107.579 174.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -102.78 137.83 40.47 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.591 -0.522 . . . . 64.15 109.591 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.83 126.66 42.14 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.592 -0.892 . . . . 73.23 108.592 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 408' ' ' ASP . 17.4 m -147.04 148.52 31.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.933 -0.765 . . . . 71.41 108.933 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.5 93.6 0.06 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.974 1.31 . . . . 71.52 110.575 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.15 137.07 39.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.378 -1.341 . . . . 72.04 107.378 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt . . . . . 0 C--N 1.286 -2.155 0 C-N-CA 123.609 0.764 . . . . 75.0 108.991 -175.547 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 45.5 m . . . . . 0 N--CA 1.426 -1.663 0 CA-C-O 120.88 0.371 . . . . 73.04 110.692 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.27 131.44 52.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.035 -0.728 . . . . 74.3 109.035 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 77.1 m -86.42 126.91 34.72 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.592 -0.892 . . . . 74.01 108.592 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 390' ' ' VAL . 77.0 t -111.94 107.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.674 -0.862 . . . . 75.2 108.674 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 23.6 m -101.21 111.22 23.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.13 -1.063 . . . . 74.22 108.13 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -88.49 123.68 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.595 0.712 . . . . 72.33 111.06 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -82.75 107.2 15.2 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-O 122.344 1.069 . . . . 71.51 110.209 173.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -40.42 84.03 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 112.288 -2.233 . . . . 74.11 112.766 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.535 ' HB2' ' CD1' ' A' ' 384' ' ' LEU . 20.4 t70 . . . . . 0 N--CA 1.501 2.099 0 C-N-CA 124.63 1.172 . . . . 75.24 112.454 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 96.4 mttt . . . . . 0 N--CA 1.423 -1.783 0 CA-C-O 120.56 0.219 . . . . 73.41 110.853 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 38.8 mm -125.12 109.16 21.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.572 -0.899 . . . . 73.44 108.572 -171.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -145.71 162.78 36.79 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.425 -0.51 . . . . 74.44 110.85 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.1 151.42 28.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 110.122 -0.325 . . . . 73.02 110.122 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -59.77 4.52 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.902 -1.518 . . . . 72.5 106.902 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 15.3 mm100 -102.55 173.11 6.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.604 -0.726 . . . . 74.44 111.007 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.26 -40.36 1.95 Allowed Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.943 -1.026 . . . . 71.14 110.651 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.0 m -122.68 126.11 46.94 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.876 -0.787 . . . . 73.55 108.876 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 77.5 m-85 -115.81 142.79 46.29 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.48 -0.933 . . . . 73.15 108.48 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 495' ' ' THR . 14.0 mp0 -123.53 146.14 48.33 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.251 -1.388 . . . . 74.11 107.251 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . 0.564 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -149.77 151.29 33.35 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.982 -1.118 . . . . 75.14 107.982 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 497' ' ' PHE . 0.4 OUTLIER -80.91 145.03 31.5 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.607 -0.886 . . . . 73.12 108.607 176.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -58.97 -29.95 67.57 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.55 0.69 . . . . 71.03 110.064 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -80.94 -1.44 43.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.455 -0.793 . . . . 72.5 112.558 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.45 -22.04 48.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.261 0.553 . . . . 64.01 111.182 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 91.6 -59.7 2.92 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.781 -0.723 . . . . 74.32 111.522 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.4 p -136.27 155.24 50.37 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.615 0.245 . . . . 74.41 110.793 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 N-CA-C 107.888 -1.153 . . . . 73.11 107.888 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.44 124.42 40.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.125 0.488 . . . . 75.02 110.592 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.0 mp -118.74 137.41 53.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.248 -1.389 . . . . 71.22 107.248 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.9 m -104.49 134.4 47.74 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.703 -0.48 . . . . 72.3 109.703 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 80.1 mt -103.85 126.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.57 -1.27 . . . . 73.42 107.57 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 44.9 mm -103.93 121.53 55.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.323 -0.991 . . . . 70.11 108.323 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 55.7 ttt180 -105.71 122.17 45.51 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.492 -0.777 . . . . 74.15 109.557 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.822 -0.626 . . . . 74.33 110.762 -178.276 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.419 -2.007 0 CA-C-O 121.497 0.665 . . . . 73.55 110.296 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.78 132.62 51.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.793 -0.817 . . . . 64.14 108.793 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 36.8 m-85 -115.62 129.3 56.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.192 0.52 . . . . 72.42 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.78 133.86 64.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.197 -1.409 . . . . 65.11 107.197 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -99.77 124.64 45.24 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.086 -0.709 . . . . 65.03 109.086 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 11.6 p90 -110.64 147.47 34.22 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.172 -0.677 . . . . 70.34 109.172 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 48.6 ttp180 -157.21 150.44 23.83 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.825 -1.176 . . . . 72.1 107.825 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 63.7 p -96.87 171.0 8.78 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.552 -0.459 . . . . 73.05 110.24 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 9.4 tp10 -137.57 158.21 44.88 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.166 -0.679 . . . . 75.25 109.166 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -31.14 -62.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.712 2.405 . . . . 72.32 113.147 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.29 -74.52 0.39 Allowed Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.069 -0.968 . . . . 72.32 111.019 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 8.8 t -154.87 16.72 0.44 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.122 -1.066 . . . . 71.02 108.122 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.8 -169.44 3.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.539 -0.755 . . . . 64.25 110.371 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.85 120.98 27.25 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.325 -0.621 . . . . 71.02 109.325 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -81.47 124.55 29.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.714 0.769 . . . . 71.14 110.553 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.49 32.0 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 109.43 -1.468 . . . . 71.21 109.43 -173.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 14.9 m -110.54 -58.55 2.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.985 -0.746 . . . . 73.12 108.985 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.556 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 14.3 m-20 -82.71 -58.26 2.97 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 122.011 0.91 . . . . 74.3 109.677 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.688 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.34 158.99 43.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.635 -0.876 . . . . 71.13 108.635 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.82 144.88 45.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.879 -0.785 . . . . 73.32 108.879 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.461 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 17.7 p90 -79.4 -18.45 52.28 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 113.054 0.761 . . . . 74.1 113.054 -173.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.491 HG21 HG21 ' A' ' 442' ' ' VAL 0.268 11.0 t 40.06 55.99 2.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 127.198 2.199 . . . . 74.43 115.311 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 1.5 pp20? -78.41 131.15 36.81 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 118.952 -1.099 . . . . 75.02 108.944 173.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -164.4 170.13 39.46 Favored Glycine 0 CA--C 1.46 -3.365 0 N-CA-C 109.93 -1.268 . . . . 72.35 109.93 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.5 m -111.35 131.63 55.02 Favored 'General case' 0 N--CA 1.394 -3.242 0 C-N-CA 119.739 -0.784 . . . . 72.14 108.888 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.67 125.49 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.941 -1.503 . . . . 75.54 106.941 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 406' ' ' PHE . 19.5 t -103.72 117.11 48.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.614 -0.884 . . . . 75.53 108.614 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.46 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 65.1 m-85 -94.91 105.02 16.91 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.188 0.518 . . . . 72.54 110.689 177.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.497 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 0.2 OUTLIER -90.12 167.64 16.47 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 114.652 -1.158 . . . . 75.43 110.315 -176.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 32.0 Cg_exo -57.03 115.09 2.24 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.872 2.381 . . . . 75.45 108.989 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.02 -38.04 3.32 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 111.523 -0.631 . . . . 72.12 111.523 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -85.97 62.37 7.4 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.717 0.77 . . . . 74.42 110.595 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 14.1 t -84.08 9.58 12.21 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 115.134 -0.939 . . . . 72.23 109.878 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -140.55 137.05 33.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -135.47 153.29 51.8 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.358 0.411 . . . . 75.35 111.193 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.26 128.54 55.67 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.537 -0.912 . . . . 71.51 108.537 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.91 149.56 19.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.857 -1.164 . . . . 73.42 107.857 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 79.9 mtm180 -133.28 143.36 49.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.174 0.511 . . . . 74.02 111.265 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -109.92 124.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.394 -0.965 . . . . 72.24 108.394 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -77.28 127.09 8.17 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.559 -0.616 . . . . 74.52 111.559 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 35.7 mm -89.97 134.74 28.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.162 -1.051 . . . . 63.44 108.162 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.2 mt -96.77 147.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.274 -1.38 . . . . 74.23 107.274 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -78.97 86.68 4.82 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.416 -0.513 . . . . 75.2 111.925 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.38 126.81 55.69 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 103.338 -2.838 . . . . 73.41 103.338 169.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.18 93.26 3.54 Favored 'General case' 0 CA--C 1.463 -2.366 0 CA-C-O 123.438 1.59 . . . . 74.11 109.785 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.748 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 51.8 mm -125.25 158.22 33.59 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.161 0 CA-C-N 111.283 -2.689 . . . . 75.5 104.608 -171.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -51.23 114.39 1.19 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.784 -1.932 . . . . 74.54 105.784 166.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.748 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 36.2 mt-10 -121.74 94.74 4.41 Favored 'General case' 0 CA--C 1.468 -2.21 0 CA-C-O 122.117 0.961 . . . . 71.44 111.476 -169.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.01 102.06 13.76 Favored 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 114.26 -1.336 . . . . 72.02 110.146 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.82 57.56 5.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.787 -1.552 . . . . 75.22 112.953 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.427 ' OE2' ' HG2' ' A' ' 451' ' ' GLU . 85.2 mt-10 -71.01 113.22 7.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.379 0.609 . . . . 73.12 109.836 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -137.47 160.36 39.34 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.874 -0.603 . . . . 75.44 110.401 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.3 p90 -140.37 177.25 8.13 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.489 -0.778 . . . . 73.14 109.735 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -117.69 138.07 52.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.335 -0.987 . . . . 71.43 108.335 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.28 120.58 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.896 -1.52 . . . . 74.44 106.896 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -114.3 149.12 36.45 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.641 0.588 . . . . 74.43 109.683 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.72 127.45 53.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 20.3 m -142.01 178.71 7.34 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.373 -0.602 . . . . 72.22 109.373 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.8 t30 50.37 86.11 0.03 OUTLIER 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.778 1.231 . . . . 75.04 113.238 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 53.4 t -84.89 116.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.55 -0.907 . . . . 75.5 108.55 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 26.3 tptp . . . . . 0 C--N 1.293 -1.872 0 N-CA-C 105.605 -1.998 . . . . 74.54 105.605 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.419 -2.009 0 N-CA-C 109.105 -0.702 . . . . 74.13 109.105 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.92 33.56 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.19 -1.041 . . . . 71.31 108.19 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 24.3 m -105.94 120.5 41.92 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.676 -0.41 . . . . 71.43 109.972 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 73.0 t -107.12 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.93 -0.767 . . . . 64.35 108.93 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 37.7 m -104.36 117.98 35.51 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.813 -0.81 . . . . 73.22 108.813 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.688 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -97.08 118.9 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 109.341 -0.614 . . . . 75.31 109.341 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.568 ' O ' HD12 ' A' ' 384' ' ' LEU . 6.1 m-85 -83.25 105.22 14.04 Favored 'General case' 0 N--CA 1.389 -3.494 0 CA-C-N 115.513 -0.767 . . . . 74.22 110.963 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.6 -57.51 12.07 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 113.088 -1.869 . . . . 75.01 109.348 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.49 1.562 0 C-N-CA 124.922 1.289 . . . . 72.21 111.246 176.821 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.3 mmtp . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 108.251 -1.018 . . . . 72.03 108.251 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.411 HG23 HG11 ' A' ' 407' ' ' VAL . 25.9 mm -95.18 119.12 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.588 -1.187 . . . . 74.23 108.434 -176.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 160.93 42.49 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.925 0.33 . . . . 71.33 110.503 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.78 148.64 29.95 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.609 -0.515 . . . . 74.44 109.609 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.3 -43.83 85.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.586 -0.524 . . . . 74.03 109.586 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -115.22 176.29 5.13 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.885 -0.598 . . . . 74.1 110.676 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -110.36 -19.17 8.11 Favored Glycine 0 C--N 1.291 -1.964 0 CA-C-N 115.063 -0.971 . . . . 33.42 110.801 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 59.8 m -140.06 135.24 32.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.117 -1.068 . . . . 74.01 108.117 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 49.8 m-85 -125.41 141.2 52.2 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.076 -1.083 . . . . 74.23 108.076 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.61 132.67 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.505 -1.294 . . . . 74.32 107.505 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 15.2 t -151.81 165.52 34.23 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.149 -1.056 . . . . 73.22 108.149 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.511 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 2.4 mm? -81.03 143.33 32.57 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.216 0.531 . . . . 71.14 111.095 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.94 -39.4 85.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.339 -0.846 . . . . 73.35 109.784 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -73.65 -4.4 34.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.534 -0.757 . . . . 75.13 112.474 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 89.1 m -71.11 -22.33 62.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 122.109 -0.369 . . . . 52.4 111.953 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 94.68 -50.11 2.04 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.706 -0.759 . . . . 43.44 111.565 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 18.9 p -139.28 160.4 39.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.911 -0.403 . . . . 65.12 109.911 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.0 p -114.83 133.8 59.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.281 -1.377 . . . . 74.2 107.281 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.41 125.83 48.11 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.201 0.524 . . . . 70.15 110.187 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.424 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.5 mp -116.52 153.68 31.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.121 -1.437 . . . . 74.35 107.121 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 28.1 m -120.6 126.93 51.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.335 0.588 . . . . 72.22 110.816 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.7 mt -100.69 120.27 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 108.204 -1.035 . . . . 64.11 108.204 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.4 HG23 ' HG2' ' A' ' 397' ' ' ARG . 46.2 mm -97.89 114.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.892 -1.049 . . . . 75.35 108.273 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.695 ' HB3' ' O ' ' A' ' 436' ' ' THR . 56.0 ttt180 -100.68 112.15 24.5 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 108.232 -1.025 . . . . 74.52 108.232 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 397' ' ' ARG . 4.3 mmp_? . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 109.518 -0.549 . . . . 75.35 109.518 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 31.9 m . . . . . 0 N--CA 1.422 -1.844 0 CA-C-O 121.757 0.789 . . . . 75.24 111.282 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.23 144.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.065 -0.97 . . . . 62.13 108.48 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -119.7 132.08 55.57 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.905 0.383 . . . . 74.11 110.027 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 429' ' ' VAL . 3.7 p -132.78 131.68 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.834 -1.543 . . . . 71.0 106.834 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -98.97 136.68 38.6 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.802 -0.561 . . . . 74.13 111.492 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -135.83 165.78 24.83 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.982 0.42 . . . . 73.21 110.536 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -167.12 155.53 9.78 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.579 -1.637 . . . . 73.3 106.579 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.669 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 26.1 p -96.62 160.81 14.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.437 -0.579 . . . . 72.42 109.437 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 16.0 tp10 -106.76 169.86 8.28 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.523 -1.288 . . . . 73.33 107.523 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 8.6 p-10 -63.03 -39.43 94.73 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.992 0.901 . . . . 64.42 110.255 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 72.21 -98.86 0.84 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.397 -1.274 . . . . 74.34 110.475 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' THR . . . . . 0.577 HG21 ' O ' ' A' ' 455' ' ' ASN . 10.8 t -122.34 -2.27 9.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.339 1.066 . . . . 74.34 108.65 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.534 ' HB1' ' OH ' ' A' ' 422' ' ' TYR . . . -124.72 -153.28 0.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.816 -1.179 . . . . 71.4 107.816 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -133.93 116.11 15.2 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 118.199 0.454 . . . . 72.1 110.019 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.69 24.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.819 -0.808 . . . . 74.22 108.819 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.13 -19.27 25.13 Favored Glycine 0 C--N 1.288 -2.099 0 N-CA-C 110.539 -1.024 . . . . 72.43 110.539 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 m -115.84 -51.05 2.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.82 0.343 . . . . 73.52 110.568 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.599 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 16.3 m-20 -79.98 -64.57 1.16 Allowed 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 122.369 1.081 . . . . 72.43 108.819 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.645 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -134.29 162.6 31.73 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.19 -1.368 . . . . 74.44 107.899 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -82.82 154.38 24.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.486 0.66 . . . . 64.32 111.792 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.669 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.5 OUTLIER -79.1 -12.11 60.0 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.16 -0.927 . . . . 72.22 113.014 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.432 HG23 HG21 ' A' ' 442' ' ' VAL 0.253 13.3 t 33.64 69.47 0.14 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.734 1.614 . . . . 72.12 113.29 -177.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.26 129.48 34.5 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.254 -0.884 . . . . 75.11 109.647 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -174.11 175.59 46.57 Favored Glycine 0 N--CA 1.405 -3.425 0 C-N-CA 119.783 -1.199 . . . . 63.22 111.025 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 7.9 m -112.81 142.26 45.66 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.247 -1.39 . . . . 72.21 107.247 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 407' ' ' VAL . 22.4 t -95.16 111.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.528 -1.656 . . . . 75.3 106.528 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.3 106.51 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 115.036 -0.984 . . . . 75.44 109.093 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 404' ' ' THR . 70.7 m-85 -77.61 94.26 4.34 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.268 -0.878 . . . . 74.43 109.887 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -73.98 163.77 65.99 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.971 -0.559 . . . . 72.44 111.021 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -51.28 113.84 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.47 2.113 . . . . 72.03 112.686 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.74 -24.0 32.95 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.832 -0.699 . . . . 65.11 111.488 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . 0.444 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 9.7 mm-40 -86.06 61.28 6.74 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.754 -0.832 . . . . 74.23 108.754 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.695 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 12.4 m -67.45 -33.73 75.74 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 107.613 -1.254 . . . . 73.35 107.613 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.26 132.8 50.13 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 106.607 -1.627 . . . . 74.21 106.607 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -118.73 147.53 43.75 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.118 0.485 . . . . 73.14 111.481 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.99 132.29 54.29 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 115.075 -0.966 . . . . 74.51 108.512 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.0 pt -119.24 146.78 23.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.435 -0.95 . . . . 74.35 108.435 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 85.9 mtt180 -126.82 141.16 51.9 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-O 121.698 0.761 . . . . 74.32 111.942 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.656 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 57.6 t -109.08 126.37 66.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.384 -1.339 . . . . 74.53 107.384 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.49 123.53 6.79 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.948 -0.861 . . . . 44.32 110.948 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.57 132.92 31.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.051 -1.833 . . . . 75.22 106.051 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -94.32 149.27 4.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 105.134 -2.172 . . . . 75.23 105.134 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.66 85.79 4.67 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.801 -0.76 . . . . 65.13 110.733 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.25 112.92 23.9 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.075 -2.195 . . . . 73.11 105.075 172.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -118.0 93.61 4.2 Favored 'General case' 0 C--N 1.275 -2.671 0 C-N-CA 117.274 -1.771 . . . . 74.11 109.538 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 44.6 mm -125.9 156.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.86 0 CA-C-N 111.693 -2.503 . . . . 71.41 105.423 -172.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -49.45 115.03 1.18 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.458 -1.682 . . . . 75.4 106.458 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.2 mt-10 -129.35 121.42 27.42 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 109.621 -0.511 . . . . 74.14 109.621 -172.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -134.01 113.9 12.64 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.661 -1.237 . . . . 73.42 107.661 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 20.8 t70 56.74 54.88 6.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.518 1.127 . . . . 71.03 110.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -86.58 98.63 11.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.332 -1.358 . . . . 72.22 107.332 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.577 ' O ' HG21 ' A' ' 415' ' ' THR . 0.0 OUTLIER -131.85 143.4 50.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 122.108 0.956 . . . . 71.01 113.274 -176.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.656 ' CZ ' HG12 ' A' ' 442' ' ' VAL . 23.9 p90 -116.74 177.04 4.84 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.742 -1.117 . . . . 74.0 109.453 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -121.94 136.4 54.92 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.647 -1.242 . . . . 74.34 107.647 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 15.6 t -108.25 131.24 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.616 -1.253 . . . . 74.03 107.616 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -123.46 164.44 18.91 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.769 0.668 . . . . 74.24 109.769 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 91.3 mt -126.51 139.27 53.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.834 -0.432 . . . . 64.23 109.834 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 50.2 m -156.94 178.5 10.29 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.536 -0.912 . . . . 75.24 108.536 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 8.3 t30 42.75 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.653 1.581 . . . . 73.12 114.731 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.37 139.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 115.834 -0.621 . . . . 73.02 109.651 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 C--N 1.297 -1.705 0 N-CA-C 107.922 -1.14 . . . . 74.42 107.922 -179.387 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.405 -2.697 0 N-CA-C 109.081 -0.711 . . . . 74.21 109.081 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.47 99.74 10.69 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.603 -1.628 . . . . 74.22 106.603 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 36.9 m -79.98 120.32 24.01 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.566 -0.531 . . . . 72.44 109.566 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.458 HG11 HG12 ' A' ' 390' ' ' VAL . 72.2 t -107.0 105.48 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 116.181 -0.463 . . . . 74.11 109.759 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 86.7 m -88.69 111.5 22.02 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.533 -0.914 . . . . 75.11 108.533 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.645 HD11 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -87.1 117.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 108.998 -0.742 . . . . 74.52 108.998 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.444 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.9 m-85 -83.47 97.58 9.06 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-O 122.182 0.991 . . . . 74.41 112.169 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -51.58 -56.24 14.64 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.212 -2.267 . . . . 74.13 108.312 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 125.72 1.608 . . . . 55.11 111.306 175.551 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 28.7 mmtp . . . . . 0 CA--C 1.491 -1.309 0 N-CA-C 109.128 -0.693 . . . . 71.35 109.128 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 31.7 mm -98.81 118.27 45.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.813 -1.54 . . . . 71.24 108.49 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -154.87 174.15 15.51 Favored 'General case' 0 C--O 1.196 -1.718 0 CA-C-N 117.728 0.24 . . . . 74.22 110.364 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -92.74 153.0 19.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.345 -0.542 . . . . 74.34 112.268 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -54.53 37.68 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.659 -1.238 . . . . 73.51 107.659 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -106.51 160.86 15.1 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.559 -0.746 . . . . 74.43 110.693 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -96.31 -18.72 30.16 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 110.057 -1.217 . . . . 62.31 110.057 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 493' ' ' THR . 73.8 m -143.07 125.54 15.72 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 109.038 -0.727 . . . . 70.21 109.038 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 45.2 m-85 -109.84 136.23 49.48 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.289 -1.004 . . . . 74.03 108.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -130.28 122.82 28.71 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 390' ' ' VAL . 94.6 m -145.14 165.4 28.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.993 -0.743 . . . . 75.43 108.993 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' LEU . . . . . 0.751 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -78.19 149.66 33.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.967 0.413 . . . . 75.11 111.357 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -60.76 -28.29 68.61 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.642 1.211 . . . . 73.13 107.833 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -81.91 -4.72 57.25 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.327 -1.761 . . . . 51.45 111.833 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 78.7 m -77.23 -14.53 59.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 122.234 -0.291 . . . . 74.31 110.811 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.19 -53.6 3.9 Favored Glycine 0 CA--C 1.5 -0.882 0 N-CA-C 111.309 -0.717 . . . . 71.43 111.309 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 11.1 p -139.03 164.31 30.09 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.674 . . . . 74.33 109.179 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.61 HG22 ' SG ' ' A' ' 383' ' ' CYS . 7.3 p -117.82 129.37 74.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.564 -1.273 . . . . 74.32 107.564 173.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 440' ' ' ILE . . . -96.53 135.31 38.6 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.873 0.368 . . . . 75.0 110.291 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.418 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -126.19 145.37 50.4 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.839 -1.171 . . . . 72.12 107.839 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.3 m -112.85 124.2 52.05 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.226 0.536 . . . . 72.3 110.362 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.21 120.03 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.883 -1.154 . . . . 73.24 107.883 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.4 mm -99.13 116.04 41.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.469 -1.241 . . . . 71.41 108.417 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 44.3 ttt180 -102.62 113.05 26.1 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.522 -1.288 . . . . 74.51 107.522 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 112.681 0.623 . . . . 75.33 112.681 -178.511 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 60.9 m . . . . . 0 N--CA 1.432 -1.343 0 CA-C-O 122.014 0.912 . . . . 63.1 111.896 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.91 140.26 35.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 113.887 -1.506 . . . . 71.55 108.292 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 16.5 m-85 -120.07 129.27 54.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.582 -0.895 . . . . 74.4 108.582 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.22 132.69 70.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.887 -1.153 . . . . 74.14 107.887 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.05 147.09 27.4 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.805 -0.442 . . . . 60.42 109.805 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -141.72 163.99 31.41 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.868 -0.52 . . . . 74.54 111.792 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -158.13 168.93 25.72 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 125.313 1.445 . . . . 73.44 109.006 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 69.0 p -96.89 162.06 13.57 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.527 -1.286 . . . . 72.13 107.527 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -126.32 151.41 47.59 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.105 -0.638 . . . . 75.41 111.032 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 416' ' ' ALA . 2.5 p30 -65.71 2.77 0.9 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.795 2.038 . . . . 71.24 115.957 -176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.48 -73.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 124.92 1.247 . . . . 74.03 116.007 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.8 t -122.37 6.62 9.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 117.716 0.758 . . . . 54.32 110.304 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 413' ' ' ASP . . . -158.76 171.89 19.25 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 109.241 -0.652 . . . . 70.21 109.241 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -120.23 131.97 55.17 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.619 0.723 . . . . 71.31 112.073 -172.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -78.67 138.66 38.4 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.879 -1.055 . . . . 64.33 108.945 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.76 65.72 Favored Glycine 0 C--N 1.3 -1.467 0 N-CA-C 109.983 -1.247 . . . . 73.14 109.983 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 49.0 m -141.28 -59.02 0.49 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 122.546 0.339 . . . . 73.24 110.215 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.632 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 12.8 m-20 -77.82 -57.91 3.55 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-O 122.038 0.923 . . . . 74.55 108.744 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' TYR . . . . . 0.75 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -140.3 168.85 18.85 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.642 -1.163 . . . . 64.33 108.14 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.12 169.71 17.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.9 -0.408 . . . . 73.32 109.9 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.579 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.7 p90 -101.56 -17.21 16.49 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.265 0.469 . . . . 74.32 112.265 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' THR . . . . . 0.444 HG22 HG21 ' A' ' 442' ' ' VAL . 9.6 t 40.54 65.36 0.78 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.096 1.758 . . . . 65.01 113.108 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.09 114.92 18.42 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.665 -0.698 . . . . 70.51 110.124 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.71 172.92 33.8 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 110.948 -0.861 . . . . 72.53 110.948 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.1 m -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.585 -0.895 . . . . 72.42 108.585 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 33.5 t -96.52 128.36 47.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.901 -0.778 . . . . 65.13 108.901 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.16 112.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.53 -0.544 . . . . 75.33 109.53 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.6 m-85 -93.56 94.42 8.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.984 0.421 . . . . 75.51 110.603 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.0 mttt -89.08 176.17 3.41 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.137 -0.938 . . . . 75.24 110.212 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 31.1 Cg_exo -62.22 119.57 6.74 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.055 1.837 . . . . 73.12 110.431 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.12 -21.81 34.73 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.14 -0.784 . . . . 74.11 111.14 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -88.3 62.27 6.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.639 -0.874 . . . . 62.15 108.639 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 5.1 m -69.74 -28.15 65.55 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.428 -1.26 . . . . 74.34 108.537 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.23 145.62 49.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.184 -1.413 . . . . 75.11 107.184 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -132.89 148.27 52.29 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.539 0.209 . . . . 75.12 110.938 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.5 131.54 54.77 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.073 -0.512 . . . . 75.53 109.851 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 391' ' ' ALA . 44.5 pt -124.11 152.13 29.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.063 -0.717 . . . . 73.22 109.063 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 67.0 mtm180 -127.01 143.61 51.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.534 0.207 . . . . 74.41 110.65 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.537 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 93.6 t -109.9 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.44 -0.948 . . . . 62.21 108.44 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . 0.401 ' HA2' HG21 ' A' ' 389' ' ' THR . . . -66.65 122.42 19.98 Favored Glycine 0 N--CA 1.437 -1.258 0 O-C-N 123.984 0.802 . . . . 52.33 111.614 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 50.4 mm -95.63 134.13 34.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.452 -0.944 . . . . 75.33 108.452 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.632 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.3 mt -99.02 148.12 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 106.019 -1.845 . . . . 74.14 106.019 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.5 89.56 7.26 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 121.767 0.794 . . . . 71.21 111.777 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.37 117.37 34.42 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.266 -1.383 . . . . 64.22 107.266 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.439 33.1 m-20 -102.43 85.02 2.53 Favored 'General case' 0 CA--C 1.446 -3.025 0 CA-C-O 123.736 1.732 . . . . 75.42 114.346 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' ILE . . . . . 0.725 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.8 mm -122.44 153.42 27.04 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 0 N-CA-C 102.368 -3.197 . . . . 74.21 102.368 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -56.86 116.37 3.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.528 -1.286 . . . . 74.32 107.528 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.725 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 45.6 mt-10 -112.3 118.66 35.87 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 121.191 0.52 . . . . 73.33 111.793 -172.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -136.41 111.62 9.05 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.095 -1.411 . . . . 74.45 107.97 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.54 26.96 14.98 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.364 0.876 . . . . 63.43 113.364 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . 0.517 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 24.4 tt0 -66.22 109.69 2.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.223 -1.028 . . . . 74.42 108.223 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.41 168.67 19.19 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.039 -0.528 . . . . 73.34 110.475 -175.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . 0.583 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 18.6 p90 -140.11 171.5 14.09 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.221 -0.659 . . . . 72.0 109.221 173.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 38.2 mt -114.4 136.34 53.1 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.532 -1.284 . . . . 74.1 107.532 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 56.7 t -102.06 113.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.415 -1.328 . . . . 74.21 107.415 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.39 136.3 48.26 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 123.571 0.545 . . . . 74.25 110.837 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.6 mt -96.86 132.18 42.87 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.001 -0.74 . . . . 72.23 109.001 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.4 m -151.07 176.26 11.32 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.704 -0.851 . . . . 74.33 108.704 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.95 81.16 0.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.192 0.997 . . . . 74.34 112.297 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 58.5 t -87.7 123.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 115.401 -0.818 . . . . 61.13 109.283 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 39.6 ttmt . . . . . 0 C--N 1.286 -2.182 0 N-CA-C 108.111 -1.07 . . . . 73.13 108.111 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.416 -2.143 0 CA-C-O 121.171 0.51 . . . . 75.3 110.164 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -109.82 118.28 36.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.115 -1.439 . . . . 74.32 107.115 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 380' ' ' THR . 41.2 m -87.67 131.66 34.38 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 120.837 0.351 . . . . 62.53 110.23 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' VAL . . . . . 0.458 HG11 HG13 ' A' ' 390' ' ' VAL . 78.5 t -116.64 106.51 20.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.668 -1.234 . . . . 73.33 107.668 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 47.9 m -97.78 112.84 24.58 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.303 -0.999 . . . . 64.12 108.303 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.75 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -89.79 115.57 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 122.144 0.973 . . . . 75.45 110.409 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . 0.751 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 83.7 m-85 -99.8 120.86 40.41 Favored 'General case' 0 N--CA 1.396 -3.129 0 CA-C-N 114.796 -1.093 . . . . 74.31 108.176 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -99.92 -7.55 25.08 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-O 122.603 1.192 . . . . 74.05 107.97 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.483 1.217 0 CA-C-N 113.276 -1.784 . . . . 73.14 106.297 -172.499 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 479' ' ' HIS . 83.4 t . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 108.235 -1.024 . . . . 73.12 108.235 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 480' ' ' VAL . 75.7 m -147.28 120.13 8.69 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.706 -0.225 . . . . 64.23 110.684 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.435 ' HA ' HG13 ' A' ' 480' ' ' VAL . 96.5 mttt -93.43 121.12 34.5 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.195 -0.668 . . . . 74.22 109.195 174.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 30.9 mm -94.71 136.31 26.3 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 105.374 -2.084 . . . . 75.31 105.374 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.409 ' HA ' HD13 ' A' ' 486' ' ' LEU . 35.2 p90 -165.6 160.53 17.65 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 118.278 0.49 . . . . 73.23 111.697 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -79.22 141.01 37.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.674 -0.491 . . . . 75.44 109.674 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -65.18 -44.99 86.68 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.592 -0.892 . . . . 74.31 108.592 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -114.44 161.68 17.66 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.401 -0.818 . . . . 74.33 111.053 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.93 -19.11 18.16 Favored Glycine 0 C--N 1.278 -2.67 0 CA-C-N 114.425 -1.261 . . . . 73.14 110.406 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.7 m -138.6 134.21 33.47 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.992 -0.744 . . . . 75.02 108.992 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 72.5 m-85 -124.5 140.38 53.0 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.704 -1.221 . . . . 75.1 107.704 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.44 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 19.2 mt-30 -129.82 140.4 51.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.576 -0.898 . . . . 63.31 108.576 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . 0.626 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.8 p -151.88 159.86 43.71 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.737 -0.838 . . . . 62.33 108.737 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.45 HD11 ' OD1' ' A' ' 386' ' ' ASN . 2.1 mm? -74.98 148.72 39.69 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.45 0.469 . . . . 74.54 109.906 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.652 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 4.5 tt0 -62.83 -36.83 84.5 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.697 0.761 . . . . 74.51 109.425 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.45 ' OD1' HD11 ' A' ' 384' ' ' LEU . 2.7 p-10 -81.15 6.21 14.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.461 -0.791 . . . . 74.21 112.283 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 54.1 t -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.395 0.617 . . . . 73.12 110.402 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.17 -61.42 0.53 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.769 -0.932 . . . . 60.5 110.769 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 6.2 p -137.71 152.57 49.39 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.708 0.29 . . . . 75.34 111.143 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.626 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 7.7 p -109.97 127.43 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 107.976 -1.12 . . . . 74.31 107.976 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.71 120.64 38.46 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.141 0.496 . . . . 54.51 110.482 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.485 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -111.1 152.86 26.47 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.269 -1.382 . . . . 63.43 107.269 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.0 m -123.93 128.47 49.48 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.27 0.557 . . . . 71.45 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.89 125.56 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.796 -1.187 . . . . 75.24 107.796 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.54 144.95 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.645 -1.243 . . . . 74.43 107.645 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.497 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 55.8 ttt180 -127.28 121.06 30.1 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 116.068 -0.515 . . . . 73.43 109.94 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -118.84 167.51 11.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.761 -0.654 . . . . 72.54 111.028 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 136.15 14.6 0.95 Allowed Glycine 0 C--N 1.303 -1.263 0 N-CA-C 111.287 -0.725 . . . . 75.51 111.287 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 92.65 -106.01 3.36 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 110.306 -1.118 . . . . 74.11 110.306 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -135.28 137.9 42.97 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.861 -0.792 . . . . 75.34 108.861 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.447 HD12 HH21 ' A' ' 396' ' ' ARG . 0.7 OUTLIER -160.35 111.87 1.93 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.2 -1.037 . . . . 72.3 108.2 -176.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 3.9 p -98.87 -8.3 25.94 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.531 0.567 . . . . 71.54 112.531 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.402 ' H ' HD11 ' A' ' 401' ' ' LEU . 2.2 m-20 -67.81 146.39 53.75 Favored 'General case' 0 C--O 1.249 1.065 0 N-CA-C 108.246 -1.02 . . . . 62.23 108.246 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 14.0 m -83.68 114.0 21.26 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.616 0.722 . . . . 65.25 111.75 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.38 133.89 43.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.231 -0.895 . . . . 70.23 108.737 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -115.94 126.97 54.59 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.75 0.42 . . . . 71.44 109.948 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.29 135.36 64.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.294 -1.743 . . . . 72.43 106.294 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 140.45 35.05 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.24 -0.652 . . . . 70.41 109.24 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -135.25 160.59 37.9 Favored 'General case' 0 C--O 1.254 1.305 0 C-N-CA 120.676 -0.41 . . . . 65.22 110.646 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 30.6 ttt180 -164.03 158.02 19.02 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.263 -1.754 . . . . 74.41 106.263 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.71 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 43.2 p -96.3 150.39 20.62 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.863 -0.791 . . . . 72.51 108.863 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.9 tp10 -105.64 139.8 39.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.735 -1.209 . . . . 74.41 107.735 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 3.7 m-20 -52.39 -39.03 60.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.512 1.125 . . . . 74.04 112.651 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 57.96 -94.99 0.05 OUTLIER Glycine 0 C--N 1.295 -1.708 0 CA-C-N 114.755 -1.111 . . . . 72.13 113.717 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -124.18 17.83 9.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.498 1.142 . . . . 63.43 108.889 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -148.27 -160.52 1.18 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.678 -1.23 . . . . 62.01 107.678 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 417' ' ' ASN . 2.8 m120 -132.71 126.71 33.16 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 113.028 0.751 . . . . 72.31 113.028 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.43 124.37 28.85 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.914 -1.143 . . . . 65.12 107.914 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.48 -5.69 54.99 Favored Glycine 0 C--N 1.3 -1.465 0 N-CA-C 110.69 -0.964 . . . . 74.35 110.69 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 19.9 m -126.13 -51.83 1.53 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.877 0.37 . . . . 74.55 110.114 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 7.6 m-20 -86.46 -57.14 3.11 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 122.205 1.002 . . . . 75.12 109.726 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.689 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.47 165.03 28.61 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 115.116 -0.947 . . . . 71.02 109.683 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.69 162.15 28.3 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.936 0.773 . . . . 71.44 111.788 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.71 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 2.4 p90 -97.93 -17.87 18.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.124 -0.943 . . . . 74.2 111.875 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.436 ' CG2' HG23 ' A' ' 442' ' ' VAL . 6.9 t 32.93 56.37 0.44 Allowed 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.594 1.558 . . . . 63.24 113.844 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.492 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.3 pt-20 -79.89 119.28 22.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.624 0.726 . . . . 73.13 111.614 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.51 -167.51 23.04 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.617 -0.993 . . . . 65.14 110.617 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.8 m -127.78 137.51 52.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 74.43 108.514 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.23 118.49 42.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.532 -0.914 . . . . 74.14 108.532 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.36 107.42 19.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.854 -1.066 . . . . 72.24 109.324 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 404' ' ' THR . 71.1 m-85 -90.38 94.35 9.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.255 0.55 . . . . 74.54 110.784 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 67.3 mttm -84.54 175.71 4.39 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.637 -1.165 . . . . 74.01 111.022 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 34.3 Cg_exo -60.87 117.75 4.55 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.324 2.016 . . . . 73.51 110.27 172.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.93 -11.4 41.16 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.454 -0.658 . . . . 43.33 111.454 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -90.58 63.45 5.48 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.714 0.768 . . . . 72.2 110.765 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 16.9 m -67.52 -22.46 65.43 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.23 -1.35 . . . . 63.35 108.474 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -136.15 149.2 48.54 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 107.284 -1.376 . . . . 75.51 107.284 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -133.07 151.72 52.01 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 120.778 0.323 . . . . 74.41 111.078 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -121.46 132.93 55.01 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.725 -0.67 . . . . 74.5 109.509 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.7 150.46 26.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.513 -0.921 . . . . 65.42 108.513 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 23.1 mtm180 -131.53 134.69 46.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.141 0.496 . . . . 72.13 111.663 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.559 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -107.66 125.56 64.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.437 -0.949 . . . . 74.34 108.437 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -74.82 138.35 23.65 Favored Glycine 0 N--CA 1.439 -1.127 0 O-C-N 123.667 0.604 . . . . 75.14 112.06 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.37 130.71 45.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.597 -1.26 . . . . 72.42 107.597 176.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 84.4 mt -92.03 151.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 108.202 -1.036 . . . . 75.53 108.202 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.03 86.67 6.09 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.708 0.289 . . . . 74.34 110.822 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.8 129.57 54.51 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.521 -2.4 . . . . 65.44 104.521 171.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.256 8.2 t0 -125.61 89.45 3.04 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 116.577 -2.049 . . . . 73.24 111.518 178.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.611 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.6 mm -115.21 156.4 16.21 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.034 0 CA-C-N 111.058 -2.792 . . . . 75.02 105.587 -174.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -59.79 115.1 3.13 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.76 -1.941 . . . . 73.54 105.76 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.621 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 34.9 mt-10 -122.22 110.78 16.15 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.044 0.926 . . . . 75.34 110.338 -169.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.44 111.93 21.53 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.146 -1.388 . . . . 73.44 108.713 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 49.34 30.38 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.914 1.686 . . . . 72.15 112.548 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.525 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.5 tt0 -60.8 112.55 2.08 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.538 -1.21 . . . . 74.24 108.809 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.84 168.51 19.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.472 -0.786 . . . . 74.12 110.168 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.585 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 31.3 p90 -139.07 175.1 9.84 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.956 -0.566 . . . . 72.23 109.552 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 27.1 mt -120.36 136.79 54.59 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.976 -1.12 . . . . 70.05 107.976 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.0 t -106.43 123.55 61.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.934 -1.136 . . . . 73.52 107.934 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -114.54 150.87 34.26 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 123.852 0.72 . . . . 75.53 109.917 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.49 HD12 HD13 ' A' ' 486' ' ' LEU . 65.5 mt -116.36 140.01 49.79 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.414 -0.958 . . . . 75.34 108.414 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 11.8 p -153.37 -179.97 8.23 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.749 -0.834 . . . . 64.44 108.749 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 49.6 86.91 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.307 1.043 . . . . 74.04 112.505 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.413 HG12 HG21 ' A' ' 480' ' ' VAL . 83.8 t -102.03 125.87 56.13 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.89 -0.782 . . . . 75.24 108.89 176.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -134.87 141.47 46.36 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.977 -1.49 . . . . 74.34 106.977 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.5 132.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.341 0.591 . . . . 71.51 111.469 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' SER . . . . . 0.435 ' HB3' ' HB ' ' A' ' 404' ' ' THR . 16.7 t -97.44 109.11 21.93 Favored 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 107.313 -1.366 . . . . 74.0 107.313 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 12.8 t -128.72 -48.08 1.26 Allowed 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.937 -1.875 . . . . 71.05 105.937 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -84.5 166.73 17.01 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.177 -1.416 . . . . 74.12 107.177 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.85 0.87 22.26 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.3 0.571 . . . . 73.1 111.691 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 8.5 t -98.23 151.58 20.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.395 -1.335 . . . . 74.22 107.395 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.51 -34.16 76.54 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.976 0.417 . . . . 74.21 111.865 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.26 93.12 8.93 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.139 -0.482 . . . . 72.24 109.733 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -77.9 105.88 2.19 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.953 -1.659 . . . . 73.35 108.953 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 49.3 mt -68.7 89.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.688 0.625 . . . . 54.34 112.688 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 68.5 mt 59.16 22.22 10.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.836 1.254 . . . . 73.25 112.406 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.36 135.06 57.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.293 0.568 . . . . 73.21 112.529 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 479' ' ' HIS . . . -73.07 22.72 0.07 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.125 1.528 . . . . 63.21 115.125 -169.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -109.14 25.65 11.55 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.702 -1.222 . . . . 71.43 107.702 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 483' ' ' LEU . 5.7 p-80 -88.71 -173.09 3.98 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.736 -1.575 . . . . 71.15 113.318 -173.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 372' ' ' SER . 90.7 t -79.85 -70.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.513 -0.767 . . . . 75.12 110.702 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 70.6 m -154.4 118.73 4.79 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.043 -0.725 . . . . 65.41 109.043 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . 70.41 -55.77 0.61 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.322 1.449 . . . . 71.2 109.086 -173.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 479' ' ' HIS . 2.0 tm? -156.13 -58.23 0.09 Allowed 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 104.419 -2.438 . . . . 72.52 104.419 170.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -143.72 149.45 37.18 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 112.632 0.604 . . . . 71.24 112.632 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 38.5 t -175.53 -173.94 0.67 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 102.972 -2.973 . . . . 73.34 102.972 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 487' ' ' GLY . 1.0 OUTLIER -148.59 143.43 26.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.238 -1.393 . . . . 72.42 107.238 176.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.524 ' N ' HD11 ' A' ' 486' ' ' LEU . . . -82.09 35.63 2.56 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 122.052 -0.118 . . . . 70.44 113.314 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.5 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 20.1 m -147.77 173.65 4.03 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 107.835 -1.172 . . . . 74.01 107.835 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 488' ' ' SER . 4.9 Cg_exo -44.4 -39.84 12.79 Favored 'Trans proline' 0 CA--C 1.575 2.564 0 N-CA-C 119.268 2.757 . . . . 71.33 119.268 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.456 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 20.1 m -101.65 109.16 20.89 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 128.645 2.778 . . . . 42.3 108.149 1.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.438 ' H ' ' HG2' ' A' ' 489' ' ' PRO . 57.6 m -140.88 106.0 5.0 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-O 120.727 0.298 . . . . 71.44 110.458 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.82 102.72 14.24 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.394 -1.706 . . . . 74.45 106.394 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 29.5 m -80.29 121.28 25.46 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.754 -0.657 . . . . 73.42 109.747 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.413 HG11 HG12 ' A' ' 390' ' ' VAL . 99.5 t -105.68 103.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 108.391 -0.966 . . . . 72.24 108.391 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 19.7 m -93.17 108.42 20.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.137 -1.06 . . . . 73.53 108.137 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.689 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -85.87 121.66 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-O 122.015 0.912 . . . . 74.44 110.992 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.447 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -83.55 95.91 8.46 Favored 'General case' 0 N--CA 1.388 -3.541 0 CA-C-N 114.896 -1.047 . . . . 71.3 110.498 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.654 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.7 t70 -51.06 -54.04 28.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 113.149 -1.841 . . . . 73.4 108.344 170.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.6 t70 68.91 -7.1 0.79 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.141 1.776 . . . . 74.11 111.683 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 498' ' ' ASP . 38.6 m-20 -82.48 -51.69 7.57 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.638 0.775 . . . . 71.41 109.492 -176.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -128.83 18.61 6.15 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.307 -1.368 . . . . 75.0 107.307 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -79.56 73.82 6.23 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.819 -1.082 . . . . 43.14 113.293 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -92.72 61.74 2.34 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 107.059 -2.416 . . . . 71.31 107.059 171.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.6 164.14 3.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 113.722 1.008 . . . . 63.15 113.722 -169.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -125.31 142.23 51.62 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 106.021 -1.844 . . . . 72.03 106.021 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 98.8 m -81.07 100.2 8.88 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-O 121.228 0.537 . . . . 73.34 111.535 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -100.91 122.76 44.04 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.231 -1.396 . . . . 73.04 107.231 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.94 138.21 40.85 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 113.142 0.793 . . . . 75.41 113.142 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--N 1.307 -1.273 0 CA-C-N 114.968 -1.015 . . . . 74.32 109.684 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.654 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.583 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.245 0.867 0 N-CA-C 108.643 -0.873 . . . . 72.22 108.643 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 49.8 m -160.16 149.42 17.57 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.069 0.395 . . . . 75.3 110.922 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -104.94 136.35 44.59 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.312 -0.625 . . . . 74.04 109.312 171.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 28.4 mm -110.4 124.61 67.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.28 -1.378 . . . . 73.21 107.28 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.446 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 45.8 p90 -154.82 169.54 23.74 Favored 'General case' 0 C--O 1.201 -1.458 0 CA-C-N 118.335 0.516 . . . . 74.53 111.633 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -85.12 148.13 26.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.3 -0.63 . . . . 74.43 109.3 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -64.51 -46.19 84.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.367 0.604 . . . . 74.53 109.459 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -109.29 -173.89 2.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.334 -0.848 . . . . 74.31 110.414 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.43 -37.22 1.02 Allowed Glycine 0 C--N 1.285 -2.297 0 N-CA-C 109.769 -1.333 . . . . 75.31 109.769 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 35.2 m -121.19 134.36 55.21 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.456 -0.942 . . . . 71.41 108.456 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 58.3 m-85 -122.19 136.62 54.93 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.814 -1.18 . . . . 71.13 107.814 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -130.43 134.76 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.867 -1.16 . . . . 73.33 107.867 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 21.2 t -154.42 164.09 39.17 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.992 -1.114 . . . . 73.05 107.992 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 497' ' ' PHE . 1.8 mm? -79.96 142.88 34.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.279 0.562 . . . . 75.24 111.826 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.6 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 13.9 tt0 -57.45 -41.61 80.86 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.438 1.095 . . . . 72.25 109.745 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -70.38 -7.76 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.424 -0.807 . . . . 74.11 113.169 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 49.7 t -68.11 -35.61 78.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.903 0.382 . . . . 72.42 110.837 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.54 -47.5 1.13 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.725 -0.75 . . . . 72.11 111.474 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 16.6 p -142.58 152.6 42.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.692 0.246 . . . . 74.1 110.636 175.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.2 p -111.42 133.15 57.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.471 -1.307 . . . . 72.4 107.471 174.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.49 120.57 41.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.114 0.483 . . . . 72.11 110.833 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 392' ' ' LEU . 3.2 mp -111.45 146.64 36.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.374 -0.973 . . . . 75.0 108.374 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.3 m -107.73 123.81 49.09 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.607 -0.516 . . . . 64.52 109.607 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 61.0 mt -98.83 124.42 52.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.869 -1.16 . . . . 70.3 107.869 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 52.2 mm -99.46 127.8 51.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.409 -0.96 . . . . 75.22 108.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -113.56 114.58 26.68 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.541 -0.911 . . . . 75.24 108.541 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -111.53 151.06 29.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.367 -0.379 . . . . 74.22 110.092 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 162.61 36.73 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.796 -0.638 . . . . 73.4 111.811 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 71.93 -98.94 0.82 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.438 -0.665 . . . . 72.31 111.438 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -150.84 121.96 7.73 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 124.192 0.997 . . . . 74.4 108.91 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.506 ' HB3' ' OD1' ' A' ' 403' ' ' ASN . 0.1 OUTLIER -157.21 136.08 11.65 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.356 -1.72 . . . . 65.13 106.356 175.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 20.3 p -86.25 7.89 23.43 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 120.975 0.417 . . . . 64.13 110.988 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 401' ' ' LEU . 19.5 p-10 -50.22 129.45 21.31 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.658 1.183 . . . . 75.31 113.471 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 7.5 m -92.96 117.72 30.36 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.783 -0.821 . . . . 74.35 108.783 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.79 143.83 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.257 -0.883 . . . . 74.13 110.074 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.496 ' CE1' HG11 ' A' ' 430' ' ' VAL . 3.5 m-85 -118.43 125.18 49.41 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.422 0.689 . . . . 74.41 109.317 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.62 135.62 63.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.63 -1.248 . . . . 73.24 107.63 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.45 145.43 27.44 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.099 -0.704 . . . . 72.12 109.099 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -142.89 157.78 44.25 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.06 -0.4 . . . . 73.41 110.461 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -161.28 163.92 30.59 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.843 -1.169 . . . . 75.21 107.843 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.664 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.5 p -95.66 172.58 7.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.003 -0.74 . . . . 65.4 109.003 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -115.42 157.72 23.53 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 120.991 0.424 . . . . 71.1 111.995 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -85.95 4.01 39.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.184 1.794 . . . . 72.22 110.571 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -23.36 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.48 1.593 0 C-N-CA 125.912 1.72 . . . . 73.35 116.579 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 455' ' ' ASN . 11.3 t -99.66 -16.48 18.18 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.564 0.697 . . . . 74.32 109.653 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -140.22 170.32 16.05 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 108.583 -0.895 . . . . 74.11 108.583 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -110.83 113.99 26.99 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 112.93 0.715 . . . . 72.1 112.93 -167.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -68.27 124.09 22.51 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.986 -1.116 . . . . 63.44 107.986 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.14 -26.79 8.52 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.391 -1.084 . . . . 63.42 110.391 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 43.2 m -116.38 -47.78 2.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.685 0.279 . . . . 63.24 111.338 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.543 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.0 m-20 -80.39 -57.77 3.44 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 122.174 0.987 . . . . 73.24 109.403 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.736 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.647 -1.161 . . . . 73.41 108.716 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -75.12 160.38 30.53 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.748 0.785 . . . . 74.3 110.702 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.664 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.3 p90 -94.69 -17.95 21.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.402 -0.817 . . . . 75.33 112.268 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.41 ' CG2' HG21 ' A' ' 442' ' ' VAL . 10.1 t 37.08 58.12 1.19 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.413 1.485 . . . . 73.3 113.688 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.92 111.86 17.77 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.997 0.903 . . . . 72.13 110.399 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.6 -173.61 22.96 Favored Glycine 0 N--CA 1.415 -2.76 0 CA-C-N 114.799 -1.091 . . . . 71.5 111.446 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.8 m -126.52 133.19 51.2 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.781 -0.822 . . . . 74.34 108.781 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 17.8 t -96.91 123.55 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.527 -0.916 . . . . 75.34 108.527 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . 0.496 HG11 ' CE1' ' A' ' 406' ' ' PHE . 44.2 t -99.29 109.96 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.051 -0.722 . . . . 63.32 109.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 404' ' ' THR . 65.6 m-85 -86.07 114.94 23.34 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.693 -0.685 . . . . 63.51 109.731 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -108.73 171.56 4.4 Favored Pre-proline 0 C--N 1.291 -1.935 0 CA-C-N 114.944 -1.025 . . . . 75.11 110.296 -175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.26 121.6 10.35 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.784 2.322 . . . . 72.33 111.205 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.81 -16.8 60.38 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.711 -0.677 . . . . 65.25 111.938 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -87.99 62.25 6.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.217 0.532 . . . . 53.11 110.143 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.4 t -70.48 -17.26 62.97 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.643 -0.708 . . . . 74.51 109.561 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -130.86 141.89 50.34 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.245 -1.391 . . . . 72.34 107.245 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -128.94 147.86 50.88 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 120.612 0.244 . . . . 71.13 111.235 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.74 127.7 54.79 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.724 -0.671 . . . . 71.43 109.599 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.95 149.29 21.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.037 -1.098 . . . . 75.13 108.037 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 62.2 mtt180 -130.6 140.12 50.42 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 120.63 -0.428 . . . . 72.52 111.418 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.592 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.1 t -108.09 127.65 64.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.11 -0.95 . . . . 73.34 108.442 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -70.82 138.82 28.99 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 124.002 0.814 . . . . 73.31 111.857 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.4 mm -104.16 128.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.298 -1.371 . . . . 75.13 107.298 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 77.5 mt -94.65 151.14 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 106.705 -1.591 . . . . 74.23 106.705 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -81.51 86.29 6.36 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.489 0.662 . . . . 75.41 110.652 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.99 124.67 52.71 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 103.338 -2.838 . . . . 75.31 103.338 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -125.89 98.45 5.53 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 117.297 -1.761 . . . . 75.02 110.027 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.658 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -122.0 156.37 26.54 Favored 'Isoleucine or valine' 1 C--N 1.237 -4.304 0 CA-C-N 111.411 -2.631 . . . . 73.25 104.669 -174.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -56.19 113.48 1.57 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.174 -2.158 . . . . 72.12 105.174 168.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.658 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.2 mt-10 -119.37 107.91 13.93 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-O 121.963 0.887 . . . . 72.22 110.568 -169.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -113.6 107.98 16.53 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 114.432 -1.258 . . . . 72.41 108.059 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 35.3 t70 51.88 61.03 3.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.097 0.873 . . . . 73.12 110.69 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.437 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 32.9 tt0 -89.52 112.68 23.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.52 -1.659 . . . . 72.33 106.52 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 415' ' ' THR . 3.2 p-10 -143.98 164.93 29.18 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.179 0.514 . . . . 72.51 110.77 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.592 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.7 p90 -136.68 178.48 7.04 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.948 -0.76 . . . . 74.33 108.948 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.08 136.71 54.92 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.149 -1.426 . . . . 73.43 107.149 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 492' ' ' ALA . 25.9 t -103.49 122.88 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.333 -1.358 . . . . 75.4 107.333 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -119.96 148.58 43.35 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.862 -0.608 . . . . 74.42 109.849 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.96 147.29 28.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.912 -0.585 . . . . 73.31 109.559 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.8 m -156.11 179.82 8.86 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.514 0.726 . . . . 72.53 109.527 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.0 t30 47.75 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.335 1.454 . . . . 61.22 114.267 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 98.5 t -91.67 127.36 44.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 C-N-CA 119.713 -0.795 . . . . 74.44 109.091 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -133.99 143.55 48.21 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.232 -1.395 . . . . 71.42 107.232 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 29.9 t -107.77 156.71 8.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.434 -0.951 . . . . 71.5 108.434 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 48.9 m -71.82 127.61 33.1 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.992 0.901 . . . . 74.44 111.341 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 29.2 m -86.32 93.14 9.01 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.383 -1.281 . . . . 71.42 109.358 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -124.05 -60.64 1.42 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.68 -0.859 . . . . 73.23 108.68 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -72.57 -55.19 7.3 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.814 -0.81 . . . . 74.34 108.814 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 35.4 p -121.63 132.05 54.45 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.876 -0.602 . . . . 55.14 109.727 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -105.06 -62.28 1.36 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.119 -1.437 . . . . 73.42 107.119 173.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -87.22 177.8 7.06 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.256 -1.016 . . . . 75.53 108.256 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 91.25 -71.14 1.91 Allowed Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.224 -0.989 . . . . 60.34 111.123 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -165.42 132.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 121.283 0.564 . . . . 75.44 110.85 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 77.2 mt -119.58 129.37 54.61 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.333 -1.728 . . . . 73.14 106.333 171.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.54 95.36 3.88 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.332 0.493 . . . . 75.01 112.332 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -69.26 -36.05 76.73 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 108.621 -0.881 . . . . 72.25 108.621 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 481' ' ' SER . 48.6 t30 -74.86 72.08 2.05 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.621 1.2 . . . . 71.43 108.798 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -140.32 -36.06 0.49 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 113.657 -1.611 . . . . 73.41 108.135 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 485' ' ' CYS . 86.0 t -96.22 -42.23 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 119.688 -0.805 . . . . 72.54 109.25 172.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' A' ' 478' ' ' ASN . 25.9 t -153.08 -171.24 3.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.893 -1.521 . . . . 63.23 106.893 173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -51.98 -43.61 63.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.132 0.973 . . . . 75.24 111.083 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.67 -76.32 0.57 Allowed 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 104.477 -2.416 . . . . 74.11 104.477 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -165.65 114.51 1.0 Allowed 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.306 -0.628 . . . . 71.24 109.306 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . 0.441 ' O ' HG12 ' A' ' 480' ' ' VAL . 37.7 t -155.94 132.48 10.29 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 104.944 -2.243 . . . . 72.12 104.944 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 1.7 mm? -89.7 -163.81 1.06 Allowed 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 109.179 -0.674 . . . . 74.53 109.179 -172.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 375' ' ' PHE . . . -63.69 137.32 41.84 Favored Glycine 0 CA--C 1.484 -1.887 0 N-CA-C 104.313 -3.515 . . . . 73.24 104.313 169.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.5 ' HA ' ' OG ' ' A' ' 490' ' ' SER . 15.1 m -110.81 75.27 1.03 Allowed Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 118.999 2.962 . . . . 72.34 118.999 -165.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.52 ' HB2' ' H ' ' A' ' 491' ' ' THR . 3.0 Cg_exo -70.76 -59.58 0.07 OUTLIER 'Trans proline' 1 N--CA 1.396 -4.225 0 N-CA-C 108.307 -1.459 . . . . 73.11 108.307 153.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 488' ' ' SER . 20.4 m -115.79 89.54 3.13 Favored 'General case' 0 C--N 1.389 2.294 0 C-N-CA 128.564 2.746 . . . . 73.23 105.483 -7.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.52 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 34.4 m -145.03 124.55 13.17 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 116.029 -0.532 . . . . 74.52 109.885 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 458' ' ' VAL . . . -109.39 108.39 18.91 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.435 -1.32 . . . . 73.05 107.435 170.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 74.4 m -83.2 111.71 19.19 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.282 -0.636 . . . . 75.4 109.282 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.413 ' HB ' ' CE1' ' A' ' 456' ' ' PHE . 71.4 t -100.62 106.62 19.64 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 108.262 -1.014 . . . . 70.14 108.262 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 25.1 m -93.47 112.16 24.0 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 107.158 -1.423 . . . . 63.15 107.158 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -86.56 119.66 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 CA-C-O 121.831 0.824 . . . . 74.2 109.616 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.477 ' O ' HD12 ' A' ' 384' ' ' LEU . 5.5 m-85 -82.79 98.08 8.94 Favored 'General case' 1 N--CA 1.378 -4.068 0 CA-C-N 115.041 -0.981 . . . . 73.33 112.34 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 500' ' ' ASP . 2.9 t70 -50.09 -60.52 2.87 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 112.019 -2.355 . . . . 71.01 108.518 170.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.455 ' OD1' HG12 ' A' ' 504' ' ' ILE . 33.4 t70 67.05 -8.98 0.4 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 113.767 -1.56 . . . . 70.14 112.363 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 498' ' ' ASP . 27.3 m-20 -69.86 -53.86 16.16 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.713 -1.217 . . . . 75.11 107.713 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -107.31 -32.89 7.58 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.63 -1.168 . . . . 64.45 108.198 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -60.23 -47.69 84.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.985 -1.007 . . . . 74.54 112.113 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 65.06 27.92 72.89 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.572 -0.346 . . . . 54.11 113.11 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.455 HG12 ' OD1' ' A' ' 499' ' ' ASP . 23.8 mm 54.06 85.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.855 1.262 . . . . 73.43 111.675 -174.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -124.6 146.81 48.86 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.648 -0.871 . . . . 74.23 108.648 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.0 t -119.09 125.4 49.21 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 106.913 -1.514 . . . . 74.33 106.913 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -107.17 115.5 30.29 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.133 0.419 . . . . 74.44 112.133 -171.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -155.12 118.31 4.41 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.487 -1.301 . . . . 74.32 107.487 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 N-CA-C 112.437 0.532 . . . . 74.53 112.437 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.6 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.628 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.454 ' HA ' ' C ' ' A' ' 478' ' ' ASN . 76.0 t . . . . . 0 N--CA 1.445 -0.675 0 N-CA-C 109.556 -0.535 . . . . 60.13 109.556 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.432 ' O ' HG11 ' A' ' 480' ' ' VAL . 50.4 m -60.97 114.7 3.23 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.898 0.749 . . . . 71.25 110.42 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -100.71 143.28 31.06 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 107.873 -1.158 . . . . 74.33 107.873 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.465 ' HB ' HD12 ' A' ' 486' ' ' LEU . 37.4 mm -110.08 112.73 41.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.092 -1.448 . . . . 74.3 107.092 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -145.76 161.41 39.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.471 -0.492 . . . . 73.13 111.87 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -79.51 150.46 31.16 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.86 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.14 -50.0 62.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.741 -1.207 . . . . 73.31 107.741 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 27.6 mm-40 -103.57 -177.69 3.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.609 -0.723 . . . . 73.11 111.494 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.44 -38.4 0.93 Allowed Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.836 -1.306 . . . . 74.45 109.836 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.8 m -123.55 131.86 53.74 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 107.582 -1.266 . . . . 73.52 107.582 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 86.1 m-85 -119.78 140.87 50.08 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.483 -1.303 . . . . 75.43 107.483 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 495' ' ' THR . 21.3 mt-30 -130.14 127.39 39.66 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.312 -0.625 . . . . 73.54 109.312 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . 0.646 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.5 p -133.83 165.06 25.85 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.488 -0.93 . . . . 64.42 108.488 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.79 146.09 24.72 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.023 0.439 . . . . 75.05 111.125 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.644 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 20.1 tt0 -62.72 -28.94 70.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.84 0.828 . . . . 65.4 109.138 175.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -86.45 2.4 47.91 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.868 -1.06 . . . . 71.24 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.76 -32.24 31.54 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 112.611 0.597 . . . . 35.05 112.611 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.71 -65.47 0.4 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.284 -0.96 . . . . 61.12 111.21 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 30.3 p -133.01 159.45 39.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.478 0.639 . . . . 73.3 111.01 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.646 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 3.6 p -111.87 129.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 107.431 -1.322 . . . . 75.51 107.431 171.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.39 128.24 44.69 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.661 -0.866 . . . . 74.34 108.661 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.28 142.82 47.74 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.456 -1.313 . . . . 74.12 107.456 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.4 m -105.64 131.43 53.03 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.188 0.518 . . . . 72.53 110.371 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.456 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 84.4 mt -106.54 128.79 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.915 -1.143 . . . . 74.45 107.915 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 46.4 mm -105.52 127.71 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 N-CA-C 108.198 -1.038 . . . . 74.41 108.198 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -110.41 112.06 23.73 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 116.118 -0.492 . . . . 71.41 109.792 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.497 ' HA ' ' HE ' ' A' ' 397' ' ' ARG . 0.6 OUTLIER -127.79 152.56 47.63 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.874 -0.788 . . . . 74.41 108.874 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 122.46 78.39 0.45 Allowed Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.849 -0.901 . . . . 74.23 110.849 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 79.24 -163.73 49.1 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.908 -0.663 . . . . 60.44 112.077 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -135.35 121.08 19.56 Favored 'General case' 0 CA--C 1.468 -2.176 0 N-CA-C 107.618 -1.253 . . . . 70.04 107.618 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 84.1 mt -146.91 132.96 19.23 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 123.618 0.573 . . . . 73.34 109.558 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 25.4 p -91.62 2.85 56.18 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.389 0.614 . . . . 64.54 110.108 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -61.09 132.5 53.97 Favored 'General case' 0 C--O 1.257 1.457 0 CA-C-N 115.236 -0.893 . . . . 73.23 109.108 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 10.0 m -80.65 112.07 17.67 Favored 'General case' 0 N--CA 1.414 -2.248 0 O-C-N 123.877 0.736 . . . . 71.34 109.253 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.71 140.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.813 -1.085 . . . . 74.22 108.207 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -123.09 128.01 49.52 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.756 -0.831 . . . . 75.42 108.756 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.434 HG11 HG23 ' A' ' 374' ' ' ILE . 7.4 p -128.92 134.57 64.01 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 106.339 -1.726 . . . . 73.14 106.339 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.47 122.43 42.54 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.497 -0.481 . . . . 70.44 110.01 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -109.57 154.17 23.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.695 -0.483 . . . . 75.31 109.695 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . 0.405 ' HE ' ' HB2' ' A' ' 410' ' ' ARG . 11.5 ttm180 -163.78 164.73 23.56 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.078 -1.452 . . . . 71.3 107.078 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.444 ' HG1' ' HA ' ' A' ' 424' ' ' PHE . 80.0 p -95.89 172.51 7.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.801 0.334 . . . . 72.53 110.268 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 8.7 tp10 -118.6 147.97 43.17 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.286 0.565 . . . . 75.41 110.257 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.72 4.02 26.77 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 127.039 2.136 . . . . 75.34 109.514 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . 0.465 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -20.35 -74.26 0.01 OUTLIER Glycine 0 N--CA 1.482 1.744 0 C-N-CA 126.113 1.816 . . . . 52.52 115.686 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.7 t -118.47 -5.46 10.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.347 0.594 . . . . 70.42 110.63 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -134.23 -179.65 5.7 Favored 'General case' 0 C--O 1.195 -1.774 0 CA-C-N 116.357 -0.383 . . . . 74.41 110.223 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.16 118.96 28.86 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.409 0.623 . . . . 74.3 110.065 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.23 137.89 49.02 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.177 -0.675 . . . . 74.33 109.177 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.24 -4.92 81.09 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 110.721 -0.952 . . . . 72.33 110.721 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.1 t -123.73 -57.83 1.61 Allowed 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.25 -1.018 . . . . 63.12 108.25 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.527 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 17.6 m-20 -82.45 -59.39 2.55 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-O 122.19 0.995 . . . . 61.53 109.097 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.704 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.23 158.92 43.32 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.267 -0.879 . . . . 74.15 109.99 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.4 142.87 46.95 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.106 -0.701 . . . . 73.13 109.106 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.444 ' HA ' ' HG1' ' A' ' 411' ' ' THR . 8.7 p90 -73.68 -24.13 59.92 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 123.304 0.642 . . . . 65.12 112.632 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.473 HG22 HG21 ' A' ' 442' ' ' VAL 0.291 10.9 t 41.6 62.42 1.56 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.37 1.868 . . . . 75.43 113.185 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.44 107.38 12.16 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.691 -1.141 . . . . 73.15 108.854 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -144.42 168.38 26.72 Favored Glycine 0 CA--C 1.46 -3.385 0 C-N-CA 120.073 -1.06 . . . . 64.32 111.49 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.6 m -112.7 138.1 50.01 Favored 'General case' 0 N--CA 1.393 -3.292 0 N-CA-C 107.652 -1.24 . . . . 64.54 107.652 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.4 117.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.759 -1.201 . . . . 74.33 107.759 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.74 105.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.496 -0.774 . . . . 70.05 109.755 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 404' ' ' THR . 57.7 m-85 -89.25 94.53 9.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.054 -0.521 . . . . 74.33 110.786 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.28 167.51 16.63 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.234 -0.894 . . . . 74.14 110.568 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.01 119.65 7.05 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 122.742 2.295 . . . . 64.53 110.881 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.24 -14.75 60.93 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.073 -0.584 . . . . 72.3 112.457 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -93.91 61.16 2.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.748 0.785 . . . . 70.0 109.381 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 8.0 m -66.09 -25.77 67.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.624 -1.171 . . . . 71.32 109.625 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.41 132.36 54.32 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.415 -1.328 . . . . 72.43 107.415 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -120.73 149.69 42.13 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.93 0.395 . . . . 74.22 111.994 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.73 131.91 56.02 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.223 -0.899 . . . . 63.5 109.435 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.57 149.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.929 -1.137 . . . . 64.13 107.929 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 51.4 mtt180 -131.62 144.01 50.74 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.253 0.549 . . . . 63.53 111.972 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.503 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 49.2 t -117.51 121.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.708 -1.219 . . . . 72.41 107.708 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -78.45 134.1 13.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.07 -0.586 . . . . 75.23 111.985 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . 0.433 HD11 HG12 ' A' ' 496' ' ' ILE . 28.9 mm -90.42 139.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.693 -1.225 . . . . 73.45 107.693 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 81.3 mt -99.29 150.98 4.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.236 -1.394 . . . . 73.55 107.236 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 88.03 3.05 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.113 0.482 . . . . 63.42 111.344 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.95 113.4 20.94 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.029 -2.211 . . . . 64.43 105.029 171.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.644 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 13.5 t70 -115.88 96.2 5.48 Favored 'General case' 0 CA--C 1.457 -2.629 0 C-N-CA 116.802 -1.959 . . . . 73.54 110.054 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.627 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 31.7 mm -121.68 155.63 25.93 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.097 0 N-CA-C 103.589 -2.745 . . . . 74.41 103.589 -175.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -58.49 114.65 2.56 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.602 -1.639 . . . . 74.4 107.55 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.627 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 24.4 mt-10 -128.65 130.32 47.08 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-N 115.518 -0.764 . . . . 71.31 109.693 -169.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.69 108.04 8.78 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.057 -0.974 . . . . 74.21 108.508 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.81 49.72 15.57 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 124.537 1.148 . . . . 73.32 110.238 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.54 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 37.2 tt0 -72.15 116.75 12.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.548 -1.649 . . . . 63.04 106.548 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 36.5 p30 -141.29 166.05 25.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.938 0.718 . . . . 74.32 112.938 -172.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.571 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 23.5 p90 -144.39 175.75 9.88 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.241 -0.891 . . . . 74.13 108.665 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.13 136.64 52.84 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.558 -1.275 . . . . 73.44 107.558 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.84 123.52 52.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.865 -1.532 . . . . 75.13 106.865 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 490' ' ' SER . 98.9 m-70 -112.66 135.03 53.86 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 123.803 0.689 . . . . 75.12 111.492 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.9 129.15 45.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.967 -1.494 . . . . 72.22 106.967 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.1 t -154.69 -176.82 6.1 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.982 -1.488 . . . . 60.1 106.982 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 50.86 81.77 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 O-C-N 124.488 1.118 . . . . 74.34 112.216 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 41.2 t -82.05 131.55 33.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 114.916 -1.038 . . . . 71.42 109.026 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -132.46 135.74 46.24 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.18 -1.415 . . . . 74.11 107.18 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.2 135.91 60.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.383 -0.599 . . . . 74.44 109.383 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.6 t -116.04 116.57 28.13 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 108.681 -0.859 . . . . 64.2 108.681 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 46.6 t -74.58 -42.76 58.15 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.409 -1.33 . . . . 71.53 107.409 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 67.87 -49.36 0.52 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.708 2.003 . . . . 75.23 111.777 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -66.9 -46.79 73.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.381 -1.34 . . . . 71.33 107.381 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 15.5 t 56.57 36.01 26.93 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.749 -1.114 . . . . 74.42 111.591 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -83.68 -6.26 59.39 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.683 -0.689 . . . . 72.11 110.492 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 12.2 t70 66.44 174.95 0.24 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.046 1.338 . . . . 75.3 110.28 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.14 18.62 76.22 Favored Glycine 0 C--O 1.242 0.652 0 N-CA-C 110.579 -1.009 . . . . 73.43 110.579 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.53 112.14 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.774 -0.824 . . . . 63.44 108.774 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.38 -3.95 24.8 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.236 -1.024 . . . . 73.44 108.236 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 478' ' ' ASN . 2.6 mp0 -82.87 44.29 0.91 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.147 -1.388 . . . . 73.32 109.846 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -83.11 23.6 0.85 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.744 0.783 . . . . 73.33 110.407 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . 0.454 ' C ' ' HA ' ' A' ' 371' ' ' VAL . 8.3 m120 -81.6 53.91 2.24 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 124.969 1.308 . . . . 63.11 108.217 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -155.24 161.05 41.25 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.619 -0.882 . . . . 63.53 108.619 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 372' ' ' SER . 28.8 m -69.42 148.18 11.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 123.402 0.439 . . . . 74.41 110.142 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 49.9 m -151.25 176.27 11.38 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.388 -1.338 . . . . 70.4 107.388 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 483' ' ' LEU . . . -69.59 85.28 0.45 Allowed 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.638 0.586 . . . . 53.51 109.792 177.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 482' ' ' ALA . 1.2 tm? 171.36 -39.94 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 104.509 -2.404 . . . . 62.21 104.509 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -92.42 -178.11 4.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.766 -1.561 . . . . 64.54 110.724 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 75.7 m -127.61 170.88 12.17 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.392 -0.966 . . . . 72.25 108.392 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.465 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.1 mm? -84.58 179.53 7.37 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.809 -0.441 . . . . 74.21 109.809 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -87.06 27.72 5.93 Favored Glycine 0 C--O 1.239 0.458 0 C-N-CA 120.935 -0.65 . . . . 74.43 112.323 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.43 ' C ' ' HA ' ' A' ' 490' ' ' SER . 20.2 m -155.23 173.23 5.04 Favored Pre-proline 0 C--N 1.288 -2.082 0 N-CA-C 105.386 -2.079 . . . . 62.44 105.386 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.653 ' N ' ' HA ' ' A' ' 490' ' ' SER . 35.8 Cg_exo -56.26 -31.99 86.29 Favored 'Trans proline' 0 CA--C 1.585 3.039 0 N-CA-C 119.582 2.878 . . . . 61.23 119.582 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.653 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 33.4 t -107.56 115.2 29.72 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 127.883 2.473 . . . . 73.35 108.881 3.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 24.4 m -126.27 128.13 46.69 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.8 -0.637 . . . . 65.34 110.171 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -129.15 122.39 29.71 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.397 -1.334 . . . . 74.35 107.397 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.9 m -89.43 121.46 31.69 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.7 -0.4 . . . . 75.14 110.394 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 74.5 t -109.54 110.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.918 -0.771 . . . . 70.33 108.918 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 91.1 m -101.49 121.61 42.29 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 108.882 -0.784 . . . . 72.51 108.882 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.704 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -95.36 117.1 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.099 0 CA-C-N 115.336 -0.847 . . . . 75.04 109.218 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.42 104.21 5.07 Favored 'General case' 0 N--CA 1.389 -3.507 0 CA-C-N 114.693 -1.14 . . . . 73.11 110.499 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.647 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 4.0 t70 -55.01 -40.92 70.67 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 112.811 -1.995 . . . . 75.35 110.803 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 498' ' ' ASP . 8.8 t70 78.01 -38.19 0.25 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.953 1.301 . . . . 75.54 112.117 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 498' ' ' ASP . 21.2 m-20 -65.67 -62.41 1.53 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 123.553 0.741 . . . . 62.35 111.421 -171.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -102.38 -0.19 33.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.912 0.863 . . . . 75.44 108.724 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.74 66.29 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.1 -0.955 . . . . 73.01 112.399 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 110.16 -19.11 27.7 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 120.122 -1.037 . . . . 75.33 112.517 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 48.3 pt -90.77 169.52 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.906 -0.776 . . . . 75.31 108.906 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -137.32 101.22 4.46 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.88 -0.415 . . . . 60.45 109.88 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 32.3 p -93.64 173.69 7.56 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.45 -0.574 . . . . 64.12 109.45 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -106.47 113.78 27.5 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.381 -0.527 . . . . 75.53 111.615 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.84 148.54 19.19 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.704 -1.591 . . . . 75.23 106.704 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--N 1.304 -1.41 0 C-N-CA 120.768 -0.373 . . . . 74.15 110.848 -177.417 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.647 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.619 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 372' ' ' SER . 12.5 t . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 106.803 -1.555 . . . . 75.22 106.803 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.452 ' H ' HG12 ' A' ' 371' ' ' VAL . 36.1 m -46.76 116.14 1.25 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 116.021 1.859 . . . . 74.11 116.021 -173.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -99.45 132.62 44.65 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 114.009 -1.45 . . . . 74.03 107.255 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.44 ' HB ' HD11 ' A' ' 486' ' ' LEU . 44.6 mm -106.9 129.36 60.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 108.065 -1.087 . . . . 74.22 108.065 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.528 ' HB2' ' OG ' ' A' ' 488' ' ' SER . 43.8 p90 -159.27 167.8 28.04 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 117.907 0.321 . . . . 74.42 110.924 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -82.52 153.4 25.59 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.828 -0.349 . . . . 72.51 110.124 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.29 -38.72 81.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.333 0.587 . . . . 73.12 109.816 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -130.5 174.21 10.11 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.59 -0.732 . . . . 72.54 112.304 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -104.12 -25.66 7.0 Favored Glycine 0 C--N 1.304 -1.245 0 CA-C-N 115.37 -0.832 . . . . 70.01 111.857 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.6 m -129.38 133.33 47.33 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.252 -0.648 . . . . 72.12 109.252 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 66.2 m-85 -124.62 136.35 53.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.996 -1.113 . . . . 74.23 107.996 176.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.449 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 87.4 mt-30 -129.46 135.34 48.53 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.221 -1.029 . . . . 73.24 108.221 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 37.8 t -148.81 165.0 32.79 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.446 -0.946 . . . . 72.25 108.446 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -79.23 141.17 37.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.417 0.448 . . . . 75.35 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.635 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 10.5 tt0 -56.93 -50.34 72.89 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.755 0.822 . . . . 75.44 110.764 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -77.25 2.56 15.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.519 0.563 . . . . 72.11 112.519 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.14 -20.6 59.31 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.236 0.541 . . . . 71.2 111.017 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.28 -57.14 0.63 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.258 -0.972 . . . . 70.35 113.105 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 14.8 p -139.33 165.35 27.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 117.189 0.495 . . . . 72.52 111.566 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.8 p -122.51 125.72 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 169.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.39 129.29 43.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.197 0.522 . . . . 73.25 110.4 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 392' ' ' LEU . 3.0 mp -121.21 140.91 51.39 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 107.876 -1.157 . . . . 73.33 107.876 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.2 m -108.33 131.52 54.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.92 -0.582 . . . . 72.2 109.511 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.09 125.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.923 -1.139 . . . . 74.31 107.923 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.8 mm -99.73 133.63 41.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.766 -0.828 . . . . 73.21 108.766 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 436' ' ' THR . 58.4 ttt180 -117.53 120.17 37.28 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.316 -0.856 . . . . 75.21 108.773 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 372' ' ' SER . 35.0 mmt180 -122.87 168.87 11.74 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.732 -1.211 . . . . 75.52 107.732 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 99.68 44.98 2.19 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 110.249 -1.14 . . . . 63.13 110.249 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 80.0 -161.35 45.53 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 110.373 -1.091 . . . . 53.03 110.373 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -153.91 146.66 24.28 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.114 -1.809 . . . . 72.21 106.114 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.62 154.23 31.3 Favored 'General case' 0 C--N 1.274 -2.698 0 O-C-N 123.546 0.529 . . . . 73.04 109.932 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 49.3 p -80.62 -0.64 38.84 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.729 0.776 . . . . 71.31 111.206 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.38 129.36 38.63 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.022 -1.103 . . . . 74.34 108.022 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 41.9 m -82.68 116.9 22.26 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.557 -0.747 . . . . 73.31 111.517 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.64 146.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.578 -0.737 . . . . 75.4 109.351 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -122.12 125.53 46.38 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.074 0.549 . . . . 73.32 110.292 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.49 130.83 70.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.208 -1.404 . . . . 71.41 107.208 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 15.1 t70 -100.25 135.0 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.688 -0.486 . . . . 71.14 109.688 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.02 153.99 48.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.45 -0.5 . . . . 74.35 110.363 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -163.43 154.57 16.67 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.752 -1.573 . . . . 71.24 106.752 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 30.8 p -96.46 162.55 13.43 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.279 0.562 . . . . 72.23 110.4 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 3.6 mm-40 -105.11 160.58 14.95 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.586 -0.734 . . . . 75.23 109.378 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.31 -37.65 63.56 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.131 -0.94 . . . . 75.2 110.035 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 48.57 -107.74 0.3 Allowed Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.228 -1.351 . . . . 65.0 114.215 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -101.53 5.03 41.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.739 0.781 . . . . 75.55 110.237 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -135.57 -159.53 0.97 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.942 0.897 . . . . 65.21 109.067 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -136.17 126.2 26.06 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.089 0.471 . . . . 73.03 111.616 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . . . -82.18 124.52 29.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.513 -0.921 . . . . 75.42 108.513 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.44 -19.42 36.79 Favored Glycine 0 C--N 1.296 -1.659 0 N-CA-C 110.123 -1.191 . . . . 60.13 110.123 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.6 m -106.94 -56.88 2.14 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.66 -0.496 . . . . 64.21 109.66 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.46 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 2.2 m-20 -84.68 -57.34 3.17 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 122.106 0.955 . . . . 74.44 110.205 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.685 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -140.01 159.78 41.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.24 -0.891 . . . . 74.52 109.002 -178.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.4 tm-20 -76.26 157.88 32.14 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 123.873 0.733 . . . . 72.02 109.794 -173.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.599 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 13.7 p90 -94.21 -16.68 23.44 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.288 0.635 . . . . 72.34 112.669 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.441 HG22 HG23 ' A' ' 442' ' ' VAL 0.303 9.9 t 37.59 67.12 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.66 1.984 . . . . 72.12 114.303 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -79.1 121.16 24.65 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.003 -0.998 . . . . 65.31 109.481 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -163.0 176.73 39.23 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 120.372 -0.918 . . . . 72.15 111.386 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 32.4 m -120.52 136.73 54.69 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.881 -1.155 . . . . 72.15 107.881 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.9 t -95.57 119.17 43.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.902 -1.147 . . . . 75.15 107.902 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 99.6 t -95.83 107.04 19.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 114.704 -1.134 . . . . 75.13 108.798 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 404' ' ' THR . 51.1 m-85 -84.55 95.08 8.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.971 -0.559 . . . . 73.54 110.586 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.49 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 10.4 mtmp? -80.52 167.83 29.94 Favored Pre-proline 0 N--CA 1.432 -1.373 0 CA-C-N 115.487 -0.778 . . . . 71.53 110.156 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -52.66 131.61 42.2 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.371 2.047 . . . . 75.33 111.803 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.66 -21.49 32.67 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.851 -0.613 . . . . 62.32 113.37 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 38.0 mt-10 -81.17 63.9 5.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.171 0.986 . . . . 72.22 112.647 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 21.4 m -67.49 -11.33 57.68 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.2 -1.364 . . . . 73.1 110.069 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -139.14 136.55 35.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.497 -0.927 . . . . 73.44 108.497 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -126.14 155.12 42.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.294 0.092 . . . . 72.02 111.05 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.22 138.04 54.12 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.807 -0.357 . . . . 71.33 110.801 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 39.9 pt -125.68 153.97 34.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.635 -0.876 . . . . 72.45 108.635 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 56.5 mtm180 -130.4 138.32 50.29 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.911 0.386 . . . . 74.42 110.865 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.49 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 58.6 t -106.54 122.25 60.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.838 -1.171 . . . . 70.41 107.838 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.88 130.7 10.71 Favored Glycine 0 N--CA 1.434 -1.453 0 O-C-N 123.583 0.552 . . . . 71.1 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 496' ' ' ILE . 38.0 mm -88.98 143.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.527 -1.657 . . . . 74.54 106.527 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.2 mt -102.04 145.94 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 N-CA-C 107.368 -1.345 . . . . 73.04 107.368 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.26 85.99 1.43 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.508 0.67 . . . . 73.5 111.497 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.55 120.22 36.1 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 105.175 -2.158 . . . . 72.54 105.175 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 20.2 t70 -122.57 95.3 4.58 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 116.951 -1.9 . . . . 74.35 110.554 173.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.649 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 34.3 mm -118.62 155.9 20.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.348 0 N-CA-C 103.61 -2.737 . . . . 71.11 103.61 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -56.89 114.6 2.16 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.058 -1.457 . . . . 74.12 107.119 171.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.649 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 29.0 mt-10 -127.19 133.94 50.22 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-N 116.06 -0.518 . . . . 73.54 109.7 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.48 112.48 7.66 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.475 -0.935 . . . . 74.22 108.475 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 33.5 t70 50.56 61.53 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.855 0.862 . . . . 64.24 112.8 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.32 123.47 41.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 118.729 -1.188 . . . . 71.4 110.932 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.28 174.36 10.64 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.87 -1.059 . . . . 73.31 110.54 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.549 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 26.0 p90 -148.0 -178.54 6.34 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.746 -1.115 . . . . 71.41 108.042 172.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -123.79 136.72 54.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.284 -1.006 . . . . 75.51 108.284 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.4 122.03 59.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.903 -1.517 . . . . 70.13 106.903 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.82 152.86 31.43 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.712 0.632 . . . . 75.14 110.005 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.48 121.43 44.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.893 -0.78 . . . . 74.02 108.893 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 46.8 m -131.1 -178.11 4.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.429 -0.952 . . . . 70.41 108.429 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 39.45 82.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.143 1.377 . . . . 74.02 112.348 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.75 123.02 44.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 119.168 -1.013 . . . . 73.41 108.911 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -134.7 174.28 10.74 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.926 -1.034 . . . . 75.21 109.453 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 69.3 t -142.18 150.72 18.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 103.974 -2.602 . . . . 74.11 103.974 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 8.5 t -74.2 109.95 8.1 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.616 -0.883 . . . . 74.53 108.616 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 20.1 m -81.35 105.62 12.68 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.691 -1.14 . . . . 75.33 110.364 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.54 -65.4 0.94 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 105.35 -2.093 . . . . 74.24 105.35 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -102.13 -79.16 0.52 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.429 -1.323 . . . . 75.42 107.429 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 12.2 m 54.3 10.19 0.29 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.09 1.515 . . . . 52.11 115.09 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -70.95 -49.44 45.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.928 0.394 . . . . 75.41 110.671 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -153.57 170.05 21.74 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.046 -1.094 . . . . 74.24 108.046 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 84.02 -65.61 4.06 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 110.429 -1.068 . . . . 72.41 110.429 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 75.5 mt -73.99 109.71 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 108.61 -0.885 . . . . 65.11 108.61 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 70.1 mt -88.08 -30.52 19.82 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.369 -0.604 . . . . 71.3 109.369 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -83.74 80.12 9.24 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.539 -0.755 . . . . 74.21 109.778 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -84.61 -49.18 8.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.073 -1.454 . . . . 74.03 107.073 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -88.31 132.26 34.47 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.272 -1.381 . . . . 54.22 107.272 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -105.53 -6.17 19.6 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.819 -0.628 . . . . 74.41 112.53 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.54 -48.36 18.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 120.036 -0.666 . . . . 75.4 112.364 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 22.8 t -146.91 -168.35 3.01 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.869 -0.732 . . . . 73.22 109.258 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.26 86.08 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.549 -0.908 . . . . 70.03 108.549 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -120.78 -79.68 0.61 Allowed 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 103.887 -2.634 . . . . 63.35 103.887 167.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -164.97 134.74 3.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.614 -0.513 . . . . 70.52 109.614 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 51.9 t -166.38 133.22 2.56 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.193 -1.41 . . . . 61.1 107.193 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.44 HD11 ' HB ' ' A' ' 374' ' ' ILE . 2.4 mm? -87.82 174.2 8.51 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 123.185 0.303 . . . . 70.43 110.221 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -75.73 -39.59 33.78 Favored Glycine 0 C--N 1.317 -0.479 0 N-CA-C 110.434 -1.067 . . . . 62.4 110.434 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.528 ' OG ' ' HB2' ' A' ' 375' ' ' PHE . 14.7 m -87.99 171.78 8.94 Favored Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 107.545 -1.279 . . . . 62.44 107.545 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.492 ' N ' ' HA ' ' A' ' 490' ' ' SER . 2.5 Cg_endo -45.53 -47.44 13.28 Favored 'Trans proline' 0 CA--C 1.584 2.983 0 C-N-CA 122.493 2.129 . . . . 64.0 117.554 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.492 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 20.6 m -109.66 138.76 45.56 Favored 'General case' 0 N--CA 1.412 -2.361 0 C-N-CA 127.912 2.485 . . . . 73.53 108.435 3.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 62.9 m -143.56 104.6 4.24 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 109.174 -0.676 . . . . 74.13 109.174 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -102.22 115.06 29.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.944 -1.132 . . . . 64.51 107.944 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 20.7 m -89.2 121.08 31.16 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.1 -0.704 . . . . 75.11 109.1 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 92.6 t -108.81 106.03 19.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.987 -0.551 . . . . 61.13 109.727 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 88.2 m -92.9 118.85 31.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.348 -0.982 . . . . 74.2 108.348 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.685 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -95.17 120.36 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 N-CA-C 108.946 -0.761 . . . . 74.23 108.946 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.451 ' CZ ' HD12 ' A' ' 504' ' ' ILE 0.316 26.1 m-85 -84.37 102.7 12.94 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-O 122.233 1.016 . . . . 74.14 113.624 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.64 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.7 t70 -51.02 -54.11 27.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 111.779 -2.464 . . . . 61.44 109.435 173.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 28.5 t70 69.1 5.35 5.03 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.578 -1.192 . . . . 72.34 111.507 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -95.8 -63.38 1.16 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.52 -0.919 . . . . 71.23 108.52 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -102.72 -30.36 10.94 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.779 -1.563 . . . . 74.05 106.779 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 451' ' ' GLU . . . -82.07 70.9 9.08 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.504 -0.771 . . . . 63.41 110.04 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -93.02 93.02 1.71 Allowed Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.85 -1.3 . . . . 63.02 109.85 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.451 HD12 ' CZ ' ' A' ' 497' ' ' PHE . 46.4 pt -85.6 167.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.306 0.574 . . . . 75.44 110.631 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -131.49 129.07 40.64 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 104.923 -2.251 . . . . 75.34 104.923 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 49.8 m -71.12 98.04 1.6 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.694 -0.484 . . . . 64.01 109.694 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -72.86 113.93 10.43 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.903 -1.517 . . . . 72.41 106.903 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.01 157.13 38.37 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.854 0.835 . . . . 74.44 112.5 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 . . . . . 0 C--N 1.292 -1.932 0 CA-C-N 114.537 -1.211 . . . . 72.31 109.265 -178.881 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.64 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.625 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 108.198 -1.038 . . . . 61.05 108.198 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 397' ' ' ARG . 15.3 m -79.42 124.05 28.08 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 109.145 -0.687 . . . . 72.21 109.145 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 97.0 mttt -112.08 146.58 37.72 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 116.153 -0.476 . . . . 74.25 112.046 -174.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.631 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 18.6 mm -104.36 121.12 55.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.027 -1.101 . . . . 72.14 108.027 -176.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.416 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 21.4 p90 -150.49 168.34 24.5 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.153 -0.619 . . . . 72.15 112.235 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -80.91 145.72 31.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.588 -0.523 . . . . 75.1 109.588 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.532 ' HB3' ' OH ' ' A' ' 381' ' ' TYR . 37.2 tt0 -58.4 -59.03 5.99 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.847 0.859 . . . . 72.4 109.746 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.514 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.8 mm100 -104.87 179.98 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.343 -0.844 . . . . 65.44 110.332 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -109.13 -22.2 6.98 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 109.687 -1.365 . . . . 65.34 109.687 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' THR . 38.5 m -143.23 132.16 22.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 115.059 -0.571 . . . . 60.13 109.607 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.532 ' OH ' ' HB3' ' A' ' 377' ' ' GLU . 48.7 m-85 -118.98 147.83 43.64 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.159 -1.052 . . . . 74.41 108.159 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 495' ' ' THR . 40.1 mt-30 -130.74 133.55 46.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.041 -1.096 . . . . 71.13 108.041 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.6 p -140.06 157.39 45.72 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 109.123 -0.695 . . . . 72.12 109.123 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -81.15 143.7 32.2 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.02 -0.733 . . . . 74.02 109.02 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.88 -31.18 70.67 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.355 0.662 . . . . 75.23 110.833 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.452 ' C ' HD21 ' A' ' 386' ' ' ASN . 0.2 OUTLIER -80.94 -2.26 46.98 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.831 -0.622 . . . . 72.24 112.496 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.7 t -68.9 -33.2 73.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.808 0.337 . . . . 72.32 111.685 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 100.78 -58.04 0.71 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.886 -0.886 . . . . 61.13 110.886 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 13.8 p -137.79 154.35 49.57 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.003 -0.369 . . . . 73.43 110.003 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.9 p -110.22 130.52 63.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.042 -1.096 . . . . 62.33 108.042 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -100.54 119.34 38.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.997 0.427 . . . . 75.34 110.26 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.432 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.7 mp -113.14 157.14 22.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.862 -1.532 . . . . 71.33 106.862 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.1 m -120.54 137.01 54.61 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.232 -0.587 . . . . 73.25 110.5 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.8 mt -101.56 121.43 52.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.386 -1.338 . . . . 74.34 107.386 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.55 115.38 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 108.248 -1.019 . . . . 74.12 108.248 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 436' ' ' THR . 52.7 ttt-85 -105.84 129.27 54.05 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.726 -1.212 . . . . 74.4 107.726 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 372' ' ' SER . 28.7 mmm180 -118.26 141.54 48.4 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.084 -0.709 . . . . 75.15 109.084 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 144.33 -9.21 1.93 Allowed Glycine 0 C--O 1.24 0.482 0 C-N-CA 120.651 -0.785 . . . . 72.34 112.959 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 126.12 179.72 15.88 Favored Glycine 0 N--CA 1.433 -1.525 0 C-N-CA 120.823 -0.703 . . . . 70.34 111.834 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -112.1 165.95 11.67 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.624 -0.88 . . . . 72.11 108.624 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.443 HD11 ' CB ' ' A' ' 478' ' ' ASN . 2.1 pt? -166.18 162.58 17.67 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.724 -0.843 . . . . 73.34 108.724 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 12.2 p -102.5 7.16 40.25 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.209 0.528 . . . . 64.13 111.965 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -81.47 179.24 7.92 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.654 -1.239 . . . . 74.32 107.654 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 24.5 m -125.42 114.26 18.6 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.373 0.606 . . . . 74.34 110.967 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 52.6 t -106.68 148.89 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.062 -0.972 . . . . 71.43 108.67 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.594 ' CE2' HG21 ' A' ' 430' ' ' VAL . 25.8 m-85 -131.41 142.55 50.05 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.037 0.446 . . . . 73.23 110.706 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.89 137.82 24.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.017 -1.475 . . . . 65.34 107.017 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -101.36 138.5 38.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.189 -0.671 . . . . 72.22 109.189 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.42 150.5 45.56 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.325 -0.991 . . . . 72.33 108.325 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . 0.436 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 10.0 ttm180 -157.85 150.42 22.63 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.446 -0.946 . . . . 73.44 108.446 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 31.9 p -96.75 156.86 16.17 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.183 -0.607 . . . . 72.2 110.319 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 11.5 tp10 -114.36 150.19 34.96 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.475 -1.676 . . . . 71.21 106.475 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 24.4 m-20 -53.86 -44.77 70.66 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.829 0.823 . . . . 71.44 112.2 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.97 3.55 Favored Glycine 0 N--CA 1.42 -2.408 0 CA-C-N 114.299 -1.319 . . . . 71.22 110.351 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 455' ' ' ASN . 9.9 t -104.99 -9.32 17.98 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.83 -0.804 . . . . 75.34 108.83 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -117.72 -159.22 0.74 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.302 -0.999 . . . . 72.22 108.302 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.416 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 3.4 m120 -131.38 127.68 38.06 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 112.878 0.696 . . . . 70.43 112.878 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.105 -1.072 . . . . 74.34 108.105 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.75 56.95 Favored Glycine 0 C--N 1.295 -1.728 0 N-CA-C 110.513 -1.035 . . . . 70.34 110.513 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.1 m -128.88 -54.79 1.21 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.155 -0.313 . . . . 74.21 110.155 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.503 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 18.2 m-20 -84.25 -53.05 5.76 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.814 0.816 . . . . 72.53 108.977 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.637 ' CE2' HD12 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -139.93 166.09 25.57 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.54 159.68 30.13 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.662 -0.866 . . . . 72.14 108.662 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.531 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -97.44 -17.69 19.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.01 0.524 . . . . 75.1 111.853 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.421 HG21 HG21 ' A' ' 442' ' ' VAL . 6.4 t 40.92 56.44 2.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.576 1.95 . . . . 73.24 113.24 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 9.4 pt-20 -77.55 108.96 11.1 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.225 1.012 . . . . 73.21 109.213 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.6 163.71 28.49 Favored Glycine 0 N--CA 1.411 -2.998 0 CA-C-N 114.905 -1.043 . . . . 71.05 110.904 -176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 11.0 m -108.71 134.23 51.71 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 108.049 -1.093 . . . . 74.21 108.049 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 48.8 t -94.78 125.24 47.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.399 -0.963 . . . . 64.44 108.399 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . 0.594 HG21 ' CE2' ' A' ' 406' ' ' PHE . 37.2 t -99.42 112.28 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 CA-C-N 114.761 -1.109 . . . . 75.44 108.392 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -83.48 105.54 14.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.3 -1.0 . . . . 71.32 108.3 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 1.0 OUTLIER -79.58 163.94 56.26 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.913 -1.039 . . . . 73.13 111.465 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.0 Cg_exo -51.41 118.1 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 123.247 2.631 . . . . 73.43 111.303 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.87 -15.96 49.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.924 -0.58 . . . . 75.23 113.88 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.8 63.65 7.56 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.393 0.886 . . . . 64.43 113.393 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.496 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 19.3 m -53.86 -24.78 16.93 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 114.496 -1.229 . . . . 74.1 112.092 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -116.23 145.27 43.26 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.763 -0.828 . . . . 62.52 108.763 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -134.48 147.55 50.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.02 0.378 . . . . 70.43 112.02 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.29 141.01 37.56 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.683 -0.689 . . . . 74.51 109.543 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.1 pt -128.42 148.44 32.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.709 -0.849 . . . . 74.12 108.709 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 73.9 mtm180 -129.02 142.66 50.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.361 0.601 . . . . 73.34 111.191 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.533 HG13 ' CZ ' ' A' ' 456' ' ' PHE . 46.1 t -116.42 124.37 72.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.503 -1.295 . . . . 74.1 107.503 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -75.71 141.67 27.77 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.989 -0.624 . . . . 71.41 112.368 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 36.6 mm -99.47 136.91 28.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.892 -1.151 . . . . 73.45 107.892 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.3 mt -98.19 148.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.48 -1.674 . . . . 74.35 106.48 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.47 86.59 5.77 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.287 -0.565 . . . . 73.03 110.707 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.0 118.66 37.03 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 103.936 -2.616 . . . . 63.51 103.936 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.605 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.258 10.7 t70 -121.21 92.5 3.77 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.493 -2.083 . . . . 75.22 110.966 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.6 mm -120.23 156.62 23.1 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.357 0 CA-C-N 111.018 -2.81 . . . . 71.54 103.825 -175.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -53.62 114.0 1.38 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.625 -1.62 . . . . 73.0 106.625 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.714 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 35.5 mt-10 -121.18 113.04 19.42 Favored 'General case' 0 CA--C 1.468 -2.208 0 CA-C-O 121.56 0.695 . . . . 60.52 110.532 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -117.81 100.55 7.66 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.691 -1.14 . . . . 75.11 109.767 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 51.75 40.89 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.447 -1.251 . . . . 74.33 113.393 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.449 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.7 pt-20 -70.12 131.84 44.91 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 119.945 -0.702 . . . . 62.55 109.81 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.2 OUTLIER -150.13 161.22 42.8 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.446 0.535 . . . . 73.44 112.446 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.533 ' CZ ' HG13 ' A' ' 442' ' ' VAL . 35.3 p90 -131.96 -179.56 5.48 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.377 -0.374 . . . . 75.42 110.611 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 47.4 mt -121.34 138.49 54.23 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.457 -0.942 . . . . 75.41 108.457 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . 0.406 ' HB ' ' HB1' ' A' ' 492' ' ' ALA . 23.0 t -111.06 129.59 66.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.34 -1.356 . . . . 72.21 107.34 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -122.67 165.75 16.01 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 123.574 0.546 . . . . 64.24 109.712 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.52 139.36 51.58 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.198 0.523 . . . . 74.53 110.536 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 37.3 m -150.57 -179.28 7.1 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.271 -1.011 . . . . 74.03 108.271 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.8 t30 45.7 88.39 0.02 OUTLIER 'General case' 0 C--O 1.248 1.02 0 C-N-CA 124.815 1.246 . . . . 73.22 113.856 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.3 123.8 42.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.219 -0.992 . . . . 75.2 108.779 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -127.35 173.5 9.73 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 121.501 0.667 . . . . 73.45 110.421 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 42.3 t -143.96 159.14 16.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 102.888 -3.005 . . . . 65.34 102.888 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.2 m -69.34 108.92 3.9 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 122.657 1.218 . . . . 63.51 108.333 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 3.5 p -82.12 82.88 7.52 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-N 112.92 -1.945 . . . . 61.12 113.319 -172.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -93.6 -44.25 8.29 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.249 -1.342 . . . . 73.11 107.801 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -103.18 -50.01 3.6 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.049 -0.978 . . . . 64.05 108.928 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 22.4 m -160.05 153.75 22.67 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.092 -1.077 . . . . 75.04 108.092 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -85.99 -39.63 16.68 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.311 -0.996 . . . . 70.33 108.311 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -120.35 110.82 16.99 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.942 -1.133 . . . . 74.54 107.942 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 147.78 -40.67 0.96 Allowed Glycine 0 C--N 1.29 -2.009 0 N-CA-C 108.78 -1.728 . . . . 72.3 108.78 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 50.5 mm -85.32 95.98 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 104.983 -2.229 . . . . 75.4 104.983 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.529 ' HA ' ' NE2' ' A' ' 479' ' ' HIS . 2.4 pp -119.38 138.65 52.94 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 113.844 1.053 . . . . 74.41 113.844 -173.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.44 162.54 35.22 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.676 -0.861 . . . . 72.44 108.676 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -69.11 -6.86 31.11 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.632 0.605 . . . . 74.53 112.632 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . 0.499 ' HA ' ' OG ' ' A' ' 372' ' ' SER . 53.6 m-80 -86.21 -0.01 54.76 Favored 'General case' 0 C--O 1.253 1.242 0 N-CA-C 113.509 0.929 . . . . 75.53 113.509 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.529 ' NE2' ' HA ' ' A' ' 475' ' ' LEU . 2.4 p-80 -139.77 173.23 11.74 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.513 0.673 . . . . 75.34 112.079 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.45 -169.45 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.104 -1.407 . . . . 72.04 108.111 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 33.6 p -162.84 -151.49 0.19 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 118.372 0.533 . . . . 71.02 110.155 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -94.58 8.62 41.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.706 -0.85 . . . . 74.22 108.706 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -118.54 -52.12 2.37 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.226 -1.768 . . . . 73.22 106.226 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.09 131.11 36.13 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.513 -2.032 . . . . 71.34 105.513 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 70.2 m -104.21 176.76 5.05 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 120.815 -0.354 . . . . 65.32 110.245 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.631 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 1.2 mm? -68.98 -164.41 0.05 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 123.743 0.652 . . . . 74.14 109.615 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.458 ' C ' ' HD3' ' A' ' 489' ' ' PRO . . . -66.81 -169.96 3.89 Favored Glycine 0 C--O 1.24 0.519 0 N-CA-C 110.133 -1.187 . . . . 64.45 110.133 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.0 m -113.28 65.34 1.03 Allowed Pre-proline 0 C--N 1.298 -1.667 0 C-N-CA 116.551 -2.06 . . . . 71.23 116.306 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.575 ' CB ' ' HA ' ' A' ' 490' ' ' SER . 10.8 Cg_endo -98.15 -80.55 0.0 OUTLIER 'Trans proline' 1 CA--C 1.61 4.318 0 C-N-CA 121.341 1.36 . . . . 75.22 111.711 161.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.575 ' HA ' ' CB ' ' A' ' 489' ' ' PRO . 22.6 m -118.88 86.49 2.55 Favored 'General case' 0 C--N 1.388 2.28 0 CA-C-N 123.591 2.905 . . . . 73.53 106.886 -5.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 53.0 m -147.55 128.7 14.66 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 109.166 -0.679 . . . . 73.33 109.166 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . 0.406 ' HB1' ' HB ' ' A' ' 458' ' ' VAL . . . -112.06 106.78 15.51 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.714 -1.217 . . . . 62.13 107.714 170.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 380' ' ' THR . 27.0 m -82.0 121.9 27.11 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.69 -0.485 . . . . 74.4 109.69 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 86.6 t -107.75 107.89 23.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.492 -0.929 . . . . 72.1 108.492 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 66.9 m -98.39 113.44 25.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.895 -0.779 . . . . 74.24 108.895 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.637 HD12 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -91.3 120.5 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.556 0.693 . . . . 75.11 110.767 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.01 101.63 13.09 Favored 'General case' 0 N--CA 1.394 -3.273 0 CA-C-N 115.013 -0.994 . . . . 72.4 110.999 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.601 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 2.1 t70 -53.6 -53.42 52.05 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.547 -2.115 . . . . 72.43 108.974 172.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 31.8 t70 69.29 -5.74 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.571 1.548 . . . . 74.12 112.1 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -78.06 -35.49 49.52 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.832 -1.173 . . . . 73.01 107.832 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -95.35 -35.45 11.76 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.322 -0.854 . . . . 71.25 110.257 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 499' ' ' ASP . . . -72.38 -73.95 0.18 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.273 0.842 . . . . 64.31 113.273 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.14 60.7 1.9 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.12 -1.192 . . . . 72.31 110.12 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 49.3 pt -97.96 178.47 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 110.337 -0.245 . . . . 74.33 110.337 -176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -85.72 125.87 33.54 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.392 -0.966 . . . . 70.4 108.392 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 2.2 p -81.44 176.15 9.94 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.005 -0.543 . . . . 74.41 111.236 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -74.29 135.89 42.61 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.567 -0.531 . . . . 75.04 109.567 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -78.74 95.43 5.31 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.273 -0.64 . . . . 74.11 109.273 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 115.244 -0.889 . . . . 72.02 108.687 -176.695 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.605 'CA ' ' OD1' ' A' ' 448' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.619 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 478' ' ' ASN . 47.0 t . . . . . 0 N--CA 1.444 -0.739 0 N-CA-C 109.275 -0.639 . . . . 74.33 109.275 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 44.9 m -126.4 150.68 48.47 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 116.259 -0.428 . . . . 55.45 110.233 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 95.6 mttt -126.85 159.17 34.69 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.095 0.558 . . . . 74.25 111.445 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.504 ' HB ' HD12 ' A' ' 486' ' ' LEU . 33.4 mm -116.23 121.41 67.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.143 -1.058 . . . . 71.45 108.143 -175.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -154.1 172.12 18.04 Favored 'General case' 0 C--O 1.193 -1.894 0 N-CA-C 112.195 0.443 . . . . 64.45 112.195 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -85.49 153.36 22.51 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.594 -0.442 . . . . 71.24 110.491 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.46 -36.79 81.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.46 0.648 . . . . 74.42 109.582 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -128.59 172.3 11.32 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.227 -0.897 . . . . 72.13 111.792 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.41 -32.3 4.93 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 114.881 -1.054 . . . . 63.25 110.966 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.3 m -130.39 125.5 34.7 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.389 -0.597 . . . . 72.43 109.389 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.17 140.69 48.33 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.449 -0.945 . . . . 75.43 108.449 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 495' ' ' THR . 37.9 mt-30 -123.96 135.52 53.71 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.404 -1.332 . . . . 75.11 107.404 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 29.7 t -146.48 165.86 28.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.279 -1.008 . . . . 74.12 108.279 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -91.14 145.54 24.59 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.634 -0.506 . . . . 71.31 109.634 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.608 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 18.1 tt0 -55.66 -54.86 39.05 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.778 0.831 . . . . 75.44 110.723 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.37 8.34 2.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.765 1.024 . . . . 73.03 113.765 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.89 -31.05 68.64 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.538 -0.541 . . . . 74.52 109.538 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.64 -60.38 0.52 Allowed Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.425 -0.893 . . . . 63.22 111.245 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 12.7 p -138.02 152.1 48.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 110.348 -0.242 . . . . 74.04 110.348 176.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.6 p -108.15 124.22 64.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.559 -1.274 . . . . 74.53 107.559 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.16 118.92 34.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.309 0.576 . . . . 71.35 110.815 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.421 HD11 ' N ' ' A' ' 392' ' ' LEU . 3.2 mp -110.93 149.99 29.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.511 -1.292 . . . . 72.24 107.511 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.4 m -116.37 125.45 52.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.235 0.54 . . . . 71.54 110.462 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 77.6 mt -97.24 123.98 49.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.346 -1.353 . . . . 73.43 107.346 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.7 mm -102.16 129.93 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-N 115.205 -0.907 . . . . 75.42 108.775 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 35.9 ttt180 -112.06 108.62 17.99 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.424 -0.807 . . . . 75.0 108.873 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -111.45 158.47 19.08 Favored 'General case' 0 CA--C 1.487 -1.462 0 CA-C-N 116.135 -0.484 . . . . 74.33 109.755 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 150.28 -40.13 0.84 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.405 -1.078 . . . . 74.4 110.405 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 156.51 -125.19 1.57 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 110.273 -1.131 . . . . 70.44 110.273 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -133.15 119.94 20.56 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.526 -0.916 . . . . 73.33 108.526 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 80.5 mt -143.43 138.01 29.03 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.166 -1.05 . . . . 73.14 108.166 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.436 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 48.4 p -98.41 6.27 47.4 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 122.165 0.983 . . . . 74.01 109.859 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.65 138.16 50.48 Favored 'General case' 0 C--O 1.258 1.516 0 CA-C-N 114.135 -1.393 . . . . 75.04 108.994 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 466' ' ' SER . 7.0 m -90.78 124.76 35.39 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 121.623 0.725 . . . . 72.21 109.832 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.87 137.25 56.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.307 -0.86 . . . . 72.11 109.132 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' A' ' 430' ' ' VAL . 17.9 m-85 -119.93 137.1 54.24 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.582 -0.896 . . . . 75.01 108.582 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.18 128.76 49.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 107.619 -1.252 . . . . 73.35 107.619 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.5 153.68 20.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.714 -0.476 . . . . 63.11 109.714 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -146.95 161.54 40.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.232 -0.293 . . . . 65.31 110.435 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -161.03 163.0 31.91 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 107.311 -1.366 . . . . 75.23 107.311 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.605 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 49.4 p -95.71 172.54 7.98 Favored 'General case' 0 C--O 1.26 1.656 0 N-CA-C 108.34 -0.985 . . . . 64.51 108.34 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -121.72 151.61 40.32 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 120.218 -0.593 . . . . 63.02 111.339 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 3.49 8.68 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 125.734 1.613 . . . . 71.33 113.045 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.85 -92.02 0.01 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 116.917 1.527 . . . . 71.43 116.917 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.3 t -101.85 9.58 40.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.212 1.006 . . . . 73.42 111.096 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -147.03 -157.58 0.82 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.492 -0.929 . . . . 41.32 108.492 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -145.17 124.37 12.94 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.95 -1.1 . . . . 63.1 111.768 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.28 124.65 25.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.255 -0.884 . . . . 74.1 108.889 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.48 -16.02 41.53 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.963 -1.255 . . . . 73.33 109.963 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 48.1 t -110.48 -58.71 2.04 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.379 -0.6 . . . . 64.14 109.379 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.563 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 15.4 m-20 -86.28 -58.39 2.65 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-O 122.261 1.029 . . . . 74.43 109.418 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.695 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.11 163.43 32.45 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.086 -0.961 . . . . 75.22 109.48 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -72.94 151.94 41.63 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 123.879 0.737 . . . . 74.31 110.735 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.605 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.1 p90 -80.54 -21.62 41.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.747 -0.661 . . . . 70.32 112.654 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 442' ' ' VAL 0.255 13.8 t 36.69 67.16 0.35 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.647 1.579 . . . . 74.13 113.754 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -87.86 113.15 23.24 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.098 -0.956 . . . . 65.42 108.756 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.65 -173.86 23.26 Favored Glycine 0 CA--C 1.482 -2.025 0 C-N-CA 120.492 -0.861 . . . . 70.43 111.365 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.7 m -120.51 137.16 54.52 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.501 -0.926 . . . . 71.1 108.501 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.56 123.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.929 -1.137 . . . . 72.42 107.929 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . 0.445 HG21 ' CE2' ' A' ' 406' ' ' PHE . 16.2 t -103.66 109.6 27.58 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-O 121.389 0.614 . . . . 74.44 111.047 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 404' ' ' THR . 55.7 m-85 -94.14 100.02 12.19 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.699 -0.682 . . . . 74.22 111.064 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.8 mttt -94.53 172.1 5.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 114.263 -1.335 . . . . 75.21 110.343 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.436 ' HG3' ' O ' ' A' ' 402' ' ' THR . 44.5 Cg_exo -58.73 126.17 20.44 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.868 2.379 . . . . 75.32 112.173 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.84 -2.04 87.07 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.601 -0.809 . . . . 61.33 114.359 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 437' ' ' GLN . 19.6 mm-40 -73.24 -70.16 0.38 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 117.654 0.727 . . . . 72.01 110.447 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 54.5 m 71.26 -35.33 0.33 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.686 0.795 . . . . 63.51 112.122 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 435' ' ' GLU . 35.8 mt-30 -125.95 140.1 52.9 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.515 -1.291 . . . . 74.12 107.515 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -132.93 143.67 49.64 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.417 -0.356 . . . . 75.52 110.322 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -106.0 134.64 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.495 -0.928 . . . . 65.22 108.495 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.4 pt -123.14 148.54 26.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.437 -1.32 . . . . 73.14 107.437 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 75.5 mtt180 -129.0 138.18 51.78 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.363 0.602 . . . . 75.41 111.93 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.658 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 52.1 t -109.62 119.0 58.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.732 -1.122 . . . . 72.21 108.628 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -66.03 132.55 33.83 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 124.192 0.933 . . . . 61.02 112.236 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . 0.4 HG21 HD12 ' A' ' 444' ' ' ILE . 31.8 mm -97.71 135.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.169 -1.419 . . . . 70.2 107.169 175.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 76.0 mt -101.72 150.57 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 106.948 -1.501 . . . . 73.4 106.948 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.23 95.47 6.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.365 -0.534 . . . . 75.03 111.317 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -122.61 128.1 50.25 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 103.539 -2.763 . . . . 72.42 103.539 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -126.54 99.85 5.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 C-N-CA 116.999 -1.881 . . . . 75.04 110.149 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.746 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -131.04 158.27 43.3 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.118 0 CA-C-N 111.077 -2.783 . . . . 72.22 105.03 -171.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -53.16 114.82 1.6 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 116.721 -1.992 . . . . 70.24 106.397 166.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.746 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.6 mt-10 -125.23 97.17 5.11 Favored 'General case' 0 CA--C 1.458 -2.571 0 N-CA-C 107.856 -1.164 . . . . 74.13 107.856 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -117.84 113.47 21.83 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 108.192 -1.04 . . . . 75.23 108.192 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 31.38 20.41 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.114 0.884 . . . . 71.23 111.366 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.477 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.0 tt0 -65.32 106.57 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.27 -1.381 . . . . 71.4 107.27 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -141.2 169.68 17.15 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.65 -0.704 . . . . 63.22 109.846 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.658 ' CZ ' HG12 ' A' ' 442' ' ' VAL . 22.5 p90 -143.35 170.44 15.76 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.749 -0.834 . . . . 74.14 108.749 173.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.74 136.5 50.92 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.058 -1.46 . . . . 73.23 107.058 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.58 124.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 106.806 -1.553 . . . . 71.11 106.806 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -120.37 142.8 48.84 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.652 -0.704 . . . . 74.11 109.242 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.5 138.13 33.61 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.931 -1.878 . . . . 73.22 105.931 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 26.0 m -148.09 155.1 41.06 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.89 -0.781 . . . . 72.31 108.89 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.5 t30 57.56 92.38 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 O-C-N 124.543 1.152 . . . . 62.43 111.95 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.75 142.46 14.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.391 -0.966 . . . . 74.1 108.391 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 464' ' ' LYS . 32.6 ttmt -140.76 120.18 13.12 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.3 -0.63 . . . . 73.51 109.3 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 50.4 t -102.74 140.51 20.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.388 -0.967 . . . . 75.34 108.388 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' SER . . . . . 0.535 ' O ' ' HB ' ' A' ' 404' ' ' THR . 71.0 m -138.89 109.54 6.63 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.465 0.65 . . . . 71.23 112.665 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 15.7 m -95.16 98.34 10.57 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.743 -1.947 . . . . 74.33 105.743 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.28 -8.29 52.64 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.706 1.373 . . . . 74.11 114.706 -172.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.03 -32.86 57.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.651 -1.24 . . . . 75.11 107.651 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 48.9 m 54.95 34.78 23.04 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.129 -1.396 . . . . 61.14 113.835 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.6 -32.28 65.84 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.927 0.87 . . . . 64.12 108.99 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -155.66 139.76 16.47 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.085 -0.961 . . . . 74.3 108.479 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -82.14 67.45 3.68 Favored Glycine 0 C--N 1.301 -1.365 0 N-CA-C 110.201 -1.16 . . . . 75.02 110.201 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 13.9 tt -74.56 141.15 16.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.162 0.506 . . . . 73.41 110.067 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.455 HD21 ' H ' ' A' ' 475' ' ' LEU . 2.5 pt? -76.42 134.46 39.59 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.456 -0.793 . . . . 75.0 110.005 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -103.32 110.48 22.49 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.291 0.567 . . . . 75.53 111.871 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -93.96 -6.06 46.3 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 122.245 1.021 . . . . 73.21 108.273 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 371' ' ' VAL . 3.4 p-10 -86.23 1.34 51.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.119 -1.401 . . . . 74.42 109.524 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -139.56 175.61 9.42 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-N 115.759 -0.655 . . . . 75.5 110.289 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 25.8 m -79.43 145.39 9.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.292 -0.867 . . . . 75.11 110.918 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 28.5 t 177.75 -78.34 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.059 1.343 . . . . 62.03 108.507 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.73 -0.35 1.93 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.332 . . . . 75.42 111.674 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -108.94 -45.14 3.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 104.54 -2.393 . . . . 75.41 104.54 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -113.32 147.95 36.62 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 106.89 -1.522 . . . . 71.21 106.89 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 77.7 m -122.32 177.89 5.18 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 108.119 -1.067 . . . . 72.31 108.119 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.504 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.5 mm? -65.51 154.48 38.48 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.521 -0.472 . . . . 73.52 109.979 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -72.83 -30.45 63.65 Favored Glycine 0 C--O 1.227 -0.344 0 C-N-CA 120.972 -0.632 . . . . 63.51 112.647 -176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 9.4 m -97.55 167.45 11.81 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 107.602 -1.259 . . . . 70.43 107.602 175.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.605 ' N ' ' HA ' ' A' ' 490' ' ' SER . 38.7 Cg_exo -57.37 -29.84 85.72 Favored 'Trans proline' 0 CA--C 1.586 3.109 0 N-CA-C 120.127 3.087 . . . . 72.35 120.127 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.605 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 14.5 m -111.61 117.63 33.48 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 128.245 2.618 . . . . 63.51 108.642 2.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 23.2 m -127.92 104.86 8.04 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.25 -0.648 . . . . 62.52 109.25 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -107.59 118.66 37.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.331 -0.989 . . . . 73.15 108.331 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 23.6 m -88.25 119.51 28.73 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.814 0.34 . . . . 65.34 110.47 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.406 HG12 HG13 ' A' ' 390' ' ' VAL . 68.4 t -104.61 106.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.424 -0.954 . . . . 75.35 108.424 176.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 27.6 m -95.53 114.23 25.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.131 -1.063 . . . . 72.14 108.131 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.695 HD11 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -92.21 117.59 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 C-N-CA 120.326 -0.55 . . . . 72.22 110.411 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.446 ' O ' HD11 ' A' ' 384' ' ' LEU . 18.3 m-85 -78.42 103.06 8.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 107.621 -1.252 . . . . 73.55 107.621 170.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 385' ' ' GLU . 0.0 OUTLIER -63.06 -30.81 71.89 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.283 -1.781 . . . . 74.21 109.459 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.9 t70 64.49 18.76 11.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.521 1.528 . . . . 74.52 110.849 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.412 ' HB2' ' OD2' ' A' ' 498' ' ' ASP . 35.6 m-20 -112.4 -52.12 2.8 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.198 -1.408 . . . . 73.31 107.198 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -130.32 -14.8 3.75 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.875 -1.057 . . . . 75.42 111.003 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -67.63 100.52 0.9 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.341 0.867 . . . . 73.31 113.341 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 77.9 -61.99 3.66 Favored Glycine 0 CA--C 1.497 -1.044 0 CA-C-N 115.733 -0.667 . . . . 75.1 111.638 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.93 160.92 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 C-N-CA 123.398 0.679 . . . . 75.44 110.036 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -114.46 124.44 51.92 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.611 -0.436 . . . . 72.33 111.588 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 18.3 m -136.44 149.37 48.22 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.826 -1.546 . . . . 74.21 106.826 173.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -75.16 138.77 42.23 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.701 0.4 . . . . 74.31 111.139 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.66 125.44 31.85 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.873 -0.788 . . . . 72.23 108.873 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 112.283 0.475 . . . . 72.44 112.283 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.608 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.634 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.423 ' O ' ' HA3' ' A' ' 398' ' ' GLY . 13.5 p . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 121.159 0.505 . . . . 74.54 109.879 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 479' ' ' HIS . 23.6 m -74.65 135.03 41.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.951 -0.568 . . . . 75.41 111.22 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -138.39 142.54 39.61 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 122.775 0.43 . . . . 74.33 110.216 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.454 ' HB ' HD12 ' A' ' 486' ' ' LEU . 44.7 mm -109.38 112.62 41.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.162 -1.421 . . . . 62.24 107.162 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -145.53 160.44 41.62 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.836 -0.746 . . . . 73.53 112.609 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.06 142.76 39.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.31 -0.626 . . . . 75.13 109.31 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.21 -48.69 80.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.806 0.842 . . . . 74.52 110.093 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.546 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 16.2 mm100 -106.25 172.4 6.83 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.816 0.817 . . . . 65.15 110.649 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.11 -34.04 4.99 Favored Glycine 0 C--N 1.284 -2.327 0 CA-C-N 114.129 -1.396 . . . . 70.44 110.167 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 42.2 m -132.93 128.43 36.47 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.226 -1.028 . . . . 54.43 108.226 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 37.3 m-85 -112.06 136.84 50.91 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.761 -0.829 . . . . 63.51 108.761 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -126.61 142.49 51.52 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 19.5 t -153.68 165.1 37.01 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.278 -1.378 . . . . 73.22 107.278 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -86.18 141.99 28.94 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.584 -0.525 . . . . 75.22 109.584 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.601 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 24.9 tt0 -55.55 -38.2 69.0 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.378 1.071 . . . . 75.21 110.128 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -84.83 7.03 22.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.04 -0.982 . . . . 71.23 111.999 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.5 t -90.45 -1.03 57.89 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 122.02 -0.425 . . . . 75.14 111.213 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.27 4.5 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 64.33 113.117 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 22.1 p -142.91 174.26 10.82 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.314 0.578 . . . . 73.1 110.843 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.6 p -125.61 125.9 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 106.802 -1.555 . . . . 74.23 106.802 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.33 122.69 41.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.996 0.427 . . . . 73.0 110.118 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.522 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.3 mp -112.45 146.42 38.43 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.05 -1.092 . . . . 74.24 108.05 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.2 m -112.46 128.53 56.35 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.448 0.467 . . . . 74.55 109.748 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 62.2 mt -100.45 121.74 51.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.17 -1.419 . . . . 74.41 107.17 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.2 mm -99.2 132.3 44.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.754 -0.832 . . . . 73.41 108.754 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -107.52 122.83 47.44 Favored 'General case' 0 N--CA 1.406 -2.666 0 C-N-CA 119.702 -0.799 . . . . 75.02 110.549 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -119.6 157.62 28.05 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.363 -0.835 . . . . 74.44 108.965 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 371' ' ' VAL . . . 91.39 49.41 3.02 Favored Glycine 0 N--CA 1.418 -2.503 0 O-C-N 124.037 0.836 . . . . 73.25 111.739 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 115.07 115.08 3.01 Favored Glycine 0 N--CA 1.415 -2.726 0 C-N-CA 120.122 -1.037 . . . . 73.24 112.735 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -100.78 121.37 41.57 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 105.766 -1.939 . . . . 73.44 105.766 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -157.08 -173.14 4.31 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 120.609 -0.437 . . . . 65.32 111.252 -173.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.8 p -102.49 -4.11 25.86 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.53 0.937 . . . . 73.23 113.53 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.88 138.67 52.69 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.955 -0.466 . . . . 74.21 110.575 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 50.7 m -93.9 124.55 37.98 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 123.93 0.892 . . . . 74.31 111.512 -176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.6 t -112.26 146.92 16.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.047 -0.524 . . . . 74.31 109.83 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.608 ' CE1' HG12 ' A' ' 430' ' ' VAL . 3.7 m-85 -120.59 129.14 53.63 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.11 0.564 . . . . 73.24 110.66 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.81 135.95 52.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.589 -1.263 . . . . 74.41 107.589 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 18.2 t70 -102.52 148.73 25.18 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.061 -0.718 . . . . 73.53 109.061 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -143.94 159.36 42.71 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.038 -0.665 . . . . 74.44 110.868 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -163.17 160.91 24.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.37 -1.715 . . . . 75.3 106.37 173.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.621 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 34.9 p -96.95 164.81 12.38 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.426 0.631 . . . . 73.12 110.581 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.4 tp10 -106.53 152.59 23.48 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.214 -1.402 . . . . 64.2 107.214 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 4.8 m-20 -60.01 -40.51 89.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.915 0.864 . . . . 71.52 110.493 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 67.69 -86.51 0.16 Allowed Glycine 0 C--N 1.299 -1.495 0 CA-C-N 114.355 -1.293 . . . . 73.21 112.964 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.1 t -135.71 11.5 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.657 -0.868 . . . . 74.12 108.657 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -141.3 -162.87 1.45 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.698 -1.593 . . . . 65.33 106.698 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 7.3 m120 -129.29 116.35 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.583 0.706 . . . . 74.02 112.141 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -78.03 124.5 28.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.903 -1.044 . . . . 71.43 108.898 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.35 -12.25 30.94 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 109.668 -1.373 . . . . 74.3 109.668 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 16.3 t -126.87 -54.84 1.4 Allowed 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.917 -0.313 . . . . 74.21 110.993 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.605 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -73.06 -58.46 3.3 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 122.4 1.095 . . . . 70.43 108.074 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.21 161.78 36.58 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.126 -1.397 . . . . 74.25 107.631 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.6 157.33 32.04 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.566 0.541 . . . . 75.1 109.649 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.621 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 15.6 p90 -90.6 -9.69 46.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.215 0.45 . . . . 74.41 112.215 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 425' ' ' THR . 12.7 t 37.34 68.67 0.27 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.052 1.741 . . . . 72.5 113.728 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -80.3 134.79 36.11 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.023 -1.071 . . . . 75.33 109.128 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -175.03 -178.54 44.97 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.677 -0.969 . . . . 72.32 110.677 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 18.3 m -125.73 139.97 53.08 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.789 -1.189 . . . . 74.24 107.789 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.1 t -99.42 119.43 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.922 -0.769 . . . . 74.14 108.922 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . 0.608 HG12 ' CE1' ' A' ' 406' ' ' PHE . 53.6 t -100.71 106.65 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.575 -0.898 . . . . 64.01 108.575 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 404' ' ' THR . 58.9 m-85 -79.17 95.0 5.49 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.736 -0.665 . . . . 74.35 110.075 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -69.46 164.58 48.36 Favored Pre-proline 0 C--N 1.316 -0.852 0 O-C-N 123.58 0.55 . . . . 75.22 111.549 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.41 113.51 1.16 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.739 2.293 . . . . 75.35 111.797 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.1 67.5 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.742 -0.742 . . . . 73.51 113.399 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -88.25 62.02 6.51 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.558 0.694 . . . . 74.03 110.691 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 m -61.47 -23.31 65.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.813 -1.085 . . . . 72.13 110.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -131.38 132.26 44.28 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.58 -1.267 . . . . 75.35 107.58 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 25.8 mmmt -122.32 149.8 43.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.484 0.55 . . . . 74.22 112.484 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -114.51 125.59 53.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.381 -0.827 . . . . 74.05 111.122 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.8 pt -116.84 146.57 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.043 -1.095 . . . . 72.31 108.043 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 71.2 mtt180 -126.01 141.45 51.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.374 -0.53 . . . . 74.01 110.8 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.572 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -106.22 121.2 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.442 -0.947 . . . . 64.42 108.442 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -62.07 125.01 35.31 Favored Glycine 0 N--CA 1.435 -1.423 0 O-C-N 124.134 0.896 . . . . 70.11 112.068 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.92 135.27 29.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.988 -1.486 . . . . 74.33 106.988 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.9 mt -103.19 151.08 6.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.169 -1.419 . . . . 74.32 107.169 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.98 101.31 8.57 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 121.3 0.571 . . . . 75.33 110.536 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 123.15 29.57 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 103.771 -2.677 . . . . 65.35 103.771 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.256 19.6 t70 -119.78 97.58 5.7 Favored 'General case' 0 CA--C 1.459 -2.553 0 C-N-CA 116.393 -2.123 . . . . 74.02 111.932 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -121.45 156.49 25.36 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.439 0 CA-C-N 111.282 -2.69 . . . . 75.23 104.727 -174.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -53.87 115.32 1.95 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.862 -1.903 . . . . 75.45 105.862 168.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 33.1 mt-10 -123.38 90.71 3.33 Favored 'General case' 0 CA--C 1.483 -1.605 0 CA-C-O 122.069 0.937 . . . . 61.41 111.104 -170.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -93.58 104.94 17.03 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.005 -1.452 . . . . 72.33 107.738 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.308 7.9 p-10 42.28 60.34 2.35 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 125.095 1.497 . . . . 61.34 112.9 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.549 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 33.1 tt0 -74.45 113.96 12.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.683 -1.599 . . . . 64.42 106.683 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -137.13 171.35 14.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.57 0.7 . . . . 74.41 112.729 -174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.581 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 28.5 p90 -146.62 -177.78 5.82 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.861 -1.063 . . . . 72.43 109.665 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 26.6 mt -123.32 141.57 51.85 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.015 -1.106 . . . . 64.32 108.015 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.56 130.85 63.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.199 -1.408 . . . . 72.43 107.199 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -124.17 134.2 53.37 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.498 0.499 . . . . 64.52 110.76 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.412 ' C ' ' HG ' ' A' ' 461' ' ' SER . 91.0 mt -95.86 140.62 30.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.048 -1.093 . . . . 73.02 108.048 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 460' ' ' LEU . 49.1 m -155.3 -177.79 6.8 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.693 -0.854 . . . . 72.04 108.693 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 51.11 83.84 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.651 1.18 . . . . 74.25 111.599 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.61 126.4 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.581 -0.848 . . . . 74.04 109.178 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -133.72 155.9 48.92 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.049 -0.523 . . . . 71.15 110.123 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.44 133.83 67.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.351 -0.981 . . . . 72.23 108.351 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' SER . . . . . 0.482 ' HB2' ' CE1' ' A' ' 406' ' ' PHE . 35.1 t -76.99 136.67 38.73 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.021 0.439 . . . . 75.21 110.534 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 470' ' ' SER . 5.4 m -65.41 116.35 6.62 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.057 -0.974 . . . . 74.25 109.595 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -77.54 -68.59 0.61 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.824 1.046 . . . . 71.24 113.824 -176.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -103.83 -57.78 1.98 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.558 0.694 . . . . 64.35 109.313 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 467' ' ' SER . 47.0 t -90.88 169.79 10.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.956 -1.127 . . . . 74.12 107.956 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.64 -22.35 62.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.009 0.433 . . . . 75.1 110.011 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.08 98.83 9.51 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.59 -0.522 . . . . 74.23 109.59 172.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -131.29 41.4 1.52 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.507 -1.037 . . . . 73.11 110.507 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 64.9 mt -92.73 102.74 13.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.125 -1.065 . . . . 73.53 108.125 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.424 ' H ' HD22 ' A' ' 475' ' ' LEU . 1.3 pt? -104.45 90.62 3.59 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.719 0.771 . . . . 74.42 112.614 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.48 69.43 10.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 122.157 0.979 . . . . 73.04 109.807 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -104.8 -69.98 0.79 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.515 -1.221 . . . . 74.43 109.935 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -134.5 15.65 3.71 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.713 0.768 . . . . 71.34 109.191 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 372' ' ' SER . 28.6 m-70 -110.16 169.03 9.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.865 -0.607 . . . . 70.14 110.512 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 22.8 m -77.34 138.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.636 -0.505 . . . . 74.3 109.636 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 10.8 p 170.63 -87.32 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.488 1.515 . . . . 75.03 108.847 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -127.42 18.54 6.93 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.69 -1.226 . . . . 74.51 107.69 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -119.38 -64.1 1.31 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.747 -2.316 . . . . 74.54 104.747 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -113.62 161.41 17.47 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 114.639 -1.164 . . . . 60.35 108.753 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 83.7 m -121.63 -168.99 1.79 Allowed 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.176 -1.416 . . . . 73.51 107.176 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.454 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.4 mm? -70.63 152.61 43.71 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.333 0.515 . . . . 75.12 110.189 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -75.72 -30.4 57.98 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 111.257 -0.737 . . . . 71.53 111.257 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.549 ' C ' ' HA ' ' A' ' 490' ' ' SER . 12.9 m -78.68 166.25 43.92 Favored Pre-proline 0 N--CA 1.429 -1.497 0 N-CA-C 108.733 -0.839 . . . . 75.24 108.733 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.632 ' N ' ' HA ' ' A' ' 490' ' ' SER . 34.0 Cg_exo -58.46 -23.81 65.89 Favored 'Trans proline' 0 CA--C 1.59 3.309 0 N-CA-C 120.582 3.262 . . . . 71.31 120.582 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.632 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 35.5 t -105.29 114.28 28.36 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 123.184 2.72 . . . . 73.21 108.168 1.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.449 ' H ' ' HD2' ' A' ' 489' ' ' PRO . 63.4 m -143.75 128.02 17.76 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.876 -0.602 . . . . 71.01 110.554 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -126.82 135.4 50.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.118 -1.438 . . . . 75.23 107.118 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 88.1 m -96.12 129.99 43.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.656 -0.498 . . . . 75.53 109.656 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 390' ' ' VAL . 69.0 t -115.31 109.37 28.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.587 -0.894 . . . . 75.51 108.587 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 35.6 m -101.55 117.12 34.27 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.457 -0.942 . . . . 74.54 108.457 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.725 HD11 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.4 125.08 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.267 0 CA-C-N 115.957 -0.565 . . . . 70.11 109.693 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.498 ' O ' HD11 ' A' ' 384' ' ' LEU . 12.0 m-85 -84.69 104.26 14.51 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-O 121.799 0.809 . . . . 74.31 111.693 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.619 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 6.2 t70 -49.01 -58.52 4.76 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.721 -2.491 . . . . 73.35 109.475 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.541 ' HA ' ' CA ' ' A' ' 503' ' ' GLY . 11.8 t0 68.99 7.92 6.53 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 125.852 1.661 . . . . 73.53 111.043 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -93.52 -56.38 2.94 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.702 -1.221 . . . . 72.03 107.702 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -104.45 -54.24 2.56 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.606 -1.179 . . . . 74.14 108.412 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -108.39 108.63 19.67 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 108.017 -1.105 . . . . 74.23 108.017 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 499' ' ' ASP . . . -139.72 179.93 18.34 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 118.718 -1.706 . . . . 72.2 115.65 -173.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.62 -4.63 3.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 113.46 -1.37 . . . . 74.4 108.96 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 72.82 83.84 0.12 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 125.464 1.506 . . . . 75.44 111.816 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 42.0 m -150.43 65.75 0.95 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.242 -1.392 . . . . 75.44 107.242 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.21 83.25 6.11 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.668 -1.151 . . . . 75.0 111.205 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.97 129.07 22.07 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.658 -1.156 . . . . 72.24 108.442 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--N 1.291 -1.977 0 CA-C-N 115.634 -0.712 . . . . 73.41 110.293 -177.221 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.619 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.633 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 121.951 0.881 . . . . 65.41 109.413 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.464 ' O ' HG11 ' A' ' 480' ' ' VAL . 49.3 m -77.3 104.53 7.87 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.03 -0.986 . . . . 55.1 109.618 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.16 140.85 29.07 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-O 121.545 0.688 . . . . 72.11 111.293 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.471 ' HB ' HD12 ' A' ' 486' ' ' LEU . 21.8 mm -104.73 121.45 56.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.725 -1.58 . . . . 74.01 108.41 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -157.51 155.16 29.83 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 117.612 0.187 . . . . 75.11 110.658 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -73.87 152.44 40.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.841 0.353 . . . . 72.44 110.981 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.02 -30.1 70.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.649 -0.705 . . . . 74.02 110.768 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -127.71 176.93 7.15 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.76 -0.654 . . . . 73.04 111.464 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.94 -36.38 3.96 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.941 -0.863 . . . . 74.53 110.941 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 49.9 m -129.46 131.81 46.8 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.338 -0.615 . . . . 73.34 109.338 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 49.9 m-85 -114.48 135.97 53.53 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.316 -0.994 . . . . 73.44 108.316 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -125.54 138.91 53.97 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.919 -0.771 . . . . 72.41 108.919 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . 0.639 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.2 p -145.82 155.37 42.87 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.525 -0.546 . . . . 75.24 109.525 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -74.67 141.98 44.52 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.243 -0.651 . . . . 75.41 109.243 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.64 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 20.9 tt0 -55.41 -45.76 76.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.927 0.87 . . . . 72.21 109.165 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.405 ' OD1' HD13 ' A' ' 384' ' ' LEU . 2.6 p-10 -82.37 21.54 0.93 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.968 -1.015 . . . . 71.44 112.813 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.28 0.64 46.03 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 121.621 -0.674 . . . . 74.12 112.035 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.82 -71.63 2.57 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.497 -0.859 . . . . 71.24 112.794 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 17.6 p -137.25 159.4 42.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.766 0.283 . . . . 70.42 110.784 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.639 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 5.4 p -112.59 125.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.524 -1.287 . . . . 61.34 107.524 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.55 127.8 43.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.149 -0.478 . . . . 73.2 110.074 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.437 HD11 ' N ' ' A' ' 392' ' ' LEU . 2.3 mp -121.22 138.38 54.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.922 -1.51 . . . . 74.53 106.922 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.4 m -109.8 127.29 54.56 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.408 0.443 . . . . 71.43 110.27 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.22 125.5 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.908 -1.145 . . . . 72.43 107.908 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.38 140.95 19.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 107.68 -1.23 . . . . 73.43 107.68 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.437 HH12 HD21 ' A' ' 401' ' ' LEU . 47.5 ttp85 -120.89 109.29 14.94 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.789 -0.449 . . . . 75.33 109.789 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -128.75 158.86 37.46 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.861 -0.608 . . . . 73.21 110.528 -175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 116.79 -25.07 9.18 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.087 -1.605 . . . . 74.32 109.087 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 158.4 -172.63 35.41 Favored Glycine 0 N--CA 1.404 -3.493 0 N-CA-C 108.175 -1.97 . . . . 75.53 108.175 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.407 ' HA ' ' NH1' ' A' ' 396' ' ' ARG . 2.5 p-10 -146.55 171.98 14.26 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.545 -0.909 . . . . 74.33 108.545 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.437 HD21 HH12 ' A' ' 396' ' ' ARG . 2.3 pt? -166.04 151.18 8.47 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.575 -2.009 . . . . 74.44 105.575 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 36.6 p -90.32 3.59 53.23 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.682 0.754 . . . . 75.33 110.558 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -74.45 151.28 39.62 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 105.7 -1.963 . . . . 72.14 105.7 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 466' ' ' SER . 4.1 m -92.83 119.23 31.96 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-O 121.408 0.623 . . . . 64.31 111.443 -171.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.66 139.55 21.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.12 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 3.0 m-85 -121.81 123.23 41.3 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 123.667 0.787 . . . . 73.53 110.048 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.78 128.69 72.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.292 -1.373 . . . . 74.52 107.292 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 15.7 t70 -98.73 140.33 33.09 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.092 -0.38 . . . . 74.42 110.434 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -134.85 162.73 31.57 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.683 0.278 . . . . 74.24 110.514 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 42.9 ttt180 -166.82 162.71 16.18 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.591 -1.633 . . . . 73.34 106.591 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.597 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 59.8 p -95.6 172.12 8.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.65 -0.87 . . . . 71.23 108.65 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.34 145.92 50.63 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.7 -0.482 . . . . 74.43 109.7 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.1 4.2 5.9 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.124 1.37 . . . . 74.21 113.697 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -17.97 -88.92 0.01 OUTLIER Glycine 0 N--CA 1.479 1.541 0 C-N-CA 126.141 1.829 . . . . 71.21 117.113 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 13.9 t -109.79 5.31 22.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 117.89 0.845 . . . . 71.41 110.532 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.11 28.15 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.204 -1.776 . . . . 75.42 106.204 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.08 127.98 53.97 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.202 -1.399 . . . . 71.1 113.205 -164.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.32 126.36 29.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.289 -0.869 . . . . 61.24 110.181 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.62 -25.03 29.85 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.769 -0.932 . . . . 72.42 110.769 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.4 m -100.27 -57.04 2.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.98 -0.748 . . . . 64.21 108.98 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.568 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.2 m-20 -84.91 -58.45 2.7 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-O 121.364 0.602 . . . . 55.35 110.499 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.521 ' CZ ' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -136.19 166.59 23.05 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 108.915 -0.772 . . . . 74.42 108.915 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.43 155.69 39.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.987 0.805 . . . . 73.34 109.716 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.597 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 3.2 p90 -91.04 -17.9 25.47 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.971 -0.559 . . . . 73.34 111.709 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.448 HG22 HG22 ' A' ' 442' ' ' VAL . 9.2 t 34.07 59.2 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 125.144 1.527 . . . . 75.31 113.024 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.43 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.1 pt-20 -79.88 119.3 22.56 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.421 -0.809 . . . . 72.54 109.656 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.74 -174.13 34.95 Favored Glycine 0 N--CA 1.419 -2.455 0 C-N-CA 120.552 -0.832 . . . . 75.43 111.426 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 4.6 m -128.8 138.56 52.14 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.321 -0.992 . . . . 74.41 108.321 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 49.1 t -95.64 123.37 47.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.971 -0.752 . . . . 62.53 108.971 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 87.9 t -100.58 107.33 20.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.874 -1.057 . . . . 73.33 109.147 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -82.52 94.37 7.46 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.071 -0.513 . . . . 71.32 110.463 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.62 160.49 58.78 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.172 -0.922 . . . . 73.14 110.476 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 402' ' ' THR . 35.2 Cg_exo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.799 2.333 . . . . 72.54 111.183 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.34 -0.86 57.16 Favored Glycine 0 C--N 1.31 -0.875 0 C-N-CA 120.972 -0.632 . . . . 72.04 113.831 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.01 -66.66 0.9 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.172 0.486 . . . . 74.31 110.756 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 m 71.64 -49.58 0.69 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.123 0.969 . . . . 70.54 110.571 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -107.85 136.05 48.22 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.235 -1.394 . . . . 74.43 107.235 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -129.32 140.17 51.49 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.979 0.419 . . . . 74.41 110.993 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.58 139.6 44.39 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.564 -0.743 . . . . 73.41 110.739 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.4 pt -121.71 150.44 24.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.887 -1.153 . . . . 72.22 107.887 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.2 mtt180 -131.27 139.37 49.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 110.106 -0.331 . . . . 75.43 110.106 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.486 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 52.2 t -110.77 122.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.579 -1.267 . . . . 75.22 107.579 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -72.19 138.7 26.99 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 63.3 111.507 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.8 mm -96.6 132.61 40.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 107.089 -1.449 . . . . 74.14 107.089 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -95.7 147.08 6.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.358 -1.719 . . . . 65.04 106.358 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.18 88.0 3.05 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.312 0.577 . . . . 75.41 111.694 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.75 113.29 22.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.587 -2.375 . . . . 72.03 104.587 172.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.639 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 22.7 t70 -120.29 94.85 4.51 Favored 'General case' 0 C--N 1.274 -2.717 0 C-N-CA 116.917 -1.913 . . . . 54.31 110.547 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.673 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.4 mm -121.34 156.64 25.12 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.042 0 CA-C-N 111.172 -2.74 . . . . 73.13 105.109 -174.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -53.13 114.78 1.58 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.139 -1.424 . . . . 71.31 107.578 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.673 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 37.1 mt-10 -129.19 123.85 33.09 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-N 115.691 -0.686 . . . . 74.3 110.202 -170.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -134.06 105.95 6.97 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.893 -1.049 . . . . 65.0 109.302 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.03 61.6 3.13 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 124.376 1.048 . . . . 65.33 113.316 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.85 124.27 39.79 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.509 -0.876 . . . . 75.05 111.125 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.6 171.85 8.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.822 -1.081 . . . . 72.41 108.37 -175.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 496' ' ' ILE . 13.8 p90 -147.73 171.98 14.81 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.972 -1.122 . . . . 75.11 107.972 168.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.9 mt -117.56 142.85 46.71 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.908 -0.775 . . . . 75.44 108.908 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.28 122.23 66.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.753 -1.573 . . . . 63.53 106.753 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' A' ' 490' ' ' SER . 92.9 m-70 -111.37 139.55 46.69 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.349 0.405 . . . . 75.23 110.322 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.9 mt -101.25 128.19 47.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.869 -1.16 . . . . 71.45 107.869 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.2 m -151.05 -175.3 5.1 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.668 -0.864 . . . . 75.33 108.668 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.2 t30 50.86 83.41 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.694 1.198 . . . . 71.12 111.248 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.27 119.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.774 -0.825 . . . . 72.03 108.774 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -129.14 145.41 51.31 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.794 -0.817 . . . . 74.24 108.794 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.08 134.55 60.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.372 -1.344 . . . . 73.12 107.372 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' SER . . . . . 0.411 ' HB3' ' HB ' ' A' ' 404' ' ' THR . 34.1 t -74.41 109.98 8.34 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 109.408 -0.59 . . . . 74.41 109.408 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 14.5 m -91.24 139.38 30.8 Favored 'General case' 0 N--CA 1.409 -2.506 0 N-CA-C 106.353 -1.721 . . . . 71.5 106.353 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.76 157.68 35.87 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.459 -0.496 . . . . 74.32 110.596 -176.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.15 -6.5 53.13 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.269 0.556 . . . . 74.42 110.742 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.9 t -80.78 163.08 23.74 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.612 -1.255 . . . . 74.04 107.612 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -61.72 -55.9 25.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.743 0.306 . . . . 73.23 111.383 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -88.9 86.67 7.0 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 120.527 -0.469 . . . . 71.44 110.069 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -98.2 83.55 0.67 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.724 -0.951 . . . . 72.31 110.724 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.65 126.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 123.074 0.55 . . . . 72.43 110.738 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 84.5 mt -109.65 103.25 12.06 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 107.435 -1.32 . . . . 74.22 107.435 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . 0.504 ' O ' ' HD2' ' A' ' 479' ' ' HIS . 9.6 mp0 -59.39 125.06 22.1 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.444 -0.947 . . . . 74.32 108.444 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -71.08 38.56 0.05 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.485 1.114 . . . . 62.14 112.485 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 476' ' ' GLU . 17.6 m120 -110.15 17.94 20.48 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.906 -1.146 . . . . 65.3 107.906 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.504 ' HD2' ' O ' ' A' ' 476' ' ' GLU . 30.1 p80 -112.09 175.34 5.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.257 -0.883 . . . . 74.34 110.433 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 372' ' ' SER . 16.2 m -101.86 159.04 4.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.855 -0.795 . . . . 72.04 108.855 173.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 35.8 t -172.4 -89.65 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.344 0.658 . . . . 62.11 109.89 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -122.3 -11.22 8.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.975 0.417 . . . . 72.4 111.405 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -94.88 -60.76 1.62 Allowed 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 104.928 -2.249 . . . . 75.21 104.928 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -97.94 128.35 44.46 Favored 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.583 -1.265 . . . . 71.35 107.583 172.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 83.7 m -106.75 -169.67 1.59 Allowed 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 107.819 -1.178 . . . . 73.2 107.819 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.471 HD12 ' HB ' ' A' ' 374' ' ' ILE . 0.6 OUTLIER -70.13 163.9 25.29 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.197 -1.038 . . . . 72.44 108.197 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -82.31 25.04 4.49 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 120.896 -0.668 . . . . 70.44 113.422 -173.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 34.5 m -155.31 177.1 2.17 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.791 -1.189 . . . . 74.43 107.791 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.584 ' N ' ' HA ' ' A' ' 490' ' ' SER . 10.4 Cg_exo -69.91 -22.3 31.59 Favored 'Trans proline' 0 CA--C 1.581 2.864 0 N-CA-C 119.395 2.806 . . . . 71.42 119.395 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.584 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 16.1 m -118.93 123.73 45.33 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 129.544 3.138 . . . . 62.53 106.528 1.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 65.4 m -133.85 106.9 7.55 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.841 0.353 . . . . 75.45 111.939 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.45 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.848 -1.167 . . . . 64.13 107.848 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 30.7 m -103.37 128.62 50.42 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.57 -0.452 . . . . 73.31 110.298 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 69.9 t -113.36 119.19 60.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.255 -1.017 . . . . 74.34 108.255 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 7.3 m -107.75 118.2 36.11 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.366 -0.976 . . . . 71.13 108.366 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.585 HD12 ' CE2' ' A' ' 456' ' ' PHE . 4.9 mp -97.74 120.75 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.596 0.712 . . . . 75.42 110.067 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.436 ' O ' HD12 ' A' ' 384' ' ' LEU 0.265 29.3 m-85 -88.0 104.46 16.67 Favored 'General case' 0 N--CA 1.388 -3.537 0 CA-C-O 122.355 1.074 . . . . 73.02 113.262 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.636 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 10.5 t70 -51.5 -55.89 16.43 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 111.748 -2.478 . . . . 71.13 109.064 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.41 ' HA ' ' CA ' ' A' ' 503' ' ' GLY . 32.5 t70 64.98 15.98 10.29 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 125.633 1.573 . . . . 71.22 111.135 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -97.1 -58.61 1.98 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.927 -1.509 . . . . 74.04 106.927 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -97.01 -51.15 4.34 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.748 -1.204 . . . . 75.44 107.748 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -121.45 124.07 43.58 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.807 -0.633 . . . . 72.54 109.835 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 499' ' ' ASP . . . -138.29 -158.06 7.64 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.31 -0.947 . . . . 62.52 113.012 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.2 pp -150.95 176.5 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 124.142 0.977 . . . . 73.12 110.272 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -71.53 107.32 4.36 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.254 -1.758 . . . . 74.45 106.254 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 8.2 m -83.35 106.85 15.45 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 116.118 -0.492 . . . . 75.11 111.767 -172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -79.64 103.08 9.31 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 104.483 -2.414 . . . . 71.51 104.483 170.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -50.7 132.01 25.93 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 124.315 1.046 . . . . 75.35 113.36 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 115.145 -0.934 . . . . 74.13 110.468 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.64 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.593 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 C--O 1.241 0.638 0 N-CA-C 109.509 -0.552 . . . . 71.21 109.509 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 19.5 m -76.01 123.97 26.62 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 108.328 -0.989 . . . . 73.21 108.328 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -112.55 155.89 23.58 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 115.831 -0.622 . . . . 74.12 111.12 -172.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.493 ' HB ' HD12 ' A' ' 486' ' ' LEU . 31.8 mm -114.93 119.14 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.282 -1.747 . . . . 73.24 106.282 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -155.85 164.42 38.54 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.934 -0.306 . . . . 74.44 111.024 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -82.35 153.9 25.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.616 -0.513 . . . . 75.12 109.616 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -62.57 -38.95 92.08 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.226 -0.657 . . . . 75.51 109.226 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -125.37 175.66 7.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.967 -1.015 . . . . 64.03 112.089 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.02 -21.58 10.86 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 115.05 -0.977 . . . . 71.42 111.657 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 30.1 m -135.85 132.4 36.56 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.67 -0.493 . . . . 74.41 109.67 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 46.1 m-85 -122.92 136.79 54.99 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.25 -1.019 . . . . 72.21 108.25 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 495' ' ' THR . 75.1 mt-30 -130.02 143.32 50.73 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.241 -1.022 . . . . 74.44 108.241 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 33.9 t -153.34 165.27 36.28 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.428 -0.952 . . . . 71.1 108.428 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.24 143.0 30.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 122.589 0.356 . . . . 74.11 111.23 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.624 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 12.0 tt0 -59.72 -37.27 78.43 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.876 -0.602 . . . . 72.02 109.672 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -83.44 8.31 14.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.968 -0.56 . . . . 73.12 112.371 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 32.2 t -89.91 -11.96 40.29 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 119.962 -0.695 . . . . 51.24 110.924 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.38 -53.61 2.43 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.628 -0.796 . . . . 75.14 113.708 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 7.8 p -141.37 164.93 28.91 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.803 0.301 . . . . 72.54 110.697 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.8 p -120.1 127.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.103 -1.073 . . . . 72.11 108.103 172.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.99 124.2 42.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 71.33 110.799 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.436 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.1 mp -116.54 146.74 42.41 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.142 -1.429 . . . . 75.31 107.142 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.6 m -116.59 129.22 56.04 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.309 -0.556 . . . . 52.33 110.624 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.411 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 73.1 mt -98.41 120.54 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 107.675 -1.232 . . . . 74.42 107.675 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.411 HG22 ' HG3' ' A' ' 397' ' ' ARG . 49.3 mm -98.62 129.01 49.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 107.436 -1.32 . . . . 73.43 107.436 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -108.64 107.7 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.464 -0.939 . . . . 74.45 108.464 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.411 ' HG3' HG22 ' A' ' 395' ' ' ILE . 59.2 mtt180 -123.84 157.74 33.43 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.041 0.448 . . . . 74.05 111.997 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 124.93 -46.78 1.06 Allowed Glycine 0 CA--C 1.49 -1.5 0 N-CA-C 108.735 -1.746 . . . . 73.34 108.735 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -166.18 162.72 36.27 Favored Glycine 0 N--CA 1.415 -2.713 0 N-CA-C 107.208 -2.357 . . . . 62.41 107.208 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -146.18 121.55 10.29 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 117.842 0.821 . . . . 73.44 109.963 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -147.25 172.57 13.63 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.909 -1.041 . . . . 74.32 109.168 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 24.3 p -71.08 5.23 2.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.625 0.972 . . . . 75.13 113.625 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.436 HD21 ' CD ' ' A' ' 476' ' ' GLU . 6.7 m-20 -67.24 132.34 47.56 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.67 0.748 . . . . 73.23 111.376 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.693 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 19.3 m -92.99 112.38 24.33 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.924 -1.489 . . . . 74.03 110.102 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.61 146.29 16.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.198 -1.365 . . . . 73.54 107.857 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 33.6 m-85 -126.4 127.32 45.29 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.125 -0.694 . . . . 75.42 109.125 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.55 129.75 68.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.695 -1.224 . . . . 72.13 107.695 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.99 140.6 31.28 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.606 0.241 . . . . 60.41 110.588 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.401 ' C ' ' HD3' ' A' ' 410' ' ' ARG . 20.7 p90 -137.1 152.34 49.9 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.751 -0.379 . . . . 74.2 111.645 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . 0.401 ' HD3' ' C ' ' A' ' 409' ' ' PHE . 0.7 OUTLIER -150.89 172.86 14.98 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.265 1.426 . . . . 74.03 108.078 174.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.627 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.9 p -106.44 161.03 14.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.971 -0.381 . . . . 65.43 109.971 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.2 tp10 -107.65 155.29 20.31 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 122.704 0.401 . . . . 73.02 110.151 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.415 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 6.8 m-20 -84.63 1.87 44.21 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 124.021 0.928 . . . . 72.22 112.333 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . 0.457 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -11.06 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.499 2.836 0 N-CA-C 117.413 1.725 . . . . 73.25 117.413 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 14.8 t -126.93 17.71 7.28 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 117.73 0.765 . . . . 71.42 110.445 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.88 -162.81 1.63 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.155 -0.475 . . . . 60.2 110.164 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.415 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 3.6 m120 -135.73 119.72 17.52 Favored 'General case' 0 CA--C 1.485 -1.546 0 CA-C-O 121.344 0.592 . . . . 74.3 111.215 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.91 124.48 27.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.447 -0.946 . . . . 75.21 108.447 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.25 -15.28 43.2 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 110.663 -0.975 . . . . 53.11 110.663 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 18.3 t -114.31 -50.55 2.8 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.17 -0.678 . . . . 63.41 109.17 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.586 ' OD1' 'CA ' ' A' ' 650' ' ' ' CA' . 20.6 m-20 -85.66 -59.66 2.25 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 122.307 1.051 . . . . 63.43 110.354 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.676 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -138.83 162.83 33.82 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.826 -1.079 . . . . 74.0 108.894 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.9 tt0 -73.82 156.87 37.33 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 124.165 0.915 . . . . 73.14 110.788 -173.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.627 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.2 p90 -89.97 -14.33 34.28 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.175 -0.92 . . . . 75.21 111.448 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.485 ' H ' ' HG2' ' A' ' 423' ' ' GLU . 15.2 t 33.24 66.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.455 1.902 . . . . 74.04 113.127 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.23 111.77 15.79 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.049 0.928 . . . . 74.12 109.592 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -151.76 173.93 30.94 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 120.061 -1.066 . . . . 64.42 111.61 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.2 m -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 106.913 -1.514 . . . . 50.23 106.913 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 32.7 t -95.74 120.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.24 -1.022 . . . . 73.05 108.24 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.68 106.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 115.255 -0.884 . . . . 75.4 109.037 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.693 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.3 m-85 -82.03 94.21 7.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.153 -0.684 . . . . 74.25 109.153 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.05 167.34 30.03 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 115.048 -0.978 . . . . 74.44 110.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.79 110.52 0.64 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.497 2.131 . . . . 64.13 111.569 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 113.56 -18.7 19.95 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.716 -0.675 . . . . 72.42 112.078 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -83.92 62.37 6.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.305 0.574 . . . . 75.42 111.974 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 m -65.64 -20.94 66.5 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.857 0.836 . . . . 72.44 109.486 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -132.01 135.07 46.26 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.066 -1.457 . . . . 64.3 107.066 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -122.99 147.8 46.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 111.565 0.209 . . . . 74.43 111.565 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -118.41 131.4 56.28 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.299 -0.63 . . . . 74.4 109.299 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.7 pt -120.96 149.4 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.099 -1.074 . . . . 74.31 108.099 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.1 mtt180 -129.49 138.53 51.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-O 120.899 0.381 . . . . 74.02 110.854 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.59 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 63.7 t -104.92 126.57 59.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.667 -0.864 . . . . 74.13 108.667 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -68.29 127.31 23.79 Favored Glycine 0 N--CA 1.433 -1.542 0 O-C-N 124.115 0.884 . . . . 73.25 111.953 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.5 mm -94.6 134.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 106.07 -1.826 . . . . 72.14 106.07 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.3 mt -98.57 144.99 10.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 106.982 -1.488 . . . . 74.4 106.982 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.2 88.3 4.28 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.667 -0.813 . . . . 72.52 111.632 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.74 97.83 5.82 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.875 -2.269 . . . . 52.21 104.875 169.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.59 87.05 2.61 Favored 'General case' 0 CA--C 1.46 -2.511 0 CA-C-O 122.905 1.336 . . . . 74.55 109.856 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.441 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 26.5 mm -116.1 154.48 17.61 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.948 0 CA-C-N 111.688 -2.506 . . . . 75.32 104.575 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -63.97 114.82 4.35 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.386 -1.726 . . . . 74.2 108.62 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.647 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 19.5 mt-10 -135.49 151.93 50.85 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.646 -1.161 . . . . 72.22 108.485 -170.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -131.55 102.1 5.78 Favored 'General case' 0 N--CA 1.411 -2.393 0 C-N-CA 119.583 -0.847 . . . . 73.43 111.165 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 14.3 t70 63.86 61.55 0.95 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 124.704 1.252 . . . . 71.45 111.018 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.41 130.77 40.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.965 -0.562 . . . . 74.2 109.576 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.94 161.86 39.11 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.885 -0.726 . . . . 73.13 109.831 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.59 ' CZ ' HG12 ' A' ' 442' ' ' VAL . 25.1 p90 -140.91 -178.99 5.81 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.98 -0.555 . . . . 70.31 109.711 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.3 mt -120.92 138.9 53.88 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.359 -1.349 . . . . 75.24 107.359 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 491' ' ' THR . 61.1 t -106.33 121.95 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.069 -1.456 . . . . 75.31 107.069 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 412' ' ' GLU . 63.5 m-70 -110.68 128.36 55.67 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.503 0.502 . . . . 73.4 111.023 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.99 131.7 42.09 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.031 -1.1 . . . . 74.24 108.031 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 12.4 p -155.7 -176.81 6.15 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.843 -0.799 . . . . 51.51 108.843 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 49.67 81.96 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.176 0.922 . . . . 70.13 112.694 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.407 ' CG1' HG23 ' A' ' 480' ' ' VAL . 61.8 t -82.12 128.36 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 115.332 -0.849 . . . . 64.13 108.772 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 72.0 tttt -133.32 148.08 51.89 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 106.381 -1.711 . . . . 65.21 106.381 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.582 ' HB ' ' O ' ' A' ' 474' ' ' ILE . 91.4 t -130.03 154.0 39.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 N-CA-C 107.97 -1.122 . . . . 74.34 107.97 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 32.7 t -74.57 111.85 10.17 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.382 -0.97 . . . . 70.31 108.382 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' SER . . . . . 0.459 ' HA ' ' HB ' ' A' ' 474' ' ' ILE . 18.7 m -76.1 111.24 11.3 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 116.273 -0.422 . . . . 73.41 110.674 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -50.4 -50.16 52.45 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.844 1.053 . . . . 74.55 113.844 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -95.74 -18.99 20.02 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.862 -0.735 . . . . 74.35 111.087 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 49.8 m 62.38 23.24 13.76 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.887 0.875 . . . . 75.22 111.041 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -67.94 -45.27 74.73 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.282 -1.377 . . . . 73.24 107.282 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -148.58 -166.49 2.56 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 104.421 -2.437 . . . . 71.22 104.421 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -84.09 134.13 12.46 Favored Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 110.914 -0.874 . . . . 72.12 110.914 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.582 ' O ' ' HB ' ' A' ' 465' ' ' VAL . 28.0 mm -107.47 132.56 54.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.477 -0.564 . . . . 71.11 109.477 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 99.0 mt -125.24 145.21 50.09 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.764 -1.569 . . . . 74.11 106.764 172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . 0.436 ' CD ' HD21 ' A' ' 403' ' ' ASN . 50.7 mt-10 -91.07 152.59 20.57 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.559 0.578 . . . . 74.11 112.559 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -99.26 -18.58 17.52 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.725 -1.125 . . . . 64.41 108.3 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -75.82 -53.41 8.51 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.77 -1.196 . . . . 71.32 107.77 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -89.72 -171.83 3.33 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.044 -0.98 . . . . 74.32 109.4 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.407 HG23 ' CG1' ' A' ' 463' ' ' VAL . 34.0 m -77.38 168.5 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.603 -0.726 . . . . 75.23 111.164 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 33.2 p -153.83 -149.5 0.29 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.434 -0.58 . . . . 62.43 109.434 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -100.01 16.7 23.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.047 -1.094 . . . . 73.4 108.047 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.68 -55.42 1.52 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 105.84 -1.911 . . . . 70.45 105.84 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.61 131.86 36.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.646 -1.242 . . . . 71.35 107.646 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.8 -178.46 3.66 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 116.032 -0.531 . . . . 75.25 110.521 -172.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.636 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 0.5 OUTLIER -74.52 -167.17 0.51 Allowed 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 109.807 -0.442 . . . . 72.41 109.807 -176.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -71.97 -130.15 0.11 Allowed Glycine 0 CA--C 1.534 1.263 0 N-CA-C 114.396 0.518 . . . . 73.11 114.396 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.746 ' O ' ' HA ' ' A' ' 490' ' ' SER . 7.0 m -78.01 140.64 62.28 Favored Pre-proline 0 C--N 1.311 -1.087 0 O-C-N 122.174 -0.604 . . . . 64.32 109.931 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . 2.367 83.7 Cg_exo 90.39 -83.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.531 1 N-CA-C 123.432 4.358 . . . . 65.1 123.432 -174.037 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' A' ' 488' ' ' SER . 6.1 m -86.41 99.31 11.54 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 124.769 1.227 . . . . 74.23 108.754 0.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 36.0 m -142.84 139.07 30.74 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 115.367 -0.833 . . . . 63.03 111.057 -172.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -125.27 136.68 53.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.441 -1.318 . . . . 75.54 107.441 172.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 28.0 m -89.94 125.82 35.51 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.715 -0.476 . . . . 75.51 109.715 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 79.2 t -111.83 109.35 28.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.065 -0.717 . . . . 63.44 109.065 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 29.5 m -99.99 122.27 42.63 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.126 -1.064 . . . . 75.55 108.126 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.676 HD11 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -101.79 124.23 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 N-CA-C 108.561 -0.903 . . . . 71.34 108.561 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.492 ' CE1' HG13 ' A' ' 504' ' ' ILE 0.277 42.0 m-85 -87.8 111.3 21.22 Favored 'General case' 0 N--CA 1.393 -3.3 0 CA-C-O 122.124 0.964 . . . . 72.45 112.514 178.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.606 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 7.6 m-20 -51.8 -52.41 49.27 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-N 111.882 -2.417 . . . . 72.25 112.364 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.7 t70 76.2 3.82 3.67 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.171 1.544 . . . . 74.41 107.956 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.616 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' 0.28 2.6 p30 -93.84 -89.02 0.22 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.632 -1.167 . . . . 74.21 111.533 -177.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -81.59 -43.28 18.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.753 -1.573 . . . . 71.11 106.753 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -82.94 90.0 6.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.151 -0.931 . . . . 64.11 108.756 174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -97.98 69.89 0.69 Allowed Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.69 -0.686 . . . . 71.14 113.368 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.492 HG13 ' CE1' ' A' ' 497' ' ' PHE . 47.3 mm -77.66 123.7 34.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.157 -1.053 . . . . 71.22 108.157 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -88.26 134.06 33.89 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.382 0.61 . . . . 74.21 112.139 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.3 t -128.65 152.76 48.01 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.306 -1.368 . . . . 65.4 107.306 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -95.69 113.4 25.04 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.095 -0.705 . . . . 73.4 109.095 -177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.8 99.29 9.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.898 -0.592 . . . . 72.33 110.248 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.308 -1.201 0 N-CA-C 107.113 -1.439 . . . . 75.12 107.113 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.637 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.647 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.449 ' N ' ' HD1' ' A' ' 479' ' ' HIS . 46.5 t . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 108.76 -0.83 . . . . 72.24 108.76 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 44.3 m -152.17 -173.51 4.57 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.95 -1.13 . . . . 74.11 107.95 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -138.86 141.59 38.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.986 -0.746 . . . . 74.25 108.986 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.45 ' HB ' HD13 ' A' ' 486' ' ' LEU . 46.1 mm -114.44 115.75 50.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.695 -1.594 . . . . 75.41 106.695 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.453 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 35.4 p90 -146.54 158.58 43.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 119.012 0.824 . . . . 71.25 112.752 -177.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -70.47 143.1 51.84 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.542 -0.54 . . . . 73.43 109.542 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.71 -39.44 80.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.533 0.683 . . . . 74.5 109.171 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 12.7 mt-30 -122.58 153.71 38.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.432 -0.804 . . . . 71.2 111.34 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.2 -22.82 26.31 Favored Glycine 0 C--N 1.304 -1.24 0 C-N-CA 120.98 -0.629 . . . . 41.4 111.644 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 85.7 m -137.0 135.72 37.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.144 -0.687 . . . . 73.42 109.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 72.0 m-85 -124.96 138.85 54.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.264 -1.013 . . . . 74.51 108.264 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 495' ' ' THR . 39.3 mt-30 -128.93 124.86 36.21 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.888 -0.782 . . . . 73.34 108.888 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -136.49 156.73 48.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.509 -0.552 . . . . 72.4 109.509 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.581 HD11 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -75.24 144.63 42.48 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 110.174 -0.306 . . . . 74.2 110.174 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -61.66 -31.56 71.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.831 0.824 . . . . 70.24 109.92 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.513 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.9 p-10 -84.52 1.74 44.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.891 -1.049 . . . . 73.54 112.698 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 45.8 t -77.0 -19.09 57.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.133 -0.354 . . . . 62.31 111.476 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.13 -61.86 2.19 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.748 -0.739 . . . . 75.11 112.208 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.3 p -136.96 148.97 47.25 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.54 0.17 . . . . 61.3 110.566 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.2 p -106.35 134.06 49.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.1 -1.445 . . . . 71.13 107.1 174.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.13 112.32 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.547 0.689 . . . . 65.34 110.835 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.473 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.9 mp -101.87 153.88 19.44 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.485 -1.302 . . . . 73.54 107.485 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -116.52 132.35 56.7 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.513 -0.475 . . . . 74.34 110.025 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 79.2 mt -104.91 122.86 58.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.186 -1.042 . . . . 73.22 108.186 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.72 127.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.54 -0.911 . . . . 72.43 108.54 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 54.7 ttt180 -113.75 110.1 19.63 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.3 -0.864 . . . . 72.41 109.157 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -116.43 145.13 43.49 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.439 -0.578 . . . . 72.13 109.439 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 170.32 -35.2 0.17 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.383 -0.687 . . . . 60.41 111.383 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 152.36 -136.91 5.63 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 111.001 -0.84 . . . . 72.24 111.001 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.13 120.55 37.7 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 103.612 -2.736 . . . . 75.41 103.612 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 84.4 mt -135.23 98.61 4.02 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 113.318 0.859 . . . . 73.41 113.318 -166.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 40.8 p -93.21 -12.45 30.22 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.147 -0.933 . . . . 71.22 109.367 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -65.06 155.48 34.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.903 -1.044 . . . . 74.11 111.626 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.9 m -105.88 118.13 35.82 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.629 0.728 . . . . 74.42 110.749 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.09 149.68 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.085 -0.961 . . . . 72.14 108.663 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.446 ' CZ ' HG13 ' A' ' 430' ' ' VAL . 22.1 m-85 -127.31 129.38 47.55 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.942 0.497 . . . . 73.15 110.19 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.66 131.1 62.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.897 -0.779 . . . . 75.22 108.897 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -99.91 135.43 41.34 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 110.066 -0.346 . . . . 75.11 110.066 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -134.98 165.66 24.82 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 122.093 -0.379 . . . . 73.14 111.158 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . 0.479 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 21.6 ttm180 -166.02 160.19 16.28 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.115 -1.068 . . . . 74.24 108.115 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 72.5 p -96.71 154.96 16.98 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.905 -0.776 . . . . 74.03 108.905 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 414' ' ' GLY . 28.5 tt0 -115.65 148.49 39.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.734 1.013 . . . . 72.45 113.734 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.79 2.61 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.885 0 C-N-CA 130.722 3.609 . . . . 72.33 114.102 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 412' ' ' GLU . . . -20.19 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 125.741 1.638 . . . . 73.42 117.156 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.1 t -136.24 16.19 3.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.117 0.958 . . . . 75.44 109.857 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.32 -164.14 1.52 Allowed 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.103 -1.073 . . . . 71.21 108.103 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -138.98 121.84 16.57 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.212 -0.995 . . . . 74.15 111.527 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.82 124.71 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.232 -0.655 . . . . 72.44 109.232 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.18 -27.8 7.56 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.552 -1.819 . . . . 73.11 108.552 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.3 t -106.78 -55.71 2.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.945 -0.627 . . . . 74.21 109.518 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.604 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -80.98 -60.28 2.35 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-O 121.608 0.718 . . . . 75.11 111.112 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.689 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -136.75 166.95 22.39 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.545 -0.909 . . . . 74.2 108.545 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -77.72 154.42 32.07 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.638 -0.875 . . . . 74.42 108.638 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.498 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.9 p90 -95.52 -13.23 24.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.97 0.73 . . . . 75.23 112.97 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.447 ' CG2' HG21 ' A' ' 442' ' ' VAL . 10.1 t 36.01 57.77 0.97 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.364 1.866 . . . . 74.23 113.791 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 10.5 pt-20 -78.51 116.44 18.9 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.741 0.781 . . . . 74.21 108.945 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -157.08 -173.61 25.73 Favored Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 115.313 -0.858 . . . . 71.13 111.194 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 17.9 m -128.54 136.59 50.97 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.327 -1.36 . . . . 72.13 107.327 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.42 127.64 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.745 -1.205 . . . . 72.02 107.745 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . 0.446 HG13 ' CZ ' ' A' ' 406' ' ' PHE . 22.7 t -105.04 106.69 20.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.831 -0.803 . . . . 73.12 108.831 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.9 m-85 -85.3 95.64 9.27 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.707 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 175.08 4.46 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 114.818 -1.083 . . . . 74.12 110.238 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.83 135.2 50.69 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.444 1.43 . . . . 73.42 109.603 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 91.85 -20.09 44.5 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.084 -0.579 . . . . 53.21 112.506 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.45 63.45 4.91 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.294 0.637 . . . . 75.45 110.821 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 m -70.69 -24.92 62.75 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.972 -1.013 . . . . 74.24 108.441 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.68 135.39 42.0 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.18 -0.674 . . . . 74.1 109.18 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -123.05 153.62 39.62 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.945 0.402 . . . . 74.34 111.864 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -113.08 129.82 56.38 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.058 -0.974 . . . . 74.35 109.49 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 40.7 pt -117.37 137.28 51.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.294 -1.002 . . . . 74.53 108.294 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 47.0 mtt180 -121.97 136.37 54.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.28 0.562 . . . . 72.22 112.134 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.609 HG13 ' CZ ' ' A' ' 456' ' ' PHE . 48.6 t -111.12 123.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.299 -1.371 . . . . 74.44 107.299 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -78.68 135.79 16.42 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.856 -0.688 . . . . 62.13 111.996 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.4 mm -94.75 131.29 42.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.602 -1.258 . . . . 73.41 107.602 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.6 mt -93.52 143.17 12.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.322 -2.103 . . . . 75.41 105.322 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.47 86.22 7.31 Favored 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 119.036 -1.065 . . . . 62.31 111.314 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.85 98.44 8.13 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 103.25 -2.87 . . . . 74.22 103.25 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.84 89.29 3.61 Favored 'General case' 0 C--N 1.271 -2.841 0 C-N-CA 117.2 -1.8 . . . . 72.32 110.911 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.422 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -123.2 153.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.449 0 N-CA-C 104.265 -2.494 . . . . 74.52 104.265 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -60.12 114.64 2.97 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.658 -1.217 . . . . 73.23 108.845 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.632 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 21.3 mt-10 -128.46 140.99 51.53 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.717 -0.674 . . . . 74.41 109.555 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -121.15 99.67 6.62 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.313 -0.858 . . . . 75.42 109.546 -173.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.303 4.3 p-10 47.28 61.15 3.03 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.413 1.485 . . . . 73.25 112.794 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.542 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.7 tt0 -74.56 127.93 34.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.817 -1.083 . . . . 63.33 108.684 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.422 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.2 p-10 -145.56 169.09 19.08 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.811 -0.555 . . . . 73.14 111.905 -173.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.609 ' CZ ' HG13 ' A' ' 442' ' ' VAL . 26.2 p90 -143.83 179.48 7.14 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.269 -0.423 . . . . 65.53 110.582 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 37.9 mt -118.08 138.68 52.08 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.724 -1.213 . . . . 74.51 107.724 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.43 126.47 69.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.216 -1.402 . . . . 72.54 107.216 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -119.66 157.07 29.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.407 0.442 . . . . 72.33 110.662 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.73 138.63 50.49 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.456 -0.572 . . . . 72.35 109.456 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.9 p -153.44 -174.3 4.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.023 0.529 . . . . 75.42 109.691 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.7 t30 34.79 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 126.201 1.8 . . . . 73.54 112.85 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.33 127.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 C-N-CA 119.9 -0.72 . . . . 71.04 109.692 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -129.28 150.28 50.72 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.993 -0.743 . . . . 74.24 108.993 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.06 149.39 13.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.701 -1.592 . . . . 73.54 106.701 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' SER . . . . . 0.442 ' CB ' ' HB ' ' A' ' 404' ' ' THR . 22.7 t -74.2 128.1 34.66 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.472 0.653 . . . . 73.31 112.397 -174.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 21.9 m -81.37 172.02 14.07 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.817 -1.92 . . . . 72.01 105.817 169.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 72.68 -58.42 0.6 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.076 0.95 . . . . 74.44 111.564 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -67.6 -27.58 67.03 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.089 0.947 . . . . 35.25 109.099 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.2 p -145.35 94.87 2.58 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 113.776 -1.556 . . . . 74.25 107.608 172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -89.44 -20.69 23.61 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.955 -1.02 . . . . 72.24 112.402 -172.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -108.05 -179.83 4.01 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.039 -0.726 . . . . 73.43 109.039 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -83.75 50.94 4.49 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 121.221 0.345 . . . . 61.21 112.624 -174.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.43 109.37 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.991 -1.115 . . . . 65.13 107.991 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.6 mt -82.51 3.27 29.09 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.505 0.669 . . . . 73.01 111.71 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -93.28 -2.53 54.88 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.473 -0.936 . . . . 73.32 108.473 172.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -105.15 -34.31 7.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.246 -0.888 . . . . 73.15 108.907 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -83.66 86.11 7.17 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.767 -1.197 . . . . 73.53 107.767 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.449 ' HD1' ' N ' ' A' ' 371' ' ' VAL . 70.2 m-70 -80.59 -66.39 0.89 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.06 0.934 . . . . 73.43 108.837 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.17 130.51 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.443 0 CA-C-N 114.431 -1.259 . . . . 71.51 108.514 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 32.2 t 149.78 -68.04 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.137 2.175 . . . . 53.55 108.413 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -111.7 14.54 21.17 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.18 -0.464 . . . . 74.55 111.876 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -141.34 -72.05 0.34 Allowed 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 106.074 -1.825 . . . . 75.03 106.074 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -98.1 171.05 8.49 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 109.144 -0.687 . . . . 73.02 109.144 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 45.7 t -125.58 -173.45 2.83 Favored 'General case' 0 C--N 1.27 -2.876 0 N-CA-C 106.086 -1.82 . . . . 73.35 106.086 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.45 HD13 ' HB ' ' A' ' 374' ' ' ILE . 0.5 OUTLIER -75.15 175.6 8.1 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.105 -1.442 . . . . 63.4 107.105 178.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 375' ' ' PHE . . . -63.72 127.46 36.53 Favored Glycine 0 C--O 1.253 1.314 0 N-CA-C 104.179 -3.568 . . . . 72.3 104.179 169.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.6 ' HA ' ' OG ' ' A' ' 490' ' ' SER . 15.4 m -109.15 70.98 0.45 Allowed Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 119.489 3.144 . . . . 53.32 119.489 -164.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.526 ' CD ' ' HA ' ' A' ' 490' ' ' SER . 3.1 Cg_exo -70.09 -61.05 0.06 OUTLIER 'Trans proline' 0 N--CA 1.404 -3.757 0 N-CA-C 109.693 -0.926 . . . . 73.44 109.693 155.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.6 ' OG ' ' HA ' ' A' ' 488' ' ' SER . 49.3 m -119.15 91.66 3.61 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 128.418 2.687 . . . . 72.33 108.117 -2.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 17.8 m -141.76 138.41 32.29 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 109.686 -0.487 . . . . 64.43 109.686 -175.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -122.75 117.39 25.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.525 -1.657 . . . . 74.22 106.525 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 89.8 m -86.09 119.77 26.75 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.237 0.542 . . . . 61.23 110.573 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 390' ' ' VAL . 80.2 t -104.08 108.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.603 -0.888 . . . . 72.41 108.603 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 90.2 m -96.58 121.01 37.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.629 -0.878 . . . . 73.42 108.629 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.689 HD11 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.94 126.88 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.179 0 CA-C-O 121.502 0.668 . . . . 73.34 109.535 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.581 ' O ' HD11 ' A' ' 384' ' ' LEU . 9.3 m-85 -93.0 104.16 16.4 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-O 121.854 0.835 . . . . 74.44 110.433 173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.458 ' HB3' ' CG ' ' A' ' 500' ' ' ASP . 8.3 m-20 -56.01 -54.02 49.9 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 112.882 -1.963 . . . . 73.42 113.283 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.7 t70 84.59 -10.98 0.83 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.174 1.79 . . . . 71.24 107.863 -170.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.59 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 3.4 p30 -76.29 -70.25 0.46 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.093 -0.958 . . . . 75.23 110.491 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -114.64 -14.43 12.05 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.0 -0.741 . . . . 74.01 109.0 172.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -68.93 104.26 2.03 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.971 -0.752 . . . . 74.42 108.971 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -75.23 72.45 1.65 Allowed Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 118.449 2.14 . . . . 61.21 118.449 -166.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.463 ' H ' HD11 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -91.15 -37.59 9.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 106.253 -1.758 . . . . 74.43 106.253 163.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 50.6 p90 179.31 173.49 0.82 Allowed 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 128.66 2.784 . . . . 74.22 105.162 173.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 6.2 m -126.95 105.3 8.52 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.279 -1.008 . . . . 74.33 108.279 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -151.75 98.88 2.53 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 120.087 -0.645 . . . . 74.51 111.844 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 72.37 -37.8 0.4 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.237 1.569 . . . . 74.1 115.237 173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 . . . . . 0 C--N 1.304 -1.395 0 CA-C-N 117.903 0.319 . . . . 71.04 111.36 -175.309 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.618 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.632 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 108.731 -0.84 . . . . 73.33 108.731 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 64.6 m -151.3 160.6 43.71 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.838 -1.171 . . . . 72.22 107.838 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -140.37 130.79 25.31 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 123.614 0.571 . . . . 74.43 109.569 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.422 ' HB ' HD13 ' A' ' 486' ' ' LEU . 39.0 mm -107.16 115.87 49.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.909 -1.886 . . . . 73.25 105.909 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.46 167.11 23.76 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 118.794 0.725 . . . . 74.14 112.487 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -78.68 147.61 33.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.107 -0.701 . . . . 73.0 109.107 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.13 -53.3 39.51 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.569 -0.9 . . . . 72.43 108.569 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -109.8 174.15 6.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.074 -0.512 . . . . 73.2 110.751 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.48 -35.49 2.85 Favored Glycine 0 C--N 1.298 -1.559 0 CA-C-N 115.264 -0.88 . . . . 62.45 111.148 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 23.1 m -121.05 134.74 55.29 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.915 -1.142 . . . . 74.33 107.915 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 61.6 m-85 -124.19 136.34 54.11 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.673 -1.232 . . . . 71.35 107.673 175.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.39 123.59 36.56 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.507 -0.923 . . . . 71.24 108.507 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.2 p -134.33 152.9 52.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.667 -0.494 . . . . 71.14 109.667 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -75.02 152.74 38.68 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.256 -0.646 . . . . 75.4 109.256 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.638 ' OE2' 'CA ' ' A' ' 600' ' ' ' CA' . 29.1 tt0 -65.52 -38.73 90.51 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.06 0.933 . . . . 64.53 109.5 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.46 ' OD1' HD13 ' A' ' 384' ' ' LEU . 2.5 p-10 -83.89 16.36 2.85 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.875 -1.057 . . . . 72.2 111.661 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.9 t -84.63 -20.59 31.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.188 0.518 . . . . 72.53 109.632 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.85 -60.37 3.15 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.913 -0.66 . . . . 72.11 111.883 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 9.0 p -143.57 155.97 44.45 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 122.662 0.385 . . . . 72.44 110.209 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -112.82 132.43 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.522 -1.288 . . . . 75.03 107.522 173.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.52 120.14 40.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.197 0.522 . . . . 71.32 110.141 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.8 mp -112.2 142.25 44.9 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.588 -1.264 . . . . 65.02 107.588 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.2 m -106.8 131.14 54.25 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.565 -0.531 . . . . 74.43 109.565 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.3 122.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.869 -1.16 . . . . 72.34 107.869 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.6 mm -98.02 123.95 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.319 -0.993 . . . . 72.43 108.319 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.492 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 51.4 ttt180 -111.02 110.89 21.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.383 -0.826 . . . . 71.32 109.639 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -115.09 168.47 9.91 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.968 -0.56 . . . . 73.21 109.578 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 145.62 -19.09 1.84 Allowed Glycine 0 C--N 1.311 -0.816 0 N-CA-C 111.443 -0.663 . . . . 74.12 111.443 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 139.95 -103.85 0.39 Allowed Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 108.836 -1.705 . . . . 75.04 108.836 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -153.09 120.25 5.83 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 107.387 -1.338 . . . . 71.22 107.387 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 52.6 mt -128.44 121.72 29.64 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.272 -0.571 . . . . 75.25 110.842 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 19.0 p -95.62 0.49 52.87 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-O 122.302 1.049 . . . . 75.43 108.405 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -74.79 159.99 31.27 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.42 -1.326 . . . . 73.31 107.42 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 4.3 m -102.12 121.01 41.39 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.47 0.652 . . . . 74.2 111.687 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.65 142.96 22.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.042 -1.095 . . . . 72.25 108.042 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 464' ' ' LYS . 26.0 m-85 -127.24 129.91 48.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.349 -0.612 . . . . 72.23 109.349 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.27 132.39 66.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.006 -1.109 . . . . 73.42 108.006 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 19.2 t70 -93.3 134.53 35.41 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.75 -0.833 . . . . 75.34 108.75 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -123.06 148.12 45.95 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.923 -0.769 . . . . 74.15 108.923 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -162.93 163.9 26.05 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.292 -1.003 . . . . 74.5 108.292 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 22.1 p -96.69 172.89 7.62 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.903 0.382 . . . . 73.31 111.035 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 4.8 tp10 -133.93 153.96 51.4 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.092 -2.188 . . . . 71.41 105.092 173.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -58.18 -45.02 88.28 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.185 0.809 . . . . 72.41 113.185 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.95 -93.73 0.16 Allowed Glycine 0 C--N 1.293 -1.857 0 CA-C-N 115.667 -0.697 . . . . 61.43 112.03 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.0 t -132.28 9.62 4.42 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.137 0.97 . . . . 72.35 109.007 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -132.14 -159.75 0.99 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.185 -1.783 . . . . 72.2 106.185 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -150.34 113.84 4.95 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.465 -0.894 . . . . 75.33 112.255 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.91 128.82 37.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.265 -0.643 . . . . 63.02 109.265 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.03 -31.63 6.18 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 109.102 -1.599 . . . . 60.05 109.102 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.2 m -110.18 -51.89 2.83 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.106 0.479 . . . . 70.23 109.859 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.608 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.1 m-20 -82.9 -61.43 1.87 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.531 0.682 . . . . 74.32 110.927 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.549 ' CZ ' HD12 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -132.31 173.42 11.28 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 107.228 -1.397 . . . . 75.21 107.228 -178.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -79.11 148.0 32.54 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.361 -0.607 . . . . 74.32 109.361 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -82.36 -16.93 47.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 113.133 0.79 . . . . 71.24 113.133 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.45 HG21 HG21 ' A' ' 442' ' ' VAL 0.251 14.0 t 35.95 73.11 0.09 Allowed 'General case' 0 CA--C 1.556 1.198 0 O-C-N 125.513 1.758 . . . . 73.34 113.279 -178.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.5 130.93 35.76 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.591 -1.186 . . . . 75.34 109.273 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.78 48.53 Favored Glycine 0 CA--C 1.476 -2.35 0 C-N-CA 119.784 -1.198 . . . . 75.03 111.86 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 60.6 m -123.68 138.63 54.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.524 -0.917 . . . . 71.03 108.524 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.39 124.8 49.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.927 -0.768 . . . . 74.3 108.927 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 23.4 t -95.3 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 75.52 109.232 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.492 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 60.5 m-85 -88.78 95.67 10.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.095 0.474 . . . . 73.41 111.236 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.466 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 57.3 mtmt -92.7 176.81 2.36 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 114.918 -1.037 . . . . 75.21 110.456 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.5 Cg_exo -56.62 131.71 47.3 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 122.479 2.119 . . . . 72.21 112.353 175.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 98.34 -33.08 6.27 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.845 -0.616 . . . . 70.11 111.985 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 33.4 mt-10 -82.54 64.15 7.04 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.803 1.241 . . . . 74.34 113.086 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 9.2 t -75.81 -13.01 60.28 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.49 -1.232 . . . . 71.44 109.816 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -135.79 137.12 41.28 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.867 -1.16 . . . . 71.25 107.867 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -130.81 157.87 41.69 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.572 0.225 . . . . 74.4 111.367 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -122.59 137.29 54.94 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.912 -0.585 . . . . 74.34 110.498 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -121.35 145.72 27.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 75.23 108.772 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 60.2 mtm180 -120.42 141.64 49.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.032 0.444 . . . . 72.42 111.097 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.476 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 42.0 t -110.72 121.54 63.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.392 -1.336 . . . . 55.22 107.392 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -72.15 140.67 30.17 Favored Glycine 0 N--CA 1.433 -1.544 0 O-C-N 123.895 0.747 . . . . 63.24 112.113 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 37.8 mm -101.15 132.56 46.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 106.74 -1.578 . . . . 75.41 106.74 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.9 mt -99.22 151.49 4.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 106.536 -1.653 . . . . 71.44 106.536 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -82.38 86.23 6.76 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.223 -0.991 . . . . 71.04 112.136 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.41 107.59 18.55 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.76 -2.682 . . . . 71.33 103.76 169.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -109.69 84.86 2.0 Allowed 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 117.864 -1.534 . . . . 71.34 109.921 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 47.6 mm -124.37 154.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 111.966 -2.379 . . . . 74.32 105.81 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.19 115.38 4.45 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.428 -1.309 . . . . 71.25 109.018 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.626 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 24.0 mt-10 -126.98 135.75 51.29 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 114.371 -1.286 . . . . 75.01 109.516 -170.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 501' ' ' HIS . 32.8 mt-10 -138.0 117.16 12.61 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.972 -1.013 . . . . 70.25 108.903 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 56.8 29.99 16.98 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.227 1.011 . . . . 73.25 110.97 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -75.38 118.24 18.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.906 -1.146 . . . . 75.32 107.906 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 2.7 p-10 -144.03 167.72 21.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.313 0.578 . . . . 70.5 110.775 -174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.516 ' CE2' HD11 ' A' ' 496' ' ' ILE . 23.9 p90 -139.12 -177.49 4.92 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.443 -0.799 . . . . 72.51 109.242 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 30.1 mt -122.13 139.64 53.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.401 -0.963 . . . . 75.32 108.401 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.81 126.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.821 -1.548 . . . . 71.51 106.821 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.62 149.62 41.66 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.672 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.08 124.84 50.25 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.275 -1.75 . . . . 75.42 106.275 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.8 m -144.25 170.91 15.08 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.212 -0.662 . . . . 74.11 109.212 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.13 86.53 0.04 OUTLIER 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.708 1.203 . . . . 73.04 112.525 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 480' ' ' VAL . 61.9 t -80.14 128.82 38.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 119.698 -0.801 . . . . 73.32 108.897 177.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 406' ' ' PHE . 39.9 ttmt -118.54 134.34 55.17 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.088 -1.449 . . . . 73.04 107.088 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 476' ' ' GLU . 13.4 t -125.55 138.22 55.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 119.748 -0.781 . . . . 75.42 109.124 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.8 t -103.39 124.56 48.93 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 116.455 -0.339 . . . . 71.53 110.537 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 23.8 m -84.76 89.7 7.58 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.68 -1.23 . . . . 73.22 107.68 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -97.06 -22.1 16.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.109 -0.496 . . . . 75.11 110.593 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -75.48 -27.4 58.82 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.407 -0.517 . . . . 74.3 111.106 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 34.9 t -164.04 143.52 7.88 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.189 -1.041 . . . . 71.44 108.189 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -95.47 -24.36 16.69 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.085 -1.08 . . . . 74.42 108.085 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -81.96 -50.15 9.47 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.16 -0.927 . . . . 65.32 110.013 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -98.57 137.98 13.6 Favored Glycine 0 N--CA 1.412 -2.966 0 N-CA-C 108.876 -1.689 . . . . 72.11 108.876 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 13.1 tt -75.48 89.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 122.406 1.098 . . . . 74.31 110.106 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 97.0 mt -115.41 96.28 5.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.696 -1.138 . . . . 75.31 108.386 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . 0.419 ' HB2' ' CG1' ' A' ' 465' ' ' VAL . 0.0 OUTLIER -146.17 -173.21 4.11 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.452 -1.249 . . . . 75.45 111.206 -175.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 479' ' ' HIS . . . -70.16 -43.92 69.84 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.985 0.735 . . . . 65.43 112.985 -175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . 0.281 9.0 p30 51.84 -20.88 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 118.049 2.611 . . . . 73.22 118.049 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 484' ' ' ALA . 58.3 m170 -51.35 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.538 0.735 . . . . 74.33 112.441 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 463' ' ' VAL . 34.1 m -76.77 120.04 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 118.586 -1.246 . . . . 62.21 109.313 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 8.9 p -161.31 -47.83 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.992 -1.003 . . . . 74.44 112.12 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.5 -66.27 0.31 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 112.563 0.579 . . . . 73.54 112.563 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -81.81 -43.31 18.47 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 105.735 -1.95 . . . . 75.41 105.735 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 479' ' ' HIS . . . -91.18 114.7 27.29 Favored 'General case' 0 N--CA 1.387 -3.615 0 N-CA-C 103.465 -2.791 . . . . 64.13 103.465 166.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 37.0 t -134.81 -167.67 2.02 Favored 'General case' 0 C--N 1.249 -3.773 0 N-CA-C 105.203 -2.147 . . . . 63.12 105.203 -173.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.439 HD21 ' H ' ' A' ' 486' ' ' LEU . 1.6 mm? -60.47 145.26 48.99 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.883 -1.155 . . . . 72.12 107.883 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -65.31 -43.39 95.22 Favored Glycine 0 CA--C 1.505 -0.583 0 C-N-CA 120.808 -0.71 . . . . 74.11 111.793 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.417 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 8.2 m -80.56 167.67 31.13 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 107.976 -1.12 . . . . 62.51 107.976 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.575 ' N ' ' HA ' ' A' ' 490' ' ' SER . 1.6 Cg_endo -43.3 -41.54 10.1 Favored 'Trans proline' 0 CA--C 1.591 3.342 0 N-CA-C 119.294 2.767 . . . . 71.03 119.294 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.575 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 50.6 m -107.22 124.5 49.84 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 127.04 2.136 . . . . 74.32 109.215 2.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 29.4 m -133.45 105.72 7.07 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 108.381 -0.97 . . . . 73.44 108.381 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -104.78 131.82 51.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.618 -1.252 . . . . 72.23 107.618 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.7 m -98.86 121.86 41.35 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 120.481 -0.488 . . . . 73.04 110.338 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 86.9 t -109.01 106.06 19.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.798 -0.816 . . . . 74.32 108.798 177.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 93.9 m -95.83 115.3 27.22 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.861 -1.162 . . . . 72.33 107.861 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.549 HD12 ' CZ ' ' A' ' 422' ' ' TYR . 4.9 mp -88.6 107.88 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 C-N-CA 119.896 -0.722 . . . . 72.01 109.867 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 38.2 m-85 -78.01 92.4 4.34 Favored 'General case' 0 CA--C 1.446 -3.044 0 N-CA-C 106.37 -1.715 . . . . 75.44 106.37 169.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.601 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 1.1 p-10 -82.79 -19.87 36.91 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 114.241 -1.345 . . . . 71.22 108.905 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.8 t70 63.75 37.82 9.65 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 112.985 -1.916 . . . . 74.21 110.565 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.62 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 2.2 m-20 -81.9 -50.33 9.3 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 118.373 -1.331 . . . . 72.23 108.659 172.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.426 ' HB3' ' HG2' ' A' ' 452' ' ' GLU . 23.9 t-80 -139.27 84.34 1.99 Allowed 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.761 -1.199 . . . . 74.21 107.761 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -143.37 -47.04 0.29 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.439 -0.8 . . . . 74.32 111.019 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 98.22 44.85 2.49 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.502 -0.856 . . . . 71.43 112.236 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 49.5 mm -89.34 140.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.466 -0.938 . . . . 72.22 108.466 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 74.08 18.71 3.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.843 1.257 . . . . 75.23 110.178 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.3 t -156.66 -159.9 0.92 Allowed 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.781 -1.192 . . . . 72.23 107.781 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -54.96 126.34 24.11 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.691 0.997 . . . . 73.42 113.691 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.87 160.67 33.78 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.161 -1.052 . . . . 73.12 108.161 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--N 1.292 -1.912 0 O-C-N 123.409 0.443 . . . . 75.0 109.922 177.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.638 'CA ' ' OE2' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.616 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 108.472 -0.936 . . . . 73.51 108.472 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 20.6 m -78.63 141.27 38.14 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.689 -0.486 . . . . 70.31 109.689 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.0 mmtp -132.76 128.67 37.35 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.899 -0.408 . . . . 73.41 109.899 176.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.458 ' HB ' HD11 ' A' ' 486' ' ' LEU . 35.6 mm -110.04 119.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.313 -1.366 . . . . 63.3 107.313 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.4 ' HB3' ' CA ' ' A' ' 487' ' ' GLY . 32.6 p90 -156.43 161.68 40.06 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 118.443 0.565 . . . . 74.31 112.305 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.17 145.04 40.17 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.133 -0.321 . . . . 74.44 110.133 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.89 -44.28 90.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.395 0.617 . . . . 72.3 109.359 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 14.4 mm100 -107.17 171.11 7.56 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.412 -0.813 . . . . 55.55 111.236 177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -105.62 -25.66 6.49 Favored Glycine 0 C--N 1.289 -2.063 0 N-CA-C 109.63 -1.388 . . . . 73.32 109.63 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 493' ' ' THR . 24.0 m -135.94 140.22 43.84 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.694 -1.225 . . . . 72.15 107.694 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 91.7 m-85 -129.13 136.69 50.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.31 -0.996 . . . . 74.43 108.31 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.66 134.45 53.74 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.131 -0.692 . . . . 74.31 109.131 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 31.7 t -148.69 165.03 32.57 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.486 -1.301 . . . . 72.35 107.486 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -84.4 143.54 29.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.627 0.603 . . . . 73.44 112.627 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.626 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 15.7 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.182 -0.917 . . . . 73.21 109.975 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -90.64 14.19 13.98 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.351 0.5 . . . . 71.31 112.351 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.78 -16.32 34.49 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.994 -0.441 . . . . 64.05 111.268 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.21 -68.77 0.37 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.527 -0.844 . . . . 74.33 112.405 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 16.7 p -135.18 161.68 34.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.094 0.473 . . . . 65.31 110.714 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 442' ' ' VAL . 5.7 p -112.5 129.13 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 107.842 -1.17 . . . . 71.04 107.842 172.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.78 120.85 40.39 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.603 0.564 . . . . 74.22 110.306 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.1 mp -112.09 141.8 45.32 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.647 -1.242 . . . . 73.01 107.647 176.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -105.3 129.01 53.74 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.81 -0.441 . . . . 70.35 109.81 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.8 122.64 55.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.164 -1.05 . . . . 73.44 108.164 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.2 mm -94.43 132.36 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 C-N-CA 124.259 1.024 . . . . 74.42 108.456 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 60.6 ttt180 -115.6 111.23 20.36 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.293 -0.867 . . . . 74.14 109.788 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -101.63 167.46 10.1 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.129 -0.941 . . . . 72.01 109.044 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 123.13 -17.01 8.09 Favored Glycine 0 C--N 1.303 -1.299 0 N-CA-C 110.715 -0.954 . . . . 74.23 110.715 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 117.15 -141.84 16.94 Favored Glycine 0 N--CA 1.419 -2.474 0 N-CA-C 111.335 -0.706 . . . . 72.42 111.335 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.03 120.97 34.91 Favored 'General case' 0 CA--C 1.471 -2.092 0 N-CA-C 108.83 -0.804 . . . . 73.23 108.83 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 74.3 mt -143.27 136.11 27.69 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 114.486 -1.233 . . . . 74.44 108.009 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 58.7 p -82.42 6.25 17.82 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.498 0.666 . . . . 73.21 110.291 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -58.59 152.56 18.15 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.578 1.151 . . . . 74.21 109.03 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 25.3 m -118.59 111.95 19.24 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-O 121.561 0.696 . . . . 74.43 110.684 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 55.8 t -104.68 143.2 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 114.428 -1.26 . . . . 74.24 108.618 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.465 ' HE1' ' OG ' ' A' ' 466' ' ' SER . 47.4 m-85 -126.22 112.77 16.14 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.544 -0.909 . . . . 74.21 108.544 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.6 124.66 71.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.1 -0.704 . . . . 73.54 109.1 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -87.41 140.49 29.48 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.094 -0.706 . . . . 73.53 109.094 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -142.83 154.66 44.38 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.44 -0.788 . . . . 75.44 111.69 -175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 56.0 mtt85 -154.6 165.58 36.05 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 125.144 1.378 . . . . 73.23 109.27 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.6 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 58.5 p -100.97 158.05 16.29 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.647 -0.706 . . . . 72.43 109.262 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 8.2 tp10 -106.02 163.92 12.38 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.006 -1.85 . . . . 75.53 106.006 176.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.8 p-10 -60.29 -40.1 89.25 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.626 0.726 . . . . 70.15 110.559 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.76 -89.26 0.3 Allowed Glycine 0 C--N 1.299 -1.514 0 CA-C-N 114.737 -1.119 . . . . 73.44 110.456 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 455' ' ' ASN . 9.6 t -131.57 -1.09 3.9 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 122.093 0.949 . . . . 71.03 109.212 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.56 ' HB1' ' OH ' ' A' ' 422' ' ' TYR . . . -129.5 -154.84 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.254 -1.017 . . . . 73.12 108.254 -173.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.41 125.6 20.06 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.101 0.477 . . . . 73.41 110.822 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -73.32 128.45 35.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.237 -0.653 . . . . 71.43 109.237 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.27 -13.08 48.34 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 110.522 -1.031 . . . . 53.4 110.522 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.4 m -117.64 -56.49 2.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.17 0.51 . . . . 72.34 109.67 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 38.1 m-20 -85.23 -57.64 3.0 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 122.174 0.988 . . . . 74.41 109.663 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.637 ' CE2' HD12 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -139.95 165.01 28.47 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.275 -0.875 . . . . 74.05 110.638 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.3 tt0 -73.82 149.16 41.82 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 124.057 0.848 . . . . 64.23 110.836 -173.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.6 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.3 OUTLIER -79.85 -16.29 55.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 73.5 111.818 176.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.519 HG21 HG21 ' A' ' 442' ' ' VAL 0.259 8.9 t 35.05 63.91 0.46 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 126.412 1.885 . . . . 72.24 113.622 -177.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -79.2 126.36 30.65 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.427 -0.806 . . . . 74.15 109.084 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -170.14 -173.2 37.32 Favored Glycine 0 N--CA 1.41 -3.065 0 N-CA-C 110.672 -0.971 . . . . 60.52 110.672 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 40.8 m -127.22 139.98 52.55 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.382 -0.97 . . . . 74.01 108.382 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.76 117.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.051 -1.092 . . . . 71.42 108.051 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.0 t -92.75 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.525 -0.761 . . . . 74.4 110.009 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.9 m-85 -91.82 94.46 9.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.129 -0.487 . . . . 74.33 110.053 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.2 mttm -82.79 174.93 5.31 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.073 -0.967 . . . . 71.42 110.296 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.2 Cg_exo -59.75 133.45 51.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 70.14 109.639 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.8 -18.8 48.88 Favored Glycine 0 C--N 1.305 -1.175 0 C-N-CA 120.564 -0.827 . . . . 64.22 113.199 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.83 63.99 7.22 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.24 0.616 . . . . 63.54 112.275 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 7.6 m -68.46 -19.27 64.55 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.182 -0.917 . . . . 73.43 109.113 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -138.28 137.78 37.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.294 -1.002 . . . . 72.33 108.294 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -124.48 151.66 44.32 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.485 -0.325 . . . . 74.02 111.028 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.76 138.99 48.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.964 -0.562 . . . . 75.21 109.946 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.51 133.9 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.445 -0.576 . . . . 74.3 109.445 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 24.5 mmt180 -104.55 133.02 50.12 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.636 -0.711 . . . . 73.04 111.123 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.65 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -110.55 124.21 67.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.14 -1.43 . . . . 75.21 107.14 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -72.7 133.86 19.77 Favored Glycine 0 N--CA 1.428 -1.841 0 O-C-N 123.903 0.752 . . . . 63.4 112.343 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . 0.401 HD11 HG12 ' A' ' 496' ' ' ILE . 34.7 mm -95.19 134.31 33.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 105.966 -1.865 . . . . 74.34 105.966 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 78.2 mt -97.03 143.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 107.732 -1.21 . . . . 73.43 107.732 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.87 95.03 0.66 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.544 0.688 . . . . 72.23 110.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.06 102.84 7.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 104.774 -2.306 . . . . 64.33 104.774 169.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -106.55 89.85 3.16 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.116 -1.434 . . . . 71.23 109.697 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.2 mm -129.63 155.57 41.43 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.28 0 CA-C-N 112.108 -2.315 . . . . 72.43 105.244 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.25 115.22 4.34 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 117.713 -1.595 . . . . 75.02 106.963 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.637 ' OE1' 'CA ' ' A' ' 650' ' ' ' CA' . 20.5 mt-10 -126.1 136.55 53.04 Favored 'General case' 0 CA--C 1.468 -2.178 0 CA-C-N 114.843 -1.071 . . . . 73.13 108.653 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -128.94 106.56 8.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.31 0.576 . . . . 75.12 110.35 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 54.74 60.67 3.36 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 125.316 1.446 . . . . 62.1 114.004 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.47 117.44 17.27 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.7 -0.852 . . . . 71.42 108.7 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.42 ' O ' HG23 ' A' ' 415' ' ' THR . 8.5 p30 -140.48 145.48 36.97 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.665 0.745 . . . . 74.34 110.115 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.65 ' CZ ' HG12 ' A' ' 442' ' ' VAL . 22.3 p90 -123.81 174.3 7.61 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.612 -1.176 . . . . 74.52 109.124 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.3 mt -120.7 136.14 54.94 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 107.072 -1.455 . . . . 75.35 107.072 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.65 126.17 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.625 -1.25 . . . . 75.3 107.625 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -121.56 140.98 51.53 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.617 0.573 . . . . 74.23 110.007 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.92 138.8 33.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.973 -1.121 . . . . 74.43 107.973 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 14.9 m -146.55 177.16 9.27 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.16 -1.052 . . . . 72.11 108.16 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 40.8 83.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.727 0 C-N-CA 125.112 1.365 . . . . 64.01 113.42 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.37 134.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.16 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -139.75 157.96 44.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.016 -1.105 . . . . 74.44 108.016 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 69.9 t -141.84 155.6 19.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.67 -1.604 . . . . 75.45 106.67 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' SER . . . . . 0.465 ' OG ' ' HE1' ' A' ' 406' ' ' PHE . 70.6 m -72.52 109.77 6.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.683 -1.229 . . . . 74.42 107.683 175.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 32.8 m -62.68 116.69 5.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.698 -1.137 . . . . 75.55 112.289 -173.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -122.75 135.92 54.71 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.509 -1.663 . . . . 73.31 106.509 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -60.89 -20.41 61.94 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.132 0.492 . . . . 72.44 112.174 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 27.5 t -81.1 82.38 7.05 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 108.073 -1.084 . . . . 74.05 108.073 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -100.77 -19.68 15.89 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.855 -0.612 . . . . 75.35 110.694 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 13.4 t70 78.26 -39.43 0.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.038 1.335 . . . . 62.1 110.872 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 177.32 160.28 23.85 Favored Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 106.678 -2.569 . . . . 54.24 106.678 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 49.4 mm -78.29 76.38 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 118.865 1.333 . . . . 74.11 109.614 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 95.1 mt -155.75 99.51 2.01 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 126.678 1.991 . . . . 75.44 106.078 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . 0.402 ' HB2' ' OG ' ' A' ' 481' ' ' SER . 35.5 mt-10 -91.81 75.95 5.64 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.411 0.624 . . . . 70.44 109.334 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -103.98 -24.11 13.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.454 -0.794 . . . . 73.03 110.826 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -65.62 -42.36 91.63 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.817 0.818 . . . . 75.23 109.448 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -123.05 153.6 39.65 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.265 -1.334 . . . . 75.25 108.779 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.95 150.29 10.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.975 0.416 . . . . 71.32 112.015 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 476' ' ' GLU . 35.5 p -165.65 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.494 -0.776 . . . . 70.12 109.954 -177.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.61 6.31 2.48 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.292 -1.373 . . . . 73.54 107.292 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.12 -62.86 1.29 Allowed 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 103.1 -2.926 . . . . 73.13 103.1 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -93.92 142.39 27.43 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 106.219 -1.771 . . . . 55.33 106.219 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 15.2 p -128.47 -170.52 2.27 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 122.392 0.277 . . . . 63.51 111.087 -174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.458 HD11 ' HB ' ' A' ' 374' ' ' ILE . 1.8 mm? -77.37 151.94 34.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.006 0.431 . . . . 74.32 110.271 -177.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 375' ' ' PHE . . . -77.95 -25.13 62.82 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 110.986 -0.846 . . . . 73.4 110.986 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.486 ' C ' ' HA ' ' A' ' 490' ' ' SER . 37.8 m -78.97 157.15 76.55 Favored Pre-proline 0 N--CA 1.429 -1.492 0 N-CA-C 108.031 -1.1 . . . . 74.53 108.031 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.652 ' N ' ' HA ' ' A' ' 490' ' ' SER . 72.6 Cg_endo -73.19 -10.71 24.57 Favored 'Trans proline' 0 CA--C 1.594 3.5 0 N-CA-C 120.683 3.301 . . . . 74.53 120.683 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.652 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 19.6 m -116.4 104.04 11.06 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 123.742 2.974 . . . . 72.21 108.137 -0.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 48.8 m -135.14 115.95 13.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 110.002 -0.37 . . . . 74.04 110.002 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.37 27.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.244 -1.021 . . . . 71.12 108.244 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 380' ' ' THR . 30.8 m -86.0 121.26 28.37 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.876 0.37 . . . . 74.43 110.486 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.427 HG12 HG12 ' A' ' 390' ' ' VAL . 73.6 t -107.25 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.411 -0.959 . . . . 74.32 108.411 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 24.5 m -98.14 112.85 24.67 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.815 -1.18 . . . . 75.21 107.815 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.637 HD12 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.59 121.63 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 N-CA-C 109.212 -0.662 . . . . 72.24 109.212 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.425 ' O ' HD13 ' A' ' 384' ' ' LEU 0.29 23.3 m-85 -81.87 99.95 9.33 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-O 122.652 1.215 . . . . 73.51 112.459 177.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 4.7 t70 -49.89 -52.11 35.46 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 111.042 -2.799 . . . . 73.23 109.862 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.1 t70 65.94 6.47 4.06 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.018 1.727 . . . . 61.15 111.317 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.615 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 58.4 m-20 -92.28 -56.0 3.21 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.911 -1.515 . . . . 75.1 106.911 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -116.75 -31.77 5.36 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.658 -1.156 . . . . 74.34 108.051 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -118.12 104.15 10.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.318 -0.553 . . . . 70.34 111.736 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -105.81 179.83 23.44 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 111.5 -0.64 . . . . 73.21 111.5 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 58.4 mt -67.22 141.62 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 122.988 0.515 . . . . 73.15 109.939 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -90.21 93.67 9.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 110.001 -0.37 . . . . 73.13 110.001 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 90.8 m 63.76 95.98 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.21 1.189 . . . . 74.11 114.21 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -160.78 113.51 1.98 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.587 -0.733 . . . . 72.55 109.25 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -147.69 162.16 39.74 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.104 -1.072 . . . . 73.41 108.104 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.295 -1.785 0 O-C-N 123.14 0.275 . . . . 73.12 110.407 -177.741 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.635 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.637 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.387 0.613 . . . . 72.33 110.668 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 15.4 m -84.41 94.54 8.53 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.488 0.661 . . . . 53.24 112.76 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -130.55 166.02 21.48 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.965 -0.561 . . . . 73.1 110.509 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.487 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 25.5 mm -115.36 124.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 107.421 -1.325 . . . . 74.31 107.421 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -155.64 -177.8 6.82 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 110.025 -0.361 . . . . 71.32 110.025 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -94.33 162.37 13.86 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.146 0.498 . . . . 73.44 112.054 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.11 -35.47 56.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.239 -0.891 . . . . 70.11 109.854 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 23.1 mm-40 -122.38 172.31 8.42 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.386 -0.825 . . . . 70.35 111.966 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -103.01 -37.18 3.21 Favored Glycine 0 C--N 1.293 -1.845 0 CA-C-N 114.465 -1.243 . . . . 72.3 110.025 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.0 m -133.02 130.98 40.15 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.452 0.644 . . . . 74.32 109.439 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 74.7 m-85 -113.43 143.9 43.71 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.112 -1.07 . . . . 71.13 108.112 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 495' ' ' THR . 15.7 mp0 -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.705 -0.85 . . . . 71.43 108.705 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 30.3 t -148.13 165.11 31.84 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.686 -0.857 . . . . 75.21 108.686 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.7 mm? -89.07 141.46 28.48 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 122.457 0.303 . . . . 75.01 110.617 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.627 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 9.6 tt0 -56.88 -35.73 69.27 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 122.163 0.982 . . . . 74.52 109.605 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -74.26 -7.83 54.12 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.897 -1.502 . . . . 73.3 111.4 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.57 -22.85 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.011 0.434 . . . . 54.25 111.239 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.14 -51.48 2.48 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.177 -1.011 . . . . 52.13 112.493 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 17.2 p -138.12 160.75 38.58 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.073 0.463 . . . . 70.31 111.175 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.6 p -116.5 132.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.126 -1.435 . . . . 71.35 107.126 172.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -104.06 115.54 30.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.405 0.621 . . . . 72.22 110.36 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.1 mp -105.65 147.43 28.49 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.825 -1.176 . . . . 71.55 107.825 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.7 m -108.76 129.45 55.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.489 -0.559 . . . . 75.23 109.489 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.1 mt -97.98 119.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.465 -1.309 . . . . 74.32 107.465 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.17 121.6 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.473 -0.785 . . . . 73.5 109.324 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.44 129.93 55.87 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.222 -1.399 . . . . 73.54 107.222 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -106.7 167.28 9.97 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.389 -0.597 . . . . 75.44 109.389 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 142.58 -16.93 2.44 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.765 -0.731 . . . . 62.22 112.1 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 94.19 -95.12 1.89 Allowed Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 109.766 -1.334 . . . . 61.04 109.766 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -129.56 119.7 24.1 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 108.752 -0.833 . . . . 74.24 108.752 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 79.7 mt -146.21 103.49 3.72 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.431 -0.951 . . . . 72.45 108.431 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 35.0 p -83.59 -1.09 53.08 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.635 0.731 . . . . 74.2 110.469 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -61.63 136.1 57.88 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 125.51 1.524 . . . . 74.44 108.681 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 33.4 m -85.04 113.72 21.66 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.336 0.588 . . . . 73.43 110.14 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.415 HG23 ' CD2' ' A' ' 479' ' ' HIS . 57.7 t -112.98 148.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.675 -0.693 . . . . 74.11 109.501 -177.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.46 ' CE1' HG13 ' A' ' 430' ' ' VAL . 4.1 m-85 -123.55 132.62 53.95 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.821 0.849 . . . . 72.14 110.137 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.23 134.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.563 -1.273 . . . . 73.43 107.563 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . 0.485 ' CB ' ' HB3' ' A' ' 462' ' ' ASN . 11.6 t70 -105.58 146.21 29.94 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.924 -0.485 . . . . 74.03 109.998 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -143.35 164.0 31.48 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.748 0.309 . . . . 62.34 110.257 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -166.42 169.28 14.12 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.693 -1.965 . . . . 73.13 105.693 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 68.5 p -96.72 145.9 25.37 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.303 0.573 . . . . 72.42 110.537 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 12.1 tp10 -108.67 133.75 52.33 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.929 -1.878 . . . . 73.13 105.929 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 64.2 m-20 -42.69 -52.66 4.82 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.112 1.365 . . . . 73.3 114.24 -173.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 74.57 -90.9 0.75 Allowed Glycine 0 C--N 1.285 -2.28 0 CA-C-N 114.975 -1.011 . . . . 74.3 110.918 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 455' ' ' ASN . 9.4 t -124.86 -13.86 6.82 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.703 -0.851 . . . . 72.01 108.703 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -105.86 -165.98 1.16 Allowed 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.288 -1.375 . . . . 74.51 107.288 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.52 115.87 10.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.116 -0.634 . . . . 62.43 110.62 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.56 138.51 46.92 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.809 -0.812 . . . . 73.12 108.809 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 97.85 -10.84 64.38 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.252 -1.139 . . . . 75.34 110.252 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 35.0 t -126.45 -56.09 1.42 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.792 -0.447 . . . . 64.41 109.792 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.582 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 13.6 m-20 -78.61 -54.88 5.66 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-O 121.541 0.686 . . . . 65.31 109.406 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -138.61 171.55 14.18 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 108.41 -0.959 . . . . 75.25 108.41 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.83 161.41 27.66 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.88 -1.156 . . . . 65.52 107.88 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.466 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 8.0 p90 -99.49 -12.98 19.69 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 112.451 0.538 . . . . 73.24 112.451 -174.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.42 ' CG2' HG21 ' A' ' 442' ' ' VAL 0.273 11.5 t 37.27 73.84 0.09 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.227 1.811 . . . . 75.04 113.449 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.71 138.31 37.29 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.397 -1.274 . . . . 70.1 108.755 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 179.66 169.31 39.81 Favored Glycine 0 N--CA 1.413 -2.863 0 C-N-CA 118.777 -1.678 . . . . 70.13 112.205 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 5.9 m -117.41 133.67 55.71 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 106.69 -1.596 . . . . 74.44 106.69 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.2 t -96.14 119.85 44.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.745 -0.835 . . . . 74.44 108.745 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.0 t -95.73 117.44 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 73.24 108.941 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.9 m-85 -89.77 110.32 21.24 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 116.056 -0.52 . . . . 73.23 111.291 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 164.82 23.31 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.476 -0.784 . . . . 71.42 110.359 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -52.28 113.57 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.664 2.243 . . . . 72.15 112.236 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.58 25.29 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 111.134 -0.787 . . . . 73.11 111.134 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -81.85 63.23 6.01 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 123.533 0.733 . . . . 74.44 110.514 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 11.3 t -79.19 -7.69 58.43 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.874 -1.158 . . . . 72.34 107.874 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -136.92 137.09 39.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.905 -1.517 . . . . 75.54 106.905 172.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -125.98 153.23 44.62 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 111.596 0.221 . . . . 74.34 111.596 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -112.48 132.5 55.04 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.475 -0.565 . . . . 53.22 109.475 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 41.1 pt -127.07 146.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.255 -1.017 . . . . 74.44 108.255 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 52.5 mtt180 -125.8 145.56 50.16 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.133 0.492 . . . . 73.03 111.886 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 389' ' ' THR . 48.9 t -113.42 124.05 69.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.269 -1.382 . . . . 74.21 107.269 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.05 137.05 20.78 Favored Glycine 0 N--CA 1.435 -1.428 0 O-C-N 123.816 0.698 . . . . 73.52 111.866 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 36.8 mm -96.8 132.28 41.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.014 -0.735 . . . . 65.33 109.014 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.5 mt -94.53 149.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.541 -1.651 . . . . 72.21 106.541 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 86.9 5.38 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.471 -0.491 . . . . 75.11 111.868 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.64 120.99 43.43 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 104.717 -2.327 . . . . 73.01 104.717 172.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.605 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.289 4.0 t70 -118.35 90.2 3.28 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 116.046 -2.262 . . . . 72.32 112.398 178.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.715 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.2 mm -120.21 155.62 23.24 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 110.747 -2.933 . . . . 74.52 104.041 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -54.26 114.84 1.78 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.602 -1.629 . . . . 73.31 106.602 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.715 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 47.4 mt-10 -107.42 98.34 7.97 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.564 1.173 . . . . 74.3 112.676 -171.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -112.58 108.47 17.57 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.673 -2.058 . . . . 71.03 107.681 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 42.07 60.56 2.23 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.99 1.431 . . . . 74.42 111.256 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.415 ' OE2' ' HG2' ' A' ' 451' ' ' GLU . 12.0 tt0 -89.15 107.22 18.93 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.914 -1.513 . . . . 74.24 106.914 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.3 OUTLIER -136.92 159.98 40.27 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 114.684 1.364 . . . . 55.02 114.684 -175.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.522 ' HB2' ' O ' ' A' ' 412' ' ' GLU . 34.0 p90 -132.97 177.61 7.52 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.359 -1.291 . . . . 74.44 108.613 174.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.47 136.99 54.58 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.82 -0.808 . . . . 75.42 108.82 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . 0.423 ' HB ' ' HB1' ' A' ' 492' ' ' ALA . 41.0 t -108.84 125.87 65.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.277 -1.009 . . . . 73.41 108.277 176.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -120.68 152.98 37.54 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.923 -0.581 . . . . 72.32 109.561 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 72.9 mt -109.19 140.61 42.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.465 -0.569 . . . . 70.33 109.465 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.7 m -152.54 -173.13 4.45 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.592 0.757 . . . . 63.43 108.961 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . 0.485 ' HB3' ' CB ' ' A' ' 408' ' ' ASP . 3.0 t30 48.89 81.28 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.95 1.3 . . . . 65.43 111.267 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.09 128.0 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.879 -1.156 . . . . 73.41 107.879 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -144.51 141.97 29.9 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-O 121.163 0.506 . . . . 75.14 111.185 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 29.2 t -110.39 146.69 15.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.542 -2.022 . . . . 74.32 105.542 175.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.4 t -103.06 120.61 40.98 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.611 -0.835 . . . . 64.41 112.249 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 48.0 t -129.28 132.89 47.26 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.347 -2.464 . . . . 74.13 104.347 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.51 -33.7 18.88 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.366 -0.534 . . . . 73.0 112.128 -172.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -103.14 -39.81 6.71 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.446 0.535 . . . . 73.54 112.446 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 47.2 t -96.48 128.02 43.02 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.167 0.508 . . . . 74.44 111.48 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -71.0 -28.6 64.54 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.847 -0.798 . . . . 73.11 108.847 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -101.16 15.89 27.25 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 115.424 -0.807 . . . . 60.41 112.226 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -81.79 44.97 3.2 Favored Glycine 0 C--N 1.315 -0.596 0 N-CA-C 110.8 -0.92 . . . . 71.13 110.8 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.47 HG22 ' OG ' ' A' ' 481' ' ' SER . 14.9 mm -126.26 30.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 106.255 -1.758 . . . . 75.32 106.255 -174.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 76.1 mt -82.28 -20.62 37.14 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.918 -1.037 . . . . 64.43 111.944 -173.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -72.6 87.73 1.23 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 122.432 1.11 . . . . 71.14 112.254 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -87.81 -11.91 46.57 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.862 -1.063 . . . . 72.52 108.902 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -52.2 -45.82 65.35 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.666 -1.152 . . . . 74.03 110.65 176.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.415 ' CD2' HG23 ' A' ' 405' ' ' VAL . 0.9 OUTLIER -82.5 -97.04 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.151 -1.426 . . . . 74.34 107.151 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.48 145.71 18.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 104.483 -2.414 . . . . 72.43 104.483 171.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.47 ' OG ' HG22 ' A' ' 474' ' ' ILE . 37.4 t -146.48 176.75 9.57 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.517 -0.92 . . . . 74.24 108.517 -175.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -77.1 72.38 3.64 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.365 0.602 . . . . 74.53 110.136 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 179.13 -38.74 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 104.902 -2.259 . . . . 74.34 104.902 -176.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.449 ' HB3' ' H ' ' A' ' 481' ' ' SER . . . -90.59 -178.59 5.34 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.006 -1.452 . . . . 73.42 109.563 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 69.1 m -131.52 -177.62 4.49 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.864 -1.161 . . . . 73.3 107.864 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 1.6 mm? -87.98 -159.53 0.55 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.252 -0.648 . . . . 74.45 109.252 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -70.76 134.59 23.99 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 104.838 -3.305 . . . . 73.43 104.838 170.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.625 ' HA ' ' OG ' ' A' ' 490' ' ' SER . 14.5 m -115.56 77.56 6.11 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 118.075 2.62 . . . . 74.13 118.075 -168.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.59 -61.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.401 -3.938 0 N-CA-C 109.199 -1.116 . . . . 74.1 109.199 155.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 488' ' ' SER . 44.8 m -125.79 89.89 3.11 Favored 'General case' 0 C--N 1.387 2.208 0 C-N-CA 129.323 3.049 . . . . 75.53 106.283 -3.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 25.7 m -143.05 113.47 7.35 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 120.381 -0.528 . . . . 73.54 110.704 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 458' ' ' VAL . . . -104.22 100.46 10.19 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.277 -1.379 . . . . 70.11 107.277 171.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 29.9 m -78.06 129.6 35.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.948 -0.76 . . . . 74.1 108.948 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.25 109.23 27.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.398 -0.593 . . . . 73.01 109.398 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.491 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 26.8 m -98.28 115.67 28.89 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.987 -0.746 . . . . 73.21 108.987 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -95.81 124.46 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 CA-C-O 122.075 0.941 . . . . 73.33 110.002 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 71.7 m-85 -108.04 126.05 52.28 Favored 'General case' 0 N--CA 1.396 -3.156 0 CA-C-N 114.588 -1.187 . . . . 74.45 109.06 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.603 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 50.4 t0 -91.28 -19.7 22.7 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 104.431 -2.433 . . . . 73.43 104.431 166.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 38.3 t70 74.45 4.15 4.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 111.795 -2.457 . . . . 73.34 111.677 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -55.24 -65.98 0.49 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.935 -1.029 . . . . 75.42 113.362 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -95.14 -0.36 53.45 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.203 0.525 . . . . 75.04 110.231 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -80.67 -74.21 0.33 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.962 -0.563 . . . . 71.13 110.298 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.28 44.57 5.87 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 121.029 -0.605 . . . . 63.01 112.24 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 46.6 pt -108.88 -13.42 10.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.762 0.792 . . . . 65.12 109.762 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -134.9 -167.91 2.07 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 105.411 -2.07 . . . . 73.33 105.411 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.5 t -140.1 108.99 5.98 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 108.052 -1.092 . . . . 63.22 108.052 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -87.76 108.67 19.24 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 108.419 -0.956 . . . . 75.12 108.419 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.28 -67.54 0.79 Allowed 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.009 -0.996 . . . . 74.25 110.624 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 C--O 1.247 0.935 0 N-CA-C 108.792 -0.818 . . . . 64.52 108.792 -175.275 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.637 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.608 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.235 0.337 0 N-CA-C 109.832 -0.433 . . . . 71.42 109.832 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 13.3 m -112.6 117.27 31.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.357 -0.979 . . . . 71.41 108.357 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 53.0 mttp -93.76 137.25 33.2 Favored 'General case' 0 CA--C 1.477 -1.846 0 C-N-CA 120.182 -0.607 . . . . 75.24 112.026 176.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.648 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 37.9 mm -114.49 106.86 21.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.252 -1.34 . . . . 74.24 108.728 -170.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.55 155.84 43.86 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 119.81 -0.756 . . . . 71.33 111.515 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -76.49 150.88 36.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.407 -0.361 . . . . 74.32 110.132 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.8 -42.27 86.21 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.532 -0.914 . . . . 73.23 108.532 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.527 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.4 mm100 -106.29 -171.75 1.96 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.869 -1.059 . . . . 71.31 110.221 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -123.02 -32.67 0.9 Allowed Glycine 0 C--N 1.289 -2.04 0 N-CA-C 109.233 -1.547 . . . . 71.24 109.233 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.2 m -127.84 141.4 51.58 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.907 -1.145 . . . . 72.31 107.907 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 64.5 m-85 -127.88 136.27 51.16 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.361 -0.978 . . . . 75.3 108.361 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.24 129.35 54.89 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.537 -1.283 . . . . 72.32 107.537 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 48.6 t -146.16 163.11 36.41 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.243 -0.651 . . . . 71.05 109.243 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -81.64 146.5 30.03 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.219 0.608 . . . . 72.04 111.917 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.642 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 11.5 tt0 -58.12 -49.63 76.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.283 -1.006 . . . . 72.21 108.283 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.478 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.8 p-10 -73.55 16.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.911 -1.041 . . . . 73.33 113.706 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.1 t -86.71 -26.65 24.15 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.184 0.516 . . . . 64.2 109.725 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 96.78 -49.92 1.57 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.762 -0.732 . . . . 75.24 111.486 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 11.4 p -143.31 152.36 41.57 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.855 0.462 . . . . 71.13 109.943 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 442' ' ' VAL . 5.7 p -107.42 133.88 50.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.146 -1.427 . . . . 73.2 107.146 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.18 126.43 50.35 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 123.299 0.375 . . . . 73.43 110.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.41 HD11 ' N ' ' A' ' 392' ' ' LEU . 3.4 mp -119.59 145.94 45.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.961 -1.496 . . . . 72.43 106.961 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 56.7 m -113.14 127.65 56.26 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.438 -0.505 . . . . 74.41 110.831 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 70.1 mt -98.43 126.22 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 107.828 -1.175 . . . . 75.21 107.828 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 397' ' ' ARG . 43.7 mm -102.24 125.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.398 -1.334 . . . . 75.01 107.398 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 16.8 ttp180 -109.38 108.49 19.06 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.464 -0.335 . . . . 74.32 110.373 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.431 ' HG3' HG21 ' A' ' 395' ' ' ILE . 80.2 mtp180 -129.34 168.24 16.55 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.281 -0.418 . . . . 70.11 111.495 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 133.78 -6.0 4.8 Favored Glycine 0 C--N 1.31 -0.869 0 N-CA-C 110.311 -1.116 . . . . 62.51 110.311 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 135.74 175.83 14.04 Favored Glycine 0 N--CA 1.424 -2.157 0 N-CA-C 108.189 -1.964 . . . . 72.34 108.189 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -118.15 120.98 39.36 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.813 -1.155 . . . . 63.33 110.75 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -139.94 158.41 44.12 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.914 -1.513 . . . . 73.33 106.914 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 77.2 p -91.02 6.78 43.43 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.961 0.41 . . . . 72.31 111.932 -175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -66.26 134.65 53.1 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.662 0.744 . . . . 64.45 112.232 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.7 m -86.13 113.76 22.43 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.131 -1.395 . . . . 75.51 109.739 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.49 133.82 51.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.599 -1.182 . . . . 65.51 109.259 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 21.8 m-85 -113.62 123.61 50.36 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.599 -0.728 . . . . 74.22 109.234 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.56 128.94 74.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.721 -0.844 . . . . 73.32 108.721 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.4 139.38 31.18 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.848 0.356 . . . . 64.13 110.725 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -132.56 153.98 50.46 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.858 -0.526 . . . . 71.13 111.108 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -159.39 163.64 35.33 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.433 -0.951 . . . . 75.43 108.433 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 77.2 p -101.01 171.85 7.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.667 0.27 . . . . 73.53 111.139 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.3 151.1 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.06 -0.719 . . . . 73.22 109.06 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.11 1.63 35.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 118.345 -0.836 . . . . 62.25 113.054 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -4.49 -97.08 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 C-N-CA 125.842 1.687 . . . . 71.44 115.185 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.9 t -105.47 -18.66 14.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.296 -0.631 . . . . 74.22 109.296 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -118.52 143.56 46.66 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.955 -0.758 . . . . 74.0 108.955 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -108.02 113.83 27.29 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 121.487 0.66 . . . . 71.54 111.59 -166.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -74.78 124.39 26.72 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.335 -0.848 . . . . 74.12 109.685 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.35 -28.35 6.05 Favored Glycine 0 C--N 1.294 -1.756 0 N-CA-C 109.19 -1.564 . . . . 65.4 109.19 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 32.6 t -117.03 -52.64 2.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.474 -0.363 . . . . 73.12 110.205 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.608 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 6.4 m-20 -75.63 -59.94 2.53 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.865 0.84 . . . . 74.01 110.24 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 444' ' ' ILE . 0.1 OUTLIER -136.93 176.48 8.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.714 -1.587 . . . . 72.41 106.714 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -83.76 157.67 22.03 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.014 -0.736 . . . . 70.43 109.014 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -91.52 -8.93 46.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.068 -0.515 . . . . 74.14 112.337 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.442 HG23 HG21 ' A' ' 442' ' ' VAL . 15.1 t 37.9 63.73 0.76 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.681 1.593 . . . . 74.44 113.252 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.56 110.98 15.39 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.216 -0.902 . . . . 63.52 109.576 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.0 174.24 33.24 Favored Glycine 0 N--CA 1.41 -3.046 0 CA-C-N 115.079 -0.964 . . . . 61.04 111.119 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 69.6 m -125.49 133.45 52.38 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 107.139 -1.43 . . . . 74.25 107.139 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.44 129.47 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.358 -0.978 . . . . 71.21 108.358 -176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.11 104.87 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.342 -0.845 . . . . 74.01 108.873 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.7 m-85 -84.8 108.39 17.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.867 -0.606 . . . . 74.42 111.325 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -90.1 165.04 25.63 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.773 -0.649 . . . . 72.34 110.093 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -50.92 127.73 22.4 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.991 2.461 . . . . 71.43 112.184 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 93.66 -17.65 58.13 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 115.839 -0.619 . . . . 73.44 113.426 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.436 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 71.2 mt-10 -84.24 63.88 7.97 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.866 0.841 . . . . 72.1 112.957 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 39.2 m -60.36 -24.06 64.77 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.009 -1.45 . . . . 74.44 110.707 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -128.57 138.88 52.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.7 -0.625 . . . . 75.24 110.36 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -134.87 145.65 48.48 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 120.941 0.401 . . . . 74.24 111.498 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -109.04 134.43 51.68 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.522 -0.763 . . . . 73.12 110.259 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.7 pt -116.34 137.05 51.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.826 -0.625 . . . . 72.42 109.514 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 17.5 mmt180 -109.05 132.84 53.73 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.297 -0.865 . . . . 74.12 111.286 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.445 ' HB ' ' CG1' ' A' ' 390' ' ' VAL . 47.9 t -108.23 116.79 52.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.674 -1.232 . . . . 73.5 107.674 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -61.2 130.79 47.52 Favored Glycine 0 N--CA 1.44 -1.096 0 O-C-N 124.482 1.114 . . . . 71.43 113.083 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 422' ' ' TYR . 33.3 mm -101.45 130.66 50.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.393 -1.336 . . . . 74.41 107.393 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 68.7 mt -98.38 150.04 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 105.485 -2.042 . . . . 75.14 105.485 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -84.64 86.13 7.35 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.405 -0.918 . . . . 72.24 111.564 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.39 124.27 51.4 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 103.269 -2.863 . . . . 73.42 103.269 169.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.625 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 25.1 t70 -119.38 94.73 4.52 Favored 'General case' 0 CA--C 1.456 -2.658 0 C-N-CA 116.836 -1.945 . . . . 62.12 110.841 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . . . . . . . . . 39.9 mm -118.29 155.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.816 0 CA-C-N 111.752 -2.476 . . . . 74.15 105.379 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.43 115.06 2.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.114 -1.81 . . . . 73.33 106.114 170.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.64 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 29.5 mt-10 -129.37 94.28 3.75 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.847 1.308 . . . . 74.23 110.442 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.74 106.29 18.56 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 113.703 -1.59 . . . . 72.42 108.747 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.28 4.4 p30 42.39 60.16 2.44 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.86 1.35 . . . . 73.22 112.971 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -87.29 135.22 33.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.252 -1.388 . . . . 72.43 107.252 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -149.55 161.45 42.13 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.238 0.542 . . . . 75.55 111.941 -172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.402 ' CZ ' HG13 ' A' ' 442' ' ' VAL . 17.4 p90 -137.91 -177.98 5.05 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.71 -0.677 . . . . 74.3 110.225 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -119.82 145.04 47.0 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.274 -1.01 . . . . 72.5 108.274 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.24 132.16 67.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 106.828 -1.545 . . . . 73.24 106.828 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -123.06 139.43 54.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.423 0.452 . . . . 60.04 111.033 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.2 mt -100.07 136.69 39.59 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 44.5 m -157.77 174.3 15.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.425 -0.583 . . . . 73.22 109.425 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.4 t30 54.18 90.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.858 1.263 . . . . 73.33 112.596 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.2 123.19 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.644 -0.707 . . . . 72.51 109.688 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 37.2 ttmt -116.86 129.45 56.08 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.362 -1.347 . . . . 74.2 107.362 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 31.3 t -103.41 151.56 6.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.77 -1.567 . . . . 74.21 106.77 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.6 t -73.81 111.68 9.19 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.215 -1.031 . . . . 73.35 108.215 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 14.9 m -82.34 157.31 23.83 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.936 -1.029 . . . . 70.45 110.272 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 67.15 25.61 9.0 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.556 1.142 . . . . 75.13 110.037 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.85 75.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.912 -1.04 . . . . 61.02 109.996 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 474' ' ' ILE . 40.3 m -146.24 99.96 3.31 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.519 -1.66 . . . . 74.32 106.519 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -57.27 -24.99 58.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.211 -0.904 . . . . 73.13 112.614 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -107.08 113.42 26.87 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.537 -1.283 . . . . 73.43 107.537 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 99.42 -49.41 1.21 Allowed Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.686 -0.768 . . . . 73.14 114.473 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 470' ' ' SER . 38.7 mm -107.72 75.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 118.249 1.024 . . . . 72.12 112.671 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.2 mt -121.56 20.35 11.11 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.973 -1.862 . . . . 73.2 105.973 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.37 167.75 21.04 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 113.04 -1.891 . . . . 64.02 110.736 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -68.2 -64.11 0.93 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.825 -0.625 . . . . 73.45 110.995 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . 0.296 0.2 OUTLIER 35.45 55.59 0.86 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.548 1.139 . . . . 74.33 113.87 -178.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 481' ' ' SER . 39.0 m80 -87.19 -172.95 4.18 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.004 -0.998 . . . . 72.53 109.581 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 373' ' ' LYS . 59.7 t -70.68 -41.46 77.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.805 0.812 . . . . 70.43 108.944 176.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 479' ' ' HIS . 34.0 t -130.11 -153.46 0.57 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.99 -1.856 . . . . 73.01 105.99 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.36 -46.58 86.04 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.211 -1.033 . . . . 72.24 108.211 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -123.87 -68.97 0.84 Allowed 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.097 -1.816 . . . . 74.14 106.097 171.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -161.24 114.86 1.97 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 113.675 0.991 . . . . 64.55 113.675 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . 0.477 ' O ' HG11 ' A' ' 480' ' ' VAL . 40.4 t -151.38 115.12 4.91 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 102.131 -3.285 . . . . 75.12 102.131 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.648 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 2.8 mm? -69.39 -56.58 7.04 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 115.026 1.491 . . . . 74.23 115.026 -166.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 155.05 -43.11 0.57 Allowed Glycine 0 C--N 1.292 -1.893 0 N-CA-C 107.369 -2.292 . . . . 71.21 107.369 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 13.1 m -85.93 173.43 6.91 Favored Pre-proline 0 C--N 1.307 -1.263 0 N-CA-C 106.503 -1.666 . . . . 71.45 106.503 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.626 ' N ' ' HA ' ' A' ' 490' ' ' SER . 32.0 Cg_exo -51.88 -35.43 59.69 Favored 'Trans proline' 0 CA--C 1.588 3.202 0 N-CA-C 119.684 2.917 . . . . 74.1 119.684 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.626 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 29.7 t -105.32 112.39 25.48 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 127.156 2.182 . . . . 74.12 108.921 0.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 55.4 m -133.25 110.29 10.0 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.638 -0.71 . . . . 64.14 109.413 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.18 130.4 53.35 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.845 -1.168 . . . . 72.22 107.845 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 123.37 41.19 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.523 -0.471 . . . . 74.33 109.9 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 76.5 t -108.3 107.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.248 -0.649 . . . . 73.44 109.248 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 10.2 m -91.03 116.54 28.88 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.069 -1.086 . . . . 73.21 108.069 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 50.1 mt -101.97 114.64 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.218 1.009 . . . . 73.4 110.902 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.492 ' O ' HD11 ' A' ' 384' ' ' LEU . 5.3 m-85 -84.05 102.36 12.46 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.24 -1.346 . . . . 74.01 110.777 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 451' ' ' GLU . 23.5 t70 -52.28 -54.87 25.86 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 112.418 -2.174 . . . . 71.21 108.518 172.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.1 t70 71.63 -10.88 0.78 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.23 -1.804 . . . . 65.21 112.003 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 498' ' ' ASP . 24.2 m-20 -73.57 -44.07 58.24 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.215 -1.772 . . . . 63.35 106.215 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -124.04 85.44 2.42 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.556 -1.202 . . . . 71.51 108.512 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -150.09 -49.97 0.14 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.764 -0.653 . . . . 73.13 110.44 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 75.09 32.42 56.36 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.869 -0.605 . . . . 62.13 111.921 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 50.5 pt -93.42 162.54 2.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 120.964 0.411 . . . . 70.45 110.533 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.51 163.39 16.14 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.432 -1.321 . . . . 73.21 107.432 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 7.3 p -79.29 82.15 5.48 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.72 0.771 . . . . 74.14 110.99 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -147.45 142.11 26.65 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 105.449 -2.056 . . . . 71.15 105.449 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.71 155.3 39.57 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.5 0.667 . . . . 73.53 112.473 -175.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 . . . . . 0 C--N 1.306 -1.298 0 CA-C-N 115.738 -0.665 . . . . 73.52 109.528 -179.581 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.642 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.64 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 477' ' ' ALA . 13.2 p . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 108.682 -0.859 . . . . 71.35 108.682 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 48.0 m -118.7 140.57 49.72 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.048 -1.093 . . . . 71.23 108.048 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 32.9 mmtp -137.33 119.64 15.73 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.199 -1.037 . . . . 74.22 108.199 169.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.424 ' HB ' HD13 ' A' ' 486' ' ' LEU . 42.7 mm -105.67 114.6 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.52 -0.919 . . . . 73.35 108.52 -175.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -149.33 174.61 12.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.488 0.585 . . . . 74.42 111.319 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.28 146.76 26.89 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.01 -0.366 . . . . 74.24 110.01 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.668 -1.604 . . . . 73.31 106.668 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 4.8 mt-30 -102.31 144.14 31.19 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.288 -0.869 . . . . 74.43 110.201 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 492' ' ' ALA . . . -93.13 -12.4 57.59 Favored Glycine 0 C--N 1.284 -2.341 0 CA-C-N 115.699 -0.682 . . . . 72.03 111.553 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 25.6 m -140.37 131.37 26.18 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.644 -0.873 . . . . 74.53 108.644 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 72.5 m-85 -127.42 136.59 52.04 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.709 -0.848 . . . . 75.32 108.709 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -121.84 123.15 41.08 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.549 -1.278 . . . . 71.14 107.549 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 43.9 t -134.9 165.38 25.45 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.512 -0.551 . . . . 74.03 109.512 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 3.3 mm? -95.38 141.64 28.7 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.478 -0.783 . . . . 73.43 109.722 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.9 -36.93 78.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.822 -0.807 . . . . 74.44 108.822 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -65.53 -14.26 60.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.621 -1.172 . . . . 73.53 112.689 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 76.6 m -72.52 -19.22 61.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.769 0.285 . . . . 75.13 111.769 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.83 -48.48 3.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.309 -0.716 . . . . 73.22 111.309 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.1 p -141.51 161.34 38.16 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.605 0.762 . . . . 75.33 109.807 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.4 p -114.14 130.0 69.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.832 -1.173 . . . . 71.14 107.832 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.98 128.3 46.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 123.558 0.536 . . . . 72.42 110.174 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.52 151.04 41.76 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.677 -1.231 . . . . 64.44 107.677 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -112.03 128.83 56.3 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.336 0.588 . . . . 73.12 111.656 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 73.3 mt -101.53 126.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 107.913 -1.143 . . . . 64.1 107.913 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.2 mm -100.0 128.23 52.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.56 -0.904 . . . . 73.14 108.56 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.488 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 59.9 ttt180 -112.58 107.65 16.45 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.527 -0.916 . . . . 65.54 108.527 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -98.69 164.35 12.27 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.708 -0.678 . . . . 72.11 111.405 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 371' ' ' VAL . . . 130.45 -11.01 5.81 Favored Glycine 0 N--CA 1.435 -1.369 0 O-C-N 124.351 1.032 . . . . 75.43 110.869 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 123.34 -127.9 6.79 Favored Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 111.279 -0.729 . . . . 62.15 111.279 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -124.58 123.98 41.25 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 106.625 -1.62 . . . . 71.55 106.625 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.08 134.38 47.33 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 113.609 0.966 . . . . 75.33 113.609 -166.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 433' ' ' PRO . 6.9 p -105.64 -2.61 23.21 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 114.523 -1.217 . . . . 73.23 110.935 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -75.07 161.62 29.26 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.722 -0.672 . . . . 74.11 110.425 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m -112.69 112.91 24.76 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.798 0.808 . . . . 65.53 111.085 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 67.2 t -115.49 149.1 17.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.702 -1.136 . . . . 75.24 109.18 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 11.8 m-85 -126.69 147.42 49.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.338 0.59 . . . . 74.45 110.015 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.1 p -143.82 130.49 16.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.557 -0.535 . . . . 75.32 109.557 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -93.41 128.56 39.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.476 -0.565 . . . . 72.33 109.476 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -123.77 153.11 41.41 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.536 -0.912 . . . . 73.22 108.536 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -161.23 161.1 30.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.6 -1.259 . . . . 72.41 107.6 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 71.2 p -96.62 172.03 8.17 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.36 0.6 . . . . 65.33 109.859 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 6.8 tp10 -127.37 153.95 45.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.517 -2.031 . . . . 75.31 105.517 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.3 p-10 -58.2 -41.94 85.05 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.626 0.579 . . . . 73.41 112.425 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.62 -94.43 0.16 Allowed Glycine 0 C--N 1.294 -1.77 0 CA-C-N 115.478 -0.783 . . . . 60.25 111.696 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.9 t -127.74 7.83 6.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.655 0.741 . . . . 62.35 109.495 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -130.94 -159.48 0.97 Allowed 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.043 -1.466 . . . . 55.41 107.043 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -141.68 116.67 9.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.072 0.463 . . . . 75.11 110.546 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -71.44 128.72 36.78 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.905 -0.589 . . . . 75.33 109.557 178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.45 -24.38 15.78 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.445 -1.462 . . . . 71.34 109.445 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 21.2 t -111.93 -55.76 2.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 109.632 -0.507 . . . . 71.33 109.632 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.6 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 11.1 m-20 -80.09 -56.72 4.03 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.844 0.83 . . . . 62.31 110.055 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.466 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -136.95 167.78 20.84 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.191 -1.411 . . . . 74.13 107.191 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -74.96 152.05 38.81 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.308 -0.627 . . . . 74.02 109.308 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -85.76 -13.17 49.1 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.93 -0.577 . . . . 75.44 111.547 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.476 HG21 HG23 ' A' ' 442' ' ' VAL 0.253 14.7 t 35.5 63.11 0.55 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 126.1 1.76 . . . . 73.02 113.152 179.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.35 107.55 12.2 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.981 -1.008 . . . . 73.44 109.097 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -147.49 171.51 28.08 Favored Glycine 1 N--CA 1.394 -4.126 0 C-N-CA 119.125 -1.512 . . . . 71.5 112.07 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 25.5 m -124.27 136.13 53.91 Favored 'General case' 0 N--CA 1.388 -3.558 0 N-CA-C 106.652 -1.61 . . . . 73.01 106.652 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.7 t -95.77 126.89 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.371 -0.974 . . . . 73.21 108.371 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' A' ' 406' ' ' PHE . 19.3 t -100.52 100.59 10.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.188 -1.041 . . . . 73.2 108.188 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.488 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 54.6 m-85 -80.91 104.51 11.46 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.32 -0.4 . . . . 75.05 111.006 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.472 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -84.53 169.47 16.6 Favored Pre-proline 0 C--O 1.256 1.432 0 CA-C-N 115.785 -0.643 . . . . 75.31 110.169 177.746 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 9.3 Cg_endo -53.08 132.74 49.17 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.79 2.327 . . . . 75.13 111.868 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.44 -25.57 17.63 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.851 -0.613 . . . . 75.11 113.224 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 44.9 mt-10 -75.57 64.47 1.66 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.86 0.864 . . . . 73.12 113.168 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 22.4 m -61.42 -23.64 65.96 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.437 -1.256 . . . . 73.45 109.149 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -132.8 143.25 49.44 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.192 -0.67 . . . . 73.05 109.192 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -131.31 149.82 52.4 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.049 -0.523 . . . . 73.4 110.457 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.1 135.51 51.51 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.798 -0.816 . . . . 75.33 108.798 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.8 pt -120.77 146.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.999 -1.111 . . . . 75.11 107.999 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 87.8 mtt180 -125.41 146.18 49.73 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.207 0.527 . . . . 75.52 110.651 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.537 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 51.1 t -113.37 120.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.863 -1.162 . . . . 73.41 107.863 178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -64.3 131.36 38.59 Favored Glycine 0 N--CA 1.439 -1.153 0 O-C-N 124.072 0.858 . . . . 74.34 111.897 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.51 133.52 39.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.563 -1.273 . . . . 75.03 107.563 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 75.6 mt -98.77 150.43 4.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.049 -1.093 . . . . 74.43 108.049 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.9 86.8 5.39 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.224 0.535 . . . . 70.14 111.421 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -112.9 101.66 9.71 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 104.579 -2.378 . . . . 75.42 104.579 171.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.629 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.285 11.3 t70 -106.61 84.44 2.01 Favored 'General case' 0 CA--C 1.458 -2.572 0 C-N-CA 115.613 -2.435 . . . . 70.15 112.025 -177.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.657 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 46.1 mm -117.06 154.0 18.77 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.75 0 N-CA-C 103.388 -2.819 . . . . 75.35 103.388 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -52.09 116.15 2.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.32 0.964 . . . . 73.01 110.158 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 27.2 mt-10 -122.48 119.0 29.66 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.436 1.113 . . . . 72.54 113.258 -171.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 501' ' ' HIS . 34.4 mt-10 -131.07 110.92 11.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.563 -1.653 . . . . 74.03 106.847 177.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 48.63 60.52 3.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.72 1.378 . . . . 63.34 114.72 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.404 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.2 pt-20 -99.5 134.6 42.14 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.781 -1.168 . . . . 75.11 108.253 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.7 p-10 -149.25 166.19 29.65 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.372 0.606 . . . . 71.32 111.534 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.537 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 30.7 p90 -137.35 -177.73 4.91 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.248 -0.887 . . . . 73.41 109.404 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.95 137.05 54.68 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.621 -1.251 . . . . 74.45 107.621 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 42.3 t -108.79 128.23 64.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.482 -1.303 . . . . 71.11 107.482 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -122.68 163.07 20.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.075 -0.511 . . . . 72.1 109.718 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 82.4 mt -118.2 134.04 55.36 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.252 -1.388 . . . . 75.3 107.252 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.0 m -150.43 161.46 42.46 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 109.222 -0.659 . . . . 60.22 109.222 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.73 87.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.257 0.973 . . . . 72.3 110.918 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.16 137.94 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.681 -1.229 . . . . 65.42 107.681 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -135.02 146.21 48.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.114 -0.698 . . . . 73.02 109.114 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 11.1 t -127.49 157.7 39.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.006 -1.479 . . . . 72.13 107.006 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 49.0 m -72.16 110.28 6.51 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.402 -0.592 . . . . 73.2 109.402 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 17.6 m -55.89 123.56 14.68 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.487 -1.233 . . . . 65.34 112.2 -174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.68 168.16 9.26 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.283 -1.006 . . . . 65.33 108.283 174.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -74.02 -15.29 61.09 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.719 0.295 . . . . 74.21 111.527 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.4 t 68.83 24.51 6.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.403 1.081 . . . . 72.54 109.384 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -78.71 -50.31 11.62 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.603 -1.999 . . . . 72.33 105.603 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -107.33 -176.29 3.03 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.704 -2.332 . . . . 75.12 104.704 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 176.8 141.4 3.94 Favored Glycine 0 C--N 1.29 -2.01 0 C-N-CA 119.572 -1.299 . . . . 73.54 112.986 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 16.2 tt -147.87 83.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.561 1.172 . . . . 72.01 109.164 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.4 mt -84.73 110.45 18.79 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.644 -1.162 . . . . 73.51 110.72 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.29 177.49 6.91 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.683 -1.228 . . . . 73.23 107.683 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 371' ' ' VAL . . . -84.65 4.47 32.29 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.031 0.443 . . . . 71.33 110.148 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -64.15 -12.86 43.91 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.687 -0.688 . . . . 73.41 112.119 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -131.19 138.79 49.57 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.289 -0.634 . . . . 74.13 109.289 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 11.7 m -66.05 132.95 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 108.737 -0.838 . . . . 74.44 108.737 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 4.3 p -159.05 -76.48 0.07 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.131 0.491 . . . . 65.31 109.774 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -133.28 142.57 48.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.264 -1.754 . . . . 70.22 106.264 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 73.35 -55.04 0.68 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.504 1.521 . . . . 62.31 107.812 -174.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.49 114.06 26.16 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 106.724 -1.584 . . . . 64.34 106.724 172.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 78.1 m -133.83 -168.74 2.17 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 107.721 -1.214 . . . . 73.31 107.721 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.424 HD13 ' HB ' ' A' ' 374' ' ' ILE . 0.4 OUTLIER -60.28 151.17 28.19 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 109.839 -0.43 . . . . 74.14 109.839 -176.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.488 ' O ' ' HD3' ' A' ' 489' ' ' PRO . . . -67.37 118.08 9.68 Favored Glycine 0 CA--C 1.483 -1.919 0 N-CA-C 103.847 -3.701 . . . . 60.0 103.847 172.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.9 m -106.5 103.39 45.95 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 115.144 1.535 . . . . 64.35 115.144 -165.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 487' ' ' GLY . 2.9 Cg_exo -71.66 -63.12 0.04 OUTLIER 'Trans proline' 0 CA--C 1.586 3.119 0 C-N-CA 120.491 0.794 . . . . 70.44 110.897 162.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.486 ' HA ' ' CD ' ' A' ' 489' ' ' PRO . 19.0 m -126.34 88.5 2.85 Favored 'General case' 0 C--N 1.38 1.895 0 C-N-CA 127.362 2.265 . . . . 71.41 108.806 -3.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 97.7 m -144.51 110.98 5.6 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 110.024 -0.361 . . . . 74.03 110.024 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -102.93 103.02 13.12 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.383 -1.339 . . . . 72.05 107.383 172.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 53.3 m -83.26 118.74 23.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.133 0.492 . . . . 71.35 110.986 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.426 HG13 HG12 ' A' ' 390' ' ' VAL . 80.4 t -106.21 110.68 32.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.782 -0.822 . . . . 73.22 108.782 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 46.9 m -98.85 121.57 40.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.36 -0.978 . . . . 65.4 108.36 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.525 HD13 ' CE2' ' A' ' 456' ' ' PHE . 5.2 mp -97.9 117.52 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 121.835 0.826 . . . . 75.3 110.764 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.698 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 55.6 m-85 -98.07 122.98 41.87 Favored 'General case' 0 N--CA 1.399 -3.005 0 N-CA-C 105.709 -1.96 . . . . 74.51 105.709 170.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.12 -3.0 23.58 Favored 'General case' 0 C--N 1.258 -3.402 0 C-N-CA 119.33 -0.948 . . . . 74.43 109.114 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.29 17.77 9.24 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 126.754 2.021 . . . . 74.51 113.191 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.626 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' 0.269 2.2 p30 -85.19 -47.33 10.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 118.034 -1.466 . . . . 75.23 112.885 -178.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.464 ' O ' ' HG2' ' A' ' 452' ' ' GLU . 2.7 t-80 -133.14 17.99 4.09 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.797 -1.186 . . . . 71.32 107.797 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -82.41 148.82 28.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.541 -1.209 . . . . 63.14 111.105 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -85.42 65.31 4.01 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 115.823 -0.626 . . . . 73.11 112.333 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 43.7 pt -142.05 -179.66 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.728 -1.212 . . . . 75.22 107.728 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -72.68 107.97 5.44 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.287 -1.005 . . . . 75.41 108.287 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 17.6 p -75.99 151.27 37.26 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.87 -1.059 . . . . 74.41 112.594 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -109.0 -39.72 5.22 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.563 -1.273 . . . . 75.24 107.563 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -83.26 158.78 22.12 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.297 -1.371 . . . . 72.45 107.297 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--N 1.307 -1.264 0 C-N-CA 120.136 -0.626 . . . . 65.43 110.203 -179.183 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.638 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.647 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 109.339 -0.615 . . . . 75.54 109.339 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 60.9 m -139.18 109.58 6.54 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.92 -1.141 . . . . 65.43 107.92 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.403 ' HA ' HG11 ' A' ' 480' ' ' VAL . 93.0 mttt -121.27 120.67 35.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 112.917 0.71 . . . . 71.14 112.917 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.459 ' HB ' HD13 ' A' ' 486' ' ' LEU . 31.5 mm -102.19 127.86 55.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.054 -1.462 . . . . 75.13 107.054 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.494 ' HB2' ' OG ' ' A' ' 488' ' ' SER . 39.3 p90 -159.85 168.73 25.13 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 117.994 0.361 . . . . 74.44 111.655 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -88.55 142.31 27.81 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 110.021 -0.363 . . . . 73.04 110.021 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . 0.416 ' HB2' HG12 ' A' ' 395' ' ' ILE . 41.4 tt0 -62.87 -51.08 68.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.518 0.675 . . . . 73.32 109.444 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -108.94 146.61 33.53 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 114.972 -1.013 . . . . 72.02 110.425 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.47 -25.43 33.19 Favored Glycine 0 C--N 1.294 -1.801 0 N-CA-C 110.686 -0.965 . . . . 73.31 110.686 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 12.9 m -127.34 136.04 51.36 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.406 -0.961 . . . . 74.22 108.406 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -127.13 137.32 52.96 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.355 -0.98 . . . . 73.43 108.355 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -127.34 129.66 48.05 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.83 -1.544 . . . . 72.45 106.83 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 11.9 t -148.72 160.3 43.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.054 -1.091 . . . . 71.03 108.054 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.546 HD11 ' OD1' ' A' ' 386' ' ' ASN . 2.6 mm? -78.43 144.76 35.55 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.294 0.569 . . . . 73.44 112.202 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.596 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 5.9 tt0 -59.48 -41.82 90.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.315 -0.857 . . . . 63.44 108.742 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.546 ' OD1' HD11 ' A' ' 384' ' ' LEU . 2.4 p-10 -78.25 9.81 3.52 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.436 -0.802 . . . . 74.11 113.065 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.3 t -83.97 -28.5 27.74 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.728 -0.608 . . . . 72.03 110.524 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.81 -58.39 0.56 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.175 -0.536 . . . . 72.31 112.209 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 5.6 p -141.95 151.41 42.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.024 0.412 . . . . 71.14 110.447 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.7 p -109.14 133.41 54.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 107.755 -1.202 . . . . 74.22 107.755 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.98 128.83 48.24 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.153 0.501 . . . . 73.33 110.39 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -120.62 145.28 47.56 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.311 -1.366 . . . . 75.21 107.311 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 29.4 m -113.67 127.06 55.9 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 121.43 0.633 . . . . 74.43 111.298 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 76.5 mt -95.05 121.34 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 N-CA-C 108.02 -1.104 . . . . 73.54 108.02 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 377' ' ' GLU . 42.8 mm -99.14 119.4 47.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.48 -1.304 . . . . 75.31 107.48 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.404 ' NH1' HG23 ' A' ' 405' ' ' VAL . 23.6 ttt85 -100.48 121.36 41.42 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-O 121.482 0.658 . . . . 73.5 110.576 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 375' ' ' PHE . 22.0 mmm180 -106.59 168.07 9.42 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.449 -0.796 . . . . 75.43 109.094 175.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 105.9 -30.83 9.11 Favored Glycine 0 C--N 1.292 -1.862 0 N-CA-C 108.151 -1.98 . . . . 73.25 108.151 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 125.61 -176.08 17.36 Favored Glycine 0 N--CA 1.408 -3.23 0 CA-C-N 114.136 -1.032 . . . . 74.53 111.523 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.67 178.02 4.83 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.831 -1.544 . . . . 75.32 106.831 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.53 161.35 6.21 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.264 -1.384 . . . . 73.33 107.264 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 433' ' ' PRO . 46.2 p -94.94 -4.2 47.21 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.027 0.918 . . . . 75.34 109.905 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.59 146.39 34.2 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.725 -1.213 . . . . 71.54 107.725 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.4 m -92.06 116.55 29.03 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.183 0.516 . . . . 75.31 111.681 -171.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 66.6 t -103.44 136.5 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.046 -0.524 . . . . 75.55 109.707 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.95 121.41 34.37 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.601 0.361 . . . . 73.2 110.582 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 5.9 p -120.8 127.62 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.354 -0.98 . . . . 74.12 108.354 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.6 143.53 27.61 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.539 -0.912 . . . . 74.23 108.539 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -142.42 158.39 43.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.941 -0.474 . . . . 75.44 110.124 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -165.68 158.01 15.0 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.548 -1.279 . . . . 75.43 107.548 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.633 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 36.5 p -96.73 156.13 16.48 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.373 -0.603 . . . . 75.21 109.373 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.2 tp10 -106.35 151.26 25.1 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.96 -1.496 . . . . 75.32 106.96 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.591 ' OD1' ' HA ' ' A' ' 417' ' ' ASN . 11.2 m-20 -55.96 -39.02 71.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.698 0.799 . . . . 61.41 112.38 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 62.93 -95.56 0.13 Allowed Glycine 0 C--N 1.297 -1.614 0 CA-C-N 114.938 -1.028 . . . . 75.55 112.63 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.9 t -121.37 8.92 10.26 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.296 -0.631 . . . . 64.31 109.296 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -137.9 -160.49 1.06 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.537 -0.912 . . . . 73.51 108.537 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.591 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 6.5 m120 -137.25 122.55 19.37 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.708 0.766 . . . . 72.53 112.021 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -68.62 129.31 39.56 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.561 -1.199 . . . . 72.52 109.394 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.95 -32.66 6.87 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 111.305 -0.718 . . . . 72.33 111.305 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 t -102.24 -44.52 5.4 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.695 -0.483 . . . . 64.44 109.695 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.544 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 23.7 m-20 -87.3 -64.27 1.17 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.049 0.928 . . . . 73.11 109.659 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.717 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.16 167.0 23.24 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.147 -0.933 . . . . 65.22 110.217 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -75.47 153.52 37.53 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.632 0.583 . . . . 73.23 110.333 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.633 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.2 p90 -88.93 -15.34 34.56 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.717 -0.674 . . . . 72.45 112.126 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 442' ' ' VAL 0.296 13.5 t 32.49 66.87 0.18 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.897 1.679 . . . . 74.53 114.414 -176.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.76 131.12 34.94 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.592 -0.892 . . . . 75.25 108.592 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -173.38 -175.74 41.36 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 120.099 -1.048 . . . . 72.43 110.957 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.3 m -116.89 138.35 51.59 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 108.159 -1.052 . . . . 75.24 108.159 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.2 t -96.12 116.42 37.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.085 -1.45 . . . . 73.12 107.085 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.17 105.69 17.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.533 -0.758 . . . . 65.31 109.749 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.436 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 78.7 m-85 -82.57 98.36 8.94 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.226 -1.028 . . . . 71.34 108.226 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.1 mttm -80.58 170.18 16.66 Favored Pre-proline 0 C--N 1.296 -1.747 0 CA-C-N 114.065 -1.425 . . . . 71.54 109.948 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 50.7 Cg_exo -52.24 109.91 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.55 2.167 . . . . 54.04 113.339 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.47 -0.34 61.47 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.126 -0.943 . . . . 44.12 114.825 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.406 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 34.6 mm-40 -76.59 64.23 2.2 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.852 0.826 . . . . 74.21 113.062 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.9 m -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 121.374 0.607 . . . . 74.34 110.381 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -131.4 139.81 49.52 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.08 -0.711 . . . . 75.52 109.08 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -130.63 151.41 51.12 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.594 -0.275 . . . . 74.02 111.65 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.85 137.3 52.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.849 -0.614 . . . . 74.41 109.644 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.28 147.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.936 -1.135 . . . . 74.21 107.936 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 49.4 mtt180 -129.57 135.07 48.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 120.996 0.426 . . . . 73.43 111.215 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.576 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 61.9 t -105.34 127.3 60.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.431 -0.804 . . . . 63.32 109.409 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -70.97 130.31 19.45 Favored Glycine 0 N--CA 1.439 -1.115 0 O-C-N 124.192 0.933 . . . . 62.23 112.37 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.7 mm -94.9 134.78 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 106.916 -1.512 . . . . 75.02 106.916 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 66.6 mt -101.7 151.19 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 108.063 -1.088 . . . . 72.44 108.063 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.96 97.6 2.33 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.995 0.426 . . . . 53.43 110.234 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.45 124.75 27.63 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 103.63 -2.73 . . . . 73.1 103.63 170.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.2 97.13 4.81 Favored 'General case' 0 CA--C 1.462 -2.436 0 C-N-CA 117.733 -1.587 . . . . 72.24 110.042 174.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.722 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 28.9 mm -123.35 156.64 29.53 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.55 0 CA-C-N 111.308 -2.678 . . . . 75.5 104.171 -173.15 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -56.86 113.49 1.69 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 116.652 -2.019 . . . . 72.34 105.777 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.722 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.7 mt-10 -120.93 121.86 38.96 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 108.986 -0.746 . . . . 75.12 108.986 -170.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -132.34 109.48 9.9 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 115.176 -0.92 . . . . 74.0 108.691 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.37 35.72 26.34 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.469 1.106 . . . . 70.32 111.18 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.3 tt0 -64.02 106.63 1.08 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.318 -1.364 . . . . 63.41 107.318 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.411 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 35.2 p30 -138.57 166.15 25.07 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.449 0.643 . . . . 75.42 112.078 -175.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.604 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 21.2 p90 -140.2 -179.24 5.87 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.182 -0.917 . . . . 73.14 109.764 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 31.9 mt -123.79 136.74 54.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.134 -1.062 . . . . 74.15 108.134 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.3 124.9 60.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.418 -1.327 . . . . 75.22 107.418 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -117.71 156.34 28.4 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.572 0.545 . . . . 74.11 109.839 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 86.5 mt -113.42 140.61 47.93 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.563 -0.903 . . . . 73.3 108.563 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.7 m -146.84 173.56 12.29 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.787 -0.449 . . . . 71.04 109.787 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.4 t30 34.65 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 126.145 1.778 . . . . 75.41 113.854 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.408 HG11 HG23 ' A' ' 480' ' ' VAL . 24.7 t -98.77 132.54 43.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.142 -1.023 . . . . 73.01 108.564 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -133.53 148.23 51.65 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.237 -1.023 . . . . 73.33 108.237 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 90.9 t -127.65 129.65 70.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 120.851 0.358 . . . . 74.02 110.471 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 58.1 m -95.63 109.27 21.55 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 106.88 -1.526 . . . . 73.22 106.88 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 11.0 p -92.84 -57.2 2.73 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.195 -0.457 . . . . 74.23 112.174 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -116.94 166.6 11.98 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.872 -0.603 . . . . 65.32 110.508 -175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.42 50.61 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.301 -0.629 . . . . 74.13 109.301 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 16.3 m -55.57 127.71 31.1 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.675 -1.148 . . . . 60.41 110.021 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.45 -47.15 57.54 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.646 -0.872 . . . . 75.01 108.646 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.41 142.71 29.7 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.02 -0.733 . . . . 61.15 109.02 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 100.29 47.29 1.72 Allowed Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.032 -1.08 . . . . 51.34 111.439 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.35 117.2 45.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.901 -0.407 . . . . 74.02 109.901 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.23 93.03 9.18 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.1 -0.704 . . . . 71.25 109.1 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -106.55 72.25 0.9 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.876 0.846 . . . . 74.33 110.72 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -91.79 -16.28 27.04 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.219 -0.901 . . . . 70.44 110.219 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 481' ' ' SER . 5.9 p-10 -163.78 131.8 3.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.268 -0.878 . . . . 64.13 109.022 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -107.24 -45.14 4.18 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.915 -1.513 . . . . 73.33 106.915 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.408 HG23 HG11 ' A' ' 463' ' ' VAL . 44.7 t -138.17 -49.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 104.039 -2.578 . . . . 75.25 104.039 174.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 478' ' ' ASN . 15.1 m -127.03 -164.7 1.38 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.52 -2.4 . . . . 71.22 104.52 171.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -51.21 -52.53 43.65 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.801 0.728 . . . . 62.32 109.927 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -107.53 -79.37 0.58 Allowed 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.239 -1.763 . . . . 74.11 106.239 171.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -163.79 114.29 1.32 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.002 0.43 . . . . 75.42 111.919 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.88 125.4 16.73 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 104.246 -2.501 . . . . 73.45 104.246 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.459 HD13 ' HB ' ' A' ' 374' ' ' ILE . 1.7 mm? -92.0 176.04 6.65 Favored 'General case' 0 C--N 1.278 -2.516 0 C-N-CA 119.75 -0.78 . . . . 72.44 111.96 -170.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -70.42 -38.6 70.03 Favored Glycine 0 CA--C 1.506 -0.5 0 N-CA-C 110.397 -1.081 . . . . 74.21 110.397 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 375' ' ' PHE . 16.2 m -93.18 170.3 8.96 Favored Pre-proline 0 N--CA 1.426 -1.626 0 N-CA-C 107.239 -1.393 . . . . 70.24 107.239 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.471 ' N ' ' HA ' ' A' ' 490' ' ' SER . 2.5 Cg_endo -40.28 -48.41 4.07 Favored 'Trans proline' 0 CA--C 1.578 2.689 0 C-N-CA 123.1 2.533 . . . . 74.33 118.511 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.471 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 31.6 m -107.8 129.06 55.09 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 127.433 2.293 . . . . 63.34 108.966 2.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 90.4 m -137.08 103.97 5.29 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.024 -1.102 . . . . 73.24 108.024 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -101.84 120.6 40.64 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.131 -1.063 . . . . 73.35 108.131 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 40.8 m -89.38 119.19 29.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.235 -0.586 . . . . 50.21 109.834 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.418 HG11 HG12 ' A' ' 390' ' ' VAL . 76.6 t -106.89 107.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 108.177 -1.046 . . . . 73.45 108.177 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.411 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 85.2 m -97.45 114.32 26.15 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.72 -0.844 . . . . 74.12 108.72 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.717 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.09 116.96 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.367 -0.833 . . . . 75.42 109.169 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.544 ' O ' HD13 ' A' ' 384' ' ' LEU . 24.2 m-85 -80.26 97.79 7.11 Favored 'General case' 0 N--CA 1.382 -3.868 0 CA-C-O 122.324 1.059 . . . . 74.54 112.366 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.3 t70 -50.17 -54.87 17.85 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 111.749 -2.478 . . . . 55.41 108.493 170.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 25.8 t70 61.35 12.64 4.4 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 113.797 -1.547 . . . . 53.21 110.965 176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -95.86 -59.69 1.8 Allowed 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.992 -1.485 . . . . 75.11 106.992 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -110.41 -24.8 10.41 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.072 -1.422 . . . . 73.53 107.979 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -64.48 115.5 5.2 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 114.828 -1.078 . . . . 75.04 111.535 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -118.43 134.68 11.07 Favored Glycine 0 N--CA 1.422 -2.286 0 N-CA-C 108.843 -1.703 . . . . 70.51 108.843 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 27.1 pt -132.81 176.65 8.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 117.413 0.606 . . . . 75.35 111.473 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 507' ' ' PHE . 24.5 p90 -113.18 179.32 3.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.299 -1.371 . . . . 74.52 107.299 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.4 m -87.04 117.67 25.92 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.36 -0.607 . . . . 74.31 109.36 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.449 ' HB3' ' CE2' ' A' ' 505' ' ' PHE . 55.0 p90 -145.05 166.57 24.98 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.316 0.579 . . . . 74.44 112.547 -176.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -139.88 109.66 6.35 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.817 -1.549 . . . . 72.35 106.817 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 . . . . . 0 C--N 1.308 -1.23 0 N-CA-C 109.516 -0.55 . . . . 63.25 109.516 -177.85 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.616 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.631 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 C--O 1.239 0.545 0 CA-C-O 121.639 0.733 . . . . 71.35 110.741 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 10.1 m -97.78 175.51 6.14 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.968 -1.014 . . . . 75.55 109.646 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -141.82 130.74 23.07 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.411 -1.329 . . . . 71.41 107.411 171.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 486' ' ' LEU . 45.3 mm -110.0 120.74 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 71.23 107.98 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -152.95 173.32 15.54 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 118.455 0.57 . . . . 73.13 110.361 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -87.41 154.68 20.47 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.21 110.873 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.12 -40.68 86.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.958 -0.756 . . . . 73.33 108.958 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -126.36 162.74 24.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.492 -0.777 . . . . 72.11 111.835 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -94.46 -19.69 31.8 Favored Glycine 0 C--N 1.3 -1.436 0 CA-C-N 115.045 -0.979 . . . . 60.33 111.712 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 62.6 m -141.86 128.51 20.33 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 39.8 m-85 -114.56 136.82 52.61 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 124.261 1.024 . . . . 75.33 108.792 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 495' ' ' THR . 43.7 mt-30 -129.51 123.92 32.68 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.429 -1.323 . . . . 74.54 107.429 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 46.6 t -139.96 165.18 28.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.356 -0.979 . . . . 72.43 108.356 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.656 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 3.8 mm? -87.13 140.56 29.43 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 123.32 0.388 . . . . 73.42 111.552 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.621 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 9.1 tt0 -58.76 -42.28 88.54 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.009 -0.737 . . . . 73.12 109.009 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -73.19 -5.42 39.17 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.354 0.872 . . . . 53.41 113.354 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 57.7 m -80.73 -7.28 59.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.8 -0.562 . . . . 72.14 111.91 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.78 -56.01 3.38 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.467 -0.873 . . . . 74.35 112.819 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 21.6 p -137.58 166.77 23.09 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.979 0.419 . . . . 74.32 111.203 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.8 p -116.93 128.84 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 106.932 -1.507 . . . . 64.01 106.932 170.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.95 118.48 37.0 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.307 0.575 . . . . 71.12 110.418 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.434 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.0 mp -109.82 139.89 44.37 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.52 -1.289 . . . . 71.21 107.52 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.9 m -109.55 127.92 54.82 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 109.391 -0.596 . . . . 71.04 109.391 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 64.1 mt -99.37 125.6 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.52 -1.289 . . . . 75.53 107.52 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.6 mm -101.48 129.04 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 115.09 -0.959 . . . . 64.22 108.421 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -115.92 108.88 16.84 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.928 -1.033 . . . . 74.41 109.226 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -123.44 168.41 12.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.72 -0.673 . . . . 72.22 110.292 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 111.88 -146.99 18.06 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 109.395 -1.482 . . . . 62.24 109.395 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -78.27 139.24 22.28 Favored Glycine 0 N--CA 1.422 -2.275 0 N-CA-C 108.691 -1.764 . . . . 64.14 108.691 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -111.87 140.84 46.19 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.72 0.771 . . . . 72.33 109.742 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.49 152.18 45.41 Favored 'General case' 0 C--N 1.267 -2.982 0 N-CA-C 105.949 -1.871 . . . . 70.22 105.949 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 44.4 p -81.9 6.12 16.83 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.406 0.521 . . . . 74.44 112.406 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -68.9 143.41 54.49 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.177 -0.675 . . . . 71.13 109.177 175.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 9.4 m -82.37 119.34 24.03 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.751 -0.659 . . . . 70.11 109.38 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.5 t -100.37 141.86 16.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.404 -0.962 . . . . 73.24 108.404 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 54.2 m-85 -128.38 119.77 25.67 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 122.735 0.414 . . . . 64.23 109.948 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.07 124.45 72.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.532 -0.914 . . . . 73.45 108.532 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 461' ' ' SER . 14.7 t70 -90.05 140.46 29.62 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 110.1 -0.333 . . . . 72.53 110.1 -177.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.95 169.1 18.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.179 -0.304 . . . . 74.54 110.179 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 411' ' ' THR . 63.5 ttt-85 -167.52 167.22 13.77 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 105.825 -1.917 . . . . 73.53 105.825 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.617 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 62.2 p -95.55 168.2 10.84 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.692 -0.855 . . . . 75.12 108.692 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.7 tp10 -106.51 150.74 25.81 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.613 0.721 . . . . 71.32 109.29 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.53 5.39 51.01 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 125.915 1.686 . . . . 55.42 110.679 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -28.73 -93.39 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.74 2.114 . . . . 61.14 116.953 -174.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 455' ' ' ASN . 5.2 t -93.74 -7.06 44.68 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.848 0.832 . . . . 74.03 110.56 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.734 ' HB2' ' OH ' ' A' ' 422' ' ' TYR . . . -151.89 153.22 33.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.409 -1.7 . . . . 71.24 106.409 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.19 145.86 33.61 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.617 0.722 . . . . 73.22 112.138 -164.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -82.93 148.71 27.48 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.072 -0.967 . . . . 71.42 108.534 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.94 79.05 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.454 -1.058 . . . . 60.12 110.454 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 38.3 m -149.44 -58.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.697 -0.483 . . . . 71.12 109.697 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.497 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 8.0 m-20 -86.23 -55.0 4.12 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.408 1.099 . . . . 71.24 108.934 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.734 ' OH ' ' HB2' ' A' ' 416' ' ' ALA . 0.1 OUTLIER -141.67 164.79 29.26 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.948 -1.024 . . . . 75.42 111.07 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.07 160.56 31.08 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.352 -0.84 . . . . 73.32 108.842 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.617 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -100.07 -20.14 16.17 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 122.936 0.495 . . . . 72.42 112.152 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.479 ' CG2' HG23 ' A' ' 442' ' ' VAL 0.323 10.1 t 39.04 64.55 0.78 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.351 1.861 . . . . 72.5 114.239 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.67 112.33 15.67 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.589 -1.187 . . . . 71.33 109.274 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -158.25 -178.62 32.46 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 110.443 -1.063 . . . . 73.14 110.443 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 17.5 m -122.63 139.72 53.62 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.358 -1.349 . . . . 73.1 107.358 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 45.0 t -95.56 118.8 42.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.8 -0.815 . . . . 74.1 108.8 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 406' ' ' PHE . 26.0 t -91.11 112.18 24.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.654 -1.157 . . . . 71.25 108.511 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 404' ' ' THR . 60.5 m-85 -97.61 101.75 13.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.69 -0.485 . . . . 71.51 109.69 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.3 mttm -85.21 172.5 8.68 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.071 -0.513 . . . . 74.43 109.979 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.9 Cg_exo -56.09 131.83 48.3 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.467 2.111 . . . . 74.35 111.649 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 87.33 -14.89 56.66 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 116.027 -0.533 . . . . 73.3 113.77 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -81.07 63.57 5.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.607 0.717 . . . . 74.0 112.391 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.1 m -60.9 -22.22 64.12 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.273 -1.33 . . . . 75.01 110.366 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -131.17 139.64 49.79 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.951 -1.129 . . . . 74.52 107.951 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -131.46 154.35 48.8 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 122.793 0.437 . . . . 73.14 110.068 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.27 132.48 50.33 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.787 -0.765 . . . . 75.15 111.076 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.5 pt -119.39 146.72 23.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.594 -0.891 . . . . 74.32 108.594 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 90.2 mtt180 -130.27 132.88 46.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.343 -0.543 . . . . 75.24 111.788 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.479 HG23 ' CG2' ' A' ' 425' ' ' THR . 62.1 t -104.71 120.56 55.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.041 -0.981 . . . . 74.41 108.451 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -71.98 136.52 24.2 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 121.134 -0.555 . . . . 71.42 112.241 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 35.5 mm -97.93 132.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.83 -1.174 . . . . 72.34 107.83 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 92.4 mt -91.57 151.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.477 -0.934 . . . . 75.35 108.477 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.29 92.54 5.15 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 120.981 0.419 . . . . 73.22 110.015 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.07 96.49 6.35 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.498 -2.778 . . . . 60.43 103.498 166.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -99.59 81.3 2.48 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 116.687 -2.005 . . . . 73.42 110.454 -173.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.6 mm -127.37 155.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.09 0 CA-C-N 110.383 -3.099 . . . . 74.45 103.993 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -56.36 114.36 1.96 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.925 -1.509 . . . . 73.14 106.925 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.7 mt-10 -111.89 128.12 56.05 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 108.259 -1.015 . . . . 73.11 108.259 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -124.27 103.85 8.47 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 115.599 -0.728 . . . . 72.45 110.086 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.82 60.38 3.58 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 125.076 1.485 . . . . 75.04 113.078 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.21 114.55 20.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.693 0.758 . . . . 75.1 109.516 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 415' ' ' THR . 3.4 p-10 -136.74 153.44 50.86 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 114.949 -1.023 . . . . 73.11 109.799 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.6 ' HD2' ' CZ ' ' A' ' 422' ' ' TYR . 20.9 p90 -136.78 -177.94 4.96 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.861 -0.609 . . . . 74.3 110.195 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 57.2 mt -121.17 139.71 52.98 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.983 -1.117 . . . . 74.52 107.983 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 491' ' ' THR . 47.5 t -107.65 110.77 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.579 -1.267 . . . . 73.22 107.579 174.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -102.78 137.83 40.47 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.591 -0.522 . . . . 64.15 109.591 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.83 126.66 42.14 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.592 -0.892 . . . . 73.23 108.592 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 408' ' ' ASP . 17.4 m -147.04 148.52 31.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.933 -0.765 . . . . 71.41 108.933 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.5 93.6 0.06 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.974 1.31 . . . . 71.52 110.575 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.15 137.07 39.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.378 -1.341 . . . . 72.04 107.378 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -131.96 150.25 52.21 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 123.609 0.764 . . . . 75.0 108.991 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.55 131.25 68.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.957 -1.498 . . . . 73.12 106.957 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 11.6 t -86.93 126.04 34.43 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.129 -0.693 . . . . 71.22 109.129 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' SER . . . . . 0.431 ' HB2' ' HB1' ' A' ' 477' ' ' ALA . 13.0 t -90.98 -146.21 0.19 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.286 -1.005 . . . . 72.33 108.286 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.28 177.55 2.27 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 123.592 0.757 . . . . 64.34 109.631 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -71.49 -22.45 61.8 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 122.122 -0.361 . . . . 71.32 111.928 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 14.5 m -70.29 106.41 3.34 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 121.234 0.54 . . . . 74.13 109.546 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -103.71 3.98 34.83 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.754 -0.657 . . . . 64.14 110.697 -176.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -81.39 132.26 35.32 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.974 -0.75 . . . . 74.22 108.974 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 80.76 -170.37 53.08 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.563 -1.015 . . . . 54.43 110.563 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 43.0 mm -119.11 125.13 74.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.616 -0.883 . . . . 71.22 108.616 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -136.21 104.5 5.67 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.527 0.679 . . . . 74.32 109.305 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -54.87 108.66 0.42 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.13 -1.395 . . . . 74.51 113.104 -176.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 467' ' ' SER . . . -106.02 12.52 30.35 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.969 -1.014 . . . . 63.53 108.355 175.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' A' ' 481' ' ' SER . 30.4 t30 -54.95 93.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.307 1.443 . . . . 73.32 113.344 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -102.45 -80.25 0.51 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.689 -1.967 . . . . 75.52 105.689 169.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 28.8 m -94.62 116.37 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.853 -0.795 . . . . 72.42 108.853 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' SER . . . . . 0.428 ' HB3' ' OD1' ' A' ' 478' ' ' ASN . 32.7 t 170.73 -74.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 125.838 1.655 . . . . 73.24 107.823 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -120.36 -2.6 10.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.309 -0.405 . . . . 52.04 111.868 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -110.0 -69.06 0.88 Allowed 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 104.981 -2.229 . . . . 75.01 104.981 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -94.81 161.53 14.13 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 105.543 -2.021 . . . . 71.42 105.543 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 61.7 m -137.26 -169.24 2.46 Favored 'General case' 0 C--N 1.255 -3.513 0 N-CA-C 107.32 -1.363 . . . . 55.55 107.32 -175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.416 HD13 ' HB ' ' A' ' 374' ' ' ILE . 2.0 mm? -68.9 157.42 36.64 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.549 -0.86 . . . . 74.11 108.903 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -65.49 -30.79 78.35 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-O 121.477 0.487 . . . . 75.34 111.953 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.512 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 14.6 m -124.06 -173.53 0.29 Allowed Pre-proline 0 C--N 1.281 -2.401 0 N-CA-C 104.377 -2.453 . . . . 75.31 104.377 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 488' ' ' SER . 4.1 Cg_exo -34.63 -51.9 0.66 Allowed 'Trans proline' 0 CA--C 1.585 3.028 0 C-N-CA 122.977 2.452 . . . . 63.55 117.865 172.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 42.3 m -113.7 136.48 52.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.82 2.448 . . . . 64.34 107.246 1.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 45.5 m -131.94 117.48 18.51 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 116.22 -0.445 . . . . 73.04 110.692 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.27 131.44 52.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.035 -0.728 . . . . 74.3 109.035 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 77.1 m -86.42 126.91 34.72 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.592 -0.892 . . . . 74.01 108.592 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 390' ' ' VAL . 77.0 t -111.94 107.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.674 -0.862 . . . . 75.2 108.674 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 23.6 m -101.21 111.22 23.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.13 -1.063 . . . . 74.22 108.13 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -88.49 123.68 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.595 0.712 . . . . 72.33 111.06 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -82.75 107.2 15.2 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-O 122.344 1.069 . . . . 71.51 110.209 173.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.61 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 0.1 OUTLIER -58.8 -40.42 84.03 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 112.288 -2.233 . . . . 74.11 112.766 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.535 ' HB2' ' CD1' ' A' ' 384' ' ' LEU . 20.4 t70 71.24 -2.06 2.51 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 124.63 1.172 . . . . 75.24 112.454 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.622 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 48.3 m-20 -101.86 -40.6 6.84 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.461 -0.57 . . . . 74.54 109.461 -174.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -145.57 -26.13 0.46 Allowed 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.857 0.863 . . . . 73.51 111.583 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 451' ' ' GLU . . . -71.77 89.69 1.05 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.015 0.746 . . . . 70.43 113.015 -176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 76.09 -68.31 2.32 Favored Glycine 0 CA--C 1.502 -0.777 0 N-CA-C 110.874 -0.89 . . . . 74.51 110.874 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.482 HG13 ' HA ' ' A' ' 499' ' ' ASP . 6.4 pt -89.33 137.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.2 -1.407 . . . . 74.24 107.2 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -146.95 155.15 42.05 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 121.043 -0.263 . . . . 73.04 110.849 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.5 t -155.43 -170.87 3.59 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.756 -1.201 . . . . 71.43 107.756 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 508' ' ' GLU . 19.1 p90 -73.62 157.53 36.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.146 -0.687 . . . . 73.44 109.146 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 507' ' ' PHE . 36.6 mt-10 70.81 96.08 0.07 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.293 0.996 . . . . 73.35 109.22 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--N 1.307 -1.246 0 CA-C-N 116.413 -0.358 . . . . 73.12 110.353 -178.11 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.622 'CA ' ' OD2' ' A' ' 500' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.615 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 122.424 1.107 . . . . 73.03 112.34 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 480' ' ' VAL . 69.9 m -156.84 107.49 2.34 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.057 -0.974 . . . . 74.44 109.405 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 96.4 mttt -92.91 148.64 21.84 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 123.392 0.432 . . . . 73.41 110.853 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.691 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 38.8 mm -125.12 109.16 21.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.572 -0.899 . . . . 73.44 108.572 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -145.71 162.78 36.79 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.425 -0.51 . . . . 74.44 110.85 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.1 151.42 28.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 110.122 -0.325 . . . . 73.02 110.122 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -59.77 4.52 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.902 -1.518 . . . . 72.5 106.902 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 15.3 mm100 -102.55 173.11 6.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.604 -0.726 . . . . 74.44 111.007 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.26 -40.36 1.95 Allowed Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.943 -1.026 . . . . 71.14 110.651 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.0 m -122.68 126.11 46.94 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.876 -0.787 . . . . 73.55 108.876 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 77.5 m-85 -115.81 142.79 46.29 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.48 -0.933 . . . . 73.15 108.48 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 495' ' ' THR . 14.0 mp0 -123.53 146.14 48.33 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.251 -1.388 . . . . 74.11 107.251 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . 0.564 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -149.77 151.29 33.35 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.982 -1.118 . . . . 75.14 107.982 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 497' ' ' PHE . 0.4 OUTLIER -80.91 145.03 31.5 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.607 -0.886 . . . . 73.12 108.607 176.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.634 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 15.0 tt0 -58.97 -29.95 67.57 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.55 0.69 . . . . 71.03 110.064 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -80.94 -1.44 43.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.455 -0.793 . . . . 72.5 112.558 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.45 -22.04 48.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.261 0.553 . . . . 64.01 111.182 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 91.6 -59.7 2.92 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.781 -0.723 . . . . 74.32 111.522 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.4 p -136.27 155.24 50.37 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.615 0.245 . . . . 74.41 110.793 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 N-CA-C 107.888 -1.153 . . . . 73.11 107.888 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.44 124.42 40.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.125 0.488 . . . . 75.02 110.592 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.0 mp -118.74 137.41 53.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.248 -1.389 . . . . 71.22 107.248 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.9 m -104.49 134.4 47.74 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.703 -0.48 . . . . 72.3 109.703 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 80.1 mt -103.85 126.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.57 -1.27 . . . . 73.42 107.57 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 44.9 mm -103.93 121.53 55.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.323 -0.991 . . . . 70.11 108.323 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 55.7 ttt180 -105.71 122.17 45.51 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.492 -0.777 . . . . 74.15 109.557 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -139.12 167.53 21.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.822 -0.626 . . . . 74.33 110.762 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 142.43 -28.56 2.19 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.687 -0.768 . . . . 63.45 111.845 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 167.02 -132.9 2.74 Favored Glycine 0 C--N 1.298 -1.577 0 N-CA-C 109.599 -1.4 . . . . 71.25 109.599 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . 0.511 ' O ' HD21 ' A' ' 401' ' ' LEU . 2.3 p-10 -139.98 121.98 15.66 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 108.671 -0.863 . . . . 74.02 108.671 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . 0.511 HD21 ' O ' ' A' ' 400' ' ' ASP . 35.1 mt -146.12 125.47 13.09 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.214 -0.903 . . . . 73.1 109.351 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 5.6 p -87.44 -0.27 56.56 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.025 0.917 . . . . 75.04 109.11 174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.38 138.12 58.25 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.275 -1.33 . . . . 65.23 109.606 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 466' ' ' SER . 0.8 OUTLIER -80.77 112.33 18.05 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 124.073 0.858 . . . . 73.55 110.296 -176.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.78 132.62 51.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.793 -0.817 . . . . 64.14 108.793 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 36.8 m-85 -115.62 129.3 56.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.192 0.52 . . . . 72.42 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.78 133.86 64.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.197 -1.409 . . . . 65.11 107.197 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -99.77 124.64 45.24 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.086 -0.709 . . . . 65.03 109.086 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 11.6 p90 -110.64 147.47 34.22 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.172 -0.677 . . . . 70.34 109.172 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 48.6 ttp180 -157.21 150.44 23.83 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.825 -1.176 . . . . 72.1 107.825 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 63.7 p -96.87 171.0 8.78 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.552 -0.459 . . . . 73.05 110.24 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 9.4 tp10 -137.57 158.21 44.88 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.166 -0.679 . . . . 75.25 109.166 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -31.14 -62.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.712 2.405 . . . . 72.32 113.147 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.29 -74.52 0.39 Allowed Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.069 -0.968 . . . . 72.32 111.019 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 8.8 t -154.87 16.72 0.44 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.122 -1.066 . . . . 71.02 108.122 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.8 -169.44 3.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.539 -0.755 . . . . 64.25 110.371 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.85 120.98 27.25 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.325 -0.621 . . . . 71.02 109.325 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -81.47 124.55 29.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.714 0.769 . . . . 71.14 110.553 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.49 32.0 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 109.43 -1.468 . . . . 71.21 109.43 -173.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 14.9 m -110.54 -58.55 2.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.985 -0.746 . . . . 73.12 108.985 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.556 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 14.3 m-20 -82.71 -58.26 2.97 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 122.011 0.91 . . . . 74.3 109.677 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.688 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.34 158.99 43.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.635 -0.876 . . . . 71.13 108.635 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.82 144.88 45.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.879 -0.785 . . . . 73.32 108.879 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.461 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 17.7 p90 -79.4 -18.45 52.28 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 113.054 0.761 . . . . 74.1 113.054 -173.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.491 HG21 HG21 ' A' ' 442' ' ' VAL 0.268 11.0 t 40.06 55.99 2.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 127.198 2.199 . . . . 74.43 115.311 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 1.5 pp20? -78.41 131.15 36.81 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 118.952 -1.099 . . . . 75.02 108.944 173.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -164.4 170.13 39.46 Favored Glycine 0 CA--C 1.46 -3.365 0 N-CA-C 109.93 -1.268 . . . . 72.35 109.93 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.5 m -111.35 131.63 55.02 Favored 'General case' 0 N--CA 1.394 -3.242 0 C-N-CA 119.739 -0.784 . . . . 72.14 108.888 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.67 125.49 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.941 -1.503 . . . . 75.54 106.941 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 406' ' ' PHE . 19.5 t -103.72 117.11 48.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.614 -0.884 . . . . 75.53 108.614 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.46 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 65.1 m-85 -94.91 105.02 16.91 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.188 0.518 . . . . 72.54 110.689 177.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.497 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 0.2 OUTLIER -90.12 167.64 16.47 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 114.652 -1.158 . . . . 75.43 110.315 -176.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 32.0 Cg_exo -57.03 115.09 2.24 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.872 2.381 . . . . 75.45 108.989 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.02 -38.04 3.32 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 111.523 -0.631 . . . . 72.12 111.523 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -85.97 62.37 7.4 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.717 0.77 . . . . 74.42 110.595 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 14.1 t -84.08 9.58 12.21 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 115.134 -0.939 . . . . 72.23 109.878 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -140.55 137.05 33.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -135.47 153.29 51.8 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.358 0.411 . . . . 75.35 111.193 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.26 128.54 55.67 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.537 -0.912 . . . . 71.51 108.537 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.91 149.56 19.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.857 -1.164 . . . . 73.42 107.857 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 79.9 mtm180 -133.28 143.36 49.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.174 0.511 . . . . 74.02 111.265 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -109.92 124.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.394 -0.965 . . . . 72.24 108.394 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -77.28 127.09 8.17 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.559 -0.616 . . . . 74.52 111.559 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 35.7 mm -89.97 134.74 28.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.162 -1.051 . . . . 63.44 108.162 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.2 mt -96.77 147.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.274 -1.38 . . . . 74.23 107.274 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -78.97 86.68 4.82 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.416 -0.513 . . . . 75.2 111.925 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.38 126.81 55.69 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 103.338 -2.838 . . . . 73.41 103.338 169.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 9.2 t70 -129.18 93.26 3.54 Favored 'General case' 0 CA--C 1.463 -2.366 0 CA-C-O 123.438 1.59 . . . . 74.11 109.785 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.748 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 51.8 mm -125.25 158.22 33.59 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.161 0 CA-C-N 111.283 -2.689 . . . . 75.5 104.608 -171.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . 0.47 ' HA ' ' CB ' ' A' ' 501' ' ' HIS . 98.2 m-85 -51.23 114.39 1.19 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.784 -1.932 . . . . 74.54 105.784 166.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.748 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 36.2 mt-10 -121.74 94.74 4.41 Favored 'General case' 0 CA--C 1.468 -2.21 0 CA-C-O 122.117 0.961 . . . . 71.44 111.476 -169.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.01 102.06 13.76 Favored 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 114.26 -1.336 . . . . 72.02 110.146 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.82 57.56 5.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.787 -1.552 . . . . 75.22 112.953 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.427 ' OE2' ' HG2' ' A' ' 451' ' ' GLU . 85.2 mt-10 -71.01 113.22 7.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.379 0.609 . . . . 73.12 109.836 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -137.47 160.36 39.34 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.874 -0.603 . . . . 75.44 110.401 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.563 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.3 p90 -140.37 177.25 8.13 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.489 -0.778 . . . . 73.14 109.735 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -117.69 138.07 52.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.335 -0.987 . . . . 71.43 108.335 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.28 120.58 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.896 -1.52 . . . . 74.44 106.896 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -114.3 149.12 36.45 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.641 0.588 . . . . 74.43 109.683 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.72 127.45 53.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 20.3 m -142.01 178.71 7.34 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.373 -0.602 . . . . 72.22 109.373 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.8 t30 50.37 86.11 0.03 OUTLIER 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.778 1.231 . . . . 75.04 113.238 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 53.4 t -84.89 116.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.55 -0.907 . . . . 75.5 108.55 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 26.3 tptp -116.89 133.33 56.14 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.605 -1.998 . . . . 74.54 105.605 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.39 138.65 51.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.439 -0.904 . . . . 74.44 111.514 -173.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' SER . . . . . 0.457 ' HB3' ' HB ' ' A' ' 404' ' ' THR . 33.9 t -137.64 150.62 47.54 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-O 121.348 0.594 . . . . 55.31 109.725 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 70.1 m -122.19 19.91 10.65 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.483 -0.932 . . . . 63.03 108.483 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.31 9.04 0.5 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.065 0.946 . . . . 74.42 112.797 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.27 -7.08 55.38 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.803 -0.814 . . . . 75.43 108.803 173.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 32.6 t -149.64 150.29 31.95 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 104.99 -2.226 . . . . 74.44 104.99 175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.87 -23.68 25.17 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.753 -0.779 . . . . 74.53 111.509 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -109.67 114.42 28.01 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.624 -0.51 . . . . 63.34 109.624 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 134.07 42.81 0.14 Allowed Glycine 0 C--N 1.299 -1.485 0 C-N-CA 120.992 -0.623 . . . . 74.43 111.657 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 41.5 mm -77.82 87.89 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.354 -0.98 . . . . 73.5 108.354 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 54.1 mt -86.84 -54.9 4.1 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.41 -0.814 . . . . 75.13 111.635 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 65.82 10.29 6.73 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.862 1.265 . . . . 71.43 112.1 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -104.91 21.28 17.3 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.228 1.013 . . . . 71.21 108.435 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -88.52 36.84 0.8 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.204 -1.406 . . . . 62.3 107.204 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -65.03 154.86 36.53 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 122.106 0.955 . . . . 73.24 113.312 -172.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 372' ' ' SER . 38.2 t -68.03 -45.42 83.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 113.058 -1.883 . . . . 74.32 109.955 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 43.6 t -128.47 -158.07 0.86 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.661 -1.607 . . . . 74.4 106.661 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -52.53 -54.8 27.87 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.264 -1.013 . . . . 62.12 108.264 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.27 -69.96 0.83 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 105.7 -1.963 . . . . 72.31 105.7 171.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -162.24 128.76 3.64 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.724 0.773 . . . . 73.24 111.299 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 36.8 t -174.4 129.25 0.35 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 102.619 -3.104 . . . . 75.41 102.619 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.691 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 2.6 mm? -72.44 -45.25 60.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 113.715 1.005 . . . . 73.01 113.715 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 144.77 -38.26 1.29 Allowed Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 107.0 -2.44 . . . . 74.3 107.0 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.467 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 15.6 m -118.32 175.05 2.26 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 103.603 -2.74 . . . . 73.53 103.603 169.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 488' ' ' SER . 3.6 Cg_exo -36.37 -52.83 1.11 Allowed 'Trans proline' 0 CA--C 1.583 2.949 0 C-N-CA 123.38 2.72 . . . . 70.11 118.491 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 27.8 m -111.8 125.72 54.3 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 126.983 2.113 . . . . 74.45 107.863 1.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 40.1 m -124.09 114.28 19.49 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 115.625 -0.716 . . . . 74.13 109.105 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.92 33.56 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.19 -1.041 . . . . 71.31 108.19 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 24.3 m -105.94 120.5 41.92 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.676 -0.41 . . . . 71.43 109.972 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . . . . . . . . . 73.0 t -107.12 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.93 -0.767 . . . . 64.35 108.93 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 37.7 m -104.36 117.98 35.51 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.813 -0.81 . . . . 73.22 108.813 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.688 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -97.08 118.9 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 109.341 -0.614 . . . . 75.31 109.341 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.568 ' O ' HD12 ' A' ' 384' ' ' LEU . 6.1 m-85 -83.25 105.22 14.04 Favored 'General case' 0 N--CA 1.389 -3.494 0 CA-C-N 115.513 -0.767 . . . . 74.22 110.963 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.667 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.2 t70 -56.6 -57.51 12.07 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 113.088 -1.869 . . . . 75.01 109.348 173.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.7 t70 69.87 0.82 3.19 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.922 1.289 . . . . 72.21 111.246 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.28 -62.64 1.36 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.834 0.826 . . . . 71.01 109.469 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.47 ' CB ' ' HA ' ' A' ' 450' ' ' PHE . 88.5 m-70 -130.77 25.81 5.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.423 -1.262 . . . . 73.41 107.878 -176.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 451' ' ' GLU . . . -67.85 -18.92 64.97 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 114.924 -1.034 . . . . 63.11 111.309 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 74.94 36.36 47.19 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 110.044 -1.222 . . . . 54.34 110.044 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.38 161.19 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 121.315 0.579 . . . . 73.45 109.568 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.25 -171.43 2.45 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 103.799 -2.667 . . . . 74.31 103.799 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 38.0 m -74.66 92.01 2.4 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 119.33 0.968 . . . . 71.45 110.208 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.42 138.87 40.18 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.612 -1.255 . . . . 74.2 107.612 177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -90.7 125.35 35.65 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.028 -0.73 . . . . 74.43 109.028 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.507 0 N-CA-C 108.168 -1.049 . . . . 74.15 108.168 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.667 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.626 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.407 ' O ' ' HA3' ' A' ' 398' ' ' GLY . 59.5 t . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.707 -0.849 . . . . 73.34 108.707 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 66.9 m -73.14 104.46 4.22 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 123.613 0.571 . . . . 53.42 110.755 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.3 mmtp -92.79 119.35 32.06 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.251 -1.018 . . . . 72.03 108.251 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.477 ' HB ' HD12 ' A' ' 486' ' ' LEU . 25.9 mm -95.18 119.12 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.588 -1.187 . . . . 74.23 108.434 -176.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 160.93 42.49 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.925 0.33 . . . . 71.33 110.503 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.78 148.64 29.95 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.609 -0.515 . . . . 74.44 109.609 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.3 -43.83 85.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.586 -0.524 . . . . 74.03 109.586 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -115.22 176.29 5.13 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.885 -0.598 . . . . 74.1 110.676 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -110.36 -19.17 8.11 Favored Glycine 0 C--N 1.291 -1.964 0 CA-C-N 115.063 -0.971 . . . . 33.42 110.801 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 59.8 m -140.06 135.24 32.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.117 -1.068 . . . . 74.01 108.117 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 49.8 m-85 -125.41 141.2 52.2 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.076 -1.083 . . . . 74.23 108.076 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.61 132.67 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.505 -1.294 . . . . 74.32 107.505 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 15.2 t -151.81 165.52 34.23 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.149 -1.056 . . . . 73.22 108.149 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.511 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 2.4 mm? -81.03 143.33 32.57 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.216 0.531 . . . . 71.14 111.095 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.627 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 16.2 tt0 -59.94 -39.4 85.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.339 -0.846 . . . . 73.35 109.784 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -73.65 -4.4 34.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.534 -0.757 . . . . 75.13 112.474 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 89.1 m -71.11 -22.33 62.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 122.109 -0.369 . . . . 52.4 111.953 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 94.68 -50.11 2.04 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.706 -0.759 . . . . 43.44 111.565 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 18.9 p -139.28 160.4 39.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.911 -0.403 . . . . 65.12 109.911 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.0 p -114.83 133.8 59.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.281 -1.377 . . . . 74.2 107.281 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.41 125.83 48.11 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.201 0.524 . . . . 70.15 110.187 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.424 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.5 mp -116.52 153.68 31.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.121 -1.437 . . . . 74.35 107.121 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 28.1 m -120.6 126.93 51.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.335 0.588 . . . . 72.22 110.816 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.7 mt -100.69 120.27 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 108.204 -1.035 . . . . 64.11 108.204 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.4 HG23 ' HG2' ' A' ' 397' ' ' ARG . 46.2 mm -97.89 114.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.892 -1.049 . . . . 75.35 108.273 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.695 ' HB3' ' O ' ' A' ' 436' ' ' THR . 56.0 ttt180 -100.68 112.15 24.5 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 108.232 -1.025 . . . . 74.52 108.232 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 397' ' ' ARG . 4.3 mmp_? -113.55 161.64 17.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.518 -0.549 . . . . 75.35 109.518 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 371' ' ' VAL . . . 106.89 2.09 36.54 Favored Glycine 0 C--N 1.304 -1.21 0 C-N-CA 120.262 -0.971 . . . . 73.24 111.8 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 158.6 105.07 0.21 Allowed Glycine 0 N--CA 1.424 -2.117 0 C-N-CA 121.025 -0.607 . . . . 74.24 112.165 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -81.55 119.67 24.06 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 104.837 -2.283 . . . . 55.4 104.837 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 53.0 mt -148.45 159.34 44.13 Favored 'General case' 0 C--N 1.269 -2.892 0 C-N-CA 119.848 -0.741 . . . . 75.15 111.745 -167.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 433' ' ' PRO . 3.0 p -88.29 -3.98 58.76 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 114.455 -1.248 . . . . 72.24 110.159 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.02 135.81 49.72 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.667 -1.152 . . . . 74.32 110.57 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 31.9 m -89.9 112.71 24.16 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.218 -0.901 . . . . 75.24 111.282 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.23 144.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.065 -0.97 . . . . 62.13 108.48 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -119.7 132.08 55.57 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.905 0.383 . . . . 74.11 110.027 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 429' ' ' VAL . 3.7 p -132.78 131.68 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.834 -1.543 . . . . 71.0 106.834 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -98.97 136.68 38.6 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.802 -0.561 . . . . 74.13 111.492 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -135.83 165.78 24.83 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.982 0.42 . . . . 73.21 110.536 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -167.12 155.53 9.78 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.579 -1.637 . . . . 73.3 106.579 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.669 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 26.1 p -96.62 160.81 14.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.437 -0.579 . . . . 72.42 109.437 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 16.0 tp10 -106.76 169.86 8.28 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.523 -1.288 . . . . 73.33 107.523 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 8.6 p-10 -63.03 -39.43 94.73 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.992 0.901 . . . . 64.42 110.255 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 72.21 -98.86 0.84 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.397 -1.274 . . . . 74.34 110.475 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.577 HG21 ' O ' ' A' ' 455' ' ' ASN . 10.8 t -122.34 -2.27 9.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.339 1.066 . . . . 74.34 108.65 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.534 ' HB1' ' OH ' ' A' ' 422' ' ' TYR . . . -124.72 -153.28 0.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.816 -1.179 . . . . 71.4 107.816 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -133.93 116.11 15.2 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 118.199 0.454 . . . . 72.1 110.019 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.69 24.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.819 -0.808 . . . . 74.22 108.819 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.13 -19.27 25.13 Favored Glycine 0 C--N 1.288 -2.099 0 N-CA-C 110.539 -1.024 . . . . 72.43 110.539 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 m -115.84 -51.05 2.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.82 0.343 . . . . 73.52 110.568 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.599 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 16.3 m-20 -79.98 -64.57 1.16 Allowed 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 122.369 1.081 . . . . 72.43 108.819 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.645 ' CE2' HD11 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -134.29 162.6 31.73 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.19 -1.368 . . . . 74.44 107.899 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -82.82 154.38 24.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.486 0.66 . . . . 64.32 111.792 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.669 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.5 OUTLIER -79.1 -12.11 60.0 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.16 -0.927 . . . . 72.22 113.014 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.432 HG23 HG21 ' A' ' 442' ' ' VAL 0.253 13.3 t 33.64 69.47 0.14 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.734 1.614 . . . . 72.12 113.29 -177.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.26 129.48 34.5 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.254 -0.884 . . . . 75.11 109.647 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -174.11 175.59 46.57 Favored Glycine 0 N--CA 1.405 -3.425 0 C-N-CA 119.783 -1.199 . . . . 63.22 111.025 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 7.9 m -112.81 142.26 45.66 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.247 -1.39 . . . . 72.21 107.247 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 407' ' ' VAL . 22.4 t -95.16 111.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.528 -1.656 . . . . 75.3 106.528 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.3 106.51 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 115.036 -0.984 . . . . 75.44 109.093 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 404' ' ' THR . 70.7 m-85 -77.61 94.26 4.34 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.268 -0.878 . . . . 74.43 109.887 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -73.98 163.77 65.99 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.971 -0.559 . . . . 72.44 111.021 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 48.1 Cg_exo -51.28 113.84 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.47 2.113 . . . . 72.03 112.686 175.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.74 -24.0 32.95 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.832 -0.699 . . . . 65.11 111.488 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.444 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 9.7 mm-40 -86.06 61.28 6.74 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.754 -0.832 . . . . 74.23 108.754 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.695 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 12.4 m -67.45 -33.73 75.74 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 107.613 -1.254 . . . . 73.35 107.613 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.26 132.8 50.13 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 106.607 -1.627 . . . . 74.21 106.607 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -118.73 147.53 43.75 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.118 0.485 . . . . 73.14 111.481 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.99 132.29 54.29 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 115.075 -0.966 . . . . 74.51 108.512 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.0 pt -119.24 146.78 23.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.435 -0.95 . . . . 74.35 108.435 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 85.9 mtt180 -126.82 141.16 51.9 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-O 121.698 0.761 . . . . 74.32 111.942 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.656 HG12 ' CZ ' ' A' ' 456' ' ' PHE . 57.6 t -109.08 126.37 66.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.384 -1.339 . . . . 74.53 107.384 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.49 123.53 6.79 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.948 -0.861 . . . . 44.32 110.948 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.57 132.92 31.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.051 -1.833 . . . . 75.22 106.051 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -94.32 149.27 4.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 105.134 -2.172 . . . . 75.23 105.134 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.66 85.79 4.67 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.801 -0.76 . . . . 65.13 110.733 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.25 112.92 23.9 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.075 -2.195 . . . . 73.11 105.075 172.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.638 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 14.4 t0 -118.0 93.61 4.2 Favored 'General case' 0 C--N 1.275 -2.671 0 C-N-CA 117.274 -1.771 . . . . 74.11 109.538 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 44.6 mm -125.9 156.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.86 0 CA-C-N 111.693 -2.503 . . . . 71.41 105.423 -172.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -49.45 115.03 1.18 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.458 -1.682 . . . . 75.4 106.458 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.631 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 30.2 mt-10 -129.35 121.42 27.42 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 109.621 -0.511 . . . . 74.14 109.621 -172.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -134.01 113.9 12.64 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.661 -1.237 . . . . 73.42 107.661 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 20.8 t70 56.74 54.88 6.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.518 1.127 . . . . 71.03 110.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -86.58 98.63 11.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.332 -1.358 . . . . 72.22 107.332 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.577 ' O ' HG21 ' A' ' 415' ' ' THR . 0.0 OUTLIER -131.85 143.4 50.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 122.108 0.956 . . . . 71.01 113.274 -176.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.656 ' CZ ' HG12 ' A' ' 442' ' ' VAL . 23.9 p90 -116.74 177.04 4.84 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.742 -1.117 . . . . 74.0 109.453 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -121.94 136.4 54.92 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.647 -1.242 . . . . 74.34 107.647 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 15.6 t -108.25 131.24 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.616 -1.253 . . . . 74.03 107.616 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -123.46 164.44 18.91 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.769 0.668 . . . . 74.24 109.769 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 91.3 mt -126.51 139.27 53.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.834 -0.432 . . . . 64.23 109.834 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 50.2 m -156.94 178.5 10.29 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.536 -0.912 . . . . 75.24 108.536 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 8.3 t30 42.75 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.653 1.581 . . . . 73.12 114.731 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.37 139.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 115.834 -0.621 . . . . 73.02 109.651 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -132.67 154.32 50.24 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.922 -1.14 . . . . 74.42 107.922 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 14.9 t -114.27 154.87 15.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 106.368 -1.715 . . . . 75.21 106.368 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.7 t -73.71 109.41 7.2 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.526 -1.657 . . . . 72.52 106.526 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 6.9 m -104.49 78.43 1.47 Allowed 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.84 -1.17 . . . . 71.55 107.84 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -99.49 -53.35 3.23 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.383 -0.826 . . . . 73.21 109.654 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -68.6 -47.06 67.67 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.359 -0.837 . . . . 73.24 109.644 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 50.6 m -133.8 134.94 43.46 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 108.113 -1.069 . . . . 72.15 108.113 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.56 -37.4 36.48 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.273 -0.64 . . . . 74.13 109.273 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -120.44 137.91 54.07 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.103 -1.073 . . . . 74.22 108.103 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 101.7 84.18 1.78 Allowed Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 108.224 -1.95 . . . . 75.45 108.224 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.28 110.92 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-O 121.528 0.68 . . . . 75.12 109.475 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 49.7 mt -67.06 -29.18 68.89 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.575 -1.193 . . . . 71.42 112.05 -174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -112.16 135.93 52.21 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.06 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -105.08 19.5 20.5 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.283 0.475 . . . . 73.25 112.283 -176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.28 5.7 49.53 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.869 -0.52 . . . . 73.42 111.288 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -87.86 150.29 23.61 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.1 0.476 . . . . 74.35 111.924 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.82 110.24 20.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.566 -0.743 . . . . 72.13 109.813 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 49.4 m -162.95 156.78 20.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 122.154 -0.341 . . . . 74.12 110.117 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . 68.28 -53.95 0.53 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.687 1.595 . . . . 73.32 114.676 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -124.61 -37.9 2.45 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.878 -1.527 . . . . 73.0 106.878 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.42 123.93 34.55 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.378 -0.828 . . . . 71.45 109.383 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 20.0 p -107.51 -171.18 1.83 Allowed 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.834 -1.173 . . . . 72.31 107.834 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.477 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.0 OUTLIER -69.54 171.98 8.03 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.324 -0.621 . . . . 72.42 109.324 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.667 ' O ' ' HD3' ' A' ' 489' ' ' PRO . . . -77.82 79.24 1.44 Allowed Glycine 0 C--O 1.209 -1.451 0 N-CA-C 105.223 -3.151 . . . . 54.22 105.223 171.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.5 m -78.89 110.55 14.84 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 116.545 2.054 . . . . 74.2 116.545 -160.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 487' ' ' GLY . 4.6 Cg_exo -71.37 -60.92 0.05 OUTLIER 'Trans proline' 0 CA--C 1.589 3.234 0 CA-C-O 118.096 -0.877 . . . . 75.13 111.017 163.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.52 ' HA ' ' CD ' ' A' ' 489' ' ' PRO . 48.7 m -121.63 88.05 2.87 Favored 'General case' 0 C--N 1.385 2.137 0 CA-C-N 121.61 2.005 . . . . 73.43 107.921 -6.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.454 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 39.0 m -145.21 105.19 4.03 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 109.081 -0.711 . . . . 74.21 109.081 177.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.47 99.74 10.69 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.603 -1.628 . . . . 74.22 106.603 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 36.9 m -79.98 120.32 24.01 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.566 -0.531 . . . . 72.44 109.566 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.458 HG11 HG12 ' A' ' 390' ' ' VAL . 72.2 t -107.0 105.48 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 116.181 -0.463 . . . . 74.11 109.759 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 86.7 m -88.69 111.5 22.02 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.533 -0.914 . . . . 75.11 108.533 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.645 HD11 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -87.1 117.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 108.998 -0.742 . . . . 74.52 108.998 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.444 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.9 m-85 -83.47 97.58 9.06 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-O 122.182 0.991 . . . . 74.41 112.169 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.8 t70 -51.58 -56.24 14.64 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.212 -2.267 . . . . 74.13 108.312 170.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.0 t70 66.71 3.01 2.79 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.72 1.608 . . . . 55.11 111.306 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -92.15 -58.62 2.33 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.735 -1.209 . . . . 74.34 107.735 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -107.24 -18.43 13.88 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.245 -1.343 . . . . 62.23 108.999 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -69.55 100.12 1.38 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.278 -1.008 . . . . 72.42 108.278 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -85.87 54.88 4.8 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 116.369 -0.378 . . . . 74.14 113.536 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -28.03 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.555 0.693 . . . . 63.55 109.79 177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -143.78 -85.25 0.14 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.281 -1.378 . . . . 73.11 107.281 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 25.9 m 46.18 87.64 0.02 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.508 1.523 . . . . 62.44 114.171 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.95 88.4 2.86 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.411 -1.7 . . . . 70.53 106.411 173.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -168.15 168.23 11.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.924 -1.509 . . . . 74.23 106.924 -171.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.195 0 C-N-CA 122.772 0.429 . . . . 75.2 111.11 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.638 'CA ' ' OD1' ' A' ' 448' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.631 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.526 -0.546 . . . . 72.44 109.526 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.528 ' O ' HG12 ' A' ' 480' ' ' VAL . 20.1 m -73.24 99.23 2.81 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.256 -0.646 . . . . 63.43 109.256 177.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 28.7 mmtp -92.01 117.72 30.09 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.431 -0.908 . . . . 71.35 109.128 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.472 ' HB ' HD11 ' A' ' 486' ' ' LEU . 31.7 mm -98.81 118.27 45.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.813 -1.54 . . . . 71.24 108.49 -175.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -154.87 174.15 15.51 Favored 'General case' 0 C--O 1.196 -1.718 0 CA-C-N 117.728 0.24 . . . . 74.22 110.364 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -92.74 153.0 19.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.345 -0.542 . . . . 74.34 112.268 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -54.53 37.68 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.659 -1.238 . . . . 73.51 107.659 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -106.51 160.86 15.1 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.559 -0.746 . . . . 74.43 110.693 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -96.31 -18.72 30.16 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 110.057 -1.217 . . . . 62.31 110.057 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 493' ' ' THR . 73.8 m -143.07 125.54 15.72 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 109.038 -0.727 . . . . 70.21 109.038 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 45.2 m-85 -109.84 136.23 49.48 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.289 -1.004 . . . . 74.03 108.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -130.28 122.82 28.71 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 390' ' ' VAL . 94.6 m -145.14 165.4 28.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.993 -0.743 . . . . 75.43 108.993 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' LEU . . . . . 0.751 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -78.19 149.66 33.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.967 0.413 . . . . 75.11 111.357 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.606 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 13.9 tt0 -60.76 -28.29 68.61 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.642 1.211 . . . . 73.13 107.833 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -81.91 -4.72 57.25 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.327 -1.761 . . . . 51.45 111.833 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 78.7 m -77.23 -14.53 59.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 122.234 -0.291 . . . . 74.31 110.811 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.19 -53.6 3.9 Favored Glycine 0 CA--C 1.5 -0.882 0 N-CA-C 111.309 -0.717 . . . . 71.43 111.309 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 11.1 p -139.03 164.31 30.09 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.674 . . . . 74.33 109.179 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.61 HG22 ' SG ' ' A' ' 383' ' ' CYS . 7.3 p -117.82 129.37 74.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.564 -1.273 . . . . 74.32 107.564 173.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 440' ' ' ILE . . . -96.53 135.31 38.6 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.873 0.368 . . . . 75.0 110.291 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.418 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -126.19 145.37 50.4 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.839 -1.171 . . . . 72.12 107.839 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.3 m -112.85 124.2 52.05 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.226 0.536 . . . . 72.3 110.362 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.21 120.03 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.883 -1.154 . . . . 73.24 107.883 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.4 mm -99.13 116.04 41.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.469 -1.241 . . . . 71.41 108.417 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 44.3 ttt180 -102.62 113.05 26.1 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.522 -1.288 . . . . 74.51 107.522 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -104.93 149.76 25.45 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.681 0.623 . . . . 75.33 112.681 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 167.1 -179.59 40.7 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 107.52 -2.232 . . . . 63.54 107.52 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -76.85 -64.81 2.07 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 110.88 -0.888 . . . . 64.43 110.88 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -144.26 121.4 11.48 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 107.015 -1.476 . . . . 74.1 107.015 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 87.3 mt -130.65 99.92 5.13 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.588 0.709 . . . . 51.52 111.47 -174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.55 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 49.3 p -102.41 1.93 35.96 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.477 -0.783 . . . . 74.53 109.429 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -70.91 171.95 9.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.46 -0.791 . . . . 64.32 109.941 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 60.9 m -124.29 113.45 18.27 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.014 0.912 . . . . 63.1 111.896 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.91 140.26 35.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 113.887 -1.506 . . . . 71.55 108.292 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 16.5 m-85 -120.07 129.27 54.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.582 -0.895 . . . . 74.4 108.582 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.22 132.69 70.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.887 -1.153 . . . . 74.14 107.887 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.05 147.09 27.4 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.805 -0.442 . . . . 60.42 109.805 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -141.72 163.99 31.41 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.868 -0.52 . . . . 74.54 111.792 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -158.13 168.93 25.72 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 125.313 1.445 . . . . 73.44 109.006 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 69.0 p -96.89 162.06 13.57 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.527 -1.286 . . . . 72.13 107.527 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -126.32 151.41 47.59 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.105 -0.638 . . . . 75.41 111.032 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 416' ' ' ALA . 2.5 p30 -65.71 2.77 0.9 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.795 2.038 . . . . 71.24 115.957 -176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.48 -73.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 124.92 1.247 . . . . 74.03 116.007 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.8 t -122.37 6.62 9.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 117.716 0.758 . . . . 54.32 110.304 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 413' ' ' ASP . . . -158.76 171.89 19.25 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 109.241 -0.652 . . . . 70.21 109.241 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -120.23 131.97 55.17 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.619 0.723 . . . . 71.31 112.073 -172.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -78.67 138.66 38.4 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.879 -1.055 . . . . 64.33 108.945 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.76 65.72 Favored Glycine 0 C--N 1.3 -1.467 0 N-CA-C 109.983 -1.247 . . . . 73.14 109.983 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 49.0 m -141.28 -59.02 0.49 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 122.546 0.339 . . . . 73.24 110.215 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.632 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 12.8 m-20 -77.82 -57.91 3.55 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-O 122.038 0.923 . . . . 74.55 108.744 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' TYR . . . . . 0.75 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -140.3 168.85 18.85 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.642 -1.163 . . . . 64.33 108.14 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.12 169.71 17.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.9 -0.408 . . . . 73.32 109.9 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.579 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.7 p90 -101.56 -17.21 16.49 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.265 0.469 . . . . 74.32 112.265 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' THR . . . . . 0.444 HG22 HG21 ' A' ' 442' ' ' VAL . 9.6 t 40.54 65.36 0.78 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.096 1.758 . . . . 65.01 113.108 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.09 114.92 18.42 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.665 -0.698 . . . . 70.51 110.124 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.71 172.92 33.8 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 110.948 -0.861 . . . . 72.53 110.948 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.1 m -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.585 -0.895 . . . . 72.42 108.585 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 33.5 t -96.52 128.36 47.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.901 -0.778 . . . . 65.13 108.901 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.16 112.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.53 -0.544 . . . . 75.33 109.53 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.6 m-85 -93.56 94.42 8.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.984 0.421 . . . . 75.51 110.603 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.0 mttt -89.08 176.17 3.41 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.137 -0.938 . . . . 75.24 110.212 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 402' ' ' THR . 31.1 Cg_exo -62.22 119.57 6.74 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.055 1.837 . . . . 73.12 110.431 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.12 -21.81 34.73 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.14 -0.784 . . . . 74.11 111.14 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -88.3 62.27 6.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.639 -0.874 . . . . 62.15 108.639 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 5.1 m -69.74 -28.15 65.55 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.428 -1.26 . . . . 74.34 108.537 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.23 145.62 49.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.184 -1.413 . . . . 75.11 107.184 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -132.89 148.27 52.29 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.539 0.209 . . . . 75.12 110.938 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.5 131.54 54.77 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.073 -0.512 . . . . 75.53 109.851 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 391' ' ' ALA . 44.5 pt -124.11 152.13 29.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.063 -0.717 . . . . 73.22 109.063 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 67.0 mtm180 -127.01 143.61 51.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.534 0.207 . . . . 74.41 110.65 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.537 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 93.6 t -109.9 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.44 -0.948 . . . . 62.21 108.44 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . 0.401 ' HA2' HG21 ' A' ' 389' ' ' THR . . . -66.65 122.42 19.98 Favored Glycine 0 N--CA 1.437 -1.258 0 O-C-N 123.984 0.802 . . . . 52.33 111.614 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 50.4 mm -95.63 134.13 34.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.452 -0.944 . . . . 75.33 108.452 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.632 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.3 mt -99.02 148.12 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 106.019 -1.845 . . . . 74.14 106.019 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.5 89.56 7.26 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 121.767 0.794 . . . . 71.21 111.777 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.37 117.37 34.42 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.266 -1.383 . . . . 64.22 107.266 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.439 33.1 m-20 -102.43 85.02 2.53 Favored 'General case' 0 CA--C 1.446 -3.025 0 CA-C-O 123.736 1.732 . . . . 75.42 114.346 177.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' ILE . . . . . 0.725 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.8 mm -122.44 153.42 27.04 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 0 N-CA-C 102.368 -3.197 . . . . 74.21 102.368 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -56.86 116.37 3.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.528 -1.286 . . . . 74.32 107.528 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.725 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 45.6 mt-10 -112.3 118.66 35.87 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 121.191 0.52 . . . . 73.33 111.793 -172.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -136.41 111.62 9.05 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.095 -1.411 . . . . 74.45 107.97 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.54 26.96 14.98 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.364 0.876 . . . . 63.43 113.364 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . 0.517 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 24.4 tt0 -66.22 109.69 2.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.223 -1.028 . . . . 74.42 108.223 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.41 168.67 19.19 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.039 -0.528 . . . . 73.34 110.475 -175.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . 0.583 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 18.6 p90 -140.11 171.5 14.09 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.221 -0.659 . . . . 72.0 109.221 173.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 38.2 mt -114.4 136.34 53.1 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.532 -1.284 . . . . 74.1 107.532 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 56.7 t -102.06 113.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.415 -1.328 . . . . 74.21 107.415 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.39 136.3 48.26 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 123.571 0.545 . . . . 74.25 110.837 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.6 mt -96.86 132.18 42.87 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.001 -0.74 . . . . 72.23 109.001 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.4 m -151.07 176.26 11.32 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.704 -0.851 . . . . 74.33 108.704 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.95 81.16 0.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.192 0.997 . . . . 74.34 112.297 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 480' ' ' VAL . 58.5 t -87.7 123.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 115.401 -0.818 . . . . 61.13 109.283 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 39.6 ttmt -116.46 131.69 56.88 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.111 -1.07 . . . . 73.13 108.111 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.24 151.49 7.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.089 -1.078 . . . . 73.33 108.089 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 35.5 t -74.18 131.29 41.12 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.49 0.662 . . . . 73.4 111.72 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 11.9 t -113.13 94.84 5.08 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 105.74 -1.948 . . . . 74.44 105.74 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.38 -167.48 1.61 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.629 -0.714 . . . . 75.33 111.242 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -66.19 -13.17 59.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.992 -0.549 . . . . 72.02 111.474 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 33.3 t -74.82 77.65 2.11 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.099 0.952 . . . . 65.12 108.446 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -86.39 -2.08 58.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.299 1.047 . . . . 72.32 109.363 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -72.38 -17.18 61.84 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.702 -1.136 . . . . 71.42 108.895 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 127.18 79.85 0.3 Allowed Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.602 -0.809 . . . . 73.22 113.066 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.58 98.04 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 107.421 -1.326 . . . . 72.52 107.421 174.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.4 mt -132.45 96.04 3.76 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.294 -1.321 . . . . 73.11 107.913 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.94 154.1 18.32 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.342 -0.844 . . . . 75.03 110.556 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -104.9 24.32 12.1 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.011 0.434 . . . . 71.22 111.139 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -108.76 31.09 5.91 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.254 -0.43 . . . . 72.43 111.013 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -129.7 176.72 7.79 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.802 -0.561 . . . . 74.25 111.483 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 372' ' ' SER . 12.7 m -102.05 148.47 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 116.069 -0.514 . . . . 72.44 110.12 175.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 68.0 m -161.07 -92.55 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.88 1.272 . . . . 64.43 109.778 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -124.53 -11.33 7.34 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 122.107 -0.371 . . . . 51.42 111.552 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -89.85 -56.14 3.35 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 104.322 -2.473 . . . . 74.3 104.322 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -107.63 134.12 51.08 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 106.465 -1.68 . . . . 73.11 106.465 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 74.1 m -120.01 -170.05 1.89 Allowed 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 109.288 -0.634 . . . . 74.52 109.288 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 374' ' ' ILE . 1.3 mm? -64.23 155.74 30.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.299 -0.26 . . . . 75.2 110.299 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -71.69 -30.09 66.72 Favored Glycine 0 C--N 1.32 -0.34 0 N-CA-C 111.774 -0.53 . . . . 63.4 111.774 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.523 ' C ' ' HA ' ' A' ' 490' ' ' SER . 15.0 m -89.85 166.84 18.97 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 108.615 -0.883 . . . . 75.02 108.615 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.661 ' N ' ' HA ' ' A' ' 490' ' ' SER . 24.6 Cg_exo -58.29 -25.09 70.99 Favored 'Trans proline' 0 CA--C 1.592 3.417 0 N-CA-C 120.237 3.13 . . . . 74.41 120.237 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.661 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 15.3 m -106.48 108.04 19.35 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 122.684 2.493 . . . . 72.44 109.055 0.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.42 ' H ' ' HD2' ' A' ' 489' ' ' PRO . 31.8 m -121.8 105.34 10.29 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-O 121.171 0.51 . . . . 75.3 110.164 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -109.82 118.28 36.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.115 -1.439 . . . . 74.32 107.115 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 380' ' ' THR . 41.2 m -87.67 131.66 34.38 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 120.837 0.351 . . . . 62.53 110.23 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' VAL . . . . . 0.458 HG11 HG13 ' A' ' 390' ' ' VAL . 78.5 t -116.64 106.51 20.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.668 -1.234 . . . . 73.33 107.668 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 47.9 m -97.78 112.84 24.58 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.303 -0.999 . . . . 64.12 108.303 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.75 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -89.79 115.57 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 122.144 0.973 . . . . 75.45 110.409 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.751 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 83.7 m-85 -99.8 120.86 40.41 Favored 'General case' 0 N--CA 1.396 -3.129 0 CA-C-N 114.796 -1.093 . . . . 74.31 108.176 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' ASP . . . . . 0.616 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 31.8 t0 -99.92 -7.55 25.08 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-O 122.603 1.192 . . . . 74.05 107.97 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 502' ' ' ALA . 16.9 t70 60.53 30.45 19.77 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 113.276 -1.784 . . . . 73.14 106.297 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 498' ' ' ASP . 13.6 t70 -71.04 -76.88 0.1 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.532 -2.122 . . . . 65.01 109.534 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -105.93 -35.93 7.14 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.588 -1.264 . . . . 75.41 107.588 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 499' ' ' ASP . . . -82.25 107.96 15.33 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.908 -1.042 . . . . 65.14 108.575 175.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -89.49 128.68 9.31 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 111.333 -0.707 . . . . 72.44 111.333 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 40.1 pt -127.36 -173.22 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 120.994 0.426 . . . . 74.52 110.651 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.9 83.71 2.14 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-O 122.491 1.139 . . . . 74.02 110.247 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 33.1 m -151.05 145.37 25.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 104.34 -2.467 . . . . 71.15 104.34 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.78 156.86 24.73 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 118.739 0.7 . . . . 75.2 111.72 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -95.57 110.42 22.51 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.983 -0.553 . . . . 75.03 110.324 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--N 1.298 -1.655 0 N-CA-C 109.361 -0.607 . . . . 73.43 109.361 178.881 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . 0.644 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' ' CA' . . . . . 0.628 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 96.5 mttt . . . . . 0 N--CA 1.415 -2.223 0 N-CA-C 109.195 -0.668 . . . . 74.22 109.195 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.455 HG21 HG11 ' A' ' 407' ' ' VAL . 30.9 mm -94.71 136.31 26.3 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 105.374 -2.084 . . . . 73.2 105.374 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -165.6 160.53 17.65 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 118.278 0.49 . . . . 72.41 111.697 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -79.22 141.01 37.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.674 -0.491 . . . . 75.44 109.674 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -65.18 -44.99 86.68 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.592 -0.892 . . . . 65.44 108.592 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -114.44 161.68 17.66 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.401 -0.818 . . . . 74.33 111.053 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.93 -19.11 18.16 Favored Glycine 0 C--N 1.278 -2.67 0 CA-C-N 114.425 -1.261 . . . . 73.14 110.406 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.7 m -138.6 134.21 33.47 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.992 -0.744 . . . . 72.22 108.992 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 72.5 m-85 -124.5 140.38 53.0 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.704 -1.221 . . . . 74.42 107.704 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.459 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 75.5 mt-30 -129.82 140.4 51.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.576 -0.898 . . . . 43.2 108.576 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.8 p -151.88 159.86 43.71 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.737 -0.838 . . . . 62.33 108.737 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.459 HD12 ' OD1' ' A' ' 386' ' ' ASN . 2.1 mm? -74.98 148.72 39.69 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.45 0.469 . . . . 64.14 109.906 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.83 -36.83 84.5 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.697 0.761 . . . . 74.51 109.425 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.459 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.7 p-10 -81.15 6.21 14.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.461 -0.791 . . . . 74.21 112.283 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 54.1 t -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.395 0.617 . . . . 61.21 110.402 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.17 -61.42 0.53 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.769 -0.932 . . . . 60.5 110.769 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 6.2 p -137.71 152.57 49.39 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.708 0.29 . . . . 75.34 111.143 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.638 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 7.7 p -109.97 127.43 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 107.976 -1.12 . . . . 74.31 107.976 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.71 120.64 38.46 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.141 0.496 . . . . 54.15 110.482 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -111.1 152.86 26.47 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.269 -1.382 . . . . 61.23 107.269 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.0 m -123.93 128.47 49.48 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.27 0.557 . . . . 71.45 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.89 125.56 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.796 -1.187 . . . . 52.22 107.796 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.54 144.95 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.645 -1.243 . . . . 72.42 107.645 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.506 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 55.8 ttt180 -127.28 121.06 30.1 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 116.068 -0.515 . . . . 73.21 109.94 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 . . . . . 0 C--N 1.309 -1.163 0 CA-C-N 115.761 -0.654 . . . . 71.11 111.028 178.426 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 14.0 m . . . . . 0 N--CA 1.429 -1.525 0 CA-C-O 121.616 0.722 . . . . 65.25 111.75 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.38 133.89 43.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.231 -0.895 . . . . 55.44 108.737 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -115.94 126.97 54.59 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.75 0.42 . . . . 71.44 109.948 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.455 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -125.29 135.36 64.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.294 -1.743 . . . . 72.23 106.294 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 140.45 35.05 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.24 -0.652 . . . . 60.24 109.24 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -135.25 160.59 37.9 Favored 'General case' 0 C--O 1.254 1.305 0 C-N-CA 120.676 -0.41 . . . . 65.22 110.646 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 30.6 ttt180 -164.03 158.02 19.02 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.263 -1.754 . . . . 52.25 106.263 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.723 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 43.2 p -96.3 150.39 20.62 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.863 -0.791 . . . . 63.34 108.863 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.9 tp10 -105.64 139.8 39.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.735 -1.209 . . . . 74.41 107.735 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.423 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 3.7 m-20 -52.39 -39.03 60.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.512 1.125 . . . . 64.4 112.651 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 57.96 -94.99 0.05 OUTLIER Glycine 0 C--N 1.295 -1.708 0 CA-C-N 114.755 -1.111 . . . . 72.13 113.717 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -124.18 17.83 9.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.498 1.142 . . . . 63.43 108.889 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -148.27 -160.52 1.18 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.678 -1.23 . . . . 53.23 107.678 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 417' ' ' ASN . 2.8 m120 -132.71 126.71 33.16 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 113.028 0.751 . . . . 72.31 113.028 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.43 124.37 28.85 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.914 -1.143 . . . . 62.32 107.914 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.48 -5.69 54.99 Favored Glycine 0 C--N 1.3 -1.465 0 N-CA-C 110.69 -0.964 . . . . 74.35 110.69 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 19.9 m -126.13 -51.83 1.53 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.877 0.37 . . . . 61.41 110.114 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.489 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 7.6 m-20 -86.46 -57.14 3.11 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 122.205 1.002 . . . . 72.32 109.726 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.689 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.47 165.03 28.61 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 115.116 -0.947 . . . . 62.53 109.683 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.69 162.15 28.3 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.936 0.773 . . . . 71.44 111.788 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.723 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 2.4 p90 -97.93 -17.87 18.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.124 -0.943 . . . . 65.24 111.875 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.495 HG21 HG22 ' A' ' 442' ' ' VAL . 6.9 t 32.93 56.37 0.44 Allowed 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.594 1.558 . . . . 45.14 113.844 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.546 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.3 pt-20 -79.89 119.28 22.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.624 0.726 . . . . 73.13 111.614 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.51 -167.51 23.04 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.617 -0.993 . . . . 55.12 110.617 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.8 m -127.78 137.51 52.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 70.11 108.514 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.23 118.49 42.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.532 -0.914 . . . . 74.14 108.532 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.36 107.42 19.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.854 -1.066 . . . . 72.24 109.324 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 404' ' ' THR . 71.1 m-85 -90.38 94.35 9.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.255 0.55 . . . . 72.52 110.784 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.476 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 67.3 mttm -84.54 175.71 4.39 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.637 -1.165 . . . . 65.53 111.022 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 34.3 Cg_exo -60.87 117.75 4.55 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.324 2.016 . . . . 73.51 110.27 172.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.93 -11.4 41.16 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.454 -0.658 . . . . 43.33 111.454 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -90.58 63.45 5.48 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.714 0.768 . . . . 72.2 110.765 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 16.9 m -67.52 -22.46 65.43 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.23 -1.35 . . . . 63.35 108.474 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -136.15 149.2 48.54 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 107.284 -1.376 . . . . 72.02 107.284 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 24.3 mmmt -133.07 151.72 52.01 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 120.778 0.323 . . . . 63.14 111.078 172.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -121.46 132.93 55.01 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.725 -0.67 . . . . 74.5 109.509 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.7 150.46 26.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.513 -0.921 . . . . 65.42 108.513 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 23.1 mtm180 -131.53 134.69 46.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.141 0.496 . . . . 72.13 111.663 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.56 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -107.66 125.56 64.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.437 -0.949 . . . . 53.31 108.437 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -74.82 138.35 23.65 Favored Glycine 0 N--CA 1.439 -1.127 0 O-C-N 123.667 0.604 . . . . 75.14 112.06 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.441 HD12 HG12 ' A' ' 496' ' ' ILE . 43.3 mm -97.37 130.71 45.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.597 -1.26 . . . . 72.42 107.597 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 84.4 mt -92.03 151.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 108.202 -1.036 . . . . 75.53 108.202 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.03 86.67 6.09 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.708 0.289 . . . . 72.15 110.822 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.8 129.57 54.51 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.521 -2.4 . . . . 55.13 104.521 171.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.256 8.2 t0 -125.61 89.45 3.04 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 116.577 -2.049 . . . . 73.24 111.518 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.623 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.6 mm -115.21 156.4 16.21 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.034 0 CA-C-N 111.058 -2.792 . . . . 62.42 105.587 -174.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -59.79 115.1 3.13 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.76 -1.941 . . . . 72.22 105.76 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.623 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 34.9 mt-10 -122.22 110.78 16.15 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.044 0.926 . . . . 75.34 110.338 -169.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.44 111.93 21.53 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.146 -1.388 . . . . 73.12 108.713 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 49.34 30.38 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.914 1.686 . . . . 72.15 112.548 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.542 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.5 tt0 -60.8 112.55 2.08 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.538 -1.21 . . . . 74.24 108.809 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.84 168.51 19.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.472 -0.786 . . . . 74.12 110.168 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.585 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 31.3 p90 -139.07 175.1 9.84 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.956 -0.566 . . . . 72.23 109.552 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 27.1 mt -120.36 136.79 54.59 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.976 -1.12 . . . . 60.13 107.976 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.0 t -106.43 123.55 61.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.934 -1.136 . . . . 73.52 107.934 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -114.54 150.87 34.26 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 123.852 0.72 . . . . 75.53 109.917 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 65.5 mt -116.36 140.01 49.79 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.414 -0.958 . . . . 70.31 108.414 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 11.8 p -153.37 -179.97 8.23 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.749 -0.834 . . . . 44.43 108.749 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 49.6 86.91 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.307 1.043 . . . . 74.04 112.505 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 83.8 t -102.03 125.87 56.13 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.89 -0.782 . . . . 34.23 108.89 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 464' ' ' LYS . 38.5 ttmt . . . . . 0 C--N 1.29 -2.002 0 N-CA-C 106.977 -1.49 . . . . 74.34 106.977 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.412 -2.34 0 CA-C-O 120.727 0.298 . . . . 65.31 110.458 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.82 102.72 14.24 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.394 -1.706 . . . . 74.45 106.394 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 29.5 m -80.29 121.28 25.46 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.754 -0.657 . . . . 72.11 109.747 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 390' ' ' VAL . 99.5 t -105.68 103.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 108.391 -0.966 . . . . 64.42 108.391 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 19.7 m -93.17 108.42 20.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.137 -1.06 . . . . 73.53 108.137 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.689 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -85.87 121.66 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-O 122.015 0.912 . . . . 74.44 110.992 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.459 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -83.55 95.91 8.46 Favored 'General case' 0 N--CA 1.388 -3.541 0 CA-C-N 114.896 -1.047 . . . . 64.43 110.498 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.06 -54.04 28.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 113.149 -1.841 . . . . 73.3 108.344 170.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.482 1.158 0 C-N-CA 126.141 1.776 . . . . 74.11 111.683 176.092 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 373' ' ' LYS . 25.8 mmtp . . . . . 0 N--CA 1.438 -1.038 0 N-CA-C 109.312 -0.625 . . . . 62.15 109.312 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 407' ' ' VAL . 28.4 mm -110.4 124.61 67.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.28 -1.378 . . . . 63.42 107.28 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -154.82 169.54 23.74 Favored 'General case' 0 C--O 1.201 -1.458 0 CA-C-N 118.335 0.516 . . . . 72.44 111.633 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -85.12 148.13 26.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.3 -0.63 . . . . 63.35 109.3 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -64.51 -46.19 84.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.367 0.604 . . . . 74.53 109.459 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -109.29 -173.89 2.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.334 -0.848 . . . . 74.31 110.414 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.43 -37.22 1.02 Allowed Glycine 0 C--N 1.285 -2.297 0 N-CA-C 109.769 -1.333 . . . . 75.31 109.769 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 35.2 m -121.19 134.36 55.21 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.456 -0.942 . . . . 71.41 108.456 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.459 ' HB2' HG22 ' A' ' 494' ' ' VAL . 58.3 m-85 -122.19 136.62 54.93 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.814 -1.18 . . . . 64.53 107.814 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -130.43 134.76 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.867 -1.16 . . . . 54.41 107.867 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 21.2 t -154.42 164.09 39.17 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.992 -1.114 . . . . 64.12 107.992 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 497' ' ' PHE . 1.8 mm? -79.96 142.88 34.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.279 0.562 . . . . 65.2 111.826 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -57.45 -41.61 80.86 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.438 1.095 . . . . 72.25 109.745 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -70.38 -7.76 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.424 -0.807 . . . . 73.31 113.169 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 49.7 t -68.11 -35.61 78.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.903 0.382 . . . . 72.42 110.837 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.54 -47.5 1.13 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.725 -0.75 . . . . 72.11 111.474 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 16.6 p -142.58 152.6 42.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.692 0.246 . . . . 73.52 110.636 175.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.2 p -111.42 133.15 57.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.471 -1.307 . . . . 72.4 107.471 174.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.49 120.57 41.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.114 0.483 . . . . 72.11 110.833 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -111.45 146.64 36.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.374 -0.973 . . . . 75.0 108.374 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.3 m -107.73 123.81 49.09 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.607 -0.516 . . . . 33.54 109.607 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 61.0 mt -98.83 124.42 52.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.869 -1.16 . . . . 70.3 107.869 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 52.2 mm -99.46 127.8 51.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.409 -0.96 . . . . 64.1 108.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -113.56 114.58 26.68 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.541 -0.911 . . . . 75.24 108.541 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 . . . . . 0 C--N 1.304 -1.391 0 CA-C-N 116.367 -0.379 . . . . 74.11 110.092 -179.605 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 7.5 m . . . . . 0 N--CA 1.416 -2.153 0 N-CA-C 108.783 -0.821 . . . . 74.35 108.783 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.79 143.83 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.257 -0.883 . . . . 72.53 110.074 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CE1' HG13 ' A' ' 430' ' ' VAL . 3.5 m-85 -118.43 125.18 49.41 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.422 0.689 . . . . 72.14 109.317 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -125.62 135.62 63.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.63 -1.248 . . . . 73.24 107.63 176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.45 145.43 27.44 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.099 -0.704 . . . . 65.54 109.099 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 17.4 p90 -142.89 157.78 44.25 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.06 -0.4 . . . . 73.41 110.461 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -161.28 163.92 30.59 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.843 -1.169 . . . . 72.31 107.843 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.678 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.5 p -95.66 172.58 7.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.003 -0.74 . . . . 55.04 109.003 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -115.42 157.72 23.53 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 120.991 0.424 . . . . 63.01 111.995 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -85.95 4.01 39.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.184 1.794 . . . . 72.22 110.571 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -23.36 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.48 1.593 0 C-N-CA 125.912 1.72 . . . . 73.35 116.579 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 455' ' ' ASN . 11.3 t -99.66 -16.48 18.18 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.564 0.697 . . . . 74.32 109.653 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -140.22 170.32 16.05 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 108.583 -0.895 . . . . 65.45 108.583 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -110.83 113.99 26.99 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 112.93 0.715 . . . . 72.1 112.93 -167.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -68.27 124.09 22.51 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.986 -1.116 . . . . 63.44 107.986 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.14 -26.79 8.52 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.391 -1.084 . . . . 54.35 110.391 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 43.2 m -116.38 -47.78 2.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.685 0.279 . . . . 53.0 111.338 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.0 m-20 -80.39 -57.77 3.44 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 122.174 0.987 . . . . 63.24 109.403 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.733 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.647 -1.161 . . . . 72.53 108.716 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -75.12 160.38 30.53 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.748 0.785 . . . . 74.3 110.702 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.678 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.3 p90 -94.69 -17.95 21.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.402 -0.817 . . . . 52.1 112.268 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 442' ' ' VAL . 10.1 t 37.08 58.12 1.19 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.413 1.485 . . . . 52.13 113.688 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 13.6 pt-20 -80.92 111.86 17.77 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.997 0.903 . . . . 72.13 110.399 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.6 -173.61 22.96 Favored Glycine 0 N--CA 1.415 -2.76 0 CA-C-N 114.799 -1.091 . . . . 63.14 111.446 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.8 m -126.52 133.19 51.2 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.781 -0.822 . . . . 74.34 108.781 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 17.8 t -96.91 123.55 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.527 -0.916 . . . . 42.41 108.527 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.5 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.2 t -99.29 109.96 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.051 -0.722 . . . . 63.32 109.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 404' ' ' THR . 65.6 m-85 -86.07 114.94 23.34 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.693 -0.685 . . . . 63.51 109.731 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 95.5 mttt -108.73 171.56 4.4 Favored Pre-proline 0 C--N 1.291 -1.935 0 CA-C-N 114.944 -1.025 . . . . 75.11 110.296 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 52.4 Cg_exo -57.26 121.6 10.35 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.784 2.322 . . . . 71.34 111.205 175.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.81 -16.8 60.38 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.711 -0.677 . . . . 14.24 111.938 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -87.99 62.25 6.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.217 0.532 . . . . 43.55 110.143 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.4 t -70.48 -17.26 62.97 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.643 -0.708 . . . . 73.21 109.561 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -130.86 141.89 50.34 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.245 -1.391 . . . . 72.34 107.245 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -128.94 147.86 50.88 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 120.612 0.244 . . . . 55.01 111.235 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.74 127.7 54.79 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.724 -0.671 . . . . 71.43 109.599 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.95 149.29 21.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.037 -1.098 . . . . 72.32 108.037 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 62.2 mtt180 -130.6 140.12 50.42 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 120.63 -0.428 . . . . 72.31 111.418 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.603 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.1 t -108.09 127.65 64.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.11 -0.95 . . . . 73.34 108.442 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -70.82 138.82 28.99 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 124.002 0.814 . . . . 72.55 111.857 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.409 HD12 HG12 ' A' ' 496' ' ' ILE . 38.4 mm -104.16 128.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.298 -1.371 . . . . 60.34 107.298 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 77.5 mt -94.65 151.14 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 106.705 -1.591 . . . . 74.21 106.705 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -81.51 86.29 6.36 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.489 0.662 . . . . 70.32 110.652 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.99 124.67 52.71 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 103.338 -2.838 . . . . 70.31 103.338 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -125.89 98.45 5.53 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 117.297 -1.761 . . . . 75.02 110.027 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.667 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -122.0 156.37 26.54 Favored 'Isoleucine or valine' 1 C--N 1.237 -4.304 0 CA-C-N 111.411 -2.631 . . . . 73.25 104.669 -174.138 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -56.19 113.48 1.57 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.174 -2.158 . . . . 72.12 105.174 168.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.2 mt-10 -119.37 107.91 13.93 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-O 121.963 0.887 . . . . 71.52 110.568 -169.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -113.6 107.98 16.53 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 114.432 -1.258 . . . . 64.33 108.059 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 35.3 t70 51.88 61.03 3.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.097 0.873 . . . . 73.12 110.69 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.453 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 32.9 tt0 -89.52 112.68 23.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.52 -1.659 . . . . 52.22 106.52 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 415' ' ' THR . 3.2 p-10 -143.98 164.93 29.18 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.179 0.514 . . . . 72.51 110.77 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.7 p90 -136.68 178.48 7.04 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.948 -0.76 . . . . 74.33 108.948 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.08 136.71 54.92 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.149 -1.426 . . . . 73.43 107.149 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 25.9 t -103.49 122.88 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.333 -1.358 . . . . 72.04 107.333 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -119.96 148.58 43.35 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.862 -0.608 . . . . 70.03 109.849 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.96 147.29 28.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.912 -0.585 . . . . 52.54 109.559 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.8 m -156.11 179.82 8.86 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.514 0.726 . . . . 72.44 109.527 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.0 t30 47.75 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.335 1.454 . . . . 61.22 114.267 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 98.5 t -91.67 127.36 44.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 C-N-CA 119.713 -0.795 . . . . 74.44 109.091 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt . . . . . 0 C--N 1.295 -1.797 0 N-CA-C 107.232 -1.395 . . . . 65.35 107.232 178.963 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.413 -2.302 0 N-CA-C 109.885 -0.413 . . . . 74.52 109.885 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 492' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -109.39 108.39 18.91 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.435 -1.32 . . . . 61.05 107.435 170.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 74.4 m -83.2 111.71 19.19 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.282 -0.636 . . . . 73.24 109.282 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.559 HG11 HG11 ' A' ' 390' ' ' VAL . 71.4 t -100.62 106.62 19.64 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 108.262 -1.014 . . . . 60.1 108.262 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 25.1 m -93.47 112.16 24.0 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 107.158 -1.423 . . . . 63.15 107.158 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.733 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -86.56 119.66 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 CA-C-O 121.831 0.824 . . . . 64.15 109.616 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.486 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.5 m-85 -82.79 98.08 8.94 Favored 'General case' 1 N--CA 1.378 -4.068 0 CA-C-N 115.041 -0.981 . . . . 73.33 112.34 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 498' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 451' ' ' GLU . 2.9 t70 -50.09 -60.52 2.87 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 112.019 -2.355 . . . . 71.01 108.518 170.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 CA--C 1.547 0.838 0 CA-C-N 113.767 -1.56 . . . . 51.22 112.363 179.271 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 N--CA 1.407 -2.576 0 N-CA-C 107.873 -1.158 . . . . 72.42 107.873 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 407' ' ' VAL . 37.4 mm -110.08 112.73 41.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.092 -1.448 . . . . 74.3 107.092 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -145.76 161.41 39.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.471 -0.492 . . . . 73.13 111.87 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -79.51 150.46 31.16 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.86 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.14 -50.0 62.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.741 -1.207 . . . . 73.31 107.741 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 16.4 mm100 -103.57 -177.69 3.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.609 -0.723 . . . . 73.11 111.494 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.44 -38.4 0.93 Allowed Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.836 -1.306 . . . . 73.13 109.836 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.8 m -123.55 131.86 53.74 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 107.582 -1.266 . . . . 70.14 107.582 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 86.1 m-85 -119.78 140.87 50.08 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.483 -1.303 . . . . 75.43 107.483 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 495' ' ' THR . 80.2 mt-30 -130.14 127.39 39.66 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.312 -0.625 . . . . 73.54 109.312 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' CYS . . . . . 0.652 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.5 p -133.83 165.06 25.85 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.488 -0.93 . . . . 62.54 108.488 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.79 146.09 24.72 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.023 0.439 . . . . 73.02 111.125 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.72 -28.94 70.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.84 0.828 . . . . 65.2 109.138 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -86.45 2.4 47.91 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.868 -1.06 . . . . 71.24 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.76 -32.24 31.54 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 112.611 0.597 . . . . 35.05 112.611 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.71 -65.47 0.4 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.284 -0.96 . . . . 55.42 111.21 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.477 HG22 ' HA2' ' A' ' 443' ' ' GLY . 30.3 p -133.01 159.45 39.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.478 0.639 . . . . 54.25 111.01 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.652 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 3.6 p -111.87 129.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 107.431 -1.322 . . . . 72.02 107.431 171.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.39 128.24 44.69 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.661 -0.866 . . . . 52.12 108.661 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.28 142.82 47.74 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.456 -1.313 . . . . 74.12 107.456 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.4 m -105.64 131.43 53.03 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.188 0.518 . . . . 72.41 110.371 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.459 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 84.4 mt -106.54 128.79 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.915 -1.143 . . . . 64.53 107.915 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.41 HG22 ' HG2' ' A' ' 397' ' ' ARG . 46.4 mm -105.52 127.71 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 N-CA-C 108.198 -1.038 . . . . 74.41 108.198 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -110.41 112.06 23.73 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 116.118 -0.492 . . . . 65.25 109.792 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ARG . . . . . 0.559 ' HA ' ' HE ' ' A' ' 397' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 108.874 -0.788 . . . . 73.23 108.874 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 10.0 m . . . . . 0 N--CA 1.414 -2.248 0 CA-C-O 121.621 0.724 . . . . 71.34 109.253 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.71 140.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.813 -1.085 . . . . 74.22 108.207 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 50.2 m-85 -123.09 128.01 49.52 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.756 -0.831 . . . . 74.53 108.756 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -128.92 134.57 64.01 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 106.339 -1.726 . . . . 73.14 106.339 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.47 122.43 42.54 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.497 -0.481 . . . . 70.44 110.01 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -109.57 154.17 23.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.695 -0.483 . . . . 54.2 109.695 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -163.78 164.73 23.56 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.078 -1.452 . . . . 63.41 107.078 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 80.0 p -95.89 172.51 7.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.801 0.334 . . . . 71.03 110.268 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 8.7 tp10 -118.6 147.97 43.17 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.286 0.565 . . . . 73.33 110.257 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.72 4.02 26.77 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 127.039 2.136 . . . . 75.34 109.514 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' GLY . . . . . 0.563 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -20.35 -74.26 0.01 OUTLIER Glycine 0 N--CA 1.482 1.744 0 C-N-CA 126.113 1.816 . . . . 44.21 115.686 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.7 t -118.47 -5.46 10.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.347 0.594 . . . . 70.42 110.63 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -134.23 -179.65 5.7 Favored 'General case' 0 C--O 1.195 -1.774 0 CA-C-N 116.357 -0.383 . . . . 74.41 110.223 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.16 118.96 28.86 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.409 0.623 . . . . 74.3 110.065 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -71.23 137.89 49.02 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.177 -0.675 . . . . 74.33 109.177 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.24 -4.92 81.09 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 110.721 -0.952 . . . . 72.33 110.721 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.1 t -123.73 -57.83 1.61 Allowed 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.25 -1.018 . . . . 50.21 108.25 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.534 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 17.6 m-20 -82.45 -59.39 2.55 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-O 122.19 0.995 . . . . 61.53 109.097 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.728 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.23 158.92 43.32 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.267 -0.879 . . . . 74.15 109.99 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.4 142.87 46.95 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.106 -0.701 . . . . 73.13 109.106 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.51 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 8.7 p90 -73.68 -24.13 59.92 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 123.304 0.642 . . . . 65.12 112.632 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.559 HG21 HG22 ' A' ' 442' ' ' VAL 0.291 10.9 t 41.6 62.42 1.56 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.37 1.868 . . . . 75.43 113.185 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.44 107.38 12.16 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.691 -1.141 . . . . 73.15 108.854 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -144.42 168.38 26.72 Favored Glycine 0 CA--C 1.46 -3.385 0 C-N-CA 120.073 -1.06 . . . . 54.13 111.49 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.6 m -112.7 138.1 50.01 Favored 'General case' 0 N--CA 1.393 -3.292 0 N-CA-C 107.652 -1.24 . . . . 45.1 107.652 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.3 t -95.4 117.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.759 -1.201 . . . . 62.12 107.759 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.74 105.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.496 -0.774 . . . . 62.42 109.755 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 404' ' ' THR . 57.7 m-85 -89.25 94.53 9.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.054 -0.521 . . . . 71.24 110.786 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.28 167.51 16.63 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.234 -0.894 . . . . 74.14 110.568 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.01 119.65 7.05 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 122.742 2.295 . . . . 50.23 110.881 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.24 -14.75 60.93 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.073 -0.584 . . . . 72.3 112.457 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -93.91 61.16 2.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.748 0.785 . . . . 70.0 109.381 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 8.0 m -66.09 -25.77 67.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.624 -1.171 . . . . 71.32 109.625 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -122.41 132.36 54.32 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.415 -1.328 . . . . 72.43 107.415 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -120.73 149.69 42.13 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.93 0.395 . . . . 62.4 111.994 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.73 131.91 56.02 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.223 -0.899 . . . . 63.5 109.435 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.57 149.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.929 -1.137 . . . . 64.13 107.929 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 51.4 mtt180 -131.62 144.01 50.74 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.253 0.549 . . . . 63.53 111.972 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 425' ' ' THR . 49.2 t -117.51 121.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.708 -1.219 . . . . 63.13 107.708 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -78.45 134.1 13.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.07 -0.586 . . . . 75.23 111.985 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 496' ' ' ILE . 28.9 mm -90.42 139.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.693 -1.225 . . . . 72.23 107.693 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 81.3 mt -99.29 150.98 4.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.236 -1.394 . . . . 63.52 107.236 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 88.03 3.05 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.113 0.482 . . . . 63.42 111.344 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.95 113.4 20.94 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.029 -2.211 . . . . 54.12 105.029 171.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -115.88 96.2 5.48 Favored 'General case' 0 CA--C 1.457 -2.629 0 C-N-CA 116.802 -1.959 . . . . 61.05 110.054 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.627 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 31.7 mm -121.68 155.63 25.93 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.097 0 N-CA-C 103.589 -2.745 . . . . 74.41 103.589 -175.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -58.49 114.65 2.56 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.602 -1.639 . . . . 74.4 107.55 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.627 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 24.4 mt-10 -128.65 130.32 47.08 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-N 115.518 -0.764 . . . . 60.43 109.693 -169.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.69 108.04 8.78 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.057 -0.974 . . . . 64.04 108.508 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.81 49.72 15.57 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 124.537 1.148 . . . . 73.32 110.238 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.556 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 37.2 tt0 -72.15 116.75 12.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.548 -1.649 . . . . 63.04 106.548 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 36.5 p30 -141.29 166.05 25.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.938 0.718 . . . . 74.32 112.938 -172.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.574 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 23.5 p90 -144.39 175.75 9.88 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.241 -0.891 . . . . 74.13 108.665 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.13 136.64 52.84 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.558 -1.275 . . . . 73.44 107.558 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.84 123.52 52.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.865 -1.532 . . . . 75.13 106.865 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -112.66 135.03 53.86 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 123.803 0.689 . . . . 75.12 111.492 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.9 129.15 45.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.967 -1.494 . . . . 72.13 106.967 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.1 t -154.69 -176.82 6.1 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.982 -1.488 . . . . 60.1 106.982 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 50.86 81.77 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 O-C-N 124.488 1.118 . . . . 74.34 112.216 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 41.2 t -82.05 131.55 33.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 114.916 -1.038 . . . . 71.42 109.026 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 4.2 tppp? . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 107.18 -1.415 . . . . 74.11 107.18 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.428 -1.553 0 N-CA-C 110.171 -0.307 . . . . 64.13 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -129.15 122.39 29.71 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.397 -1.334 . . . . 74.35 107.397 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.9 m -89.43 121.46 31.69 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.7 -0.4 . . . . 75.14 110.394 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 390' ' ' VAL . 74.5 t -109.54 110.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.918 -0.771 . . . . 61.22 108.918 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 91.1 m -101.49 121.61 42.29 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 108.882 -0.784 . . . . 71.31 108.882 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.728 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -95.36 117.1 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.099 0 CA-C-N 115.336 -0.847 . . . . 63.24 109.218 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.42 104.21 5.07 Favored 'General case' 0 N--CA 1.389 -3.507 0 CA-C-N 114.693 -1.14 . . . . 73.11 110.499 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 499' ' ' ASP . 4.0 t70 -55.01 -40.92 70.67 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 112.811 -1.995 . . . . 74.55 110.803 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 498' ' ' ASP . 8.8 t70 . . . . . 0 N--CA 1.484 1.237 0 C-N-CA 124.953 1.301 . . . . 72.22 112.117 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 30.7 mmtp . . . . . 0 N--CA 1.418 -2.047 0 N-CA-C 107.255 -1.387 . . . . 74.03 107.255 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 44.6 mm -106.9 129.36 60.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 108.065 -1.087 . . . . 74.11 108.065 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -159.27 167.8 28.04 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 117.907 0.321 . . . . 74.42 110.924 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -82.52 153.4 25.59 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.828 -0.349 . . . . 64.14 110.124 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.29 -38.72 81.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.333 0.587 . . . . 73.12 109.816 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.401 ' NE2' ' HA ' ' A' ' 378' ' ' GLN . 17.5 mm-40 -130.5 174.21 10.11 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.59 -0.732 . . . . 72.54 112.304 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -104.12 -25.66 7.0 Favored Glycine 0 C--N 1.304 -1.245 0 CA-C-N 115.37 -0.832 . . . . 63.52 111.857 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.6 m -129.38 133.33 47.33 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.252 -0.648 . . . . 45.15 109.252 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 66.2 m-85 -124.62 136.35 53.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.996 -1.113 . . . . 71.35 107.996 176.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.473 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 87.4 mt-30 -129.46 135.34 48.53 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.221 -1.029 . . . . 73.24 108.221 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 37.8 t -148.81 165.0 32.79 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.446 -0.946 . . . . 55.22 108.446 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -79.23 141.17 37.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.417 0.448 . . . . 75.35 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.93 -50.34 72.89 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.755 0.822 . . . . 61.02 110.764 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -77.25 2.56 15.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.519 0.563 . . . . 72.11 112.519 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.14 -20.6 59.31 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.236 0.541 . . . . 71.2 111.017 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.28 -57.14 0.63 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.258 -0.972 . . . . 70.35 113.105 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 14.8 p -139.33 165.35 27.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 117.189 0.495 . . . . 72.52 111.566 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.606 HG11 HG11 ' A' ' 494' ' ' VAL . 6.8 p -122.51 125.72 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 169.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.39 129.29 43.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.197 0.522 . . . . 73.25 110.4 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.21 140.91 51.39 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 107.876 -1.157 . . . . 71.3 107.876 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.2 m -108.33 131.52 54.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.92 -0.582 . . . . 72.2 109.511 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.09 125.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.923 -1.139 . . . . 62.15 107.923 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.8 mm -99.73 133.63 41.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.766 -0.828 . . . . 73.21 108.766 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 436' ' ' THR . 58.4 ttt180 -117.53 120.17 37.28 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.316 -0.856 . . . . 75.21 108.773 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 107.732 -1.211 . . . . 75.52 107.732 179.211 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 41.9 m . . . . . 0 N--CA 1.421 -1.885 0 CA-C-O 121.001 0.429 . . . . 63.11 111.517 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.64 146.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.578 -0.737 . . . . 75.4 109.351 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -122.12 125.53 46.38 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.074 0.549 . . . . 61.22 110.292 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.49 130.83 70.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.208 -1.404 . . . . 71.41 107.208 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 15.1 t70 -100.25 135.0 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.688 -0.486 . . . . 71.14 109.688 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.02 153.99 48.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.45 -0.5 . . . . 74.35 110.363 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 426' ' ' GLU . 33.6 ttp180 -163.43 154.57 16.67 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.752 -1.573 . . . . 71.24 106.752 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.607 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 30.8 p -96.46 162.55 13.43 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.279 0.562 . . . . 72.23 110.4 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 3.6 mm-40 -105.11 160.58 14.95 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.586 -0.734 . . . . 75.23 109.378 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.31 -37.65 63.56 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.131 -0.94 . . . . 75.2 110.035 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 48.57 -107.74 0.3 Allowed Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.228 -1.351 . . . . 40.0 114.215 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -101.53 5.03 41.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.739 0.781 . . . . 62.35 110.237 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -135.57 -159.53 0.97 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.942 0.897 . . . . 34.13 109.067 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 417' ' ' ASN . 1.2 m120 -136.17 126.2 26.06 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.089 0.471 . . . . 73.03 111.616 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -82.18 124.52 29.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.513 -0.921 . . . . 75.42 108.513 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.44 -19.42 36.79 Favored Glycine 0 C--N 1.296 -1.659 0 N-CA-C 110.123 -1.191 . . . . 60.13 110.123 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.6 m -106.94 -56.88 2.14 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.66 -0.496 . . . . 64.21 109.66 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 2.2 m-20 -84.68 -57.34 3.17 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 122.106 0.955 . . . . 74.44 110.205 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.686 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -140.01 159.78 41.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.24 -0.891 . . . . 74.52 109.002 -178.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.4 tm-20 -76.26 157.88 32.14 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 123.873 0.733 . . . . 70.12 109.794 -173.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.607 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 13.7 p90 -94.21 -16.68 23.44 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.288 0.635 . . . . 61.42 112.669 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.508 HG21 HG22 ' A' ' 442' ' ' VAL 0.303 9.9 t 37.59 67.12 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.66 1.984 . . . . 70.24 114.303 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.423 ' HB3' ' HD3' ' A' ' 410' ' ' ARG . 9.5 pt-20 -79.1 121.16 24.65 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.003 -0.998 . . . . 64.42 109.481 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -163.0 176.73 39.23 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 120.372 -0.918 . . . . 61.14 111.386 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 32.4 m -120.52 136.73 54.69 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.881 -1.155 . . . . 72.15 107.881 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.9 t -95.57 119.17 43.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.902 -1.147 . . . . 75.15 107.902 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 99.6 t -95.83 107.04 19.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 114.704 -1.134 . . . . 71.04 108.798 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 404' ' ' THR . 51.1 m-85 -84.55 95.08 8.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.971 -0.559 . . . . 73.54 110.586 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.478 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 10.4 mtmp? -80.52 167.83 29.94 Favored Pre-proline 0 N--CA 1.432 -1.373 0 CA-C-N 115.487 -0.778 . . . . 71.35 110.156 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 54.9 Cg_exo -52.66 131.61 42.2 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.371 2.047 . . . . 74.23 111.803 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.66 -21.49 32.67 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.851 -0.613 . . . . 51.11 113.37 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 38.0 mt-10 -81.17 63.9 5.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.171 0.986 . . . . 71.15 112.647 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 21.4 m -67.49 -11.33 57.68 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.2 -1.364 . . . . 62.15 110.069 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -139.14 136.55 35.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.497 -0.927 . . . . 73.44 108.497 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -126.14 155.12 42.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.294 0.092 . . . . 71.53 111.05 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.22 138.04 54.12 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.807 -0.357 . . . . 64.11 110.801 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 39.9 pt -125.68 153.97 34.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.635 -0.876 . . . . 51.0 108.635 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 56.5 mtm180 -130.4 138.32 50.29 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.911 0.386 . . . . 64.43 110.865 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.516 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.6 t -106.54 122.25 60.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.838 -1.171 . . . . 60.4 107.838 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.88 130.7 10.71 Favored Glycine 0 N--CA 1.434 -1.453 0 O-C-N 123.583 0.552 . . . . 71.1 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 496' ' ' ILE . 38.0 mm -88.98 143.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.527 -1.657 . . . . 74.54 106.527 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.2 mt -102.04 145.94 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 N-CA-C 107.368 -1.345 . . . . 61.4 107.368 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.26 85.99 1.43 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.508 0.67 . . . . 73.5 111.497 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.55 120.22 36.1 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 105.175 -2.158 . . . . 72.54 105.175 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -122.57 95.3 4.58 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 116.951 -1.9 . . . . 74.35 110.554 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.647 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 34.3 mm -118.62 155.9 20.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.348 0 N-CA-C 103.61 -2.737 . . . . 63.34 103.61 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -56.89 114.6 2.16 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.058 -1.457 . . . . 73.12 107.119 171.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 29.0 mt-10 -127.19 133.94 50.22 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-N 116.06 -0.518 . . . . 73.54 109.7 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.48 112.48 7.66 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.475 -0.935 . . . . 74.22 108.475 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 33.5 t70 50.56 61.53 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.855 0.862 . . . . 64.24 112.8 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.32 123.47 41.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 118.729 -1.188 . . . . 71.4 110.932 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.28 174.36 10.64 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.87 -1.059 . . . . 73.31 110.54 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.554 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 26.0 p90 -148.0 -178.54 6.34 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.746 -1.115 . . . . 71.41 108.042 172.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -123.79 136.72 54.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.284 -1.006 . . . . 64.3 108.284 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.4 122.03 59.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.903 -1.517 . . . . 55.43 106.903 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.82 152.86 31.43 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.712 0.632 . . . . 75.14 110.005 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.48 121.43 44.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.893 -0.78 . . . . 74.02 108.893 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 46.8 m -131.1 -178.11 4.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.429 -0.952 . . . . 60.25 108.429 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 39.45 82.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.143 1.377 . . . . 74.02 112.348 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.75 123.02 44.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 119.168 -1.013 . . . . 73.41 108.911 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 C--N 1.286 -2.167 0 CA-C-N 114.926 -1.034 . . . . 75.21 109.453 -177.1 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.412 -2.36 0 N-CA-C 109.174 -0.676 . . . . 74.02 109.174 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -102.22 115.06 29.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.944 -1.132 . . . . 61.51 107.944 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 20.7 m -89.2 121.08 31.16 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.1 -0.704 . . . . 61.11 109.1 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.606 HG11 HG11 ' A' ' 390' ' ' VAL . 92.6 t -108.81 106.03 19.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.987 -0.551 . . . . 61.12 109.727 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 88.2 m -92.9 118.85 31.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.348 -0.982 . . . . 62.24 108.348 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.686 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -95.17 120.36 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 N-CA-C 108.946 -0.761 . . . . 71.11 108.946 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . 0.316 26.1 m-85 -84.37 102.7 12.94 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-O 122.233 1.016 . . . . 53.24 113.624 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.02 -54.11 27.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 111.779 -2.464 . . . . 61.44 109.435 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.478 0.955 0 CA-C-N 114.578 -1.192 . . . . 72.34 111.507 174.975 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 97.0 mttt . . . . . 0 N--CA 1.425 -1.702 0 N-CA-C 112.046 0.387 . . . . 74.25 112.046 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 18.6 mm -104.36 121.12 55.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.027 -1.101 . . . . 63.41 108.027 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -150.49 168.34 24.5 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.153 -0.619 . . . . 52.24 112.235 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -80.91 145.72 31.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.588 -0.523 . . . . 74.21 109.588 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.543 ' HB3' ' OH ' ' A' ' 381' ' ' TYR . 37.2 tt0 -58.4 -59.03 5.99 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.847 0.859 . . . . 72.4 109.746 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.521 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.8 mm100 -104.87 179.98 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.343 -0.844 . . . . 65.44 110.332 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -109.13 -22.2 6.98 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 109.687 -1.365 . . . . 61.03 109.687 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 493' ' ' THR . 38.5 m -143.23 132.16 22.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 115.059 -0.571 . . . . 50.35 109.607 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.543 ' OH ' ' HB3' ' A' ' 377' ' ' GLU . 48.7 m-85 -118.98 147.83 43.64 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.159 -1.052 . . . . 65.03 108.159 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 495' ' ' THR . 40.1 mt-30 -130.74 133.55 46.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.041 -1.096 . . . . 71.13 108.041 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.6 p -140.06 157.39 45.72 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 109.123 -0.695 . . . . 72.12 109.123 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -81.15 143.7 32.2 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.02 -0.733 . . . . 74.02 109.02 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.88 -31.18 70.67 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.355 0.662 . . . . 72.34 110.833 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -80.94 -2.26 46.98 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.831 -0.622 . . . . 61.43 112.496 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.7 t -68.9 -33.2 73.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.808 0.337 . . . . 72.32 111.685 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 100.78 -58.04 0.71 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.886 -0.886 . . . . 61.13 110.886 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.8 p -137.79 154.35 49.57 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.003 -0.369 . . . . 73.43 110.003 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.9 p -110.22 130.52 63.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.042 -1.096 . . . . 62.33 108.042 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -100.54 119.34 38.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.997 0.427 . . . . 75.34 110.26 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.449 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.7 mp -113.14 157.14 22.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.862 -1.532 . . . . 71.33 106.862 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.1 m -120.54 137.01 54.61 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.232 -0.587 . . . . 70.44 110.5 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.8 mt -101.56 121.43 52.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.386 -1.338 . . . . 74.34 107.386 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.55 115.38 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 108.248 -1.019 . . . . 71.53 108.248 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 436' ' ' THR . 52.7 ttt-85 -105.84 129.27 54.05 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.726 -1.212 . . . . 71.43 107.726 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 109.084 -0.709 . . . . 75.15 109.084 179.189 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.423 -1.794 0 CA-C-O 121.373 0.606 . . . . 73.54 110.967 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 52.6 t -106.68 148.89 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.062 -0.972 . . . . 61.11 108.67 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.605 ' CE2' HG22 ' A' ' 430' ' ' VAL . 25.8 m-85 -131.41 142.55 50.05 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.037 0.446 . . . . 61.11 110.706 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.89 137.82 24.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.017 -1.475 . . . . 62.31 107.017 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.3 t70 -101.36 138.5 38.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.189 -0.671 . . . . 72.22 109.189 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.42 150.5 45.56 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.325 -0.991 . . . . 70.11 108.325 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 10.0 ttm180 -157.85 150.42 22.63 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.446 -0.946 . . . . 65.24 108.446 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 31.9 p -96.75 156.86 16.17 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.183 -0.607 . . . . 44.23 110.319 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 11.5 tp10 -114.36 150.19 34.96 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.475 -1.676 . . . . 65.35 106.475 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 24.4 m-20 -53.86 -44.77 70.66 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.829 0.823 . . . . 71.44 112.2 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.97 3.55 Favored Glycine 0 N--CA 1.42 -2.408 0 CA-C-N 114.299 -1.319 . . . . 55.2 110.351 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 455' ' ' ASN . 9.9 t -104.99 -9.32 17.98 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.83 -0.804 . . . . 73.53 108.83 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -117.72 -159.22 0.74 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.302 -0.999 . . . . 61.15 108.302 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.402 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 3.4 m120 -131.38 127.68 38.06 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 112.878 0.696 . . . . 70.43 112.878 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.105 -1.072 . . . . 73.13 108.105 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.75 56.95 Favored Glycine 0 C--N 1.295 -1.728 0 N-CA-C 110.513 -1.035 . . . . 60.11 110.513 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.1 m -128.88 -54.79 1.21 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.155 -0.313 . . . . 74.21 110.155 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.51 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 18.2 m-20 -84.25 -53.05 5.76 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.814 0.816 . . . . 72.53 108.977 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -139.93 166.09 25.57 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.54 159.68 30.13 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.662 -0.866 . . . . 70.44 108.662 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.558 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 6.6 p90 -97.44 -17.69 19.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.01 0.524 . . . . 71.24 111.853 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.531 HG21 HG22 ' A' ' 442' ' ' VAL . 6.4 t 40.92 56.44 2.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.576 1.95 . . . . 73.24 113.24 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 9.4 pt-20 -77.55 108.96 11.1 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.225 1.012 . . . . 73.0 109.213 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.6 163.71 28.49 Favored Glycine 0 N--CA 1.411 -2.998 0 CA-C-N 114.905 -1.043 . . . . 71.05 110.904 -176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 11.0 m -108.71 134.23 51.71 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 108.049 -1.093 . . . . 63.25 108.049 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 48.8 t -94.78 125.24 47.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.399 -0.963 . . . . 53.22 108.399 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.605 HG22 ' CE2' ' A' ' 406' ' ' PHE . 37.2 t -99.42 112.28 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 CA-C-N 114.761 -1.109 . . . . 75.44 108.392 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -83.48 105.54 14.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.3 -1.0 . . . . 53.24 108.3 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 1.0 OUTLIER -79.58 163.94 56.26 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.913 -1.039 . . . . 53.45 111.465 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.0 Cg_exo -51.41 118.1 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 123.247 2.631 . . . . 72.41 111.303 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.87 -15.96 49.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.924 -0.58 . . . . 73.31 113.88 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.8 63.65 7.56 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.393 0.886 . . . . 64.43 113.393 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 19.3 m -53.86 -24.78 16.93 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 114.496 -1.229 . . . . 74.1 112.092 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -116.23 145.27 43.26 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.763 -0.828 . . . . 61.11 108.763 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -134.48 147.55 50.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.02 0.378 . . . . 70.43 112.02 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.29 141.01 37.56 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.683 -0.689 . . . . 74.51 109.543 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.1 pt -128.42 148.44 32.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.709 -0.849 . . . . 63.44 108.709 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 73.9 mtm180 -129.02 142.66 50.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.361 0.601 . . . . 63.14 111.191 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 46.1 t -116.42 124.37 72.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.503 -1.295 . . . . 74.1 107.503 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -75.71 141.67 27.77 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.989 -0.624 . . . . 55.31 112.368 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.452 HD12 HG12 ' A' ' 496' ' ' ILE . 36.6 mm -99.47 136.91 28.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.892 -1.151 . . . . 73.45 107.892 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.3 mt -98.19 148.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.48 -1.674 . . . . 73.12 106.48 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.47 86.59 5.77 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.287 -0.565 . . . . 73.03 110.707 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.0 118.66 37.03 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 103.936 -2.616 . . . . 63.51 103.936 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.258 10.7 t70 -121.21 92.5 3.77 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.493 -2.083 . . . . 75.22 110.966 176.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.723 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.6 mm -120.23 156.62 23.1 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.357 0 CA-C-N 111.018 -2.81 . . . . 71.51 103.825 -175.353 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -53.62 114.0 1.38 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.625 -1.62 . . . . 73.0 106.625 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.723 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 35.5 mt-10 -121.18 113.04 19.42 Favored 'General case' 0 CA--C 1.468 -2.208 0 CA-C-O 121.56 0.695 . . . . 60.52 110.532 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -117.81 100.55 7.66 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.691 -1.14 . . . . 75.11 109.767 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 51.75 40.89 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.447 -1.251 . . . . 74.33 113.393 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.431 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.7 pt-20 -70.12 131.84 44.91 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 119.945 -0.702 . . . . 62.55 109.81 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.634 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 34.1 p30 -150.13 161.22 42.8 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.446 0.535 . . . . 63.23 112.446 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 35.3 p90 -131.96 -179.56 5.48 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.377 -0.374 . . . . 75.34 110.611 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 47.4 mt -121.34 138.49 54.23 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.457 -0.942 . . . . 75.1 108.457 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 23.0 t -111.06 129.59 66.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.34 -1.356 . . . . 54.2 107.34 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -122.67 165.75 16.01 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 123.574 0.546 . . . . 64.24 109.712 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.52 139.36 51.58 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.198 0.523 . . . . 74.53 110.536 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 37.3 m -150.57 -179.28 7.1 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.271 -1.011 . . . . 65.15 108.271 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.8 t30 45.7 88.39 0.02 OUTLIER 'General case' 0 C--O 1.248 1.02 0 C-N-CA 124.815 1.246 . . . . 72.33 113.856 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.3 123.8 42.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.219 -0.992 . . . . 73.44 108.779 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.6 mttm . . . . . 0 C--N 1.29 -1.978 0 CA-C-O 121.501 0.667 . . . . 72.54 110.421 179.581 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.41 -2.44 0 N-CA-C 109.166 -0.679 . . . . 62.22 109.166 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 492' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -112.06 106.78 15.51 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.714 -1.217 . . . . 53.44 107.714 170.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 380' ' ' THR . 27.0 m -82.0 121.9 27.11 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.69 -0.485 . . . . 74.4 109.69 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.517 HG11 HG11 ' A' ' 390' ' ' VAL . 86.6 t -107.75 107.89 23.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.492 -0.929 . . . . 62.22 108.492 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.634 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 66.9 m -98.39 113.44 25.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.895 -0.779 . . . . 72.1 108.895 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.617 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -91.3 120.5 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.556 0.693 . . . . 75.11 110.767 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.01 101.63 13.09 Favored 'General case' 0 N--CA 1.394 -3.273 0 CA-C-N 115.013 -0.994 . . . . 72.4 110.999 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.6 -53.42 52.05 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.547 -2.115 . . . . 63.51 108.974 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 125.571 1.548 . . . . 74.12 112.1 177.311 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 95.6 mttt . . . . . 0 N--CA 1.435 -1.221 0 CA-C-O 120.861 0.363 . . . . 73.32 111.445 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.23 121.41 67.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.143 -1.058 . . . . 70.41 108.143 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -154.1 172.12 18.04 Favored 'General case' 0 C--O 1.193 -1.894 0 N-CA-C 112.195 0.443 . . . . 64.41 112.195 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -85.49 153.36 22.51 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.594 -0.442 . . . . 71.11 110.491 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.46 -36.79 81.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.46 0.648 . . . . 72.13 109.582 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -128.59 172.3 11.32 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.227 -0.897 . . . . 70.32 111.792 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.41 -32.3 4.93 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 114.881 -1.054 . . . . 63.25 110.966 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.3 m -130.39 125.5 34.7 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.389 -0.597 . . . . 72.43 109.389 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.17 140.69 48.33 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.449 -0.945 . . . . 71.55 108.449 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 495' ' ' THR . 37.9 mt-30 -123.96 135.52 53.71 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.404 -1.332 . . . . 75.11 107.404 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 29.7 t -146.48 165.86 28.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.279 -1.008 . . . . 74.0 108.279 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -91.14 145.54 24.59 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.634 -0.506 . . . . 70.41 109.634 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 385' ' ' GLU . . . . . 0.699 ' HB2' ' HA ' ' A' ' 498' ' ' ASP . 18.1 tt0 -55.66 -54.86 39.05 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.778 0.831 . . . . 75.44 110.723 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -74.37 8.34 2.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.765 1.024 . . . . 65.31 113.765 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.89 -31.05 68.64 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.538 -0.541 . . . . 65.02 109.538 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.64 -60.38 0.52 Allowed Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.425 -0.893 . . . . 62.31 111.245 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 12.7 p -138.02 152.1 48.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 110.348 -0.242 . . . . 74.04 110.348 176.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 494' ' ' VAL . 3.6 p -108.15 124.22 64.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.559 -1.274 . . . . 74.53 107.559 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.16 118.92 34.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.309 0.576 . . . . 71.35 110.815 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -110.93 149.99 29.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.511 -1.292 . . . . 51.45 107.511 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.4 m -116.37 125.45 52.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.235 0.54 . . . . 71.54 110.462 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 77.6 mt -97.24 123.98 49.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.346 -1.353 . . . . 71.14 107.346 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.7 mm -102.16 129.93 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-N 115.205 -0.907 . . . . 74.33 108.775 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 35.9 ttt180 -112.06 108.62 17.99 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.424 -0.807 . . . . 71.21 108.873 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 . . . . . 0 CA--C 1.487 -1.462 0 CA-C-N 116.135 -0.484 . . . . 73.13 109.755 -178.809 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 7.0 m . . . . . 0 N--CA 1.416 -2.129 0 CA-C-O 121.623 0.725 . . . . 72.21 109.832 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.87 137.25 56.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.307 -0.86 . . . . 72.11 109.132 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.446 ' CE2' HG22 ' A' ' 430' ' ' VAL . 17.9 m-85 -119.93 137.1 54.24 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.582 -0.896 . . . . 72.51 108.582 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.18 128.76 49.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 107.619 -1.252 . . . . 73.35 107.619 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.5 153.68 20.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.714 -0.476 . . . . 63.11 109.714 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -146.95 161.54 40.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.232 -0.293 . . . . 65.31 110.435 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -161.03 163.0 31.91 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 107.311 -1.366 . . . . 75.23 107.311 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 49.4 p -95.71 172.54 7.98 Favored 'General case' 0 C--O 1.26 1.656 0 N-CA-C 108.34 -0.985 . . . . 64.51 108.34 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -121.72 151.61 40.32 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 120.218 -0.593 . . . . 63.02 111.339 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 3.49 8.68 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 125.734 1.613 . . . . 71.33 113.045 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.85 -92.02 0.01 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 116.917 1.527 . . . . 71.43 116.917 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.3 t -101.85 9.58 40.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.212 1.006 . . . . 73.42 111.096 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -147.03 -157.58 0.82 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.492 -0.929 . . . . 34.41 108.492 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -145.17 124.37 12.94 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.95 -1.1 . . . . 41.34 111.768 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -72.28 124.65 25.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.255 -0.884 . . . . 74.1 108.889 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.48 -16.02 41.53 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.963 -1.255 . . . . 73.33 109.963 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 48.1 t -110.48 -58.71 2.04 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.379 -0.6 . . . . 32.43 109.379 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 15.4 m-20 -86.28 -58.39 2.65 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-O 122.261 1.029 . . . . 73.11 109.418 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.712 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.11 163.43 32.45 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.086 -0.961 . . . . 75.22 109.48 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -72.94 151.94 41.63 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 123.879 0.737 . . . . 73.04 110.735 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.619 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.1 p90 -80.54 -21.62 41.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.747 -0.661 . . . . 70.32 112.654 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 442' ' ' VAL 0.255 13.8 t 36.69 67.16 0.35 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.647 1.579 . . . . 74.13 113.754 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -87.86 113.15 23.24 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.098 -0.956 . . . . 65.42 108.756 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.65 -173.86 23.26 Favored Glycine 0 CA--C 1.482 -2.025 0 C-N-CA 120.492 -0.861 . . . . 54.24 111.365 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.7 m -120.51 137.16 54.52 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.501 -0.926 . . . . 71.1 108.501 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 22.0 t -96.56 123.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.929 -1.137 . . . . 72.13 107.929 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.446 HG22 ' CE2' ' A' ' 406' ' ' PHE . 16.2 t -103.66 109.6 27.58 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-O 121.389 0.614 . . . . 74.22 111.047 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 404' ' ' THR . 55.7 m-85 -94.14 100.02 12.19 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.699 -0.682 . . . . 74.22 111.064 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.8 mttt -94.53 172.1 5.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 114.263 -1.335 . . . . 75.21 110.343 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 44.5 Cg_exo -58.73 126.17 20.44 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.868 2.379 . . . . 75.32 112.173 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.84 -2.04 87.07 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.601 -0.809 . . . . 61.33 114.359 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.24 -70.16 0.38 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 117.654 0.727 . . . . 72.01 110.447 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 54.5 m 71.26 -35.33 0.33 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.686 0.795 . . . . 63.51 112.122 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -125.95 140.1 52.9 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.515 -1.291 . . . . 74.12 107.515 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -132.93 143.67 49.64 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.417 -0.356 . . . . 62.51 110.322 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 392' ' ' LEU . 36.8 tt0 -106.0 134.64 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.495 -0.928 . . . . 65.22 108.495 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.4 pt -123.14 148.54 26.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.437 -1.32 . . . . 71.43 107.437 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 75.5 mtt180 -129.0 138.18 51.78 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.363 0.602 . . . . 71.41 111.93 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.661 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 52.1 t -109.62 119.0 58.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.732 -1.122 . . . . 72.21 108.628 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.419 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -66.03 132.55 33.83 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 124.192 0.933 . . . . 61.02 112.236 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 31.8 mm -97.71 135.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.169 -1.419 . . . . 70.04 107.169 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 76.0 mt -101.72 150.57 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 106.948 -1.501 . . . . 72.05 106.948 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.23 95.47 6.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.365 -0.534 . . . . 71.04 111.317 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -122.61 128.1 50.25 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 103.539 -2.763 . . . . 72.42 103.539 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -126.54 99.85 5.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 C-N-CA 116.999 -1.881 . . . . 75.04 110.149 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.761 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -131.04 158.27 43.3 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.118 0 CA-C-N 111.077 -2.783 . . . . 72.22 105.03 -171.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -53.16 114.82 1.6 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 116.721 -1.992 . . . . 70.24 106.397 166.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.761 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.6 mt-10 -125.23 97.17 5.11 Favored 'General case' 0 CA--C 1.458 -2.571 0 N-CA-C 107.856 -1.164 . . . . 74.13 107.856 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -117.84 113.47 21.83 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 108.192 -1.04 . . . . 75.23 108.192 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 31.38 20.41 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.114 0.884 . . . . 71.23 111.366 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.492 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.0 tt0 -65.32 106.57 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.27 -1.381 . . . . 65.14 107.27 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -141.2 169.68 17.15 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.65 -0.704 . . . . 63.22 109.846 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.661 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 22.5 p90 -143.35 170.44 15.76 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.749 -0.834 . . . . 63.11 108.749 173.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.74 136.5 50.92 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.058 -1.46 . . . . 73.23 107.058 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.58 124.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 106.806 -1.553 . . . . 71.11 106.806 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -120.37 142.8 48.84 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.652 -0.704 . . . . 74.11 109.242 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.5 138.13 33.61 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.931 -1.878 . . . . 73.22 105.931 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 26.0 m -148.09 155.1 41.06 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.89 -0.781 . . . . 54.13 108.89 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.56 92.38 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 O-C-N 124.543 1.152 . . . . 62.43 111.95 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.75 142.46 14.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.391 -0.966 . . . . 73.23 108.391 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 464' ' ' LYS . 32.6 ttmt . . . . . 0 N--CA 1.429 -1.52 0 N-CA-C 109.3 -0.63 . . . . 71.41 109.3 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.425 -1.687 0 N-CA-C 109.25 -0.648 . . . . 50.25 109.25 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -107.59 118.66 37.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.331 -0.989 . . . . 73.15 108.331 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 23.6 m -88.25 119.51 28.73 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.814 0.34 . . . . 60.11 110.47 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 390' ' ' VAL . 68.4 t -104.61 106.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.424 -0.954 . . . . 72.04 108.424 176.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 27.6 m -95.53 114.23 25.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.131 -1.063 . . . . 72.14 108.131 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.712 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -92.21 117.59 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 C-N-CA 120.326 -0.55 . . . . 70.32 110.411 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.43 ' O ' HD13 ' A' ' 384' ' ' LEU . 18.3 m-85 -78.42 103.06 8.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 107.621 -1.252 . . . . 63.43 107.621 170.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 498' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 385' ' ' GLU . 0.0 OUTLIER -63.06 -30.81 71.89 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.283 -1.781 . . . . 74.21 109.459 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 125.521 1.528 . . . . 72.14 110.849 174.808 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 120.798 0.333 . . . . 74.33 110.216 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.46 HD13 ' HG3' ' A' ' 396' ' ' ARG . 44.7 mm -109.38 112.62 41.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.162 -1.421 . . . . 44.34 107.162 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -145.53 160.44 41.62 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.836 -0.746 . . . . 73.53 112.609 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.06 142.76 39.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.31 -0.626 . . . . 75.13 109.31 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.21 -48.69 80.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.806 0.842 . . . . 74.52 110.093 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.554 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 16.2 mm100 -106.25 172.4 6.83 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.816 0.817 . . . . 64.03 110.649 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.11 -34.04 4.99 Favored Glycine 0 C--N 1.284 -2.327 0 CA-C-N 114.129 -1.396 . . . . 62.31 110.167 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 42.2 m -132.93 128.43 36.47 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.226 -1.028 . . . . 51.21 108.226 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 37.3 m-85 -112.06 136.84 50.91 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 495' ' ' THR . 75.4 mt-30 -126.61 142.49 51.52 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.178 -1.045 . . . . 72.22 108.178 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 19.5 t -153.68 165.1 37.01 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.278 -1.378 . . . . 73.22 107.278 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -86.18 141.99 28.94 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.584 -0.525 . . . . 74.32 109.584 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -55.55 -38.2 69.0 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.378 1.071 . . . . 61.2 110.128 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -84.83 7.03 22.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.04 -0.982 . . . . 71.23 111.999 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.5 t -90.45 -1.03 57.89 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 122.02 -0.425 . . . . 75.14 111.213 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.27 4.5 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 64.33 113.117 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 22.1 p -142.91 174.26 10.82 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.314 0.578 . . . . 71.23 110.843 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 494' ' ' VAL . 4.6 p -125.61 125.9 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 106.802 -1.555 . . . . 74.23 106.802 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.33 122.69 41.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.996 0.427 . . . . 73.0 110.118 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.546 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.3 mp -112.45 146.42 38.43 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.05 -1.092 . . . . 74.24 108.05 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.2 m -112.46 128.53 56.35 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.448 0.467 . . . . 74.55 109.748 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 62.2 mt -100.45 121.74 51.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.17 -1.419 . . . . 74.41 107.17 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.2 mm -99.2 132.3 44.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.754 -0.832 . . . . 64.51 108.754 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.46 ' HG3' HD13 ' A' ' 374' ' ' ILE . 3.3 ttp85 -107.52 122.83 47.44 Favored 'General case' 0 N--CA 1.406 -2.666 0 C-N-CA 119.702 -0.799 . . . . 75.02 110.549 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 . . . . . 0 C--N 1.284 -2.266 0 CA-C-N 115.363 -0.835 . . . . 74.44 108.965 176.262 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 50.7 m . . . . . 0 N--CA 1.439 -0.998 0 CA-C-O 121.492 0.663 . . . . 62.33 111.512 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.6 t -112.26 146.92 16.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.047 -0.524 . . . . 74.31 109.83 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.604 ' CE1' HG13 ' A' ' 430' ' ' VAL . 3.7 m-85 -120.59 129.14 53.63 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.11 0.564 . . . . 73.24 110.66 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.81 135.95 52.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.589 -1.263 . . . . 61.44 107.589 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 18.2 t70 -102.52 148.73 25.18 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.061 -0.718 . . . . 72.44 109.061 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -143.94 159.36 42.71 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.038 -0.665 . . . . 74.14 110.868 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -163.17 160.91 24.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.37 -1.715 . . . . 75.3 106.37 173.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.633 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 34.9 p -96.95 164.81 12.38 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.426 0.631 . . . . 73.12 110.581 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.4 tp10 -106.53 152.59 23.48 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.214 -1.402 . . . . 64.2 107.214 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.486 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 4.8 m-20 -60.01 -40.51 89.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.915 0.864 . . . . 71.52 110.493 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' GLY . . . . . 0.428 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . 67.69 -86.51 0.16 Allowed Glycine 0 C--N 1.299 -1.495 0 CA-C-N 114.355 -1.293 . . . . 73.21 112.964 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.1 t -135.71 11.5 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.657 -0.868 . . . . 64.13 108.657 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -141.3 -162.87 1.45 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.698 -1.593 . . . . 65.33 106.698 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.486 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 7.3 m120 -129.29 116.35 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.583 0.706 . . . . 74.02 112.141 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -78.03 124.5 28.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.903 -1.044 . . . . 64.41 108.898 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.35 -12.25 30.94 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 109.668 -1.373 . . . . 74.3 109.668 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 16.3 t -126.87 -54.84 1.4 Allowed 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.917 -0.313 . . . . 74.21 110.993 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.611 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -73.06 -58.46 3.3 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 122.4 1.095 . . . . 70.43 108.074 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.72 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.21 161.78 36.58 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.126 -1.397 . . . . 74.25 107.631 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.6 157.33 32.04 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.566 0.541 . . . . 75.1 109.649 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.633 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 15.6 p90 -90.6 -9.69 46.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.215 0.45 . . . . 64.41 112.215 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.478 HG21 HG22 ' A' ' 442' ' ' VAL . 12.7 t 37.34 68.67 0.27 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.052 1.741 . . . . 72.5 113.728 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -80.3 134.79 36.11 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.023 -1.071 . . . . 70.35 109.128 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -175.03 -178.54 44.97 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.677 -0.969 . . . . 65.22 110.677 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 18.3 m -125.73 139.97 53.08 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.789 -1.189 . . . . 73.42 107.789 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.1 t -99.42 119.43 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.922 -0.769 . . . . 55.42 108.922 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 406' ' ' PHE . 53.6 t -100.71 106.65 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.575 -0.898 . . . . 54.43 108.575 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 404' ' ' THR . 58.9 m-85 -79.17 95.0 5.49 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.736 -0.665 . . . . 74.35 110.075 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.443 ' HD2' HG12 ' A' ' 430' ' ' VAL . 5.3 mptp? -69.46 164.58 48.36 Favored Pre-proline 0 C--N 1.316 -0.852 0 O-C-N 123.58 0.55 . . . . 75.22 111.549 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.41 113.51 1.16 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.739 2.293 . . . . 75.35 111.797 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.1 67.5 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.742 -0.742 . . . . 60.1 113.399 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -88.25 62.02 6.51 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.558 0.694 . . . . 74.03 110.691 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 m -61.47 -23.31 65.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.813 -1.085 . . . . 43.54 110.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -131.38 132.26 44.28 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.58 -1.267 . . . . 75.35 107.58 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 25.8 mmmt -122.32 149.8 43.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.484 0.55 . . . . 61.54 112.484 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -114.51 125.59 53.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.381 -0.827 . . . . 64.23 111.122 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.8 pt -116.84 146.57 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.043 -1.095 . . . . 62.24 108.043 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 71.2 mtt180 -126.01 141.45 51.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.374 -0.53 . . . . 74.01 110.8 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -106.22 121.2 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.442 -0.947 . . . . 54.32 108.442 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -62.07 125.01 35.31 Favored Glycine 0 N--CA 1.435 -1.423 0 O-C-N 124.134 0.896 . . . . 70.11 112.068 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.437 HD12 HG12 ' A' ' 496' ' ' ILE . 49.5 mm -94.92 135.27 29.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.988 -1.486 . . . . 65.44 106.988 175.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.9 mt -103.19 151.08 6.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.169 -1.419 . . . . 74.22 107.169 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.98 101.31 8.57 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 121.3 0.571 . . . . 75.33 110.536 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 123.15 29.57 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 103.771 -2.677 . . . . 62.32 103.771 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.256 19.6 t70 -119.78 97.58 5.7 Favored 'General case' 0 CA--C 1.459 -2.553 0 C-N-CA 116.393 -2.123 . . . . 74.02 111.932 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.701 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -121.45 156.49 25.36 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.439 0 CA-C-N 111.282 -2.69 . . . . 74.51 104.727 -174.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -53.87 115.32 1.95 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.862 -1.903 . . . . 75.45 105.862 168.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.701 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 33.1 mt-10 -123.38 90.71 3.33 Favored 'General case' 0 CA--C 1.483 -1.605 0 CA-C-O 122.069 0.937 . . . . 42.42 111.104 -170.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -93.58 104.94 17.03 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.005 -1.452 . . . . 63.04 107.738 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.308 7.9 p-10 42.28 60.34 2.35 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 125.095 1.497 . . . . 61.34 112.9 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.564 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 33.1 tt0 -74.45 113.96 12.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.683 -1.599 . . . . 64.42 106.683 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -137.13 171.35 14.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.57 0.7 . . . . 74.41 112.729 -174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 28.5 p90 -146.62 -177.78 5.82 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.861 -1.063 . . . . 71.32 109.665 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 412' ' ' GLU . 26.6 mt -123.32 141.57 51.85 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.015 -1.106 . . . . 63.24 108.015 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 411' ' ' THR . 25.7 t -110.56 130.85 63.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.199 -1.408 . . . . 53.03 107.199 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -124.17 134.2 53.37 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.498 0.499 . . . . 63.22 110.76 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.86 140.62 30.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.048 -1.093 . . . . 73.02 108.048 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 49.1 m -155.3 -177.79 6.8 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.693 -0.854 . . . . 64.24 108.693 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 23.2 t-20 51.11 83.84 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.651 1.18 . . . . 54.51 111.599 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.61 126.4 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.581 -0.848 . . . . 53.32 109.178 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 116.049 -0.523 . . . . 64.24 110.123 -178.547 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 63.4 m . . . . . 0 N--CA 1.423 -1.776 0 CA-C-O 120.832 0.348 . . . . 60.44 110.554 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -126.82 135.4 50.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.118 -1.438 . . . . 74.1 107.118 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 88.1 m -96.12 129.99 43.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.656 -0.498 . . . . 75.53 109.656 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 390' ' ' VAL . 69.0 t -115.31 109.37 28.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.587 -0.894 . . . . 74.14 108.587 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 35.6 m -101.55 117.12 34.27 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.457 -0.942 . . . . 74.54 108.457 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.72 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.4 125.08 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.267 0 CA-C-N 115.957 -0.565 . . . . 62.13 109.693 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.489 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.0 m-85 -84.69 104.26 14.51 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-O 121.799 0.809 . . . . 74.31 111.693 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 498' ' ' ASP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 451' ' ' GLU . 6.2 t70 -49.01 -58.52 4.76 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.721 -2.491 . . . . 73.35 109.475 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.8 t0 . . . . . 0 C--N 1.311 -1.068 0 C-N-CA 125.852 1.661 . . . . 73.53 111.043 177.077 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 94.3 mttt . . . . . 0 N--CA 1.418 -2.036 0 CA-C-O 121.545 0.688 . . . . 72.11 111.293 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 21.8 mm -104.73 121.45 56.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.725 -1.58 . . . . 62.11 108.41 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -157.51 155.16 29.83 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 117.612 0.187 . . . . 64.11 110.658 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -73.87 152.44 40.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.841 0.353 . . . . 50.14 110.981 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.02 -30.1 70.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.649 -0.705 . . . . 74.02 110.768 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -127.71 176.93 7.15 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.76 -0.654 . . . . 63.24 111.464 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.94 -36.38 3.96 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.941 -0.863 . . . . 74.53 110.941 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 49.9 m -129.46 131.81 46.8 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.338 -0.615 . . . . 73.03 109.338 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 49.9 m-85 -114.48 135.97 53.53 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.316 -0.994 . . . . 65.31 108.316 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.411 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 72.4 mt-30 -125.54 138.91 53.97 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.919 -0.771 . . . . 72.41 108.919 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.2 p -145.82 155.37 42.87 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.525 -0.546 . . . . 75.24 109.525 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -74.67 141.98 44.52 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.243 -0.651 . . . . 51.03 109.243 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -55.41 -45.76 76.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.927 0.87 . . . . 72.21 109.165 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.414 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.6 p-10 -82.37 21.54 0.93 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.968 -1.015 . . . . 71.44 112.813 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.28 0.64 46.03 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 121.621 -0.674 . . . . 74.12 112.035 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.82 -71.63 2.57 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.497 -0.859 . . . . 23.33 112.794 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.571 HG22 ' HA2' ' A' ' 443' ' ' GLY . 17.6 p -137.25 159.4 42.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.766 0.283 . . . . 70.42 110.784 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.647 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 5.4 p -112.59 125.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.524 -1.287 . . . . 61.22 107.524 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.55 127.8 43.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.149 -0.478 . . . . 73.2 110.074 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.3 mp -121.22 138.38 54.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.922 -1.51 . . . . 74.01 106.922 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.4 m -109.8 127.29 54.56 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.408 0.443 . . . . 71.43 110.27 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.22 125.5 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.908 -1.145 . . . . 72.43 107.908 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.503 HG22 ' HG2' ' A' ' 397' ' ' ARG . 30.5 mm -102.38 140.95 19.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 107.68 -1.23 . . . . 73.43 107.68 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 47.5 ttp85 -120.89 109.29 14.94 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.789 -0.449 . . . . 74.43 109.789 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ARG . . . . . 0.503 ' HG2' HG22 ' A' ' 395' ' ' ILE . 31.7 mmm180 . . . . . 0 CA--C 1.511 -0.529 0 CA-C-N 115.861 -0.608 . . . . 73.21 110.528 -175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.398 -3.049 0 CA-C-O 121.408 0.623 . . . . 64.31 111.443 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.66 139.55 21.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.12 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 3.0 m-85 -121.81 123.23 41.3 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 123.667 0.787 . . . . 73.53 110.048 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.78 128.69 72.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.292 -1.373 . . . . 74.52 107.292 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 15.7 t70 -98.73 140.33 33.09 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.092 -0.38 . . . . 74.42 110.434 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -134.85 162.73 31.57 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.683 0.278 . . . . 63.32 110.514 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 42.9 ttt180 -166.82 162.71 16.18 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.591 -1.633 . . . . 55.13 106.591 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.613 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 59.8 p -95.6 172.12 8.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.65 -0.87 . . . . 71.23 108.65 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.34 145.92 50.63 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.7 -0.482 . . . . 74.1 109.7 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.1 4.2 5.9 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.124 1.37 . . . . 73.15 113.697 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -17.97 -88.92 0.01 OUTLIER Glycine 0 N--CA 1.479 1.541 0 C-N-CA 126.141 1.829 . . . . 71.21 117.113 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 13.9 t -109.79 5.31 22.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 117.89 0.845 . . . . 64.15 110.532 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.11 28.15 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.204 -1.776 . . . . 75.42 106.204 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -107.08 127.98 53.97 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.202 -1.399 . . . . 64.25 113.205 -164.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -69.32 126.36 29.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.289 -0.869 . . . . 61.24 110.181 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.62 -25.03 29.85 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.769 -0.932 . . . . 72.42 110.769 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.4 m -100.27 -57.04 2.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.98 -0.748 . . . . 64.21 108.98 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.58 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.2 m-20 -84.91 -58.45 2.7 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-O 121.364 0.602 . . . . 55.35 110.499 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.555 ' CZ ' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -136.19 166.59 23.05 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 108.915 -0.772 . . . . 74.42 108.915 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.43 155.69 39.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.987 0.805 . . . . 73.34 109.716 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.613 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 3.2 p90 -91.04 -17.9 25.47 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.971 -0.559 . . . . 73.34 111.709 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.546 HG21 HG22 ' A' ' 442' ' ' VAL . 9.2 t 34.07 59.2 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 125.144 1.527 . . . . 75.31 113.024 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.1 pt-20 -79.88 119.3 22.56 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.421 -0.809 . . . . 72.41 109.656 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.74 -174.13 34.95 Favored Glycine 0 N--CA 1.419 -2.455 0 C-N-CA 120.552 -0.832 . . . . 70.5 111.426 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 4.6 m -128.8 138.56 52.14 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.321 -0.992 . . . . 74.41 108.321 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 49.1 t -95.64 123.37 47.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.971 -0.752 . . . . 62.45 108.971 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 87.9 t -100.58 107.33 20.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.874 -1.057 . . . . 72.41 109.147 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -82.52 94.37 7.46 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.071 -0.513 . . . . 63.02 110.463 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.62 160.49 58.78 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.172 -0.922 . . . . 44.03 110.476 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.799 2.333 . . . . 72.54 111.183 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.34 -0.86 57.16 Favored Glycine 0 C--N 1.31 -0.875 0 C-N-CA 120.972 -0.632 . . . . 72.04 113.831 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.01 -66.66 0.9 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.172 0.486 . . . . 74.31 110.756 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 m 71.64 -49.58 0.69 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.123 0.969 . . . . 70.54 110.571 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -107.85 136.05 48.22 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.235 -1.394 . . . . 74.43 107.235 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -129.32 140.17 51.49 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.979 0.419 . . . . 74.41 110.993 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.58 139.6 44.39 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.564 -0.743 . . . . 72.23 110.739 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.4 pt -121.71 150.44 24.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.887 -1.153 . . . . 72.22 107.887 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.2 mtt180 -131.27 139.37 49.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 110.106 -0.331 . . . . 72.52 110.106 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.546 HG22 HG21 ' A' ' 425' ' ' THR . 52.2 t -110.77 122.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.579 -1.267 . . . . 75.22 107.579 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.19 138.7 26.99 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 63.3 111.507 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.8 mm -96.6 132.61 40.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 107.089 -1.449 . . . . 70.2 107.089 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -95.7 147.08 6.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.358 -1.719 . . . . 65.04 106.358 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.18 88.0 3.05 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.312 0.577 . . . . 63.53 111.694 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.75 113.29 22.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.587 -2.375 . . . . 72.03 104.587 172.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -120.29 94.85 4.51 Favored 'General case' 0 C--N 1.274 -2.717 0 C-N-CA 116.917 -1.913 . . . . 54.31 110.547 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.4 mm -121.34 156.64 25.12 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.042 0 CA-C-N 111.172 -2.74 . . . . 73.13 105.109 -174.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -53.13 114.78 1.58 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.139 -1.424 . . . . 71.31 107.578 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 37.1 mt-10 -129.19 123.85 33.09 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-N 115.691 -0.686 . . . . 63.43 110.202 -170.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -134.06 105.95 6.97 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.893 -1.049 . . . . 51.34 109.302 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.03 61.6 3.13 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 124.376 1.048 . . . . 65.33 113.316 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.85 124.27 39.79 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.509 -0.876 . . . . 73.5 111.125 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.6 171.85 8.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.822 -1.081 . . . . 72.41 108.37 -175.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.567 ' CE2' HD11 ' A' ' 496' ' ' ILE . 13.8 p90 -147.73 171.98 14.81 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.972 -1.122 . . . . 73.03 107.972 168.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.9 mt -117.56 142.85 46.71 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.908 -0.775 . . . . 74.42 108.908 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.28 122.23 66.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.753 -1.573 . . . . 44.21 106.753 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -111.37 139.55 46.69 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.349 0.405 . . . . 75.23 110.322 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.9 mt -101.25 128.19 47.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.869 -1.16 . . . . 71.34 107.869 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.2 m -151.05 -175.3 5.1 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.668 -0.864 . . . . 61.34 108.668 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.2 t30 50.86 83.41 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.694 1.198 . . . . 71.12 111.248 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.27 119.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.774 -0.825 . . . . 54.1 108.774 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? . . . . . 0 C--N 1.291 -1.971 0 N-CA-C 108.794 -0.817 . . . . 32.2 108.794 -179.075 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 65.4 m . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 120.841 0.353 . . . . 63.22 111.939 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.45 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.848 -1.167 . . . . 64.13 107.848 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 30.7 m -103.37 128.62 50.42 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.57 -0.452 . . . . 64.13 110.298 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.471 HG11 HG11 ' A' ' 390' ' ' VAL . 69.9 t -113.36 119.19 60.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.255 -1.017 . . . . 74.34 108.255 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.411 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 7.3 m -107.75 118.2 36.11 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.366 -0.976 . . . . 71.13 108.366 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.567 HD11 ' CE2' ' A' ' 456' ' ' PHE . 4.9 mp -97.74 120.75 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.596 0.712 . . . . 75.42 110.067 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.446 ' O ' HD13 ' A' ' 384' ' ' LEU 0.265 29.3 m-85 -88.0 104.46 16.67 Favored 'General case' 0 N--CA 1.388 -3.537 0 CA-C-O 122.355 1.074 . . . . 72.35 113.262 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.5 -55.89 16.43 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 111.748 -2.478 . . . . 71.13 109.064 172.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 C--N 1.313 -0.995 0 C-N-CA 125.633 1.573 . . . . 53.2 111.135 177.627 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 N--CA 1.415 -2.203 0 CA-C-O 121.275 0.559 . . . . 64.13 111.12 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 31.8 mm -114.93 119.14 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.282 -1.747 . . . . 72.21 106.282 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -155.85 164.42 38.54 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.934 -0.306 . . . . 74.44 111.024 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -82.35 153.9 25.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.616 -0.513 . . . . 75.12 109.616 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -62.57 -38.95 92.08 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.226 -0.657 . . . . 75.51 109.226 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -125.37 175.66 7.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.967 -1.015 . . . . 64.03 112.089 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.02 -21.58 10.86 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 115.05 -0.977 . . . . 71.42 111.657 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 30.1 m -135.85 132.4 36.56 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.67 -0.493 . . . . 64.24 109.67 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 46.1 m-85 -122.92 136.79 54.99 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.25 -1.019 . . . . 65.3 108.25 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 495' ' ' THR . 75.1 mt-30 -130.02 143.32 50.73 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.241 -1.022 . . . . 73.15 108.241 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 33.9 t -153.34 165.27 36.28 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.428 -0.952 . . . . 71.1 108.428 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.24 143.0 30.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 122.589 0.356 . . . . 60.41 111.23 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -59.72 -37.27 78.43 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.876 -0.602 . . . . 71.24 109.672 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.44 8.31 14.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.968 -0.56 . . . . 73.12 112.371 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 32.2 t -89.91 -11.96 40.29 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 119.962 -0.695 . . . . 51.24 110.924 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.38 -53.61 2.43 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.628 -0.796 . . . . 75.14 113.708 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 7.8 p -141.37 164.93 28.91 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.803 0.301 . . . . 64.22 110.697 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.645 HG11 HG11 ' A' ' 494' ' ' VAL . 4.8 p -120.1 127.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.103 -1.073 . . . . 72.11 108.103 172.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.99 124.2 42.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 71.33 110.799 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.448 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.1 mp -116.54 146.74 42.41 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.142 -1.429 . . . . 75.31 107.142 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.6 m -116.59 129.22 56.04 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.309 -0.556 . . . . 43.13 110.624 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.414 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 73.1 mt -98.41 120.54 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 107.675 -1.232 . . . . 74.42 107.675 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 397' ' ' ARG . 49.3 mm -98.62 129.01 49.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 107.436 -1.32 . . . . 73.43 107.436 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -108.64 107.7 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.464 -0.939 . . . . 72.45 108.464 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ARG . . . . . 0.508 ' HG3' HG22 ' A' ' 395' ' ' ILE . 59.2 mtt180 . . . . . 0 CA--C 1.501 -0.917 0 CA-C-O 121.041 0.448 . . . . 74.05 111.997 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 19.3 m . . . . . 0 N--CA 1.41 -2.428 0 CA-C-O 121.767 0.794 . . . . 74.03 110.102 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.61 146.29 16.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.198 -1.365 . . . . 73.54 107.857 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 33.6 m-85 -126.4 127.32 45.29 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.125 -0.694 . . . . 65.41 109.125 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.55 129.75 68.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.695 -1.224 . . . . 64.13 107.695 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 13.7 t70 -96.99 140.6 31.28 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.606 0.241 . . . . 60.41 110.588 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -137.1 152.34 49.9 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.751 -0.379 . . . . 72.52 111.645 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.89 172.86 14.98 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.265 1.426 . . . . 74.03 108.078 174.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.9 p -106.44 161.03 14.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.971 -0.381 . . . . 65.43 109.971 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.2 tp10 -107.65 155.29 20.31 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 122.704 0.401 . . . . 43.31 110.151 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 6.8 m-20 -84.63 1.87 44.21 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 124.021 0.928 . . . . 72.22 112.333 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -11.06 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.499 2.836 0 N-CA-C 117.413 1.725 . . . . 73.25 117.413 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 14.8 t -126.93 17.71 7.28 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 117.73 0.765 . . . . 63.01 110.445 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.88 -162.81 1.63 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.155 -0.475 . . . . 60.2 110.164 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.417 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 63.2 m-20 -135.73 119.72 17.52 Favored 'General case' 0 CA--C 1.485 -1.546 0 CA-C-O 121.344 0.592 . . . . 74.3 111.215 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.91 124.48 27.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.447 -0.946 . . . . 74.31 108.447 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.25 -15.28 43.2 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 110.663 -0.975 . . . . 53.11 110.663 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 18.3 t -114.31 -50.55 2.8 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.17 -0.678 . . . . 54.41 109.17 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 20.6 m-20 -85.66 -59.66 2.25 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 122.307 1.051 . . . . 63.43 110.354 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.683 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -138.83 162.83 33.82 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.826 -1.079 . . . . 73.45 108.894 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.558 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.9 tt0 -73.82 156.87 37.33 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 124.165 0.915 . . . . 73.14 110.788 -173.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.642 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.2 p90 -89.97 -14.33 34.28 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.175 -0.92 . . . . 74.14 111.448 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.558 ' H ' ' HG2' ' A' ' 423' ' ' GLU . 15.2 t 33.24 66.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.455 1.902 . . . . 74.04 113.127 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.23 111.77 15.79 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.049 0.928 . . . . 72.14 109.592 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -151.76 173.93 30.94 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 120.061 -1.066 . . . . 22.35 111.61 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 9.2 m -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 106.913 -1.514 . . . . 50.23 106.913 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 32.7 t -95.74 120.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.24 -1.022 . . . . 64.24 108.24 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.68 106.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 115.255 -0.884 . . . . 75.4 109.037 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.3 m-85 -82.03 94.21 7.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.153 -0.684 . . . . 72.14 109.153 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.05 167.34 30.03 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 115.048 -0.978 . . . . 63.15 110.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.79 110.52 0.64 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.497 2.131 . . . . 64.13 111.569 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 113.56 -18.7 19.95 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.716 -0.675 . . . . 72.42 112.078 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -83.92 62.37 6.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.305 0.574 . . . . 75.42 111.974 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 m -65.64 -20.94 66.5 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.857 0.836 . . . . 53.32 109.486 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -132.01 135.07 46.26 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.066 -1.457 . . . . 64.3 107.066 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -122.99 147.8 46.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 111.565 0.209 . . . . 74.21 111.565 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -118.41 131.4 56.28 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.299 -0.63 . . . . 61.21 109.299 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.7 pt -120.96 149.4 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.099 -1.074 . . . . 74.31 108.099 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.1 mtt180 -129.49 138.53 51.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-O 120.899 0.381 . . . . 74.02 110.854 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.609 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 63.7 t -104.92 126.57 59.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.667 -0.864 . . . . 74.13 108.667 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -68.29 127.31 23.79 Favored Glycine 0 N--CA 1.433 -1.542 0 O-C-N 124.115 0.884 . . . . 73.25 111.953 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.456 HD12 HG12 ' A' ' 496' ' ' ILE . 43.5 mm -94.6 134.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 106.07 -1.826 . . . . 72.14 106.07 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.3 mt -98.57 144.99 10.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 106.982 -1.488 . . . . 74.4 106.982 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.2 88.3 4.28 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.667 -0.813 . . . . 72.52 111.632 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.74 97.83 5.82 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.875 -2.269 . . . . 52.21 104.875 169.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.59 87.05 2.61 Favored 'General case' 0 CA--C 1.46 -2.511 0 CA-C-O 122.905 1.336 . . . . 74.1 109.856 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.425 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 26.5 mm -116.1 154.48 17.61 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.948 0 CA-C-N 111.688 -2.506 . . . . 75.32 104.575 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -63.97 114.82 4.35 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.386 -1.726 . . . . 71.44 108.62 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.428 ' HB2' ' OD1' ' A' ' 498' ' ' ASP . 19.5 mt-10 -135.49 151.93 50.85 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.646 -1.161 . . . . 62.22 108.485 -170.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -131.55 102.1 5.78 Favored 'General case' 0 N--CA 1.411 -2.393 0 C-N-CA 119.583 -0.847 . . . . 72.32 111.165 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 14.3 t70 63.86 61.55 0.95 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 124.704 1.252 . . . . 54.41 111.018 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.41 130.77 40.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.965 -0.562 . . . . 74.2 109.576 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.94 161.86 39.11 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.885 -0.726 . . . . 72.55 109.831 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.609 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 25.1 p90 -140.91 -178.99 5.81 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.98 -0.555 . . . . 70.31 109.711 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.3 mt -120.92 138.9 53.88 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.359 -1.349 . . . . 75.24 107.359 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 491' ' ' THR . 61.1 t -106.33 121.95 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.069 -1.456 . . . . 75.31 107.069 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 412' ' ' GLU . 63.5 m-70 -110.68 128.36 55.67 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.503 0.502 . . . . 73.4 111.023 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.99 131.7 42.09 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.031 -1.1 . . . . 74.24 108.031 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 12.4 p -155.7 -176.81 6.15 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.843 -0.799 . . . . 51.14 108.843 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 2.4 t-20 49.67 81.96 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.176 0.922 . . . . 70.13 112.694 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.12 128.36 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 115.332 -0.849 . . . . 64.13 108.772 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 72.0 tttt . . . . . 0 N--CA 1.403 -2.776 0 N-CA-C 106.381 -1.711 . . . . 65.21 106.381 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 36.0 m . . . . . 0 N--CA 1.42 -1.955 0 CA-C-O 120.672 0.272 . . . . 54.14 111.057 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -125.27 136.68 53.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.441 -1.318 . . . . 75.54 107.441 172.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 28.0 m -89.94 125.82 35.51 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.715 -0.476 . . . . 75.51 109.715 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.645 HG11 HG11 ' A' ' 390' ' ' VAL . 79.2 t -111.83 109.35 28.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.065 -0.717 . . . . 61.43 109.065 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 29.5 m -99.99 122.27 42.63 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.126 -1.064 . . . . 75.55 108.126 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.683 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -101.79 124.23 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 N-CA-C 108.561 -0.903 . . . . 71.34 108.561 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . 0.277 42.0 m-85 -87.8 111.3 21.22 Favored 'General case' 0 N--CA 1.393 -3.3 0 CA-C-O 122.124 0.964 . . . . 64.25 112.514 178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 498' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 451' ' ' GLU . 7.6 m-20 -51.8 -52.41 49.27 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-N 111.882 -2.417 . . . . 72.25 112.364 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 N--CA 1.472 0.641 0 O-C-N 125.171 1.544 . . . . 74.41 107.956 -173.979 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp . . . . . 0 C--O 1.24 0.576 0 N-CA-C 108.986 -0.746 . . . . 53.21 108.986 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.44 115.75 50.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.695 -1.594 . . . . 73.24 106.695 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -146.54 158.58 43.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 119.012 0.824 . . . . 71.25 112.752 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -70.47 143.1 51.84 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.542 -0.54 . . . . 73.43 109.542 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.71 -39.44 80.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.533 0.683 . . . . 74.5 109.171 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 12.7 mt-30 -122.58 153.71 38.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.432 -0.804 . . . . 71.2 111.34 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.2 -22.82 26.31 Favored Glycine 0 C--N 1.304 -1.24 0 C-N-CA 120.98 -0.629 . . . . 41.4 111.644 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 85.7 m -137.0 135.72 37.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.144 -0.687 . . . . 55.5 109.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 72.0 m-85 -124.96 138.85 54.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.264 -1.013 . . . . 71.23 108.264 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 495' ' ' THR . 39.3 mt-30 -128.93 124.86 36.21 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.888 -0.782 . . . . 73.34 108.888 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' CYS . . . . . 0.573 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -136.49 156.73 48.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.509 -0.552 . . . . 72.4 109.509 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -75.24 144.63 42.48 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 110.174 -0.306 . . . . 63.1 110.174 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 498' ' ' ASP . 51.8 tt0 -61.66 -31.56 71.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.831 0.824 . . . . 70.24 109.92 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.521 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.9 p-10 -84.52 1.74 44.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.891 -1.049 . . . . 73.54 112.698 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 45.8 t -77.0 -19.09 57.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.133 -0.354 . . . . 54.43 111.476 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.13 -61.86 2.19 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.748 -0.739 . . . . 75.11 112.208 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.3 p -136.96 148.97 47.25 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.54 0.17 . . . . 54.31 110.566 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.2 p -106.35 134.06 49.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.1 -1.445 . . . . 63.22 107.1 174.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.13 112.32 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.547 0.689 . . . . 63.41 110.835 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.499 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.9 mp -101.87 153.88 19.44 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.485 -1.302 . . . . 64.34 107.485 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -116.52 132.35 56.7 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.513 -0.475 . . . . 54.21 110.025 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 79.2 mt -104.91 122.86 58.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.186 -1.042 . . . . 73.22 108.186 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.72 127.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.54 -0.911 . . . . 54.44 108.54 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 54.7 ttt180 -113.75 110.1 19.63 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.3 -0.864 . . . . 63.24 109.157 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 . . . . . 0 C--N 1.304 -1.412 0 N-CA-C 109.439 -0.578 . . . . 71.11 109.439 -178.846 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.9 m . . . . . 0 N--CA 1.437 -1.107 0 CA-C-O 121.629 0.728 . . . . 63.43 110.749 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.09 149.68 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.085 -0.961 . . . . 71.54 108.663 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.423 ' CZ ' HG13 ' A' ' 430' ' ' VAL . 22.1 m-85 -127.31 129.38 47.55 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.942 0.497 . . . . 73.15 110.19 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.66 131.1 62.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.897 -0.779 . . . . 75.22 108.897 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 21.5 t70 -99.91 135.43 41.34 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 110.066 -0.346 . . . . 75.11 110.066 -175.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -134.98 165.66 24.82 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 122.093 -0.379 . . . . 72.45 111.158 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.515 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 21.6 ttm180 -166.02 160.19 16.28 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.115 -1.068 . . . . 73.42 108.115 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 72.5 p -96.71 154.96 16.98 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.905 -0.776 . . . . 72.54 108.905 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -115.65 148.49 39.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.734 1.013 . . . . 72.45 113.734 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.79 2.61 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.885 0 C-N-CA 130.722 3.609 . . . . 72.33 114.102 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -20.19 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 125.741 1.638 . . . . 73.42 117.156 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.1 t -136.24 16.19 3.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.117 0.958 . . . . 75.43 109.857 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.32 -164.14 1.52 Allowed 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.103 -1.073 . . . . 41.34 108.103 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -138.98 121.84 16.57 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.212 -0.995 . . . . 74.15 111.527 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -80.82 124.71 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.232 -0.655 . . . . 44.13 109.232 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.18 -27.8 7.56 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.552 -1.819 . . . . 73.11 108.552 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.3 t -106.78 -55.71 2.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.945 -0.627 . . . . 74.21 109.518 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.615 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -80.98 -60.28 2.35 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-O 121.608 0.718 . . . . 74.14 111.112 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.701 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -136.75 166.95 22.39 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.545 -0.909 . . . . 71.25 108.545 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.3 tm-20 -77.72 154.42 32.07 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.638 -0.875 . . . . 74.42 108.638 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.504 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.9 p90 -95.52 -13.23 24.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.97 0.73 . . . . 64.22 112.97 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.502 HG21 HG22 ' A' ' 442' ' ' VAL . 10.1 t 36.01 57.77 0.97 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.364 1.866 . . . . 74.23 113.791 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 10.5 pt-20 -78.51 116.44 18.9 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.741 0.781 . . . . 72.22 108.945 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -157.08 -173.61 25.73 Favored Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 115.313 -0.858 . . . . 71.13 111.194 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 17.9 m -128.54 136.59 50.97 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.327 -1.36 . . . . 61.02 107.327 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.42 127.64 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.745 -1.205 . . . . 62.21 107.745 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.423 HG13 ' CZ ' ' A' ' 406' ' ' PHE . 22.7 t -105.04 106.69 20.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.831 -0.803 . . . . 55.11 108.831 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.9 m-85 -85.3 95.64 9.27 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.707 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 175.08 4.46 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 114.818 -1.083 . . . . 64.32 110.238 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.83 135.2 50.69 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.444 1.43 . . . . 73.42 109.603 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 91.85 -20.09 44.5 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.084 -0.579 . . . . 44.13 112.506 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.45 63.45 4.91 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.294 0.637 . . . . 75.45 110.821 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 m -70.69 -24.92 62.75 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.972 -1.013 . . . . 74.24 108.441 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.68 135.39 42.0 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.18 -0.674 . . . . 74.1 109.18 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -123.05 153.62 39.62 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.945 0.402 . . . . 51.24 111.864 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -113.08 129.82 56.38 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.058 -0.974 . . . . 74.02 109.49 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.403 ' CG1' ' HB2' ' A' ' 392' ' ' LEU . 40.7 pt -117.37 137.28 51.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.294 -1.002 . . . . 61.54 108.294 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 47.0 mtt180 -121.97 136.37 54.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.28 0.562 . . . . 72.22 112.134 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.627 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.6 t -111.12 123.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.299 -1.371 . . . . 74.44 107.299 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -78.68 135.79 16.42 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.856 -0.688 . . . . 62.13 111.996 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.455 HD12 HG12 ' A' ' 496' ' ' ILE . 38.4 mm -94.75 131.29 42.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.602 -1.258 . . . . 73.41 107.602 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.6 mt -93.52 143.17 12.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.322 -2.103 . . . . 75.41 105.322 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.47 86.22 7.31 Favored 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 119.036 -1.065 . . . . 62.31 111.314 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.85 98.44 8.13 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 103.25 -2.87 . . . . 72.33 103.25 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.84 89.29 3.61 Favored 'General case' 0 C--N 1.271 -2.841 0 C-N-CA 117.2 -1.8 . . . . 72.32 110.911 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.426 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -123.2 153.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.449 0 N-CA-C 104.265 -2.494 . . . . 74.52 104.265 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -60.12 114.64 2.97 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.658 -1.217 . . . . 73.23 108.845 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 21.3 mt-10 -128.46 140.99 51.53 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.717 -0.674 . . . . 74.41 109.555 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -121.15 99.67 6.62 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.313 -0.858 . . . . 75.42 109.546 -173.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.303 4.3 p-10 47.28 61.15 3.03 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.413 1.485 . . . . 64.54 112.794 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.559 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.7 tt0 -74.56 127.93 34.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.817 -1.083 . . . . 63.33 108.684 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.433 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.2 p-10 -145.56 169.09 19.08 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.811 -0.555 . . . . 73.14 111.905 -173.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.627 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 26.2 p90 -143.83 179.48 7.14 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.269 -0.423 . . . . 65.44 110.582 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 37.9 mt -118.08 138.68 52.08 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.724 -1.213 . . . . 74.51 107.724 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 491' ' ' THR . 41.1 t -112.43 126.47 69.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.216 -1.402 . . . . 72.54 107.216 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -119.66 157.07 29.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.407 0.442 . . . . 72.33 110.662 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.73 138.63 50.49 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.456 -0.572 . . . . 70.43 109.456 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.9 p -153.44 -174.3 4.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.023 0.529 . . . . 70.54 109.691 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.7 t30 34.79 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 126.201 1.8 . . . . 65.21 112.85 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.33 127.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 C-N-CA 119.9 -0.72 . . . . 65.45 109.692 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 108.993 -0.743 . . . . 73.41 108.993 -177.553 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 17.8 m . . . . . 0 N--CA 1.414 -2.265 0 N-CA-C 109.686 -0.487 . . . . 64.43 109.686 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -122.75 117.39 25.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.525 -1.657 . . . . 64.01 106.525 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 89.8 m -86.09 119.77 26.75 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.237 0.542 . . . . 61.23 110.573 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.557 HG11 HG11 ' A' ' 390' ' ' VAL . 80.2 t -104.08 108.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.603 -0.888 . . . . 55.04 108.603 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 90.2 m -96.58 121.01 37.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.629 -0.878 . . . . 73.42 108.629 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.94 126.88 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.179 0 CA-C-O 121.502 0.668 . . . . 73.34 109.535 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.59 ' O ' HD13 ' A' ' 384' ' ' LEU . 9.3 m-85 -93.0 104.16 16.4 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-O 121.854 0.835 . . . . 73.43 110.433 173.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 498' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 385' ' ' GLU . 8.3 m-20 -56.01 -54.02 49.9 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 112.882 -1.963 . . . . 73.42 113.283 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 N--CA 1.48 1.039 0 C-N-CA 126.174 1.79 . . . . 71.24 107.863 -170.129 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp . . . . . 0 N--CA 1.444 -0.766 0 N-CA-C 109.569 -0.53 . . . . 72.1 109.569 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 39.0 mm -107.16 115.87 49.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.909 -1.886 . . . . 72.54 105.909 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.46 167.11 23.76 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 118.794 0.725 . . . . 60.13 112.487 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -78.68 147.61 33.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.107 -0.701 . . . . 73.0 109.107 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.13 -53.3 39.51 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.569 -0.9 . . . . 71.11 108.569 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -109.8 174.15 6.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.074 -0.512 . . . . 65.31 110.751 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.48 -35.49 2.85 Favored Glycine 0 C--N 1.298 -1.559 0 CA-C-N 115.264 -0.88 . . . . 62.45 111.148 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 23.1 m -121.05 134.74 55.29 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.915 -1.142 . . . . 62.24 107.915 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 61.6 m-85 -124.19 136.34 54.11 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.673 -1.232 . . . . 71.35 107.673 175.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.39 123.59 36.56 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.507 -0.923 . . . . 71.24 108.507 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.2 p -134.33 152.9 52.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.667 -0.494 . . . . 71.14 109.667 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -75.02 152.74 38.68 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.256 -0.646 . . . . 75.4 109.256 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 498' ' ' ASP . 29.1 tt0 -65.52 -38.73 90.51 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.06 0.933 . . . . 64.53 109.5 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.464 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.5 p-10 -83.89 16.36 2.85 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.875 -1.057 . . . . 72.2 111.661 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.9 t -84.63 -20.59 31.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.188 0.518 . . . . 61.13 109.632 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.85 -60.37 3.15 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.913 -0.66 . . . . 72.11 111.883 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.53 HG22 ' HA2' ' A' ' 443' ' ' GLY . 9.0 p -143.57 155.97 44.45 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 122.662 0.385 . . . . 50.25 110.209 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -112.82 132.43 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.522 -1.288 . . . . 62.02 107.522 173.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.52 120.14 40.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.197 0.522 . . . . 51.13 110.141 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.8 mp -112.2 142.25 44.9 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.588 -1.264 . . . . 63.41 107.588 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.2 m -106.8 131.14 54.25 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.565 -0.531 . . . . 70.32 109.565 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.3 122.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.869 -1.16 . . . . 64.43 107.869 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.6 mm -98.02 123.95 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.319 -0.993 . . . . 54.23 108.319 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.505 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 51.4 ttt180 -111.02 110.89 21.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.383 -0.826 . . . . 71.32 109.639 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 . . . . . 0 C--N 1.308 -1.215 0 CA-C-N 115.968 -0.56 . . . . 64.22 109.578 -179.327 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 4.3 m . . . . . 0 N--CA 1.42 -1.959 0 CA-C-O 121.47 0.652 . . . . 43.01 111.687 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.65 142.96 22.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.042 -1.095 . . . . 72.25 108.042 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 464' ' ' LYS . 26.0 m-85 -127.24 129.91 48.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.349 -0.612 . . . . 72.23 109.349 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.27 132.39 66.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.006 -1.109 . . . . 73.42 108.006 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 19.2 t70 -93.3 134.53 35.41 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.75 -0.833 . . . . 71.02 108.75 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -123.06 148.12 45.95 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.923 -0.769 . . . . 74.15 108.923 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 410' ' ' ARG . 6.6 ttm180 -162.93 163.9 26.05 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.292 -1.003 . . . . 61.03 108.292 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 22.1 p -96.69 172.89 7.62 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.903 0.382 . . . . 73.31 111.035 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 4.8 tp10 -133.93 153.96 51.4 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.092 -2.188 . . . . 71.41 105.092 173.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -58.18 -45.02 88.28 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.185 0.809 . . . . 72.41 113.185 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.95 -93.73 0.16 Allowed Glycine 0 C--N 1.293 -1.857 0 CA-C-N 115.667 -0.697 . . . . 53.23 112.03 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.0 t -132.28 9.62 4.42 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.137 0.97 . . . . 72.35 109.007 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -132.14 -159.75 0.99 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.185 -1.783 . . . . 72.2 106.185 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -150.34 113.84 4.95 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.465 -0.894 . . . . 71.14 112.255 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.91 128.82 37.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.265 -0.643 . . . . 34.03 109.265 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.03 -31.63 6.18 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 109.102 -1.599 . . . . 42.43 109.102 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.2 m -110.18 -51.89 2.83 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.106 0.479 . . . . 61.4 109.859 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.625 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.1 m-20 -82.9 -61.43 1.87 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.531 0.682 . . . . 74.23 110.927 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.554 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.2 OUTLIER -132.31 173.42 11.28 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 107.228 -1.397 . . . . 75.21 107.228 -178.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.462 ' HG2' ' H ' ' A' ' 425' ' ' THR . 30.2 tt0 -79.11 148.0 32.54 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.361 -0.607 . . . . 72.24 109.361 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -82.36 -16.93 47.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 113.133 0.79 . . . . 63.21 113.133 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.581 HG21 HG22 ' A' ' 442' ' ' VAL 0.251 14.0 t 35.95 73.11 0.09 Allowed 'General case' 0 CA--C 1.556 1.198 0 O-C-N 125.513 1.758 . . . . 73.34 113.279 -178.117 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.5 130.93 35.76 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.591 -1.186 . . . . 75.23 109.273 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.78 48.53 Favored Glycine 0 CA--C 1.476 -2.35 0 C-N-CA 119.784 -1.198 . . . . 52.41 111.86 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 60.6 m -123.68 138.63 54.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.524 -0.917 . . . . 71.03 108.524 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.39 124.8 49.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.927 -0.768 . . . . 65.22 108.927 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 432' ' ' LYS . 23.4 t -95.3 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.25 109.232 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.505 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 60.5 m-85 -88.78 95.67 10.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.095 0.474 . . . . 73.41 111.236 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 57.3 mtmt -92.7 176.81 2.36 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 114.918 -1.037 . . . . 72.32 110.456 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.5 Cg_exo -56.62 131.71 47.3 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 122.479 2.119 . . . . 72.21 112.353 175.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 98.34 -33.08 6.27 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.845 -0.616 . . . . 70.11 111.985 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.458 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 33.4 mt-10 -82.54 64.15 7.04 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.803 1.241 . . . . 74.34 113.086 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 9.2 t -75.81 -13.01 60.28 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.49 -1.232 . . . . 62.22 109.816 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -135.79 137.12 41.28 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.867 -1.16 . . . . 71.25 107.867 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -130.81 157.87 41.69 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.572 0.225 . . . . 72.43 111.367 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -122.59 137.29 54.94 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.912 -0.585 . . . . 74.34 110.498 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -121.35 145.72 27.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 75.23 108.772 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 60.2 mtm180 -120.42 141.64 49.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.032 0.444 . . . . 71.53 111.097 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.581 HG22 HG21 ' A' ' 425' ' ' THR . 42.0 t -110.72 121.54 63.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.392 -1.336 . . . . 55.22 107.392 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.53 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.15 140.67 30.17 Favored Glycine 0 N--CA 1.433 -1.544 0 O-C-N 123.895 0.747 . . . . 61.52 112.113 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.406 HG23 ' HD1' ' A' ' 422' ' ' TYR . 37.8 mm -101.15 132.56 46.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 106.74 -1.578 . . . . 73.4 106.74 175.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.625 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.9 mt -99.22 151.49 4.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 106.536 -1.653 . . . . 71.44 106.536 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -82.38 86.23 6.76 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.223 -0.991 . . . . 71.04 112.136 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.41 107.59 18.55 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.76 -2.682 . . . . 71.33 103.76 169.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -109.69 84.86 2.0 Allowed 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 117.864 -1.534 . . . . 71.34 109.921 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 47.6 mm -124.37 154.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 111.966 -2.379 . . . . 72.3 105.81 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.19 115.38 4.45 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.428 -1.309 . . . . 62.3 109.018 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 24.0 mt-10 -126.98 135.75 51.29 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 114.371 -1.286 . . . . 75.01 109.516 -170.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -138.0 117.16 12.61 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.972 -1.013 . . . . 70.25 108.903 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 56.8 29.99 16.98 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.227 1.011 . . . . 72.11 110.97 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -75.38 118.24 18.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.906 -1.146 . . . . 70.13 107.906 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 2.7 p-10 -144.03 167.72 21.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.313 0.578 . . . . 70.5 110.775 -174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.546 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.9 p90 -139.12 -177.49 4.92 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.443 -0.799 . . . . 72.51 109.242 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 30.1 mt -122.13 139.64 53.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.401 -0.963 . . . . 54.33 108.401 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.81 126.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.821 -1.548 . . . . 71.51 106.821 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -119.62 149.62 41.66 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.164 -0.471 . . . . 53.51 110.672 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.08 124.84 50.25 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.275 -1.75 . . . . 65.35 106.275 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.8 m -144.25 170.91 15.08 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.212 -0.662 . . . . 74.11 109.212 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.13 86.53 0.04 OUTLIER 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.708 1.203 . . . . 63.4 112.525 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 61.9 t -80.14 128.82 38.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 119.698 -0.801 . . . . 61.42 108.897 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 406' ' ' PHE . 39.9 ttmt . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 107.088 -1.449 . . . . 72.41 107.088 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.413 -2.324 0 N-CA-C 108.381 -0.97 . . . . 73.44 108.381 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -104.78 131.82 51.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.618 -1.252 . . . . 50.23 107.618 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.7 m -98.86 121.86 41.35 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 120.481 -0.488 . . . . 70.11 110.338 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 86.9 t -109.01 106.06 19.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.798 -0.816 . . . . 70.44 108.798 177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 93.9 m -95.83 115.3 27.22 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.861 -1.162 . . . . 72.33 107.861 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.541 HD13 ' CZ ' ' A' ' 422' ' ' TYR . 4.9 mp -88.6 107.88 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 C-N-CA 119.896 -0.722 . . . . 52.44 109.867 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 38.2 m-85 -78.01 92.4 4.34 Favored 'General case' 0 CA--C 1.446 -3.044 0 N-CA-C 106.37 -1.715 . . . . 75.44 106.37 169.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 498' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 385' ' ' GLU . 1.1 p-10 -82.79 -19.87 36.91 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 114.241 -1.345 . . . . 71.22 108.905 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 N--CA 1.428 -1.552 0 CA-C-N 112.985 -1.916 . . . . 71.11 110.565 179.288 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.0 mmtp . . . . . 0 CA--C 1.505 -0.783 0 N-CA-C 109.899 -0.408 . . . . 73.34 109.899 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 35.6 mm -110.04 119.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.313 -1.366 . . . . 63.3 107.313 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -156.43 161.68 40.06 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 118.443 0.565 . . . . 64.44 112.305 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.17 145.04 40.17 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.133 -0.321 . . . . 73.2 110.133 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.89 -44.28 90.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.395 0.617 . . . . 72.3 109.359 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 14.4 mm100 -107.17 171.11 7.56 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.412 -0.813 . . . . 51.4 111.236 177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -105.62 -25.66 6.49 Favored Glycine 0 C--N 1.289 -2.063 0 N-CA-C 109.63 -1.388 . . . . 73.32 109.63 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 493' ' ' THR . 24.0 m -135.94 140.22 43.84 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.694 -1.225 . . . . 65.44 107.694 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 91.7 m-85 -129.13 136.69 50.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.31 -0.996 . . . . 74.43 108.31 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.66 134.45 53.74 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.131 -0.692 . . . . 74.31 109.131 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 31.7 t -148.69 165.03 32.57 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.486 -1.301 . . . . 72.35 107.486 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -84.4 143.54 29.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.627 0.603 . . . . 72.15 112.627 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.182 -0.917 . . . . 61.01 109.975 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.64 14.19 13.98 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.351 0.5 . . . . 71.31 112.351 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.78 -16.32 34.49 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.994 -0.441 . . . . 64.05 111.268 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.21 -68.77 0.37 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.527 -0.844 . . . . 74.33 112.405 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.522 HG22 ' HA2' ' A' ' 443' ' ' GLY . 16.7 p -135.18 161.68 34.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.094 0.473 . . . . 65.31 110.714 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 494' ' ' VAL . 5.7 p -112.5 129.13 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 107.842 -1.17 . . . . 71.04 107.842 172.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.78 120.85 40.39 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.603 0.564 . . . . 74.22 110.306 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.09 141.8 45.32 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.647 -1.242 . . . . 70.04 107.647 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -105.3 129.01 53.74 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.81 -0.441 . . . . 63.13 109.81 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.8 122.64 55.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.164 -1.05 . . . . 73.44 108.164 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.2 mm -94.43 132.36 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 C-N-CA 124.259 1.024 . . . . 70.44 108.456 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 60.6 ttt180 -115.6 111.23 20.36 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.293 -0.867 . . . . 70.41 109.788 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 . . . . . 0 C--N 1.299 -1.616 0 CA-C-N 115.129 -0.941 . . . . 72.01 109.044 179.473 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 25.3 m . . . . . 0 N--CA 1.403 -2.812 0 CA-C-O 121.561 0.696 . . . . 74.22 110.684 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 55.8 t -104.68 143.2 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 114.428 -1.26 . . . . 71.14 108.618 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 47.4 m-85 -126.22 112.77 16.14 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.544 -0.909 . . . . 64.34 108.544 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.6 124.66 71.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.1 -0.704 . . . . 73.54 109.1 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -87.41 140.49 29.48 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.094 -0.706 . . . . 73.22 109.094 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -142.83 154.66 44.38 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.44 -0.788 . . . . 74.12 111.69 -175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 426' ' ' GLU . 56.0 mtt85 -154.6 165.58 36.05 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 125.144 1.378 . . . . 63.44 109.27 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.607 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 58.5 p -100.97 158.05 16.29 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.647 -0.706 . . . . 70.34 109.262 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 8.2 tp10 -106.02 163.92 12.38 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.006 -1.85 . . . . 75.53 106.006 176.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.8 p-10 -60.29 -40.1 89.25 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.626 0.726 . . . . 70.15 110.559 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.76 -89.26 0.3 Allowed Glycine 0 C--N 1.299 -1.514 0 CA-C-N 114.737 -1.119 . . . . 73.44 110.456 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.433 ' CG2' ' H ' ' A' ' 455' ' ' ASN . 9.6 t -131.57 -1.09 3.9 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 122.093 0.949 . . . . 43.34 109.212 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -129.5 -154.84 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.254 -1.017 . . . . 73.12 108.254 -173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.41 125.6 20.06 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.101 0.477 . . . . 54.54 110.822 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -73.32 128.45 35.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.237 -0.653 . . . . 40.32 109.237 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.27 -13.08 48.34 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 110.522 -1.031 . . . . 24.24 110.522 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.4 m -117.64 -56.49 2.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.17 0.51 . . . . 72.34 109.67 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 38.1 m-20 -85.23 -57.64 3.0 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 122.174 0.988 . . . . 74.41 109.663 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.635 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -139.95 165.01 28.47 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.275 -0.875 . . . . 74.05 110.638 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.3 tt0 -73.82 149.16 41.82 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 124.057 0.848 . . . . 62.02 110.836 -173.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.607 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.3 OUTLIER -79.85 -16.29 55.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 73.5 111.818 176.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.608 HG21 HG22 ' A' ' 442' ' ' VAL 0.259 8.9 t 35.05 63.91 0.46 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 126.412 1.885 . . . . 72.24 113.622 -177.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' A' ' 410' ' ' ARG . 21.5 pt-20 -79.2 126.36 30.65 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.427 -0.806 . . . . 74.15 109.084 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -170.14 -173.2 37.32 Favored Glycine 0 N--CA 1.41 -3.065 0 N-CA-C 110.672 -0.971 . . . . 60.52 110.672 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 40.8 m -127.22 139.98 52.55 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.382 -0.97 . . . . 70.51 108.382 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.76 117.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.051 -1.092 . . . . 71.41 108.051 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.0 t -92.75 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.525 -0.761 . . . . 53.41 110.009 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.9 m-85 -91.82 94.46 9.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.129 -0.487 . . . . 74.33 110.053 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.2 mttm -82.79 174.93 5.31 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.073 -0.967 . . . . 64.33 110.296 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.2 Cg_exo -59.75 133.45 51.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 70.14 109.639 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.8 -18.8 48.88 Favored Glycine 0 C--N 1.305 -1.175 0 C-N-CA 120.564 -0.827 . . . . 44.11 113.199 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.83 63.99 7.22 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.24 0.616 . . . . 63.54 112.275 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 7.6 m -68.46 -19.27 64.55 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.182 -0.917 . . . . 73.24 109.113 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -138.28 137.78 37.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.294 -1.002 . . . . 72.33 108.294 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -124.48 151.66 44.32 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.485 -0.325 . . . . 74.02 111.028 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.76 138.99 48.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.964 -0.562 . . . . 64.11 109.946 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.51 133.9 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.445 -0.576 . . . . 74.3 109.445 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 24.5 mmt180 -104.55 133.02 50.12 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.636 -0.711 . . . . 73.04 111.123 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.685 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -110.55 124.21 67.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.14 -1.43 . . . . 64.31 107.14 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.7 133.86 19.77 Favored Glycine 0 N--CA 1.428 -1.841 0 O-C-N 123.903 0.752 . . . . 35.41 112.343 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 496' ' ' ILE . 34.7 mm -95.19 134.31 33.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 105.966 -1.865 . . . . 74.34 105.966 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 78.2 mt -97.03 143.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 107.732 -1.21 . . . . 64.32 107.732 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.87 95.03 0.66 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.544 0.688 . . . . 72.23 110.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.06 102.84 7.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 104.774 -2.306 . . . . 63.24 104.774 169.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -106.55 89.85 3.16 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.116 -1.434 . . . . 62.31 109.697 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.2 mm -129.63 155.57 41.43 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.28 0 CA-C-N 112.108 -2.315 . . . . 44.42 105.244 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.25 115.22 4.34 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 117.713 -1.595 . . . . 75.02 106.963 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 20.5 mt-10 -126.1 136.55 53.04 Favored 'General case' 0 CA--C 1.468 -2.178 0 CA-C-N 114.843 -1.071 . . . . 73.13 108.653 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -128.94 106.56 8.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.31 0.576 . . . . 63.3 110.35 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 54.74 60.67 3.36 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 125.316 1.446 . . . . 62.1 114.004 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.47 117.44 17.27 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.7 -0.852 . . . . 71.42 108.7 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.433 ' H ' ' CG2' ' A' ' 415' ' ' THR . 8.5 p30 -140.48 145.48 36.97 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.665 0.745 . . . . 74.34 110.115 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.685 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 22.3 p90 -123.81 174.3 7.61 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.612 -1.176 . . . . 74.15 109.124 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.3 mt -120.7 136.14 54.94 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 107.072 -1.455 . . . . 75.23 107.072 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.65 126.17 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.625 -1.25 . . . . 75.3 107.625 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -121.56 140.98 51.53 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.617 0.573 . . . . 74.23 110.007 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.92 138.8 33.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.973 -1.121 . . . . 74.43 107.973 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 14.9 m -146.55 177.16 9.27 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.16 -1.052 . . . . 72.11 108.16 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 46.3 t30 40.8 83.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.727 0 C-N-CA 125.112 1.365 . . . . 54.53 113.42 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.37 134.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.688 -0.687 . . . . 72.44 109.16 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 23.3 ttmm . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 108.016 -1.105 . . . . 74.44 108.016 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 110.002 -0.37 . . . . 73.13 110.002 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.37 27.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.244 -1.021 . . . . 71.12 108.244 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 380' ' ' THR . 30.8 m -86.0 121.26 28.37 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.876 0.37 . . . . 65.32 110.486 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 390' ' ' VAL . 73.6 t -107.25 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.411 -0.959 . . . . 65.33 108.411 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 24.5 m -98.14 112.85 24.67 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.815 -1.18 . . . . 75.21 107.815 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.635 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.59 121.63 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 N-CA-C 109.212 -0.662 . . . . 72.24 109.212 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.436 ' O ' HD13 ' A' ' 384' ' ' LEU 0.29 23.3 m-85 -81.87 99.95 9.33 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-O 122.652 1.215 . . . . 71.21 112.459 177.028 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -49.89 -52.11 35.46 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 111.042 -2.799 . . . . 64.31 109.862 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 N--CA 1.479 0.983 0 C-N-CA 126.018 1.727 . . . . 61.15 111.317 177.561 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 51.7 mttm . . . . . 0 N--CA 1.427 -1.621 0 CA-C-O 120.533 0.206 . . . . 72.42 110.509 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 25.5 mm -115.36 124.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 107.421 -1.325 . . . . 64.21 107.421 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -155.64 -177.8 6.82 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 110.025 -0.361 . . . . 64.45 110.025 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -94.33 162.37 13.86 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.146 0.498 . . . . 63.02 112.054 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.11 -35.47 56.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.239 -0.891 . . . . 70.11 109.854 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 23.1 mm-40 -122.38 172.31 8.42 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.386 -0.825 . . . . 70.35 111.966 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -103.01 -37.18 3.21 Favored Glycine 0 C--N 1.293 -1.845 0 CA-C-N 114.465 -1.243 . . . . 65.35 110.025 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' THR . . . . . 0.456 HG23 ' HB ' ' A' ' 493' ' ' THR . 26.0 m -133.02 130.98 40.15 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.452 0.644 . . . . 74.32 109.439 176.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 74.7 m-85 -113.43 143.9 43.71 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.112 -1.07 . . . . 71.12 108.112 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 495' ' ' THR . 15.7 mp0 -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.705 -0.85 . . . . 71.34 108.705 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 30.3 t -148.13 165.11 31.84 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.686 -0.857 . . . . 71.32 108.686 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.7 mm? -89.07 141.46 28.48 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 122.457 0.303 . . . . 60.15 110.617 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -56.88 -35.73 69.27 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 122.163 0.982 . . . . 74.52 109.605 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -74.26 -7.83 54.12 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.897 -1.502 . . . . 73.3 111.4 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.57 -22.85 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.011 0.434 . . . . 54.25 111.239 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.14 -51.48 2.48 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.177 -1.011 . . . . 44.22 112.493 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 17.2 p -138.12 160.75 38.58 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.073 0.463 . . . . 54.22 111.175 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.6 p -116.5 132.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.126 -1.435 . . . . 71.35 107.126 172.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -104.06 115.54 30.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.405 0.621 . . . . 54.35 110.36 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.1 mp -105.65 147.43 28.49 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.825 -1.176 . . . . 71.55 107.825 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.7 m -108.76 129.45 55.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.489 -0.559 . . . . 75.23 109.489 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.1 mt -97.98 119.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.465 -1.309 . . . . 74.32 107.465 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.17 121.6 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.473 -0.785 . . . . 55.24 109.324 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.44 129.93 55.87 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.222 -1.399 . . . . 73.54 107.222 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 . . . . . 0 C--N 1.285 -2.209 0 N-CA-C 109.389 -0.597 . . . . 74.11 109.389 177.661 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 33.4 m . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 121.336 0.588 . . . . 73.43 110.14 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.98 148.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.675 -0.693 . . . . 70.33 109.501 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.465 ' CE1' HG13 ' A' ' 430' ' ' VAL . 4.1 m-85 -123.55 132.62 53.95 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.821 0.849 . . . . 64.54 110.137 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.23 134.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.563 -1.273 . . . . 70.41 107.563 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.509 ' CB ' ' HB3' ' A' ' 462' ' ' ASN . 11.6 t70 -105.58 146.21 29.94 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.924 -0.485 . . . . 65.24 109.998 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -143.35 164.0 31.48 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.748 0.309 . . . . 62.24 110.257 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 17.2 ttp180 -166.42 169.28 14.12 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.693 -1.965 . . . . 73.13 105.693 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 68.5 p -96.72 145.9 25.37 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.303 0.573 . . . . 72.42 110.537 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 12.1 tp10 -108.67 133.75 52.33 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.929 -1.878 . . . . 73.13 105.929 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 64.2 m-20 -42.69 -52.66 4.82 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.112 1.365 . . . . 63.45 114.24 -173.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 74.57 -90.9 0.75 Allowed Glycine 0 C--N 1.285 -2.28 0 CA-C-N 114.975 -1.011 . . . . 63.45 110.918 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 455' ' ' ASN . 9.4 t -124.86 -13.86 6.82 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.703 -0.851 . . . . 72.01 108.703 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -105.86 -165.98 1.16 Allowed 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.288 -1.375 . . . . 74.51 107.288 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.52 115.87 10.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.116 -0.634 . . . . 60.41 110.62 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -72.56 138.51 46.92 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.809 -0.812 . . . . 73.12 108.809 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 97.85 -10.84 64.38 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.252 -1.139 . . . . 53.3 110.252 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 35.0 t -126.45 -56.09 1.42 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.792 -0.447 . . . . 64.41 109.792 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.593 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 13.6 m-20 -78.61 -54.88 5.66 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-O 121.541 0.686 . . . . 63.22 109.406 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.613 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -138.61 171.55 14.18 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 108.41 -0.959 . . . . 75.25 108.41 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.1 tm-20 -77.83 161.41 27.66 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.88 -1.156 . . . . 65.52 107.88 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.483 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 8.0 p90 -99.49 -12.98 19.69 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 112.451 0.538 . . . . 73.24 112.451 -174.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.485 HG21 HG22 ' A' ' 442' ' ' VAL 0.273 11.5 t 37.27 73.84 0.09 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.227 1.811 . . . . 65.41 113.449 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 0.6 OUTLIER -79.71 138.31 37.29 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.397 -1.274 . . . . 64.14 108.755 177.551 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 179.66 169.31 39.81 Favored Glycine 0 N--CA 1.413 -2.863 0 C-N-CA 118.777 -1.678 . . . . 70.13 112.205 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 5.9 m -117.41 133.67 55.71 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 106.69 -1.596 . . . . 63.34 106.69 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.2 t -96.14 119.85 44.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.745 -0.835 . . . . 70.13 108.745 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.465 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.0 t -95.73 117.44 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 71.22 108.941 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.9 m-85 -89.77 110.32 21.24 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 116.056 -0.52 . . . . 63.35 111.291 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 164.82 23.31 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.476 -0.784 . . . . 71.42 110.359 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -52.28 113.57 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.664 2.243 . . . . 72.15 112.236 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.58 25.29 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 111.134 -0.787 . . . . 73.11 111.134 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -81.85 63.23 6.01 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 123.533 0.733 . . . . 63.14 110.514 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 11.3 t -79.19 -7.69 58.43 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.874 -1.158 . . . . 71.52 107.874 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -136.92 137.09 39.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.905 -1.517 . . . . 75.54 106.905 172.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -125.98 153.23 44.62 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 111.596 0.221 . . . . 70.42 111.596 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -112.48 132.5 55.04 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.475 -0.565 . . . . 53.22 109.475 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 41.1 pt -127.07 146.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.255 -1.017 . . . . 64.42 108.255 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 52.5 mtt180 -125.8 145.56 50.16 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.133 0.492 . . . . 71.25 111.886 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 425' ' ' THR . 48.9 t -113.42 124.05 69.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.269 -1.382 . . . . 74.21 107.269 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -76.05 137.05 20.78 Favored Glycine 0 N--CA 1.435 -1.428 0 O-C-N 123.816 0.698 . . . . 73.52 111.866 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.507 HD12 HG12 ' A' ' 496' ' ' ILE . 36.8 mm -96.8 132.28 41.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.014 -0.735 . . . . 65.33 109.014 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.5 mt -94.53 149.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.541 -1.651 . . . . 34.23 106.541 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 86.9 5.38 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.471 -0.491 . . . . 75.11 111.868 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.64 120.99 43.43 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 104.717 -2.327 . . . . 73.01 104.717 172.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.289 4.0 t70 -118.35 90.2 3.28 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 116.046 -2.262 . . . . 72.32 112.398 178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.731 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.2 mm -120.21 155.62 23.24 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 110.747 -2.933 . . . . 74.52 104.041 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -54.26 114.84 1.78 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.602 -1.629 . . . . 71.01 106.602 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 47.4 mt-10 -107.42 98.34 7.97 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.564 1.173 . . . . 71.21 112.676 -171.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -112.58 108.47 17.57 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.673 -2.058 . . . . 71.03 107.681 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 42.07 60.56 2.23 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.99 1.431 . . . . 52.11 111.256 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.407 ' OE2' ' HG2' ' A' ' 451' ' ' GLU . 12.0 tt0 -89.15 107.22 18.93 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.914 -1.513 . . . . 63.51 106.914 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.3 OUTLIER -136.92 159.98 40.27 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 114.684 1.364 . . . . 55.02 114.684 -175.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 412' ' ' GLU . 34.0 p90 -132.97 177.61 7.52 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.359 -1.291 . . . . 74.44 108.613 174.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.47 136.99 54.58 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.82 -0.808 . . . . 75.42 108.82 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 41.0 t -108.84 125.87 65.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.277 -1.009 . . . . 73.41 108.277 176.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -120.68 152.98 37.54 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.923 -0.581 . . . . 72.32 109.561 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 72.9 mt -109.19 140.61 42.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.465 -0.569 . . . . 70.33 109.465 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.7 m -152.54 -173.13 4.45 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.592 0.757 . . . . 43.13 108.961 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' ASN . . . . . 0.509 ' HB3' ' CB ' ' A' ' 408' ' ' ASP . 3.0 t30 48.89 81.28 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.95 1.3 . . . . 65.43 111.267 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.09 128.0 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.879 -1.156 . . . . 72.24 107.879 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 88.0 tttt . . . . . 0 N--CA 1.42 -1.956 0 CA-C-O 121.163 0.506 . . . . 75.0 111.185 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 25.7 m . . . . . 0 N--CA 1.419 -1.998 0 CA-C-O 120.588 0.232 . . . . 64.32 110.704 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 492' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -104.22 100.46 10.19 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.277 -1.379 . . . . 42.23 107.277 171.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 493' ' ' THR . . . . . 0.456 ' HB ' HG23 ' A' ' 380' ' ' THR . 29.9 m -78.06 129.6 35.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.948 -0.76 . . . . 72.42 108.948 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 390' ' ' VAL . 92.4 t -117.25 109.23 27.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.398 -0.593 . . . . 73.01 109.398 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 26.8 m -98.28 115.67 28.89 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.987 -0.746 . . . . 73.21 108.987 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.613 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -95.81 124.46 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 CA-C-O 122.075 0.941 . . . . 73.33 110.002 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 71.7 m-85 -108.04 126.05 52.28 Favored 'General case' 0 N--CA 1.396 -3.156 0 CA-C-N 114.588 -1.187 . . . . 71.5 109.06 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -91.28 -19.7 22.7 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 104.431 -2.433 . . . . 73.43 104.431 166.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 111.795 -2.457 . . . . 73.34 111.677 178.443 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 53.0 mttp . . . . . 0 CA--C 1.477 -1.846 0 CA-C-O 121.242 0.544 . . . . 72.24 112.026 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 37.9 mm -114.49 106.86 21.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.252 -1.34 . . . . 70.33 108.728 -170.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.55 155.84 43.86 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 119.81 -0.756 . . . . 61.53 111.515 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -76.49 150.88 36.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.407 -0.361 . . . . 73.23 110.132 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.8 -42.27 86.21 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.532 -0.914 . . . . 71.22 108.532 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.543 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.4 mm100 -106.29 -171.75 1.96 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.869 -1.059 . . . . 62.34 110.221 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -123.02 -32.67 0.9 Allowed Glycine 0 C--N 1.289 -2.04 0 N-CA-C 109.233 -1.547 . . . . 71.24 109.233 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.2 m -127.84 141.4 51.58 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.907 -1.145 . . . . 72.31 107.907 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 64.5 m-85 -127.88 136.27 51.16 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.361 -0.978 . . . . 75.3 108.361 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -119.24 129.35 54.89 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.537 -1.283 . . . . 70.52 107.537 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 48.6 t -146.16 163.11 36.41 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.243 -0.651 . . . . 71.05 109.243 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -81.64 146.5 30.03 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.219 0.608 . . . . 71.34 111.917 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -58.12 -49.63 76.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.283 -1.006 . . . . 72.21 108.283 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.487 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.8 p-10 -73.55 16.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.911 -1.041 . . . . 71.15 113.706 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.1 t -86.71 -26.65 24.15 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.184 0.516 . . . . 62.21 109.725 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 96.78 -49.92 1.57 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.762 -0.732 . . . . 75.24 111.486 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.424 HG22 ' HA2' ' A' ' 443' ' ' GLY . 11.4 p -143.31 152.36 41.57 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.855 0.462 . . . . 71.13 109.943 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.52 HG12 ' HB ' ' A' ' 442' ' ' VAL . 5.7 p -107.42 133.88 50.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.146 -1.427 . . . . 65.32 107.146 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.18 126.43 50.35 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 123.299 0.375 . . . . 62.24 110.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.4 mp -119.59 145.94 45.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.961 -1.496 . . . . 72.43 106.961 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 56.7 m -113.14 127.65 56.26 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.438 -0.505 . . . . 74.3 110.831 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 70.1 mt -98.43 126.22 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 107.828 -1.175 . . . . 75.21 107.828 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 397' ' ' ARG . 43.7 mm -102.24 125.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.398 -1.334 . . . . 75.01 107.398 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 16.8 ttp180 -109.38 108.49 19.06 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.464 -0.335 . . . . 63.4 110.373 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 395' ' ' ILE . 80.2 mtp180 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 116.281 -0.418 . . . . 55.34 111.495 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.7 m . . . . . 0 N--CA 1.419 -2.016 0 CA-C-O 121.625 0.726 . . . . 65.11 109.739 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.49 133.82 51.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.599 -1.182 . . . . 65.51 109.259 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.496 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 21.8 m-85 -113.62 123.61 50.36 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.599 -0.728 . . . . 73.5 109.234 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.56 128.94 74.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.721 -0.844 . . . . 60.43 108.721 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 26.8 t70 -94.4 139.38 31.18 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.848 0.356 . . . . 62.54 110.725 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -132.56 153.98 50.46 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.858 -0.526 . . . . 71.13 111.108 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -159.39 163.64 35.33 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.433 -0.951 . . . . 75.43 108.433 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 77.2 p -101.01 171.85 7.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.667 0.27 . . . . 72.34 111.139 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.3 151.1 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.06 -0.719 . . . . 73.22 109.06 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.11 1.63 35.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 118.345 -0.836 . . . . 62.25 113.054 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -4.49 -97.08 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 C-N-CA 125.842 1.687 . . . . 71.44 115.185 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.9 t -105.47 -18.66 14.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.296 -0.631 . . . . 74.22 109.296 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.471 ' HB2' ' HG2' ' A' ' 454' ' ' GLU . . . -118.52 143.56 46.66 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.955 -0.758 . . . . 63.11 108.955 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -108.02 113.83 27.29 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 121.487 0.66 . . . . 71.54 111.59 -166.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -74.78 124.39 26.72 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.335 -0.848 . . . . 64.44 109.685 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.35 -28.35 6.05 Favored Glycine 0 C--N 1.294 -1.756 0 N-CA-C 109.19 -1.564 . . . . 65.4 109.19 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 32.6 t -117.03 -52.64 2.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.474 -0.363 . . . . 71.43 110.205 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.624 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 6.4 m-20 -75.63 -59.94 2.53 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.865 0.84 . . . . 41.24 110.24 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.525 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.1 OUTLIER -136.93 176.48 8.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.714 -1.587 . . . . 72.03 106.714 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -83.76 157.67 22.03 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.014 -0.736 . . . . 50.31 109.014 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -91.52 -8.93 46.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.068 -0.515 . . . . 74.14 112.337 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 442' ' ' VAL . 15.1 t 37.9 63.73 0.76 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.681 1.593 . . . . 74.44 113.252 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.56 110.98 15.39 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.216 -0.902 . . . . 63.52 109.576 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.0 174.24 33.24 Favored Glycine 0 N--CA 1.41 -3.046 0 CA-C-N 115.079 -0.964 . . . . 54.41 111.119 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 69.6 m -125.49 133.45 52.38 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 107.139 -1.43 . . . . 74.25 107.139 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.44 129.47 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.358 -0.978 . . . . 54.01 108.358 -176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.11 104.87 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.342 -0.845 . . . . 73.04 108.873 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.7 m-85 -84.8 108.39 17.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.867 -0.606 . . . . 73.33 111.325 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.441 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -90.1 165.04 25.63 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.773 -0.649 . . . . 60.41 110.093 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -50.92 127.73 22.4 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.991 2.461 . . . . 71.43 112.184 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 93.66 -17.65 58.13 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 115.839 -0.619 . . . . 70.34 113.426 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 71.2 mt-10 -84.24 63.88 7.97 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.866 0.841 . . . . 71.32 112.957 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 39.2 m -60.36 -24.06 64.77 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.009 -1.45 . . . . 55.1 110.707 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -128.57 138.88 52.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.7 -0.625 . . . . 75.24 110.36 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 438' ' ' LYS . 20.1 mmmt -134.87 145.65 48.48 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 120.941 0.401 . . . . 71.15 111.498 173.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -109.04 134.43 51.68 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.522 -0.763 . . . . 65.13 110.259 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.7 pt -116.34 137.05 51.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.826 -0.625 . . . . 60.43 109.514 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 17.5 mmt180 -109.05 132.84 53.73 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.297 -0.865 . . . . 74.03 111.286 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 425' ' ' THR . 47.9 t -108.23 116.79 52.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.674 -1.232 . . . . 73.5 107.674 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -61.2 130.79 47.52 Favored Glycine 0 N--CA 1.44 -1.096 0 O-C-N 124.482 1.114 . . . . 71.43 113.083 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.429 ' HA ' ' HB3' ' A' ' 422' ' ' TYR . 33.3 mm -101.45 130.66 50.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.393 -1.336 . . . . 74.41 107.393 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 68.7 mt -98.38 150.04 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 105.485 -2.042 . . . . 75.14 105.485 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -84.64 86.13 7.35 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.405 -0.918 . . . . 72.24 111.564 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.39 124.27 51.4 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 103.269 -2.863 . . . . 51.12 103.269 169.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -119.38 94.73 4.52 Favored 'General case' 0 CA--C 1.456 -2.658 0 C-N-CA 116.836 -1.945 . . . . 62.12 110.841 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' ILE . . . . . . . . . . . . . 39.9 mm -118.29 155.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.816 0 CA-C-N 111.752 -2.476 . . . . 74.15 105.379 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.43 115.06 2.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.114 -1.81 . . . . 73.33 106.114 170.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 498' ' ' ASP . 29.5 mt-10 -129.37 94.28 3.75 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.847 1.308 . . . . 74.23 110.442 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.74 106.29 18.56 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 113.703 -1.59 . . . . 72.42 108.747 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.28 4.4 p30 42.39 60.16 2.44 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.86 1.35 . . . . 73.22 112.971 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 416' ' ' ALA . 36.4 tt0 -87.29 135.22 33.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.252 -1.388 . . . . 70.31 107.252 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -149.55 161.45 42.13 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.238 0.542 . . . . 75.55 111.941 -172.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.495 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.4 p90 -137.91 -177.98 5.05 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.71 -0.677 . . . . 73.11 110.225 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -119.82 145.04 47.0 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.274 -1.01 . . . . 72.5 108.274 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.24 132.16 67.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 106.828 -1.545 . . . . 51.12 106.828 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -123.06 139.43 54.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.423 0.452 . . . . 52.25 111.033 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.2 mt -100.07 136.69 39.59 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 44.5 m -157.77 174.3 15.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.425 -0.583 . . . . 53.43 109.425 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.4 t30 54.18 90.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.858 1.263 . . . . 73.33 112.596 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.2 123.19 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.644 -0.707 . . . . 52.44 109.688 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 37.2 ttmt . . . . . 0 C--N 1.281 -2.392 0 N-CA-C 107.362 -1.347 . . . . 74.2 107.362 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 109.413 -0.588 . . . . 61.13 109.413 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.18 130.4 53.35 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.845 -1.168 . . . . 72.22 107.845 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 123.37 41.19 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.523 -0.471 . . . . 74.33 109.9 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.502 HG11 HG11 ' A' ' 390' ' ' VAL . 76.5 t -108.3 107.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.248 -0.649 . . . . 61.14 109.248 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 10.2 m -91.03 116.54 28.88 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.069 -1.086 . . . . 54.43 108.069 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 50.1 mt -101.97 114.64 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.218 1.009 . . . . 73.4 110.902 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.504 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -84.05 102.36 12.46 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.24 -1.346 . . . . 74.01 110.777 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 498' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 451' ' ' GLU . 23.5 t70 -52.28 -54.87 25.86 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 112.418 -2.174 . . . . 71.21 108.518 172.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.474 0.769 0 CA-C-N 113.23 -1.804 . . . . 44.51 112.003 176.519 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 32.9 mmtp . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 108.199 -1.037 . . . . 74.22 108.199 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 42.7 mm -105.67 114.6 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.52 -0.919 . . . . 73.35 108.52 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -149.33 174.61 12.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.488 0.585 . . . . 72.21 111.319 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.28 146.76 26.89 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.01 -0.366 . . . . 71.3 110.01 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.668 -1.604 . . . . 73.31 106.668 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.512 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 33.6 mt-30 -102.31 144.14 31.19 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.288 -0.869 . . . . 62.42 110.201 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.13 -12.4 57.59 Favored Glycine 0 C--N 1.284 -2.341 0 CA-C-N 115.699 -0.682 . . . . 72.03 111.553 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 25.6 m -140.37 131.37 26.18 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.644 -0.873 . . . . 65.22 108.644 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 72.5 m-85 -127.42 136.59 52.04 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.709 -0.848 . . . . 75.32 108.709 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -121.84 123.15 41.08 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.549 -1.278 . . . . 71.14 107.549 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 43.9 t -134.9 165.38 25.45 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.512 -0.551 . . . . 74.03 109.512 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 3.3 mm? -95.38 141.64 28.7 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.478 -0.783 . . . . 73.43 109.722 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.9 -36.93 78.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.822 -0.807 . . . . 61.43 108.822 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -65.53 -14.26 60.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.621 -1.172 . . . . 73.53 112.689 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 76.6 m -72.52 -19.22 61.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.769 0.285 . . . . 75.13 111.769 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.83 -48.48 3.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.309 -0.716 . . . . 64.2 111.309 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.1 p -141.51 161.34 38.16 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.605 0.762 . . . . 51.32 109.807 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.4 p -114.14 130.0 69.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.832 -1.173 . . . . 71.14 107.832 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.98 128.3 46.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 123.558 0.536 . . . . 72.42 110.174 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.52 151.04 41.76 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.677 -1.231 . . . . 53.55 107.677 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -112.03 128.83 56.3 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.336 0.588 . . . . 73.12 111.656 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 73.3 mt -101.53 126.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 107.913 -1.143 . . . . 62.33 107.913 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.2 mm -100.0 128.23 52.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.56 -0.904 . . . . 73.14 108.56 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.498 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 59.9 ttt180 -112.58 107.65 16.45 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.527 -0.916 . . . . 65.54 108.527 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 . . . . . 0 C--N 1.293 -1.874 0 CA-C-N 115.708 -0.678 . . . . 72.11 111.405 -178.885 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.437 -1.112 0 CA-C-O 121.798 0.808 . . . . 65.53 111.085 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 67.2 t -115.49 149.1 17.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.702 -1.136 . . . . 55.2 109.18 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 11.8 m-85 -126.69 147.42 49.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.338 0.59 . . . . 74.45 110.015 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.1 p -143.82 130.49 16.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.557 -0.535 . . . . 75.32 109.557 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -93.41 128.56 39.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.476 -0.565 . . . . 72.33 109.476 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -123.77 153.11 41.41 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.536 -0.912 . . . . 72.1 108.536 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -161.23 161.1 30.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.6 -1.259 . . . . 63.35 107.6 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 71.2 p -96.62 172.03 8.17 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.36 0.6 . . . . 63.04 109.859 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 6.8 tp10 -127.37 153.95 45.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.517 -2.031 . . . . 75.23 105.517 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.3 p-10 -58.2 -41.94 85.05 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.626 0.579 . . . . 64.05 112.425 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.62 -94.43 0.16 Allowed Glycine 0 C--N 1.294 -1.77 0 CA-C-N 115.478 -0.783 . . . . 53.24 111.696 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.9 t -127.74 7.83 6.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.655 0.741 . . . . 53.42 109.495 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -130.94 -159.48 0.97 Allowed 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.043 -1.466 . . . . 55.41 107.043 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -141.68 116.67 9.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.072 0.463 . . . . 75.11 110.546 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -71.44 128.72 36.78 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.905 -0.589 . . . . 75.33 109.557 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.45 -24.38 15.78 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.445 -1.462 . . . . 71.34 109.445 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 21.2 t -111.93 -55.76 2.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 109.632 -0.507 . . . . 63.04 109.632 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 11.1 m-20 -80.09 -56.72 4.03 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.844 0.83 . . . . 62.31 110.055 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.5 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.0 OUTLIER -136.95 167.78 20.84 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.191 -1.411 . . . . 74.13 107.191 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -74.96 152.05 38.81 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.308 -0.627 . . . . 74.02 109.308 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.461 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -85.76 -13.17 49.1 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.93 -0.577 . . . . 75.44 111.547 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 442' ' ' VAL 0.253 14.7 t 35.5 63.11 0.55 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 126.1 1.76 . . . . 73.02 113.152 179.106 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.35 107.55 12.2 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.981 -1.008 . . . . 73.44 109.097 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -147.49 171.51 28.08 Favored Glycine 1 N--CA 1.394 -4.126 0 C-N-CA 119.125 -1.512 . . . . 71.5 112.07 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 25.5 m -124.27 136.13 53.91 Favored 'General case' 0 N--CA 1.388 -3.558 0 N-CA-C 106.652 -1.61 . . . . 51.33 106.652 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.7 t -95.77 126.89 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.371 -0.974 . . . . 61.51 108.371 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.502 HG22 ' CE2' ' A' ' 406' ' ' PHE . 19.3 t -100.52 100.59 10.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.188 -1.041 . . . . 73.2 108.188 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.498 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 54.6 m-85 -80.91 104.51 11.46 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.32 -0.4 . . . . 75.05 111.006 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -84.53 169.47 16.6 Favored Pre-proline 0 C--O 1.256 1.432 0 CA-C-N 115.785 -0.643 . . . . 75.31 110.169 177.746 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.08 132.74 49.17 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.79 2.327 . . . . 73.41 111.868 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.44 -25.57 17.63 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.851 -0.613 . . . . 75.11 113.224 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.48 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 44.9 mt-10 -75.57 64.47 1.66 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.86 0.864 . . . . 60.41 113.168 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 22.4 m -61.42 -23.64 65.96 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.437 -1.256 . . . . 73.42 109.149 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -132.8 143.25 49.44 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.192 -0.67 . . . . 71.3 109.192 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -131.31 149.82 52.4 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.049 -0.523 . . . . 73.4 110.457 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.1 135.51 51.51 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.798 -0.816 . . . . 54.01 108.798 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.8 pt -120.77 146.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.999 -1.111 . . . . 75.11 107.999 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 87.8 mtt180 -125.41 146.18 49.73 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.207 0.527 . . . . 73.31 110.651 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 425' ' ' THR . 51.1 t -113.37 120.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.863 -1.162 . . . . 73.41 107.863 178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -64.3 131.36 38.59 Favored Glycine 0 N--CA 1.439 -1.153 0 O-C-N 124.072 0.858 . . . . 74.34 111.897 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.51 133.52 39.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.563 -1.273 . . . . 75.03 107.563 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 75.6 mt -98.77 150.43 4.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.049 -1.093 . . . . 63.42 108.049 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.9 86.8 5.39 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.224 0.535 . . . . 70.14 111.421 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -112.9 101.66 9.71 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 104.579 -2.378 . . . . 75.42 104.579 171.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.285 11.3 t70 -106.61 84.44 2.01 Favored 'General case' 0 CA--C 1.458 -2.572 0 C-N-CA 115.613 -2.435 . . . . 70.15 112.025 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 46.1 mm -117.06 154.0 18.77 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.75 0 N-CA-C 103.388 -2.819 . . . . 65.33 103.388 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -52.09 116.15 2.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.32 0.964 . . . . 63.54 110.158 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 27.2 mt-10 -122.48 119.0 29.66 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.436 1.113 . . . . 72.54 113.258 -171.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.07 110.92 11.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.563 -1.653 . . . . 74.03 106.847 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 48.63 60.52 3.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.72 1.378 . . . . 53.33 114.72 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.2 pt-20 -99.5 134.6 42.14 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.781 -1.168 . . . . 74.14 108.253 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.7 p-10 -149.25 166.19 29.65 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.372 0.606 . . . . 71.32 111.534 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.561 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 30.7 p90 -137.35 -177.73 4.91 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.248 -0.887 . . . . 73.41 109.404 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.95 137.05 54.68 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.621 -1.251 . . . . 72.21 107.621 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 42.3 t -108.79 128.23 64.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.482 -1.303 . . . . 65.44 107.482 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -122.68 163.07 20.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.075 -0.511 . . . . 72.1 109.718 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 82.4 mt -118.2 134.04 55.36 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.252 -1.388 . . . . 64.24 107.252 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.0 m -150.43 161.46 42.46 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 109.222 -0.659 . . . . 52.52 109.222 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 59.73 87.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.257 0.973 . . . . 72.3 110.918 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.16 137.94 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.681 -1.229 . . . . 65.42 107.681 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 C--N 1.301 -1.51 0 N-CA-C 109.114 -0.698 . . . . 65.22 109.114 -176.65 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 110.024 -0.361 . . . . 71.34 110.024 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 492' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -102.93 103.02 13.12 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.383 -1.339 . . . . 72.05 107.383 172.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 53.3 m -83.26 118.74 23.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.133 0.492 . . . . 60.31 110.986 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.584 HG11 HG11 ' A' ' 390' ' ' VAL . 80.4 t -106.21 110.68 32.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.782 -0.822 . . . . 63.44 108.782 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 46.9 m -98.85 121.57 40.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.36 -0.978 . . . . 63.55 108.36 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.549 HD11 ' CE2' ' A' ' 456' ' ' PHE . 5.2 mp -97.9 117.52 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 121.835 0.826 . . . . 74.51 110.764 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.716 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 55.6 m-85 -98.07 122.98 41.87 Favored 'General case' 0 N--CA 1.399 -3.005 0 N-CA-C 105.709 -1.96 . . . . 74.31 105.709 170.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.12 -3.0 23.58 Favored 'General case' 0 C--N 1.258 -3.402 0 C-N-CA 119.33 -0.948 . . . . 74.43 109.114 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.312 -1.058 0 C-N-CA 126.754 2.021 . . . . 63.12 113.191 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 93.0 mttt . . . . . 0 CA--C 1.494 -1.183 0 N-CA-C 112.917 0.71 . . . . 71.14 112.917 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 31.5 mm -102.19 127.86 55.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.054 -1.462 . . . . 71.22 107.054 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' PHE . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 397' ' ' ARG . 39.3 p90 -159.85 168.73 25.13 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 117.994 0.361 . . . . 70.23 111.655 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -88.55 142.31 27.81 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 110.021 -0.363 . . . . 70.32 110.021 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 395' ' ' ILE . 41.4 tt0 -62.87 -51.08 68.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.518 0.675 . . . . 73.23 109.444 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -108.94 146.61 33.53 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 114.972 -1.013 . . . . 72.02 110.425 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.47 -25.43 33.19 Favored Glycine 0 C--N 1.294 -1.801 0 N-CA-C 110.686 -0.965 . . . . 42.03 110.686 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 12.9 m -127.34 136.04 51.36 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.406 -0.961 . . . . 62.51 108.406 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -127.13 137.32 52.96 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.355 -0.98 . . . . 73.43 108.355 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -127.34 129.66 48.05 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.83 -1.544 . . . . 72.45 106.83 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 11.9 t -148.72 160.3 43.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.054 -1.091 . . . . 61.03 108.054 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.556 HD12 ' OD1' ' A' ' 386' ' ' ASN . 2.6 mm? -78.43 144.76 35.55 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.294 0.569 . . . . 72.35 112.202 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -59.48 -41.82 90.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.315 -0.857 . . . . 63.04 108.742 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.556 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.4 p-10 -78.25 9.81 3.52 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.436 -0.802 . . . . 74.11 113.065 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.3 t -83.97 -28.5 27.74 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.728 -0.608 . . . . 72.03 110.524 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.81 -58.39 0.56 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.175 -0.536 . . . . 53.44 112.209 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 5.6 p -141.95 151.41 42.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.024 0.412 . . . . 43.44 110.447 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 494' ' ' VAL . 5.7 p -109.14 133.41 54.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 107.755 -1.202 . . . . 74.22 107.755 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.98 128.83 48.24 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.153 0.501 . . . . 73.33 110.39 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -120.62 145.28 47.56 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.311 -1.366 . . . . 75.21 107.311 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 29.4 m -113.67 127.06 55.9 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 121.43 0.633 . . . . 73.51 111.298 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 76.5 mt -95.05 121.34 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 N-CA-C 108.02 -1.104 . . . . 73.54 108.02 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 377' ' ' GLU . 42.8 mm -99.14 119.4 47.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.48 -1.304 . . . . 74.12 107.48 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.416 ' NH1' HG21 ' A' ' 405' ' ' VAL . 23.6 ttt85 -100.48 121.36 41.42 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-O 121.482 0.658 . . . . 61.41 110.576 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 375' ' ' PHE . 22.0 mmm180 . . . . . 0 C--N 1.295 -1.788 0 CA-C-N 115.449 -0.796 . . . . 75.43 109.094 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.434 -1.251 0 CA-C-O 121.183 0.516 . . . . 75.31 111.681 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 66.6 t -103.44 136.5 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.046 -0.524 . . . . 71.55 109.707 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.95 121.41 34.37 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.601 0.361 . . . . 72.23 110.582 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 463' ' ' VAL . 5.9 p -120.8 127.62 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.354 -0.98 . . . . 61.25 108.354 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.6 143.53 27.61 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.539 -0.912 . . . . 74.23 108.539 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -142.42 158.39 43.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.941 -0.474 . . . . 75.44 110.124 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -165.68 158.01 15.0 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.548 -1.279 . . . . 72.33 107.548 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.646 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 36.5 p -96.73 156.13 16.48 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.373 -0.603 . . . . 74.51 109.373 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.2 tp10 -106.35 151.26 25.1 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.96 -1.496 . . . . 70.33 106.96 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 417' ' ' ASN . 11.2 m-20 -55.96 -39.02 71.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.698 0.799 . . . . 61.32 112.38 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 62.93 -95.56 0.13 Allowed Glycine 0 C--N 1.297 -1.614 0 CA-C-N 114.938 -1.028 . . . . 34.24 112.63 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.9 t -121.37 8.92 10.26 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.296 -0.631 . . . . 62.02 109.296 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -137.9 -160.49 1.06 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.537 -0.912 . . . . 73.51 108.537 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.589 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 6.5 m120 -137.25 122.55 19.37 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.708 0.766 . . . . 72.53 112.021 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -68.62 129.31 39.56 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.561 -1.199 . . . . 72.52 109.394 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.95 -32.66 6.87 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 111.305 -0.718 . . . . 64.3 111.305 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 t -102.24 -44.52 5.4 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.695 -0.483 . . . . 60.34 109.695 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.551 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 23.7 m-20 -87.3 -64.27 1.17 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.049 0.928 . . . . 63.14 109.659 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.714 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.16 167.0 23.24 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.147 -0.933 . . . . 65.22 110.217 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 425' ' ' THR . 23.1 tt0 -75.47 153.52 37.53 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.632 0.583 . . . . 43.43 110.333 -174.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.646 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.2 p90 -88.93 -15.34 34.56 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.717 -0.674 . . . . 65.33 112.126 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.439 ' CG2' HG22 ' A' ' 442' ' ' VAL 0.296 13.5 t 32.49 66.87 0.18 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.897 1.679 . . . . 74.53 114.414 -176.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.76 131.12 34.94 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.592 -0.892 . . . . 71.0 108.592 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -173.38 -175.74 41.36 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 120.099 -1.048 . . . . 72.43 110.957 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.3 m -116.89 138.35 51.59 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 108.159 -1.052 . . . . 75.24 108.159 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.2 t -96.12 116.42 37.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.085 -1.45 . . . . 72.04 107.085 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.17 105.69 17.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.533 -0.758 . . . . 64.05 109.749 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 78.7 m-85 -82.57 98.36 8.94 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.226 -1.028 . . . . 50.03 108.226 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.1 mttm -80.58 170.18 16.66 Favored Pre-proline 0 C--N 1.296 -1.747 0 CA-C-N 114.065 -1.425 . . . . 63.43 109.948 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.7 Cg_exo -52.24 109.91 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.55 2.167 . . . . 54.04 113.339 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.47 -0.34 61.47 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.126 -0.943 . . . . 44.12 114.825 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.406 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 34.6 mm-40 -76.59 64.23 2.2 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.852 0.826 . . . . 74.21 113.062 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.9 m -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 121.374 0.607 . . . . 74.34 110.381 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -131.4 139.81 49.52 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.08 -0.711 . . . . 74.12 109.08 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -130.63 151.41 51.12 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.594 -0.275 . . . . 63.43 111.65 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.85 137.3 52.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.849 -0.614 . . . . 73.41 109.644 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.28 147.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.936 -1.135 . . . . 71.44 107.936 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 49.4 mtt180 -129.57 135.07 48.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 120.996 0.426 . . . . 61.52 111.215 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.6 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 61.9 t -105.34 127.3 60.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.431 -0.804 . . . . 34.22 109.409 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -70.97 130.31 19.45 Favored Glycine 0 N--CA 1.439 -1.115 0 O-C-N 124.192 0.933 . . . . 62.23 112.37 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.489 HD12 HG12 ' A' ' 496' ' ' ILE . 38.7 mm -94.9 134.78 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 106.916 -1.512 . . . . 73.31 106.916 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 66.6 mt -101.7 151.19 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 108.063 -1.088 . . . . 71.45 108.063 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.96 97.6 2.33 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.995 0.426 . . . . 42.53 110.234 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.45 124.75 27.63 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 103.63 -2.73 . . . . 73.1 103.63 170.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.2 97.13 4.81 Favored 'General case' 0 CA--C 1.462 -2.436 0 C-N-CA 117.733 -1.587 . . . . 54.23 110.042 174.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.733 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 28.9 mm -123.35 156.64 29.53 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.55 0 CA-C-N 111.308 -2.678 . . . . 75.5 104.171 -173.15 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -56.86 113.49 1.69 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 116.652 -2.019 . . . . 72.34 105.777 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.733 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.7 mt-10 -120.93 121.86 38.96 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 108.986 -0.746 . . . . 70.54 108.986 -170.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -132.34 109.48 9.9 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 115.176 -0.92 . . . . 63.22 108.691 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.37 35.72 26.34 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.469 1.106 . . . . 70.32 111.18 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.434 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.3 tt0 -64.02 106.63 1.08 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.318 -1.364 . . . . 63.41 107.318 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.476 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 35.2 p30 -138.57 166.15 25.07 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.449 0.643 . . . . 75.42 112.078 -175.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.605 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 21.2 p90 -140.2 -179.24 5.87 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.182 -0.917 . . . . 60.12 109.764 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 31.9 mt -123.79 136.74 54.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.134 -1.062 . . . . 60.52 108.134 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.3 124.9 60.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.418 -1.327 . . . . 63.41 107.418 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -117.71 156.34 28.4 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.572 0.545 . . . . 41.11 109.839 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 86.5 mt -113.42 140.61 47.93 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.563 -0.903 . . . . 73.3 108.563 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.7 m -146.84 173.56 12.29 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.787 -0.449 . . . . 71.04 109.787 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.4 t30 34.65 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 126.145 1.778 . . . . 75.41 113.854 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 407' ' ' VAL . 24.7 t -98.77 132.54 43.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.142 -1.023 . . . . 73.01 108.564 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.2 tptp . . . . . 0 C--N 1.296 -1.74 0 N-CA-C 108.237 -1.023 . . . . 72.31 108.237 -179.55 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 N--CA 1.409 -2.51 0 N-CA-C 108.024 -1.102 . . . . 73.24 108.024 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -101.84 120.6 40.64 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.131 -1.063 . . . . 73.24 108.131 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 40.8 m -89.38 119.19 29.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.235 -0.586 . . . . 40.12 109.834 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 390' ' ' VAL . 76.6 t -106.89 107.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 108.177 -1.046 . . . . 73.45 108.177 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.476 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 85.2 m -97.45 114.32 26.15 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.72 -0.844 . . . . 74.12 108.72 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.714 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.09 116.96 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.367 -0.833 . . . . 72.31 109.169 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.554 ' O ' HD13 ' A' ' 384' ' ' LEU . 24.2 m-85 -80.26 97.79 7.11 Favored 'General case' 0 N--CA 1.382 -3.868 0 CA-C-O 122.324 1.059 . . . . 74.54 112.366 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 498' ' ' ASP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 451' ' ' GLU . 3.3 t70 -50.17 -54.87 17.85 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 111.749 -2.478 . . . . 55.41 108.493 170.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.476 0.853 0 CA-C-N 113.797 -1.547 . . . . 45.44 110.965 176.95 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 107.411 -1.329 . . . . 71.41 107.411 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.0 120.74 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 60.23 107.98 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -152.95 173.32 15.54 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 118.455 0.57 . . . . 73.13 110.361 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -87.41 154.68 20.47 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.21 110.873 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.12 -40.68 86.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.958 -0.756 . . . . 73.33 108.958 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -126.36 162.74 24.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.492 -0.777 . . . . 72.11 111.835 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -94.46 -19.69 31.8 Favored Glycine 0 C--N 1.3 -1.436 0 CA-C-N 115.045 -0.979 . . . . 60.33 111.712 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 62.6 m -141.86 128.51 20.33 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.457 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 39.8 m-85 -114.56 136.82 52.61 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 124.261 1.024 . . . . 75.33 108.792 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 495' ' ' THR . 43.7 mt-30 -129.51 123.92 32.68 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.429 -1.323 . . . . 74.54 107.429 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 46.6 t -139.96 165.18 28.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.356 -0.979 . . . . 72.43 108.356 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.671 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 3.8 mm? -87.13 140.56 29.43 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 123.32 0.388 . . . . 73.42 111.552 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -58.76 -42.28 88.54 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.009 -0.737 . . . . 73.12 109.009 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -73.19 -5.42 39.17 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.354 0.872 . . . . 53.41 113.354 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 57.7 m -80.73 -7.28 59.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.8 -0.562 . . . . 72.14 111.91 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.78 -56.01 3.38 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.467 -0.873 . . . . 74.34 112.819 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.473 HG22 ' HA2' ' A' ' 443' ' ' GLY . 21.6 p -137.58 166.77 23.09 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.979 0.419 . . . . 74.32 111.203 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 494' ' ' VAL . 3.8 p -116.93 128.84 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 106.932 -1.507 . . . . 64.01 106.932 170.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.95 118.48 37.0 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.307 0.575 . . . . 71.12 110.418 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.0 mp -109.82 139.89 44.37 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.52 -1.289 . . . . 71.21 107.52 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.9 m -109.55 127.92 54.82 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 109.391 -0.596 . . . . 71.04 109.391 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 64.1 mt -99.37 125.6 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.52 -1.289 . . . . 75.53 107.52 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.458 HG22 ' HG3' ' A' ' 397' ' ' ARG . 43.6 mm -101.48 129.04 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 115.09 -0.959 . . . . 50.01 108.421 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -115.92 108.88 16.84 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.928 -1.033 . . . . 74.14 109.226 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 395' ' ' ILE . 32.4 mtp180 . . . . . 0 C--N 1.301 -1.53 0 CA-C-N 115.72 -0.673 . . . . 64.13 110.292 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 9.4 m . . . . . 0 N--CA 1.411 -2.382 0 N-CA-C 109.38 -0.6 . . . . 65.31 109.38 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 57.5 t -100.37 141.86 16.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.404 -0.962 . . . . 72.43 108.404 -177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 54.2 m-85 -128.38 119.77 25.67 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 122.735 0.414 . . . . 62.31 109.948 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.07 124.45 72.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.532 -0.914 . . . . 73.45 108.532 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 14.7 t70 -90.05 140.46 29.62 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 110.1 -0.333 . . . . 71.31 110.1 -177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.95 169.1 18.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.179 -0.304 . . . . 74.54 110.179 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 411' ' ' THR . 63.5 ttt-85 -167.52 167.22 13.77 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 105.825 -1.917 . . . . 71.41 105.825 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.632 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 62.2 p -95.55 168.2 10.84 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.692 -0.855 . . . . 75.12 108.692 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.594 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.7 tp10 -106.51 150.74 25.81 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.613 0.721 . . . . 71.32 109.29 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.53 5.39 51.01 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 125.915 1.686 . . . . 44.55 110.679 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' GLY . . . . . 0.594 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -28.73 -93.39 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.74 2.114 . . . . 61.14 116.953 -174.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 455' ' ' ASN . 5.2 t -93.74 -7.06 44.68 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.848 0.832 . . . . 74.03 110.56 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.779 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . . . -151.89 153.22 33.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.409 -1.7 . . . . 60.23 106.409 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.19 145.86 33.61 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.617 0.722 . . . . 72.43 112.138 -164.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -82.93 148.71 27.48 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.072 -0.967 . . . . 71.42 108.534 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.94 79.05 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.454 -1.058 . . . . 60.12 110.454 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 38.3 m -149.44 -58.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.697 -0.483 . . . . 54.22 109.697 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.505 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 8.0 m-20 -86.23 -55.0 4.12 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.408 1.099 . . . . 71.24 108.934 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.779 ' OH ' ' HB3' ' A' ' 416' ' ' ALA . 0.1 OUTLIER -141.67 164.79 29.26 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.948 -1.024 . . . . 75.42 111.07 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 425' ' ' THR . 0.9 OUTLIER -74.07 160.56 31.08 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.352 -0.84 . . . . 71.23 108.842 -177.186 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.632 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -100.07 -20.14 16.17 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 122.936 0.495 . . . . 72.42 112.152 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.49 ' CG2' HG22 ' A' ' 442' ' ' VAL 0.323 10.1 t 39.04 64.55 0.78 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.351 1.861 . . . . 72.5 114.239 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.67 112.33 15.67 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.589 -1.187 . . . . 61.41 109.274 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -158.25 -178.62 32.46 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 110.443 -1.063 . . . . 73.14 110.443 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 17.5 m -122.63 139.72 53.62 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.358 -1.349 . . . . 73.1 107.358 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 45.0 t -95.56 118.8 42.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.8 -0.815 . . . . 73.12 108.8 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 406' ' ' PHE . 26.0 t -91.11 112.18 24.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.654 -1.157 . . . . 71.25 108.511 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 60.5 m-85 -97.61 101.75 13.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.69 -0.485 . . . . 71.51 109.69 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.3 mttm -85.21 172.5 8.68 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.071 -0.513 . . . . 74.43 109.979 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.9 Cg_exo -56.09 131.83 48.3 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.467 2.111 . . . . 74.35 111.649 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 87.33 -14.89 56.66 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 116.027 -0.533 . . . . 73.3 113.77 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -81.07 63.57 5.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.607 0.717 . . . . 71.14 112.391 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.1 m -60.9 -22.22 64.12 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.273 -1.33 . . . . 75.01 110.366 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -131.17 139.64 49.79 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.951 -1.129 . . . . 65.11 107.951 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -131.46 154.35 48.8 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 122.793 0.437 . . . . 73.14 110.068 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.27 132.48 50.33 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.787 -0.765 . . . . 74.01 111.076 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.5 pt -119.39 146.72 23.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.594 -0.891 . . . . 74.32 108.594 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 90.2 mtt180 -130.27 132.88 46.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.343 -0.543 . . . . 75.24 111.788 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.49 HG22 ' CG2' ' A' ' 425' ' ' THR . 62.1 t -104.71 120.56 55.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.041 -0.981 . . . . 72.3 108.451 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -71.98 136.52 24.2 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 121.134 -0.555 . . . . 71.42 112.241 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.464 HD12 HG12 ' A' ' 496' ' ' ILE . 35.5 mm -97.93 132.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.83 -1.174 . . . . 71.12 107.83 177.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 92.4 mt -91.57 151.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.477 -0.934 . . . . 74.43 108.477 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.29 92.54 5.15 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 120.981 0.419 . . . . 73.22 110.015 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.07 96.49 6.35 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.498 -2.778 . . . . 60.43 103.498 166.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -99.59 81.3 2.48 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 116.687 -2.005 . . . . 63.53 110.454 -173.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.6 mm -127.37 155.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.09 0 CA-C-N 110.383 -3.099 . . . . 73.14 103.993 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -56.36 114.36 1.96 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.925 -1.509 . . . . 62.23 106.925 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.7 mt-10 -111.89 128.12 56.05 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 108.259 -1.015 . . . . 73.11 108.259 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -124.27 103.85 8.47 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 115.599 -0.728 . . . . 72.45 110.086 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.82 60.38 3.58 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 125.076 1.485 . . . . 74.31 113.078 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.21 114.55 20.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.693 0.758 . . . . 75.1 109.516 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.469 ' O ' HG22 ' A' ' 415' ' ' THR . 3.4 p-10 -136.74 153.44 50.86 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 114.949 -1.023 . . . . 70.5 109.799 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 422' ' ' TYR . 20.9 p90 -136.78 -177.94 4.96 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.861 -0.609 . . . . 74.3 110.195 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.457 ' H ' ' HB3' ' A' ' 412' ' ' GLU . 57.2 mt -121.17 139.71 52.98 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.983 -1.117 . . . . 72.2 107.983 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 491' ' ' THR . 47.5 t -107.65 110.77 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.579 -1.267 . . . . 73.22 107.579 174.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -102.78 137.83 40.47 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.591 -0.522 . . . . 63.05 109.591 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.83 126.66 42.14 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.592 -0.892 . . . . 73.23 108.592 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 408' ' ' ASP . 17.4 m -147.04 148.52 31.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.933 -0.765 . . . . 63.11 108.933 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.5 93.6 0.06 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.974 1.31 . . . . 61.2 110.575 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.15 137.07 39.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.378 -1.341 . . . . 72.04 107.378 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt . . . . . 0 C--N 1.286 -2.155 0 C-N-CA 123.609 0.764 . . . . 75.0 108.991 -175.547 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 45.5 m . . . . . 0 N--CA 1.426 -1.663 0 CA-C-O 120.88 0.371 . . . . 64.24 110.692 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.27 131.44 52.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.035 -0.728 . . . . 52.43 109.035 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 77.1 m -86.42 126.91 34.72 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.592 -0.892 . . . . 71.55 108.592 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 390' ' ' VAL . 77.0 t -111.94 107.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.674 -0.862 . . . . 73.2 108.674 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 23.6 m -101.21 111.22 23.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.13 -1.063 . . . . 71.02 108.13 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.625 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -88.49 123.68 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.595 0.712 . . . . 72.33 111.06 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -82.75 107.2 15.2 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-O 122.344 1.069 . . . . 71.51 110.209 173.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -40.42 84.03 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 112.288 -2.233 . . . . 43.14 112.766 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.549 ' HB2' ' CD1' ' A' ' 384' ' ' LEU . 20.4 t70 . . . . . 0 N--CA 1.501 2.099 0 C-N-CA 124.63 1.172 . . . . 75.24 112.454 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 96.4 mttt . . . . . 0 N--CA 1.423 -1.783 0 CA-C-O 120.56 0.219 . . . . 71.14 110.853 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.476 HG21 HG11 ' A' ' 407' ' ' VAL . 38.8 mm -125.12 109.16 21.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.572 -0.899 . . . . 73.44 108.572 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -145.71 162.78 36.79 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.425 -0.51 . . . . 71.43 110.85 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.1 151.42 28.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 110.122 -0.325 . . . . 71.44 110.122 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -59.77 4.52 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.902 -1.518 . . . . 72.5 106.902 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 15.3 mm100 -102.55 173.11 6.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.604 -0.726 . . . . 74.44 111.007 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.26 -40.36 1.95 Allowed Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.943 -1.026 . . . . 71.14 110.651 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.0 m -122.68 126.11 46.94 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.876 -0.787 . . . . 72.03 108.876 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 77.5 m-85 -115.81 142.79 46.29 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.48 -0.933 . . . . 72.21 108.48 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 495' ' ' THR . 14.0 mp0 -123.53 146.14 48.33 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.251 -1.388 . . . . 73.42 107.251 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' CYS . . . . . 0.569 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -149.77 151.29 33.35 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.982 -1.118 . . . . 63.44 107.982 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.4 OUTLIER -80.91 145.03 31.5 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.607 -0.886 . . . . 73.12 108.607 176.289 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -58.97 -29.95 67.57 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.55 0.69 . . . . 61.23 110.064 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 384' ' ' LEU . 34.5 p30 -80.94 -1.44 43.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.455 -0.793 . . . . 65.23 112.558 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.45 -22.04 48.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.261 0.553 . . . . 64.01 111.182 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 91.6 -59.7 2.92 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.781 -0.723 . . . . 74.32 111.522 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.4 p -136.27 155.24 50.37 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.615 0.245 . . . . 74.41 110.793 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 N-CA-C 107.888 -1.153 . . . . 63.01 107.888 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.44 124.42 40.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.125 0.488 . . . . 64.11 110.592 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.74 137.41 53.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.248 -1.389 . . . . 52.44 107.248 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.9 m -104.49 134.4 47.74 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.703 -0.48 . . . . 72.3 109.703 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 80.1 mt -103.85 126.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.57 -1.27 . . . . 72.41 107.57 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 44.9 mm -103.93 121.53 55.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.323 -0.991 . . . . 60.24 108.323 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 55.7 ttt180 -105.71 122.17 45.51 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.492 -0.777 . . . . 74.15 109.557 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.822 -0.626 . . . . 64.24 110.762 -178.276 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.419 -2.007 0 CA-C-O 121.497 0.665 . . . . 64.4 110.296 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.78 132.62 51.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.793 -0.817 . . . . 64.14 108.793 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 36.8 m-85 -115.62 129.3 56.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.192 0.52 . . . . 72.42 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.476 HG11 HG21 ' A' ' 374' ' ' ILE . 7.6 p -129.78 133.86 64.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.197 -1.409 . . . . 63.12 107.197 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -99.77 124.64 45.24 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.086 -0.709 . . . . 51.11 109.086 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 11.6 p90 -110.64 147.47 34.22 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.172 -0.677 . . . . 63.33 109.172 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 48.6 ttp180 -157.21 150.44 23.83 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.825 -1.176 . . . . 72.1 107.825 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 63.7 p -96.87 171.0 8.78 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.552 -0.459 . . . . 73.05 110.24 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 9.4 tp10 -137.57 158.21 44.88 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.166 -0.679 . . . . 74.43 109.166 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -31.14 -62.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.712 2.405 . . . . 72.32 113.147 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.29 -74.52 0.39 Allowed Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.069 -0.968 . . . . 51.2 111.019 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 8.8 t -154.87 16.72 0.44 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.122 -1.066 . . . . 71.02 108.122 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.8 -169.44 3.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.539 -0.755 . . . . 64.25 110.371 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -128.85 120.98 27.25 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.325 -0.621 . . . . 71.02 109.325 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.47 124.55 29.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.714 0.769 . . . . 71.14 110.553 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.49 32.0 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 109.43 -1.468 . . . . 31.33 109.43 -173.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 14.9 m -110.54 -58.55 2.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.985 -0.746 . . . . 62.32 108.985 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.561 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 14.3 m-20 -82.71 -58.26 2.97 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 122.011 0.91 . . . . 74.3 109.677 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.701 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.34 158.99 43.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.635 -0.876 . . . . 71.13 108.635 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.82 144.88 45.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.879 -0.785 . . . . 73.32 108.879 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.538 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 17.7 p90 -79.4 -18.45 52.28 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 113.054 0.761 . . . . 74.1 113.054 -173.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 442' ' ' VAL 0.268 11.0 t 40.06 55.99 2.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 127.198 2.199 . . . . 74.42 115.311 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 1.5 pp20? -78.41 131.15 36.81 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 118.952 -1.099 . . . . 75.02 108.944 173.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -164.4 170.13 39.46 Favored Glycine 0 CA--C 1.46 -3.365 0 N-CA-C 109.93 -1.268 . . . . 72.35 109.93 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.5 m -111.35 131.63 55.02 Favored 'General case' 0 N--CA 1.394 -3.242 0 C-N-CA 119.739 -0.784 . . . . 72.14 108.888 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.67 125.49 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.941 -1.503 . . . . 71.23 106.941 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' VAL . . . . . 0.44 HG22 ' CE2' ' A' ' 406' ' ' PHE . 19.5 t -103.72 117.11 48.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.614 -0.884 . . . . 62.13 108.614 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.473 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 65.1 m-85 -94.91 105.02 16.91 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.188 0.518 . . . . 72.3 110.689 177.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 0.2 OUTLIER -90.12 167.64 16.47 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 114.652 -1.158 . . . . 71.5 110.315 -176.141 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 32.0 Cg_exo -57.03 115.09 2.24 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.872 2.381 . . . . 73.41 108.989 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.02 -38.04 3.32 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 111.523 -0.631 . . . . 62.3 111.523 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -85.97 62.37 7.4 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.717 0.77 . . . . 74.42 110.595 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 14.1 t -84.08 9.58 12.21 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 115.134 -0.939 . . . . 71.55 109.878 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -140.55 137.05 33.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -135.47 153.29 51.8 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.358 0.411 . . . . 75.35 111.193 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.26 128.54 55.67 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.537 -0.912 . . . . 71.51 108.537 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.91 149.56 19.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.857 -1.164 . . . . 73.21 107.857 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 79.9 mtm180 -133.28 143.36 49.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.174 0.511 . . . . 71.32 111.265 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 425' ' ' THR . 48.7 t -109.92 124.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.394 -0.965 . . . . 63.1 108.394 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -77.28 127.09 8.17 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.559 -0.616 . . . . 63.32 111.559 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.498 HD12 HG12 ' A' ' 496' ' ' ILE . 35.7 mm -89.97 134.74 28.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.162 -1.051 . . . . 63.44 108.162 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.2 mt -96.77 147.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.274 -1.38 . . . . 74.23 107.274 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -78.97 86.68 4.82 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.416 -0.513 . . . . 75.2 111.925 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.38 126.81 55.69 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 103.338 -2.838 . . . . 73.41 103.338 169.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.18 93.26 3.54 Favored 'General case' 0 CA--C 1.463 -2.366 0 CA-C-O 123.438 1.59 . . . . 64.23 109.785 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.756 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 51.8 mm -125.25 158.22 33.59 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.161 0 CA-C-N 111.283 -2.689 . . . . 42.33 104.608 -171.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -51.23 114.39 1.19 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.784 -1.932 . . . . 74.54 105.784 166.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.756 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 36.2 mt-10 -121.74 94.74 4.41 Favored 'General case' 0 CA--C 1.468 -2.21 0 CA-C-O 122.117 0.961 . . . . 71.44 111.476 -169.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.01 102.06 13.76 Favored 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 114.26 -1.336 . . . . 64.34 110.146 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.82 57.56 5.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.787 -1.552 . . . . 75.22 112.953 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . 85.2 mt-10 -71.01 113.22 7.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.379 0.609 . . . . 64.43 109.836 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -137.47 160.36 39.34 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.874 -0.603 . . . . 74.02 110.401 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.589 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.3 p90 -140.37 177.25 8.13 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.489 -0.778 . . . . 73.14 109.735 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -117.69 138.07 52.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.335 -0.987 . . . . 71.43 108.335 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.28 120.58 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.896 -1.52 . . . . 74.44 106.896 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -114.3 149.12 36.45 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.641 0.588 . . . . 74.43 109.683 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.72 127.45 53.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 20.3 m -142.01 178.71 7.34 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.373 -0.602 . . . . 72.22 109.373 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.8 t30 50.37 86.11 0.03 OUTLIER 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.778 1.231 . . . . 75.04 113.238 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 53.4 t -84.89 116.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.55 -0.907 . . . . 75.5 108.55 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 26.3 tptp . . . . . 0 C--N 1.293 -1.872 0 N-CA-C 105.605 -1.998 . . . . 74.54 105.605 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.419 -2.009 0 N-CA-C 109.105 -0.702 . . . . 71.41 109.105 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.92 33.56 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.19 -1.041 . . . . 61.3 108.19 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 24.3 m -105.94 120.5 41.92 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.676 -0.41 . . . . 71.43 109.972 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 390' ' ' VAL . 73.0 t -107.12 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.93 -0.767 . . . . 52.33 108.93 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 37.7 m -104.36 117.98 35.51 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.813 -0.81 . . . . 73.22 108.813 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -97.08 118.9 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 109.341 -0.614 . . . . 63.33 109.341 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.577 ' O ' HD13 ' A' ' 384' ' ' LEU . 6.1 m-85 -83.25 105.22 14.04 Favored 'General case' 0 N--CA 1.389 -3.494 0 CA-C-N 115.513 -0.767 . . . . 62.41 110.963 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.6 -57.51 12.07 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 113.088 -1.869 . . . . 75.01 109.348 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.49 1.562 0 C-N-CA 124.922 1.289 . . . . 72.21 111.246 176.821 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.3 mmtp . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 108.251 -1.018 . . . . 72.03 108.251 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.482 HG21 HG11 ' A' ' 407' ' ' VAL . 25.9 mm -95.18 119.12 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.588 -1.187 . . . . 52.51 108.434 -176.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 160.93 42.49 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.925 0.33 . . . . 64.14 110.503 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.78 148.64 29.95 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.609 -0.515 . . . . 74.44 109.609 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.3 -43.83 85.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.586 -0.524 . . . . 60.54 109.586 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -115.22 176.29 5.13 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.885 -0.598 . . . . 64.33 110.676 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -110.36 -19.17 8.11 Favored Glycine 0 C--N 1.291 -1.964 0 CA-C-N 115.063 -0.971 . . . . 21.21 110.801 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 59.8 m -140.06 135.24 32.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.117 -1.068 . . . . 74.01 108.117 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 49.8 m-85 -125.41 141.2 52.2 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.076 -1.083 . . . . 70.53 108.076 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.61 132.67 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.505 -1.294 . . . . 74.32 107.505 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 15.2 t -151.81 165.52 34.23 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.149 -1.056 . . . . 72.14 108.149 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 2.4 mm? -81.03 143.33 32.57 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.216 0.531 . . . . 71.14 111.095 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.94 -39.4 85.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.339 -0.846 . . . . 71.23 109.784 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -73.65 -4.4 34.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.534 -0.757 . . . . 75.13 112.474 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 89.1 m -71.11 -22.33 62.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 122.109 -0.369 . . . . 51.1 111.953 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 94.68 -50.11 2.04 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.706 -0.759 . . . . 43.43 111.565 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.464 HG22 ' HA2' ' A' ' 443' ' ' GLY . 18.9 p -139.28 160.4 39.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.911 -0.403 . . . . 51.25 109.911 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 494' ' ' VAL . 6.0 p -114.83 133.8 59.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.281 -1.377 . . . . 74.2 107.281 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.41 125.83 48.11 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.201 0.524 . . . . 44.12 110.187 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.5 mp -116.52 153.68 31.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.121 -1.437 . . . . 72.23 107.121 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 28.1 m -120.6 126.93 51.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.335 0.588 . . . . 72.22 110.816 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.7 mt -100.69 120.27 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 108.204 -1.035 . . . . 44.42 108.204 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.481 HG22 ' HG2' ' A' ' 397' ' ' ARG . 46.2 mm -97.89 114.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.892 -1.049 . . . . 73.43 108.273 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.705 ' HB3' ' O ' ' A' ' 436' ' ' THR . 56.0 ttt180 -100.68 112.15 24.5 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 108.232 -1.025 . . . . 72.14 108.232 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 397' ' ' ARG . 4.3 mmp_? . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 109.518 -0.549 . . . . 75.35 109.518 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 31.9 m . . . . . 0 N--CA 1.422 -1.844 0 CA-C-O 121.757 0.789 . . . . 71.31 111.282 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.23 144.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.065 -0.97 . . . . 62.13 108.48 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 14.7 m-85 -119.7 132.08 55.57 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.905 0.383 . . . . 74.11 110.027 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 374' ' ' ILE . 3.7 p -132.78 131.68 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.834 -1.543 . . . . 63.01 106.834 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 11.3 t70 -98.97 136.68 38.6 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.802 -0.561 . . . . 74.13 111.492 -173.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -135.83 165.78 24.83 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.982 0.42 . . . . 72.42 110.536 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -167.12 155.53 9.78 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.579 -1.637 . . . . 73.3 106.579 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.681 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 26.1 p -96.62 160.81 14.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.437 -0.579 . . . . 54.31 109.437 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 16.0 tp10 -106.76 169.86 8.28 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.523 -1.288 . . . . 70.22 107.523 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 8.6 p-10 -63.03 -39.43 94.73 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.992 0.901 . . . . 64.42 110.255 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 72.21 -98.86 0.84 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.397 -1.274 . . . . 65.15 110.475 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 455' ' ' ASN . 10.8 t -122.34 -2.27 9.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.339 1.066 . . . . 74.34 108.65 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . . . -124.72 -153.28 0.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.816 -1.179 . . . . 31.43 107.816 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -133.93 116.11 15.2 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 118.199 0.454 . . . . 72.02 110.019 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.69 24.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.819 -0.808 . . . . 62.32 108.819 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.13 -19.27 25.13 Favored Glycine 0 C--N 1.288 -2.099 0 N-CA-C 110.539 -1.024 . . . . 64.41 110.539 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 m -115.84 -51.05 2.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.82 0.343 . . . . 64.1 110.568 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.613 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 16.3 m-20 -79.98 -64.57 1.16 Allowed 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 122.369 1.081 . . . . 72.43 108.819 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.652 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -134.29 162.6 31.73 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.19 -1.368 . . . . 74.44 107.899 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 425' ' ' THR . 5.9 tp10 -82.82 154.38 24.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.486 0.66 . . . . 64.32 111.792 -172.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.681 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.5 OUTLIER -79.1 -12.11 60.0 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.16 -0.927 . . . . 72.22 113.014 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.528 HG21 HG22 ' A' ' 442' ' ' VAL 0.253 13.3 t 33.64 69.47 0.14 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.734 1.614 . . . . 70.03 113.29 -177.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.26 129.48 34.5 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.254 -0.884 . . . . 73.22 109.647 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -174.11 175.59 46.57 Favored Glycine 0 N--CA 1.405 -3.425 0 C-N-CA 119.783 -1.199 . . . . 63.22 111.025 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 7.9 m -112.81 142.26 45.66 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.247 -1.39 . . . . 72.21 107.247 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 407' ' ' VAL . 22.4 t -95.16 111.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.528 -1.656 . . . . 74.22 106.528 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.3 106.51 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 115.036 -0.984 . . . . 75.44 109.093 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' ' 404' ' ' THR . 70.7 m-85 -77.61 94.26 4.34 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.268 -0.878 . . . . 74.43 109.887 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -73.98 163.77 65.99 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.971 -0.559 . . . . 44.2 111.021 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -51.28 113.84 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.47 2.113 . . . . 72.03 112.686 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.74 -24.0 32.95 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.832 -0.699 . . . . 53.13 111.488 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLU . . . . . 0.443 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 9.7 mm-40 -86.06 61.28 6.74 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.754 -0.832 . . . . 74.23 108.754 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.705 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 12.4 m -67.45 -33.73 75.74 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 107.613 -1.254 . . . . 73.35 107.613 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -104.26 132.8 50.13 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 106.607 -1.627 . . . . 63.31 106.607 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -118.73 147.53 43.75 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.118 0.485 . . . . 73.14 111.481 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.99 132.29 54.29 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 115.075 -0.966 . . . . 74.51 108.512 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.0 pt -119.24 146.78 23.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.435 -0.95 . . . . 71.32 108.435 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 85.9 mtt180 -126.82 141.16 51.9 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-O 121.698 0.761 . . . . 73.35 111.942 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.661 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 57.6 t -109.08 126.37 66.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.384 -1.339 . . . . 74.53 107.384 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -76.49 123.53 6.79 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.948 -0.861 . . . . 42.51 110.948 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.508 HD12 HG12 ' A' ' 496' ' ' ILE . 42.1 mm -86.57 132.92 31.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.051 -1.833 . . . . 75.22 106.051 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.613 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -94.32 149.27 4.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 105.134 -2.172 . . . . 63.33 105.134 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.66 85.79 4.67 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.801 -0.76 . . . . 65.13 110.733 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.25 112.92 23.9 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.075 -2.195 . . . . 73.11 105.075 172.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -118.0 93.61 4.2 Favored 'General case' 0 C--N 1.275 -2.671 0 C-N-CA 117.274 -1.771 . . . . 74.11 109.538 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.636 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 44.6 mm -125.9 156.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.86 0 CA-C-N 111.693 -2.503 . . . . 62.44 105.423 -172.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -49.45 115.03 1.18 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.458 -1.682 . . . . 75.4 106.458 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.2 mt-10 -129.35 121.42 27.42 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 109.621 -0.511 . . . . 74.13 109.621 -172.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -134.01 113.9 12.64 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.661 -1.237 . . . . 73.42 107.661 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 20.8 t70 56.74 54.88 6.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.518 1.127 . . . . 54.35 110.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -86.58 98.63 11.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.332 -1.358 . . . . 72.22 107.332 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.584 ' O ' HG22 ' A' ' 415' ' ' THR . 0.0 OUTLIER -131.85 143.4 50.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 122.108 0.956 . . . . 71.01 113.274 -176.467 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.661 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.9 p90 -116.74 177.04 4.84 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.742 -1.117 . . . . 74.0 109.453 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -121.94 136.4 54.92 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.647 -1.242 . . . . 74.34 107.647 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 15.6 t -108.25 131.24 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.616 -1.253 . . . . 62.24 107.616 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -123.46 164.44 18.91 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.769 0.668 . . . . 74.24 109.769 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 91.3 mt -126.51 139.27 53.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.834 -0.432 . . . . 62.13 109.834 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 50.2 m -156.94 178.5 10.29 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.536 -0.912 . . . . 75.24 108.536 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 8.3 t30 42.75 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.653 1.581 . . . . 73.12 114.731 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.37 139.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 115.834 -0.621 . . . . 73.02 109.651 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 24.4 ttmm . . . . . 0 C--N 1.297 -1.705 0 N-CA-C 107.922 -1.14 . . . . 71.43 107.922 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.405 -2.697 0 N-CA-C 109.081 -0.711 . . . . 70.01 109.081 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 492' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -99.47 99.74 10.69 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.603 -1.628 . . . . 74.22 106.603 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 36.9 m -79.98 120.32 24.01 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.566 -0.531 . . . . 61.13 109.566 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 390' ' ' VAL . 72.2 t -107.0 105.48 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 116.181 -0.463 . . . . 71.01 109.759 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 86.7 m -88.69 111.5 22.02 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.533 -0.914 . . . . 73.41 108.533 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.652 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -87.1 117.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 108.998 -0.742 . . . . 73.21 108.998 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.452 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.9 m-85 -83.47 97.58 9.06 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-O 122.182 0.991 . . . . 74.41 112.169 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -51.58 -56.24 14.64 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.212 -2.267 . . . . 62.1 108.312 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 125.72 1.608 . . . . 50.32 111.306 175.551 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 373' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 28.7 mmtp . . . . . 0 CA--C 1.491 -1.309 0 N-CA-C 109.128 -0.693 . . . . 44.25 109.128 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 31.7 mm -98.81 118.27 45.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.813 -1.54 . . . . 71.24 108.49 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -154.87 174.15 15.51 Favored 'General case' 0 C--O 1.196 -1.718 0 CA-C-N 117.728 0.24 . . . . 74.22 110.364 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -92.74 153.0 19.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.345 -0.542 . . . . 74.34 112.268 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -54.53 37.68 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.659 -1.238 . . . . 73.51 107.659 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -106.51 160.86 15.1 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.559 -0.746 . . . . 74.33 110.693 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -96.31 -18.72 30.16 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 110.057 -1.217 . . . . 35.12 110.057 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 493' ' ' THR . 73.8 m -143.07 125.54 15.72 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 109.038 -0.727 . . . . 70.21 109.038 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 45.2 m-85 -109.84 136.23 49.48 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.289 -1.004 . . . . 74.03 108.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -130.28 122.82 28.71 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 390' ' ' VAL . 94.6 m -145.14 165.4 28.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.993 -0.743 . . . . 74.1 108.993 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' LEU . . . . . 0.755 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -78.19 149.66 33.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.967 0.413 . . . . 75.11 111.357 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' GLU . . . . . 0.459 ' HA ' HG21 ' A' ' 444' ' ' ILE . 13.9 tt0 -60.76 -28.29 68.61 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.642 1.211 . . . . 73.13 107.833 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -81.91 -4.72 57.25 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.327 -1.761 . . . . 51.03 111.833 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 78.7 m -77.23 -14.53 59.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 122.234 -0.291 . . . . 65.31 110.811 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.19 -53.6 3.9 Favored Glycine 0 CA--C 1.5 -0.882 0 N-CA-C 111.309 -0.717 . . . . 53.02 111.309 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' THR . . . . . 0.548 HG22 ' HA2' ' A' ' 443' ' ' GLY . 11.1 p -139.03 164.31 30.09 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.674 . . . . 52.03 109.179 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 494' ' ' VAL . 7.3 p -117.82 129.37 74.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.564 -1.273 . . . . 63.1 107.564 173.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 440' ' ' ILE . . . -96.53 135.31 38.6 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.873 0.368 . . . . 75.0 110.291 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.436 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -126.19 145.37 50.4 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.839 -1.171 . . . . 64.13 107.839 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.3 m -112.85 124.2 52.05 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.226 0.536 . . . . 62.51 110.362 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.21 120.03 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.883 -1.154 . . . . 73.24 107.883 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.4 mm -99.13 116.04 41.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.469 -1.241 . . . . 64.53 108.417 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 44.3 ttt180 -102.62 113.05 26.1 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.522 -1.288 . . . . 74.51 107.522 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 112.681 0.623 . . . . 75.33 112.681 -178.511 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 60.9 m . . . . . 0 N--CA 1.432 -1.343 0 CA-C-O 122.014 0.912 . . . . 63.1 111.896 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.91 140.26 35.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 113.887 -1.506 . . . . 44.04 108.292 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 16.5 m-85 -120.07 129.27 54.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.582 -0.895 . . . . 73.32 108.582 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.22 132.69 70.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.887 -1.153 . . . . 64.24 107.887 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.05 147.09 27.4 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.805 -0.442 . . . . 60.42 109.805 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -141.72 163.99 31.41 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.868 -0.52 . . . . 74.54 111.792 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -158.13 168.93 25.72 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 125.313 1.445 . . . . 73.44 109.006 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 69.0 p -96.89 162.06 13.57 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.527 -1.286 . . . . 72.13 107.527 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -126.32 151.41 47.59 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.105 -0.638 . . . . 75.41 111.032 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 416' ' ' ALA . 2.5 p30 -65.71 2.77 0.9 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.795 2.038 . . . . 71.24 115.957 -176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.48 -73.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 124.92 1.247 . . . . 74.03 116.007 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.8 t -122.37 6.62 9.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 117.716 0.758 . . . . 54.32 110.304 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 413' ' ' ASP . . . -158.76 171.89 19.25 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 109.241 -0.652 . . . . 70.21 109.241 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -120.23 131.97 55.17 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.619 0.723 . . . . 71.31 112.073 -172.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -78.67 138.66 38.4 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.879 -1.055 . . . . 55.1 108.945 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.76 65.72 Favored Glycine 0 C--N 1.3 -1.467 0 N-CA-C 109.983 -1.247 . . . . 73.14 109.983 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 49.0 m -141.28 -59.02 0.49 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 122.546 0.339 . . . . 71.44 110.215 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.639 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 12.8 m-20 -77.82 -57.91 3.55 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-O 122.038 0.923 . . . . 73.43 108.744 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' TYR . . . . . 0.758 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -140.3 168.85 18.85 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.642 -1.163 . . . . 64.33 108.14 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.12 169.71 17.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.9 -0.408 . . . . 73.32 109.9 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.596 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.7 p90 -101.56 -17.21 16.49 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.265 0.469 . . . . 74.32 112.265 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 425' ' ' THR . . . . . 0.536 HG21 HG22 ' A' ' 442' ' ' VAL . 9.6 t 40.54 65.36 0.78 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.096 1.758 . . . . 53.02 113.108 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.09 114.92 18.42 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.665 -0.698 . . . . 70.51 110.124 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.71 172.92 33.8 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 110.948 -0.861 . . . . 71.53 110.948 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.1 m -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.585 -0.895 . . . . 63.43 108.585 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 33.5 t -96.52 128.36 47.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.901 -0.778 . . . . 65.13 108.901 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.16 112.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.53 -0.544 . . . . 75.33 109.53 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.6 m-85 -93.56 94.42 8.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.984 0.421 . . . . 74.41 110.603 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.0 mttt -89.08 176.17 3.41 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.137 -0.938 . . . . 75.24 110.212 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 31.1 Cg_exo -62.22 119.57 6.74 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.055 1.837 . . . . 70.21 110.431 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.12 -21.81 34.73 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.14 -0.784 . . . . 52.23 111.14 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -88.3 62.27 6.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.639 -0.874 . . . . 62.15 108.639 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 5.1 m -69.74 -28.15 65.55 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.428 -1.26 . . . . 73.13 108.537 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.23 145.62 49.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.184 -1.413 . . . . 74.32 107.184 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -132.89 148.27 52.29 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.539 0.209 . . . . 65.04 110.938 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.5 131.54 54.77 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.073 -0.512 . . . . 72.13 109.851 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 391' ' ' ALA . 44.5 pt -124.11 152.13 29.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.063 -0.717 . . . . 73.01 109.063 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 67.0 mtm180 -127.01 143.61 51.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.534 0.207 . . . . 72.43 110.65 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.548 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 93.6 t -109.9 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.44 -0.948 . . . . 62.21 108.44 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -66.65 122.42 19.98 Favored Glycine 0 N--CA 1.437 -1.258 0 O-C-N 123.984 0.802 . . . . 51.11 111.614 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.502 HD12 HG12 ' A' ' 496' ' ' ILE . 50.4 mm -95.63 134.13 34.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.452 -0.944 . . . . 63.01 108.452 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.3 mt -99.02 148.12 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 106.019 -1.845 . . . . 74.14 106.019 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.5 89.56 7.26 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 121.767 0.794 . . . . 54.12 111.777 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.37 117.37 34.42 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.266 -1.383 . . . . 64.22 107.266 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.439 33.1 m-20 -102.43 85.02 2.53 Favored 'General case' 0 CA--C 1.446 -3.025 0 CA-C-O 123.736 1.732 . . . . 75.42 114.346 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 449' ' ' ILE . . . . . 0.741 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.8 mm -122.44 153.42 27.04 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 0 N-CA-C 102.368 -3.197 . . . . 74.21 102.368 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -56.86 116.37 3.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.528 -1.286 . . . . 74.32 107.528 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.741 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 45.6 mt-10 -112.3 118.66 35.87 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 121.191 0.52 . . . . 72.33 111.793 -172.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -136.41 111.62 9.05 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.095 -1.411 . . . . 74.45 107.97 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.54 26.96 14.98 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.364 0.876 . . . . 53.21 113.364 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' GLU . . . . . 0.532 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 24.4 tt0 -66.22 109.69 2.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.223 -1.028 . . . . 74.42 108.223 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.41 168.67 19.19 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.039 -0.528 . . . . 73.34 110.475 -175.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' PHE . . . . . 0.586 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 18.6 p90 -140.11 171.5 14.09 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.221 -0.659 . . . . 72.0 109.221 173.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 38.2 mt -114.4 136.34 53.1 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.532 -1.284 . . . . 71.33 107.532 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 56.7 t -102.06 113.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.415 -1.328 . . . . 74.21 107.415 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.39 136.3 48.26 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 123.571 0.545 . . . . 71.43 110.837 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.6 mt -96.86 132.18 42.87 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.001 -0.74 . . . . 64.54 109.001 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.4 m -151.07 176.26 11.32 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.704 -0.851 . . . . 74.33 108.704 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.95 81.16 0.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.192 0.997 . . . . 72.35 112.297 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 58.5 t -87.7 123.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 115.401 -0.818 . . . . 61.13 109.283 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 39.6 ttmt . . . . . 0 C--N 1.286 -2.182 0 N-CA-C 108.111 -1.07 . . . . 72.21 108.111 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.416 -2.143 0 CA-C-O 121.171 0.51 . . . . 74.15 110.164 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -109.82 118.28 36.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.115 -1.439 . . . . 72.41 107.115 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 380' ' ' THR . 41.2 m -87.67 131.66 34.38 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 120.837 0.351 . . . . 62.53 110.23 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 494' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 390' ' ' VAL . 78.5 t -116.64 106.51 20.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.668 -1.234 . . . . 73.33 107.668 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 47.9 m -97.78 112.84 24.58 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.303 -0.999 . . . . 52.31 108.303 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.758 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -89.79 115.57 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 122.144 0.973 . . . . 72.11 110.409 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 497' ' ' PHE . . . . . 0.755 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 83.7 m-85 -99.8 120.86 40.41 Favored 'General case' 0 N--CA 1.396 -3.129 0 CA-C-N 114.796 -1.093 . . . . 74.31 108.176 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -99.92 -7.55 25.08 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-O 122.603 1.192 . . . . 74.05 107.97 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.483 1.217 0 CA-C-N 113.276 -1.784 . . . . 64.21 106.297 -172.499 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 479' ' ' HIS . 83.4 t . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 108.235 -1.024 . . . . 65.23 108.235 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 480' ' ' VAL . 75.7 m -147.28 120.13 8.69 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.706 -0.225 . . . . 64.23 110.684 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.463 ' HA ' HG13 ' A' ' 480' ' ' VAL . 96.5 mttt -93.43 121.12 34.5 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.195 -0.668 . . . . 74.22 109.195 174.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.455 HG21 HG11 ' A' ' 407' ' ' VAL . 30.9 mm -94.71 136.31 26.3 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 105.374 -2.084 . . . . 73.2 105.374 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.4 ' HA ' HD11 ' A' ' 486' ' ' LEU . 35.2 p90 -165.6 160.53 17.65 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 118.278 0.49 . . . . 72.41 111.697 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -79.22 141.01 37.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.674 -0.491 . . . . 75.44 109.674 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -65.18 -44.99 86.68 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.592 -0.892 . . . . 65.44 108.592 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -114.44 161.68 17.66 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.401 -0.818 . . . . 74.33 111.053 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.93 -19.11 18.16 Favored Glycine 0 C--N 1.278 -2.67 0 CA-C-N 114.425 -1.261 . . . . 73.14 110.406 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.7 m -138.6 134.21 33.47 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.992 -0.744 . . . . 72.22 108.992 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 72.5 m-85 -124.5 140.38 53.0 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.704 -1.221 . . . . 74.42 107.704 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.459 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 75.5 mt-30 -129.82 140.4 51.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.576 -0.898 . . . . 43.2 108.576 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.8 p -151.88 159.86 43.71 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.737 -0.838 . . . . 62.33 108.737 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.459 HD12 ' OD1' ' A' ' 386' ' ' ASN . 2.1 mm? -74.98 148.72 39.69 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.45 0.469 . . . . 64.14 109.906 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.652 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 4.5 tt0 -62.83 -36.83 84.5 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.697 0.761 . . . . 74.51 109.425 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.459 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.7 p-10 -81.15 6.21 14.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.461 -0.791 . . . . 74.21 112.283 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 54.1 t -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.395 0.617 . . . . 61.21 110.402 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.17 -61.42 0.53 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.769 -0.932 . . . . 60.5 110.769 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 6.2 p -137.71 152.57 49.39 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.708 0.29 . . . . 75.34 111.143 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.638 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 7.7 p -109.97 127.43 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 107.976 -1.12 . . . . 74.31 107.976 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.71 120.64 38.46 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.141 0.496 . . . . 54.15 110.482 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -111.1 152.86 26.47 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.269 -1.382 . . . . 61.23 107.269 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.0 m -123.93 128.47 49.48 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.27 0.557 . . . . 71.45 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.89 125.56 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.796 -1.187 . . . . 52.22 107.796 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.54 144.95 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.645 -1.243 . . . . 72.42 107.645 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.506 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 55.8 ttt180 -127.28 121.06 30.1 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 116.068 -0.515 . . . . 73.21 109.94 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -118.84 167.51 11.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.761 -0.654 . . . . 71.11 111.028 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 136.15 14.6 0.95 Allowed Glycine 0 C--N 1.303 -1.263 0 N-CA-C 111.287 -0.725 . . . . 75.51 111.287 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 92.65 -106.01 3.36 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 110.306 -1.118 . . . . 42.24 110.306 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -135.28 137.9 42.97 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.861 -0.792 . . . . 75.34 108.861 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.467 HD13 ' H ' ' A' ' 403' ' ' ASN . 0.7 OUTLIER -160.35 111.87 1.93 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.2 -1.037 . . . . 72.12 108.2 -176.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 3.9 p -98.87 -8.3 25.94 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.531 0.567 . . . . 71.54 112.531 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.467 ' H ' HD13 ' A' ' 401' ' ' LEU . 2.2 m-20 -67.81 146.39 53.75 Favored 'General case' 0 C--O 1.249 1.065 0 N-CA-C 108.246 -1.02 . . . . 53.34 108.246 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 14.0 m -83.68 114.0 21.26 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.616 0.722 . . . . 65.25 111.75 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.38 133.89 43.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.231 -0.895 . . . . 55.44 108.737 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -115.94 126.97 54.59 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.75 0.42 . . . . 71.44 109.948 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.455 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -125.29 135.36 64.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.294 -1.743 . . . . 72.23 106.294 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 140.45 35.05 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.24 -0.652 . . . . 60.24 109.24 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -135.25 160.59 37.9 Favored 'General case' 0 C--O 1.254 1.305 0 C-N-CA 120.676 -0.41 . . . . 65.22 110.646 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 30.6 ttt180 -164.03 158.02 19.02 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.263 -1.754 . . . . 52.25 106.263 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.723 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 43.2 p -96.3 150.39 20.62 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.863 -0.791 . . . . 63.34 108.863 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.9 tp10 -105.64 139.8 39.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.735 -1.209 . . . . 74.41 107.735 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.423 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 3.7 m-20 -52.39 -39.03 60.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.512 1.125 . . . . 64.4 112.651 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 57.96 -94.99 0.05 OUTLIER Glycine 0 C--N 1.295 -1.708 0 CA-C-N 114.755 -1.111 . . . . 72.13 113.717 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -124.18 17.83 9.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.498 1.142 . . . . 63.43 108.889 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -148.27 -160.52 1.18 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.678 -1.23 . . . . 53.23 107.678 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 417' ' ' ASN . 2.8 m120 -132.71 126.71 33.16 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 113.028 0.751 . . . . 72.31 113.028 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.43 124.37 28.85 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.914 -1.143 . . . . 62.32 107.914 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.48 -5.69 54.99 Favored Glycine 0 C--N 1.3 -1.465 0 N-CA-C 110.69 -0.964 . . . . 74.35 110.69 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 19.9 m -126.13 -51.83 1.53 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.877 0.37 . . . . 61.41 110.114 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.489 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 7.6 m-20 -86.46 -57.14 3.11 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 122.205 1.002 . . . . 72.32 109.726 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.689 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.47 165.03 28.61 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 115.116 -0.947 . . . . 62.53 109.683 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.69 162.15 28.3 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.936 0.773 . . . . 71.44 111.788 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.723 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 2.4 p90 -97.93 -17.87 18.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.124 -0.943 . . . . 65.24 111.875 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.495 HG21 HG22 ' A' ' 442' ' ' VAL . 6.9 t 32.93 56.37 0.44 Allowed 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.594 1.558 . . . . 45.14 113.844 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.546 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.3 pt-20 -79.89 119.28 22.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.624 0.726 . . . . 73.13 111.614 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.51 -167.51 23.04 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.617 -0.993 . . . . 55.12 110.617 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.8 m -127.78 137.51 52.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 70.11 108.514 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.23 118.49 42.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.532 -0.914 . . . . 74.14 108.532 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.36 107.42 19.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.854 -1.066 . . . . 72.24 109.324 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 404' ' ' THR . 71.1 m-85 -90.38 94.35 9.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.255 0.55 . . . . 72.52 110.784 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.476 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 67.3 mttm -84.54 175.71 4.39 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.637 -1.165 . . . . 65.53 111.022 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 34.3 Cg_exo -60.87 117.75 4.55 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.324 2.016 . . . . 73.51 110.27 172.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.93 -11.4 41.16 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.454 -0.658 . . . . 43.33 111.454 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -90.58 63.45 5.48 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.714 0.768 . . . . 72.2 110.765 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 16.9 m -67.52 -22.46 65.43 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.23 -1.35 . . . . 63.35 108.474 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -136.15 149.2 48.54 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 107.284 -1.376 . . . . 72.02 107.284 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 24.3 mmmt -133.07 151.72 52.01 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 120.778 0.323 . . . . 63.14 111.078 172.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -121.46 132.93 55.01 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.725 -0.67 . . . . 74.5 109.509 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.7 150.46 26.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.513 -0.921 . . . . 65.42 108.513 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 23.1 mtm180 -131.53 134.69 46.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.141 0.496 . . . . 72.13 111.663 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.56 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -107.66 125.56 64.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.437 -0.949 . . . . 53.31 108.437 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -74.82 138.35 23.65 Favored Glycine 0 N--CA 1.439 -1.127 0 O-C-N 123.667 0.604 . . . . 75.14 112.06 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.441 HD12 HG12 ' A' ' 496' ' ' ILE . 43.3 mm -97.37 130.71 45.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.597 -1.26 . . . . 72.42 107.597 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 84.4 mt -92.03 151.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 108.202 -1.036 . . . . 75.53 108.202 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.03 86.67 6.09 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.708 0.289 . . . . 72.15 110.822 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.8 129.57 54.51 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.521 -2.4 . . . . 55.13 104.521 171.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.256 8.2 t0 -125.61 89.45 3.04 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 116.577 -2.049 . . . . 73.24 111.518 178.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.623 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.6 mm -115.21 156.4 16.21 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.034 0 CA-C-N 111.058 -2.792 . . . . 62.42 105.587 -174.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -59.79 115.1 3.13 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.76 -1.941 . . . . 72.22 105.76 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.623 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 34.9 mt-10 -122.22 110.78 16.15 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.044 0.926 . . . . 75.34 110.338 -169.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 504' ' ' ILE . 33.0 mt-10 -115.44 111.93 21.53 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.146 -1.388 . . . . 73.12 108.713 -175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 49.34 30.38 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.914 1.686 . . . . 72.15 112.548 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.542 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.5 tt0 -60.8 112.55 2.08 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.538 -1.21 . . . . 74.24 108.809 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.84 168.51 19.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.472 -0.786 . . . . 74.12 110.168 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.585 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 31.3 p90 -139.07 175.1 9.84 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.956 -0.566 . . . . 72.23 109.552 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 27.1 mt -120.36 136.79 54.59 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.976 -1.12 . . . . 60.13 107.976 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.0 t -106.43 123.55 61.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.934 -1.136 . . . . 73.52 107.934 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -114.54 150.87 34.26 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 123.852 0.72 . . . . 75.53 109.917 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 486' ' ' LEU . 65.5 mt -116.36 140.01 49.79 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.414 -0.958 . . . . 70.31 108.414 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 11.8 p -153.37 -179.97 8.23 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.749 -0.834 . . . . 44.43 108.749 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 49.6 86.91 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.307 1.043 . . . . 74.04 112.505 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.57 HG11 HG23 ' A' ' 480' ' ' VAL . 83.8 t -102.03 125.87 56.13 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.89 -0.782 . . . . 34.23 108.89 176.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 464' ' ' LYS . 38.5 ttmt -134.87 141.47 46.36 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.977 -1.49 . . . . 74.34 106.977 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.5 132.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.341 0.591 . . . . 61.01 111.469 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.48 ' HB3' ' HB ' ' A' ' 404' ' ' THR . 16.7 t -97.44 109.11 21.93 Favored 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 107.313 -1.366 . . . . 54.42 107.313 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 12.8 t -128.72 -48.08 1.26 Allowed 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.937 -1.875 . . . . 71.05 105.937 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -84.5 166.73 17.01 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.177 -1.416 . . . . 74.12 107.177 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.85 0.87 22.26 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.3 0.571 . . . . 73.1 111.691 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 8.5 t -98.23 151.58 20.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.395 -1.335 . . . . 74.22 107.395 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.51 -34.16 76.54 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.976 0.417 . . . . 64.14 111.865 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.26 93.12 8.93 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.139 -0.482 . . . . 72.24 109.733 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -77.9 105.88 2.19 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.953 -1.659 . . . . 73.35 108.953 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 49.3 mt -68.7 89.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.688 0.625 . . . . 54.34 112.688 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 68.5 mt 59.16 22.22 10.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.836 1.254 . . . . 72.42 112.406 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.36 135.06 57.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.293 0.568 . . . . 73.13 112.529 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' ALA . . . . . 0.446 ' HA ' ' CE1' ' A' ' 479' ' ' HIS . . . -73.07 22.72 0.07 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.125 1.528 . . . . 61.41 115.125 -169.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -109.14 25.65 11.55 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.702 -1.222 . . . . 71.43 107.702 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' A' ' 483' ' ' LEU . 5.7 p-80 -88.71 -173.09 3.98 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.736 -1.575 . . . . 71.04 113.318 -173.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.57 HG23 HG11 ' A' ' 463' ' ' VAL . 90.7 t -79.85 -70.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.513 -0.767 . . . . 61.14 110.702 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 70.6 m -154.4 118.73 4.79 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.043 -0.725 . . . . 55.03 109.043 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . 70.41 -55.77 0.61 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.322 1.449 . . . . 61.21 109.086 -173.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 479' ' ' HIS . 2.0 tm? -156.13 -58.23 0.09 Allowed 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 104.419 -2.438 . . . . 72.52 104.419 170.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 463' ' ' VAL . . . -143.72 149.45 37.18 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 112.632 0.604 . . . . 64.44 112.632 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 38.5 t -175.53 -173.94 0.67 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 102.972 -2.973 . . . . 73.34 102.972 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 460' ' ' LEU . 1.0 OUTLIER -148.59 143.43 26.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.238 -1.393 . . . . 61.21 107.238 176.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.517 ' N ' HD13 ' A' ' 486' ' ' LEU . . . -82.09 35.63 2.56 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 122.052 -0.118 . . . . 70.44 113.314 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.541 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 20.1 m -147.77 173.65 4.03 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 107.835 -1.172 . . . . 74.01 107.835 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 488' ' ' SER . 4.9 Cg_exo -44.4 -39.84 12.79 Favored 'Trans proline' 0 CA--C 1.575 2.564 0 N-CA-C 119.268 2.757 . . . . 71.33 119.268 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.472 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 20.1 m -101.65 109.16 20.89 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 128.645 2.778 . . . . 42.3 108.149 1.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.479 ' H ' ' HG2' ' A' ' 489' ' ' PRO . 57.6 m -140.88 106.0 5.0 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-O 120.727 0.298 . . . . 65.31 110.458 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.82 102.72 14.24 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.394 -1.706 . . . . 74.45 106.394 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 29.5 m -80.29 121.28 25.46 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.754 -0.657 . . . . 72.11 109.747 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 390' ' ' VAL . 99.5 t -105.68 103.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 108.391 -0.966 . . . . 64.42 108.391 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 19.7 m -93.17 108.42 20.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.137 -1.06 . . . . 73.53 108.137 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.689 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -85.87 121.66 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-O 122.015 0.912 . . . . 74.44 110.992 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.459 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -83.55 95.91 8.46 Favored 'General case' 0 N--CA 1.388 -3.541 0 CA-C-N 114.896 -1.047 . . . . 64.43 110.498 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.654 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.7 t70 -51.06 -54.04 28.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 113.149 -1.841 . . . . 73.3 108.344 170.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.6 t70 68.91 -7.1 0.79 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.141 1.776 . . . . 74.11 111.683 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -82.48 -51.69 7.57 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.638 0.775 . . . . 63.43 109.492 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -128.83 18.61 6.15 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.307 -1.368 . . . . 75.0 107.307 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -79.56 73.82 6.23 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.819 -1.082 . . . . 43.14 113.293 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -92.72 61.74 2.34 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 107.059 -2.416 . . . . 71.31 107.059 171.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 452' ' ' GLU . 0.2 OUTLIER -74.6 164.14 3.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 113.722 1.008 . . . . 63.15 113.722 -169.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -125.31 142.23 51.62 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 106.021 -1.844 . . . . 61.54 106.021 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 98.8 m -81.07 100.2 8.88 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-O 121.228 0.537 . . . . 72.13 111.535 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -100.91 122.76 44.04 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.231 -1.396 . . . . 72.13 107.231 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.94 138.21 40.85 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 113.142 0.793 . . . . 60.52 113.142 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--N 1.307 -1.273 0 CA-C-N 114.968 -1.015 . . . . 74.32 109.684 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.654 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.583 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.245 0.867 0 N-CA-C 108.643 -0.873 . . . . 62.21 108.643 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 49.8 m -160.16 149.42 17.57 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.069 0.395 . . . . 75.3 110.922 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 373' ' ' LYS . 25.8 mmtp -104.94 136.35 44.59 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.312 -0.625 . . . . 62.15 109.312 171.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.573 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 28.4 mm -110.4 124.61 67.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.28 -1.378 . . . . 63.42 107.28 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.495 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 45.8 p90 -154.82 169.54 23.74 Favored 'General case' 0 C--O 1.201 -1.458 0 CA-C-N 118.335 0.516 . . . . 72.44 111.633 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -85.12 148.13 26.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.3 -0.63 . . . . 63.35 109.3 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -64.51 -46.19 84.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.367 0.604 . . . . 74.53 109.459 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -109.29 -173.89 2.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.334 -0.848 . . . . 74.31 110.414 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.43 -37.22 1.02 Allowed Glycine 0 C--N 1.285 -2.297 0 N-CA-C 109.769 -1.333 . . . . 75.31 109.769 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 35.2 m -121.19 134.36 55.21 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.456 -0.942 . . . . 71.41 108.456 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.459 ' HB2' HG22 ' A' ' 494' ' ' VAL . 58.3 m-85 -122.19 136.62 54.93 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.814 -1.18 . . . . 64.53 107.814 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -130.43 134.76 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.867 -1.16 . . . . 54.41 107.867 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 21.2 t -154.42 164.09 39.17 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.992 -1.114 . . . . 64.12 107.992 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 497' ' ' PHE . 1.8 mm? -79.96 142.88 34.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.279 0.562 . . . . 65.2 111.826 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.6 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 13.9 tt0 -57.45 -41.61 80.86 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.438 1.095 . . . . 72.25 109.745 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -70.38 -7.76 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.424 -0.807 . . . . 73.31 113.169 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 49.7 t -68.11 -35.61 78.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.903 0.382 . . . . 72.42 110.837 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.54 -47.5 1.13 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.725 -0.75 . . . . 72.11 111.474 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 16.6 p -142.58 152.6 42.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.692 0.246 . . . . 73.52 110.636 175.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.2 p -111.42 133.15 57.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.471 -1.307 . . . . 72.4 107.471 174.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.49 120.57 41.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.114 0.483 . . . . 72.11 110.833 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -111.45 146.64 36.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.374 -0.973 . . . . 75.0 108.374 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.3 m -107.73 123.81 49.09 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.607 -0.516 . . . . 33.54 109.607 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 61.0 mt -98.83 124.42 52.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.869 -1.16 . . . . 70.3 107.869 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 52.2 mm -99.46 127.8 51.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.409 -0.96 . . . . 64.1 108.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -113.56 114.58 26.68 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.541 -0.911 . . . . 75.24 108.541 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -111.53 151.06 29.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.367 -0.379 . . . . 74.11 110.092 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 162.61 36.73 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.796 -0.638 . . . . 73.4 111.811 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 71.93 -98.94 0.82 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.438 -0.665 . . . . 54.23 111.438 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -150.84 121.96 7.73 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 124.192 0.997 . . . . 73.22 108.91 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.514 ' HB3' ' OD1' ' A' ' 403' ' ' ASN . 0.1 OUTLIER -157.21 136.08 11.65 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.356 -1.72 . . . . 40.4 106.356 175.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 20.3 p -86.25 7.89 23.43 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 120.975 0.417 . . . . 43.41 110.988 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 401' ' ' LEU . 19.5 p-10 -50.22 129.45 21.31 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.658 1.183 . . . . 43.35 113.471 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 7.5 m -92.96 117.72 30.36 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.783 -0.821 . . . . 74.35 108.783 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.79 143.83 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.257 -0.883 . . . . 72.53 110.074 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CE1' HG13 ' A' ' 430' ' ' VAL . 3.5 m-85 -118.43 125.18 49.41 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.422 0.689 . . . . 72.14 109.317 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -125.62 135.62 63.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.63 -1.248 . . . . 73.24 107.63 176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.45 145.43 27.44 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.099 -0.704 . . . . 65.54 109.099 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 17.4 p90 -142.89 157.78 44.25 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.06 -0.4 . . . . 73.41 110.461 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -161.28 163.92 30.59 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.843 -1.169 . . . . 72.31 107.843 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.678 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.5 p -95.66 172.58 7.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.003 -0.74 . . . . 55.04 109.003 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -115.42 157.72 23.53 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 120.991 0.424 . . . . 63.01 111.995 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -85.95 4.01 39.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.184 1.794 . . . . 72.22 110.571 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -23.36 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.48 1.593 0 C-N-CA 125.912 1.72 . . . . 73.35 116.579 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 455' ' ' ASN . 11.3 t -99.66 -16.48 18.18 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.564 0.697 . . . . 74.32 109.653 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -140.22 170.32 16.05 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 108.583 -0.895 . . . . 65.45 108.583 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -110.83 113.99 26.99 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 112.93 0.715 . . . . 72.1 112.93 -167.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -68.27 124.09 22.51 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.986 -1.116 . . . . 63.44 107.986 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.14 -26.79 8.52 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.391 -1.084 . . . . 54.35 110.391 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 43.2 m -116.38 -47.78 2.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.685 0.279 . . . . 53.0 111.338 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.0 m-20 -80.39 -57.77 3.44 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 122.174 0.987 . . . . 63.24 109.403 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.733 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.647 -1.161 . . . . 72.53 108.716 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -75.12 160.38 30.53 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.748 0.785 . . . . 74.3 110.702 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.678 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.3 p90 -94.69 -17.95 21.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.402 -0.817 . . . . 52.1 112.268 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 442' ' ' VAL . 10.1 t 37.08 58.12 1.19 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.413 1.485 . . . . 52.13 113.688 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 13.6 pt-20 -80.92 111.86 17.77 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.997 0.903 . . . . 72.13 110.399 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.6 -173.61 22.96 Favored Glycine 0 N--CA 1.415 -2.76 0 CA-C-N 114.799 -1.091 . . . . 63.14 111.446 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.8 m -126.52 133.19 51.2 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.781 -0.822 . . . . 74.34 108.781 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 17.8 t -96.91 123.55 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.527 -0.916 . . . . 42.41 108.527 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.5 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.2 t -99.29 109.96 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.051 -0.722 . . . . 63.32 109.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 404' ' ' THR . 65.6 m-85 -86.07 114.94 23.34 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.693 -0.685 . . . . 63.51 109.731 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 95.5 mttt -108.73 171.56 4.4 Favored Pre-proline 0 C--N 1.291 -1.935 0 CA-C-N 114.944 -1.025 . . . . 75.11 110.296 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 52.4 Cg_exo -57.26 121.6 10.35 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.784 2.322 . . . . 71.34 111.205 175.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.81 -16.8 60.38 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.711 -0.677 . . . . 14.24 111.938 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -87.99 62.25 6.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.217 0.532 . . . . 43.55 110.143 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.4 t -70.48 -17.26 62.97 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.643 -0.708 . . . . 73.21 109.561 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -130.86 141.89 50.34 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.245 -1.391 . . . . 72.34 107.245 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -128.94 147.86 50.88 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 120.612 0.244 . . . . 55.01 111.235 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.74 127.7 54.79 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.724 -0.671 . . . . 71.43 109.599 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.95 149.29 21.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.037 -1.098 . . . . 72.32 108.037 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 62.2 mtt180 -130.6 140.12 50.42 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 120.63 -0.428 . . . . 72.31 111.418 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.603 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.1 t -108.09 127.65 64.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.11 -0.95 . . . . 73.34 108.442 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -70.82 138.82 28.99 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 124.002 0.814 . . . . 72.55 111.857 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.409 HD12 HG12 ' A' ' 496' ' ' ILE . 38.4 mm -104.16 128.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.298 -1.371 . . . . 60.34 107.298 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 77.5 mt -94.65 151.14 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 106.705 -1.591 . . . . 74.21 106.705 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -81.51 86.29 6.36 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.489 0.662 . . . . 70.32 110.652 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.99 124.67 52.71 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 103.338 -2.838 . . . . 70.31 103.338 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -125.89 98.45 5.53 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 117.297 -1.761 . . . . 75.02 110.027 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.667 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -122.0 156.37 26.54 Favored 'Isoleucine or valine' 1 C--N 1.237 -4.304 0 CA-C-N 111.411 -2.631 . . . . 73.25 104.669 -174.138 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -56.19 113.48 1.57 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.174 -2.158 . . . . 72.12 105.174 168.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.2 mt-10 -119.37 107.91 13.93 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-O 121.963 0.887 . . . . 71.52 110.568 -169.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -113.6 107.98 16.53 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 114.432 -1.258 . . . . 64.33 108.059 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 35.3 t70 51.88 61.03 3.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.097 0.873 . . . . 73.12 110.69 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.453 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 32.9 tt0 -89.52 112.68 23.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.52 -1.659 . . . . 52.22 106.52 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 415' ' ' THR . 3.2 p-10 -143.98 164.93 29.18 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.179 0.514 . . . . 72.51 110.77 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.7 p90 -136.68 178.48 7.04 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.948 -0.76 . . . . 74.33 108.948 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.08 136.71 54.92 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.149 -1.426 . . . . 73.43 107.149 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 25.9 t -103.49 122.88 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.333 -1.358 . . . . 72.04 107.333 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -119.96 148.58 43.35 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.862 -0.608 . . . . 70.03 109.849 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.96 147.29 28.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.912 -0.585 . . . . 52.54 109.559 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.8 m -156.11 179.82 8.86 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.514 0.726 . . . . 72.44 109.527 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.0 t30 47.75 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.335 1.454 . . . . 61.22 114.267 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 98.5 t -91.67 127.36 44.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 C-N-CA 119.713 -0.795 . . . . 74.44 109.091 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -133.99 143.55 48.21 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.232 -1.395 . . . . 65.35 107.232 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 29.9 t -107.77 156.71 8.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.434 -0.951 . . . . 71.5 108.434 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 48.9 m -71.82 127.61 33.1 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.992 0.901 . . . . 63.13 111.341 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' A' ' 471' ' ' GLU . 29.2 m -86.32 93.14 9.01 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.383 -1.281 . . . . 63.25 109.358 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -124.05 -60.64 1.42 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.68 -0.859 . . . . 73.23 108.68 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -72.57 -55.19 7.3 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.814 -0.81 . . . . 74.34 108.814 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 35.4 p -121.63 132.05 54.45 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.876 -0.602 . . . . 44.52 109.727 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 467' ' ' SER . 44.8 tt0 -105.06 -62.28 1.36 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.119 -1.437 . . . . 73.42 107.119 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -87.22 177.8 7.06 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.256 -1.016 . . . . 73.12 108.256 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 91.25 -71.14 1.91 Allowed Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.224 -0.989 . . . . 44.14 111.123 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -165.42 132.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 121.283 0.564 . . . . 74.42 110.85 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 77.2 mt -119.58 129.37 54.61 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.333 -1.728 . . . . 52.13 106.333 171.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.54 95.36 3.88 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.332 0.493 . . . . 75.01 112.332 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -69.26 -36.05 76.73 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 108.621 -0.881 . . . . 72.25 108.621 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 481' ' ' SER . 48.6 t30 -74.86 72.08 2.05 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.621 1.2 . . . . 71.43 108.798 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -140.32 -36.06 0.49 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 113.657 -1.611 . . . . 73.41 108.135 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 485' ' ' CYS . 86.0 t -96.22 -42.23 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 119.688 -0.805 . . . . 64.24 109.25 172.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 478' ' ' ASN . 25.9 t -153.08 -171.24 3.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.893 -1.521 . . . . 61.14 106.893 173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -51.98 -43.61 63.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.132 0.973 . . . . 70.32 111.083 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.67 -76.32 0.57 Allowed 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 104.477 -2.416 . . . . 65.11 104.477 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -165.65 114.51 1.0 Allowed 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.306 -0.628 . . . . 65.42 109.306 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' CYS . . . . . 0.437 ' O ' HG12 ' A' ' 480' ' ' VAL . 37.7 t -155.94 132.48 10.29 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 104.944 -2.243 . . . . 72.12 104.944 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.573 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 1.7 mm? -89.7 -163.81 1.06 Allowed 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 109.179 -0.674 . . . . 74.53 109.179 -172.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 375' ' ' PHE . . . -63.69 137.32 41.84 Favored Glycine 0 CA--C 1.484 -1.887 0 N-CA-C 104.313 -3.515 . . . . 73.24 104.313 169.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.496 ' HA ' ' OG ' ' A' ' 490' ' ' SER . 15.1 m -110.81 75.27 1.03 Allowed Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 118.999 2.962 . . . . 63.25 118.999 -165.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.569 ' HB2' ' H ' ' A' ' 491' ' ' THR . 3.0 Cg_exo -70.76 -59.58 0.07 OUTLIER 'Trans proline' 1 N--CA 1.396 -4.225 0 N-CA-C 108.307 -1.459 . . . . 64.45 108.307 153.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.546 ' HA ' ' CD ' ' A' ' 489' ' ' PRO . 20.4 m -115.79 89.54 3.13 Favored 'General case' 0 C--N 1.389 2.294 0 C-N-CA 128.564 2.746 . . . . 71.15 105.483 -7.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.569 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 34.4 m -145.03 124.55 13.17 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 116.029 -0.532 . . . . 74.52 109.885 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -109.39 108.39 18.91 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.435 -1.32 . . . . 61.05 107.435 170.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 74.4 m -83.2 111.71 19.19 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.282 -0.636 . . . . 73.24 109.282 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.559 HG11 HG11 ' A' ' 390' ' ' VAL . 71.4 t -100.62 106.62 19.64 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 108.262 -1.014 . . . . 60.1 108.262 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 25.1 m -93.47 112.16 24.0 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 107.158 -1.423 . . . . 63.15 107.158 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.733 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -86.56 119.66 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 CA-C-O 121.831 0.824 . . . . 64.15 109.616 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.486 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.5 m-85 -82.79 98.08 8.94 Favored 'General case' 1 N--CA 1.378 -4.068 0 CA-C-N 115.041 -0.981 . . . . 73.33 112.34 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 451' ' ' GLU . 2.9 t70 -50.09 -60.52 2.87 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 112.019 -2.355 . . . . 71.01 108.518 170.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.518 ' H ' ' HB3' ' A' ' 502' ' ' ALA . 33.4 t70 67.05 -8.98 0.4 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 113.767 -1.56 . . . . 51.22 112.363 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 498' ' ' ASP . 27.3 m-20 -69.86 -53.86 16.16 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.713 -1.217 . . . . 74.23 107.713 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -107.31 -32.89 7.58 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.63 -1.168 . . . . 62.24 108.198 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.518 ' HB3' ' H ' ' A' ' 499' ' ' ASP . . . -60.23 -47.69 84.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.985 -1.007 . . . . 74.54 112.113 -177.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 65.06 27.92 72.89 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.572 -0.346 . . . . 54.11 113.11 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.473 HG12 ' OD1' ' A' ' 499' ' ' ASP . 23.8 mm 54.06 85.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.855 1.262 . . . . 73.23 111.675 -174.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -124.6 146.81 48.86 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.648 -0.871 . . . . 74.23 108.648 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.0 t -119.09 125.4 49.21 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 106.913 -1.514 . . . . 61.23 106.913 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -107.17 115.5 30.29 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.133 0.419 . . . . 74.44 112.133 -171.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -155.12 118.31 4.41 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.487 -1.301 . . . . 74.32 107.487 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 N-CA-C 112.437 0.532 . . . . 74.53 112.437 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.6 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.628 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.466 ' HA ' ' C ' ' A' ' 478' ' ' ASN . 76.0 t . . . . . 0 N--CA 1.445 -0.675 0 N-CA-C 109.556 -0.535 . . . . 60.13 109.556 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 480' ' ' VAL . 50.4 m -60.97 114.7 3.23 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.898 0.749 . . . . 53.44 110.42 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -100.71 143.28 31.06 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 107.873 -1.158 . . . . 72.42 107.873 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 407' ' ' VAL . 37.4 mm -110.08 112.73 41.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.092 -1.448 . . . . 74.3 107.092 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -145.76 161.41 39.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.471 -0.492 . . . . 73.13 111.87 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -79.51 150.46 31.16 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.86 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.14 -50.0 62.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.741 -1.207 . . . . 73.31 107.741 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 16.4 mm100 -103.57 -177.69 3.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.609 -0.723 . . . . 73.11 111.494 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.44 -38.4 0.93 Allowed Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.836 -1.306 . . . . 73.13 109.836 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.8 m -123.55 131.86 53.74 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 107.582 -1.266 . . . . 70.14 107.582 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 86.1 m-85 -119.78 140.87 50.08 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.483 -1.303 . . . . 75.43 107.483 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 495' ' ' THR . 80.2 mt-30 -130.14 127.39 39.66 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.312 -0.625 . . . . 73.54 109.312 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' CYS . . . . . 0.652 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.5 p -133.83 165.06 25.85 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.488 -0.93 . . . . 62.54 108.488 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.79 146.09 24.72 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.023 0.439 . . . . 73.02 111.125 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.644 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 20.1 tt0 -62.72 -28.94 70.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.84 0.828 . . . . 65.2 109.138 175.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -86.45 2.4 47.91 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.868 -1.06 . . . . 71.24 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.76 -32.24 31.54 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 112.611 0.597 . . . . 35.05 112.611 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.71 -65.47 0.4 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.284 -0.96 . . . . 55.42 111.21 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.477 HG22 ' HA2' ' A' ' 443' ' ' GLY . 30.3 p -133.01 159.45 39.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.478 0.639 . . . . 54.25 111.01 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.652 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 3.6 p -111.87 129.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 107.431 -1.322 . . . . 72.02 107.431 171.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.39 128.24 44.69 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.661 -0.866 . . . . 52.12 108.661 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.28 142.82 47.74 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.456 -1.313 . . . . 74.12 107.456 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.4 m -105.64 131.43 53.03 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.188 0.518 . . . . 72.41 110.371 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.459 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 84.4 mt -106.54 128.79 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.915 -1.143 . . . . 64.53 107.915 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.41 HG22 ' HG2' ' A' ' 397' ' ' ARG . 46.4 mm -105.52 127.71 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 N-CA-C 108.198 -1.038 . . . . 74.41 108.198 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -110.41 112.06 23.73 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 116.118 -0.492 . . . . 65.25 109.792 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.559 ' HA ' ' HE ' ' A' ' 397' ' ' ARG . 0.6 OUTLIER -127.79 152.56 47.63 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.874 -0.788 . . . . 73.23 108.874 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 122.46 78.39 0.45 Allowed Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.849 -0.901 . . . . 50.31 110.849 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 79.24 -163.73 49.1 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.908 -0.663 . . . . 41.24 112.077 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -135.35 121.08 19.56 Favored 'General case' 0 CA--C 1.468 -2.176 0 N-CA-C 107.618 -1.253 . . . . 70.04 107.618 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 84.1 mt -146.91 132.96 19.23 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 123.618 0.573 . . . . 73.33 109.558 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 25.4 p -91.62 2.85 56.18 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.389 0.614 . . . . 64.54 110.108 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -61.09 132.5 53.97 Favored 'General case' 0 C--O 1.257 1.457 0 CA-C-N 115.236 -0.893 . . . . 73.23 109.108 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 10.0 m -80.65 112.07 17.67 Favored 'General case' 0 N--CA 1.414 -2.248 0 O-C-N 123.877 0.736 . . . . 71.34 109.253 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.71 140.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.813 -1.085 . . . . 74.22 108.207 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 50.2 m-85 -123.09 128.01 49.52 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.756 -0.831 . . . . 74.53 108.756 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -128.92 134.57 64.01 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 106.339 -1.726 . . . . 73.14 106.339 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.47 122.43 42.54 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.497 -0.481 . . . . 70.44 110.01 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -109.57 154.17 23.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.695 -0.483 . . . . 54.2 109.695 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -163.78 164.73 23.56 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.078 -1.452 . . . . 63.41 107.078 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 80.0 p -95.89 172.51 7.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.801 0.334 . . . . 71.03 110.268 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 8.7 tp10 -118.6 147.97 43.17 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.286 0.565 . . . . 73.33 110.257 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.72 4.02 26.77 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 127.039 2.136 . . . . 75.34 109.514 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' GLY . . . . . 0.563 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -20.35 -74.26 0.01 OUTLIER Glycine 0 N--CA 1.482 1.744 0 C-N-CA 126.113 1.816 . . . . 44.21 115.686 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.7 t -118.47 -5.46 10.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.347 0.594 . . . . 70.42 110.63 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -134.23 -179.65 5.7 Favored 'General case' 0 C--O 1.195 -1.774 0 CA-C-N 116.357 -0.383 . . . . 74.41 110.223 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.16 118.96 28.86 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.409 0.623 . . . . 74.3 110.065 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -71.23 137.89 49.02 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.177 -0.675 . . . . 74.33 109.177 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.24 -4.92 81.09 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 110.721 -0.952 . . . . 72.33 110.721 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.1 t -123.73 -57.83 1.61 Allowed 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.25 -1.018 . . . . 50.21 108.25 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.534 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 17.6 m-20 -82.45 -59.39 2.55 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-O 122.19 0.995 . . . . 61.53 109.097 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.728 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.23 158.92 43.32 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.267 -0.879 . . . . 74.15 109.99 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.4 142.87 46.95 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.106 -0.701 . . . . 73.13 109.106 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.51 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 8.7 p90 -73.68 -24.13 59.92 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 123.304 0.642 . . . . 65.12 112.632 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.559 HG21 HG22 ' A' ' 442' ' ' VAL 0.291 10.9 t 41.6 62.42 1.56 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.37 1.868 . . . . 75.43 113.185 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.44 107.38 12.16 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.691 -1.141 . . . . 73.15 108.854 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -144.42 168.38 26.72 Favored Glycine 0 CA--C 1.46 -3.385 0 C-N-CA 120.073 -1.06 . . . . 54.13 111.49 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.6 m -112.7 138.1 50.01 Favored 'General case' 0 N--CA 1.393 -3.292 0 N-CA-C 107.652 -1.24 . . . . 45.1 107.652 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.3 t -95.4 117.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.759 -1.201 . . . . 62.12 107.759 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.74 105.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.496 -0.774 . . . . 62.42 109.755 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 404' ' ' THR . 57.7 m-85 -89.25 94.53 9.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.054 -0.521 . . . . 71.24 110.786 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.28 167.51 16.63 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.234 -0.894 . . . . 74.14 110.568 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.01 119.65 7.05 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 122.742 2.295 . . . . 50.23 110.881 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.24 -14.75 60.93 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.073 -0.584 . . . . 72.3 112.457 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -93.91 61.16 2.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.748 0.785 . . . . 70.0 109.381 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 8.0 m -66.09 -25.77 67.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.624 -1.171 . . . . 71.32 109.625 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -122.41 132.36 54.32 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.415 -1.328 . . . . 72.43 107.415 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -120.73 149.69 42.13 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.93 0.395 . . . . 62.4 111.994 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.73 131.91 56.02 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.223 -0.899 . . . . 63.5 109.435 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.57 149.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.929 -1.137 . . . . 64.13 107.929 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 51.4 mtt180 -131.62 144.01 50.74 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.253 0.549 . . . . 63.53 111.972 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 425' ' ' THR . 49.2 t -117.51 121.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.708 -1.219 . . . . 63.13 107.708 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -78.45 134.1 13.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.07 -0.586 . . . . 75.23 111.985 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 496' ' ' ILE . 28.9 mm -90.42 139.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.693 -1.225 . . . . 72.23 107.693 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 81.3 mt -99.29 150.98 4.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.236 -1.394 . . . . 63.52 107.236 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 88.03 3.05 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.113 0.482 . . . . 63.42 111.344 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.95 113.4 20.94 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.029 -2.211 . . . . 54.12 105.029 171.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.644 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 13.5 t70 -115.88 96.2 5.48 Favored 'General case' 0 CA--C 1.457 -2.629 0 C-N-CA 116.802 -1.959 . . . . 61.05 110.054 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.627 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 31.7 mm -121.68 155.63 25.93 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.097 0 N-CA-C 103.589 -2.745 . . . . 74.41 103.589 -175.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -58.49 114.65 2.56 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.602 -1.639 . . . . 74.4 107.55 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.627 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 24.4 mt-10 -128.65 130.32 47.08 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-N 115.518 -0.764 . . . . 60.43 109.693 -169.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.69 108.04 8.78 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.057 -0.974 . . . . 64.04 108.508 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.81 49.72 15.57 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 124.537 1.148 . . . . 73.32 110.238 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.556 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 37.2 tt0 -72.15 116.75 12.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.548 -1.649 . . . . 63.04 106.548 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 36.5 p30 -141.29 166.05 25.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.938 0.718 . . . . 74.32 112.938 -172.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.574 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 23.5 p90 -144.39 175.75 9.88 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.241 -0.891 . . . . 74.13 108.665 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.13 136.64 52.84 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.558 -1.275 . . . . 73.44 107.558 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.84 123.52 52.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.865 -1.532 . . . . 75.13 106.865 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 490' ' ' SER . 98.9 m-70 -112.66 135.03 53.86 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 123.803 0.689 . . . . 75.12 111.492 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.9 129.15 45.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.967 -1.494 . . . . 72.13 106.967 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.1 t -154.69 -176.82 6.1 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.982 -1.488 . . . . 60.1 106.982 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 50.86 81.77 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 O-C-N 124.488 1.118 . . . . 74.34 112.216 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 41.2 t -82.05 131.55 33.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 114.916 -1.038 . . . . 71.42 109.026 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 4.2 tppp? -132.46 135.74 46.24 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.18 -1.415 . . . . 74.11 107.18 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.2 135.91 60.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.383 -0.599 . . . . 74.44 109.383 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.6 t -116.04 116.57 28.13 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 108.681 -0.859 . . . . 64.2 108.681 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 46.6 t -74.58 -42.76 58.15 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.409 -1.33 . . . . 71.53 107.409 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 67.87 -49.36 0.52 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.708 2.003 . . . . 75.23 111.777 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -66.9 -46.79 73.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.381 -1.34 . . . . 71.01 107.381 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 15.5 t 56.57 36.01 26.93 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.749 -1.114 . . . . 74.42 111.591 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -83.68 -6.26 59.39 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.683 -0.689 . . . . 72.11 110.492 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 12.2 t70 66.44 174.95 0.24 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.046 1.338 . . . . 75.13 110.28 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.14 18.62 76.22 Favored Glycine 0 C--O 1.242 0.652 0 N-CA-C 110.579 -1.009 . . . . 64.3 110.579 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.53 112.14 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.774 -0.824 . . . . 61.11 108.774 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.38 -3.95 24.8 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.236 -1.024 . . . . 71.34 108.236 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.87 44.29 0.91 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.147 -1.388 . . . . 65.45 109.846 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -83.11 23.6 0.85 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.744 0.783 . . . . 73.33 110.407 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ASN . . . . . 0.466 ' C ' ' HA ' ' A' ' 371' ' ' VAL . 8.3 m120 -81.6 53.91 2.24 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 124.969 1.308 . . . . 63.11 108.217 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -155.24 161.05 41.25 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.619 -0.882 . . . . 63.14 108.619 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 372' ' ' SER . 28.8 m -69.42 148.18 11.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 123.402 0.439 . . . . 74.41 110.142 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 49.9 m -151.25 176.27 11.38 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.388 -1.338 . . . . 55.23 107.388 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 483' ' ' LEU . . . -69.59 85.28 0.45 Allowed 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.638 0.586 . . . . 41.54 109.792 177.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 482' ' ' ALA . 1.2 tm? 171.36 -39.94 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 104.509 -2.404 . . . . 60.52 104.509 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -92.42 -178.11 4.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.766 -1.561 . . . . 64.43 110.724 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 75.7 m -127.61 170.88 12.17 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.392 -0.966 . . . . 61.31 108.392 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.513 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.1 mm? -84.58 179.53 7.37 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.809 -0.441 . . . . 74.21 109.809 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -87.06 27.72 5.93 Favored Glycine 0 C--O 1.239 0.458 0 C-N-CA 120.935 -0.65 . . . . 72.33 112.323 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.408 ' C ' ' HA ' ' A' ' 490' ' ' SER . 20.2 m -155.23 173.23 5.04 Favored Pre-proline 0 C--N 1.288 -2.082 0 N-CA-C 105.386 -2.079 . . . . 50.21 105.386 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.639 ' N ' ' HA ' ' A' ' 490' ' ' SER . 35.8 Cg_exo -56.26 -31.99 86.29 Favored 'Trans proline' 0 CA--C 1.585 3.039 0 N-CA-C 119.582 2.878 . . . . 61.23 119.582 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.639 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 33.4 t -107.56 115.2 29.72 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 127.883 2.473 . . . . 53.33 108.881 3.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.404 ' H ' ' HD2' ' A' ' 489' ' ' PRO . 24.4 m -126.27 128.13 46.69 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.8 -0.637 . . . . 64.13 110.171 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -129.15 122.39 29.71 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.397 -1.334 . . . . 74.35 107.397 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.9 m -89.43 121.46 31.69 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.7 -0.4 . . . . 75.14 110.394 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 390' ' ' VAL . 74.5 t -109.54 110.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.918 -0.771 . . . . 61.22 108.918 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 91.1 m -101.49 121.61 42.29 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 108.882 -0.784 . . . . 71.31 108.882 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.728 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -95.36 117.1 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.099 0 CA-C-N 115.336 -0.847 . . . . 63.24 109.218 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.42 104.21 5.07 Favored 'General case' 0 N--CA 1.389 -3.507 0 CA-C-N 114.693 -1.14 . . . . 73.11 110.499 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.647 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 4.0 t70 -55.01 -40.92 70.67 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 112.811 -1.995 . . . . 74.55 110.803 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 498' ' ' ASP . 8.8 t70 78.01 -38.19 0.25 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.953 1.301 . . . . 72.22 112.117 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -65.67 -62.41 1.53 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 123.553 0.741 . . . . 62.35 111.421 -171.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -102.38 -0.19 33.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.912 0.863 . . . . 75.44 108.724 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.74 66.29 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.1 -0.955 . . . . 71.12 112.399 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 110.16 -19.11 27.7 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 120.122 -1.037 . . . . 74.25 112.517 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 48.3 pt -90.77 169.52 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.906 -0.776 . . . . 71.41 108.906 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -137.32 101.22 4.46 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.88 -0.415 . . . . 60.32 109.88 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 32.3 p -93.64 173.69 7.56 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.45 -0.574 . . . . 64.12 109.45 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -106.47 113.78 27.5 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.381 -0.527 . . . . 75.53 111.615 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.84 148.54 19.19 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.704 -1.591 . . . . 71.23 106.704 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--N 1.304 -1.41 0 C-N-CA 120.768 -0.373 . . . . 74.15 110.848 -177.417 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.647 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.619 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 372' ' ' SER . 12.5 t . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 106.803 -1.555 . . . . 75.22 106.803 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.501 ' H ' HG12 ' A' ' 371' ' ' VAL . 36.1 m -46.76 116.14 1.25 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 116.021 1.859 . . . . 70.04 116.021 -173.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 30.7 mmtp -99.45 132.62 44.65 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 114.009 -1.45 . . . . 74.03 107.255 171.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.494 ' HB ' HD12 ' A' ' 486' ' ' LEU . 44.6 mm -106.9 129.36 60.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 108.065 -1.087 . . . . 74.11 108.065 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.548 ' HB2' ' OG ' ' A' ' 488' ' ' SER . 43.8 p90 -159.27 167.8 28.04 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 117.907 0.321 . . . . 74.42 110.924 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -82.52 153.4 25.59 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.828 -0.349 . . . . 64.14 110.124 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.29 -38.72 81.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.333 0.587 . . . . 73.12 109.816 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.401 ' NE2' ' HA ' ' A' ' 378' ' ' GLN . 17.5 mm-40 -130.5 174.21 10.11 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.59 -0.732 . . . . 72.54 112.304 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -104.12 -25.66 7.0 Favored Glycine 0 C--N 1.304 -1.245 0 CA-C-N 115.37 -0.832 . . . . 63.52 111.857 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.6 m -129.38 133.33 47.33 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.252 -0.648 . . . . 45.15 109.252 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 66.2 m-85 -124.62 136.35 53.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.996 -1.113 . . . . 71.35 107.996 176.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.473 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 87.4 mt-30 -129.46 135.34 48.53 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.221 -1.029 . . . . 73.24 108.221 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 37.8 t -148.81 165.0 32.79 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.446 -0.946 . . . . 55.22 108.446 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -79.23 141.17 37.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.417 0.448 . . . . 75.35 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.635 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 10.5 tt0 -56.93 -50.34 72.89 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.755 0.822 . . . . 61.02 110.764 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -77.25 2.56 15.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.519 0.563 . . . . 72.11 112.519 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.14 -20.6 59.31 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.236 0.541 . . . . 71.2 111.017 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.28 -57.14 0.63 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.258 -0.972 . . . . 70.35 113.105 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 14.8 p -139.33 165.35 27.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 117.189 0.495 . . . . 72.52 111.566 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.606 HG11 HG11 ' A' ' 494' ' ' VAL . 6.8 p -122.51 125.72 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 169.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.39 129.29 43.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.197 0.522 . . . . 73.25 110.4 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.21 140.91 51.39 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 107.876 -1.157 . . . . 71.3 107.876 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.2 m -108.33 131.52 54.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.92 -0.582 . . . . 72.2 109.511 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.09 125.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.923 -1.139 . . . . 62.15 107.923 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.8 mm -99.73 133.63 41.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.766 -0.828 . . . . 73.21 108.766 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 436' ' ' THR . 58.4 ttt180 -117.53 120.17 37.28 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.316 -0.856 . . . . 75.21 108.773 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 372' ' ' SER . 35.0 mmt180 -122.87 168.87 11.74 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.732 -1.211 . . . . 75.52 107.732 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 99.68 44.98 2.19 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 110.249 -1.14 . . . . 61.35 110.249 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 80.0 -161.35 45.53 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 110.373 -1.091 . . . . 53.03 110.373 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -153.91 146.66 24.28 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.114 -1.809 . . . . 72.21 106.114 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.62 154.23 31.3 Favored 'General case' 0 C--N 1.274 -2.698 0 O-C-N 123.546 0.529 . . . . 73.04 109.932 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 49.3 p -80.62 -0.64 38.84 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.729 0.776 . . . . 71.31 111.206 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.38 129.36 38.63 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.022 -1.103 . . . . 74.03 108.022 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 41.9 m -82.68 116.9 22.26 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.557 -0.747 . . . . 63.11 111.517 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.64 146.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.578 -0.737 . . . . 75.4 109.351 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -122.12 125.53 46.38 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.074 0.549 . . . . 61.22 110.292 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.49 130.83 70.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.208 -1.404 . . . . 71.41 107.208 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 15.1 t70 -100.25 135.0 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.688 -0.486 . . . . 71.14 109.688 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.02 153.99 48.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.45 -0.5 . . . . 74.35 110.363 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 426' ' ' GLU . 33.6 ttp180 -163.43 154.57 16.67 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.752 -1.573 . . . . 71.24 106.752 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.607 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 30.8 p -96.46 162.55 13.43 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.279 0.562 . . . . 72.23 110.4 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 3.6 mm-40 -105.11 160.58 14.95 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.586 -0.734 . . . . 75.23 109.378 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.31 -37.65 63.56 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.131 -0.94 . . . . 75.2 110.035 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 48.57 -107.74 0.3 Allowed Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.228 -1.351 . . . . 40.0 114.215 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -101.53 5.03 41.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.739 0.781 . . . . 62.35 110.237 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -135.57 -159.53 0.97 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.942 0.897 . . . . 34.13 109.067 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 417' ' ' ASN . 1.2 m120 -136.17 126.2 26.06 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.089 0.471 . . . . 73.03 111.616 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -82.18 124.52 29.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.513 -0.921 . . . . 75.42 108.513 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.44 -19.42 36.79 Favored Glycine 0 C--N 1.296 -1.659 0 N-CA-C 110.123 -1.191 . . . . 60.13 110.123 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.6 m -106.94 -56.88 2.14 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.66 -0.496 . . . . 64.21 109.66 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 2.2 m-20 -84.68 -57.34 3.17 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 122.106 0.955 . . . . 74.44 110.205 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.686 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -140.01 159.78 41.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.24 -0.891 . . . . 74.52 109.002 -178.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.4 tm-20 -76.26 157.88 32.14 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 123.873 0.733 . . . . 70.12 109.794 -173.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.607 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 13.7 p90 -94.21 -16.68 23.44 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.288 0.635 . . . . 61.42 112.669 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.508 HG21 HG22 ' A' ' 442' ' ' VAL 0.303 9.9 t 37.59 67.12 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.66 1.984 . . . . 70.24 114.303 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.423 ' HB3' ' HD3' ' A' ' 410' ' ' ARG . 9.5 pt-20 -79.1 121.16 24.65 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.003 -0.998 . . . . 64.42 109.481 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -163.0 176.73 39.23 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 120.372 -0.918 . . . . 61.14 111.386 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 32.4 m -120.52 136.73 54.69 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.881 -1.155 . . . . 72.15 107.881 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.9 t -95.57 119.17 43.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.902 -1.147 . . . . 75.15 107.902 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 99.6 t -95.83 107.04 19.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 114.704 -1.134 . . . . 71.04 108.798 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 404' ' ' THR . 51.1 m-85 -84.55 95.08 8.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.971 -0.559 . . . . 73.54 110.586 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.478 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 10.4 mtmp? -80.52 167.83 29.94 Favored Pre-proline 0 N--CA 1.432 -1.373 0 CA-C-N 115.487 -0.778 . . . . 71.35 110.156 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 54.9 Cg_exo -52.66 131.61 42.2 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.371 2.047 . . . . 74.23 111.803 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.66 -21.49 32.67 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.851 -0.613 . . . . 51.11 113.37 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 38.0 mt-10 -81.17 63.9 5.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.171 0.986 . . . . 71.15 112.647 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 21.4 m -67.49 -11.33 57.68 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.2 -1.364 . . . . 62.15 110.069 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -139.14 136.55 35.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.497 -0.927 . . . . 73.44 108.497 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -126.14 155.12 42.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.294 0.092 . . . . 71.53 111.05 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.22 138.04 54.12 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.807 -0.357 . . . . 64.11 110.801 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 39.9 pt -125.68 153.97 34.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.635 -0.876 . . . . 51.0 108.635 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 56.5 mtm180 -130.4 138.32 50.29 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.911 0.386 . . . . 64.43 110.865 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.516 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.6 t -106.54 122.25 60.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.838 -1.171 . . . . 60.4 107.838 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.88 130.7 10.71 Favored Glycine 0 N--CA 1.434 -1.453 0 O-C-N 123.583 0.552 . . . . 71.1 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 496' ' ' ILE . 38.0 mm -88.98 143.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.527 -1.657 . . . . 74.54 106.527 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.2 mt -102.04 145.94 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 N-CA-C 107.368 -1.345 . . . . 61.4 107.368 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.26 85.99 1.43 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.508 0.67 . . . . 73.5 111.497 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.55 120.22 36.1 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 105.175 -2.158 . . . . 72.54 105.175 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 20.2 t70 -122.57 95.3 4.58 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 116.951 -1.9 . . . . 74.35 110.554 173.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.647 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 34.3 mm -118.62 155.9 20.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.348 0 N-CA-C 103.61 -2.737 . . . . 63.34 103.61 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -56.89 114.6 2.16 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.058 -1.457 . . . . 73.12 107.119 171.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 29.0 mt-10 -127.19 133.94 50.22 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-N 116.06 -0.518 . . . . 73.54 109.7 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.48 112.48 7.66 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.475 -0.935 . . . . 74.22 108.475 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 33.5 t70 50.56 61.53 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.855 0.862 . . . . 64.24 112.8 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.32 123.47 41.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 118.729 -1.188 . . . . 71.4 110.932 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.28 174.36 10.64 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.87 -1.059 . . . . 73.31 110.54 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.554 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 26.0 p90 -148.0 -178.54 6.34 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.746 -1.115 . . . . 71.41 108.042 172.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -123.79 136.72 54.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.284 -1.006 . . . . 64.3 108.284 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.4 122.03 59.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.903 -1.517 . . . . 55.43 106.903 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.82 152.86 31.43 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.712 0.632 . . . . 75.14 110.005 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.48 121.43 44.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.893 -0.78 . . . . 74.02 108.893 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 46.8 m -131.1 -178.11 4.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.429 -0.952 . . . . 60.25 108.429 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 39.45 82.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.143 1.377 . . . . 74.02 112.348 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.75 123.02 44.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 119.168 -1.013 . . . . 73.41 108.911 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -134.7 174.28 10.74 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.926 -1.034 . . . . 75.21 109.453 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 69.3 t -142.18 150.72 18.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 103.974 -2.602 . . . . 72.33 103.974 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 8.5 t -74.2 109.95 8.1 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.616 -0.883 . . . . 52.51 108.616 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 470' ' ' SER . 20.1 m -81.35 105.62 12.68 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.691 -1.14 . . . . 75.33 110.364 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.54 -65.4 0.94 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 105.35 -2.093 . . . . 70.15 105.35 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -102.13 -79.16 0.52 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.429 -1.323 . . . . 74.24 107.429 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 467' ' ' SER . 12.2 m 54.3 10.19 0.29 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.09 1.515 . . . . 51.2 115.09 174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -70.95 -49.44 45.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.928 0.394 . . . . 75.41 110.671 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -153.57 170.05 21.74 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.046 -1.094 . . . . 74.24 108.046 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 84.02 -65.61 4.06 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 110.429 -1.068 . . . . 62.34 110.429 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 75.5 mt -73.99 109.71 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 108.61 -0.885 . . . . 65.11 108.61 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 70.1 mt -88.08 -30.52 19.82 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.369 -0.604 . . . . 41.41 109.369 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -83.74 80.12 9.24 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.539 -0.755 . . . . 74.21 109.778 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -84.61 -49.18 8.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.073 -1.454 . . . . 73.21 107.073 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -88.31 132.26 34.47 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.272 -1.381 . . . . 54.22 107.272 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -105.53 -6.17 19.6 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.819 -0.628 . . . . 74.41 112.53 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.54 -48.36 18.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 120.036 -0.666 . . . . 75.4 112.364 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 22.8 t -146.91 -168.35 3.01 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.869 -0.732 . . . . 73.22 109.258 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.26 86.08 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.549 -0.908 . . . . 70.03 108.549 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -120.78 -79.68 0.61 Allowed 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 103.887 -2.634 . . . . 54.41 103.887 167.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -164.97 134.74 3.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.614 -0.513 . . . . 70.52 109.614 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 51.9 t -166.38 133.22 2.56 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.193 -1.41 . . . . 52.14 107.193 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.494 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.4 mm? -87.82 174.2 8.51 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 123.185 0.303 . . . . 63.32 110.221 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -75.73 -39.59 33.78 Favored Glycine 0 C--N 1.317 -0.479 0 N-CA-C 110.434 -1.067 . . . . 62.4 110.434 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.548 ' OG ' ' HB2' ' A' ' 375' ' ' PHE . 14.7 m -87.99 171.78 8.94 Favored Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 107.545 -1.279 . . . . 62.44 107.545 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.487 ' N ' ' HA ' ' A' ' 490' ' ' SER . 2.5 Cg_endo -45.53 -47.44 13.28 Favored 'Trans proline' 0 CA--C 1.584 2.983 0 C-N-CA 122.493 2.129 . . . . 64.0 117.554 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.487 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 20.6 m -109.66 138.76 45.56 Favored 'General case' 0 N--CA 1.412 -2.361 0 C-N-CA 127.912 2.485 . . . . 70.23 108.435 3.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 62.9 m -143.56 104.6 4.24 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 109.174 -0.676 . . . . 74.02 109.174 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -102.22 115.06 29.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.944 -1.132 . . . . 61.51 107.944 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 20.7 m -89.2 121.08 31.16 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.1 -0.704 . . . . 61.11 109.1 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.606 HG11 HG11 ' A' ' 390' ' ' VAL . 92.6 t -108.81 106.03 19.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.987 -0.551 . . . . 61.12 109.727 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 88.2 m -92.9 118.85 31.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.348 -0.982 . . . . 62.24 108.348 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.686 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -95.17 120.36 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 N-CA-C 108.946 -0.761 . . . . 71.11 108.946 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.458 ' CZ ' HD13 ' A' ' 504' ' ' ILE 0.316 26.1 m-85 -84.37 102.7 12.94 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-O 122.233 1.016 . . . . 53.24 113.624 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.64 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.7 t70 -51.02 -54.11 27.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 111.779 -2.464 . . . . 61.44 109.435 173.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 28.5 t70 69.1 5.35 5.03 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.578 -1.192 . . . . 72.34 111.507 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -95.8 -63.38 1.16 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.52 -0.919 . . . . 71.23 108.52 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -102.72 -30.36 10.94 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.779 -1.563 . . . . 74.05 106.779 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 498' ' ' ASP . . . -82.07 70.9 9.08 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.504 -0.771 . . . . 52.15 110.04 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -93.02 93.02 1.71 Allowed Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.85 -1.3 . . . . 54.5 109.85 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.458 HD13 ' CZ ' ' A' ' 497' ' ' PHE . 46.4 pt -85.6 167.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.306 0.574 . . . . 70.53 110.631 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -131.49 129.07 40.64 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 104.923 -2.251 . . . . 75.34 104.923 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 49.8 m -71.12 98.04 1.6 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.694 -0.484 . . . . 64.01 109.694 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -72.86 113.93 10.43 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.903 -1.517 . . . . 72.41 106.903 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.01 157.13 38.37 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.854 0.835 . . . . 52.12 112.5 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 . . . . . 0 C--N 1.292 -1.932 0 CA-C-N 114.537 -1.211 . . . . 72.31 109.265 -178.881 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.64 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.625 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 108.198 -1.038 . . . . 61.05 108.198 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 397' ' ' ARG . 15.3 m -79.42 124.05 28.08 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 109.145 -0.687 . . . . 72.21 109.145 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 97.0 mttt -112.08 146.58 37.72 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 116.153 -0.476 . . . . 74.25 112.046 -174.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.634 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 18.6 mm -104.36 121.12 55.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.027 -1.101 . . . . 63.41 108.027 -176.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.447 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 21.4 p90 -150.49 168.34 24.5 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.153 -0.619 . . . . 52.24 112.235 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -80.91 145.72 31.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.588 -0.523 . . . . 74.21 109.588 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.543 ' HB3' ' OH ' ' A' ' 381' ' ' TYR . 37.2 tt0 -58.4 -59.03 5.99 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.847 0.859 . . . . 72.4 109.746 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.521 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.8 mm100 -104.87 179.98 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.343 -0.844 . . . . 65.44 110.332 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -109.13 -22.2 6.98 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 109.687 -1.365 . . . . 61.03 109.687 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 493' ' ' THR . 38.5 m -143.23 132.16 22.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 115.059 -0.571 . . . . 50.35 109.607 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.543 ' OH ' ' HB3' ' A' ' 377' ' ' GLU . 48.7 m-85 -118.98 147.83 43.64 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.159 -1.052 . . . . 65.03 108.159 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 495' ' ' THR . 40.1 mt-30 -130.74 133.55 46.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.041 -1.096 . . . . 71.13 108.041 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.6 p -140.06 157.39 45.72 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 109.123 -0.695 . . . . 72.12 109.123 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -81.15 143.7 32.2 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.02 -0.733 . . . . 74.02 109.02 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.88 -31.18 70.67 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.355 0.662 . . . . 72.34 110.833 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -80.94 -2.26 46.98 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.831 -0.622 . . . . 61.43 112.496 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.7 t -68.9 -33.2 73.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.808 0.337 . . . . 72.32 111.685 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 100.78 -58.04 0.71 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.886 -0.886 . . . . 61.13 110.886 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.8 p -137.79 154.35 49.57 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.003 -0.369 . . . . 73.43 110.003 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.9 p -110.22 130.52 63.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.042 -1.096 . . . . 62.33 108.042 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -100.54 119.34 38.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.997 0.427 . . . . 75.34 110.26 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.449 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.7 mp -113.14 157.14 22.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.862 -1.532 . . . . 71.33 106.862 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.1 m -120.54 137.01 54.61 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.232 -0.587 . . . . 70.44 110.5 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.8 mt -101.56 121.43 52.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.386 -1.338 . . . . 74.34 107.386 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.55 115.38 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 108.248 -1.019 . . . . 71.53 108.248 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 436' ' ' THR . 52.7 ttt-85 -105.84 129.27 54.05 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.726 -1.212 . . . . 71.43 107.726 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 372' ' ' SER . 28.7 mmm180 -118.26 141.54 48.4 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.084 -0.709 . . . . 75.15 109.084 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 144.33 -9.21 1.93 Allowed Glycine 0 C--O 1.24 0.482 0 C-N-CA 120.651 -0.785 . . . . 63.13 112.959 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 126.12 179.72 15.88 Favored Glycine 0 N--CA 1.433 -1.525 0 C-N-CA 120.823 -0.703 . . . . 62.15 111.834 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -112.1 165.95 11.67 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.624 -0.88 . . . . 72.11 108.624 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.453 HD13 ' CB ' ' A' ' 478' ' ' ASN . 2.1 pt? -166.18 162.58 17.67 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.724 -0.843 . . . . 64.34 108.724 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 433' ' ' PRO . 12.2 p -102.5 7.16 40.25 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.209 0.528 . . . . 64.13 111.965 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 401' ' ' LEU . 20.4 t-20 -81.47 179.24 7.92 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.654 -1.239 . . . . 64.44 107.654 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 24.5 m -125.42 114.26 18.6 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.373 0.606 . . . . 73.54 110.967 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 52.6 t -106.68 148.89 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.062 -0.972 . . . . 61.11 108.67 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.605 ' CE2' HG22 ' A' ' 430' ' ' VAL . 25.8 m-85 -131.41 142.55 50.05 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.037 0.446 . . . . 61.11 110.706 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.89 137.82 24.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.017 -1.475 . . . . 62.31 107.017 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.3 t70 -101.36 138.5 38.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.189 -0.671 . . . . 72.22 109.189 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.42 150.5 45.56 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.325 -0.991 . . . . 70.11 108.325 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 10.0 ttm180 -157.85 150.42 22.63 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.446 -0.946 . . . . 65.24 108.446 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 31.9 p -96.75 156.86 16.17 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.183 -0.607 . . . . 44.23 110.319 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 11.5 tp10 -114.36 150.19 34.96 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.475 -1.676 . . . . 65.35 106.475 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 24.4 m-20 -53.86 -44.77 70.66 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.829 0.823 . . . . 71.44 112.2 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.97 3.55 Favored Glycine 0 N--CA 1.42 -2.408 0 CA-C-N 114.299 -1.319 . . . . 55.2 110.351 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 455' ' ' ASN . 9.9 t -104.99 -9.32 17.98 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.83 -0.804 . . . . 73.53 108.83 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -117.72 -159.22 0.74 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.302 -0.999 . . . . 61.15 108.302 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.402 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 3.4 m120 -131.38 127.68 38.06 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 112.878 0.696 . . . . 70.43 112.878 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.105 -1.072 . . . . 73.13 108.105 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.75 56.95 Favored Glycine 0 C--N 1.295 -1.728 0 N-CA-C 110.513 -1.035 . . . . 60.11 110.513 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.1 m -128.88 -54.79 1.21 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.155 -0.313 . . . . 74.21 110.155 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.51 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 18.2 m-20 -84.25 -53.05 5.76 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.814 0.816 . . . . 72.53 108.977 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -139.93 166.09 25.57 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.54 159.68 30.13 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.662 -0.866 . . . . 70.44 108.662 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.558 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 6.6 p90 -97.44 -17.69 19.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.01 0.524 . . . . 71.24 111.853 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.531 HG21 HG22 ' A' ' 442' ' ' VAL . 6.4 t 40.92 56.44 2.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.576 1.95 . . . . 73.24 113.24 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 9.4 pt-20 -77.55 108.96 11.1 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.225 1.012 . . . . 73.0 109.213 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.6 163.71 28.49 Favored Glycine 0 N--CA 1.411 -2.998 0 CA-C-N 114.905 -1.043 . . . . 71.05 110.904 -176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 11.0 m -108.71 134.23 51.71 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 108.049 -1.093 . . . . 63.25 108.049 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 48.8 t -94.78 125.24 47.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.399 -0.963 . . . . 53.22 108.399 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.605 HG22 ' CE2' ' A' ' 406' ' ' PHE . 37.2 t -99.42 112.28 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 CA-C-N 114.761 -1.109 . . . . 75.44 108.392 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -83.48 105.54 14.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.3 -1.0 . . . . 53.24 108.3 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 1.0 OUTLIER -79.58 163.94 56.26 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.913 -1.039 . . . . 53.45 111.465 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.0 Cg_exo -51.41 118.1 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 123.247 2.631 . . . . 72.41 111.303 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.87 -15.96 49.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.924 -0.58 . . . . 73.31 113.88 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.8 63.65 7.56 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.393 0.886 . . . . 64.43 113.393 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 19.3 m -53.86 -24.78 16.93 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 114.496 -1.229 . . . . 74.1 112.092 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -116.23 145.27 43.26 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.763 -0.828 . . . . 61.11 108.763 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -134.48 147.55 50.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.02 0.378 . . . . 70.43 112.02 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.29 141.01 37.56 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.683 -0.689 . . . . 74.51 109.543 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.1 pt -128.42 148.44 32.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.709 -0.849 . . . . 63.44 108.709 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 73.9 mtm180 -129.02 142.66 50.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.361 0.601 . . . . 63.14 111.191 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 46.1 t -116.42 124.37 72.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.503 -1.295 . . . . 74.1 107.503 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -75.71 141.67 27.77 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.989 -0.624 . . . . 55.31 112.368 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.452 HD12 HG12 ' A' ' 496' ' ' ILE . 36.6 mm -99.47 136.91 28.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.892 -1.151 . . . . 73.45 107.892 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.3 mt -98.19 148.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.48 -1.674 . . . . 73.12 106.48 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.47 86.59 5.77 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.287 -0.565 . . . . 73.03 110.707 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.0 118.66 37.03 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 103.936 -2.616 . . . . 63.51 103.936 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.605 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.258 10.7 t70 -121.21 92.5 3.77 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.493 -2.083 . . . . 75.22 110.966 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.723 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.6 mm -120.23 156.62 23.1 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.357 0 CA-C-N 111.018 -2.81 . . . . 71.51 103.825 -175.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -53.62 114.0 1.38 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.625 -1.62 . . . . 73.0 106.625 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.723 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 35.5 mt-10 -121.18 113.04 19.42 Favored 'General case' 0 CA--C 1.468 -2.208 0 CA-C-O 121.56 0.695 . . . . 60.52 110.532 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -117.81 100.55 7.66 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.691 -1.14 . . . . 75.11 109.767 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 51.75 40.89 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.447 -1.251 . . . . 74.33 113.393 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.431 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.7 pt-20 -70.12 131.84 44.91 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 119.945 -0.702 . . . . 62.55 109.81 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.634 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 34.1 p30 -150.13 161.22 42.8 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.446 0.535 . . . . 63.23 112.446 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 35.3 p90 -131.96 -179.56 5.48 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.377 -0.374 . . . . 75.34 110.611 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 47.4 mt -121.34 138.49 54.23 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.457 -0.942 . . . . 75.1 108.457 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 23.0 t -111.06 129.59 66.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.34 -1.356 . . . . 54.2 107.34 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -122.67 165.75 16.01 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 123.574 0.546 . . . . 64.24 109.712 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.52 139.36 51.58 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.198 0.523 . . . . 74.53 110.536 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 37.3 m -150.57 -179.28 7.1 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.271 -1.011 . . . . 65.15 108.271 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.8 t30 45.7 88.39 0.02 OUTLIER 'General case' 0 C--O 1.248 1.02 0 C-N-CA 124.815 1.246 . . . . 72.33 113.856 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.493 HG11 HG23 ' A' ' 480' ' ' VAL . 45.3 t -90.3 123.8 42.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.219 -0.992 . . . . 73.44 108.779 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -127.35 173.5 9.73 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 121.501 0.667 . . . . 72.54 110.421 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 42.3 t -143.96 159.14 16.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 102.888 -3.005 . . . . 65.34 102.888 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.2 m -69.34 108.92 3.9 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 122.657 1.218 . . . . 63.51 108.333 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 3.5 p -82.12 82.88 7.52 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-N 112.92 -1.945 . . . . 61.12 113.319 -172.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -93.6 -44.25 8.29 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.249 -1.342 . . . . 73.11 107.801 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -103.18 -50.01 3.6 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.049 -0.978 . . . . 62.25 108.928 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 22.4 m -160.05 153.75 22.67 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.092 -1.077 . . . . 75.04 108.092 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -85.99 -39.63 16.68 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.311 -0.996 . . . . 62.24 108.311 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -120.35 110.82 16.99 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.942 -1.133 . . . . 74.54 107.942 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 147.78 -40.67 0.96 Allowed Glycine 0 C--N 1.29 -2.009 0 N-CA-C 108.78 -1.728 . . . . 70.25 108.78 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 50.5 mm -85.32 95.98 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 104.983 -2.229 . . . . 73.15 104.983 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.563 ' HA ' ' NE2' ' A' ' 479' ' ' HIS . 2.4 pp -119.38 138.65 52.94 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 113.844 1.053 . . . . 61.13 113.844 -173.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.44 162.54 35.22 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.676 -0.861 . . . . 72.44 108.676 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -69.11 -6.86 31.11 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.632 0.605 . . . . 72.2 112.632 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ASN . . . . . 0.499 ' HA ' ' OG ' ' A' ' 372' ' ' SER . 53.6 m-80 -86.21 -0.01 54.76 Favored 'General case' 0 C--O 1.253 1.242 0 N-CA-C 113.509 0.929 . . . . 75.53 113.509 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.563 ' NE2' ' HA ' ' A' ' 475' ' ' LEU . 2.4 p-80 -139.77 173.23 11.74 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.513 0.673 . . . . 73.31 112.079 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.493 HG23 HG11 ' A' ' 463' ' ' VAL . 18.5 m -113.45 -169.45 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.104 -1.407 . . . . 61.44 108.111 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 33.6 p -162.84 -151.49 0.19 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 118.372 0.533 . . . . 61.13 110.155 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -94.58 8.62 41.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.706 -0.85 . . . . 74.22 108.706 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -118.54 -52.12 2.37 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.226 -1.768 . . . . 73.22 106.226 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.09 131.11 36.13 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.513 -2.032 . . . . 71.3 105.513 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 70.2 m -104.21 176.76 5.05 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 120.815 -0.354 . . . . 65.32 110.245 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.634 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 1.2 mm? -68.98 -164.41 0.05 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 123.743 0.652 . . . . 55.13 109.615 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.479 ' C ' ' HD3' ' A' ' 489' ' ' PRO . . . -66.81 -169.96 3.89 Favored Glycine 0 C--O 1.24 0.519 0 N-CA-C 110.133 -1.187 . . . . 63.42 110.133 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.0 m -113.28 65.34 1.03 Allowed Pre-proline 0 C--N 1.298 -1.667 0 C-N-CA 116.551 -2.06 . . . . 62.01 116.306 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.589 ' CG ' ' HA ' ' A' ' 490' ' ' SER . 10.8 Cg_endo -98.15 -80.55 0.0 OUTLIER 'Trans proline' 1 CA--C 1.61 4.318 0 C-N-CA 121.341 1.36 . . . . 75.22 111.711 161.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.589 ' HA ' ' CG ' ' A' ' 489' ' ' PRO . 22.6 m -118.88 86.49 2.55 Favored 'General case' 0 C--N 1.388 2.28 0 CA-C-N 123.591 2.905 . . . . 71.54 106.886 -5.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.509 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 53.0 m -147.55 128.7 14.66 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 109.166 -0.679 . . . . 62.22 109.166 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -112.06 106.78 15.51 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.714 -1.217 . . . . 53.44 107.714 170.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 380' ' ' THR . 27.0 m -82.0 121.9 27.11 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.69 -0.485 . . . . 74.4 109.69 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.517 HG11 HG11 ' A' ' 390' ' ' VAL . 86.6 t -107.75 107.89 23.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.492 -0.929 . . . . 62.22 108.492 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.634 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 66.9 m -98.39 113.44 25.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.895 -0.779 . . . . 72.1 108.895 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.617 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -91.3 120.5 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.556 0.693 . . . . 75.11 110.767 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.01 101.63 13.09 Favored 'General case' 0 N--CA 1.394 -3.273 0 CA-C-N 115.013 -0.994 . . . . 72.4 110.999 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.601 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 2.1 t70 -53.6 -53.42 52.05 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.547 -2.115 . . . . 63.51 108.974 172.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.468 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 31.8 t70 69.29 -5.74 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.571 1.548 . . . . 74.12 112.1 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -78.06 -35.49 49.52 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.832 -1.173 . . . . 73.01 107.832 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -95.35 -35.45 11.76 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.322 -0.854 . . . . 53.33 110.257 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 499' ' ' ASP . . . -72.38 -73.95 0.18 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.273 0.842 . . . . 64.31 113.273 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.14 60.7 1.9 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.12 -1.192 . . . . 72.31 110.12 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 49.3 pt -97.96 178.47 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 110.337 -0.245 . . . . 74.33 110.337 -176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -85.72 125.87 33.54 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.392 -0.966 . . . . 70.4 108.392 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 2.2 p -81.44 176.15 9.94 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.005 -0.543 . . . . 65.31 111.236 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -74.29 135.89 42.61 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.567 -0.531 . . . . 63.22 109.567 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -78.74 95.43 5.31 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.273 -0.64 . . . . 74.11 109.273 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 115.244 -0.889 . . . . 72.02 108.687 -176.695 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.605 'CA ' ' OD1' ' A' ' 448' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.619 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 478' ' ' ASN . 47.0 t . . . . . 0 N--CA 1.444 -0.739 0 N-CA-C 109.275 -0.639 . . . . 74.15 109.275 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.419 ' HA ' ' HA3' ' A' ' 398' ' ' GLY . 44.9 m -126.4 150.68 48.47 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 116.259 -0.428 . . . . 41.32 110.233 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 95.6 mttt -126.85 159.17 34.69 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.095 0.558 . . . . 73.32 111.445 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.611 ' HB ' HD12 ' A' ' 486' ' ' LEU . 33.4 mm -116.23 121.41 67.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.143 -1.058 . . . . 70.41 108.143 -175.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.436 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 21.0 p90 -154.1 172.12 18.04 Favored 'General case' 0 C--O 1.193 -1.894 0 N-CA-C 112.195 0.443 . . . . 64.41 112.195 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -85.49 153.36 22.51 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.594 -0.442 . . . . 71.11 110.491 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.46 -36.79 81.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.46 0.648 . . . . 72.13 109.582 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -128.59 172.3 11.32 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.227 -0.897 . . . . 70.32 111.792 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.41 -32.3 4.93 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 114.881 -1.054 . . . . 63.25 110.966 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.3 m -130.39 125.5 34.7 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.389 -0.597 . . . . 72.43 109.389 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.17 140.69 48.33 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.449 -0.945 . . . . 71.55 108.449 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 495' ' ' THR . 37.9 mt-30 -123.96 135.52 53.71 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.404 -1.332 . . . . 75.11 107.404 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 29.7 t -146.48 165.86 28.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.279 -1.008 . . . . 74.0 108.279 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -91.14 145.54 24.59 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.634 -0.506 . . . . 70.41 109.634 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.699 ' HB2' ' HA ' ' A' ' 498' ' ' ASP . 18.1 tt0 -55.66 -54.86 39.05 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.778 0.831 . . . . 75.44 110.723 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -74.37 8.34 2.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.765 1.024 . . . . 65.31 113.765 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.89 -31.05 68.64 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.538 -0.541 . . . . 65.02 109.538 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.64 -60.38 0.52 Allowed Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.425 -0.893 . . . . 62.31 111.245 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 12.7 p -138.02 152.1 48.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 110.348 -0.242 . . . . 74.04 110.348 176.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 494' ' ' VAL . 3.6 p -108.15 124.22 64.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.559 -1.274 . . . . 74.53 107.559 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.16 118.92 34.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.309 0.576 . . . . 71.35 110.815 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -110.93 149.99 29.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.511 -1.292 . . . . 51.45 107.511 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.4 m -116.37 125.45 52.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.235 0.54 . . . . 71.54 110.462 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 77.6 mt -97.24 123.98 49.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.346 -1.353 . . . . 71.14 107.346 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.7 mm -102.16 129.93 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-N 115.205 -0.907 . . . . 74.33 108.775 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 35.9 ttt180 -112.06 108.62 17.99 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.424 -0.807 . . . . 71.21 108.873 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -111.45 158.47 19.08 Favored 'General case' 0 CA--C 1.487 -1.462 0 CA-C-N 116.135 -0.484 . . . . 73.13 109.755 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 372' ' ' SER . . . 150.28 -40.13 0.84 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.405 -1.078 . . . . 70.3 110.405 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 156.51 -125.19 1.57 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 110.273 -1.131 . . . . 70.44 110.273 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -133.15 119.94 20.56 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.526 -0.916 . . . . 61.43 108.526 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 80.5 mt -143.43 138.01 29.03 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.166 -1.05 . . . . 63.21 108.166 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.44 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 48.4 p -98.41 6.27 47.4 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 122.165 0.983 . . . . 74.01 109.859 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.65 138.16 50.48 Favored 'General case' 0 C--O 1.258 1.516 0 CA-C-N 114.135 -1.393 . . . . 75.04 108.994 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 466' ' ' SER . 7.0 m -90.78 124.76 35.39 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 121.623 0.725 . . . . 72.21 109.832 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.87 137.25 56.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.307 -0.86 . . . . 72.11 109.132 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.446 ' CE2' HG22 ' A' ' 430' ' ' VAL . 17.9 m-85 -119.93 137.1 54.24 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.582 -0.896 . . . . 72.51 108.582 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.18 128.76 49.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 107.619 -1.252 . . . . 73.35 107.619 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.5 153.68 20.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.714 -0.476 . . . . 63.11 109.714 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -146.95 161.54 40.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.232 -0.293 . . . . 65.31 110.435 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -161.03 163.0 31.91 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 107.311 -1.366 . . . . 75.23 107.311 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 49.4 p -95.71 172.54 7.98 Favored 'General case' 0 C--O 1.26 1.656 0 N-CA-C 108.34 -0.985 . . . . 64.51 108.34 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -121.72 151.61 40.32 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 120.218 -0.593 . . . . 63.02 111.339 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 3.49 8.68 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 125.734 1.613 . . . . 71.33 113.045 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.85 -92.02 0.01 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 116.917 1.527 . . . . 71.43 116.917 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.3 t -101.85 9.58 40.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.212 1.006 . . . . 73.42 111.096 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -147.03 -157.58 0.82 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.492 -0.929 . . . . 34.41 108.492 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -145.17 124.37 12.94 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.95 -1.1 . . . . 41.34 111.768 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -72.28 124.65 25.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.255 -0.884 . . . . 74.1 108.889 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.48 -16.02 41.53 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.963 -1.255 . . . . 73.33 109.963 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 48.1 t -110.48 -58.71 2.04 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.379 -0.6 . . . . 32.43 109.379 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 15.4 m-20 -86.28 -58.39 2.65 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-O 122.261 1.029 . . . . 73.11 109.418 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.712 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.11 163.43 32.45 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.086 -0.961 . . . . 75.22 109.48 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -72.94 151.94 41.63 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 123.879 0.737 . . . . 73.04 110.735 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.619 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.1 p90 -80.54 -21.62 41.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.747 -0.661 . . . . 70.32 112.654 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 442' ' ' VAL 0.255 13.8 t 36.69 67.16 0.35 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.647 1.579 . . . . 74.13 113.754 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -87.86 113.15 23.24 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.098 -0.956 . . . . 65.42 108.756 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.65 -173.86 23.26 Favored Glycine 0 CA--C 1.482 -2.025 0 C-N-CA 120.492 -0.861 . . . . 54.24 111.365 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.7 m -120.51 137.16 54.52 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.501 -0.926 . . . . 71.1 108.501 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 22.0 t -96.56 123.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.929 -1.137 . . . . 72.13 107.929 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.446 HG22 ' CE2' ' A' ' 406' ' ' PHE . 16.2 t -103.66 109.6 27.58 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-O 121.389 0.614 . . . . 74.22 111.047 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 404' ' ' THR . 55.7 m-85 -94.14 100.02 12.19 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.699 -0.682 . . . . 74.22 111.064 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.8 mttt -94.53 172.1 5.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 114.263 -1.335 . . . . 75.21 110.343 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 44.5 Cg_exo -58.73 126.17 20.44 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.868 2.379 . . . . 75.32 112.173 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.84 -2.04 87.07 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.601 -0.809 . . . . 61.33 114.359 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.24 -70.16 0.38 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 117.654 0.727 . . . . 72.01 110.447 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 54.5 m 71.26 -35.33 0.33 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.686 0.795 . . . . 63.51 112.122 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -125.95 140.1 52.9 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.515 -1.291 . . . . 74.12 107.515 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -132.93 143.67 49.64 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.417 -0.356 . . . . 62.51 110.322 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 392' ' ' LEU . 36.8 tt0 -106.0 134.64 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.495 -0.928 . . . . 65.22 108.495 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.4 pt -123.14 148.54 26.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.437 -1.32 . . . . 71.43 107.437 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 75.5 mtt180 -129.0 138.18 51.78 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.363 0.602 . . . . 71.41 111.93 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.661 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 52.1 t -109.62 119.0 58.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.732 -1.122 . . . . 72.21 108.628 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.419 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -66.03 132.55 33.83 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 124.192 0.933 . . . . 61.02 112.236 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 31.8 mm -97.71 135.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.169 -1.419 . . . . 70.04 107.169 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 76.0 mt -101.72 150.57 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 106.948 -1.501 . . . . 72.05 106.948 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.23 95.47 6.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.365 -0.534 . . . . 71.04 111.317 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -122.61 128.1 50.25 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 103.539 -2.763 . . . . 72.42 103.539 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -126.54 99.85 5.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 C-N-CA 116.999 -1.881 . . . . 75.04 110.149 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.761 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -131.04 158.27 43.3 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.118 0 CA-C-N 111.077 -2.783 . . . . 72.22 105.03 -171.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -53.16 114.82 1.6 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 116.721 -1.992 . . . . 70.24 106.397 166.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.761 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.6 mt-10 -125.23 97.17 5.11 Favored 'General case' 0 CA--C 1.458 -2.571 0 N-CA-C 107.856 -1.164 . . . . 74.13 107.856 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -117.84 113.47 21.83 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 108.192 -1.04 . . . . 75.23 108.192 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 31.38 20.41 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.114 0.884 . . . . 71.23 111.366 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.492 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.0 tt0 -65.32 106.57 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.27 -1.381 . . . . 65.14 107.27 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -141.2 169.68 17.15 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.65 -0.704 . . . . 63.22 109.846 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.661 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 22.5 p90 -143.35 170.44 15.76 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.749 -0.834 . . . . 63.11 108.749 173.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.74 136.5 50.92 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.058 -1.46 . . . . 73.23 107.058 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.58 124.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 106.806 -1.553 . . . . 71.11 106.806 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -120.37 142.8 48.84 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.652 -0.704 . . . . 74.11 109.242 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.5 138.13 33.61 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.931 -1.878 . . . . 73.22 105.931 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 26.0 m -148.09 155.1 41.06 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.89 -0.781 . . . . 54.13 108.89 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.56 92.38 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 O-C-N 124.543 1.152 . . . . 62.43 111.95 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.75 142.46 14.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.391 -0.966 . . . . 73.23 108.391 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 464' ' ' LYS . 32.6 ttmt -140.76 120.18 13.12 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.3 -0.63 . . . . 71.41 109.3 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 50.4 t -102.74 140.51 20.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.388 -0.967 . . . . 75.34 108.388 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.54 ' O ' ' HB ' ' A' ' 404' ' ' THR . 71.0 m -138.89 109.54 6.63 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.465 0.65 . . . . 71.23 112.665 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 15.7 m -95.16 98.34 10.57 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.743 -1.947 . . . . 74.33 105.743 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.28 -8.29 52.64 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.706 1.373 . . . . 74.11 114.706 -172.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.03 -32.86 57.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.651 -1.24 . . . . 73.42 107.651 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 48.9 m 54.95 34.78 23.04 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.129 -1.396 . . . . 61.14 113.835 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.6 -32.28 65.84 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.927 0.87 . . . . 64.12 108.99 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -155.66 139.76 16.47 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.085 -0.961 . . . . 65.41 108.479 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -82.14 67.45 3.68 Favored Glycine 0 C--N 1.301 -1.365 0 N-CA-C 110.201 -1.16 . . . . 73.14 110.201 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 13.9 tt -74.56 141.15 16.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.162 0.506 . . . . 61.44 110.067 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 475' ' ' LEU . 2.5 pt? -76.42 134.46 39.59 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.456 -0.793 . . . . 64.44 110.005 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -103.32 110.48 22.49 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.291 0.567 . . . . 75.53 111.871 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -93.96 -6.06 46.3 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 122.245 1.021 . . . . 73.21 108.273 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 371' ' ' VAL . 3.4 p-10 -86.23 1.34 51.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.119 -1.401 . . . . 65.25 109.524 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -139.56 175.61 9.42 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-N 115.759 -0.655 . . . . 75.5 110.289 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 25.8 m -79.43 145.39 9.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.292 -0.867 . . . . 75.01 110.918 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 28.5 t 177.75 -78.34 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.059 1.343 . . . . 60.02 108.507 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.73 -0.35 1.93 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.332 . . . . 75.42 111.674 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -108.94 -45.14 3.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 104.54 -2.393 . . . . 75.41 104.54 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -113.32 147.95 36.62 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 106.89 -1.522 . . . . 71.21 106.89 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 77.7 m -122.32 177.89 5.18 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 108.119 -1.067 . . . . 72.31 108.119 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.611 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.5 mm? -65.51 154.48 38.48 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.521 -0.472 . . . . 70.22 109.979 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 375' ' ' PHE . . . -72.83 -30.45 63.65 Favored Glycine 0 C--O 1.227 -0.344 0 C-N-CA 120.972 -0.632 . . . . 63.51 112.647 -176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 9.4 m -97.55 167.45 11.81 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 107.602 -1.259 . . . . 70.43 107.602 175.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.606 ' N ' ' HA ' ' A' ' 490' ' ' SER . 38.7 Cg_exo -57.37 -29.84 85.72 Favored 'Trans proline' 0 CA--C 1.586 3.109 0 N-CA-C 120.127 3.087 . . . . 62.41 120.127 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.606 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 14.5 m -111.61 117.63 33.48 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 128.245 2.618 . . . . 63.51 108.642 2.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 23.2 m -127.92 104.86 8.04 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.25 -0.648 . . . . 50.25 109.25 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -107.59 118.66 37.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.331 -0.989 . . . . 73.15 108.331 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 23.6 m -88.25 119.51 28.73 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.814 0.34 . . . . 60.11 110.47 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 390' ' ' VAL . 68.4 t -104.61 106.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.424 -0.954 . . . . 72.04 108.424 176.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 27.6 m -95.53 114.23 25.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.131 -1.063 . . . . 72.14 108.131 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.712 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -92.21 117.59 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 C-N-CA 120.326 -0.55 . . . . 70.32 110.411 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.43 ' O ' HD13 ' A' ' 384' ' ' LEU . 18.3 m-85 -78.42 103.06 8.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 107.621 -1.252 . . . . 63.43 107.621 170.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 385' ' ' GLU . 0.0 OUTLIER -63.06 -30.81 71.89 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.283 -1.781 . . . . 74.21 109.459 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.9 t70 64.49 18.76 11.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.521 1.528 . . . . 72.14 110.849 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' ASP . . . . . 0.4 ' HB2' ' OD2' ' A' ' 498' ' ' ASP . 35.6 m-20 -112.4 -52.12 2.8 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.198 -1.408 . . . . 73.31 107.198 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.44 ' HB2' ' H ' ' A' ' 451' ' ' GLU . 32.7 m80 -130.32 -14.8 3.75 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.875 -1.057 . . . . 75.42 111.003 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -67.63 100.52 0.9 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.341 0.867 . . . . 73.3 113.341 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 77.9 -61.99 3.66 Favored Glycine 0 CA--C 1.497 -1.044 0 CA-C-N 115.733 -0.667 . . . . 75.1 111.638 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.93 160.92 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 C-N-CA 123.398 0.679 . . . . 71.11 110.036 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -114.46 124.44 51.92 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.611 -0.436 . . . . 72.33 111.588 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 18.3 m -136.44 149.37 48.22 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.826 -1.546 . . . . 74.21 106.826 173.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -75.16 138.77 42.23 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.701 0.4 . . . . 74.31 111.139 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.66 125.44 31.85 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.873 -0.788 . . . . 65.34 108.873 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 112.283 0.475 . . . . 64.3 112.283 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.608 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.634 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.433 ' O ' ' HA3' ' A' ' 398' ' ' GLY . 13.5 p . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 121.159 0.505 . . . . 63.25 109.879 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 479' ' ' HIS . 23.6 m -74.65 135.03 41.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.951 -0.568 . . . . 75.41 111.22 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -138.39 142.54 39.61 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 122.775 0.43 . . . . 74.33 110.216 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.645 ' HB ' HD12 ' A' ' 486' ' ' LEU . 44.7 mm -109.38 112.62 41.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.162 -1.421 . . . . 44.34 107.162 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -145.53 160.44 41.62 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.836 -0.746 . . . . 73.53 112.609 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.06 142.76 39.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.31 -0.626 . . . . 75.13 109.31 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.21 -48.69 80.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.806 0.842 . . . . 74.52 110.093 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.554 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 16.2 mm100 -106.25 172.4 6.83 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.816 0.817 . . . . 64.03 110.649 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.11 -34.04 4.99 Favored Glycine 0 C--N 1.284 -2.327 0 CA-C-N 114.129 -1.396 . . . . 62.31 110.167 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 42.2 m -132.93 128.43 36.47 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.226 -1.028 . . . . 51.21 108.226 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 37.3 m-85 -112.06 136.84 50.91 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 495' ' ' THR . 75.4 mt-30 -126.61 142.49 51.52 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.178 -1.045 . . . . 72.22 108.178 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 19.5 t -153.68 165.1 37.01 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.278 -1.378 . . . . 73.22 107.278 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -86.18 141.99 28.94 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.584 -0.525 . . . . 74.32 109.584 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.601 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 24.9 tt0 -55.55 -38.2 69.0 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.378 1.071 . . . . 61.2 110.128 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 509' ' ' GLU . 23.1 m120 -84.83 7.03 22.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.04 -0.982 . . . . 71.23 111.999 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.5 t -90.45 -1.03 57.89 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 122.02 -0.425 . . . . 75.14 111.213 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.27 4.5 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 64.33 113.117 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 22.1 p -142.91 174.26 10.82 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.314 0.578 . . . . 71.23 110.843 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 494' ' ' VAL . 4.6 p -125.61 125.9 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 106.802 -1.555 . . . . 74.23 106.802 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.33 122.69 41.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.996 0.427 . . . . 73.0 110.118 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.546 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.3 mp -112.45 146.42 38.43 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.05 -1.092 . . . . 74.24 108.05 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.2 m -112.46 128.53 56.35 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.448 0.467 . . . . 74.55 109.748 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 62.2 mt -100.45 121.74 51.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.17 -1.419 . . . . 74.41 107.17 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.2 mm -99.2 132.3 44.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.754 -0.832 . . . . 64.51 108.754 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.46 ' HG3' HD13 ' A' ' 374' ' ' ILE . 3.3 ttp85 -107.52 122.83 47.44 Favored 'General case' 0 N--CA 1.406 -2.666 0 C-N-CA 119.702 -0.799 . . . . 75.02 110.549 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -119.6 157.62 28.05 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.363 -0.835 . . . . 74.44 108.965 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 371' ' ' VAL . . . 91.39 49.41 3.02 Favored Glycine 0 N--CA 1.418 -2.503 0 O-C-N 124.037 0.836 . . . . 73.25 111.739 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 115.07 115.08 3.01 Favored Glycine 0 N--CA 1.415 -2.726 0 C-N-CA 120.122 -1.037 . . . . 73.24 112.735 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -100.78 121.37 41.57 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 105.766 -1.939 . . . . 65.3 105.766 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 403' ' ' ASN . 2.0 pt? -157.08 -173.14 4.31 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 120.609 -0.437 . . . . 65.32 111.252 -173.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.8 p -102.49 -4.11 25.86 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.53 0.937 . . . . 73.23 113.53 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.421 ' H ' ' HG ' ' A' ' 401' ' ' LEU . 94.6 m-20 -69.88 138.67 52.69 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.955 -0.466 . . . . 72.14 110.575 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 50.7 m -93.9 124.55 37.98 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 123.93 0.892 . . . . 62.33 111.512 -176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.6 t -112.26 146.92 16.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.047 -0.524 . . . . 74.31 109.83 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.604 ' CE1' HG13 ' A' ' 430' ' ' VAL . 3.7 m-85 -120.59 129.14 53.63 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.11 0.564 . . . . 73.24 110.66 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.81 135.95 52.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.589 -1.263 . . . . 61.44 107.589 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 18.2 t70 -102.52 148.73 25.18 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.061 -0.718 . . . . 72.44 109.061 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -143.94 159.36 42.71 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.038 -0.665 . . . . 74.14 110.868 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -163.17 160.91 24.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.37 -1.715 . . . . 75.3 106.37 173.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.633 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 34.9 p -96.95 164.81 12.38 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.426 0.631 . . . . 73.12 110.581 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.4 tp10 -106.53 152.59 23.48 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.214 -1.402 . . . . 64.2 107.214 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.486 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 4.8 m-20 -60.01 -40.51 89.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.915 0.864 . . . . 71.52 110.493 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' GLY . . . . . 0.428 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . 67.69 -86.51 0.16 Allowed Glycine 0 C--N 1.299 -1.495 0 CA-C-N 114.355 -1.293 . . . . 73.21 112.964 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.1 t -135.71 11.5 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.657 -0.868 . . . . 64.13 108.657 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -141.3 -162.87 1.45 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.698 -1.593 . . . . 65.33 106.698 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.486 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 7.3 m120 -129.29 116.35 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.583 0.706 . . . . 74.02 112.141 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -78.03 124.5 28.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.903 -1.044 . . . . 64.41 108.898 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.35 -12.25 30.94 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 109.668 -1.373 . . . . 74.3 109.668 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 16.3 t -126.87 -54.84 1.4 Allowed 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.917 -0.313 . . . . 74.21 110.993 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.611 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -73.06 -58.46 3.3 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 122.4 1.095 . . . . 70.43 108.074 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.72 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.21 161.78 36.58 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.126 -1.397 . . . . 74.25 107.631 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.6 157.33 32.04 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.566 0.541 . . . . 75.1 109.649 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.633 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 15.6 p90 -90.6 -9.69 46.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.215 0.45 . . . . 64.41 112.215 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.478 HG21 HG22 ' A' ' 442' ' ' VAL . 12.7 t 37.34 68.67 0.27 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.052 1.741 . . . . 72.5 113.728 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -80.3 134.79 36.11 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.023 -1.071 . . . . 70.35 109.128 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -175.03 -178.54 44.97 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.677 -0.969 . . . . 65.22 110.677 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 18.3 m -125.73 139.97 53.08 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.789 -1.189 . . . . 73.42 107.789 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.1 t -99.42 119.43 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.922 -0.769 . . . . 55.42 108.922 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 406' ' ' PHE . 53.6 t -100.71 106.65 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.575 -0.898 . . . . 54.43 108.575 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 404' ' ' THR . 58.9 m-85 -79.17 95.0 5.49 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.736 -0.665 . . . . 74.35 110.075 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.443 ' HD2' HG12 ' A' ' 430' ' ' VAL . 5.3 mptp? -69.46 164.58 48.36 Favored Pre-proline 0 C--N 1.316 -0.852 0 O-C-N 123.58 0.55 . . . . 75.22 111.549 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.41 113.51 1.16 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.739 2.293 . . . . 75.35 111.797 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.1 67.5 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.742 -0.742 . . . . 60.1 113.399 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -88.25 62.02 6.51 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.558 0.694 . . . . 74.03 110.691 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 m -61.47 -23.31 65.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.813 -1.085 . . . . 43.54 110.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -131.38 132.26 44.28 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.58 -1.267 . . . . 75.35 107.58 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 25.8 mmmt -122.32 149.8 43.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.484 0.55 . . . . 61.54 112.484 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -114.51 125.59 53.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.381 -0.827 . . . . 64.23 111.122 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.8 pt -116.84 146.57 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.043 -1.095 . . . . 62.24 108.043 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 71.2 mtt180 -126.01 141.45 51.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.374 -0.53 . . . . 74.01 110.8 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -106.22 121.2 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.442 -0.947 . . . . 54.32 108.442 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -62.07 125.01 35.31 Favored Glycine 0 N--CA 1.435 -1.423 0 O-C-N 124.134 0.896 . . . . 70.11 112.068 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.437 HD12 HG12 ' A' ' 496' ' ' ILE . 49.5 mm -94.92 135.27 29.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.988 -1.486 . . . . 65.44 106.988 175.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.9 mt -103.19 151.08 6.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.169 -1.419 . . . . 74.22 107.169 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.98 101.31 8.57 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 121.3 0.571 . . . . 75.33 110.536 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 123.15 29.57 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 103.771 -2.677 . . . . 62.32 103.771 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.256 19.6 t70 -119.78 97.58 5.7 Favored 'General case' 0 CA--C 1.459 -2.553 0 C-N-CA 116.393 -2.123 . . . . 74.02 111.932 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.701 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -121.45 156.49 25.36 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.439 0 CA-C-N 111.282 -2.69 . . . . 74.51 104.727 -174.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -53.87 115.32 1.95 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.862 -1.903 . . . . 75.45 105.862 168.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.701 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 33.1 mt-10 -123.38 90.71 3.33 Favored 'General case' 0 CA--C 1.483 -1.605 0 CA-C-O 122.069 0.937 . . . . 42.42 111.104 -170.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -93.58 104.94 17.03 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.005 -1.452 . . . . 63.04 107.738 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.308 7.9 p-10 42.28 60.34 2.35 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 125.095 1.497 . . . . 61.34 112.9 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.564 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 33.1 tt0 -74.45 113.96 12.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.683 -1.599 . . . . 64.42 106.683 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -137.13 171.35 14.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.57 0.7 . . . . 74.41 112.729 -174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 28.5 p90 -146.62 -177.78 5.82 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.861 -1.063 . . . . 71.32 109.665 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 412' ' ' GLU . 26.6 mt -123.32 141.57 51.85 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.015 -1.106 . . . . 63.24 108.015 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 411' ' ' THR . 25.7 t -110.56 130.85 63.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.199 -1.408 . . . . 53.03 107.199 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -124.17 134.2 53.37 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.498 0.499 . . . . 63.22 110.76 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.405 ' HB2' ' HG ' ' A' ' 486' ' ' LEU . 91.0 mt -95.86 140.62 30.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.048 -1.093 . . . . 73.02 108.048 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 49.1 m -155.3 -177.79 6.8 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.693 -0.854 . . . . 64.24 108.693 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 23.2 t-20 51.11 83.84 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.651 1.18 . . . . 54.51 111.599 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.61 126.4 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.581 -0.848 . . . . 53.32 109.178 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -133.72 155.9 48.92 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.049 -0.523 . . . . 64.24 110.123 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.44 133.83 67.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.351 -0.981 . . . . 72.23 108.351 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.488 ' HB2' ' CE1' ' A' ' 406' ' ' PHE . 35.1 t -76.99 136.67 38.73 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.021 0.439 . . . . 75.21 110.534 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 470' ' ' SER . 5.4 m -65.41 116.35 6.62 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.057 -0.974 . . . . 50.01 109.595 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -77.54 -68.59 0.61 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.824 1.046 . . . . 71.24 113.824 -176.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -103.83 -57.78 1.98 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.558 0.694 . . . . 64.35 109.313 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 467' ' ' SER . 47.0 t -90.88 169.79 10.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.956 -1.127 . . . . 71.23 107.956 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.64 -22.35 62.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.009 0.433 . . . . 74.14 110.011 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.08 98.83 9.51 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.59 -0.522 . . . . 74.23 109.59 172.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -131.29 41.4 1.52 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.507 -1.037 . . . . 73.11 110.507 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 64.9 mt -92.73 102.74 13.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.125 -1.065 . . . . 72.35 108.125 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 475' ' ' LEU . 1.3 pt? -104.45 90.62 3.59 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.719 0.771 . . . . 74.03 112.614 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.48 69.43 10.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 122.157 0.979 . . . . 73.04 109.807 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -104.8 -69.98 0.79 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.515 -1.221 . . . . 45.32 109.935 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -134.5 15.65 3.71 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.713 0.768 . . . . 71.34 109.191 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 372' ' ' SER . 28.6 m-70 -110.16 169.03 9.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.865 -0.607 . . . . 62.11 110.512 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 22.8 m -77.34 138.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.636 -0.505 . . . . 62.54 109.636 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 10.8 p 170.63 -87.32 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.488 1.515 . . . . 75.03 108.847 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -127.42 18.54 6.93 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.69 -1.226 . . . . 74.51 107.69 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -119.38 -64.1 1.31 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.747 -2.316 . . . . 74.54 104.747 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -113.62 161.41 17.47 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 114.639 -1.164 . . . . 33.11 108.753 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 83.7 m -121.63 -168.99 1.79 Allowed 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.176 -1.416 . . . . 73.51 107.176 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.645 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.4 mm? -70.63 152.61 43.71 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.333 0.515 . . . . 74.44 110.189 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -75.72 -30.4 57.98 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 111.257 -0.737 . . . . 71.53 111.257 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.534 ' C ' ' HA ' ' A' ' 490' ' ' SER . 12.9 m -78.68 166.25 43.92 Favored Pre-proline 0 N--CA 1.429 -1.497 0 N-CA-C 108.733 -0.839 . . . . 62.2 108.733 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.61 ' N ' ' HA ' ' A' ' 490' ' ' SER . 34.0 Cg_exo -58.46 -23.81 65.89 Favored 'Trans proline' 0 CA--C 1.59 3.309 0 N-CA-C 120.582 3.262 . . . . 53.12 120.582 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.61 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 35.5 t -105.29 114.28 28.36 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 123.184 2.72 . . . . 73.21 108.168 1.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.486 ' H ' ' HD2' ' A' ' 489' ' ' PRO . 63.4 m -143.75 128.02 17.76 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.876 -0.602 . . . . 60.44 110.554 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -126.82 135.4 50.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.118 -1.438 . . . . 74.1 107.118 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 88.1 m -96.12 129.99 43.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.656 -0.498 . . . . 75.53 109.656 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 390' ' ' VAL . 69.0 t -115.31 109.37 28.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.587 -0.894 . . . . 74.14 108.587 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 35.6 m -101.55 117.12 34.27 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.457 -0.942 . . . . 74.54 108.457 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.72 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.4 125.08 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.267 0 CA-C-N 115.957 -0.565 . . . . 62.13 109.693 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.489 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.0 m-85 -84.69 104.26 14.51 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-O 121.799 0.809 . . . . 74.31 111.693 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.619 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 6.2 t70 -49.01 -58.52 4.76 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.721 -2.491 . . . . 73.35 109.475 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.551 ' HA ' ' CA ' ' A' ' 503' ' ' GLY . 11.8 t0 68.99 7.92 6.53 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 125.852 1.661 . . . . 73.53 111.043 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -93.52 -56.38 2.94 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.702 -1.221 . . . . 72.03 107.702 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -104.45 -54.24 2.56 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.606 -1.179 . . . . 74.14 108.412 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -108.39 108.63 19.67 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 108.017 -1.105 . . . . 74.23 108.017 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 499' ' ' ASP . . . -139.72 179.93 18.34 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 118.718 -1.706 . . . . 72.2 115.65 -173.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.62 -4.63 3.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 113.46 -1.37 . . . . 74.25 108.96 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 72.82 83.84 0.12 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 125.464 1.506 . . . . 75.44 111.816 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 42.0 m -150.43 65.75 0.95 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.242 -1.392 . . . . 75.44 107.242 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.21 83.25 6.11 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.668 -1.151 . . . . 75.0 111.205 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.97 129.07 22.07 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.658 -1.156 . . . . 72.24 108.442 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 386' ' ' ASN . 43.6 tt0 . . . . . 0 C--N 1.291 -1.977 0 CA-C-N 115.634 -0.712 . . . . 72.54 110.293 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.619 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.633 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 121.951 0.881 . . . . 64.23 109.413 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 480' ' ' VAL . 49.3 m -77.3 104.53 7.87 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.03 -0.986 . . . . 44.41 109.618 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.16 140.85 29.07 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-O 121.545 0.688 . . . . 72.11 111.293 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.584 ' HB ' HD12 ' A' ' 486' ' ' LEU . 21.8 mm -104.73 121.45 56.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.725 -1.58 . . . . 62.11 108.41 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -157.51 155.16 29.83 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 117.612 0.187 . . . . 64.11 110.658 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -73.87 152.44 40.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.841 0.353 . . . . 50.14 110.981 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.02 -30.1 70.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.649 -0.705 . . . . 74.02 110.768 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -127.71 176.93 7.15 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.76 -0.654 . . . . 63.24 111.464 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.94 -36.38 3.96 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.941 -0.863 . . . . 74.53 110.941 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 49.9 m -129.46 131.81 46.8 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.338 -0.615 . . . . 73.03 109.338 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 49.9 m-85 -114.48 135.97 53.53 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.316 -0.994 . . . . 65.31 108.316 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.411 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 72.4 mt-30 -125.54 138.91 53.97 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.919 -0.771 . . . . 72.41 108.919 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.2 p -145.82 155.37 42.87 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.525 -0.546 . . . . 75.24 109.525 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -74.67 141.98 44.52 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.243 -0.651 . . . . 51.03 109.243 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.64 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 20.9 tt0 -55.41 -45.76 76.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.927 0.87 . . . . 72.21 109.165 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.414 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.6 p-10 -82.37 21.54 0.93 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.968 -1.015 . . . . 71.44 112.813 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.28 0.64 46.03 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 121.621 -0.674 . . . . 74.12 112.035 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.82 -71.63 2.57 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.497 -0.859 . . . . 23.33 112.794 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.571 HG22 ' HA2' ' A' ' 443' ' ' GLY . 17.6 p -137.25 159.4 42.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.766 0.283 . . . . 70.42 110.784 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.647 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 5.4 p -112.59 125.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.524 -1.287 . . . . 61.22 107.524 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.55 127.8 43.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.149 -0.478 . . . . 73.2 110.074 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.3 mp -121.22 138.38 54.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.922 -1.51 . . . . 74.01 106.922 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.4 m -109.8 127.29 54.56 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.408 0.443 . . . . 71.43 110.27 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.22 125.5 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.908 -1.145 . . . . 72.43 107.908 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.503 HG22 ' HG2' ' A' ' 397' ' ' ARG . 30.5 mm -102.38 140.95 19.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 107.68 -1.23 . . . . 73.43 107.68 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.502 HH12 HD23 ' A' ' 401' ' ' LEU . 47.5 ttp85 -120.89 109.29 14.94 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.789 -0.449 . . . . 74.43 109.789 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.503 ' HG2' HG22 ' A' ' 395' ' ' ILE . 31.7 mmm180 -128.75 158.86 37.46 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.861 -0.608 . . . . 73.21 110.528 -175.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 116.79 -25.07 9.18 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.087 -1.605 . . . . 71.14 109.087 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 158.4 -172.63 35.41 Favored Glycine 0 N--CA 1.404 -3.493 0 N-CA-C 108.175 -1.97 . . . . 75.53 108.175 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.404 ' HA ' ' NH1' ' A' ' 396' ' ' ARG . 2.5 p-10 -146.55 171.98 14.26 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.545 -0.909 . . . . 72.0 108.545 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.502 HD23 HH12 ' A' ' 396' ' ' ARG . 2.3 pt? -166.04 151.18 8.47 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.575 -2.009 . . . . 73.32 105.575 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 36.6 p -90.32 3.59 53.23 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.682 0.754 . . . . 73.34 110.558 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -74.45 151.28 39.62 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 105.7 -1.963 . . . . 51.03 105.7 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 466' ' ' SER . 4.1 m -92.83 119.23 31.96 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-O 121.408 0.623 . . . . 64.31 111.443 -171.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.66 139.55 21.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.12 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 3.0 m-85 -121.81 123.23 41.3 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 123.667 0.787 . . . . 73.53 110.048 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.78 128.69 72.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.292 -1.373 . . . . 74.52 107.292 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 15.7 t70 -98.73 140.33 33.09 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.092 -0.38 . . . . 74.42 110.434 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -134.85 162.73 31.57 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.683 0.278 . . . . 63.32 110.514 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 42.9 ttt180 -166.82 162.71 16.18 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.591 -1.633 . . . . 55.13 106.591 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.613 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 59.8 p -95.6 172.12 8.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.65 -0.87 . . . . 71.23 108.65 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.34 145.92 50.63 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.7 -0.482 . . . . 74.1 109.7 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.1 4.2 5.9 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.124 1.37 . . . . 73.15 113.697 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -17.97 -88.92 0.01 OUTLIER Glycine 0 N--CA 1.479 1.541 0 C-N-CA 126.141 1.829 . . . . 71.21 117.113 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 13.9 t -109.79 5.31 22.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 117.89 0.845 . . . . 64.15 110.532 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.11 28.15 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.204 -1.776 . . . . 75.42 106.204 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -107.08 127.98 53.97 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.202 -1.399 . . . . 64.25 113.205 -164.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -69.32 126.36 29.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.289 -0.869 . . . . 61.24 110.181 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.62 -25.03 29.85 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.769 -0.932 . . . . 72.42 110.769 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.4 m -100.27 -57.04 2.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.98 -0.748 . . . . 64.21 108.98 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.58 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.2 m-20 -84.91 -58.45 2.7 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-O 121.364 0.602 . . . . 55.35 110.499 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.555 ' CZ ' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -136.19 166.59 23.05 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 108.915 -0.772 . . . . 74.42 108.915 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.43 155.69 39.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.987 0.805 . . . . 73.34 109.716 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.613 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 3.2 p90 -91.04 -17.9 25.47 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.971 -0.559 . . . . 73.34 111.709 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.546 HG21 HG22 ' A' ' 442' ' ' VAL . 9.2 t 34.07 59.2 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 125.144 1.527 . . . . 75.31 113.024 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.1 pt-20 -79.88 119.3 22.56 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.421 -0.809 . . . . 72.41 109.656 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.74 -174.13 34.95 Favored Glycine 0 N--CA 1.419 -2.455 0 C-N-CA 120.552 -0.832 . . . . 70.5 111.426 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 4.6 m -128.8 138.56 52.14 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.321 -0.992 . . . . 74.41 108.321 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 49.1 t -95.64 123.37 47.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.971 -0.752 . . . . 62.45 108.971 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 87.9 t -100.58 107.33 20.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.874 -1.057 . . . . 72.41 109.147 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -82.52 94.37 7.46 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.071 -0.513 . . . . 63.02 110.463 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.62 160.49 58.78 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.172 -0.922 . . . . 44.03 110.476 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.449 ' HG3' ' O ' ' A' ' 402' ' ' THR . 35.2 Cg_exo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.799 2.333 . . . . 72.54 111.183 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.34 -0.86 57.16 Favored Glycine 0 C--N 1.31 -0.875 0 C-N-CA 120.972 -0.632 . . . . 72.04 113.831 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.01 -66.66 0.9 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.172 0.486 . . . . 74.31 110.756 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 m 71.64 -49.58 0.69 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.123 0.969 . . . . 70.54 110.571 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -107.85 136.05 48.22 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.235 -1.394 . . . . 74.43 107.235 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -129.32 140.17 51.49 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.979 0.419 . . . . 74.41 110.993 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.58 139.6 44.39 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.564 -0.743 . . . . 72.23 110.739 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.4 pt -121.71 150.44 24.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.887 -1.153 . . . . 72.22 107.887 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.2 mtt180 -131.27 139.37 49.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 110.106 -0.331 . . . . 72.52 110.106 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.546 HG22 HG21 ' A' ' 425' ' ' THR . 52.2 t -110.77 122.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.579 -1.267 . . . . 75.22 107.579 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.19 138.7 26.99 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 63.3 111.507 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.8 mm -96.6 132.61 40.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 107.089 -1.449 . . . . 70.2 107.089 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -95.7 147.08 6.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.358 -1.719 . . . . 65.04 106.358 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.18 88.0 3.05 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.312 0.577 . . . . 63.53 111.694 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.75 113.29 22.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.587 -2.375 . . . . 72.03 104.587 172.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.639 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 22.7 t70 -120.29 94.85 4.51 Favored 'General case' 0 C--N 1.274 -2.717 0 C-N-CA 116.917 -1.913 . . . . 54.31 110.547 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.4 mm -121.34 156.64 25.12 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.042 0 CA-C-N 111.172 -2.74 . . . . 73.13 105.109 -174.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -53.13 114.78 1.58 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.139 -1.424 . . . . 71.31 107.578 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 37.1 mt-10 -129.19 123.85 33.09 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-N 115.691 -0.686 . . . . 63.43 110.202 -170.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 31.2 mt-10 -134.06 105.95 6.97 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.893 -1.049 . . . . 51.34 109.302 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.03 61.6 3.13 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 124.376 1.048 . . . . 65.33 113.316 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.85 124.27 39.79 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.509 -0.876 . . . . 73.5 111.125 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.6 171.85 8.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.822 -1.081 . . . . 72.41 108.37 -175.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.567 ' CE2' HD11 ' A' ' 496' ' ' ILE . 13.8 p90 -147.73 171.98 14.81 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.972 -1.122 . . . . 73.03 107.972 168.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.9 mt -117.56 142.85 46.71 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.908 -0.775 . . . . 74.42 108.908 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.28 122.23 66.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.753 -1.573 . . . . 44.21 106.753 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 490' ' ' SER . 92.9 m-70 -111.37 139.55 46.69 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.349 0.405 . . . . 75.23 110.322 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.9 mt -101.25 128.19 47.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.869 -1.16 . . . . 71.34 107.869 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.2 m -151.05 -175.3 5.1 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.668 -0.864 . . . . 61.34 108.668 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.2 t30 50.86 83.41 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.694 1.198 . . . . 71.12 111.248 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.27 119.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.774 -0.825 . . . . 54.1 108.774 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -129.14 145.41 51.31 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.794 -0.817 . . . . 32.2 108.794 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.08 134.55 60.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.372 -1.344 . . . . 72.14 107.372 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.484 ' HB3' ' HB ' ' A' ' 404' ' ' THR . 34.1 t -74.41 109.98 8.34 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 109.408 -0.59 . . . . 74.41 109.408 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 14.5 m -91.24 139.38 30.8 Favored 'General case' 0 N--CA 1.409 -2.506 0 N-CA-C 106.353 -1.721 . . . . 71.5 106.353 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.76 157.68 35.87 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.459 -0.496 . . . . 74.32 110.596 -176.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.15 -6.5 53.13 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.269 0.556 . . . . 74.42 110.742 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.9 t -80.78 163.08 23.74 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.612 -1.255 . . . . 72.11 107.612 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -61.72 -55.9 25.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.743 0.306 . . . . 73.23 111.383 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -88.9 86.67 7.0 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 120.527 -0.469 . . . . 71.4 110.069 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -98.2 83.55 0.67 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.724 -0.951 . . . . 32.5 110.724 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.65 126.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 123.074 0.55 . . . . 72.43 110.738 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 84.5 mt -109.65 103.25 12.06 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 107.435 -1.32 . . . . 70.32 107.435 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLU . . . . . 0.505 ' O ' ' HD2' ' A' ' 479' ' ' HIS . 9.6 mp0 -59.39 125.06 22.1 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.444 -0.947 . . . . 74.32 108.444 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -71.08 38.56 0.05 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.485 1.114 . . . . 62.14 112.485 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 476' ' ' GLU . 17.6 m120 -110.15 17.94 20.48 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.906 -1.146 . . . . 64.44 107.906 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.505 ' HD2' ' O ' ' A' ' 476' ' ' GLU . 30.1 p80 -112.09 175.34 5.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.257 -0.883 . . . . 73.32 110.433 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 372' ' ' SER . 16.2 m -101.86 159.04 4.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.855 -0.795 . . . . 72.04 108.855 173.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 35.8 t -172.4 -89.65 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.344 0.658 . . . . 52.03 109.89 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -122.3 -11.22 8.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.975 0.417 . . . . 51.33 111.405 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -94.88 -60.76 1.62 Allowed 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 104.928 -2.249 . . . . 73.43 104.928 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -97.94 128.35 44.46 Favored 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.583 -1.265 . . . . 71.35 107.583 172.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 83.7 m -106.75 -169.67 1.59 Allowed 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 107.819 -1.178 . . . . 73.2 107.819 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.584 HD12 ' HB ' ' A' ' 374' ' ' ILE . 0.6 OUTLIER -70.13 163.9 25.29 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.197 -1.038 . . . . 72.44 108.197 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -82.31 25.04 4.49 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 120.896 -0.668 . . . . 70.44 113.422 -173.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 34.5 m -155.31 177.1 2.17 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.791 -1.189 . . . . 62.15 107.791 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.575 ' N ' ' HA ' ' A' ' 490' ' ' SER . 10.4 Cg_exo -69.91 -22.3 31.59 Favored 'Trans proline' 0 CA--C 1.581 2.864 0 N-CA-C 119.395 2.806 . . . . 54.35 119.395 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.575 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 16.1 m -118.93 123.73 45.33 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 129.544 3.138 . . . . 62.53 106.528 1.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 65.4 m -133.85 106.9 7.55 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.841 0.353 . . . . 63.22 111.939 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.45 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.848 -1.167 . . . . 64.13 107.848 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 30.7 m -103.37 128.62 50.42 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.57 -0.452 . . . . 64.13 110.298 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.471 HG11 HG11 ' A' ' 390' ' ' VAL . 69.9 t -113.36 119.19 60.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.255 -1.017 . . . . 74.34 108.255 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.411 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 7.3 m -107.75 118.2 36.11 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.366 -0.976 . . . . 71.13 108.366 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.567 HD11 ' CE2' ' A' ' 456' ' ' PHE . 4.9 mp -97.74 120.75 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.596 0.712 . . . . 75.42 110.067 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.446 ' O ' HD13 ' A' ' 384' ' ' LEU 0.265 29.3 m-85 -88.0 104.46 16.67 Favored 'General case' 0 N--CA 1.388 -3.537 0 CA-C-O 122.355 1.074 . . . . 72.35 113.262 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.636 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 10.5 t70 -51.5 -55.89 16.43 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 111.748 -2.478 . . . . 71.13 109.064 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.431 ' HA ' ' CA ' ' A' ' 503' ' ' GLY . 32.5 t70 64.98 15.98 10.29 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 125.633 1.573 . . . . 53.2 111.135 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -97.1 -58.61 1.98 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.927 -1.509 . . . . 74.04 106.927 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -97.01 -51.15 4.34 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.748 -1.204 . . . . 72.33 107.748 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 452' ' ' GLU . . . -121.45 124.07 43.58 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.807 -0.633 . . . . 72.54 109.835 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 499' ' ' ASP . . . -138.29 -158.06 7.64 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.31 -0.947 . . . . 61.21 113.012 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.2 pp -150.95 176.5 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 124.142 0.977 . . . . 73.12 110.272 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -71.53 107.32 4.36 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.254 -1.758 . . . . 72.15 106.254 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 8.2 m -83.35 106.85 15.45 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 116.118 -0.492 . . . . 75.11 111.767 -172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -79.64 103.08 9.31 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 104.483 -2.414 . . . . 65.04 104.483 170.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -50.7 132.01 25.93 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 124.315 1.046 . . . . 75.35 113.36 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 115.145 -0.934 . . . . 72.32 110.468 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.64 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.593 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 C--O 1.241 0.638 0 N-CA-C 109.509 -0.552 . . . . 71.21 109.509 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.409 ' HA ' ' HA3' ' A' ' 398' ' ' GLY . 19.5 m -76.01 123.97 26.62 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 108.328 -0.989 . . . . 63.43 108.328 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -112.55 155.89 23.58 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 115.831 -0.622 . . . . 64.13 111.12 -172.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.621 ' HB ' HD12 ' A' ' 486' ' ' LEU . 31.8 mm -114.93 119.14 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.282 -1.747 . . . . 72.21 106.282 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -155.85 164.42 38.54 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.934 -0.306 . . . . 74.44 111.024 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -82.35 153.9 25.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.616 -0.513 . . . . 75.12 109.616 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -62.57 -38.95 92.08 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.226 -0.657 . . . . 75.51 109.226 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -125.37 175.66 7.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.967 -1.015 . . . . 64.03 112.089 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.02 -21.58 10.86 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 115.05 -0.977 . . . . 71.42 111.657 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 30.1 m -135.85 132.4 36.56 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.67 -0.493 . . . . 64.24 109.67 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 46.1 m-85 -122.92 136.79 54.99 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.25 -1.019 . . . . 65.3 108.25 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 495' ' ' THR . 75.1 mt-30 -130.02 143.32 50.73 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.241 -1.022 . . . . 73.15 108.241 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 33.9 t -153.34 165.27 36.28 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.428 -0.952 . . . . 71.1 108.428 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.24 143.0 30.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 122.589 0.356 . . . . 60.41 111.23 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.624 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 12.0 tt0 -59.72 -37.27 78.43 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.876 -0.602 . . . . 71.24 109.672 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.44 8.31 14.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.968 -0.56 . . . . 73.12 112.371 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 32.2 t -89.91 -11.96 40.29 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 119.962 -0.695 . . . . 51.24 110.924 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.38 -53.61 2.43 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.628 -0.796 . . . . 75.14 113.708 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 7.8 p -141.37 164.93 28.91 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.803 0.301 . . . . 64.22 110.697 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.645 HG11 HG11 ' A' ' 494' ' ' VAL . 4.8 p -120.1 127.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.103 -1.073 . . . . 72.11 108.103 172.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.99 124.2 42.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 71.33 110.799 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.448 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.1 mp -116.54 146.74 42.41 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.142 -1.429 . . . . 75.31 107.142 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.6 m -116.59 129.22 56.04 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.309 -0.556 . . . . 43.13 110.624 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.414 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 73.1 mt -98.41 120.54 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 107.675 -1.232 . . . . 74.42 107.675 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 397' ' ' ARG . 49.3 mm -98.62 129.01 49.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 107.436 -1.32 . . . . 73.43 107.436 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -108.64 107.7 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.464 -0.939 . . . . 72.45 108.464 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.508 ' HG3' HG22 ' A' ' 395' ' ' ILE . 59.2 mtt180 -123.84 157.74 33.43 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.041 0.448 . . . . 74.05 111.997 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 372' ' ' SER . . . 124.93 -46.78 1.06 Allowed Glycine 0 CA--C 1.49 -1.5 0 N-CA-C 108.735 -1.746 . . . . 73.12 108.735 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -166.18 162.72 36.27 Favored Glycine 0 N--CA 1.415 -2.713 0 N-CA-C 107.208 -2.357 . . . . 62.41 107.208 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -146.18 121.55 10.29 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 117.842 0.821 . . . . 73.44 109.963 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -147.25 172.57 13.63 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.909 -1.041 . . . . 74.32 109.168 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 24.3 p -71.08 5.23 2.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.625 0.972 . . . . 73.54 113.625 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.24 132.34 47.56 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.67 0.748 . . . . 64.22 111.376 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 19.3 m -92.99 112.38 24.33 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.924 -1.489 . . . . 74.03 110.102 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.61 146.29 16.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.198 -1.365 . . . . 73.54 107.857 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 33.6 m-85 -126.4 127.32 45.29 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.125 -0.694 . . . . 65.41 109.125 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.55 129.75 68.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.695 -1.224 . . . . 64.13 107.695 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 13.7 t70 -96.99 140.6 31.28 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.606 0.241 . . . . 60.41 110.588 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -137.1 152.34 49.9 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.751 -0.379 . . . . 72.52 111.645 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.89 172.86 14.98 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.265 1.426 . . . . 74.03 108.078 174.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.9 p -106.44 161.03 14.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.971 -0.381 . . . . 65.43 109.971 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.2 tp10 -107.65 155.29 20.31 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 122.704 0.401 . . . . 43.31 110.151 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 6.8 m-20 -84.63 1.87 44.21 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 124.021 0.928 . . . . 72.22 112.333 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -11.06 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.499 2.836 0 N-CA-C 117.413 1.725 . . . . 73.25 117.413 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 14.8 t -126.93 17.71 7.28 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 117.73 0.765 . . . . 63.01 110.445 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.88 -162.81 1.63 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.155 -0.475 . . . . 60.2 110.164 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.417 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 63.2 m-20 -135.73 119.72 17.52 Favored 'General case' 0 CA--C 1.485 -1.546 0 CA-C-O 121.344 0.592 . . . . 74.3 111.215 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.91 124.48 27.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.447 -0.946 . . . . 74.31 108.447 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.25 -15.28 43.2 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 110.663 -0.975 . . . . 53.11 110.663 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 18.3 t -114.31 -50.55 2.8 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.17 -0.678 . . . . 54.41 109.17 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.586 ' OD1' 'CA ' ' A' ' 650' ' ' ' CA' . 20.6 m-20 -85.66 -59.66 2.25 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 122.307 1.051 . . . . 63.43 110.354 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.683 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -138.83 162.83 33.82 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.826 -1.079 . . . . 73.45 108.894 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.558 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.9 tt0 -73.82 156.87 37.33 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 124.165 0.915 . . . . 73.14 110.788 -173.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.642 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.2 p90 -89.97 -14.33 34.28 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.175 -0.92 . . . . 74.14 111.448 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.558 ' H ' ' HG2' ' A' ' 423' ' ' GLU . 15.2 t 33.24 66.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.455 1.902 . . . . 74.04 113.127 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.23 111.77 15.79 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.049 0.928 . . . . 72.14 109.592 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -151.76 173.93 30.94 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 120.061 -1.066 . . . . 22.35 111.61 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 9.2 m -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 106.913 -1.514 . . . . 50.23 106.913 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 32.7 t -95.74 120.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.24 -1.022 . . . . 64.24 108.24 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.68 106.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 115.255 -0.884 . . . . 75.4 109.037 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.3 m-85 -82.03 94.21 7.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.153 -0.684 . . . . 72.14 109.153 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.05 167.34 30.03 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 115.048 -0.978 . . . . 63.15 110.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.79 110.52 0.64 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.497 2.131 . . . . 64.13 111.569 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 113.56 -18.7 19.95 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.716 -0.675 . . . . 72.42 112.078 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -83.92 62.37 6.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.305 0.574 . . . . 75.42 111.974 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 m -65.64 -20.94 66.5 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.857 0.836 . . . . 53.32 109.486 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -132.01 135.07 46.26 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.066 -1.457 . . . . 64.3 107.066 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -122.99 147.8 46.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 111.565 0.209 . . . . 74.21 111.565 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -118.41 131.4 56.28 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.299 -0.63 . . . . 61.21 109.299 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.7 pt -120.96 149.4 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.099 -1.074 . . . . 74.31 108.099 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.1 mtt180 -129.49 138.53 51.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-O 120.899 0.381 . . . . 74.02 110.854 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.609 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 63.7 t -104.92 126.57 59.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.667 -0.864 . . . . 74.13 108.667 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -68.29 127.31 23.79 Favored Glycine 0 N--CA 1.433 -1.542 0 O-C-N 124.115 0.884 . . . . 73.25 111.953 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.456 HD12 HG12 ' A' ' 496' ' ' ILE . 43.5 mm -94.6 134.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 106.07 -1.826 . . . . 72.14 106.07 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.3 mt -98.57 144.99 10.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 106.982 -1.488 . . . . 74.4 106.982 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.2 88.3 4.28 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.667 -0.813 . . . . 72.52 111.632 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.74 97.83 5.82 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.875 -2.269 . . . . 52.21 104.875 169.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.59 87.05 2.61 Favored 'General case' 0 CA--C 1.46 -2.511 0 CA-C-O 122.905 1.336 . . . . 74.1 109.856 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.425 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 26.5 mm -116.1 154.48 17.61 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.948 0 CA-C-N 111.688 -2.506 . . . . 75.32 104.575 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -63.97 114.82 4.35 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.386 -1.726 . . . . 71.44 108.62 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.647 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 19.5 mt-10 -135.49 151.93 50.85 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.646 -1.161 . . . . 62.22 108.485 -170.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 502' ' ' ALA . 31.4 mt-10 -131.55 102.1 5.78 Favored 'General case' 0 N--CA 1.411 -2.393 0 C-N-CA 119.583 -0.847 . . . . 72.32 111.165 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 14.3 t70 63.86 61.55 0.95 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 124.704 1.252 . . . . 54.41 111.018 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.41 130.77 40.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.965 -0.562 . . . . 74.2 109.576 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.94 161.86 39.11 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.885 -0.726 . . . . 72.55 109.831 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.609 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 25.1 p90 -140.91 -178.99 5.81 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.98 -0.555 . . . . 70.31 109.711 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.3 mt -120.92 138.9 53.88 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.359 -1.349 . . . . 75.24 107.359 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 491' ' ' THR . 61.1 t -106.33 121.95 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.069 -1.456 . . . . 75.31 107.069 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 412' ' ' GLU . 63.5 m-70 -110.68 128.36 55.67 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.503 0.502 . . . . 73.4 111.023 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.99 131.7 42.09 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.031 -1.1 . . . . 74.24 108.031 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 12.4 p -155.7 -176.81 6.15 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.843 -0.799 . . . . 51.14 108.843 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 2.4 t-20 49.67 81.96 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.176 0.922 . . . . 70.13 112.694 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.516 HG11 HG23 ' A' ' 480' ' ' VAL . 61.8 t -82.12 128.36 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 115.332 -0.849 . . . . 64.13 108.772 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 72.0 tttt -133.32 148.08 51.89 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 106.381 -1.711 . . . . 65.21 106.381 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 474' ' ' ILE . 91.4 t -130.03 154.0 39.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 N-CA-C 107.97 -1.122 . . . . 73.21 107.97 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 32.7 t -74.57 111.85 10.17 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.382 -0.97 . . . . 62.3 108.382 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' SER . . . . . 0.485 ' HA ' ' HB ' ' A' ' 474' ' ' ILE . 18.7 m -76.1 111.24 11.3 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 116.273 -0.422 . . . . 73.41 110.674 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -50.4 -50.16 52.45 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.844 1.053 . . . . 74.22 113.844 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -95.74 -18.99 20.02 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.862 -0.735 . . . . 74.35 111.087 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 49.8 m 62.38 23.24 13.76 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.887 0.875 . . . . 75.22 111.041 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -67.94 -45.27 74.73 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.282 -1.377 . . . . 71.44 107.282 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -148.58 -166.49 2.56 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 104.421 -2.437 . . . . 71.22 104.421 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -84.09 134.13 12.46 Favored Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 110.914 -0.874 . . . . 72.12 110.914 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.598 ' O ' ' HB ' ' A' ' 465' ' ' VAL . 28.0 mm -107.47 132.56 54.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.477 -0.564 . . . . 62.14 109.477 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 99.0 mt -125.24 145.21 50.09 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.764 -1.569 . . . . 74.11 106.764 172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLU . . . . . 0.491 ' HG3' HG11 ' A' ' 465' ' ' VAL . 50.7 mt-10 -91.07 152.59 20.57 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.559 0.578 . . . . 74.11 112.559 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -99.26 -18.58 17.52 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.725 -1.125 . . . . 62.03 108.3 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -75.82 -53.41 8.51 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.77 -1.196 . . . . 71.32 107.77 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -89.72 -171.83 3.33 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.044 -0.98 . . . . 74.32 109.4 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.516 HG23 HG11 ' A' ' 463' ' ' VAL . 34.0 m -77.38 168.5 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.603 -0.726 . . . . 75.23 111.164 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 33.2 p -153.83 -149.5 0.29 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.434 -0.58 . . . . 34.11 109.434 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -100.01 16.7 23.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.047 -1.094 . . . . 73.4 108.047 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.68 -55.42 1.52 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 105.84 -1.911 . . . . 70.45 105.84 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.61 131.86 36.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.646 -1.242 . . . . 70.32 107.646 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.8 -178.46 3.66 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 116.032 -0.531 . . . . 75.25 110.521 -172.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.646 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 0.5 OUTLIER -74.52 -167.17 0.51 Allowed 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 109.807 -0.442 . . . . 54.52 109.807 -176.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -71.97 -130.15 0.11 Allowed Glycine 0 CA--C 1.534 1.263 0 N-CA-C 114.396 0.518 . . . . 54.51 114.396 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.763 ' O ' ' HA ' ' A' ' 490' ' ' SER . 7.0 m -78.01 140.64 62.28 Favored Pre-proline 0 C--N 1.311 -1.087 0 O-C-N 122.174 -0.604 . . . . 63.52 109.931 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.589 ' HA ' ' N ' ' A' ' 491' ' ' THR 2.367 83.7 Cg_exo 90.39 -83.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.531 1 N-CA-C 123.432 4.358 . . . . 65.1 123.432 -174.037 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.763 ' HA ' ' O ' ' A' ' 488' ' ' SER . 6.1 m -86.41 99.31 11.54 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 124.769 1.227 . . . . 74.23 108.754 0.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.589 ' N ' ' HA ' ' A' ' 489' ' ' PRO . 36.0 m -142.84 139.07 30.74 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 115.367 -0.833 . . . . 54.14 111.057 -172.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -125.27 136.68 53.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.441 -1.318 . . . . 75.54 107.441 172.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 28.0 m -89.94 125.82 35.51 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.715 -0.476 . . . . 75.51 109.715 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.645 HG11 HG11 ' A' ' 390' ' ' VAL . 79.2 t -111.83 109.35 28.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.065 -0.717 . . . . 61.43 109.065 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 29.5 m -99.99 122.27 42.63 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.126 -1.064 . . . . 75.55 108.126 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.683 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -101.79 124.23 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 N-CA-C 108.561 -0.903 . . . . 71.34 108.561 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.508 ' CE1' HG13 ' A' ' 504' ' ' ILE 0.277 42.0 m-85 -87.8 111.3 21.22 Favored 'General case' 0 N--CA 1.393 -3.3 0 CA-C-O 122.124 0.964 . . . . 64.25 112.514 178.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.606 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 7.6 m-20 -51.8 -52.41 49.27 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-N 111.882 -2.417 . . . . 72.25 112.364 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.7 t70 76.2 3.82 3.67 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.171 1.544 . . . . 74.41 107.956 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' ASP . . . . . 0.616 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' 0.28 2.6 p30 -93.84 -89.02 0.22 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.632 -1.167 . . . . 74.21 111.533 -177.558 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -81.59 -43.28 18.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.753 -1.573 . . . . 65.12 106.753 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 452' ' ' GLU . . . -82.94 90.0 6.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.151 -0.931 . . . . 40.44 108.756 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -97.98 69.89 0.69 Allowed Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.69 -0.686 . . . . 71.14 113.368 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.508 HG13 ' CE1' ' A' ' 497' ' ' PHE . 47.3 mm -77.66 123.7 34.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.157 -1.053 . . . . 54.54 108.157 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -88.26 134.06 33.89 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.382 0.61 . . . . 41.11 112.139 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.3 t -128.65 152.76 48.01 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.306 -1.368 . . . . 52.12 107.306 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -95.69 113.4 25.04 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.095 -0.705 . . . . 73.4 109.095 -177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.8 99.29 9.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.898 -0.592 . . . . 71.44 110.248 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.308 -1.201 0 N-CA-C 107.113 -1.439 . . . . 75.12 107.113 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.637 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.647 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.487 ' N ' ' HD1' ' A' ' 479' ' ' HIS . 46.5 t . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 108.76 -0.83 . . . . 55.14 108.76 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 44.3 m -152.17 -173.51 4.57 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.95 -1.13 . . . . 70.22 107.95 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -138.86 141.59 38.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.986 -0.746 . . . . 53.21 108.986 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.605 ' HB ' HD12 ' A' ' 486' ' ' LEU . 46.1 mm -114.44 115.75 50.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.695 -1.594 . . . . 73.24 106.695 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.502 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 35.4 p90 -146.54 158.58 43.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 119.012 0.824 . . . . 71.25 112.752 -177.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -70.47 143.1 51.84 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.542 -0.54 . . . . 73.43 109.542 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.71 -39.44 80.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.533 0.683 . . . . 74.5 109.171 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 12.7 mt-30 -122.58 153.71 38.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.432 -0.804 . . . . 71.2 111.34 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.2 -22.82 26.31 Favored Glycine 0 C--N 1.304 -1.24 0 C-N-CA 120.98 -0.629 . . . . 41.4 111.644 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 85.7 m -137.0 135.72 37.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.144 -0.687 . . . . 55.5 109.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 72.0 m-85 -124.96 138.85 54.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.264 -1.013 . . . . 71.23 108.264 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 495' ' ' THR . 39.3 mt-30 -128.93 124.86 36.21 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.888 -0.782 . . . . 73.34 108.888 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' CYS . . . . . 0.573 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -136.49 156.73 48.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.509 -0.552 . . . . 72.4 109.509 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -75.24 144.63 42.48 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 110.174 -0.306 . . . . 63.1 110.174 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 498' ' ' ASP . 51.8 tt0 -61.66 -31.56 71.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.831 0.824 . . . . 70.24 109.92 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.521 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.9 p-10 -84.52 1.74 44.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.891 -1.049 . . . . 73.54 112.698 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 45.8 t -77.0 -19.09 57.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.133 -0.354 . . . . 54.43 111.476 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.13 -61.86 2.19 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.748 -0.739 . . . . 75.11 112.208 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.3 p -136.96 148.97 47.25 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.54 0.17 . . . . 54.31 110.566 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.2 p -106.35 134.06 49.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.1 -1.445 . . . . 63.22 107.1 174.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.13 112.32 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.547 0.689 . . . . 63.41 110.835 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.499 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.9 mp -101.87 153.88 19.44 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.485 -1.302 . . . . 64.34 107.485 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -116.52 132.35 56.7 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.513 -0.475 . . . . 54.21 110.025 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 79.2 mt -104.91 122.86 58.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.186 -1.042 . . . . 73.22 108.186 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.72 127.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.54 -0.911 . . . . 54.44 108.54 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 54.7 ttt180 -113.75 110.1 19.63 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.3 -0.864 . . . . 63.24 109.157 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -116.43 145.13 43.49 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.439 -0.578 . . . . 71.11 109.439 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 170.32 -35.2 0.17 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.383 -0.687 . . . . 60.41 111.383 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 152.36 -136.91 5.63 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 111.001 -0.84 . . . . 72.24 111.001 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.13 120.55 37.7 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 103.612 -2.736 . . . . 75.41 103.612 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 84.4 mt -135.23 98.61 4.02 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 113.318 0.859 . . . . 73.15 113.318 -166.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 40.8 p -93.21 -12.45 30.22 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.147 -0.933 . . . . 71.22 109.367 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -65.06 155.48 34.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.903 -1.044 . . . . 74.11 111.626 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.9 m -105.88 118.13 35.82 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.629 0.728 . . . . 63.43 110.749 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.09 149.68 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.085 -0.961 . . . . 71.54 108.663 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.423 ' CZ ' HG13 ' A' ' 430' ' ' VAL . 22.1 m-85 -127.31 129.38 47.55 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.942 0.497 . . . . 73.15 110.19 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.66 131.1 62.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.897 -0.779 . . . . 75.22 108.897 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 21.5 t70 -99.91 135.43 41.34 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 110.066 -0.346 . . . . 75.11 110.066 -175.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -134.98 165.66 24.82 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 122.093 -0.379 . . . . 72.45 111.158 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.515 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 21.6 ttm180 -166.02 160.19 16.28 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.115 -1.068 . . . . 73.42 108.115 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 72.5 p -96.71 154.96 16.98 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.905 -0.776 . . . . 72.54 108.905 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -115.65 148.49 39.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.734 1.013 . . . . 72.45 113.734 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.79 2.61 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.885 0 C-N-CA 130.722 3.609 . . . . 72.33 114.102 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -20.19 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 125.741 1.638 . . . . 73.42 117.156 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.1 t -136.24 16.19 3.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.117 0.958 . . . . 75.43 109.857 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.32 -164.14 1.52 Allowed 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.103 -1.073 . . . . 41.34 108.103 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -138.98 121.84 16.57 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.212 -0.995 . . . . 74.15 111.527 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -80.82 124.71 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.232 -0.655 . . . . 44.13 109.232 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.18 -27.8 7.56 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.552 -1.819 . . . . 73.11 108.552 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.3 t -106.78 -55.71 2.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.945 -0.627 . . . . 74.21 109.518 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.615 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -80.98 -60.28 2.35 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-O 121.608 0.718 . . . . 74.14 111.112 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.701 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -136.75 166.95 22.39 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.545 -0.909 . . . . 71.25 108.545 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.3 tm-20 -77.72 154.42 32.07 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.638 -0.875 . . . . 74.42 108.638 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.504 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.9 p90 -95.52 -13.23 24.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.97 0.73 . . . . 64.22 112.97 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.502 HG21 HG22 ' A' ' 442' ' ' VAL . 10.1 t 36.01 57.77 0.97 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.364 1.866 . . . . 74.23 113.791 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 10.5 pt-20 -78.51 116.44 18.9 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.741 0.781 . . . . 72.22 108.945 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -157.08 -173.61 25.73 Favored Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 115.313 -0.858 . . . . 71.13 111.194 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 17.9 m -128.54 136.59 50.97 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.327 -1.36 . . . . 61.02 107.327 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.42 127.64 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.745 -1.205 . . . . 62.21 107.745 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.423 HG13 ' CZ ' ' A' ' 406' ' ' PHE . 22.7 t -105.04 106.69 20.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.831 -0.803 . . . . 55.11 108.831 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.9 m-85 -85.3 95.64 9.27 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.707 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 175.08 4.46 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 114.818 -1.083 . . . . 64.32 110.238 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.83 135.2 50.69 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.444 1.43 . . . . 73.42 109.603 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 91.85 -20.09 44.5 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.084 -0.579 . . . . 44.13 112.506 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.45 63.45 4.91 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.294 0.637 . . . . 75.45 110.821 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 m -70.69 -24.92 62.75 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.972 -1.013 . . . . 74.24 108.441 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.68 135.39 42.0 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.18 -0.674 . . . . 74.1 109.18 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -123.05 153.62 39.62 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.945 0.402 . . . . 51.24 111.864 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -113.08 129.82 56.38 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.058 -0.974 . . . . 74.02 109.49 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.403 ' CG1' ' HB2' ' A' ' 392' ' ' LEU . 40.7 pt -117.37 137.28 51.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.294 -1.002 . . . . 61.54 108.294 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 47.0 mtt180 -121.97 136.37 54.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.28 0.562 . . . . 72.22 112.134 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.627 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.6 t -111.12 123.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.299 -1.371 . . . . 74.44 107.299 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -78.68 135.79 16.42 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.856 -0.688 . . . . 62.13 111.996 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.455 HD12 HG12 ' A' ' 496' ' ' ILE . 38.4 mm -94.75 131.29 42.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.602 -1.258 . . . . 73.41 107.602 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.6 mt -93.52 143.17 12.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.322 -2.103 . . . . 75.41 105.322 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.47 86.22 7.31 Favored 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 119.036 -1.065 . . . . 62.31 111.314 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.85 98.44 8.13 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 103.25 -2.87 . . . . 72.33 103.25 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.84 89.29 3.61 Favored 'General case' 0 C--N 1.271 -2.841 0 C-N-CA 117.2 -1.8 . . . . 72.32 110.911 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.426 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -123.2 153.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.449 0 N-CA-C 104.265 -2.494 . . . . 74.52 104.265 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -60.12 114.64 2.97 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.658 -1.217 . . . . 73.23 108.845 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.632 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 21.3 mt-10 -128.46 140.99 51.53 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.717 -0.674 . . . . 74.41 109.555 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -121.15 99.67 6.62 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.313 -0.858 . . . . 75.42 109.546 -173.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.303 4.3 p-10 47.28 61.15 3.03 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.413 1.485 . . . . 64.54 112.794 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.559 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.7 tt0 -74.56 127.93 34.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.817 -1.083 . . . . 63.33 108.684 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.433 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.2 p-10 -145.56 169.09 19.08 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.811 -0.555 . . . . 73.14 111.905 -173.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.627 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 26.2 p90 -143.83 179.48 7.14 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.269 -0.423 . . . . 65.44 110.582 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 37.9 mt -118.08 138.68 52.08 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.724 -1.213 . . . . 74.51 107.724 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 491' ' ' THR . 41.1 t -112.43 126.47 69.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.216 -1.402 . . . . 72.54 107.216 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -119.66 157.07 29.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.407 0.442 . . . . 72.33 110.662 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.73 138.63 50.49 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.456 -0.572 . . . . 70.43 109.456 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.9 p -153.44 -174.3 4.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.023 0.529 . . . . 70.54 109.691 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.7 t30 34.79 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 126.201 1.8 . . . . 65.21 112.85 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.33 127.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 C-N-CA 119.9 -0.72 . . . . 65.45 109.692 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -129.28 150.28 50.72 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.993 -0.743 . . . . 73.41 108.993 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.06 149.39 13.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.701 -1.592 . . . . 73.54 106.701 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.47 ' CB ' ' HB ' ' A' ' 404' ' ' THR . 22.7 t -74.2 128.1 34.66 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.472 0.653 . . . . 45.35 112.397 -174.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 21.9 m -81.37 172.02 14.07 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.817 -1.92 . . . . 72.01 105.817 169.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 72.68 -58.42 0.6 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.076 0.95 . . . . 74.44 111.564 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -67.6 -27.58 67.03 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.089 0.947 . . . . 35.25 109.099 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.2 p -145.35 94.87 2.58 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 113.776 -1.556 . . . . 74.25 107.608 172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -89.44 -20.69 23.61 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.955 -1.02 . . . . 71.41 112.402 -172.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -108.05 -179.83 4.01 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.039 -0.726 . . . . 72.15 109.039 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -83.75 50.94 4.49 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 121.221 0.345 . . . . 61.21 112.624 -174.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.43 109.37 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.991 -1.115 . . . . 64.1 107.991 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.6 mt -82.51 3.27 29.09 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.505 0.669 . . . . 72.1 111.71 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -93.28 -2.53 54.88 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.473 -0.936 . . . . 70.35 108.473 172.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -105.15 -34.31 7.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.246 -0.888 . . . . 73.15 108.907 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -83.66 86.11 7.17 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.767 -1.197 . . . . 54.23 107.767 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.487 ' HD1' ' N ' ' A' ' 371' ' ' VAL . 70.2 m-70 -80.59 -66.39 0.89 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.06 0.934 . . . . 72.34 108.837 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.17 130.51 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.443 0 CA-C-N 114.431 -1.259 . . . . 61.31 108.514 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 32.2 t 149.78 -68.04 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.137 2.175 . . . . 53.55 108.413 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -111.7 14.54 21.17 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.18 -0.464 . . . . 74.55 111.876 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -141.34 -72.05 0.34 Allowed 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 106.074 -1.825 . . . . 75.03 106.074 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -98.1 171.05 8.49 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 109.144 -0.687 . . . . 51.51 109.144 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 45.7 t -125.58 -173.45 2.83 Favored 'General case' 0 C--N 1.27 -2.876 0 N-CA-C 106.086 -1.82 . . . . 64.12 106.086 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.605 HD12 ' HB ' ' A' ' 374' ' ' ILE . 0.5 OUTLIER -75.15 175.6 8.1 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.105 -1.442 . . . . 62.44 107.105 178.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 375' ' ' PHE . . . -63.72 127.46 36.53 Favored Glycine 0 C--O 1.253 1.314 0 N-CA-C 104.179 -3.568 . . . . 72.3 104.179 169.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.591 ' HA ' ' OG ' ' A' ' 490' ' ' SER . 15.4 m -109.15 70.98 0.45 Allowed Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 119.489 3.144 . . . . 41.4 119.489 -164.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.558 ' CD ' ' HA ' ' A' ' 490' ' ' SER . 3.1 Cg_exo -70.09 -61.05 0.06 OUTLIER 'Trans proline' 0 N--CA 1.404 -3.757 0 N-CA-C 109.693 -0.926 . . . . 73.44 109.693 155.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 488' ' ' SER . 49.3 m -119.15 91.66 3.61 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 128.418 2.687 . . . . 72.14 108.117 -2.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.504 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 17.8 m -141.76 138.41 32.29 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 109.686 -0.487 . . . . 64.43 109.686 -175.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -122.75 117.39 25.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.525 -1.657 . . . . 64.01 106.525 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 89.8 m -86.09 119.77 26.75 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.237 0.542 . . . . 61.23 110.573 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.557 HG11 HG11 ' A' ' 390' ' ' VAL . 80.2 t -104.08 108.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.603 -0.888 . . . . 55.04 108.603 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 90.2 m -96.58 121.01 37.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.629 -0.878 . . . . 73.42 108.629 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.94 126.88 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.179 0 CA-C-O 121.502 0.668 . . . . 73.34 109.535 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.59 ' O ' HD13 ' A' ' 384' ' ' LEU . 9.3 m-85 -93.0 104.16 16.4 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-O 121.854 0.835 . . . . 73.43 110.433 173.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.47 ' HB3' ' CG ' ' A' ' 500' ' ' ASP . 8.3 m-20 -56.01 -54.02 49.9 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 112.882 -1.963 . . . . 73.42 113.283 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.7 t70 84.59 -10.98 0.83 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.174 1.79 . . . . 71.24 107.863 -170.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' ASP . . . . . 0.59 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 3.4 p30 -76.29 -70.25 0.46 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.093 -0.958 . . . . 75.11 110.491 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -114.64 -14.43 12.05 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.0 -0.741 . . . . 71.13 109.0 172.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -68.93 104.26 2.03 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.971 -0.752 . . . . 61.31 108.971 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -75.23 72.45 1.65 Allowed Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 118.449 2.14 . . . . 34.54 118.449 -166.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.61 HD13 ' H ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER -91.15 -37.59 9.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 106.253 -1.758 . . . . 74.43 106.253 163.464 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 50.6 p90 179.31 173.49 0.82 Allowed 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 128.66 2.784 . . . . 62.01 105.162 173.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 6.2 m -126.95 105.3 8.52 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.279 -1.008 . . . . 54.54 108.279 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -151.75 98.88 2.53 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 120.087 -0.645 . . . . 74.51 111.844 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 72.37 -37.8 0.4 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.237 1.569 . . . . 62.13 115.237 173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 . . . . . 0 C--N 1.304 -1.395 0 CA-C-N 117.903 0.319 . . . . 64.42 111.36 -175.309 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.618 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.632 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 108.731 -0.84 . . . . 72.54 108.731 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 64.6 m -151.3 160.6 43.71 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.838 -1.171 . . . . 72.12 107.838 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -140.37 130.79 25.31 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 123.614 0.571 . . . . 72.1 109.569 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.522 ' HB ' HD12 ' A' ' 486' ' ' LEU . 39.0 mm -107.16 115.87 49.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.909 -1.886 . . . . 72.54 105.909 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.46 167.11 23.76 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 118.794 0.725 . . . . 60.13 112.487 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -78.68 147.61 33.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.107 -0.701 . . . . 73.0 109.107 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.13 -53.3 39.51 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.569 -0.9 . . . . 71.11 108.569 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -109.8 174.15 6.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.074 -0.512 . . . . 65.31 110.751 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.48 -35.49 2.85 Favored Glycine 0 C--N 1.298 -1.559 0 CA-C-N 115.264 -0.88 . . . . 62.45 111.148 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 23.1 m -121.05 134.74 55.29 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.915 -1.142 . . . . 62.24 107.915 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 61.6 m-85 -124.19 136.34 54.11 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.673 -1.232 . . . . 71.35 107.673 175.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.39 123.59 36.56 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.507 -0.923 . . . . 71.24 108.507 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.2 p -134.33 152.9 52.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.667 -0.494 . . . . 71.14 109.667 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -75.02 152.74 38.68 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.256 -0.646 . . . . 75.4 109.256 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.638 ' OE2' 'CA ' ' A' ' 600' ' ' ' CA' . 29.1 tt0 -65.52 -38.73 90.51 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.06 0.933 . . . . 64.53 109.5 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.464 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.5 p-10 -83.89 16.36 2.85 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.875 -1.057 . . . . 72.2 111.661 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.9 t -84.63 -20.59 31.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.188 0.518 . . . . 61.13 109.632 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.85 -60.37 3.15 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.913 -0.66 . . . . 72.11 111.883 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.53 HG22 ' HA2' ' A' ' 443' ' ' GLY . 9.0 p -143.57 155.97 44.45 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 122.662 0.385 . . . . 50.25 110.209 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -112.82 132.43 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.522 -1.288 . . . . 62.02 107.522 173.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.52 120.14 40.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.197 0.522 . . . . 51.13 110.141 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.8 mp -112.2 142.25 44.9 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.588 -1.264 . . . . 63.41 107.588 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.2 m -106.8 131.14 54.25 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.565 -0.531 . . . . 70.32 109.565 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.3 122.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.869 -1.16 . . . . 64.43 107.869 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.6 mm -98.02 123.95 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.319 -0.993 . . . . 54.23 108.319 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.505 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 51.4 ttt180 -111.02 110.89 21.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.383 -0.826 . . . . 71.32 109.639 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -115.09 168.47 9.91 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.968 -0.56 . . . . 64.22 109.578 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 145.62 -19.09 1.84 Allowed Glycine 0 C--N 1.311 -0.816 0 N-CA-C 111.443 -0.663 . . . . 74.12 111.443 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 139.95 -103.85 0.39 Allowed Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 108.836 -1.705 . . . . 75.04 108.836 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -153.09 120.25 5.83 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 107.387 -1.338 . . . . 71.22 107.387 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 52.6 mt -128.44 121.72 29.64 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.272 -0.571 . . . . 63.25 110.842 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 19.0 p -95.62 0.49 52.87 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-O 122.302 1.049 . . . . 72.42 108.405 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -74.79 159.99 31.27 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.42 -1.326 . . . . 73.31 107.42 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 4.3 m -102.12 121.01 41.39 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.47 0.652 . . . . 43.01 111.687 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.65 142.96 22.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.042 -1.095 . . . . 72.25 108.042 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 464' ' ' LYS . 26.0 m-85 -127.24 129.91 48.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.349 -0.612 . . . . 72.23 109.349 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.27 132.39 66.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.006 -1.109 . . . . 73.42 108.006 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 19.2 t70 -93.3 134.53 35.41 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.75 -0.833 . . . . 71.02 108.75 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -123.06 148.12 45.95 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.923 -0.769 . . . . 74.15 108.923 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 410' ' ' ARG . 6.6 ttm180 -162.93 163.9 26.05 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.292 -1.003 . . . . 61.03 108.292 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 22.1 p -96.69 172.89 7.62 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.903 0.382 . . . . 73.31 111.035 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 4.8 tp10 -133.93 153.96 51.4 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.092 -2.188 . . . . 71.41 105.092 173.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -58.18 -45.02 88.28 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.185 0.809 . . . . 72.41 113.185 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.95 -93.73 0.16 Allowed Glycine 0 C--N 1.293 -1.857 0 CA-C-N 115.667 -0.697 . . . . 53.23 112.03 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.0 t -132.28 9.62 4.42 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.137 0.97 . . . . 72.35 109.007 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -132.14 -159.75 0.99 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.185 -1.783 . . . . 72.2 106.185 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -150.34 113.84 4.95 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.465 -0.894 . . . . 71.14 112.255 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.91 128.82 37.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.265 -0.643 . . . . 34.03 109.265 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.03 -31.63 6.18 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 109.102 -1.599 . . . . 42.43 109.102 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.2 m -110.18 -51.89 2.83 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.106 0.479 . . . . 61.4 109.859 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.625 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.1 m-20 -82.9 -61.43 1.87 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.531 0.682 . . . . 74.23 110.927 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.554 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.2 OUTLIER -132.31 173.42 11.28 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 107.228 -1.397 . . . . 75.21 107.228 -178.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.462 ' HG2' ' H ' ' A' ' 425' ' ' THR . 30.2 tt0 -79.11 148.0 32.54 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.361 -0.607 . . . . 72.24 109.361 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -82.36 -16.93 47.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 113.133 0.79 . . . . 63.21 113.133 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.581 HG21 HG22 ' A' ' 442' ' ' VAL 0.251 14.0 t 35.95 73.11 0.09 Allowed 'General case' 0 CA--C 1.556 1.198 0 O-C-N 125.513 1.758 . . . . 73.34 113.279 -178.117 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.5 130.93 35.76 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.591 -1.186 . . . . 75.23 109.273 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.78 48.53 Favored Glycine 0 CA--C 1.476 -2.35 0 C-N-CA 119.784 -1.198 . . . . 52.41 111.86 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 60.6 m -123.68 138.63 54.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.524 -0.917 . . . . 71.03 108.524 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.39 124.8 49.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.927 -0.768 . . . . 65.22 108.927 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 432' ' ' LYS . 23.4 t -95.3 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.25 109.232 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.505 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 60.5 m-85 -88.78 95.67 10.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.095 0.474 . . . . 73.41 111.236 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 57.3 mtmt -92.7 176.81 2.36 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 114.918 -1.037 . . . . 72.32 110.456 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.5 Cg_exo -56.62 131.71 47.3 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 122.479 2.119 . . . . 72.21 112.353 175.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 98.34 -33.08 6.27 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.845 -0.616 . . . . 70.11 111.985 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.458 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 33.4 mt-10 -82.54 64.15 7.04 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.803 1.241 . . . . 74.34 113.086 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 9.2 t -75.81 -13.01 60.28 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.49 -1.232 . . . . 62.22 109.816 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -135.79 137.12 41.28 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.867 -1.16 . . . . 71.25 107.867 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -130.81 157.87 41.69 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.572 0.225 . . . . 72.43 111.367 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -122.59 137.29 54.94 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.912 -0.585 . . . . 74.34 110.498 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -121.35 145.72 27.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 75.23 108.772 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 60.2 mtm180 -120.42 141.64 49.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.032 0.444 . . . . 71.53 111.097 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.581 HG22 HG21 ' A' ' 425' ' ' THR . 42.0 t -110.72 121.54 63.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.392 -1.336 . . . . 55.22 107.392 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.53 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.15 140.67 30.17 Favored Glycine 0 N--CA 1.433 -1.544 0 O-C-N 123.895 0.747 . . . . 61.52 112.113 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.406 HG23 ' HD1' ' A' ' 422' ' ' TYR . 37.8 mm -101.15 132.56 46.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 106.74 -1.578 . . . . 73.4 106.74 175.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.625 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.9 mt -99.22 151.49 4.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 106.536 -1.653 . . . . 71.44 106.536 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -82.38 86.23 6.76 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.223 -0.991 . . . . 71.04 112.136 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.41 107.59 18.55 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.76 -2.682 . . . . 71.33 103.76 169.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -109.69 84.86 2.0 Allowed 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 117.864 -1.534 . . . . 71.34 109.921 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 47.6 mm -124.37 154.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 111.966 -2.379 . . . . 72.3 105.81 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.19 115.38 4.45 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.428 -1.309 . . . . 62.3 109.018 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.626 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 24.0 mt-10 -126.98 135.75 51.29 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 114.371 -1.286 . . . . 75.01 109.516 -170.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 501' ' ' HIS . 32.8 mt-10 -138.0 117.16 12.61 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.972 -1.013 . . . . 70.25 108.903 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 56.8 29.99 16.98 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.227 1.011 . . . . 72.11 110.97 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -75.38 118.24 18.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.906 -1.146 . . . . 70.13 107.906 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 2.7 p-10 -144.03 167.72 21.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.313 0.578 . . . . 70.5 110.775 -174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.546 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.9 p90 -139.12 -177.49 4.92 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.443 -0.799 . . . . 72.51 109.242 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 30.1 mt -122.13 139.64 53.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.401 -0.963 . . . . 54.33 108.401 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.81 126.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.821 -1.548 . . . . 71.51 106.821 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.62 149.62 41.66 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.164 -0.471 . . . . 53.51 110.672 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.08 124.84 50.25 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.275 -1.75 . . . . 65.35 106.275 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.8 m -144.25 170.91 15.08 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.212 -0.662 . . . . 74.11 109.212 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.13 86.53 0.04 OUTLIER 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.708 1.203 . . . . 63.4 112.525 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 480' ' ' VAL . 61.9 t -80.14 128.82 38.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 119.698 -0.801 . . . . 61.42 108.897 177.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 406' ' ' PHE . 39.9 ttmt -118.54 134.34 55.17 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.088 -1.449 . . . . 72.41 107.088 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 476' ' ' GLU . 13.4 t -125.55 138.22 55.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 119.748 -0.781 . . . . 74.44 109.124 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.8 t -103.39 124.56 48.93 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 116.455 -0.339 . . . . 71.53 110.537 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 23.8 m -84.76 89.7 7.58 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.68 -1.23 . . . . 73.22 107.68 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -97.06 -22.1 16.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.109 -0.496 . . . . 75.11 110.593 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -75.48 -27.4 58.82 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.407 -0.517 . . . . 74.3 111.106 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 34.9 t -164.04 143.52 7.88 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.189 -1.041 . . . . 61.25 108.189 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -95.47 -24.36 16.69 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.085 -1.08 . . . . 62.03 108.085 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -81.96 -50.15 9.47 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.16 -0.927 . . . . 65.32 110.013 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -98.57 137.98 13.6 Favored Glycine 0 N--CA 1.412 -2.966 0 N-CA-C 108.876 -1.689 . . . . 60.14 108.876 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 13.1 tt -75.48 89.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 122.406 1.098 . . . . 74.31 110.106 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 97.0 mt -115.41 96.28 5.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.696 -1.138 . . . . 75.31 108.386 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLU . . . . . 0.522 ' HB2' HG12 ' A' ' 465' ' ' VAL . 0.0 OUTLIER -146.17 -173.21 4.11 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.452 -1.249 . . . . 72.12 111.206 -175.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.92 69.84 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.985 0.735 . . . . 61.31 112.985 -175.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . 0.281 9.0 p30 51.84 -20.88 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 118.049 2.611 . . . . 73.22 118.049 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' A' ' 484' ' ' ALA . 58.3 m170 -51.35 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.538 0.735 . . . . 74.33 112.441 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.485 HG23 HG11 ' A' ' 463' ' ' VAL . 34.1 m -76.77 120.04 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 118.586 -1.246 . . . . 62.21 109.313 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 8.9 p -161.31 -47.83 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.992 -1.003 . . . . 74.44 112.12 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.5 -66.27 0.31 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 112.563 0.579 . . . . 70.44 112.563 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -81.81 -43.31 18.47 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 105.735 -1.95 . . . . 71.44 105.735 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 479' ' ' HIS . . . -91.18 114.7 27.29 Favored 'General case' 0 N--CA 1.387 -3.615 0 N-CA-C 103.465 -2.791 . . . . 64.13 103.465 166.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 37.0 t -134.81 -167.67 2.02 Favored 'General case' 0 C--N 1.249 -3.773 0 N-CA-C 105.203 -2.147 . . . . 54.55 105.203 -173.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.557 ' H ' HD22 ' A' ' 486' ' ' LEU . 1.6 mm? -60.47 145.26 48.99 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.883 -1.155 . . . . 71.04 107.883 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -65.31 -43.39 95.22 Favored Glycine 0 CA--C 1.505 -0.583 0 C-N-CA 120.808 -0.71 . . . . 61.12 111.793 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 8.2 m -80.56 167.67 31.13 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 107.976 -1.12 . . . . 62.51 107.976 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.58 ' N ' ' HA ' ' A' ' 490' ' ' SER . 1.6 Cg_endo -43.3 -41.54 10.1 Favored 'Trans proline' 0 CA--C 1.591 3.342 0 N-CA-C 119.294 2.767 . . . . 52.42 119.294 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.58 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 50.6 m -107.22 124.5 49.84 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 127.04 2.136 . . . . 74.32 109.215 2.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 29.4 m -133.45 105.72 7.07 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 108.381 -0.97 . . . . 73.44 108.381 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -104.78 131.82 51.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.618 -1.252 . . . . 50.23 107.618 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.7 m -98.86 121.86 41.35 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 120.481 -0.488 . . . . 70.11 110.338 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 86.9 t -109.01 106.06 19.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.798 -0.816 . . . . 70.44 108.798 177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 93.9 m -95.83 115.3 27.22 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.861 -1.162 . . . . 72.33 107.861 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.541 HD13 ' CZ ' ' A' ' 422' ' ' TYR . 4.9 mp -88.6 107.88 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 C-N-CA 119.896 -0.722 . . . . 52.44 109.867 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 38.2 m-85 -78.01 92.4 4.34 Favored 'General case' 0 CA--C 1.446 -3.044 0 N-CA-C 106.37 -1.715 . . . . 75.44 106.37 169.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.601 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 1.1 p-10 -82.79 -19.87 36.91 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 114.241 -1.345 . . . . 71.22 108.905 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.8 t70 63.75 37.82 9.65 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 112.985 -1.916 . . . . 71.11 110.565 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' ASP . . . . . 0.62 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 2.2 m-20 -81.9 -50.33 9.3 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 118.373 -1.331 . . . . 72.23 108.659 172.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.477 ' HB3' ' HG2' ' A' ' 452' ' ' GLU . 23.9 t-80 -139.27 84.34 1.99 Allowed 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.761 -1.199 . . . . 74.21 107.761 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -143.37 -47.04 0.29 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.439 -0.8 . . . . 74.32 111.019 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 98.22 44.85 2.49 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.502 -0.856 . . . . 71.43 112.236 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 49.5 mm -89.34 140.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.466 -0.938 . . . . 72.22 108.466 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 74.08 18.71 3.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.843 1.257 . . . . 75.23 110.178 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.3 t -156.66 -159.9 0.92 Allowed 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.781 -1.192 . . . . 72.23 107.781 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -54.96 126.34 24.11 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.691 0.997 . . . . 73.42 113.691 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.87 160.67 33.78 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.161 -1.052 . . . . 73.12 108.161 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--N 1.292 -1.912 0 O-C-N 123.409 0.443 . . . . 52.02 109.922 177.826 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.638 'CA ' ' OE2' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.616 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 108.472 -0.936 . . . . 73.51 108.472 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 20.6 m -78.63 141.27 38.14 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.689 -0.486 . . . . 70.31 109.689 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.0 mmtp -132.76 128.67 37.35 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.899 -0.408 . . . . 73.34 109.899 176.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.554 ' HB ' HD12 ' A' ' 486' ' ' LEU . 35.6 mm -110.04 119.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.313 -1.366 . . . . 63.3 107.313 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.412 ' HB3' ' CA ' ' A' ' 487' ' ' GLY . 32.6 p90 -156.43 161.68 40.06 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 118.443 0.565 . . . . 64.44 112.305 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.17 145.04 40.17 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.133 -0.321 . . . . 73.2 110.133 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.89 -44.28 90.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.395 0.617 . . . . 72.3 109.359 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 14.4 mm100 -107.17 171.11 7.56 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.412 -0.813 . . . . 51.4 111.236 177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -105.62 -25.66 6.49 Favored Glycine 0 C--N 1.289 -2.063 0 N-CA-C 109.63 -1.388 . . . . 73.32 109.63 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 493' ' ' THR . 24.0 m -135.94 140.22 43.84 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.694 -1.225 . . . . 65.44 107.694 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 91.7 m-85 -129.13 136.69 50.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.31 -0.996 . . . . 74.43 108.31 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.66 134.45 53.74 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.131 -0.692 . . . . 74.31 109.131 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 31.7 t -148.69 165.03 32.57 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.486 -1.301 . . . . 72.35 107.486 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -84.4 143.54 29.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.627 0.603 . . . . 72.15 112.627 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.626 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 15.7 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.182 -0.917 . . . . 61.01 109.975 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.64 14.19 13.98 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.351 0.5 . . . . 71.31 112.351 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.78 -16.32 34.49 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.994 -0.441 . . . . 64.05 111.268 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.21 -68.77 0.37 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.527 -0.844 . . . . 74.33 112.405 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.522 HG22 ' HA2' ' A' ' 443' ' ' GLY . 16.7 p -135.18 161.68 34.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.094 0.473 . . . . 65.31 110.714 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 494' ' ' VAL . 5.7 p -112.5 129.13 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 107.842 -1.17 . . . . 71.04 107.842 172.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.78 120.85 40.39 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.603 0.564 . . . . 74.22 110.306 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.09 141.8 45.32 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.647 -1.242 . . . . 70.04 107.647 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -105.3 129.01 53.74 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.81 -0.441 . . . . 63.13 109.81 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.8 122.64 55.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.164 -1.05 . . . . 73.44 108.164 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.2 mm -94.43 132.36 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 C-N-CA 124.259 1.024 . . . . 70.44 108.456 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 60.6 ttt180 -115.6 111.23 20.36 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.293 -0.867 . . . . 70.41 109.788 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -101.63 167.46 10.1 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.129 -0.941 . . . . 72.01 109.044 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 123.13 -17.01 8.09 Favored Glycine 0 C--N 1.303 -1.299 0 N-CA-C 110.715 -0.954 . . . . 70.31 110.715 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 117.15 -141.84 16.94 Favored Glycine 0 N--CA 1.419 -2.474 0 N-CA-C 111.335 -0.706 . . . . 54.5 111.335 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.03 120.97 34.91 Favored 'General case' 0 CA--C 1.471 -2.092 0 N-CA-C 108.83 -0.804 . . . . 73.23 108.83 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 74.3 mt -143.27 136.11 27.69 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 114.486 -1.233 . . . . 72.35 108.009 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 58.7 p -82.42 6.25 17.82 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.498 0.666 . . . . 54.43 110.291 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -58.59 152.56 18.15 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.578 1.151 . . . . 74.21 109.03 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 25.3 m -118.59 111.95 19.24 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-O 121.561 0.696 . . . . 74.22 110.684 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 55.8 t -104.68 143.2 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 114.428 -1.26 . . . . 71.14 108.618 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 47.4 m-85 -126.22 112.77 16.14 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.544 -0.909 . . . . 64.34 108.544 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.6 124.66 71.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.1 -0.704 . . . . 73.54 109.1 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -87.41 140.49 29.48 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.094 -0.706 . . . . 73.22 109.094 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -142.83 154.66 44.38 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.44 -0.788 . . . . 74.12 111.69 -175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 426' ' ' GLU . 56.0 mtt85 -154.6 165.58 36.05 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 125.144 1.378 . . . . 63.44 109.27 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.607 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 58.5 p -100.97 158.05 16.29 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.647 -0.706 . . . . 70.34 109.262 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 8.2 tp10 -106.02 163.92 12.38 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.006 -1.85 . . . . 75.53 106.006 176.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.8 p-10 -60.29 -40.1 89.25 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.626 0.726 . . . . 70.15 110.559 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.76 -89.26 0.3 Allowed Glycine 0 C--N 1.299 -1.514 0 CA-C-N 114.737 -1.119 . . . . 73.44 110.456 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.433 ' CG2' ' H ' ' A' ' 455' ' ' ASN . 9.6 t -131.57 -1.09 3.9 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 122.093 0.949 . . . . 43.34 109.212 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -129.5 -154.84 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.254 -1.017 . . . . 73.12 108.254 -173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.41 125.6 20.06 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.101 0.477 . . . . 54.54 110.822 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -73.32 128.45 35.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.237 -0.653 . . . . 40.32 109.237 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.27 -13.08 48.34 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 110.522 -1.031 . . . . 24.24 110.522 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.4 m -117.64 -56.49 2.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.17 0.51 . . . . 72.34 109.67 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 38.1 m-20 -85.23 -57.64 3.0 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 122.174 0.988 . . . . 74.41 109.663 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.635 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -139.95 165.01 28.47 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.275 -0.875 . . . . 74.05 110.638 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.3 tt0 -73.82 149.16 41.82 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 124.057 0.848 . . . . 62.02 110.836 -173.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.607 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.3 OUTLIER -79.85 -16.29 55.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 73.5 111.818 176.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.608 HG21 HG22 ' A' ' 442' ' ' VAL 0.259 8.9 t 35.05 63.91 0.46 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 126.412 1.885 . . . . 72.24 113.622 -177.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' A' ' 410' ' ' ARG . 21.5 pt-20 -79.2 126.36 30.65 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.427 -0.806 . . . . 74.15 109.084 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -170.14 -173.2 37.32 Favored Glycine 0 N--CA 1.41 -3.065 0 N-CA-C 110.672 -0.971 . . . . 60.52 110.672 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 40.8 m -127.22 139.98 52.55 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.382 -0.97 . . . . 70.51 108.382 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.76 117.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.051 -1.092 . . . . 71.41 108.051 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.0 t -92.75 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.525 -0.761 . . . . 53.41 110.009 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.9 m-85 -91.82 94.46 9.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.129 -0.487 . . . . 74.33 110.053 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.2 mttm -82.79 174.93 5.31 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.073 -0.967 . . . . 64.33 110.296 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.2 Cg_exo -59.75 133.45 51.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 70.14 109.639 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.8 -18.8 48.88 Favored Glycine 0 C--N 1.305 -1.175 0 C-N-CA 120.564 -0.827 . . . . 44.11 113.199 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.83 63.99 7.22 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.24 0.616 . . . . 63.54 112.275 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 7.6 m -68.46 -19.27 64.55 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.182 -0.917 . . . . 73.24 109.113 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -138.28 137.78 37.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.294 -1.002 . . . . 72.33 108.294 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -124.48 151.66 44.32 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.485 -0.325 . . . . 74.02 111.028 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.76 138.99 48.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.964 -0.562 . . . . 64.11 109.946 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.51 133.9 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.445 -0.576 . . . . 74.3 109.445 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 24.5 mmt180 -104.55 133.02 50.12 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.636 -0.711 . . . . 73.04 111.123 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.685 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -110.55 124.21 67.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.14 -1.43 . . . . 64.31 107.14 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.7 133.86 19.77 Favored Glycine 0 N--CA 1.428 -1.841 0 O-C-N 123.903 0.752 . . . . 35.41 112.343 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 496' ' ' ILE . 34.7 mm -95.19 134.31 33.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 105.966 -1.865 . . . . 74.34 105.966 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 78.2 mt -97.03 143.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 107.732 -1.21 . . . . 64.32 107.732 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.87 95.03 0.66 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.544 0.688 . . . . 72.23 110.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.06 102.84 7.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 104.774 -2.306 . . . . 63.24 104.774 169.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -106.55 89.85 3.16 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.116 -1.434 . . . . 62.31 109.697 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.2 mm -129.63 155.57 41.43 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.28 0 CA-C-N 112.108 -2.315 . . . . 44.42 105.244 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.25 115.22 4.34 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 117.713 -1.595 . . . . 75.02 106.963 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.637 ' OE1' 'CA ' ' A' ' 650' ' ' ' CA' . 20.5 mt-10 -126.1 136.55 53.04 Favored 'General case' 0 CA--C 1.468 -2.178 0 CA-C-N 114.843 -1.071 . . . . 73.13 108.653 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 502' ' ' ALA . 30.4 mt-10 -128.94 106.56 8.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.31 0.576 . . . . 63.3 110.35 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 54.74 60.67 3.36 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 125.316 1.446 . . . . 62.1 114.004 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.47 117.44 17.27 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.7 -0.852 . . . . 71.42 108.7 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.433 ' H ' ' CG2' ' A' ' 415' ' ' THR . 8.5 p30 -140.48 145.48 36.97 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.665 0.745 . . . . 74.34 110.115 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.685 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 22.3 p90 -123.81 174.3 7.61 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.612 -1.176 . . . . 74.15 109.124 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.3 mt -120.7 136.14 54.94 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 107.072 -1.455 . . . . 75.23 107.072 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.65 126.17 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.625 -1.25 . . . . 75.3 107.625 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -121.56 140.98 51.53 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.617 0.573 . . . . 74.23 110.007 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.92 138.8 33.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.973 -1.121 . . . . 74.43 107.973 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 14.9 m -146.55 177.16 9.27 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.16 -1.052 . . . . 72.11 108.16 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 46.3 t30 40.8 83.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.727 0 C-N-CA 125.112 1.365 . . . . 54.53 113.42 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.37 134.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.688 -0.687 . . . . 72.44 109.16 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 23.3 ttmm -139.75 157.96 44.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.016 -1.105 . . . . 74.44 108.016 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 69.9 t -141.84 155.6 19.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.67 -1.604 . . . . 75.45 106.67 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.485 ' HG ' ' HE1' ' A' ' 406' ' ' PHE . 70.6 m -72.52 109.77 6.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.683 -1.229 . . . . 74.42 107.683 175.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 32.8 m -62.68 116.69 5.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.698 -1.137 . . . . 34.42 112.289 -173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -122.75 135.92 54.71 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.509 -1.663 . . . . 73.31 106.509 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -60.89 -20.41 61.94 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.132 0.492 . . . . 72.44 112.174 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 27.5 t -81.1 82.38 7.05 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 108.073 -1.084 . . . . 42.33 108.073 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -100.77 -19.68 15.89 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.855 -0.612 . . . . 75.35 110.694 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 13.4 t70 78.26 -39.43 0.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.038 1.335 . . . . 62.1 110.872 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 177.32 160.28 23.85 Favored Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 106.678 -2.569 . . . . 54.24 106.678 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 49.4 mm -78.29 76.38 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 118.865 1.333 . . . . 64.12 109.614 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 95.1 mt -155.75 99.51 2.01 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 126.678 1.991 . . . . 75.2 106.078 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLU . . . . . 0.427 ' HB2' ' OG ' ' A' ' 481' ' ' SER . 35.5 mt-10 -91.81 75.95 5.64 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.411 0.624 . . . . 70.44 109.334 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -103.98 -24.11 13.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.454 -0.794 . . . . 73.03 110.826 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -65.62 -42.36 91.63 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.817 0.818 . . . . 75.23 109.448 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -123.05 153.6 39.65 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.265 -1.334 . . . . 75.25 108.779 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.56 ' HA ' ' HB3' ' A' ' 484' ' ' ALA . 31.4 m -64.95 150.29 10.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.975 0.416 . . . . 63.25 112.015 -177.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 476' ' ' GLU . 35.5 p -165.65 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.494 -0.776 . . . . 70.12 109.954 -177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.61 6.31 2.48 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.292 -1.373 . . . . 73.54 107.292 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.12 -62.86 1.29 Allowed 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 103.1 -2.926 . . . . 54.32 103.1 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 480' ' ' VAL . . . -93.92 142.39 27.43 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 106.219 -1.771 . . . . 42.03 106.219 170.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 15.2 p -128.47 -170.52 2.27 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 122.392 0.277 . . . . 63.51 111.087 -174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.554 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.8 mm? -77.37 151.94 34.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.006 0.431 . . . . 74.32 110.271 -177.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.412 ' CA ' ' HB3' ' A' ' 375' ' ' PHE . . . -77.95 -25.13 62.82 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 110.986 -0.846 . . . . 73.4 110.986 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.474 ' C ' ' HA ' ' A' ' 490' ' ' SER . 37.8 m -78.97 157.15 76.55 Favored Pre-proline 0 N--CA 1.429 -1.492 0 N-CA-C 108.031 -1.1 . . . . 71.23 108.031 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.648 ' N ' ' HA ' ' A' ' 490' ' ' SER . 72.6 Cg_endo -73.19 -10.71 24.57 Favored 'Trans proline' 0 CA--C 1.594 3.5 0 N-CA-C 120.683 3.301 . . . . 61.51 120.683 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.648 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 19.6 m -116.4 104.04 11.06 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 123.742 2.974 . . . . 72.21 108.137 -0.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 48.8 m -135.14 115.95 13.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 110.002 -0.37 . . . . 73.13 110.002 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.37 27.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.244 -1.021 . . . . 71.12 108.244 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 380' ' ' THR . 30.8 m -86.0 121.26 28.37 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.876 0.37 . . . . 65.32 110.486 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 390' ' ' VAL . 73.6 t -107.25 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.411 -0.959 . . . . 65.33 108.411 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 24.5 m -98.14 112.85 24.67 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.815 -1.18 . . . . 75.21 107.815 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.635 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.59 121.63 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 N-CA-C 109.212 -0.662 . . . . 72.24 109.212 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.436 ' O ' HD13 ' A' ' 384' ' ' LEU 0.29 23.3 m-85 -81.87 99.95 9.33 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-O 122.652 1.215 . . . . 71.21 112.459 177.028 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 4.7 t70 -49.89 -52.11 35.46 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 111.042 -2.799 . . . . 64.31 109.862 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.1 t70 65.94 6.47 4.06 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.018 1.727 . . . . 61.15 111.317 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' ASP . . . . . 0.615 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 58.4 m-20 -92.28 -56.0 3.21 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.911 -1.515 . . . . 75.1 106.911 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -116.75 -31.77 5.36 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.658 -1.156 . . . . 74.34 108.051 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 452' ' ' GLU . . . -118.12 104.15 10.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.318 -0.553 . . . . 70.34 111.736 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -105.81 179.83 23.44 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 111.5 -0.64 . . . . 71.22 111.5 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 58.4 mt -67.22 141.62 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 122.988 0.515 . . . . 72.33 109.939 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -90.21 93.67 9.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 110.001 -0.37 . . . . 61.44 110.001 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 90.8 m 63.76 95.98 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.21 1.189 . . . . 74.11 114.21 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -160.78 113.51 1.98 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.587 -0.733 . . . . 72.55 109.25 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -147.69 162.16 39.74 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.104 -1.072 . . . . 73.41 108.104 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.295 -1.785 0 O-C-N 123.14 0.275 . . . . 73.12 110.407 -177.741 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.635 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.637 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.387 0.613 . . . . 72.33 110.668 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 479' ' ' HIS . 15.4 m -84.41 94.54 8.53 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.488 0.661 . . . . 51.25 112.76 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.432 ' HD3' ' HA2' ' A' ' 487' ' ' GLY . 51.7 mttm -130.55 166.02 21.48 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.965 -0.561 . . . . 72.42 110.509 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 25.5 mm -115.36 124.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 107.421 -1.325 . . . . 64.21 107.421 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -155.64 -177.8 6.82 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 110.025 -0.361 . . . . 64.45 110.025 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -94.33 162.37 13.86 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.146 0.498 . . . . 63.02 112.054 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.11 -35.47 56.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.239 -0.891 . . . . 70.11 109.854 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 23.1 mm-40 -122.38 172.31 8.42 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.386 -0.825 . . . . 70.35 111.966 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -103.01 -37.18 3.21 Favored Glycine 0 C--N 1.293 -1.845 0 CA-C-N 114.465 -1.243 . . . . 65.35 110.025 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' THR . . . . . 0.456 HG23 ' HB ' ' A' ' 493' ' ' THR . 26.0 m -133.02 130.98 40.15 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.452 0.644 . . . . 74.32 109.439 176.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 74.7 m-85 -113.43 143.9 43.71 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.112 -1.07 . . . . 71.12 108.112 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 495' ' ' THR . 15.7 mp0 -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.705 -0.85 . . . . 71.34 108.705 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 30.3 t -148.13 165.11 31.84 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.686 -0.857 . . . . 71.32 108.686 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.7 mm? -89.07 141.46 28.48 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 122.457 0.303 . . . . 60.15 110.617 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.627 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 9.6 tt0 -56.88 -35.73 69.27 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 122.163 0.982 . . . . 74.52 109.605 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -74.26 -7.83 54.12 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.897 -1.502 . . . . 73.3 111.4 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.57 -22.85 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.011 0.434 . . . . 54.25 111.239 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.14 -51.48 2.48 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.177 -1.011 . . . . 44.22 112.493 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 17.2 p -138.12 160.75 38.58 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.073 0.463 . . . . 54.22 111.175 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.6 p -116.5 132.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.126 -1.435 . . . . 71.35 107.126 172.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -104.06 115.54 30.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.405 0.621 . . . . 54.35 110.36 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.1 mp -105.65 147.43 28.49 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.825 -1.176 . . . . 71.55 107.825 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.7 m -108.76 129.45 55.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.489 -0.559 . . . . 75.23 109.489 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.1 mt -97.98 119.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.465 -1.309 . . . . 74.32 107.465 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.17 121.6 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.473 -0.785 . . . . 55.24 109.324 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.44 129.93 55.87 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.222 -1.399 . . . . 73.54 107.222 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -106.7 167.28 9.97 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.389 -0.597 . . . . 74.11 109.389 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 142.58 -16.93 2.44 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.765 -0.731 . . . . 62.22 112.1 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 94.19 -95.12 1.89 Allowed Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 109.766 -1.334 . . . . 45.44 109.766 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -129.56 119.7 24.1 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 108.752 -0.833 . . . . 74.24 108.752 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 79.7 mt -146.21 103.49 3.72 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.431 -0.951 . . . . 64.12 108.431 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 35.0 p -83.59 -1.09 53.08 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.635 0.731 . . . . 52.1 110.469 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -61.63 136.1 57.88 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 125.51 1.524 . . . . 64.33 108.681 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 33.4 m -85.04 113.72 21.66 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.336 0.588 . . . . 73.43 110.14 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 479' ' ' HIS . 57.7 t -112.98 148.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.675 -0.693 . . . . 70.33 109.501 -177.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.465 ' CE1' HG13 ' A' ' 430' ' ' VAL . 4.1 m-85 -123.55 132.62 53.95 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.821 0.849 . . . . 64.54 110.137 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.23 134.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.563 -1.273 . . . . 70.41 107.563 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.509 ' CB ' ' HB3' ' A' ' 462' ' ' ASN . 11.6 t70 -105.58 146.21 29.94 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.924 -0.485 . . . . 65.24 109.998 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -143.35 164.0 31.48 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.748 0.309 . . . . 62.24 110.257 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 17.2 ttp180 -166.42 169.28 14.12 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.693 -1.965 . . . . 73.13 105.693 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 68.5 p -96.72 145.9 25.37 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.303 0.573 . . . . 72.42 110.537 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 12.1 tp10 -108.67 133.75 52.33 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.929 -1.878 . . . . 73.13 105.929 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 64.2 m-20 -42.69 -52.66 4.82 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.112 1.365 . . . . 63.45 114.24 -173.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 74.57 -90.9 0.75 Allowed Glycine 0 C--N 1.285 -2.28 0 CA-C-N 114.975 -1.011 . . . . 63.45 110.918 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 455' ' ' ASN . 9.4 t -124.86 -13.86 6.82 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.703 -0.851 . . . . 72.01 108.703 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -105.86 -165.98 1.16 Allowed 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.288 -1.375 . . . . 74.51 107.288 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.52 115.87 10.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.116 -0.634 . . . . 60.41 110.62 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -72.56 138.51 46.92 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.809 -0.812 . . . . 73.12 108.809 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 97.85 -10.84 64.38 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.252 -1.139 . . . . 53.3 110.252 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 35.0 t -126.45 -56.09 1.42 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.792 -0.447 . . . . 64.41 109.792 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.593 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 13.6 m-20 -78.61 -54.88 5.66 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-O 121.541 0.686 . . . . 63.22 109.406 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.613 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -138.61 171.55 14.18 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 108.41 -0.959 . . . . 75.25 108.41 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.1 tm-20 -77.83 161.41 27.66 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.88 -1.156 . . . . 65.52 107.88 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.483 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 8.0 p90 -99.49 -12.98 19.69 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 112.451 0.538 . . . . 73.24 112.451 -174.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.485 HG21 HG22 ' A' ' 442' ' ' VAL 0.273 11.5 t 37.27 73.84 0.09 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.227 1.811 . . . . 65.41 113.449 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 0.6 OUTLIER -79.71 138.31 37.29 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.397 -1.274 . . . . 64.14 108.755 177.551 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 179.66 169.31 39.81 Favored Glycine 0 N--CA 1.413 -2.863 0 C-N-CA 118.777 -1.678 . . . . 70.13 112.205 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 5.9 m -117.41 133.67 55.71 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 106.69 -1.596 . . . . 63.34 106.69 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.2 t -96.14 119.85 44.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.745 -0.835 . . . . 70.13 108.745 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.465 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.0 t -95.73 117.44 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 71.22 108.941 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.9 m-85 -89.77 110.32 21.24 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 116.056 -0.52 . . . . 63.35 111.291 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 164.82 23.31 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.476 -0.784 . . . . 71.42 110.359 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -52.28 113.57 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.664 2.243 . . . . 72.15 112.236 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.58 25.29 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 111.134 -0.787 . . . . 73.11 111.134 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -81.85 63.23 6.01 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 123.533 0.733 . . . . 63.14 110.514 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 11.3 t -79.19 -7.69 58.43 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.874 -1.158 . . . . 71.52 107.874 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -136.92 137.09 39.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.905 -1.517 . . . . 75.54 106.905 172.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -125.98 153.23 44.62 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 111.596 0.221 . . . . 70.42 111.596 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -112.48 132.5 55.04 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.475 -0.565 . . . . 53.22 109.475 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 41.1 pt -127.07 146.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.255 -1.017 . . . . 64.42 108.255 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 52.5 mtt180 -125.8 145.56 50.16 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.133 0.492 . . . . 71.25 111.886 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 425' ' ' THR . 48.9 t -113.42 124.05 69.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.269 -1.382 . . . . 74.21 107.269 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -76.05 137.05 20.78 Favored Glycine 0 N--CA 1.435 -1.428 0 O-C-N 123.816 0.698 . . . . 73.52 111.866 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.507 HD12 HG12 ' A' ' 496' ' ' ILE . 36.8 mm -96.8 132.28 41.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.014 -0.735 . . . . 65.33 109.014 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.5 mt -94.53 149.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.541 -1.651 . . . . 34.23 106.541 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 86.9 5.38 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.471 -0.491 . . . . 75.11 111.868 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.64 120.99 43.43 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 104.717 -2.327 . . . . 73.01 104.717 172.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.605 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.289 4.0 t70 -118.35 90.2 3.28 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 116.046 -2.262 . . . . 72.32 112.398 178.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.731 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.2 mm -120.21 155.62 23.24 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 110.747 -2.933 . . . . 74.52 104.041 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -54.26 114.84 1.78 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.602 -1.629 . . . . 71.01 106.602 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 47.4 mt-10 -107.42 98.34 7.97 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.564 1.173 . . . . 71.21 112.676 -171.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -112.58 108.47 17.57 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.673 -2.058 . . . . 71.03 107.681 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 42.07 60.56 2.23 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.99 1.431 . . . . 52.11 111.256 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.407 ' OE2' ' HG2' ' A' ' 451' ' ' GLU . 12.0 tt0 -89.15 107.22 18.93 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.914 -1.513 . . . . 63.51 106.914 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.3 OUTLIER -136.92 159.98 40.27 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 114.684 1.364 . . . . 55.02 114.684 -175.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 412' ' ' GLU . 34.0 p90 -132.97 177.61 7.52 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.359 -1.291 . . . . 74.44 108.613 174.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.47 136.99 54.58 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.82 -0.808 . . . . 75.42 108.82 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 41.0 t -108.84 125.87 65.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.277 -1.009 . . . . 73.41 108.277 176.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -120.68 152.98 37.54 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.923 -0.581 . . . . 72.32 109.561 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 72.9 mt -109.19 140.61 42.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.465 -0.569 . . . . 70.33 109.465 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.7 m -152.54 -173.13 4.45 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.592 0.757 . . . . 43.13 108.961 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' ASN . . . . . 0.509 ' HB3' ' CB ' ' A' ' 408' ' ' ASP . 3.0 t30 48.89 81.28 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.95 1.3 . . . . 65.43 111.267 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.09 128.0 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.879 -1.156 . . . . 72.24 107.879 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 88.0 tttt -144.51 141.97 29.9 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-O 121.163 0.506 . . . . 75.0 111.185 -174.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 29.2 t -110.39 146.69 15.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.542 -2.022 . . . . 61.54 105.542 175.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.4 t -103.06 120.61 40.98 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.611 -0.835 . . . . 63.14 112.249 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 48.0 t -129.28 132.89 47.26 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.347 -2.464 . . . . 74.13 104.347 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.51 -33.7 18.88 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.366 -0.534 . . . . 63.52 112.128 -172.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -103.14 -39.81 6.71 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.446 0.535 . . . . 62.21 112.446 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 47.2 t -96.48 128.02 43.02 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.167 0.508 . . . . 74.44 111.48 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -71.0 -28.6 64.54 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.847 -0.798 . . . . 73.11 108.847 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -101.16 15.89 27.25 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 115.424 -0.807 . . . . 52.15 112.226 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -81.79 44.97 3.2 Favored Glycine 0 C--N 1.315 -0.596 0 N-CA-C 110.8 -0.92 . . . . 71.13 110.8 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.482 HG22 ' OG ' ' A' ' 481' ' ' SER . 14.9 mm -126.26 30.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 106.255 -1.758 . . . . 75.32 106.255 -174.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 76.1 mt -82.28 -20.62 37.14 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.918 -1.037 . . . . 42.23 111.944 -173.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -72.6 87.73 1.23 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 122.432 1.11 . . . . 71.14 112.254 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -87.81 -11.91 46.57 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.862 -1.063 . . . . 62.51 108.902 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -52.2 -45.82 65.35 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.666 -1.152 . . . . 74.03 110.65 176.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 372' ' ' SER . 0.9 OUTLIER -82.5 -97.04 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.151 -1.426 . . . . 74.34 107.151 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.48 145.71 18.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 104.483 -2.414 . . . . 72.43 104.483 171.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.503 ' H ' ' HB3' ' A' ' 484' ' ' ALA . 37.4 t -146.48 176.75 9.57 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.517 -0.92 . . . . 41.21 108.517 -175.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -77.1 72.38 3.64 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.365 0.602 . . . . 73.33 110.136 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 179.13 -38.74 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 104.902 -2.259 . . . . 72.53 104.902 -176.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.503 ' HB3' ' H ' ' A' ' 481' ' ' SER . . . -90.59 -178.59 5.34 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.006 -1.452 . . . . 73.42 109.563 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 69.1 m -131.52 -177.62 4.49 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.864 -1.161 . . . . 73.3 107.864 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.496 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 1.6 mm? -87.98 -159.53 0.55 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.252 -0.648 . . . . 73.02 109.252 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.432 ' HA2' ' HD3' ' A' ' 373' ' ' LYS . . . -70.76 134.59 23.99 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 104.838 -3.305 . . . . 73.43 104.838 170.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.613 ' HA ' ' OG ' ' A' ' 490' ' ' SER . 14.5 m -115.56 77.56 6.11 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 118.075 2.62 . . . . 63.44 118.075 -168.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 490' ' ' SER . 17.1 Cg_exo -70.59 -61.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.401 -3.938 0 N-CA-C 109.199 -1.116 . . . . 74.1 109.199 155.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.613 ' OG ' ' HA ' ' A' ' 488' ' ' SER . 44.8 m -125.79 89.89 3.11 Favored 'General case' 0 C--N 1.387 2.208 0 C-N-CA 129.323 3.049 . . . . 75.53 106.283 -3.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 25.7 m -143.05 113.47 7.35 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 120.381 -0.528 . . . . 64.32 110.704 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -104.22 100.46 10.19 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.277 -1.379 . . . . 42.23 107.277 171.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 493' ' ' THR . . . . . 0.456 ' HB ' HG23 ' A' ' 380' ' ' THR . 29.9 m -78.06 129.6 35.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.948 -0.76 . . . . 72.42 108.948 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 390' ' ' VAL . 92.4 t -117.25 109.23 27.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.398 -0.593 . . . . 73.01 109.398 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 26.8 m -98.28 115.67 28.89 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.987 -0.746 . . . . 73.21 108.987 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.613 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -95.81 124.46 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 CA-C-O 122.075 0.941 . . . . 73.33 110.002 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 71.7 m-85 -108.04 126.05 52.28 Favored 'General case' 0 N--CA 1.396 -3.156 0 CA-C-N 114.588 -1.187 . . . . 71.5 109.06 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.603 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 50.4 t0 -91.28 -19.7 22.7 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 104.431 -2.433 . . . . 73.43 104.431 166.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 38.3 t70 74.45 4.15 4.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 111.795 -2.457 . . . . 73.34 111.677 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -55.24 -65.98 0.49 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.935 -1.029 . . . . 72.43 113.362 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -95.14 -0.36 53.45 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.203 0.525 . . . . 75.04 110.231 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 499' ' ' ASP . . . -80.67 -74.21 0.33 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.962 -0.563 . . . . 71.13 110.298 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.28 44.57 5.87 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 121.029 -0.605 . . . . 60.34 112.24 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 46.6 pt -108.88 -13.42 10.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.762 0.792 . . . . 54.41 109.762 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -134.9 -167.91 2.07 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 105.411 -2.07 . . . . 73.14 105.411 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.5 t -140.1 108.99 5.98 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 108.052 -1.092 . . . . 63.22 108.052 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -87.76 108.67 19.24 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 108.419 -0.956 . . . . 75.12 108.419 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.28 -67.54 0.79 Allowed 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.009 -0.996 . . . . 74.25 110.624 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 C--O 1.247 0.935 0 N-CA-C 108.792 -0.818 . . . . 64.52 108.792 -175.275 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.637 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.608 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.235 0.337 0 N-CA-C 109.832 -0.433 . . . . 44.04 109.832 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.403 ' OG ' HD21 ' A' ' 401' ' ' LEU . 13.3 m -112.6 117.27 31.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.357 -0.979 . . . . 45.52 108.357 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.693 ' HA ' HG13 ' A' ' 480' ' ' VAL . 53.0 mttp -93.76 137.25 33.2 Favored 'General case' 0 CA--C 1.477 -1.846 0 C-N-CA 120.182 -0.607 . . . . 72.24 112.026 176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.657 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 37.9 mm -114.49 106.86 21.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.252 -1.34 . . . . 70.33 108.728 -170.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.55 155.84 43.86 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 119.81 -0.756 . . . . 61.53 111.515 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -76.49 150.88 36.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.407 -0.361 . . . . 73.23 110.132 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.8 -42.27 86.21 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.532 -0.914 . . . . 71.22 108.532 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.543 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.4 mm100 -106.29 -171.75 1.96 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.869 -1.059 . . . . 62.34 110.221 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -123.02 -32.67 0.9 Allowed Glycine 0 C--N 1.289 -2.04 0 N-CA-C 109.233 -1.547 . . . . 71.24 109.233 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.2 m -127.84 141.4 51.58 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.907 -1.145 . . . . 72.31 107.907 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 64.5 m-85 -127.88 136.27 51.16 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.361 -0.978 . . . . 75.3 108.361 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -119.24 129.35 54.89 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.537 -1.283 . . . . 70.52 107.537 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 48.6 t -146.16 163.11 36.41 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.243 -0.651 . . . . 71.05 109.243 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -81.64 146.5 30.03 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.219 0.608 . . . . 71.34 111.917 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.642 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 11.5 tt0 -58.12 -49.63 76.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.283 -1.006 . . . . 72.21 108.283 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.487 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.8 p-10 -73.55 16.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.911 -1.041 . . . . 71.15 113.706 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.1 t -86.71 -26.65 24.15 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.184 0.516 . . . . 62.21 109.725 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 96.78 -49.92 1.57 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.762 -0.732 . . . . 75.24 111.486 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.424 HG22 ' HA2' ' A' ' 443' ' ' GLY . 11.4 p -143.31 152.36 41.57 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.855 0.462 . . . . 71.13 109.943 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.52 HG12 ' HB ' ' A' ' 442' ' ' VAL . 5.7 p -107.42 133.88 50.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.146 -1.427 . . . . 65.32 107.146 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.18 126.43 50.35 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 123.299 0.375 . . . . 62.24 110.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.4 mp -119.59 145.94 45.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.961 -1.496 . . . . 72.43 106.961 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 56.7 m -113.14 127.65 56.26 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.438 -0.505 . . . . 74.3 110.831 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 70.1 mt -98.43 126.22 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 107.828 -1.175 . . . . 75.21 107.828 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 397' ' ' ARG . 43.7 mm -102.24 125.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.398 -1.334 . . . . 75.01 107.398 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 16.8 ttp180 -109.38 108.49 19.06 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.464 -0.335 . . . . 63.4 110.373 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 395' ' ' ILE . 80.2 mtp180 -129.34 168.24 16.55 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.281 -0.418 . . . . 55.34 111.495 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 133.78 -6.0 4.8 Favored Glycine 0 C--N 1.31 -0.869 0 N-CA-C 110.311 -1.116 . . . . 62.51 110.311 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 135.74 175.83 14.04 Favored Glycine 0 N--CA 1.424 -2.157 0 N-CA-C 108.189 -1.964 . . . . 65.23 108.189 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -118.15 120.98 39.36 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.813 -1.155 . . . . 63.33 110.75 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.403 HD21 ' OG ' ' A' ' 372' ' ' SER . 1.7 pt? -139.94 158.41 44.12 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.914 -1.513 . . . . 73.33 106.914 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 77.2 p -91.02 6.78 43.43 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.961 0.41 . . . . 71.34 111.932 -175.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -66.26 134.65 53.1 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.662 0.744 . . . . 64.45 112.232 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.7 m -86.13 113.76 22.43 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.131 -1.395 . . . . 65.11 109.739 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.49 133.82 51.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.599 -1.182 . . . . 65.51 109.259 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.496 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 21.8 m-85 -113.62 123.61 50.36 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.599 -0.728 . . . . 73.5 109.234 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.56 128.94 74.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.721 -0.844 . . . . 60.43 108.721 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 26.8 t70 -94.4 139.38 31.18 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.848 0.356 . . . . 62.54 110.725 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -132.56 153.98 50.46 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.858 -0.526 . . . . 71.13 111.108 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -159.39 163.64 35.33 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.433 -0.951 . . . . 75.43 108.433 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 77.2 p -101.01 171.85 7.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.667 0.27 . . . . 72.34 111.139 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.3 151.1 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.06 -0.719 . . . . 73.22 109.06 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.11 1.63 35.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 118.345 -0.836 . . . . 62.25 113.054 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -4.49 -97.08 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 C-N-CA 125.842 1.687 . . . . 71.44 115.185 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.9 t -105.47 -18.66 14.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.296 -0.631 . . . . 74.22 109.296 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.471 ' HB2' ' HG2' ' A' ' 454' ' ' GLU . . . -118.52 143.56 46.66 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.955 -0.758 . . . . 63.11 108.955 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -108.02 113.83 27.29 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 121.487 0.66 . . . . 71.54 111.59 -166.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -74.78 124.39 26.72 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.335 -0.848 . . . . 64.44 109.685 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.35 -28.35 6.05 Favored Glycine 0 C--N 1.294 -1.756 0 N-CA-C 109.19 -1.564 . . . . 65.4 109.19 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 32.6 t -117.03 -52.64 2.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.474 -0.363 . . . . 71.43 110.205 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.624 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 6.4 m-20 -75.63 -59.94 2.53 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.865 0.84 . . . . 41.24 110.24 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.525 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.1 OUTLIER -136.93 176.48 8.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.714 -1.587 . . . . 72.03 106.714 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -83.76 157.67 22.03 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.014 -0.736 . . . . 50.31 109.014 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -91.52 -8.93 46.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.068 -0.515 . . . . 74.14 112.337 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 442' ' ' VAL . 15.1 t 37.9 63.73 0.76 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.681 1.593 . . . . 74.44 113.252 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.56 110.98 15.39 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.216 -0.902 . . . . 63.52 109.576 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.0 174.24 33.24 Favored Glycine 0 N--CA 1.41 -3.046 0 CA-C-N 115.079 -0.964 . . . . 54.41 111.119 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 69.6 m -125.49 133.45 52.38 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 107.139 -1.43 . . . . 74.25 107.139 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.44 129.47 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.358 -0.978 . . . . 54.01 108.358 -176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.11 104.87 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.342 -0.845 . . . . 73.04 108.873 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.7 m-85 -84.8 108.39 17.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.867 -0.606 . . . . 73.33 111.325 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.441 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -90.1 165.04 25.63 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.773 -0.649 . . . . 60.41 110.093 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -50.92 127.73 22.4 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.991 2.461 . . . . 71.43 112.184 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 93.66 -17.65 58.13 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 115.839 -0.619 . . . . 70.34 113.426 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 71.2 mt-10 -84.24 63.88 7.97 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.866 0.841 . . . . 71.32 112.957 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 39.2 m -60.36 -24.06 64.77 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.009 -1.45 . . . . 55.1 110.707 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -128.57 138.88 52.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.7 -0.625 . . . . 75.24 110.36 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 438' ' ' LYS . 20.1 mmmt -134.87 145.65 48.48 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 120.941 0.401 . . . . 71.15 111.498 173.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -109.04 134.43 51.68 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.522 -0.763 . . . . 65.13 110.259 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.7 pt -116.34 137.05 51.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.826 -0.625 . . . . 60.43 109.514 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 17.5 mmt180 -109.05 132.84 53.73 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.297 -0.865 . . . . 74.03 111.286 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 425' ' ' THR . 47.9 t -108.23 116.79 52.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.674 -1.232 . . . . 73.5 107.674 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -61.2 130.79 47.52 Favored Glycine 0 N--CA 1.44 -1.096 0 O-C-N 124.482 1.114 . . . . 71.43 113.083 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.429 ' HA ' ' HB3' ' A' ' 422' ' ' TYR . 33.3 mm -101.45 130.66 50.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.393 -1.336 . . . . 74.41 107.393 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 68.7 mt -98.38 150.04 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 105.485 -2.042 . . . . 75.14 105.485 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -84.64 86.13 7.35 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.405 -0.918 . . . . 72.24 111.564 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.39 124.27 51.4 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 103.269 -2.863 . . . . 51.12 103.269 169.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.625 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 25.1 t70 -119.38 94.73 4.52 Favored 'General case' 0 CA--C 1.456 -2.658 0 C-N-CA 116.836 -1.945 . . . . 62.12 110.841 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' ILE . . . . . . . . . . . . . 39.9 mm -118.29 155.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.816 0 CA-C-N 111.752 -2.476 . . . . 74.15 105.379 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.43 115.06 2.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.114 -1.81 . . . . 73.33 106.114 170.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.64 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 29.5 mt-10 -129.37 94.28 3.75 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.847 1.308 . . . . 74.23 110.442 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.74 106.29 18.56 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 113.703 -1.59 . . . . 72.42 108.747 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.28 4.4 p30 42.39 60.16 2.44 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.86 1.35 . . . . 73.22 112.971 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 416' ' ' ALA . 36.4 tt0 -87.29 135.22 33.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.252 -1.388 . . . . 70.31 107.252 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -149.55 161.45 42.13 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.238 0.542 . . . . 75.55 111.941 -172.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.495 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.4 p90 -137.91 -177.98 5.05 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.71 -0.677 . . . . 73.11 110.225 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -119.82 145.04 47.0 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.274 -1.01 . . . . 72.5 108.274 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.24 132.16 67.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 106.828 -1.545 . . . . 51.12 106.828 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -123.06 139.43 54.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.423 0.452 . . . . 52.25 111.033 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.2 mt -100.07 136.69 39.59 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 44.5 m -157.77 174.3 15.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.425 -0.583 . . . . 53.43 109.425 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.4 t30 54.18 90.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.858 1.263 . . . . 73.33 112.596 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.531 HG11 HG23 ' A' ' 480' ' ' VAL . 99.1 t -90.2 123.19 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.644 -0.707 . . . . 52.44 109.688 176.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 37.2 ttmt -116.86 129.45 56.08 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.362 -1.347 . . . . 74.2 107.362 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 31.3 t -103.41 151.56 6.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.77 -1.567 . . . . 73.23 106.77 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 404' ' ' THR . 17.6 t -73.81 111.68 9.19 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.215 -1.031 . . . . 73.35 108.215 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 14.9 m -82.34 157.31 23.83 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.936 -1.029 . . . . 70.45 110.272 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 67.15 25.61 9.0 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.556 1.142 . . . . 62.11 110.037 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.85 75.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.912 -1.04 . . . . 61.02 109.996 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' SER . . . . . 0.462 ' HB2' ' HB ' ' A' ' 474' ' ' ILE . 40.3 m -146.24 99.96 3.31 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.519 -1.66 . . . . 74.32 106.519 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -57.27 -24.99 58.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.211 -0.904 . . . . 73.13 112.614 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -107.08 113.42 26.87 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.537 -1.283 . . . . 73.43 107.537 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 99.42 -49.41 1.21 Allowed Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.686 -0.768 . . . . 64.13 114.473 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 470' ' ' SER . 38.7 mm -107.72 75.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 118.249 1.024 . . . . 72.12 112.671 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.2 mt -121.56 20.35 11.11 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.973 -1.862 . . . . 72.21 105.973 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.37 167.75 21.04 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 113.04 -1.891 . . . . 62.42 110.736 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -68.2 -64.11 0.93 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.825 -0.625 . . . . 62.32 110.995 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . 0.296 0.2 OUTLIER 35.45 55.59 0.86 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.548 1.139 . . . . 70.42 113.87 -178.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 481' ' ' SER . 39.0 m80 -87.19 -172.95 4.18 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.004 -0.998 . . . . 72.53 109.581 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.693 HG13 ' HA ' ' A' ' 373' ' ' LYS . 59.7 t -70.68 -41.46 77.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.805 0.812 . . . . 62.43 108.944 176.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 479' ' ' HIS . 34.0 t -130.11 -153.46 0.57 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.99 -1.856 . . . . 73.01 105.99 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.36 -46.58 86.04 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.211 -1.033 . . . . 72.24 108.211 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -123.87 -68.97 0.84 Allowed 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.097 -1.816 . . . . 74.14 106.097 171.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -161.24 114.86 1.97 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 113.675 0.991 . . . . 62.52 113.675 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 40.4 t -151.38 115.12 4.91 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 102.131 -3.285 . . . . 74.15 102.131 171.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.657 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 2.8 mm? -69.39 -56.58 7.04 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 115.026 1.491 . . . . 74.23 115.026 -166.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 155.05 -43.11 0.57 Allowed Glycine 0 C--N 1.292 -1.893 0 N-CA-C 107.369 -2.292 . . . . 71.21 107.369 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 13.1 m -85.93 173.43 6.91 Favored Pre-proline 0 C--N 1.307 -1.263 0 N-CA-C 106.503 -1.666 . . . . 71.45 106.503 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.616 ' N ' ' HA ' ' A' ' 490' ' ' SER . 32.0 Cg_exo -51.88 -35.43 59.69 Favored 'Trans proline' 0 CA--C 1.588 3.202 0 N-CA-C 119.684 2.917 . . . . 63.52 119.684 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.616 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 29.7 t -105.32 112.39 25.48 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 127.156 2.182 . . . . 74.12 108.921 0.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 55.4 m -133.25 110.29 10.0 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.638 -0.71 . . . . 61.13 109.413 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.18 130.4 53.35 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.845 -1.168 . . . . 72.22 107.845 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 123.37 41.19 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.523 -0.471 . . . . 74.33 109.9 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.502 HG11 HG11 ' A' ' 390' ' ' VAL . 76.5 t -108.3 107.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.248 -0.649 . . . . 61.14 109.248 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 10.2 m -91.03 116.54 28.88 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.069 -1.086 . . . . 54.43 108.069 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 50.1 mt -101.97 114.64 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.218 1.009 . . . . 73.4 110.902 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.504 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -84.05 102.36 12.46 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.24 -1.346 . . . . 74.01 110.777 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 451' ' ' GLU . 23.5 t70 -52.28 -54.87 25.86 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 112.418 -2.174 . . . . 71.21 108.518 172.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.1 t70 71.63 -10.88 0.78 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.23 -1.804 . . . . 44.51 112.003 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -73.57 -44.07 58.24 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.215 -1.772 . . . . 63.35 106.215 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -124.04 85.44 2.42 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.556 -1.202 . . . . 70.43 108.512 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -150.09 -49.97 0.14 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.764 -0.653 . . . . 73.13 110.44 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 75.09 32.42 56.36 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.869 -0.605 . . . . 55.0 111.921 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 50.5 pt -93.42 162.54 2.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 120.964 0.411 . . . . 70.45 110.533 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.51 163.39 16.14 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.432 -1.321 . . . . 73.21 107.432 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 7.3 p -79.29 82.15 5.48 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.72 0.771 . . . . 74.14 110.99 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -147.45 142.11 26.65 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 105.449 -2.056 . . . . 71.15 105.449 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.71 155.3 39.57 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.5 0.667 . . . . 62.52 112.473 -175.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 . . . . . 0 C--N 1.306 -1.298 0 CA-C-N 115.738 -0.665 . . . . 72.32 109.528 -179.581 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.642 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.64 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 477' ' ' ALA . 13.2 p . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 108.682 -0.859 . . . . 71.35 108.682 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 48.0 m -118.7 140.57 49.72 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.048 -1.093 . . . . 71.23 108.048 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 32.9 mmtp -137.33 119.64 15.73 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.199 -1.037 . . . . 74.22 108.199 169.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.571 ' HB ' HD12 ' A' ' 486' ' ' LEU . 42.7 mm -105.67 114.6 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.52 -0.919 . . . . 73.35 108.52 -175.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -149.33 174.61 12.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.488 0.585 . . . . 72.21 111.319 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.28 146.76 26.89 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.01 -0.366 . . . . 71.3 110.01 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.668 -1.604 . . . . 73.31 106.668 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.512 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 33.6 mt-30 -102.31 144.14 31.19 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.288 -0.869 . . . . 62.42 110.201 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.13 -12.4 57.59 Favored Glycine 0 C--N 1.284 -2.341 0 CA-C-N 115.699 -0.682 . . . . 72.03 111.553 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 25.6 m -140.37 131.37 26.18 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.644 -0.873 . . . . 65.22 108.644 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 72.5 m-85 -127.42 136.59 52.04 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.709 -0.848 . . . . 75.32 108.709 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -121.84 123.15 41.08 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.549 -1.278 . . . . 71.14 107.549 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 43.9 t -134.9 165.38 25.45 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.512 -0.551 . . . . 74.03 109.512 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 3.3 mm? -95.38 141.64 28.7 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.478 -0.783 . . . . 73.43 109.722 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.9 -36.93 78.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.822 -0.807 . . . . 61.43 108.822 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -65.53 -14.26 60.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.621 -1.172 . . . . 73.53 112.689 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 76.6 m -72.52 -19.22 61.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.769 0.285 . . . . 75.13 111.769 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.83 -48.48 3.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.309 -0.716 . . . . 64.2 111.309 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.1 p -141.51 161.34 38.16 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.605 0.762 . . . . 51.32 109.807 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.4 p -114.14 130.0 69.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.832 -1.173 . . . . 71.14 107.832 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.98 128.3 46.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 123.558 0.536 . . . . 72.42 110.174 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.52 151.04 41.76 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.677 -1.231 . . . . 53.55 107.677 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -112.03 128.83 56.3 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.336 0.588 . . . . 73.12 111.656 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 73.3 mt -101.53 126.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 107.913 -1.143 . . . . 62.33 107.913 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.2 mm -100.0 128.23 52.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.56 -0.904 . . . . 73.14 108.56 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.498 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 59.9 ttt180 -112.58 107.65 16.45 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.527 -0.916 . . . . 65.54 108.527 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -98.69 164.35 12.27 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.708 -0.678 . . . . 72.11 111.405 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 371' ' ' VAL . . . 130.45 -11.01 5.81 Favored Glycine 0 N--CA 1.435 -1.369 0 O-C-N 124.351 1.032 . . . . 75.43 110.869 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 123.34 -127.9 6.79 Favored Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 111.279 -0.729 . . . . 62.15 111.279 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -124.58 123.98 41.25 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 106.625 -1.62 . . . . 52.23 106.625 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.08 134.38 47.33 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 113.609 0.966 . . . . 75.33 113.609 -166.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 433' ' ' PRO . 6.9 p -105.64 -2.61 23.21 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 114.523 -1.217 . . . . 73.23 110.935 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -75.07 161.62 29.26 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.722 -0.672 . . . . 74.11 110.425 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m -112.69 112.91 24.76 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.798 0.808 . . . . 65.53 111.085 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 67.2 t -115.49 149.1 17.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.702 -1.136 . . . . 55.2 109.18 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 11.8 m-85 -126.69 147.42 49.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.338 0.59 . . . . 74.45 110.015 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.1 p -143.82 130.49 16.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.557 -0.535 . . . . 75.32 109.557 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -93.41 128.56 39.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.476 -0.565 . . . . 72.33 109.476 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -123.77 153.11 41.41 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.536 -0.912 . . . . 72.1 108.536 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -161.23 161.1 30.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.6 -1.259 . . . . 63.35 107.6 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 71.2 p -96.62 172.03 8.17 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.36 0.6 . . . . 63.04 109.859 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 6.8 tp10 -127.37 153.95 45.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.517 -2.031 . . . . 75.23 105.517 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.3 p-10 -58.2 -41.94 85.05 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.626 0.579 . . . . 64.05 112.425 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.62 -94.43 0.16 Allowed Glycine 0 C--N 1.294 -1.77 0 CA-C-N 115.478 -0.783 . . . . 53.24 111.696 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.9 t -127.74 7.83 6.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.655 0.741 . . . . 53.42 109.495 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -130.94 -159.48 0.97 Allowed 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.043 -1.466 . . . . 55.41 107.043 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -141.68 116.67 9.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.072 0.463 . . . . 75.11 110.546 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -71.44 128.72 36.78 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.905 -0.589 . . . . 75.33 109.557 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.45 -24.38 15.78 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.445 -1.462 . . . . 71.34 109.445 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 21.2 t -111.93 -55.76 2.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 109.632 -0.507 . . . . 63.04 109.632 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 11.1 m-20 -80.09 -56.72 4.03 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.844 0.83 . . . . 62.31 110.055 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.5 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.0 OUTLIER -136.95 167.78 20.84 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.191 -1.411 . . . . 74.13 107.191 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -74.96 152.05 38.81 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.308 -0.627 . . . . 74.02 109.308 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.461 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -85.76 -13.17 49.1 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.93 -0.577 . . . . 75.44 111.547 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 442' ' ' VAL 0.253 14.7 t 35.5 63.11 0.55 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 126.1 1.76 . . . . 73.02 113.152 179.106 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.35 107.55 12.2 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.981 -1.008 . . . . 73.44 109.097 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -147.49 171.51 28.08 Favored Glycine 1 N--CA 1.394 -4.126 0 C-N-CA 119.125 -1.512 . . . . 71.5 112.07 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 25.5 m -124.27 136.13 53.91 Favored 'General case' 0 N--CA 1.388 -3.558 0 N-CA-C 106.652 -1.61 . . . . 51.33 106.652 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.7 t -95.77 126.89 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.371 -0.974 . . . . 61.51 108.371 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.502 HG22 ' CE2' ' A' ' 406' ' ' PHE . 19.3 t -100.52 100.59 10.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.188 -1.041 . . . . 73.2 108.188 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.498 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 54.6 m-85 -80.91 104.51 11.46 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.32 -0.4 . . . . 75.05 111.006 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -84.53 169.47 16.6 Favored Pre-proline 0 C--O 1.256 1.432 0 CA-C-N 115.785 -0.643 . . . . 75.31 110.169 177.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 402' ' ' THR . 9.3 Cg_endo -53.08 132.74 49.17 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.79 2.327 . . . . 73.41 111.868 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.44 -25.57 17.63 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.851 -0.613 . . . . 75.11 113.224 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.48 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 44.9 mt-10 -75.57 64.47 1.66 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.86 0.864 . . . . 60.41 113.168 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 22.4 m -61.42 -23.64 65.96 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.437 -1.256 . . . . 73.42 109.149 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -132.8 143.25 49.44 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.192 -0.67 . . . . 71.3 109.192 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -131.31 149.82 52.4 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.049 -0.523 . . . . 73.4 110.457 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.1 135.51 51.51 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.798 -0.816 . . . . 54.01 108.798 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.8 pt -120.77 146.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.999 -1.111 . . . . 75.11 107.999 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 87.8 mtt180 -125.41 146.18 49.73 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.207 0.527 . . . . 73.31 110.651 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 425' ' ' THR . 51.1 t -113.37 120.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.863 -1.162 . . . . 73.41 107.863 178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -64.3 131.36 38.59 Favored Glycine 0 N--CA 1.439 -1.153 0 O-C-N 124.072 0.858 . . . . 74.34 111.897 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.51 133.52 39.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.563 -1.273 . . . . 75.03 107.563 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 75.6 mt -98.77 150.43 4.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.049 -1.093 . . . . 63.42 108.049 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.9 86.8 5.39 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.224 0.535 . . . . 70.14 111.421 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -112.9 101.66 9.71 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 104.579 -2.378 . . . . 75.42 104.579 171.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.629 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.285 11.3 t70 -106.61 84.44 2.01 Favored 'General case' 0 CA--C 1.458 -2.572 0 C-N-CA 115.613 -2.435 . . . . 70.15 112.025 -177.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 46.1 mm -117.06 154.0 18.77 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.75 0 N-CA-C 103.388 -2.819 . . . . 65.33 103.388 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -52.09 116.15 2.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.32 0.964 . . . . 63.54 110.158 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 27.2 mt-10 -122.48 119.0 29.66 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.436 1.113 . . . . 72.54 113.258 -171.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 501' ' ' HIS . 34.4 mt-10 -131.07 110.92 11.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.563 -1.653 . . . . 74.03 106.847 177.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 48.63 60.52 3.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.72 1.378 . . . . 53.33 114.72 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.2 pt-20 -99.5 134.6 42.14 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.781 -1.168 . . . . 74.14 108.253 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.7 p-10 -149.25 166.19 29.65 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.372 0.606 . . . . 71.32 111.534 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.561 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 30.7 p90 -137.35 -177.73 4.91 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.248 -0.887 . . . . 73.41 109.404 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.95 137.05 54.68 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.621 -1.251 . . . . 72.21 107.621 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 42.3 t -108.79 128.23 64.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.482 -1.303 . . . . 65.44 107.482 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -122.68 163.07 20.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.075 -0.511 . . . . 72.1 109.718 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 82.4 mt -118.2 134.04 55.36 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.252 -1.388 . . . . 64.24 107.252 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.0 m -150.43 161.46 42.46 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 109.222 -0.659 . . . . 52.52 109.222 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 59.73 87.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.257 0.973 . . . . 72.3 110.918 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.16 137.94 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.681 -1.229 . . . . 65.42 107.681 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -135.02 146.21 48.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.114 -0.698 . . . . 65.22 109.114 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 11.1 t -127.49 157.7 39.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.006 -1.479 . . . . 72.13 107.006 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 49.0 m -72.16 110.28 6.51 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.402 -0.592 . . . . 61.34 109.402 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 17.6 m -55.89 123.56 14.68 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.487 -1.233 . . . . 65.34 112.2 -174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.68 168.16 9.26 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.283 -1.006 . . . . 65.33 108.283 174.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -74.02 -15.29 61.09 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.719 0.295 . . . . 60.53 111.527 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.4 t 68.83 24.51 6.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.403 1.081 . . . . 60.44 109.384 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -78.71 -50.31 11.62 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.603 -1.999 . . . . 62.23 105.603 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -107.33 -176.29 3.03 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.704 -2.332 . . . . 71.22 104.704 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 176.8 141.4 3.94 Favored Glycine 0 C--N 1.29 -2.01 0 C-N-CA 119.572 -1.299 . . . . 73.54 112.986 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 16.2 tt -147.87 83.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.561 1.172 . . . . 71.12 109.164 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.4 mt -84.73 110.45 18.79 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.644 -1.162 . . . . 71.1 110.72 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.29 177.49 6.91 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.683 -1.228 . . . . 73.23 107.683 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 371' ' ' VAL . . . -84.65 4.47 32.29 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.031 0.443 . . . . 71.33 110.148 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -64.15 -12.86 43.91 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.687 -0.688 . . . . 73.41 112.119 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -131.19 138.79 49.57 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.289 -0.634 . . . . 72.41 109.289 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 11.7 m -66.05 132.95 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 108.737 -0.838 . . . . 74.44 108.737 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 4.3 p -159.05 -76.48 0.07 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.131 0.491 . . . . 65.31 109.774 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -133.28 142.57 48.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.264 -1.754 . . . . 53.32 106.264 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 73.35 -55.04 0.68 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.504 1.521 . . . . 62.31 107.812 -174.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.49 114.06 26.16 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 106.724 -1.584 . . . . 34.24 106.724 172.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 78.1 m -133.83 -168.74 2.17 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 107.721 -1.214 . . . . 70.44 107.721 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.571 HD12 ' HB ' ' A' ' 374' ' ' ILE . 0.4 OUTLIER -60.28 151.17 28.19 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 109.839 -0.43 . . . . 73.33 109.839 -176.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.528 ' O ' ' HD3' ' A' ' 489' ' ' PRO . . . -67.37 118.08 9.68 Favored Glycine 0 CA--C 1.483 -1.919 0 N-CA-C 103.847 -3.701 . . . . 34.14 103.847 172.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.9 m -106.5 103.39 45.95 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 115.144 1.535 . . . . 64.35 115.144 -165.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 487' ' ' GLY . 2.9 Cg_exo -71.66 -63.12 0.04 OUTLIER 'Trans proline' 0 CA--C 1.586 3.119 0 C-N-CA 120.491 0.794 . . . . 64.14 110.897 162.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.514 ' HA ' ' CD ' ' A' ' 489' ' ' PRO . 19.0 m -126.34 88.5 2.85 Favored 'General case' 0 C--N 1.38 1.895 0 C-N-CA 127.362 2.265 . . . . 71.41 108.806 -3.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 97.7 m -144.51 110.98 5.6 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 110.024 -0.361 . . . . 71.34 110.024 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -102.93 103.02 13.12 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.383 -1.339 . . . . 72.05 107.383 172.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 53.3 m -83.26 118.74 23.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.133 0.492 . . . . 60.31 110.986 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.584 HG11 HG11 ' A' ' 390' ' ' VAL . 80.4 t -106.21 110.68 32.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.782 -0.822 . . . . 63.44 108.782 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 46.9 m -98.85 121.57 40.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.36 -0.978 . . . . 63.55 108.36 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.549 HD11 ' CE2' ' A' ' 456' ' ' PHE . 5.2 mp -97.9 117.52 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 121.835 0.826 . . . . 74.51 110.764 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.716 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 55.6 m-85 -98.07 122.98 41.87 Favored 'General case' 0 N--CA 1.399 -3.005 0 N-CA-C 105.709 -1.96 . . . . 74.31 105.709 170.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.12 -3.0 23.58 Favored 'General case' 0 C--N 1.258 -3.402 0 C-N-CA 119.33 -0.948 . . . . 74.43 109.114 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.29 17.77 9.24 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 126.754 2.021 . . . . 63.12 113.191 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 500' ' ' ASP . . . . . 0.626 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' 0.269 2.2 p30 -85.19 -47.33 10.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 118.034 -1.466 . . . . 60.11 112.885 -178.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.47 ' O ' ' HG2' ' A' ' 452' ' ' GLU . 2.7 t-80 -133.14 17.99 4.09 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.797 -1.186 . . . . 71.32 107.797 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -82.41 148.82 28.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.541 -1.209 . . . . 62.3 111.105 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -85.42 65.31 4.01 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 115.823 -0.626 . . . . 73.11 112.333 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 43.7 pt -142.05 -179.66 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.728 -1.212 . . . . 74.35 107.728 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -72.68 107.97 5.44 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.287 -1.005 . . . . 63.01 108.287 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 17.6 p -75.99 151.27 37.26 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.87 -1.059 . . . . 74.33 112.594 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -109.0 -39.72 5.22 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.563 -1.273 . . . . 71.43 107.563 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -83.26 158.78 22.12 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.297 -1.371 . . . . 72.45 107.297 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--N 1.307 -1.264 0 C-N-CA 120.136 -0.626 . . . . 65.43 110.203 -179.183 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.638 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.647 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 109.339 -0.615 . . . . 72.35 109.339 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 480' ' ' VAL . 60.9 m -139.18 109.58 6.54 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.92 -1.141 . . . . 60.04 107.92 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 480' ' ' VAL . 93.0 mttt -121.27 120.67 35.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 112.917 0.71 . . . . 71.14 112.917 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.521 ' HB ' HD12 ' A' ' 486' ' ' LEU . 31.5 mm -102.19 127.86 55.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.054 -1.462 . . . . 71.22 107.054 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.518 ' HB2' ' OG ' ' A' ' 488' ' ' SER . 39.3 p90 -159.85 168.73 25.13 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 117.994 0.361 . . . . 70.23 111.655 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -88.55 142.31 27.81 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 110.021 -0.363 . . . . 70.32 110.021 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 395' ' ' ILE . 41.4 tt0 -62.87 -51.08 68.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.518 0.675 . . . . 73.23 109.444 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -108.94 146.61 33.53 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 114.972 -1.013 . . . . 72.02 110.425 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.47 -25.43 33.19 Favored Glycine 0 C--N 1.294 -1.801 0 N-CA-C 110.686 -0.965 . . . . 42.03 110.686 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 12.9 m -127.34 136.04 51.36 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.406 -0.961 . . . . 62.51 108.406 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -127.13 137.32 52.96 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.355 -0.98 . . . . 73.43 108.355 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -127.34 129.66 48.05 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.83 -1.544 . . . . 72.45 106.83 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 11.9 t -148.72 160.3 43.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.054 -1.091 . . . . 61.03 108.054 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.556 HD12 ' OD1' ' A' ' 386' ' ' ASN . 2.6 mm? -78.43 144.76 35.55 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.294 0.569 . . . . 72.35 112.202 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.596 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 5.9 tt0 -59.48 -41.82 90.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.315 -0.857 . . . . 63.04 108.742 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.556 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.4 p-10 -78.25 9.81 3.52 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.436 -0.802 . . . . 74.11 113.065 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.3 t -83.97 -28.5 27.74 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.728 -0.608 . . . . 72.03 110.524 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.81 -58.39 0.56 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.175 -0.536 . . . . 53.44 112.209 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 5.6 p -141.95 151.41 42.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.024 0.412 . . . . 43.44 110.447 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 494' ' ' VAL . 5.7 p -109.14 133.41 54.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 107.755 -1.202 . . . . 74.22 107.755 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.98 128.83 48.24 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.153 0.501 . . . . 73.33 110.39 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -120.62 145.28 47.56 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.311 -1.366 . . . . 75.21 107.311 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 29.4 m -113.67 127.06 55.9 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 121.43 0.633 . . . . 73.51 111.298 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 76.5 mt -95.05 121.34 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 N-CA-C 108.02 -1.104 . . . . 73.54 108.02 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 377' ' ' GLU . 42.8 mm -99.14 119.4 47.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.48 -1.304 . . . . 74.12 107.48 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.416 ' NH1' HG21 ' A' ' 405' ' ' VAL . 23.6 ttt85 -100.48 121.36 41.42 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-O 121.482 0.658 . . . . 61.41 110.576 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 375' ' ' PHE . 22.0 mmm180 -106.59 168.07 9.42 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.449 -0.796 . . . . 75.43 109.094 175.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 105.9 -30.83 9.11 Favored Glycine 0 C--N 1.292 -1.862 0 N-CA-C 108.151 -1.98 . . . . 64.31 108.151 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 125.61 -176.08 17.36 Favored Glycine 0 N--CA 1.408 -3.23 0 CA-C-N 114.136 -1.032 . . . . 72.02 111.523 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.67 178.02 4.83 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.831 -1.544 . . . . 75.32 106.831 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 403' ' ' ASN . 1.1 pt? -171.53 161.35 6.21 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.264 -1.384 . . . . 73.33 107.264 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 46.2 p -94.94 -4.2 47.21 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.027 0.918 . . . . 75.34 109.905 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.424 ' HB2' HD12 ' A' ' 401' ' ' LEU . 4.9 m-20 -78.59 146.39 34.2 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.725 -1.213 . . . . 71.54 107.725 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 466' ' ' SER . 9.4 m -92.06 116.55 29.03 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.183 0.516 . . . . 75.31 111.681 -171.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 66.6 t -103.44 136.5 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.046 -0.524 . . . . 71.55 109.707 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.95 121.41 34.37 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.601 0.361 . . . . 72.23 110.582 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 463' ' ' VAL . 5.9 p -120.8 127.62 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.354 -0.98 . . . . 61.25 108.354 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.6 143.53 27.61 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.539 -0.912 . . . . 74.23 108.539 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -142.42 158.39 43.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.941 -0.474 . . . . 75.44 110.124 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -165.68 158.01 15.0 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.548 -1.279 . . . . 72.33 107.548 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.646 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 36.5 p -96.73 156.13 16.48 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.373 -0.603 . . . . 74.51 109.373 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.2 tp10 -106.35 151.26 25.1 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.96 -1.496 . . . . 70.33 106.96 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 417' ' ' ASN . 11.2 m-20 -55.96 -39.02 71.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.698 0.799 . . . . 61.32 112.38 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 62.93 -95.56 0.13 Allowed Glycine 0 C--N 1.297 -1.614 0 CA-C-N 114.938 -1.028 . . . . 34.24 112.63 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.9 t -121.37 8.92 10.26 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.296 -0.631 . . . . 62.02 109.296 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -137.9 -160.49 1.06 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.537 -0.912 . . . . 73.51 108.537 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.589 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 6.5 m120 -137.25 122.55 19.37 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.708 0.766 . . . . 72.53 112.021 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -68.62 129.31 39.56 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.561 -1.199 . . . . 72.52 109.394 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.95 -32.66 6.87 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 111.305 -0.718 . . . . 64.3 111.305 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 t -102.24 -44.52 5.4 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.695 -0.483 . . . . 60.34 109.695 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.551 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 23.7 m-20 -87.3 -64.27 1.17 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.049 0.928 . . . . 63.14 109.659 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.714 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.16 167.0 23.24 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.147 -0.933 . . . . 65.22 110.217 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 425' ' ' THR . 23.1 tt0 -75.47 153.52 37.53 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.632 0.583 . . . . 43.43 110.333 -174.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.646 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.2 p90 -88.93 -15.34 34.56 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.717 -0.674 . . . . 65.33 112.126 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.439 ' CG2' HG22 ' A' ' 442' ' ' VAL 0.296 13.5 t 32.49 66.87 0.18 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.897 1.679 . . . . 74.53 114.414 -176.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.76 131.12 34.94 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.592 -0.892 . . . . 71.0 108.592 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -173.38 -175.74 41.36 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 120.099 -1.048 . . . . 72.43 110.957 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.3 m -116.89 138.35 51.59 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 108.159 -1.052 . . . . 75.24 108.159 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.2 t -96.12 116.42 37.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.085 -1.45 . . . . 72.04 107.085 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.17 105.69 17.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.533 -0.758 . . . . 64.05 109.749 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 78.7 m-85 -82.57 98.36 8.94 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.226 -1.028 . . . . 50.03 108.226 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.1 mttm -80.58 170.18 16.66 Favored Pre-proline 0 C--N 1.296 -1.747 0 CA-C-N 114.065 -1.425 . . . . 63.43 109.948 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.7 Cg_exo -52.24 109.91 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.55 2.167 . . . . 54.04 113.339 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.47 -0.34 61.47 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.126 -0.943 . . . . 44.12 114.825 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.406 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 34.6 mm-40 -76.59 64.23 2.2 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.852 0.826 . . . . 74.21 113.062 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.9 m -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 121.374 0.607 . . . . 74.34 110.381 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -131.4 139.81 49.52 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.08 -0.711 . . . . 74.12 109.08 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -130.63 151.41 51.12 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.594 -0.275 . . . . 63.43 111.65 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.85 137.3 52.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.849 -0.614 . . . . 73.41 109.644 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.28 147.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.936 -1.135 . . . . 71.44 107.936 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 49.4 mtt180 -129.57 135.07 48.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 120.996 0.426 . . . . 61.52 111.215 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.6 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 61.9 t -105.34 127.3 60.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.431 -0.804 . . . . 34.22 109.409 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -70.97 130.31 19.45 Favored Glycine 0 N--CA 1.439 -1.115 0 O-C-N 124.192 0.933 . . . . 62.23 112.37 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.489 HD12 HG12 ' A' ' 496' ' ' ILE . 38.7 mm -94.9 134.78 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 106.916 -1.512 . . . . 73.31 106.916 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 66.6 mt -101.7 151.19 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 108.063 -1.088 . . . . 71.45 108.063 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.96 97.6 2.33 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.995 0.426 . . . . 42.53 110.234 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.45 124.75 27.63 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 103.63 -2.73 . . . . 73.1 103.63 170.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.2 97.13 4.81 Favored 'General case' 0 CA--C 1.462 -2.436 0 C-N-CA 117.733 -1.587 . . . . 54.23 110.042 174.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.733 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 28.9 mm -123.35 156.64 29.53 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.55 0 CA-C-N 111.308 -2.678 . . . . 75.5 104.171 -173.15 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -56.86 113.49 1.69 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 116.652 -2.019 . . . . 72.34 105.777 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.733 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.7 mt-10 -120.93 121.86 38.96 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 108.986 -0.746 . . . . 70.54 108.986 -170.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -132.34 109.48 9.9 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 115.176 -0.92 . . . . 63.22 108.691 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.37 35.72 26.34 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.469 1.106 . . . . 70.32 111.18 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.434 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.3 tt0 -64.02 106.63 1.08 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.318 -1.364 . . . . 63.41 107.318 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.476 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 35.2 p30 -138.57 166.15 25.07 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.449 0.643 . . . . 75.42 112.078 -175.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.605 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 21.2 p90 -140.2 -179.24 5.87 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.182 -0.917 . . . . 60.12 109.764 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 31.9 mt -123.79 136.74 54.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.134 -1.062 . . . . 60.52 108.134 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.3 124.9 60.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.418 -1.327 . . . . 63.41 107.418 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -117.71 156.34 28.4 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.572 0.545 . . . . 41.11 109.839 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 86.5 mt -113.42 140.61 47.93 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.563 -0.903 . . . . 73.3 108.563 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.7 m -146.84 173.56 12.29 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.787 -0.449 . . . . 71.04 109.787 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.4 t30 34.65 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 126.145 1.778 . . . . 75.41 113.854 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.49 HG11 HG23 ' A' ' 480' ' ' VAL . 24.7 t -98.77 132.54 43.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.142 -1.023 . . . . 73.01 108.564 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -133.53 148.23 51.65 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.237 -1.023 . . . . 72.31 108.237 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 90.9 t -127.65 129.65 70.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 120.851 0.358 . . . . 60.44 110.471 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 404' ' ' THR . 58.1 m -95.63 109.27 21.55 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 106.88 -1.526 . . . . 73.22 106.88 173.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 11.0 p -92.84 -57.2 2.73 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.195 -0.457 . . . . 74.23 112.174 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -116.94 166.6 11.98 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.872 -0.603 . . . . 65.32 110.508 -175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.42 50.61 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.301 -0.629 . . . . 74.13 109.301 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 16.3 m -55.57 127.71 31.1 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.675 -1.148 . . . . 60.41 110.021 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.45 -47.15 57.54 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.646 -0.872 . . . . 75.01 108.646 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.41 142.71 29.7 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.02 -0.733 . . . . 61.15 109.02 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 100.29 47.29 1.72 Allowed Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.032 -1.08 . . . . 51.34 111.439 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.35 117.2 45.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.901 -0.407 . . . . 74.02 109.901 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.23 93.03 9.18 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.1 -0.704 . . . . 71.25 109.1 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -106.55 72.25 0.9 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.876 0.846 . . . . 74.33 110.72 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -91.79 -16.28 27.04 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.219 -0.901 . . . . 54.21 110.219 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 481' ' ' SER . 5.9 p-10 -163.78 131.8 3.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.268 -0.878 . . . . 64.13 109.022 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -107.24 -45.14 4.18 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.915 -1.513 . . . . 73.33 106.915 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.49 HG23 HG11 ' A' ' 463' ' ' VAL . 44.7 t -138.17 -49.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 104.039 -2.578 . . . . 75.25 104.039 174.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 478' ' ' ASN . 15.1 m -127.03 -164.7 1.38 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.52 -2.4 . . . . 62.43 104.52 171.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -51.21 -52.53 43.65 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.801 0.728 . . . . 51.23 109.927 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -107.53 -79.37 0.58 Allowed 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.239 -1.763 . . . . 70.42 106.239 171.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -163.79 114.29 1.32 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.002 0.43 . . . . 74.51 111.919 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' CYS . . . . . 0.404 ' HB3' ' OG ' ' A' ' 481' ' ' SER . 42.7 t -141.88 125.4 16.73 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 104.246 -2.501 . . . . 43.45 104.246 172.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.521 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.7 mm? -92.0 176.04 6.65 Favored 'General case' 0 C--N 1.278 -2.516 0 C-N-CA 119.75 -0.78 . . . . 63.35 111.96 -170.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -70.42 -38.6 70.03 Favored Glycine 0 CA--C 1.506 -0.5 0 N-CA-C 110.397 -1.081 . . . . 74.21 110.397 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 375' ' ' PHE . 16.2 m -93.18 170.3 8.96 Favored Pre-proline 0 N--CA 1.426 -1.626 0 N-CA-C 107.239 -1.393 . . . . 70.24 107.239 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.469 ' N ' ' HA ' ' A' ' 490' ' ' SER . 2.5 Cg_endo -40.28 -48.41 4.07 Favored 'Trans proline' 0 CA--C 1.578 2.689 0 C-N-CA 123.1 2.533 . . . . 74.33 118.511 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.469 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 31.6 m -107.8 129.06 55.09 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 127.433 2.293 . . . . 63.34 108.966 2.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 90.4 m -137.08 103.97 5.29 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.024 -1.102 . . . . 73.24 108.024 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -101.84 120.6 40.64 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.131 -1.063 . . . . 73.24 108.131 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 40.8 m -89.38 119.19 29.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.235 -0.586 . . . . 40.12 109.834 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 390' ' ' VAL . 76.6 t -106.89 107.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 108.177 -1.046 . . . . 73.45 108.177 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.476 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 85.2 m -97.45 114.32 26.15 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.72 -0.844 . . . . 74.12 108.72 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.714 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.09 116.96 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.367 -0.833 . . . . 72.31 109.169 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.554 ' O ' HD13 ' A' ' 384' ' ' LEU . 24.2 m-85 -80.26 97.79 7.11 Favored 'General case' 0 N--CA 1.382 -3.868 0 CA-C-O 122.324 1.059 . . . . 74.54 112.366 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.3 t70 -50.17 -54.87 17.85 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 111.749 -2.478 . . . . 55.41 108.493 170.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.46 ' H ' ' HB3' ' A' ' 502' ' ' ALA . 25.8 t70 61.35 12.64 4.4 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 113.797 -1.547 . . . . 45.44 110.965 176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -95.86 -59.69 1.8 Allowed 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.992 -1.485 . . . . 75.11 106.992 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -110.41 -24.8 10.41 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.072 -1.422 . . . . 72.51 107.979 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.46 ' HB3' ' H ' ' A' ' 499' ' ' ASP . . . -64.48 115.5 5.2 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 114.828 -1.078 . . . . 75.04 111.535 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -118.43 134.68 11.07 Favored Glycine 0 N--CA 1.422 -2.286 0 N-CA-C 108.843 -1.703 . . . . 70.51 108.843 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 27.1 pt -132.81 176.65 8.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 117.413 0.606 . . . . 73.35 111.473 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 507' ' ' PHE . 24.5 p90 -113.18 179.32 3.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.299 -1.371 . . . . 74.52 107.299 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.4 m -87.04 117.67 25.92 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.36 -0.607 . . . . 74.22 109.36 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.46 ' HB3' ' CE2' ' A' ' 505' ' ' PHE . 55.0 p90 -145.05 166.57 24.98 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.316 0.579 . . . . 74.44 112.547 -176.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -139.88 109.66 6.35 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.817 -1.549 . . . . 72.35 106.817 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 . . . . . 0 C--N 1.308 -1.23 0 N-CA-C 109.516 -0.55 . . . . 62.15 109.516 -177.85 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.616 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.631 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 C--O 1.239 0.545 0 CA-C-O 121.639 0.733 . . . . 52.2 110.741 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 10.1 m -97.78 175.51 6.14 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.968 -1.014 . . . . 65.45 109.646 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -141.82 130.74 23.07 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.411 -1.329 . . . . 71.41 107.411 171.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 486' ' ' LEU . 45.3 mm -110.0 120.74 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 60.23 107.98 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -152.95 173.32 15.54 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 118.455 0.57 . . . . 73.13 110.361 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -87.41 154.68 20.47 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.21 110.873 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.12 -40.68 86.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.958 -0.756 . . . . 73.33 108.958 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -126.36 162.74 24.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.492 -0.777 . . . . 72.11 111.835 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -94.46 -19.69 31.8 Favored Glycine 0 C--N 1.3 -1.436 0 CA-C-N 115.045 -0.979 . . . . 60.33 111.712 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 62.6 m -141.86 128.51 20.33 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.967 -0.753 . . . . 74.22 108.967 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.457 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 39.8 m-85 -114.56 136.82 52.61 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 124.261 1.024 . . . . 75.33 108.792 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 495' ' ' THR . 43.7 mt-30 -129.51 123.92 32.68 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.429 -1.323 . . . . 74.54 107.429 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 46.6 t -139.96 165.18 28.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.356 -0.979 . . . . 72.43 108.356 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.671 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 3.8 mm? -87.13 140.56 29.43 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 123.32 0.388 . . . . 73.42 111.552 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.621 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 9.1 tt0 -58.76 -42.28 88.54 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.009 -0.737 . . . . 73.12 109.009 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -73.19 -5.42 39.17 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.354 0.872 . . . . 53.41 113.354 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 57.7 m -80.73 -7.28 59.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.8 -0.562 . . . . 72.14 111.91 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.78 -56.01 3.38 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.467 -0.873 . . . . 74.34 112.819 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.473 HG22 ' HA2' ' A' ' 443' ' ' GLY . 21.6 p -137.58 166.77 23.09 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.979 0.419 . . . . 74.32 111.203 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 494' ' ' VAL . 3.8 p -116.93 128.84 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 106.932 -1.507 . . . . 64.01 106.932 170.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.95 118.48 37.0 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.307 0.575 . . . . 71.12 110.418 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.0 mp -109.82 139.89 44.37 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.52 -1.289 . . . . 71.21 107.52 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.9 m -109.55 127.92 54.82 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 109.391 -0.596 . . . . 71.04 109.391 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 64.1 mt -99.37 125.6 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.52 -1.289 . . . . 75.53 107.52 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.458 HG22 ' HG3' ' A' ' 397' ' ' ARG . 43.6 mm -101.48 129.04 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 115.09 -0.959 . . . . 50.01 108.421 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -115.92 108.88 16.84 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.928 -1.033 . . . . 74.14 109.226 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 395' ' ' ILE . 32.4 mtp180 -123.44 168.41 12.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.72 -0.673 . . . . 64.13 110.292 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 111.88 -146.99 18.06 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 109.395 -1.482 . . . . 42.42 109.395 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -78.27 139.24 22.28 Favored Glycine 0 N--CA 1.422 -2.275 0 N-CA-C 108.691 -1.764 . . . . 64.14 108.691 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -111.87 140.84 46.19 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.72 0.771 . . . . 72.33 109.742 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 401' ' ' LEU . 2.2 pt? -140.49 152.18 45.41 Favored 'General case' 0 C--N 1.267 -2.982 0 N-CA-C 105.949 -1.871 . . . . 70.22 105.949 -177.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 44.4 p -81.9 6.12 16.83 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.406 0.521 . . . . 74.44 112.406 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -68.9 143.41 54.49 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.177 -0.675 . . . . 71.13 109.177 175.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 9.4 m -82.37 119.34 24.03 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.751 -0.659 . . . . 65.31 109.38 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 57.5 t -100.37 141.86 16.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.404 -0.962 . . . . 72.43 108.404 -177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 54.2 m-85 -128.38 119.77 25.67 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 122.735 0.414 . . . . 62.31 109.948 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.07 124.45 72.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.532 -0.914 . . . . 73.45 108.532 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 14.7 t70 -90.05 140.46 29.62 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 110.1 -0.333 . . . . 71.31 110.1 -177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.95 169.1 18.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.179 -0.304 . . . . 74.54 110.179 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 411' ' ' THR . 63.5 ttt-85 -167.52 167.22 13.77 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 105.825 -1.917 . . . . 71.41 105.825 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.632 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 62.2 p -95.55 168.2 10.84 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.692 -0.855 . . . . 75.12 108.692 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.594 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.7 tp10 -106.51 150.74 25.81 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.613 0.721 . . . . 71.32 109.29 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.53 5.39 51.01 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 125.915 1.686 . . . . 44.55 110.679 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' GLY . . . . . 0.594 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -28.73 -93.39 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.74 2.114 . . . . 61.14 116.953 -174.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 455' ' ' ASN . 5.2 t -93.74 -7.06 44.68 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.848 0.832 . . . . 74.03 110.56 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.779 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . . . -151.89 153.22 33.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.409 -1.7 . . . . 60.23 106.409 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.19 145.86 33.61 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.617 0.722 . . . . 72.43 112.138 -164.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -82.93 148.71 27.48 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.072 -0.967 . . . . 71.42 108.534 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.94 79.05 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.454 -1.058 . . . . 60.12 110.454 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 38.3 m -149.44 -58.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.697 -0.483 . . . . 54.22 109.697 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.505 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 8.0 m-20 -86.23 -55.0 4.12 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.408 1.099 . . . . 71.24 108.934 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.779 ' OH ' ' HB3' ' A' ' 416' ' ' ALA . 0.1 OUTLIER -141.67 164.79 29.26 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.948 -1.024 . . . . 75.42 111.07 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 425' ' ' THR . 0.9 OUTLIER -74.07 160.56 31.08 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.352 -0.84 . . . . 71.23 108.842 -177.186 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.632 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -100.07 -20.14 16.17 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 122.936 0.495 . . . . 72.42 112.152 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.49 ' CG2' HG22 ' A' ' 442' ' ' VAL 0.323 10.1 t 39.04 64.55 0.78 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.351 1.861 . . . . 72.5 114.239 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.67 112.33 15.67 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.589 -1.187 . . . . 61.41 109.274 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -158.25 -178.62 32.46 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 110.443 -1.063 . . . . 73.14 110.443 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 17.5 m -122.63 139.72 53.62 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.358 -1.349 . . . . 73.1 107.358 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 45.0 t -95.56 118.8 42.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.8 -0.815 . . . . 73.12 108.8 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 406' ' ' PHE . 26.0 t -91.11 112.18 24.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.654 -1.157 . . . . 71.25 108.511 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 60.5 m-85 -97.61 101.75 13.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.69 -0.485 . . . . 71.51 109.69 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.3 mttm -85.21 172.5 8.68 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.071 -0.513 . . . . 74.43 109.979 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.9 Cg_exo -56.09 131.83 48.3 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.467 2.111 . . . . 74.35 111.649 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 87.33 -14.89 56.66 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 116.027 -0.533 . . . . 73.3 113.77 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -81.07 63.57 5.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.607 0.717 . . . . 71.14 112.391 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.1 m -60.9 -22.22 64.12 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.273 -1.33 . . . . 75.01 110.366 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -131.17 139.64 49.79 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.951 -1.129 . . . . 65.11 107.951 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -131.46 154.35 48.8 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 122.793 0.437 . . . . 73.14 110.068 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.27 132.48 50.33 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.787 -0.765 . . . . 74.01 111.076 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.5 pt -119.39 146.72 23.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.594 -0.891 . . . . 74.32 108.594 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 90.2 mtt180 -130.27 132.88 46.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.343 -0.543 . . . . 75.24 111.788 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.49 HG22 ' CG2' ' A' ' 425' ' ' THR . 62.1 t -104.71 120.56 55.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.041 -0.981 . . . . 72.3 108.451 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -71.98 136.52 24.2 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 121.134 -0.555 . . . . 71.42 112.241 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.464 HD12 HG12 ' A' ' 496' ' ' ILE . 35.5 mm -97.93 132.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.83 -1.174 . . . . 71.12 107.83 177.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 92.4 mt -91.57 151.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.477 -0.934 . . . . 74.43 108.477 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.29 92.54 5.15 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 120.981 0.419 . . . . 73.22 110.015 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.07 96.49 6.35 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.498 -2.778 . . . . 60.43 103.498 166.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -99.59 81.3 2.48 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 116.687 -2.005 . . . . 63.53 110.454 -173.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.6 mm -127.37 155.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.09 0 CA-C-N 110.383 -3.099 . . . . 73.14 103.993 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -56.36 114.36 1.96 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.925 -1.509 . . . . 62.23 106.925 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.7 mt-10 -111.89 128.12 56.05 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 108.259 -1.015 . . . . 73.11 108.259 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -124.27 103.85 8.47 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 115.599 -0.728 . . . . 72.45 110.086 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.82 60.38 3.58 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 125.076 1.485 . . . . 74.31 113.078 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.21 114.55 20.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.693 0.758 . . . . 75.1 109.516 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.469 ' O ' HG22 ' A' ' 415' ' ' THR . 3.4 p-10 -136.74 153.44 50.86 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 114.949 -1.023 . . . . 70.5 109.799 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 422' ' ' TYR . 20.9 p90 -136.78 -177.94 4.96 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.861 -0.609 . . . . 74.3 110.195 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.457 ' H ' ' HB3' ' A' ' 412' ' ' GLU . 57.2 mt -121.17 139.71 52.98 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.983 -1.117 . . . . 72.2 107.983 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 491' ' ' THR . 47.5 t -107.65 110.77 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.579 -1.267 . . . . 73.22 107.579 174.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -102.78 137.83 40.47 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.591 -0.522 . . . . 63.05 109.591 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.83 126.66 42.14 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.592 -0.892 . . . . 73.23 108.592 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 408' ' ' ASP . 17.4 m -147.04 148.52 31.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.933 -0.765 . . . . 63.11 108.933 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.5 93.6 0.06 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.974 1.31 . . . . 61.2 110.575 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.15 137.07 39.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.378 -1.341 . . . . 72.04 107.378 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -131.96 150.25 52.21 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 123.609 0.764 . . . . 75.0 108.991 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.55 131.25 68.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.957 -1.498 . . . . 71.54 106.957 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 11.6 t -86.93 126.04 34.43 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.129 -0.693 . . . . 71.22 109.129 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 477' ' ' ALA . 13.0 t -90.98 -146.21 0.19 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.286 -1.005 . . . . 72.33 108.286 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.28 177.55 2.27 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 123.592 0.757 . . . . 64.34 109.631 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -71.49 -22.45 61.8 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 122.122 -0.361 . . . . 71.14 111.928 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 14.5 m -70.29 106.41 3.34 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 121.234 0.54 . . . . 74.13 109.546 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -103.71 3.98 34.83 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.754 -0.657 . . . . 62.35 110.697 -176.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -81.39 132.26 35.32 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.974 -0.75 . . . . 70.11 108.974 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 80.76 -170.37 53.08 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.563 -1.015 . . . . 54.43 110.563 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 43.0 mm -119.11 125.13 74.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.616 -0.883 . . . . 70.52 108.616 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -136.21 104.5 5.67 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.527 0.679 . . . . 74.32 109.305 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -54.87 108.66 0.42 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.13 -1.395 . . . . 74.51 113.104 -176.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 467' ' ' SER . . . -106.02 12.52 30.35 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.969 -1.014 . . . . 62.41 108.355 175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' A' ' 481' ' ' SER . 30.4 t30 -54.95 93.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.307 1.443 . . . . 73.2 113.344 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -102.45 -80.25 0.51 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.689 -1.967 . . . . 52.11 105.689 169.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 28.8 m -94.62 116.37 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.853 -0.795 . . . . 71.32 108.853 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' SER . . . . . 0.437 ' HB3' ' OD1' ' A' ' 478' ' ' ASN . 32.7 t 170.73 -74.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 125.838 1.655 . . . . 73.24 107.823 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -120.36 -2.6 10.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.309 -0.405 . . . . 52.04 111.868 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -110.0 -69.06 0.88 Allowed 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 104.981 -2.229 . . . . 75.01 104.981 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -94.81 161.53 14.13 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 105.543 -2.021 . . . . 40.23 105.543 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 61.7 m -137.26 -169.24 2.46 Favored 'General case' 0 C--N 1.255 -3.513 0 N-CA-C 107.32 -1.363 . . . . 44.32 107.32 -175.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.513 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.0 mm? -68.9 157.42 36.64 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.549 -0.86 . . . . 74.11 108.903 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -65.49 -30.79 78.35 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-O 121.477 0.487 . . . . 72.15 111.953 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.576 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 14.6 m -124.06 -173.53 0.29 Allowed Pre-proline 0 C--N 1.281 -2.401 0 N-CA-C 104.377 -2.453 . . . . 51.44 104.377 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 488' ' ' SER . 4.1 Cg_exo -34.63 -51.9 0.66 Allowed 'Trans proline' 0 CA--C 1.585 3.028 0 C-N-CA 122.977 2.452 . . . . 63.55 117.865 172.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 42.3 m -113.7 136.48 52.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.82 2.448 . . . . 64.34 107.246 1.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 45.5 m -131.94 117.48 18.51 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 116.22 -0.445 . . . . 64.24 110.692 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.27 131.44 52.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.035 -0.728 . . . . 52.43 109.035 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 77.1 m -86.42 126.91 34.72 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.592 -0.892 . . . . 71.55 108.592 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 390' ' ' VAL . 77.0 t -111.94 107.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.674 -0.862 . . . . 73.2 108.674 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 23.6 m -101.21 111.22 23.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.13 -1.063 . . . . 71.02 108.13 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.625 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -88.49 123.68 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.595 0.712 . . . . 72.33 111.06 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -82.75 107.2 15.2 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-O 122.344 1.069 . . . . 71.51 110.209 173.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.61 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 0.1 OUTLIER -58.8 -40.42 84.03 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 112.288 -2.233 . . . . 43.14 112.766 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.549 ' HB2' ' CD1' ' A' ' 384' ' ' LEU . 20.4 t70 71.24 -2.06 2.51 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 124.63 1.172 . . . . 75.24 112.454 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 500' ' ' ASP . . . . . 0.622 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 48.3 m-20 -101.86 -40.6 6.84 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.461 -0.57 . . . . 74.54 109.461 -174.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -145.57 -26.13 0.46 Allowed 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.857 0.863 . . . . 73.51 111.583 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 451' ' ' GLU . . . -71.77 89.69 1.05 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.015 0.746 . . . . 63.32 113.015 -176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 76.09 -68.31 2.32 Favored Glycine 0 CA--C 1.502 -0.777 0 N-CA-C 110.874 -0.89 . . . . 61.05 110.874 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 499' ' ' ASP . 6.4 pt -89.33 137.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.2 -1.407 . . . . 72.42 107.2 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -146.95 155.15 42.05 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 121.043 -0.263 . . . . 72.52 110.849 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.5 t -155.43 -170.87 3.59 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.756 -1.201 . . . . 61.33 107.756 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.445 ' CD2' ' HG3' ' A' ' 508' ' ' GLU . 19.1 p90 -73.62 157.53 36.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.146 -0.687 . . . . 72.02 109.146 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' CD2' ' A' ' 507' ' ' PHE . 36.6 mt-10 70.81 96.08 0.07 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.293 0.996 . . . . 73.11 109.22 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--N 1.307 -1.246 0 CA-C-N 116.413 -0.358 . . . . 71.21 110.353 -178.11 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.622 'CA ' ' OD2' ' A' ' 500' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.615 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 122.424 1.107 . . . . 70.13 112.34 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 480' ' ' VAL . 69.9 m -156.84 107.49 2.34 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.057 -0.974 . . . . 54.23 109.405 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 96.4 mttt -92.91 148.64 21.84 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 123.392 0.432 . . . . 71.14 110.853 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.701 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 38.8 mm -125.12 109.16 21.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.572 -0.899 . . . . 73.44 108.572 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -145.71 162.78 36.79 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.425 -0.51 . . . . 71.43 110.85 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.1 151.42 28.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 110.122 -0.325 . . . . 71.44 110.122 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -59.77 4.52 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.902 -1.518 . . . . 72.5 106.902 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 15.3 mm100 -102.55 173.11 6.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.604 -0.726 . . . . 74.44 111.007 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.26 -40.36 1.95 Allowed Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.943 -1.026 . . . . 71.14 110.651 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.0 m -122.68 126.11 46.94 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.876 -0.787 . . . . 72.03 108.876 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 77.5 m-85 -115.81 142.79 46.29 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.48 -0.933 . . . . 72.21 108.48 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 495' ' ' THR . 14.0 mp0 -123.53 146.14 48.33 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.251 -1.388 . . . . 73.42 107.251 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' CYS . . . . . 0.569 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -149.77 151.29 33.35 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.982 -1.118 . . . . 63.44 107.982 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.4 OUTLIER -80.91 145.03 31.5 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.607 -0.886 . . . . 73.12 108.607 176.289 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.634 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 15.0 tt0 -58.97 -29.95 67.57 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.55 0.69 . . . . 61.23 110.064 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 384' ' ' LEU . 34.5 p30 -80.94 -1.44 43.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.455 -0.793 . . . . 65.23 112.558 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.45 -22.04 48.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.261 0.553 . . . . 64.01 111.182 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 91.6 -59.7 2.92 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.781 -0.723 . . . . 74.32 111.522 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.4 p -136.27 155.24 50.37 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.615 0.245 . . . . 74.41 110.793 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 N-CA-C 107.888 -1.153 . . . . 63.01 107.888 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.44 124.42 40.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.125 0.488 . . . . 64.11 110.592 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.74 137.41 53.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.248 -1.389 . . . . 52.44 107.248 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.9 m -104.49 134.4 47.74 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.703 -0.48 . . . . 72.3 109.703 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 80.1 mt -103.85 126.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.57 -1.27 . . . . 72.41 107.57 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 44.9 mm -103.93 121.53 55.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.323 -0.991 . . . . 60.24 108.323 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 55.7 ttt180 -105.71 122.17 45.51 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.492 -0.777 . . . . 74.15 109.557 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -139.12 167.53 21.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.822 -0.626 . . . . 64.24 110.762 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 142.43 -28.56 2.19 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.687 -0.768 . . . . 63.45 111.845 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 167.02 -132.9 2.74 Favored Glycine 0 C--N 1.298 -1.577 0 N-CA-C 109.599 -1.4 . . . . 71.25 109.599 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ASP . . . . . 0.482 ' O ' HD23 ' A' ' 401' ' ' LEU . 2.3 p-10 -139.98 121.98 15.66 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 108.671 -0.863 . . . . 74.02 108.671 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 400' ' ' ASP . 35.1 mt -146.12 125.47 13.09 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.214 -0.903 . . . . 62.42 109.351 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 5.6 p -87.44 -0.27 56.56 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.025 0.917 . . . . 74.3 109.11 174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.38 138.12 58.25 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.275 -1.33 . . . . 65.23 109.606 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 466' ' ' SER . 0.8 OUTLIER -80.77 112.33 18.05 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 124.073 0.858 . . . . 64.4 110.296 -176.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.78 132.62 51.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.793 -0.817 . . . . 64.14 108.793 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 36.8 m-85 -115.62 129.3 56.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.192 0.52 . . . . 72.42 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.476 HG11 HG21 ' A' ' 374' ' ' ILE . 7.6 p -129.78 133.86 64.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.197 -1.409 . . . . 63.12 107.197 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -99.77 124.64 45.24 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.086 -0.709 . . . . 51.11 109.086 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 11.6 p90 -110.64 147.47 34.22 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.172 -0.677 . . . . 63.33 109.172 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 48.6 ttp180 -157.21 150.44 23.83 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.825 -1.176 . . . . 72.1 107.825 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 63.7 p -96.87 171.0 8.78 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.552 -0.459 . . . . 73.05 110.24 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 9.4 tp10 -137.57 158.21 44.88 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.166 -0.679 . . . . 74.43 109.166 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -31.14 -62.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.712 2.405 . . . . 72.32 113.147 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.29 -74.52 0.39 Allowed Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.069 -0.968 . . . . 51.2 111.019 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 8.8 t -154.87 16.72 0.44 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.122 -1.066 . . . . 71.02 108.122 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.8 -169.44 3.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.539 -0.755 . . . . 64.25 110.371 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -128.85 120.98 27.25 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.325 -0.621 . . . . 71.02 109.325 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.47 124.55 29.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.714 0.769 . . . . 71.14 110.553 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.49 32.0 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 109.43 -1.468 . . . . 31.33 109.43 -173.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 14.9 m -110.54 -58.55 2.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.985 -0.746 . . . . 62.32 108.985 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.561 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 14.3 m-20 -82.71 -58.26 2.97 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 122.011 0.91 . . . . 74.3 109.677 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.701 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.34 158.99 43.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.635 -0.876 . . . . 71.13 108.635 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.82 144.88 45.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.879 -0.785 . . . . 73.32 108.879 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.538 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 17.7 p90 -79.4 -18.45 52.28 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 113.054 0.761 . . . . 74.1 113.054 -173.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 442' ' ' VAL 0.268 11.0 t 40.06 55.99 2.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 127.198 2.199 . . . . 74.42 115.311 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 1.5 pp20? -78.41 131.15 36.81 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 118.952 -1.099 . . . . 75.02 108.944 173.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -164.4 170.13 39.46 Favored Glycine 0 CA--C 1.46 -3.365 0 N-CA-C 109.93 -1.268 . . . . 72.35 109.93 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.5 m -111.35 131.63 55.02 Favored 'General case' 0 N--CA 1.394 -3.242 0 C-N-CA 119.739 -0.784 . . . . 72.14 108.888 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.67 125.49 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.941 -1.503 . . . . 71.23 106.941 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' VAL . . . . . 0.44 HG22 ' CE2' ' A' ' 406' ' ' PHE . 19.5 t -103.72 117.11 48.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.614 -0.884 . . . . 62.13 108.614 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.473 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 65.1 m-85 -94.91 105.02 16.91 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.188 0.518 . . . . 72.3 110.689 177.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 0.2 OUTLIER -90.12 167.64 16.47 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 114.652 -1.158 . . . . 71.5 110.315 -176.141 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 32.0 Cg_exo -57.03 115.09 2.24 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.872 2.381 . . . . 73.41 108.989 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.02 -38.04 3.32 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 111.523 -0.631 . . . . 62.3 111.523 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -85.97 62.37 7.4 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.717 0.77 . . . . 74.42 110.595 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 14.1 t -84.08 9.58 12.21 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 115.134 -0.939 . . . . 71.55 109.878 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -140.55 137.05 33.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -135.47 153.29 51.8 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.358 0.411 . . . . 75.35 111.193 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.26 128.54 55.67 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.537 -0.912 . . . . 71.51 108.537 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.91 149.56 19.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.857 -1.164 . . . . 73.21 107.857 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 79.9 mtm180 -133.28 143.36 49.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.174 0.511 . . . . 71.32 111.265 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 425' ' ' THR . 48.7 t -109.92 124.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.394 -0.965 . . . . 63.1 108.394 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -77.28 127.09 8.17 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.559 -0.616 . . . . 63.32 111.559 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.498 HD12 HG12 ' A' ' 496' ' ' ILE . 35.7 mm -89.97 134.74 28.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.162 -1.051 . . . . 63.44 108.162 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.2 mt -96.77 147.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.274 -1.38 . . . . 74.23 107.274 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -78.97 86.68 4.82 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.416 -0.513 . . . . 75.2 111.925 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.38 126.81 55.69 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 103.338 -2.838 . . . . 73.41 103.338 169.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 9.2 t70 -129.18 93.26 3.54 Favored 'General case' 0 CA--C 1.463 -2.366 0 CA-C-O 123.438 1.59 . . . . 64.23 109.785 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.756 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 51.8 mm -125.25 158.22 33.59 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.161 0 CA-C-N 111.283 -2.689 . . . . 42.33 104.608 -171.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 450' ' ' PHE . . . . . 0.469 ' HA ' ' CB ' ' A' ' 501' ' ' HIS . 98.2 m-85 -51.23 114.39 1.19 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.784 -1.932 . . . . 74.54 105.784 166.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.756 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 36.2 mt-10 -121.74 94.74 4.41 Favored 'General case' 0 CA--C 1.468 -2.21 0 CA-C-O 122.117 0.961 . . . . 71.44 111.476 -169.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.01 102.06 13.76 Favored 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 114.26 -1.336 . . . . 64.34 110.146 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.82 57.56 5.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.787 -1.552 . . . . 75.22 112.953 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . 85.2 mt-10 -71.01 113.22 7.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.379 0.609 . . . . 64.43 109.836 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -137.47 160.36 39.34 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.874 -0.603 . . . . 74.02 110.401 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.589 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.3 p90 -140.37 177.25 8.13 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.489 -0.778 . . . . 73.14 109.735 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -117.69 138.07 52.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.335 -0.987 . . . . 71.43 108.335 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.28 120.58 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.896 -1.52 . . . . 74.44 106.896 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -114.3 149.12 36.45 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.641 0.588 . . . . 74.43 109.683 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.72 127.45 53.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 20.3 m -142.01 178.71 7.34 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.373 -0.602 . . . . 72.22 109.373 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.8 t30 50.37 86.11 0.03 OUTLIER 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.778 1.231 . . . . 75.04 113.238 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 53.4 t -84.89 116.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.55 -0.907 . . . . 75.5 108.55 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 26.3 tptp -116.89 133.33 56.14 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.605 -1.998 . . . . 74.54 105.605 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.39 138.65 51.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.439 -0.904 . . . . 74.44 111.514 -173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.473 ' HB3' ' HB ' ' A' ' 404' ' ' THR . 33.9 t -137.64 150.62 47.54 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-O 121.348 0.594 . . . . 55.31 109.725 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 70.1 m -122.19 19.91 10.65 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.483 -0.932 . . . . 53.44 108.483 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.31 9.04 0.5 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.065 0.946 . . . . 70.43 112.797 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.27 -7.08 55.38 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.803 -0.814 . . . . 75.43 108.803 173.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 32.6 t -149.64 150.29 31.95 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 104.99 -2.226 . . . . 74.44 104.99 175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.87 -23.68 25.17 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.753 -0.779 . . . . 62.01 111.509 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -109.67 114.42 28.01 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.624 -0.51 . . . . 63.34 109.624 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 134.07 42.81 0.14 Allowed Glycine 0 C--N 1.299 -1.485 0 C-N-CA 120.992 -0.623 . . . . 54.12 111.657 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 41.5 mm -77.82 87.89 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.354 -0.98 . . . . 73.5 108.354 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 54.1 mt -86.84 -54.9 4.1 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.41 -0.814 . . . . 75.13 111.635 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 65.82 10.29 6.73 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.862 1.265 . . . . 63.43 112.1 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -104.91 21.28 17.3 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.228 1.013 . . . . 63.12 108.435 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -88.52 36.84 0.8 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.204 -1.406 . . . . 62.3 107.204 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -65.03 154.86 36.53 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 122.106 0.955 . . . . 72.55 113.312 -172.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 372' ' ' SER . 38.2 t -68.03 -45.42 83.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 113.058 -1.883 . . . . 65.23 109.955 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 43.6 t -128.47 -158.07 0.86 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.661 -1.607 . . . . 34.24 106.661 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -52.53 -54.8 27.87 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.264 -1.013 . . . . 41.15 108.264 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.27 -69.96 0.83 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 105.7 -1.963 . . . . 71.43 105.7 171.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -162.24 128.76 3.64 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.724 0.773 . . . . 73.24 111.299 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 36.8 t -174.4 129.25 0.35 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 102.619 -3.104 . . . . 73.11 102.619 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.701 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 2.6 mm? -72.44 -45.25 60.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 113.715 1.005 . . . . 73.01 113.715 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 144.77 -38.26 1.29 Allowed Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 107.0 -2.44 . . . . 74.3 107.0 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.489 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 15.6 m -118.32 175.05 2.26 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 103.603 -2.74 . . . . 73.53 103.603 169.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 488' ' ' SER . 3.6 Cg_exo -36.37 -52.83 1.11 Allowed 'Trans proline' 0 CA--C 1.583 2.949 0 C-N-CA 123.38 2.72 . . . . 70.11 118.491 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 27.8 m -111.8 125.72 54.3 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 126.983 2.113 . . . . 74.45 107.863 1.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 40.1 m -124.09 114.28 19.49 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 115.625 -0.716 . . . . 71.41 109.105 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.92 33.56 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.19 -1.041 . . . . 61.3 108.19 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 24.3 m -105.94 120.5 41.92 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.676 -0.41 . . . . 71.43 109.972 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 390' ' ' VAL . 73.0 t -107.12 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.93 -0.767 . . . . 52.33 108.93 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 37.7 m -104.36 117.98 35.51 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.813 -0.81 . . . . 73.22 108.813 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -97.08 118.9 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 109.341 -0.614 . . . . 63.33 109.341 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.577 ' O ' HD13 ' A' ' 384' ' ' LEU . 6.1 m-85 -83.25 105.22 14.04 Favored 'General case' 0 N--CA 1.389 -3.494 0 CA-C-N 115.513 -0.767 . . . . 62.41 110.963 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.667 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.2 t70 -56.6 -57.51 12.07 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 113.088 -1.869 . . . . 75.01 109.348 173.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.7 t70 69.87 0.82 3.19 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.922 1.289 . . . . 72.21 111.246 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.28 -62.64 1.36 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.834 0.826 . . . . 60.3 109.469 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.469 ' CB ' ' HA ' ' A' ' 450' ' ' PHE . 88.5 m-70 -130.77 25.81 5.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.423 -1.262 . . . . 73.41 107.878 -176.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 451' ' ' GLU . . . -67.85 -18.92 64.97 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 114.924 -1.034 . . . . 63.11 111.309 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 74.94 36.36 47.19 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 110.044 -1.222 . . . . 54.34 110.044 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.38 161.19 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 121.315 0.579 . . . . 61.21 109.568 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.25 -171.43 2.45 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 103.799 -2.667 . . . . 74.31 103.799 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 38.0 m -74.66 92.01 2.4 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 119.33 0.968 . . . . 55.22 110.208 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.42 138.87 40.18 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.612 -1.255 . . . . 74.2 107.612 177.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -90.7 125.35 35.65 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.028 -0.73 . . . . 74.43 109.028 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.507 0 N-CA-C 108.168 -1.049 . . . . 74.15 108.168 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.667 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.626 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.413 ' O ' ' HA3' ' A' ' 398' ' ' GLY . 59.5 t . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.707 -0.849 . . . . 72.05 108.707 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 66.9 m -73.14 104.46 4.22 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 123.613 0.571 . . . . 53.42 110.755 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.3 mmtp -92.79 119.35 32.06 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.251 -1.018 . . . . 72.03 108.251 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.563 ' HB ' HD12 ' A' ' 486' ' ' LEU . 25.9 mm -95.18 119.12 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.588 -1.187 . . . . 52.51 108.434 -176.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 160.93 42.49 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.925 0.33 . . . . 64.14 110.503 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.78 148.64 29.95 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.609 -0.515 . . . . 74.44 109.609 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.3 -43.83 85.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.586 -0.524 . . . . 60.54 109.586 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -115.22 176.29 5.13 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.885 -0.598 . . . . 64.33 110.676 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -110.36 -19.17 8.11 Favored Glycine 0 C--N 1.291 -1.964 0 CA-C-N 115.063 -0.971 . . . . 21.21 110.801 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 59.8 m -140.06 135.24 32.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.117 -1.068 . . . . 74.01 108.117 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 49.8 m-85 -125.41 141.2 52.2 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.076 -1.083 . . . . 70.53 108.076 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.61 132.67 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.505 -1.294 . . . . 74.32 107.505 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 15.2 t -151.81 165.52 34.23 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.149 -1.056 . . . . 72.14 108.149 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 2.4 mm? -81.03 143.33 32.57 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.216 0.531 . . . . 71.14 111.095 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.627 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 16.2 tt0 -59.94 -39.4 85.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.339 -0.846 . . . . 71.23 109.784 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -73.65 -4.4 34.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.534 -0.757 . . . . 75.13 112.474 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 89.1 m -71.11 -22.33 62.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 122.109 -0.369 . . . . 51.1 111.953 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 94.68 -50.11 2.04 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.706 -0.759 . . . . 43.43 111.565 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.464 HG22 ' HA2' ' A' ' 443' ' ' GLY . 18.9 p -139.28 160.4 39.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.911 -0.403 . . . . 51.25 109.911 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 494' ' ' VAL . 6.0 p -114.83 133.8 59.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.281 -1.377 . . . . 74.2 107.281 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.41 125.83 48.11 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.201 0.524 . . . . 44.12 110.187 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.5 mp -116.52 153.68 31.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.121 -1.437 . . . . 72.23 107.121 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 28.1 m -120.6 126.93 51.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.335 0.588 . . . . 72.22 110.816 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.7 mt -100.69 120.27 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 108.204 -1.035 . . . . 44.42 108.204 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.481 HG22 ' HG2' ' A' ' 397' ' ' ARG . 46.2 mm -97.89 114.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.892 -1.049 . . . . 73.43 108.273 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.705 ' HB3' ' O ' ' A' ' 436' ' ' THR . 56.0 ttt180 -100.68 112.15 24.5 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 108.232 -1.025 . . . . 72.14 108.232 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 397' ' ' ARG . 4.3 mmp_? -113.55 161.64 17.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.518 -0.549 . . . . 75.35 109.518 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 371' ' ' VAL . . . 106.89 2.09 36.54 Favored Glycine 0 C--N 1.304 -1.21 0 C-N-CA 120.262 -0.971 . . . . 73.24 111.8 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 158.6 105.07 0.21 Allowed Glycine 0 N--CA 1.424 -2.117 0 C-N-CA 121.025 -0.607 . . . . 51.43 112.165 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -81.55 119.67 24.06 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 104.837 -2.283 . . . . 41.41 104.837 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 53.0 mt -148.45 159.34 44.13 Favored 'General case' 0 C--N 1.269 -2.892 0 C-N-CA 119.848 -0.741 . . . . 75.15 111.745 -167.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 433' ' ' PRO . 3.0 p -88.29 -3.98 58.76 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 114.455 -1.248 . . . . 72.24 110.159 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.412 ' HB3' ' OE1' ' A' ' 476' ' ' GLU . 2.3 m-20 -70.02 135.81 49.72 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.667 -1.152 . . . . 74.32 110.57 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 31.9 m -89.9 112.71 24.16 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.218 -0.901 . . . . 71.31 111.282 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.23 144.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.065 -0.97 . . . . 62.13 108.48 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 14.7 m-85 -119.7 132.08 55.57 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.905 0.383 . . . . 74.11 110.027 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 374' ' ' ILE . 3.7 p -132.78 131.68 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.834 -1.543 . . . . 63.01 106.834 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 11.3 t70 -98.97 136.68 38.6 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.802 -0.561 . . . . 74.13 111.492 -173.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -135.83 165.78 24.83 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.982 0.42 . . . . 72.42 110.536 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -167.12 155.53 9.78 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.579 -1.637 . . . . 73.3 106.579 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.681 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 26.1 p -96.62 160.81 14.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.437 -0.579 . . . . 54.31 109.437 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 16.0 tp10 -106.76 169.86 8.28 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.523 -1.288 . . . . 70.22 107.523 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 8.6 p-10 -63.03 -39.43 94.73 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.992 0.901 . . . . 64.42 110.255 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 72.21 -98.86 0.84 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.397 -1.274 . . . . 65.15 110.475 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 455' ' ' ASN . 10.8 t -122.34 -2.27 9.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.339 1.066 . . . . 74.34 108.65 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . . . -124.72 -153.28 0.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.816 -1.179 . . . . 31.43 107.816 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -133.93 116.11 15.2 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 118.199 0.454 . . . . 72.02 110.019 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.69 24.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.819 -0.808 . . . . 62.32 108.819 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.13 -19.27 25.13 Favored Glycine 0 C--N 1.288 -2.099 0 N-CA-C 110.539 -1.024 . . . . 64.41 110.539 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 m -115.84 -51.05 2.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.82 0.343 . . . . 64.1 110.568 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.613 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 16.3 m-20 -79.98 -64.57 1.16 Allowed 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 122.369 1.081 . . . . 72.43 108.819 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.652 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -134.29 162.6 31.73 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.19 -1.368 . . . . 74.44 107.899 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 425' ' ' THR . 5.9 tp10 -82.82 154.38 24.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.486 0.66 . . . . 64.32 111.792 -172.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.681 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.5 OUTLIER -79.1 -12.11 60.0 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.16 -0.927 . . . . 72.22 113.014 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.528 HG21 HG22 ' A' ' 442' ' ' VAL 0.253 13.3 t 33.64 69.47 0.14 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.734 1.614 . . . . 70.03 113.29 -177.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.26 129.48 34.5 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.254 -0.884 . . . . 73.22 109.647 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -174.11 175.59 46.57 Favored Glycine 0 N--CA 1.405 -3.425 0 C-N-CA 119.783 -1.199 . . . . 63.22 111.025 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 7.9 m -112.81 142.26 45.66 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.247 -1.39 . . . . 72.21 107.247 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 407' ' ' VAL . 22.4 t -95.16 111.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.528 -1.656 . . . . 74.22 106.528 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.3 106.51 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 115.036 -0.984 . . . . 75.44 109.093 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' ' 404' ' ' THR . 70.7 m-85 -77.61 94.26 4.34 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.268 -0.878 . . . . 74.43 109.887 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -73.98 163.77 65.99 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.971 -0.559 . . . . 44.2 111.021 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 48.1 Cg_exo -51.28 113.84 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.47 2.113 . . . . 72.03 112.686 175.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.74 -24.0 32.95 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.832 -0.699 . . . . 53.13 111.488 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.443 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 9.7 mm-40 -86.06 61.28 6.74 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.754 -0.832 . . . . 74.23 108.754 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.705 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 12.4 m -67.45 -33.73 75.74 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 107.613 -1.254 . . . . 73.35 107.613 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -104.26 132.8 50.13 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 106.607 -1.627 . . . . 63.31 106.607 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -118.73 147.53 43.75 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.118 0.485 . . . . 73.14 111.481 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.99 132.29 54.29 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 115.075 -0.966 . . . . 74.51 108.512 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.0 pt -119.24 146.78 23.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.435 -0.95 . . . . 71.32 108.435 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 85.9 mtt180 -126.82 141.16 51.9 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-O 121.698 0.761 . . . . 73.35 111.942 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.661 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 57.6 t -109.08 126.37 66.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.384 -1.339 . . . . 74.53 107.384 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -76.49 123.53 6.79 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.948 -0.861 . . . . 42.51 110.948 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.508 HD12 HG12 ' A' ' 496' ' ' ILE . 42.1 mm -86.57 132.92 31.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.051 -1.833 . . . . 75.22 106.051 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.613 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -94.32 149.27 4.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 105.134 -2.172 . . . . 63.33 105.134 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.66 85.79 4.67 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.801 -0.76 . . . . 65.13 110.733 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.25 112.92 23.9 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.075 -2.195 . . . . 73.11 105.075 172.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.638 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 14.4 t0 -118.0 93.61 4.2 Favored 'General case' 0 C--N 1.275 -2.671 0 C-N-CA 117.274 -1.771 . . . . 74.11 109.538 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.636 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 44.6 mm -125.9 156.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.86 0 CA-C-N 111.693 -2.503 . . . . 62.44 105.423 -172.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -49.45 115.03 1.18 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.458 -1.682 . . . . 75.4 106.458 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.2 mt-10 -129.35 121.42 27.42 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 109.621 -0.511 . . . . 74.13 109.621 -172.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -134.01 113.9 12.64 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.661 -1.237 . . . . 73.42 107.661 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 20.8 t70 56.74 54.88 6.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.518 1.127 . . . . 54.35 110.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -86.58 98.63 11.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.332 -1.358 . . . . 72.22 107.332 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.584 ' O ' HG22 ' A' ' 415' ' ' THR . 0.0 OUTLIER -131.85 143.4 50.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 122.108 0.956 . . . . 71.01 113.274 -176.467 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.661 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.9 p90 -116.74 177.04 4.84 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.742 -1.117 . . . . 74.0 109.453 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -121.94 136.4 54.92 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.647 -1.242 . . . . 74.34 107.647 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 15.6 t -108.25 131.24 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.616 -1.253 . . . . 62.24 107.616 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -123.46 164.44 18.91 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.769 0.668 . . . . 74.24 109.769 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 91.3 mt -126.51 139.27 53.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.834 -0.432 . . . . 62.13 109.834 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 50.2 m -156.94 178.5 10.29 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.536 -0.912 . . . . 75.24 108.536 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 8.3 t30 42.75 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.653 1.581 . . . . 73.12 114.731 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.37 139.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 115.834 -0.621 . . . . 73.02 109.651 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 24.4 ttmm -132.67 154.32 50.24 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.922 -1.14 . . . . 71.43 107.922 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 14.9 t -114.27 154.87 15.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 106.368 -1.715 . . . . 75.21 106.368 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.7 t -73.71 109.41 7.2 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.526 -1.657 . . . . 71.34 106.526 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 6.9 m -104.49 78.43 1.47 Allowed 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.84 -1.17 . . . . 71.42 107.84 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -99.49 -53.35 3.23 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.383 -0.826 . . . . 65.01 109.654 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -68.6 -47.06 67.67 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.359 -0.837 . . . . 73.24 109.644 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 50.6 m -133.8 134.94 43.46 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 108.113 -1.069 . . . . 50.44 108.113 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.56 -37.4 36.48 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.273 -0.64 . . . . 74.13 109.273 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -120.44 137.91 54.07 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.103 -1.073 . . . . 63.41 108.103 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 101.7 84.18 1.78 Allowed Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 108.224 -1.95 . . . . 75.45 108.224 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.28 110.92 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-O 121.528 0.68 . . . . 75.12 109.475 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 49.7 mt -67.06 -29.18 68.89 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.575 -1.193 . . . . 70.43 112.05 -174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLU . . . . . 0.412 ' OE1' ' HB3' ' A' ' 403' ' ' ASN . 13.8 pt-20 -112.16 135.93 52.21 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.06 -175.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -105.08 19.5 20.5 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.283 0.475 . . . . 73.25 112.283 -176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.28 5.7 49.53 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.869 -0.52 . . . . 73.42 111.288 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -87.86 150.29 23.61 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.1 0.476 . . . . 74.35 111.924 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.82 110.24 20.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.566 -0.743 . . . . 71.2 109.813 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 49.4 m -162.95 156.78 20.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 122.154 -0.341 . . . . 74.12 110.117 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . 68.28 -53.95 0.53 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.687 1.595 . . . . 73.32 114.676 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -124.61 -37.9 2.45 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.878 -1.527 . . . . 55.14 106.878 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.42 123.93 34.55 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.378 -0.828 . . . . 71.45 109.383 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 20.0 p -107.51 -171.18 1.83 Allowed 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.834 -1.173 . . . . 72.3 107.834 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.0 OUTLIER -69.54 171.98 8.03 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.324 -0.621 . . . . 72.42 109.324 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.666 ' O ' ' HD3' ' A' ' 489' ' ' PRO . . . -77.82 79.24 1.44 Allowed Glycine 0 C--O 1.209 -1.451 0 N-CA-C 105.223 -3.151 . . . . 54.22 105.223 171.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.5 m -78.89 110.55 14.84 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 116.545 2.054 . . . . 74.2 116.545 -160.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 487' ' ' GLY . 4.6 Cg_exo -71.37 -60.92 0.05 OUTLIER 'Trans proline' 0 CA--C 1.589 3.234 0 CA-C-O 118.096 -0.877 . . . . 75.13 111.017 163.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.561 ' HA ' ' CD ' ' A' ' 489' ' ' PRO . 48.7 m -121.63 88.05 2.87 Favored 'General case' 0 C--N 1.385 2.137 0 CA-C-N 121.61 2.005 . . . . 71.44 107.921 -6.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 39.0 m -145.21 105.19 4.03 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 109.081 -0.711 . . . . 70.01 109.081 177.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 492' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -99.47 99.74 10.69 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.603 -1.628 . . . . 74.22 106.603 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 36.9 m -79.98 120.32 24.01 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.566 -0.531 . . . . 61.13 109.566 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 390' ' ' VAL . 72.2 t -107.0 105.48 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 116.181 -0.463 . . . . 71.01 109.759 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 86.7 m -88.69 111.5 22.02 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.533 -0.914 . . . . 73.41 108.533 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.652 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -87.1 117.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 108.998 -0.742 . . . . 73.21 108.998 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.452 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.9 m-85 -83.47 97.58 9.06 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-O 122.182 0.991 . . . . 74.41 112.169 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.8 t70 -51.58 -56.24 14.64 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.212 -2.267 . . . . 62.1 108.312 170.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.0 t70 66.71 3.01 2.79 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.72 1.608 . . . . 50.32 111.306 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -92.15 -58.62 2.33 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.735 -1.209 . . . . 74.34 107.735 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -107.24 -18.43 13.88 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.245 -1.343 . . . . 54.43 108.999 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -69.55 100.12 1.38 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.278 -1.008 . . . . 61.53 108.278 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -85.87 54.88 4.8 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 116.369 -0.378 . . . . 62.04 113.536 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.54 HD13 ' H ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER -84.14 -28.03 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.555 0.693 . . . . 63.55 109.79 177.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.405 ' CD2' HG12 ' A' ' 504' ' ' ILE . 75.4 m-85 -143.78 -85.25 0.14 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.281 -1.378 . . . . 73.11 107.281 175.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 25.9 m 46.18 87.64 0.02 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.508 1.523 . . . . 62.21 114.171 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.95 88.4 2.86 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.411 -1.7 . . . . 70.53 106.411 173.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -168.15 168.23 11.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.924 -1.509 . . . . 74.23 106.924 -171.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.195 0 C-N-CA 122.772 0.429 . . . . 75.2 111.11 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.638 'CA ' ' OD1' ' A' ' 448' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.631 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.526 -0.546 . . . . 72.44 109.526 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 480' ' ' VAL . 20.1 m -73.24 99.23 2.81 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.256 -0.646 . . . . 63.43 109.256 177.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 28.7 mmtp -92.01 117.72 30.09 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.431 -0.908 . . . . 44.25 109.128 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.651 ' HB ' HD12 ' A' ' 486' ' ' LEU . 31.7 mm -98.81 118.27 45.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.813 -1.54 . . . . 71.24 108.49 -175.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -154.87 174.15 15.51 Favored 'General case' 0 C--O 1.196 -1.718 0 CA-C-N 117.728 0.24 . . . . 74.22 110.364 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -92.74 153.0 19.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.345 -0.542 . . . . 74.34 112.268 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -54.53 37.68 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.659 -1.238 . . . . 73.51 107.659 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -106.51 160.86 15.1 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.559 -0.746 . . . . 74.33 110.693 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -96.31 -18.72 30.16 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 110.057 -1.217 . . . . 35.12 110.057 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 493' ' ' THR . 73.8 m -143.07 125.54 15.72 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 109.038 -0.727 . . . . 70.21 109.038 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 45.2 m-85 -109.84 136.23 49.48 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.289 -1.004 . . . . 74.03 108.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -130.28 122.82 28.71 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 390' ' ' VAL . 94.6 m -145.14 165.4 28.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.993 -0.743 . . . . 74.1 108.993 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' LEU . . . . . 0.755 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -78.19 149.66 33.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.967 0.413 . . . . 75.11 111.357 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.606 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 13.9 tt0 -60.76 -28.29 68.61 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.642 1.211 . . . . 73.13 107.833 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -81.91 -4.72 57.25 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.327 -1.761 . . . . 51.03 111.833 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 78.7 m -77.23 -14.53 59.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 122.234 -0.291 . . . . 65.31 110.811 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.19 -53.6 3.9 Favored Glycine 0 CA--C 1.5 -0.882 0 N-CA-C 111.309 -0.717 . . . . 53.02 111.309 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' THR . . . . . 0.548 HG22 ' HA2' ' A' ' 443' ' ' GLY . 11.1 p -139.03 164.31 30.09 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.674 . . . . 52.03 109.179 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 494' ' ' VAL . 7.3 p -117.82 129.37 74.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.564 -1.273 . . . . 63.1 107.564 173.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 440' ' ' ILE . . . -96.53 135.31 38.6 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.873 0.368 . . . . 75.0 110.291 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.436 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -126.19 145.37 50.4 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.839 -1.171 . . . . 64.13 107.839 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.3 m -112.85 124.2 52.05 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.226 0.536 . . . . 62.51 110.362 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.21 120.03 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.883 -1.154 . . . . 73.24 107.883 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.4 mm -99.13 116.04 41.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.469 -1.241 . . . . 64.53 108.417 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 44.3 ttt180 -102.62 113.05 26.1 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.522 -1.288 . . . . 74.51 107.522 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -104.93 149.76 25.45 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.681 0.623 . . . . 75.33 112.681 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 167.1 -179.59 40.7 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 107.52 -2.232 . . . . 63.54 107.52 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -76.85 -64.81 2.07 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 110.88 -0.888 . . . . 61.52 110.88 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -144.26 121.4 11.48 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 107.015 -1.476 . . . . 74.1 107.015 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 87.3 mt -130.65 99.92 5.13 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.588 0.709 . . . . 50.44 111.47 -174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 49.3 p -102.41 1.93 35.96 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.477 -0.783 . . . . 74.53 109.429 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -70.91 171.95 9.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.46 -0.791 . . . . 64.32 109.941 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 60.9 m -124.29 113.45 18.27 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.014 0.912 . . . . 63.1 111.896 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.91 140.26 35.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 113.887 -1.506 . . . . 44.04 108.292 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 16.5 m-85 -120.07 129.27 54.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.582 -0.895 . . . . 73.32 108.582 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.22 132.69 70.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.887 -1.153 . . . . 64.24 107.887 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.05 147.09 27.4 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.805 -0.442 . . . . 60.42 109.805 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -141.72 163.99 31.41 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.868 -0.52 . . . . 74.54 111.792 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -158.13 168.93 25.72 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 125.313 1.445 . . . . 73.44 109.006 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 69.0 p -96.89 162.06 13.57 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.527 -1.286 . . . . 72.13 107.527 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -126.32 151.41 47.59 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.105 -0.638 . . . . 75.41 111.032 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 416' ' ' ALA . 2.5 p30 -65.71 2.77 0.9 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.795 2.038 . . . . 71.24 115.957 -176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.48 -73.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 124.92 1.247 . . . . 74.03 116.007 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.8 t -122.37 6.62 9.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 117.716 0.758 . . . . 54.32 110.304 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 413' ' ' ASP . . . -158.76 171.89 19.25 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 109.241 -0.652 . . . . 70.21 109.241 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -120.23 131.97 55.17 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.619 0.723 . . . . 71.31 112.073 -172.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -78.67 138.66 38.4 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.879 -1.055 . . . . 55.1 108.945 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.76 65.72 Favored Glycine 0 C--N 1.3 -1.467 0 N-CA-C 109.983 -1.247 . . . . 73.14 109.983 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 49.0 m -141.28 -59.02 0.49 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 122.546 0.339 . . . . 71.44 110.215 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.639 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 12.8 m-20 -77.82 -57.91 3.55 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-O 122.038 0.923 . . . . 73.43 108.744 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' TYR . . . . . 0.758 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -140.3 168.85 18.85 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.642 -1.163 . . . . 64.33 108.14 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.12 169.71 17.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.9 -0.408 . . . . 73.32 109.9 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.596 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.7 p90 -101.56 -17.21 16.49 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.265 0.469 . . . . 74.32 112.265 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' THR . . . . . 0.536 HG21 HG22 ' A' ' 442' ' ' VAL . 9.6 t 40.54 65.36 0.78 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.096 1.758 . . . . 53.02 113.108 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.09 114.92 18.42 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.665 -0.698 . . . . 70.51 110.124 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.71 172.92 33.8 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 110.948 -0.861 . . . . 71.53 110.948 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.1 m -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.585 -0.895 . . . . 63.43 108.585 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 33.5 t -96.52 128.36 47.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.901 -0.778 . . . . 65.13 108.901 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.16 112.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.53 -0.544 . . . . 75.33 109.53 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.6 m-85 -93.56 94.42 8.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.984 0.421 . . . . 74.41 110.603 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.0 mttt -89.08 176.17 3.41 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.137 -0.938 . . . . 75.24 110.212 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.546 ' HG3' ' O ' ' A' ' 402' ' ' THR . 31.1 Cg_exo -62.22 119.57 6.74 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.055 1.837 . . . . 70.21 110.431 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.12 -21.81 34.73 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.14 -0.784 . . . . 52.23 111.14 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -88.3 62.27 6.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.639 -0.874 . . . . 62.15 108.639 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 5.1 m -69.74 -28.15 65.55 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.428 -1.26 . . . . 73.13 108.537 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.23 145.62 49.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.184 -1.413 . . . . 74.32 107.184 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -132.89 148.27 52.29 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.539 0.209 . . . . 65.04 110.938 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.5 131.54 54.77 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.073 -0.512 . . . . 72.13 109.851 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 391' ' ' ALA . 44.5 pt -124.11 152.13 29.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.063 -0.717 . . . . 73.01 109.063 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 67.0 mtm180 -127.01 143.61 51.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.534 0.207 . . . . 72.43 110.65 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.548 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 93.6 t -109.9 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.44 -0.948 . . . . 62.21 108.44 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -66.65 122.42 19.98 Favored Glycine 0 N--CA 1.437 -1.258 0 O-C-N 123.984 0.802 . . . . 51.11 111.614 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.502 HD12 HG12 ' A' ' 496' ' ' ILE . 50.4 mm -95.63 134.13 34.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.452 -0.944 . . . . 63.01 108.452 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.3 mt -99.02 148.12 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 106.019 -1.845 . . . . 74.14 106.019 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.5 89.56 7.26 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 121.767 0.794 . . . . 54.12 111.777 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.37 117.37 34.42 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.266 -1.383 . . . . 64.22 107.266 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.439 33.1 m-20 -102.43 85.02 2.53 Favored 'General case' 0 CA--C 1.446 -3.025 0 CA-C-O 123.736 1.732 . . . . 75.42 114.346 177.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 449' ' ' ILE . . . . . 0.741 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.8 mm -122.44 153.42 27.04 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 0 N-CA-C 102.368 -3.197 . . . . 74.21 102.368 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -56.86 116.37 3.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.528 -1.286 . . . . 74.32 107.528 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.741 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 45.6 mt-10 -112.3 118.66 35.87 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 121.191 0.52 . . . . 72.33 111.793 -172.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -136.41 111.62 9.05 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.095 -1.411 . . . . 74.45 107.97 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.54 26.96 14.98 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.364 0.876 . . . . 53.21 113.364 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLU . . . . . 0.532 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 24.4 tt0 -66.22 109.69 2.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.223 -1.028 . . . . 74.42 108.223 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.41 168.67 19.19 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.039 -0.528 . . . . 73.34 110.475 -175.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' PHE . . . . . 0.586 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 18.6 p90 -140.11 171.5 14.09 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.221 -0.659 . . . . 72.0 109.221 173.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 38.2 mt -114.4 136.34 53.1 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.532 -1.284 . . . . 71.33 107.532 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 56.7 t -102.06 113.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.415 -1.328 . . . . 74.21 107.415 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.39 136.3 48.26 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 123.571 0.545 . . . . 71.43 110.837 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.6 mt -96.86 132.18 42.87 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.001 -0.74 . . . . 64.54 109.001 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.4 m -151.07 176.26 11.32 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.704 -0.851 . . . . 74.33 108.704 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.95 81.16 0.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.192 0.997 . . . . 72.35 112.297 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.453 HG11 ' O ' ' A' ' 480' ' ' VAL . 58.5 t -87.7 123.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 115.401 -0.818 . . . . 61.13 109.283 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 39.6 ttmt -116.46 131.69 56.88 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.111 -1.07 . . . . 72.21 108.111 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.24 151.49 7.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.089 -1.078 . . . . 71.32 108.089 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 35.5 t -74.18 131.29 41.12 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.49 0.662 . . . . 73.4 111.72 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 11.9 t -113.13 94.84 5.08 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 105.74 -1.948 . . . . 71.21 105.74 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.38 -167.48 1.61 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.629 -0.714 . . . . 75.33 111.242 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -66.19 -13.17 59.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.992 -0.549 . . . . 65.23 111.474 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 33.3 t -74.82 77.65 2.11 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.099 0.952 . . . . 65.12 108.446 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -86.39 -2.08 58.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.299 1.047 . . . . 70.34 109.363 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -72.38 -17.18 61.84 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.702 -1.136 . . . . 71.42 108.895 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 127.18 79.85 0.3 Allowed Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.602 -0.809 . . . . 54.34 113.066 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.58 98.04 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 107.421 -1.326 . . . . 72.31 107.421 174.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.4 mt -132.45 96.04 3.76 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.294 -1.321 . . . . 73.11 107.913 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.94 154.1 18.32 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.342 -0.844 . . . . 73.25 110.556 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -104.9 24.32 12.1 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.011 0.434 . . . . 71.22 111.139 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -108.76 31.09 5.91 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.254 -0.43 . . . . 72.43 111.013 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -129.7 176.72 7.79 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.802 -0.561 . . . . 70.31 111.483 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 372' ' ' SER . 12.7 m -102.05 148.47 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 116.069 -0.514 . . . . 72.44 110.12 175.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 68.0 m -161.07 -92.55 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.88 1.272 . . . . 64.43 109.778 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -124.53 -11.33 7.34 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 122.107 -0.371 . . . . 51.42 111.552 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -89.85 -56.14 3.35 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 104.322 -2.473 . . . . 74.3 104.322 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -107.63 134.12 51.08 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 106.465 -1.68 . . . . 63.34 106.465 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 74.1 m -120.01 -170.05 1.89 Allowed 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 109.288 -0.634 . . . . 74.52 109.288 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.651 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.3 mm? -64.23 155.74 30.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.299 -0.26 . . . . 75.2 110.299 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -71.69 -30.09 66.72 Favored Glycine 0 C--N 1.32 -0.34 0 N-CA-C 111.774 -0.53 . . . . 41.15 111.774 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.507 ' C ' ' HA ' ' A' ' 490' ' ' SER . 15.0 m -89.85 166.84 18.97 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 108.615 -0.883 . . . . 54.23 108.615 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.662 ' N ' ' HA ' ' A' ' 490' ' ' SER . 24.6 Cg_exo -58.29 -25.09 70.99 Favored 'Trans proline' 0 CA--C 1.592 3.417 0 N-CA-C 120.237 3.13 . . . . 64.15 120.237 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.662 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 15.3 m -106.48 108.04 19.35 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 122.684 2.493 . . . . 72.44 109.055 0.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.453 ' H ' ' HD2' ' A' ' 489' ' ' PRO . 31.8 m -121.8 105.34 10.29 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-O 121.171 0.51 . . . . 74.15 110.164 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -109.82 118.28 36.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.115 -1.439 . . . . 72.41 107.115 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 380' ' ' THR . 41.2 m -87.67 131.66 34.38 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 120.837 0.351 . . . . 62.53 110.23 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 494' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 390' ' ' VAL . 78.5 t -116.64 106.51 20.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.668 -1.234 . . . . 73.33 107.668 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 47.9 m -97.78 112.84 24.58 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.303 -0.999 . . . . 52.31 108.303 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.758 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -89.79 115.57 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 122.144 0.973 . . . . 72.11 110.409 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.755 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 83.7 m-85 -99.8 120.86 40.41 Favored 'General case' 0 N--CA 1.396 -3.129 0 CA-C-N 114.796 -1.093 . . . . 74.31 108.176 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 498' ' ' ASP . . . . . 0.616 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 31.8 t0 -99.92 -7.55 25.08 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-O 122.603 1.192 . . . . 74.05 107.97 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 502' ' ' ALA . 16.9 t70 60.53 30.45 19.77 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 113.276 -1.784 . . . . 64.21 106.297 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 500' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 498' ' ' ASP . 13.6 t70 -71.04 -76.88 0.1 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.532 -2.122 . . . . 65.01 109.534 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -105.93 -35.93 7.14 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.588 -1.264 . . . . 75.41 107.588 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 499' ' ' ASP . . . -82.25 107.96 15.33 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.908 -1.042 . . . . 51.42 108.575 175.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -89.49 128.68 9.31 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 111.333 -0.707 . . . . 52.55 111.333 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 40.1 pt -127.36 -173.22 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 120.994 0.426 . . . . 74.21 110.651 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.9 83.71 2.14 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-O 122.491 1.139 . . . . 54.21 110.247 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 33.1 m -151.05 145.37 25.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 104.34 -2.467 . . . . 71.15 104.34 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.78 156.86 24.73 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 118.739 0.7 . . . . 71.03 111.72 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -95.57 110.42 22.51 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.983 -0.553 . . . . 75.03 110.324 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--N 1.298 -1.655 0 N-CA-C 109.361 -0.607 . . . . 72.41 109.361 178.881 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . 0.644 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 650' ' ' ' CA' . . . . . 0.628 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 96.5 mttt . . . . . 0 N--CA 1.415 -2.223 0 N-CA-C 109.195 -0.668 . . . . 74.219999999999999 109.195 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.455 HG21 HG11 ' A' ' 407' ' ' VAL . 30.9 mm -94.71 136.31 26.3 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 105.374 -2.084 . . . . 73.200000000000003 105.374 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -165.6 160.53 17.65 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 118.278 0.49 . . . . 72.409999999999997 111.697 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -79.22 141.01 37.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.674 -0.491 . . . . 75.439999999999998 109.674 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -65.18 -44.99 86.68 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.592 -0.892 . . . . 65.439999999999998 108.592 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -114.44 161.68 17.66 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.401 -0.818 . . . . 74.329999999999998 111.053 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.93 -19.11 18.16 Favored Glycine 0 C--N 1.278 -2.67 0 CA-C-N 114.425 -1.261 . . . . 73.140000000000001 110.406 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.7 m -138.6 134.21 33.47 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.992 -0.744 . . . . 72.219999999999999 108.992 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 72.5 m-85 -124.5 140.38 53.0 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.704 -1.221 . . . . 74.420000000000002 107.704 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.459 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 19.2 mt-30 -129.82 140.4 51.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.576 -0.898 . . . . 43.200000000000003 108.576 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.8 p -151.88 159.86 43.71 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.737 -0.838 . . . . 62.329999999999998 108.737 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.1 mm? -74.98 148.72 39.69 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.45 0.469 . . . . 64.140000000000001 109.906 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.83 -36.83 84.5 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.697 0.761 . . . . 74.510000000000005 109.425 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.459 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.7 p-10 -81.15 6.21 14.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.461 -0.791 . . . . 74.209999999999994 112.283 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 54.1 t -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.395 0.617 . . . . 61.210000000000001 110.402 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.17 -61.42 0.53 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.769 -0.932 . . . . 60.5 110.769 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 6.2 p -137.71 152.57 49.39 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.708 0.29 . . . . 75.340000000000003 111.143 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.638 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 7.7 p -109.97 127.43 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 107.976 -1.12 . . . . 74.310000000000002 107.976 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.71 120.64 38.46 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.141 0.496 . . . . 54.149999999999999 110.482 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -111.1 152.86 26.47 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.269 -1.382 . . . . 61.229999999999997 107.269 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.0 m -123.93 128.47 49.48 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.27 0.557 . . . . 71.450000000000003 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.89 125.56 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.796 -1.187 . . . . 52.219999999999999 107.796 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.54 144.95 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.645 -1.243 . . . . 72.420000000000002 107.645 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.506 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 55.8 ttt180 -127.28 121.06 30.1 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 116.068 -0.515 . . . . 73.209999999999994 109.94 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 . . . . . 0 C--N 1.309 -1.163 0 CA-C-N 115.761 -0.654 . . . . 71.109999999999999 111.028 178.426 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 14.0 m . . . . . 0 N--CA 1.429 -1.525 0 CA-C-O 121.616 0.722 . . . . 65.25 111.75 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.38 133.89 43.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.231 -0.895 . . . . 55.439999999999998 108.737 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -115.94 126.97 54.59 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.75 0.42 . . . . 71.439999999999998 109.948 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.455 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -125.29 135.36 64.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.294 -1.743 . . . . 72.230000000000004 106.294 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 140.45 35.05 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.24 -0.652 . . . . 60.240000000000002 109.24 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -135.25 160.59 37.9 Favored 'General case' 0 C--O 1.254 1.305 0 C-N-CA 120.676 -0.41 . . . . 65.219999999999999 110.646 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 30.6 ttt180 -164.03 158.02 19.02 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.263 -1.754 . . . . 52.25 106.263 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.723 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 43.2 p -96.3 150.39 20.62 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.863 -0.791 . . . . 63.340000000000003 108.863 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.9 tp10 -105.64 139.8 39.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.735 -1.209 . . . . 74.409999999999997 107.735 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.423 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 3.7 m-20 -52.39 -39.03 60.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.512 1.125 . . . . 64.400000000000006 112.651 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 57.96 -94.99 0.05 OUTLIER Glycine 0 C--N 1.295 -1.708 0 CA-C-N 114.755 -1.111 . . . . 72.129999999999995 113.717 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -124.18 17.83 9.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.498 1.142 . . . . 63.43 108.889 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -148.27 -160.52 1.18 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.678 -1.23 . . . . 53.229999999999997 107.678 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 417' ' ' ASN . 2.8 m120 -132.71 126.71 33.16 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 113.028 0.751 . . . . 72.310000000000002 113.028 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.43 124.37 28.85 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.914 -1.143 . . . . 62.32 107.914 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.48 -5.69 54.99 Favored Glycine 0 C--N 1.3 -1.465 0 N-CA-C 110.69 -0.964 . . . . 74.349999999999994 110.69 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 19.9 m -126.13 -51.83 1.53 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.877 0.37 . . . . 61.409999999999997 110.114 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.489 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 7.6 m-20 -86.46 -57.14 3.11 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 122.205 1.002 . . . . 72.319999999999993 109.726 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.689 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.47 165.03 28.61 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 115.116 -0.947 . . . . 62.530000000000001 109.683 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.69 162.15 28.3 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.936 0.773 . . . . 71.439999999999998 111.788 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.723 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 2.4 p90 -97.93 -17.87 18.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.124 -0.943 . . . . 65.239999999999995 111.875 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.495 HG21 HG22 ' A' ' 442' ' ' VAL . 6.9 t 32.93 56.37 0.44 Allowed 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.594 1.558 . . . . 45.140000000000001 113.844 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.546 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.3 pt-20 -79.89 119.28 22.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.624 0.726 . . . . 73.129999999999995 111.614 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.51 -167.51 23.04 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.617 -0.993 . . . . 55.119999999999997 110.617 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.8 m -127.78 137.51 52.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 70.109999999999999 108.514 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.23 118.49 42.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.532 -0.914 . . . . 74.140000000000001 108.532 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.36 107.42 19.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.854 -1.066 . . . . 72.239999999999995 109.324 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 404' ' ' THR . 71.1 m-85 -90.38 94.35 9.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.255 0.55 . . . . 72.519999999999996 110.784 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.476 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 67.3 mttm -84.54 175.71 4.39 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.637 -1.165 . . . . 65.530000000000001 111.022 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 34.3 Cg_exo -60.87 117.75 4.55 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.324 2.016 . . . . 73.510000000000005 110.27 172.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.93 -11.4 41.16 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.454 -0.658 . . . . 43.329999999999998 111.454 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -90.58 63.45 5.48 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.714 0.768 . . . . 72.200000000000003 110.765 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 16.9 m -67.52 -22.46 65.43 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.23 -1.35 . . . . 63.350000000000001 108.474 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -136.15 149.2 48.54 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 107.284 -1.376 . . . . 72.019999999999996 107.284 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 24.3 mmmt -133.07 151.72 52.01 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 120.778 0.323 . . . . 63.140000000000001 111.078 172.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -121.46 132.93 55.01 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.725 -0.67 . . . . 74.5 109.509 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.7 150.46 26.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.513 -0.921 . . . . 65.420000000000002 108.513 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 23.1 mtm180 -131.53 134.69 46.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.141 0.496 . . . . 72.129999999999995 111.663 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.56 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -107.66 125.56 64.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.437 -0.949 . . . . 53.310000000000002 108.437 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -74.82 138.35 23.65 Favored Glycine 0 N--CA 1.439 -1.127 0 O-C-N 123.667 0.604 . . . . 75.140000000000001 112.06 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.441 HD12 HG12 ' A' ' 496' ' ' ILE . 43.3 mm -97.37 130.71 45.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.597 -1.26 . . . . 72.420000000000002 107.597 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 84.4 mt -92.03 151.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 108.202 -1.036 . . . . 75.530000000000001 108.202 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.03 86.67 6.09 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.708 0.289 . . . . 72.150000000000006 110.822 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.8 129.57 54.51 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.521 -2.4 . . . . 55.130000000000003 104.521 171.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.256 8.2 t0 -125.61 89.45 3.04 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 116.577 -2.049 . . . . 73.239999999999995 111.518 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.623 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.6 mm -115.21 156.4 16.21 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.034 0 CA-C-N 111.058 -2.792 . . . . 62.420000000000002 105.587 -174.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -59.79 115.1 3.13 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.76 -1.941 . . . . 72.219999999999999 105.76 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.623 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 34.9 mt-10 -122.22 110.78 16.15 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.044 0.926 . . . . 75.340000000000003 110.338 -169.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.44 111.93 21.53 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.146 -1.388 . . . . 73.120000000000005 108.713 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 49.34 30.38 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.914 1.686 . . . . 72.150000000000006 112.548 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.542 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.5 tt0 -60.8 112.55 2.08 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.538 -1.21 . . . . 74.239999999999995 108.809 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.84 168.51 19.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.472 -0.786 . . . . 74.120000000000005 110.168 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.585 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 31.3 p90 -139.07 175.1 9.84 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.956 -0.566 . . . . 72.230000000000004 109.552 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 27.1 mt -120.36 136.79 54.59 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.976 -1.12 . . . . 60.130000000000003 107.976 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.0 t -106.43 123.55 61.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.934 -1.136 . . . . 73.519999999999996 107.934 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -114.54 150.87 34.26 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 123.852 0.72 . . . . 75.530000000000001 109.917 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 65.5 mt -116.36 140.01 49.79 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.414 -0.958 . . . . 70.310000000000002 108.414 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 11.8 p -153.37 -179.97 8.23 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.749 -0.834 . . . . 44.43 108.749 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 49.6 86.91 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.307 1.043 . . . . 74.040000000000006 112.505 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 83.8 t -102.03 125.87 56.13 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.89 -0.782 . . . . 34.229999999999997 108.89 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 464' ' ' LYS . 38.5 ttmt . . . . . 0 C--N 1.29 -2.002 0 N-CA-C 106.977 -1.49 . . . . 74.340000000000003 106.977 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.412 -2.34 0 CA-C-O 120.727 0.298 . . . . 65.310000000000002 110.458 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.82 102.72 14.24 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.394 -1.706 . . . . 74.450000000000003 106.394 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 29.5 m -80.29 121.28 25.46 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.754 -0.657 . . . . 72.109999999999999 109.747 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 390' ' ' VAL . 99.5 t -105.68 103.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 108.391 -0.966 . . . . 64.420000000000002 108.391 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 19.7 m -93.17 108.42 20.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.137 -1.06 . . . . 73.530000000000001 108.137 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.689 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -85.87 121.66 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-O 122.015 0.912 . . . . 74.439999999999998 110.992 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.459 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -83.55 95.91 8.46 Favored 'General case' 0 N--CA 1.388 -3.541 0 CA-C-N 114.896 -1.047 . . . . 64.430000000000007 110.498 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.06 -54.04 28.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 113.149 -1.841 . . . . 73.299999999999997 108.344 170.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.482 1.158 0 C-N-CA 126.141 1.776 . . . . 74.109999999999999 111.683 176.092 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 373' ' ' LYS . 25.8 mmtp . . . . . 0 N--CA 1.438 -1.038 0 N-CA-C 109.312 -0.625 . . . . 62.149999999999999 109.312 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 407' ' ' VAL . 28.4 mm -110.4 124.61 67.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.28 -1.378 . . . . 63.420000000000002 107.28 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -154.82 169.54 23.74 Favored 'General case' 0 C--O 1.201 -1.458 0 CA-C-N 118.335 0.516 . . . . 72.439999999999998 111.633 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -85.12 148.13 26.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.3 -0.63 . . . . 63.350000000000001 109.3 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -64.51 -46.19 84.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.367 0.604 . . . . 74.530000000000001 109.459 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -109.29 -173.89 2.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.334 -0.848 . . . . 74.310000000000002 110.414 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.43 -37.22 1.02 Allowed Glycine 0 C--N 1.285 -2.297 0 N-CA-C 109.769 -1.333 . . . . 75.310000000000002 109.769 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 35.2 m -121.19 134.36 55.21 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.456 -0.942 . . . . 71.409999999999997 108.456 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.459 ' HB2' HG22 ' A' ' 494' ' ' VAL . 58.3 m-85 -122.19 136.62 54.93 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.814 -1.18 . . . . 64.530000000000001 107.814 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -130.43 134.76 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.867 -1.16 . . . . 54.409999999999997 107.867 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 21.2 t -154.42 164.09 39.17 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.992 -1.114 . . . . 64.120000000000005 107.992 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 497' ' ' PHE . 1.8 mm? -79.96 142.88 34.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.279 0.562 . . . . 65.200000000000003 111.826 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -57.45 -41.61 80.86 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.438 1.095 . . . . 72.25 109.745 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -70.38 -7.76 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.424 -0.807 . . . . 73.310000000000002 113.169 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 49.7 t -68.11 -35.61 78.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.903 0.382 . . . . 72.420000000000002 110.837 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.54 -47.5 1.13 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.725 -0.75 . . . . 72.109999999999999 111.474 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 16.6 p -142.58 152.6 42.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.692 0.246 . . . . 73.519999999999996 110.636 175.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.2 p -111.42 133.15 57.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.471 -1.307 . . . . 72.400000000000006 107.471 174.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.49 120.57 41.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.114 0.483 . . . . 72.109999999999999 110.833 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -111.45 146.64 36.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.374 -0.973 . . . . 75.0 108.374 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.3 m -107.73 123.81 49.09 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.607 -0.516 . . . . 33.539999999999999 109.607 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 61.0 mt -98.83 124.42 52.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.869 -1.16 . . . . 70.299999999999997 107.869 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 52.2 mm -99.46 127.8 51.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.409 -0.96 . . . . 64.099999999999994 108.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -113.56 114.58 26.68 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.541 -0.911 . . . . 75.239999999999995 108.541 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 . . . . . 0 C--N 1.304 -1.391 0 CA-C-N 116.367 -0.379 . . . . 74.109999999999999 110.092 -179.605 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 7.5 m . . . . . 0 N--CA 1.416 -2.153 0 N-CA-C 108.783 -0.821 . . . . 74.349999999999994 108.783 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.79 143.83 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.257 -0.883 . . . . 72.530000000000001 110.074 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CE1' HG13 ' A' ' 430' ' ' VAL . 3.5 m-85 -118.43 125.18 49.41 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.422 0.689 . . . . 72.140000000000001 109.317 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -125.62 135.62 63.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.63 -1.248 . . . . 73.239999999999995 107.63 176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.45 145.43 27.44 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.099 -0.704 . . . . 65.540000000000006 109.099 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 17.4 p90 -142.89 157.78 44.25 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.06 -0.4 . . . . 73.409999999999997 110.461 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -161.28 163.92 30.59 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.843 -1.169 . . . . 72.310000000000002 107.843 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.678 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.5 p -95.66 172.58 7.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.003 -0.74 . . . . 55.039999999999999 109.003 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -115.42 157.72 23.53 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 120.991 0.424 . . . . 63.009999999999998 111.995 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -85.95 4.01 39.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.184 1.794 . . . . 72.219999999999999 110.571 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -23.36 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.48 1.593 0 C-N-CA 125.912 1.72 . . . . 73.349999999999994 116.579 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 455' ' ' ASN . 11.3 t -99.66 -16.48 18.18 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.564 0.697 . . . . 74.319999999999993 109.653 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -140.22 170.32 16.05 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 108.583 -0.895 . . . . 65.450000000000003 108.583 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -110.83 113.99 26.99 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 112.93 0.715 . . . . 72.099999999999994 112.93 -167.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -68.27 124.09 22.51 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.986 -1.116 . . . . 63.439999999999998 107.986 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.14 -26.79 8.52 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.391 -1.084 . . . . 54.350000000000001 110.391 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 43.2 m -116.38 -47.78 2.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.685 0.279 . . . . 53.0 111.338 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.0 m-20 -80.39 -57.77 3.44 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 122.174 0.987 . . . . 63.240000000000002 109.403 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.733 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.647 -1.161 . . . . 72.530000000000001 108.716 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -75.12 160.38 30.53 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.748 0.785 . . . . 74.299999999999997 110.702 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.678 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.3 p90 -94.69 -17.95 21.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.402 -0.817 . . . . 52.100000000000001 112.268 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 442' ' ' VAL . 10.1 t 37.08 58.12 1.19 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.413 1.485 . . . . 52.130000000000003 113.688 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 13.6 pt-20 -80.92 111.86 17.77 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.997 0.903 . . . . 72.129999999999995 110.399 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.6 -173.61 22.96 Favored Glycine 0 N--CA 1.415 -2.76 0 CA-C-N 114.799 -1.091 . . . . 63.140000000000001 111.446 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.8 m -126.52 133.19 51.2 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.781 -0.822 . . . . 74.340000000000003 108.781 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 17.8 t -96.91 123.55 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.527 -0.916 . . . . 42.409999999999997 108.527 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.5 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.2 t -99.29 109.96 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.051 -0.722 . . . . 63.32 109.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 404' ' ' THR . 65.6 m-85 -86.07 114.94 23.34 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.693 -0.685 . . . . 63.509999999999998 109.731 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 95.5 mttt -108.73 171.56 4.4 Favored Pre-proline 0 C--N 1.291 -1.935 0 CA-C-N 114.944 -1.025 . . . . 75.109999999999999 110.296 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 52.4 Cg_exo -57.26 121.6 10.35 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.784 2.322 . . . . 71.340000000000003 111.205 175.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.81 -16.8 60.38 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.711 -0.677 . . . . 14.24 111.938 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -87.99 62.25 6.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.217 0.532 . . . . 43.549999999999997 110.143 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.4 t -70.48 -17.26 62.97 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.643 -0.708 . . . . 73.209999999999994 109.561 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -130.86 141.89 50.34 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.245 -1.391 . . . . 72.340000000000003 107.245 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -128.94 147.86 50.88 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 120.612 0.244 . . . . 55.009999999999998 111.235 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.74 127.7 54.79 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.724 -0.671 . . . . 71.430000000000007 109.599 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.95 149.29 21.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.037 -1.098 . . . . 72.319999999999993 108.037 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 62.2 mtt180 -130.6 140.12 50.42 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 120.63 -0.428 . . . . 72.310000000000002 111.418 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.603 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.1 t -108.09 127.65 64.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.11 -0.95 . . . . 73.340000000000003 108.442 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -70.82 138.82 28.99 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 124.002 0.814 . . . . 72.549999999999997 111.857 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.409 HD12 HG12 ' A' ' 496' ' ' ILE . 38.4 mm -104.16 128.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.298 -1.371 . . . . 60.340000000000003 107.298 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 77.5 mt -94.65 151.14 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 106.705 -1.591 . . . . 74.209999999999994 106.705 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -81.51 86.29 6.36 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.489 0.662 . . . . 70.319999999999993 110.652 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.99 124.67 52.71 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 103.338 -2.838 . . . . 70.310000000000002 103.338 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -125.89 98.45 5.53 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 117.297 -1.761 . . . . 75.019999999999996 110.027 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.667 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -122.0 156.37 26.54 Favored 'Isoleucine or valine' 1 C--N 1.237 -4.304 0 CA-C-N 111.411 -2.631 . . . . 73.25 104.669 -174.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -56.19 113.48 1.57 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.174 -2.158 . . . . 72.120000000000005 105.174 168.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.2 mt-10 -119.37 107.91 13.93 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-O 121.963 0.887 . . . . 71.519999999999996 110.568 -169.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -113.6 107.98 16.53 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 114.432 -1.258 . . . . 64.329999999999998 108.059 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 35.3 t70 51.88 61.03 3.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.097 0.873 . . . . 73.120000000000005 110.69 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.453 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 32.9 tt0 -89.52 112.68 23.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.52 -1.659 . . . . 52.219999999999999 106.52 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 415' ' ' THR . 3.2 p-10 -143.98 164.93 29.18 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.179 0.514 . . . . 72.510000000000005 110.77 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.7 p90 -136.68 178.48 7.04 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.948 -0.76 . . . . 74.329999999999998 108.948 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.08 136.71 54.92 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.149 -1.426 . . . . 73.430000000000007 107.149 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 25.9 t -103.49 122.88 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.333 -1.358 . . . . 72.040000000000006 107.333 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -119.96 148.58 43.35 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.862 -0.608 . . . . 70.030000000000001 109.849 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.96 147.29 28.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.912 -0.585 . . . . 52.539999999999999 109.559 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.8 m -156.11 179.82 8.86 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.514 0.726 . . . . 72.439999999999998 109.527 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.0 t30 47.75 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.335 1.454 . . . . 61.219999999999999 114.267 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 98.5 t -91.67 127.36 44.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 C-N-CA 119.713 -0.795 . . . . 74.439999999999998 109.091 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt . . . . . 0 C--N 1.295 -1.797 0 N-CA-C 107.232 -1.395 . . . . 65.349999999999994 107.232 178.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.413 -2.302 0 N-CA-C 109.885 -0.413 . . . . 74.519999999999996 109.885 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -109.39 108.39 18.91 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.435 -1.32 . . . . 61.049999999999997 107.435 170.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 74.4 m -83.2 111.71 19.19 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.282 -0.636 . . . . 73.239999999999995 109.282 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.559 HG11 HG11 ' A' ' 390' ' ' VAL . 71.4 t -100.62 106.62 19.64 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 108.262 -1.014 . . . . 60.100000000000001 108.262 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 25.1 m -93.47 112.16 24.0 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 107.158 -1.423 . . . . 63.149999999999999 107.158 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.733 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -86.56 119.66 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 CA-C-O 121.831 0.824 . . . . 64.150000000000006 109.616 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.486 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.5 m-85 -82.79 98.08 8.94 Favored 'General case' 1 N--CA 1.378 -4.068 0 CA-C-N 115.041 -0.981 . . . . 73.329999999999998 112.34 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 451' ' ' GLU . 2.9 t70 -50.09 -60.52 2.87 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 112.019 -2.355 . . . . 71.010000000000005 108.518 170.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 CA--C 1.547 0.838 0 CA-C-N 113.767 -1.56 . . . . 51.219999999999999 112.363 179.271 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 N--CA 1.407 -2.576 0 N-CA-C 107.873 -1.158 . . . . 72.420000000000002 107.873 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 407' ' ' VAL . 37.4 mm -110.08 112.73 41.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.092 -1.448 . . . . 74.299999999999997 107.092 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -145.76 161.41 39.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.471 -0.492 . . . . 73.129999999999995 111.87 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -79.51 150.46 31.16 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.17 -0.468 . . . . 74.430000000000007 110.86 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.14 -50.0 62.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.741 -1.207 . . . . 73.310000000000002 107.741 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 27.6 mm-40 -103.57 -177.69 3.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.609 -0.723 . . . . 73.109999999999999 111.494 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.44 -38.4 0.93 Allowed Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.836 -1.306 . . . . 73.129999999999995 109.836 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.8 m -123.55 131.86 53.74 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 107.582 -1.266 . . . . 70.140000000000001 107.582 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 86.1 m-85 -119.78 140.87 50.08 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.483 -1.303 . . . . 75.430000000000007 107.483 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 495' ' ' THR . 21.3 mt-30 -130.14 127.39 39.66 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.312 -0.625 . . . . 73.540000000000006 109.312 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . 0.652 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.5 p -133.83 165.06 25.85 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.488 -0.93 . . . . 62.539999999999999 108.488 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.79 146.09 24.72 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.023 0.439 . . . . 73.019999999999996 111.125 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.72 -28.94 70.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.84 0.828 . . . . 65.200000000000003 109.138 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -86.45 2.4 47.91 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.868 -1.06 . . . . 71.239999999999995 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.76 -32.24 31.54 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 112.611 0.597 . . . . 35.049999999999997 112.611 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.71 -65.47 0.4 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.284 -0.96 . . . . 55.420000000000002 111.21 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.477 HG22 ' HA2' ' A' ' 443' ' ' GLY . 30.3 p -133.01 159.45 39.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.478 0.639 . . . . 54.25 111.01 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.652 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 3.6 p -111.87 129.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 107.431 -1.322 . . . . 72.019999999999996 107.431 171.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.39 128.24 44.69 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.661 -0.866 . . . . 52.119999999999997 108.661 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.28 142.82 47.74 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.456 -1.313 . . . . 74.120000000000005 107.456 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.4 m -105.64 131.43 53.03 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.188 0.518 . . . . 72.409999999999997 110.371 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.459 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 84.4 mt -106.54 128.79 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.915 -1.143 . . . . 64.530000000000001 107.915 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.41 HG22 ' HG2' ' A' ' 397' ' ' ARG . 46.4 mm -105.52 127.71 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 N-CA-C 108.198 -1.038 . . . . 74.409999999999997 108.198 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -110.41 112.06 23.73 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 116.118 -0.492 . . . . 65.25 109.792 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . 0.559 ' HA ' ' HE ' ' A' ' 397' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 108.874 -0.788 . . . . 73.230000000000004 108.874 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 10.0 m . . . . . 0 N--CA 1.414 -2.248 0 CA-C-O 121.621 0.724 . . . . 71.340000000000003 109.253 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.71 140.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.813 -1.085 . . . . 74.219999999999999 108.207 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 50.2 m-85 -123.09 128.01 49.52 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.756 -0.831 . . . . 74.530000000000001 108.756 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -128.92 134.57 64.01 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 106.339 -1.726 . . . . 73.140000000000001 106.339 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.47 122.43 42.54 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.497 -0.481 . . . . 70.439999999999998 110.01 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -109.57 154.17 23.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.695 -0.483 . . . . 54.200000000000003 109.695 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -163.78 164.73 23.56 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.078 -1.452 . . . . 63.409999999999997 107.078 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 80.0 p -95.89 172.51 7.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.801 0.334 . . . . 71.030000000000001 110.268 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 8.7 tp10 -118.6 147.97 43.17 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.286 0.565 . . . . 73.329999999999998 110.257 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.72 4.02 26.77 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 127.039 2.136 . . . . 75.340000000000003 109.514 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . 0.563 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -20.35 -74.26 0.01 OUTLIER Glycine 0 N--CA 1.482 1.744 0 C-N-CA 126.113 1.816 . . . . 44.210000000000001 115.686 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.7 t -118.47 -5.46 10.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.347 0.594 . . . . 70.420000000000002 110.63 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -134.23 -179.65 5.7 Favored 'General case' 0 C--O 1.195 -1.774 0 CA-C-N 116.357 -0.383 . . . . 74.409999999999997 110.223 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.16 118.96 28.86 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.409 0.623 . . . . 74.299999999999997 110.065 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -71.23 137.89 49.02 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.177 -0.675 . . . . 74.329999999999998 109.177 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.24 -4.92 81.09 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 110.721 -0.952 . . . . 72.329999999999998 110.721 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.1 t -123.73 -57.83 1.61 Allowed 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.25 -1.018 . . . . 50.210000000000001 108.25 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.534 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 17.6 m-20 -82.45 -59.39 2.55 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-O 122.19 0.995 . . . . 61.530000000000001 109.097 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.728 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.23 158.92 43.32 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.267 -0.879 . . . . 74.150000000000006 109.99 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.4 142.87 46.95 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.106 -0.701 . . . . 73.129999999999995 109.106 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.51 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 8.7 p90 -73.68 -24.13 59.92 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 123.304 0.642 . . . . 65.120000000000005 112.632 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.559 HG21 HG22 ' A' ' 442' ' ' VAL 0.291 10.9 t 41.6 62.42 1.56 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.37 1.868 . . . . 75.430000000000007 113.185 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.44 107.38 12.16 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.691 -1.141 . . . . 73.150000000000006 108.854 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -144.42 168.38 26.72 Favored Glycine 0 CA--C 1.46 -3.385 0 C-N-CA 120.073 -1.06 . . . . 54.130000000000003 111.49 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.6 m -112.7 138.1 50.01 Favored 'General case' 0 N--CA 1.393 -3.292 0 N-CA-C 107.652 -1.24 . . . . 45.100000000000001 107.652 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.3 t -95.4 117.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.759 -1.201 . . . . 62.119999999999997 107.759 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.74 105.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.496 -0.774 . . . . 62.420000000000002 109.755 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 404' ' ' THR . 57.7 m-85 -89.25 94.53 9.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.054 -0.521 . . . . 71.239999999999995 110.786 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.28 167.51 16.63 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.234 -0.894 . . . . 74.140000000000001 110.568 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.01 119.65 7.05 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 122.742 2.295 . . . . 50.229999999999997 110.881 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.24 -14.75 60.93 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.073 -0.584 . . . . 72.299999999999997 112.457 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -93.91 61.16 2.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.748 0.785 . . . . 70.0 109.381 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 8.0 m -66.09 -25.77 67.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.624 -1.171 . . . . 71.319999999999993 109.625 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.41 132.36 54.32 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.415 -1.328 . . . . 72.430000000000007 107.415 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -120.73 149.69 42.13 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.93 0.395 . . . . 62.399999999999999 111.994 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.73 131.91 56.02 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.223 -0.899 . . . . 63.5 109.435 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.57 149.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.929 -1.137 . . . . 64.129999999999995 107.929 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 51.4 mtt180 -131.62 144.01 50.74 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.253 0.549 . . . . 63.530000000000001 111.972 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 425' ' ' THR . 49.2 t -117.51 121.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.708 -1.219 . . . . 63.130000000000003 107.708 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -78.45 134.1 13.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.07 -0.586 . . . . 75.230000000000004 111.985 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 496' ' ' ILE . 28.9 mm -90.42 139.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.693 -1.225 . . . . 72.230000000000004 107.693 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 81.3 mt -99.29 150.98 4.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.236 -1.394 . . . . 63.520000000000003 107.236 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 88.03 3.05 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.113 0.482 . . . . 63.420000000000002 111.344 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.95 113.4 20.94 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.029 -2.211 . . . . 54.119999999999997 105.029 171.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -115.88 96.2 5.48 Favored 'General case' 0 CA--C 1.457 -2.629 0 C-N-CA 116.802 -1.959 . . . . 61.049999999999997 110.054 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.627 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 31.7 mm -121.68 155.63 25.93 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.097 0 N-CA-C 103.589 -2.745 . . . . 74.409999999999997 103.589 -175.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -58.49 114.65 2.56 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.602 -1.639 . . . . 74.400000000000006 107.55 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.627 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 24.4 mt-10 -128.65 130.32 47.08 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-N 115.518 -0.764 . . . . 60.43 109.693 -169.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.69 108.04 8.78 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.057 -0.974 . . . . 64.040000000000006 108.508 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.81 49.72 15.57 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 124.537 1.148 . . . . 73.319999999999993 110.238 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.556 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 37.2 tt0 -72.15 116.75 12.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.548 -1.649 . . . . 63.039999999999999 106.548 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 36.5 p30 -141.29 166.05 25.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.938 0.718 . . . . 74.319999999999993 112.938 -172.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.574 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 23.5 p90 -144.39 175.75 9.88 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.241 -0.891 . . . . 74.129999999999995 108.665 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.13 136.64 52.84 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.558 -1.275 . . . . 73.439999999999998 107.558 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.84 123.52 52.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.865 -1.532 . . . . 75.129999999999995 106.865 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -112.66 135.03 53.86 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 123.803 0.689 . . . . 75.120000000000005 111.492 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.9 129.15 45.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.967 -1.494 . . . . 72.129999999999995 106.967 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.1 t -154.69 -176.82 6.1 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.982 -1.488 . . . . 60.100000000000001 106.982 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 50.86 81.77 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 O-C-N 124.488 1.118 . . . . 74.340000000000003 112.216 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 41.2 t -82.05 131.55 33.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 114.916 -1.038 . . . . 71.420000000000002 109.026 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 4.2 tppp? . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 107.18 -1.415 . . . . 74.109999999999999 107.18 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.428 -1.553 0 N-CA-C 110.171 -0.307 . . . . 64.129999999999995 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -129.15 122.39 29.71 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.397 -1.334 . . . . 74.349999999999994 107.397 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.9 m -89.43 121.46 31.69 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.7 -0.4 . . . . 75.140000000000001 110.394 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 390' ' ' VAL . 74.5 t -109.54 110.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.918 -0.771 . . . . 61.219999999999999 108.918 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 91.1 m -101.49 121.61 42.29 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 108.882 -0.784 . . . . 71.310000000000002 108.882 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.728 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -95.36 117.1 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.099 0 CA-C-N 115.336 -0.847 . . . . 63.240000000000002 109.218 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.42 104.21 5.07 Favored 'General case' 0 N--CA 1.389 -3.507 0 CA-C-N 114.693 -1.14 . . . . 73.109999999999999 110.499 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 499' ' ' ASP . 4.0 t70 -55.01 -40.92 70.67 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 112.811 -1.995 . . . . 74.549999999999997 110.803 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 498' ' ' ASP . 8.8 t70 . . . . . 0 N--CA 1.484 1.237 0 C-N-CA 124.953 1.301 . . . . 72.219999999999999 112.117 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 30.7 mmtp . . . . . 0 N--CA 1.418 -2.047 0 N-CA-C 107.255 -1.387 . . . . 74.030000000000001 107.255 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 44.6 mm -106.9 129.36 60.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 108.065 -1.087 . . . . 74.109999999999999 108.065 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -159.27 167.8 28.04 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 117.907 0.321 . . . . 74.420000000000002 110.924 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -82.52 153.4 25.59 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.828 -0.349 . . . . 64.140000000000001 110.124 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.29 -38.72 81.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.333 0.587 . . . . 73.120000000000005 109.816 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.401 ' NE2' ' HA ' ' A' ' 378' ' ' GLN . 17.5 mm-40 -130.5 174.21 10.11 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.59 -0.732 . . . . 72.540000000000006 112.304 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -104.12 -25.66 7.0 Favored Glycine 0 C--N 1.304 -1.245 0 CA-C-N 115.37 -0.832 . . . . 63.520000000000003 111.857 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.6 m -129.38 133.33 47.33 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.252 -0.648 . . . . 45.149999999999999 109.252 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 66.2 m-85 -124.62 136.35 53.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.996 -1.113 . . . . 71.349999999999994 107.996 176.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.473 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 87.4 mt-30 -129.46 135.34 48.53 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.221 -1.029 . . . . 73.239999999999995 108.221 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 37.8 t -148.81 165.0 32.79 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.446 -0.946 . . . . 55.219999999999999 108.446 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -79.23 141.17 37.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.417 0.448 . . . . 75.349999999999994 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.93 -50.34 72.89 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.755 0.822 . . . . 61.020000000000003 110.764 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -77.25 2.56 15.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.519 0.563 . . . . 72.109999999999999 112.519 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.14 -20.6 59.31 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.236 0.541 . . . . 71.200000000000003 111.017 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.28 -57.14 0.63 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.258 -0.972 . . . . 70.349999999999994 113.105 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 14.8 p -139.33 165.35 27.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 117.189 0.495 . . . . 72.519999999999996 111.566 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.606 HG11 HG11 ' A' ' 494' ' ' VAL . 6.8 p -122.51 125.72 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 169.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.39 129.29 43.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.197 0.522 . . . . 73.25 110.4 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.21 140.91 51.39 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 107.876 -1.157 . . . . 71.299999999999997 107.876 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.2 m -108.33 131.52 54.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.92 -0.582 . . . . 72.200000000000003 109.511 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.09 125.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.923 -1.139 . . . . 62.149999999999999 107.923 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.8 mm -99.73 133.63 41.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.766 -0.828 . . . . 73.209999999999994 108.766 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 436' ' ' THR . 58.4 ttt180 -117.53 120.17 37.28 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.316 -0.856 . . . . 75.209999999999994 108.773 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 107.732 -1.211 . . . . 75.519999999999996 107.732 179.211 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 41.9 m . . . . . 0 N--CA 1.421 -1.885 0 CA-C-O 121.001 0.429 . . . . 63.109999999999999 111.517 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.64 146.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.578 -0.737 . . . . 75.400000000000006 109.351 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -122.12 125.53 46.38 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.074 0.549 . . . . 61.219999999999999 110.292 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.49 130.83 70.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.208 -1.404 . . . . 71.409999999999997 107.208 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 15.1 t70 -100.25 135.0 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.688 -0.486 . . . . 71.140000000000001 109.688 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.02 153.99 48.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.45 -0.5 . . . . 74.349999999999994 110.363 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 426' ' ' GLU . 33.6 ttp180 -163.43 154.57 16.67 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.752 -1.573 . . . . 71.239999999999995 106.752 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.607 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 30.8 p -96.46 162.55 13.43 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.279 0.562 . . . . 72.230000000000004 110.4 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 3.6 mm-40 -105.11 160.58 14.95 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.586 -0.734 . . . . 75.230000000000004 109.378 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.31 -37.65 63.56 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.131 -0.94 . . . . 75.200000000000003 110.035 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 48.57 -107.74 0.3 Allowed Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.228 -1.351 . . . . 40.0 114.215 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -101.53 5.03 41.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.739 0.781 . . . . 62.350000000000001 110.237 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -135.57 -159.53 0.97 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.942 0.897 . . . . 34.130000000000003 109.067 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 417' ' ' ASN . 1.2 m120 -136.17 126.2 26.06 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.089 0.471 . . . . 73.030000000000001 111.616 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -82.18 124.52 29.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.513 -0.921 . . . . 75.420000000000002 108.513 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.44 -19.42 36.79 Favored Glycine 0 C--N 1.296 -1.659 0 N-CA-C 110.123 -1.191 . . . . 60.130000000000003 110.123 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.6 m -106.94 -56.88 2.14 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.66 -0.496 . . . . 64.209999999999994 109.66 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 2.2 m-20 -84.68 -57.34 3.17 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 122.106 0.955 . . . . 74.439999999999998 110.205 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.686 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -140.01 159.78 41.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.24 -0.891 . . . . 74.519999999999996 109.002 -178.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.4 tm-20 -76.26 157.88 32.14 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 123.873 0.733 . . . . 70.120000000000005 109.794 -173.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.607 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 13.7 p90 -94.21 -16.68 23.44 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.288 0.635 . . . . 61.420000000000002 112.669 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.508 HG21 HG22 ' A' ' 442' ' ' VAL 0.303 9.9 t 37.59 67.12 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.66 1.984 . . . . 70.239999999999995 114.303 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.423 ' HB3' ' HD3' ' A' ' 410' ' ' ARG . 9.5 pt-20 -79.1 121.16 24.65 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.003 -0.998 . . . . 64.420000000000002 109.481 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -163.0 176.73 39.23 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 120.372 -0.918 . . . . 61.140000000000001 111.386 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 32.4 m -120.52 136.73 54.69 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.881 -1.155 . . . . 72.150000000000006 107.881 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.9 t -95.57 119.17 43.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.902 -1.147 . . . . 75.150000000000006 107.902 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 99.6 t -95.83 107.04 19.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 114.704 -1.134 . . . . 71.040000000000006 108.798 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 404' ' ' THR . 51.1 m-85 -84.55 95.08 8.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.971 -0.559 . . . . 73.540000000000006 110.586 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.478 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 10.4 mtmp? -80.52 167.83 29.94 Favored Pre-proline 0 N--CA 1.432 -1.373 0 CA-C-N 115.487 -0.778 . . . . 71.349999999999994 110.156 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 54.9 Cg_exo -52.66 131.61 42.2 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.371 2.047 . . . . 74.230000000000004 111.803 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.66 -21.49 32.67 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.851 -0.613 . . . . 51.109999999999999 113.37 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 38.0 mt-10 -81.17 63.9 5.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.171 0.986 . . . . 71.150000000000006 112.647 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 21.4 m -67.49 -11.33 57.68 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.2 -1.364 . . . . 62.149999999999999 110.069 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -139.14 136.55 35.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.497 -0.927 . . . . 73.439999999999998 108.497 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -126.14 155.12 42.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.294 0.092 . . . . 71.530000000000001 111.05 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.22 138.04 54.12 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.807 -0.357 . . . . 64.109999999999999 110.801 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 39.9 pt -125.68 153.97 34.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.635 -0.876 . . . . 51.0 108.635 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 56.5 mtm180 -130.4 138.32 50.29 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.911 0.386 . . . . 64.430000000000007 110.865 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.516 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.6 t -106.54 122.25 60.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.838 -1.171 . . . . 60.399999999999999 107.838 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.88 130.7 10.71 Favored Glycine 0 N--CA 1.434 -1.453 0 O-C-N 123.583 0.552 . . . . 71.099999999999994 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 496' ' ' ILE . 38.0 mm -88.98 143.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.527 -1.657 . . . . 74.540000000000006 106.527 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.2 mt -102.04 145.94 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 N-CA-C 107.368 -1.345 . . . . 61.399999999999999 107.368 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.26 85.99 1.43 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.508 0.67 . . . . 73.5 111.497 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.55 120.22 36.1 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 105.175 -2.158 . . . . 72.540000000000006 105.175 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -122.57 95.3 4.58 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 116.951 -1.9 . . . . 74.349999999999994 110.554 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.647 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 34.3 mm -118.62 155.9 20.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.348 0 N-CA-C 103.61 -2.737 . . . . 63.340000000000003 103.61 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -56.89 114.6 2.16 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.058 -1.457 . . . . 73.120000000000005 107.119 171.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 29.0 mt-10 -127.19 133.94 50.22 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-N 116.06 -0.518 . . . . 73.540000000000006 109.7 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.48 112.48 7.66 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.475 -0.935 . . . . 74.219999999999999 108.475 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 33.5 t70 50.56 61.53 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.855 0.862 . . . . 64.239999999999995 112.8 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.32 123.47 41.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 118.729 -1.188 . . . . 71.400000000000006 110.932 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.28 174.36 10.64 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.87 -1.059 . . . . 73.310000000000002 110.54 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.554 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 26.0 p90 -148.0 -178.54 6.34 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.746 -1.115 . . . . 71.409999999999997 108.042 172.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -123.79 136.72 54.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.284 -1.006 . . . . 64.299999999999997 108.284 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.4 122.03 59.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.903 -1.517 . . . . 55.43 106.903 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.82 152.86 31.43 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.712 0.632 . . . . 75.140000000000001 110.005 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.48 121.43 44.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.893 -0.78 . . . . 74.019999999999996 108.893 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 46.8 m -131.1 -178.11 4.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.429 -0.952 . . . . 60.25 108.429 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 39.45 82.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.143 1.377 . . . . 74.019999999999996 112.348 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.75 123.02 44.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 119.168 -1.013 . . . . 73.409999999999997 108.911 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt . . . . . 0 C--N 1.286 -2.167 0 CA-C-N 114.926 -1.034 . . . . 75.209999999999994 109.453 -177.1 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.412 -2.36 0 N-CA-C 109.174 -0.676 . . . . 74.019999999999996 109.174 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -102.22 115.06 29.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.944 -1.132 . . . . 61.509999999999998 107.944 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 20.7 m -89.2 121.08 31.16 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.1 -0.704 . . . . 61.109999999999999 109.1 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.606 HG11 HG11 ' A' ' 390' ' ' VAL . 92.6 t -108.81 106.03 19.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.987 -0.551 . . . . 61.119999999999997 109.727 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 88.2 m -92.9 118.85 31.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.348 -0.982 . . . . 62.240000000000002 108.348 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.686 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -95.17 120.36 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 N-CA-C 108.946 -0.761 . . . . 71.109999999999999 108.946 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . 0.316 26.1 m-85 -84.37 102.7 12.94 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-O 122.233 1.016 . . . . 53.240000000000002 113.624 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.02 -54.11 27.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 111.779 -2.464 . . . . 61.439999999999998 109.435 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.478 0.955 0 CA-C-N 114.578 -1.192 . . . . 72.340000000000003 111.507 174.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 97.0 mttt . . . . . 0 N--CA 1.425 -1.702 0 N-CA-C 112.046 0.387 . . . . 74.25 112.046 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 18.6 mm -104.36 121.12 55.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.027 -1.101 . . . . 63.409999999999997 108.027 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -150.49 168.34 24.5 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.153 -0.619 . . . . 52.240000000000002 112.235 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -80.91 145.72 31.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.588 -0.523 . . . . 74.209999999999994 109.588 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.543 ' HB3' ' OH ' ' A' ' 381' ' ' TYR . 37.2 tt0 -58.4 -59.03 5.99 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.847 0.859 . . . . 72.400000000000006 109.746 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.521 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.8 mm100 -104.87 179.98 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.343 -0.844 . . . . 65.439999999999998 110.332 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -109.13 -22.2 6.98 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 109.687 -1.365 . . . . 61.030000000000001 109.687 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 493' ' ' THR . 38.5 m -143.23 132.16 22.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 115.059 -0.571 . . . . 50.350000000000001 109.607 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.543 ' OH ' ' HB3' ' A' ' 377' ' ' GLU . 48.7 m-85 -118.98 147.83 43.64 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.159 -1.052 . . . . 65.030000000000001 108.159 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 495' ' ' THR . 40.1 mt-30 -130.74 133.55 46.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.041 -1.096 . . . . 71.129999999999995 108.041 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.6 p -140.06 157.39 45.72 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 109.123 -0.695 . . . . 72.120000000000005 109.123 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -81.15 143.7 32.2 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.02 -0.733 . . . . 74.019999999999996 109.02 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.88 -31.18 70.67 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.355 0.662 . . . . 72.340000000000003 110.833 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.485 ' C ' HD22 ' A' ' 386' ' ' ASN . 0.2 OUTLIER -80.94 -2.26 46.98 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.831 -0.622 . . . . 61.43 112.496 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.7 t -68.9 -33.2 73.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.808 0.337 . . . . 72.319999999999993 111.685 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 100.78 -58.04 0.71 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.886 -0.886 . . . . 61.130000000000003 110.886 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.8 p -137.79 154.35 49.57 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.003 -0.369 . . . . 73.430000000000007 110.003 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.9 p -110.22 130.52 63.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.042 -1.096 . . . . 62.329999999999998 108.042 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -100.54 119.34 38.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.997 0.427 . . . . 75.340000000000003 110.26 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.449 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.7 mp -113.14 157.14 22.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.862 -1.532 . . . . 71.329999999999998 106.862 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.1 m -120.54 137.01 54.61 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.232 -0.587 . . . . 70.439999999999998 110.5 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.8 mt -101.56 121.43 52.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.386 -1.338 . . . . 74.340000000000003 107.386 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.55 115.38 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 108.248 -1.019 . . . . 71.530000000000001 108.248 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 436' ' ' THR . 52.7 ttt-85 -105.84 129.27 54.05 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.726 -1.212 . . . . 71.430000000000007 107.726 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 109.084 -0.709 . . . . 75.150000000000006 109.084 179.189 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.423 -1.794 0 CA-C-O 121.373 0.606 . . . . 73.540000000000006 110.967 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 52.6 t -106.68 148.89 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.062 -0.972 . . . . 61.109999999999999 108.67 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.605 ' CE2' HG22 ' A' ' 430' ' ' VAL . 25.8 m-85 -131.41 142.55 50.05 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.037 0.446 . . . . 61.109999999999999 110.706 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.89 137.82 24.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.017 -1.475 . . . . 62.310000000000002 107.017 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.3 t70 -101.36 138.5 38.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.189 -0.671 . . . . 72.219999999999999 109.189 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.42 150.5 45.56 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.325 -0.991 . . . . 70.109999999999999 108.325 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 10.0 ttm180 -157.85 150.42 22.63 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.446 -0.946 . . . . 65.239999999999995 108.446 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 31.9 p -96.75 156.86 16.17 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.183 -0.607 . . . . 44.229999999999997 110.319 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 11.5 tp10 -114.36 150.19 34.96 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.475 -1.676 . . . . 65.349999999999994 106.475 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 24.4 m-20 -53.86 -44.77 70.66 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.829 0.823 . . . . 71.439999999999998 112.2 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.97 3.55 Favored Glycine 0 N--CA 1.42 -2.408 0 CA-C-N 114.299 -1.319 . . . . 55.200000000000003 110.351 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 455' ' ' ASN . 9.9 t -104.99 -9.32 17.98 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.83 -0.804 . . . . 73.530000000000001 108.83 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -117.72 -159.22 0.74 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.302 -0.999 . . . . 61.149999999999999 108.302 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.402 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 3.4 m120 -131.38 127.68 38.06 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 112.878 0.696 . . . . 70.430000000000007 112.878 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.105 -1.072 . . . . 73.129999999999995 108.105 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.75 56.95 Favored Glycine 0 C--N 1.295 -1.728 0 N-CA-C 110.513 -1.035 . . . . 60.109999999999999 110.513 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.1 m -128.88 -54.79 1.21 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.155 -0.313 . . . . 74.209999999999994 110.155 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.51 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 18.2 m-20 -84.25 -53.05 5.76 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.814 0.816 . . . . 72.530000000000001 108.977 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -139.93 166.09 25.57 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.699 -0.852 . . . . 75.140000000000001 108.699 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.54 159.68 30.13 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.662 -0.866 . . . . 70.439999999999998 108.662 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.558 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 6.6 p90 -97.44 -17.69 19.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.01 0.524 . . . . 71.239999999999995 111.853 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.531 HG21 HG22 ' A' ' 442' ' ' VAL . 6.4 t 40.92 56.44 2.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.576 1.95 . . . . 73.239999999999995 113.24 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 9.4 pt-20 -77.55 108.96 11.1 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.225 1.012 . . . . 73.0 109.213 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.6 163.71 28.49 Favored Glycine 0 N--CA 1.411 -2.998 0 CA-C-N 114.905 -1.043 . . . . 71.049999999999997 110.904 -176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 11.0 m -108.71 134.23 51.71 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 108.049 -1.093 . . . . 63.25 108.049 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 48.8 t -94.78 125.24 47.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.399 -0.963 . . . . 53.219999999999999 108.399 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.605 HG22 ' CE2' ' A' ' 406' ' ' PHE . 37.2 t -99.42 112.28 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 CA-C-N 114.761 -1.109 . . . . 75.439999999999998 108.392 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -83.48 105.54 14.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.3 -1.0 . . . . 53.240000000000002 108.3 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 1.0 OUTLIER -79.58 163.94 56.26 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.913 -1.039 . . . . 53.450000000000003 111.465 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.0 Cg_exo -51.41 118.1 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 123.247 2.631 . . . . 72.409999999999997 111.303 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.87 -15.96 49.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.924 -0.58 . . . . 73.310000000000002 113.88 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.8 63.65 7.56 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.393 0.886 . . . . 64.430000000000007 113.393 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 19.3 m -53.86 -24.78 16.93 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 114.496 -1.229 . . . . 74.099999999999994 112.092 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -116.23 145.27 43.26 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.763 -0.828 . . . . 61.109999999999999 108.763 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -134.48 147.55 50.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.02 0.378 . . . . 70.430000000000007 112.02 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.29 141.01 37.56 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.683 -0.689 . . . . 74.510000000000005 109.543 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.1 pt -128.42 148.44 32.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.709 -0.849 . . . . 63.439999999999998 108.709 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 73.9 mtm180 -129.02 142.66 50.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.361 0.601 . . . . 63.140000000000001 111.191 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 46.1 t -116.42 124.37 72.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.503 -1.295 . . . . 74.099999999999994 107.503 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -75.71 141.67 27.77 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.989 -0.624 . . . . 55.310000000000002 112.368 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.452 HD12 HG12 ' A' ' 496' ' ' ILE . 36.6 mm -99.47 136.91 28.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.892 -1.151 . . . . 73.450000000000003 107.892 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.3 mt -98.19 148.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.48 -1.674 . . . . 73.120000000000005 106.48 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.47 86.59 5.77 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.287 -0.565 . . . . 73.030000000000001 110.707 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.0 118.66 37.03 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 103.936 -2.616 . . . . 63.509999999999998 103.936 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.258 10.7 t70 -121.21 92.5 3.77 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.493 -2.083 . . . . 75.219999999999999 110.966 176.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.723 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.6 mm -120.23 156.62 23.1 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.357 0 CA-C-N 111.018 -2.81 . . . . 71.510000000000005 103.825 -175.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -53.62 114.0 1.38 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.625 -1.62 . . . . 73.0 106.625 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.723 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 35.5 mt-10 -121.18 113.04 19.42 Favored 'General case' 0 CA--C 1.468 -2.208 0 CA-C-O 121.56 0.695 . . . . 60.520000000000003 110.532 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -117.81 100.55 7.66 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.691 -1.14 . . . . 75.109999999999999 109.767 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 51.75 40.89 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.447 -1.251 . . . . 74.329999999999998 113.393 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.431 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.7 pt-20 -70.12 131.84 44.91 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 119.945 -0.702 . . . . 62.549999999999997 109.81 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.634 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.2 OUTLIER -150.13 161.22 42.8 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.446 0.535 . . . . 63.229999999999997 112.446 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 35.3 p90 -131.96 -179.56 5.48 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.377 -0.374 . . . . 75.340000000000003 110.611 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 47.4 mt -121.34 138.49 54.23 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.457 -0.942 . . . . 75.099999999999994 108.457 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 23.0 t -111.06 129.59 66.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.34 -1.356 . . . . 54.200000000000003 107.34 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -122.67 165.75 16.01 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 123.574 0.546 . . . . 64.239999999999995 109.712 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.52 139.36 51.58 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.198 0.523 . . . . 74.530000000000001 110.536 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 37.3 m -150.57 -179.28 7.1 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.271 -1.011 . . . . 65.150000000000006 108.271 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.8 t30 45.7 88.39 0.02 OUTLIER 'General case' 0 C--O 1.248 1.02 0 C-N-CA 124.815 1.246 . . . . 72.329999999999998 113.856 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.3 123.8 42.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.219 -0.992 . . . . 73.439999999999998 108.779 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.6 mttm . . . . . 0 C--N 1.29 -1.978 0 CA-C-O 121.501 0.667 . . . . 72.540000000000006 110.421 179.581 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.41 -2.44 0 N-CA-C 109.166 -0.679 . . . . 62.219999999999999 109.166 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -112.06 106.78 15.51 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.714 -1.217 . . . . 53.439999999999998 107.714 170.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 380' ' ' THR . 27.0 m -82.0 121.9 27.11 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.69 -0.485 . . . . 74.400000000000006 109.69 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.517 HG11 HG11 ' A' ' 390' ' ' VAL . 86.6 t -107.75 107.89 23.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.492 -0.929 . . . . 62.219999999999999 108.492 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.634 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 66.9 m -98.39 113.44 25.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.895 -0.779 . . . . 72.099999999999994 108.895 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.617 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -91.3 120.5 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.556 0.693 . . . . 75.109999999999999 110.767 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.01 101.63 13.09 Favored 'General case' 0 N--CA 1.394 -3.273 0 CA-C-N 115.013 -0.994 . . . . 72.400000000000006 110.999 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.6 -53.42 52.05 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.547 -2.115 . . . . 63.509999999999998 108.974 172.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 125.571 1.548 . . . . 74.120000000000005 112.1 177.311 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 95.6 mttt . . . . . 0 N--CA 1.435 -1.221 0 CA-C-O 120.861 0.363 . . . . 73.319999999999993 111.445 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.23 121.41 67.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.143 -1.058 . . . . 70.409999999999997 108.143 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -154.1 172.12 18.04 Favored 'General case' 0 C--O 1.193 -1.894 0 N-CA-C 112.195 0.443 . . . . 64.409999999999997 112.195 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -85.49 153.36 22.51 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.594 -0.442 . . . . 71.109999999999999 110.491 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.46 -36.79 81.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.46 0.648 . . . . 72.129999999999995 109.582 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -128.59 172.3 11.32 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.227 -0.897 . . . . 70.319999999999993 111.792 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.41 -32.3 4.93 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 114.881 -1.054 . . . . 63.25 110.966 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.3 m -130.39 125.5 34.7 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.389 -0.597 . . . . 72.430000000000007 109.389 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.17 140.69 48.33 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.449 -0.945 . . . . 71.549999999999997 108.449 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 495' ' ' THR . 37.9 mt-30 -123.96 135.52 53.71 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.404 -1.332 . . . . 75.109999999999999 107.404 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 29.7 t -146.48 165.86 28.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.279 -1.008 . . . . 74.0 108.279 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -91.14 145.54 24.59 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.634 -0.506 . . . . 70.409999999999997 109.634 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . 0.699 ' HB2' ' HA ' ' A' ' 498' ' ' ASP . 18.1 tt0 -55.66 -54.86 39.05 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.778 0.831 . . . . 75.439999999999998 110.723 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.418 ' C ' HD22 ' A' ' 386' ' ' ASN . 0.2 OUTLIER -74.37 8.34 2.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.765 1.024 . . . . 65.310000000000002 113.765 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.89 -31.05 68.64 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.538 -0.541 . . . . 65.019999999999996 109.538 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.64 -60.38 0.52 Allowed Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.425 -0.893 . . . . 62.310000000000002 111.245 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 12.7 p -138.02 152.1 48.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 110.348 -0.242 . . . . 74.040000000000006 110.348 176.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 494' ' ' VAL . 3.6 p -108.15 124.22 64.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.559 -1.274 . . . . 74.530000000000001 107.559 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.16 118.92 34.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.309 0.576 . . . . 71.349999999999994 110.815 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -110.93 149.99 29.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.511 -1.292 . . . . 51.450000000000003 107.511 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.4 m -116.37 125.45 52.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.235 0.54 . . . . 71.540000000000006 110.462 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 77.6 mt -97.24 123.98 49.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.346 -1.353 . . . . 71.140000000000001 107.346 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.7 mm -102.16 129.93 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-N 115.205 -0.907 . . . . 74.329999999999998 108.775 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 35.9 ttt180 -112.06 108.62 17.99 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.424 -0.807 . . . . 71.209999999999994 108.873 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 . . . . . 0 CA--C 1.487 -1.462 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 109.755 -178.809 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 7.0 m . . . . . 0 N--CA 1.416 -2.129 0 CA-C-O 121.623 0.725 . . . . 72.209999999999994 109.832 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.87 137.25 56.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.307 -0.86 . . . . 72.109999999999999 109.132 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.446 ' CE2' HG22 ' A' ' 430' ' ' VAL . 17.9 m-85 -119.93 137.1 54.24 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.582 -0.896 . . . . 72.510000000000005 108.582 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.18 128.76 49.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 107.619 -1.252 . . . . 73.349999999999994 107.619 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.5 153.68 20.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.714 -0.476 . . . . 63.109999999999999 109.714 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -146.95 161.54 40.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.232 -0.293 . . . . 65.310000000000002 110.435 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -161.03 163.0 31.91 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 107.311 -1.366 . . . . 75.230000000000004 107.311 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 49.4 p -95.71 172.54 7.98 Favored 'General case' 0 C--O 1.26 1.656 0 N-CA-C 108.34 -0.985 . . . . 64.510000000000005 108.34 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -121.72 151.61 40.32 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 120.218 -0.593 . . . . 63.020000000000003 111.339 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 3.49 8.68 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 125.734 1.613 . . . . 71.329999999999998 113.045 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.85 -92.02 0.01 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 116.917 1.527 . . . . 71.430000000000007 116.917 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.3 t -101.85 9.58 40.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.212 1.006 . . . . 73.420000000000002 111.096 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -147.03 -157.58 0.82 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.492 -0.929 . . . . 34.409999999999997 108.492 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -145.17 124.37 12.94 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.95 -1.1 . . . . 41.340000000000003 111.768 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -72.28 124.65 25.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.255 -0.884 . . . . 74.099999999999994 108.889 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.48 -16.02 41.53 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.963 -1.255 . . . . 73.329999999999998 109.963 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 48.1 t -110.48 -58.71 2.04 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.379 -0.6 . . . . 32.43 109.379 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 15.4 m-20 -86.28 -58.39 2.65 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-O 122.261 1.029 . . . . 73.109999999999999 109.418 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.712 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.11 163.43 32.45 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.086 -0.961 . . . . 75.219999999999999 109.48 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -72.94 151.94 41.63 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 123.879 0.737 . . . . 73.040000000000006 110.735 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.619 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.1 p90 -80.54 -21.62 41.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.747 -0.661 . . . . 70.319999999999993 112.654 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 442' ' ' VAL 0.255 13.8 t 36.69 67.16 0.35 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.647 1.579 . . . . 74.129999999999995 113.754 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -87.86 113.15 23.24 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.098 -0.956 . . . . 65.420000000000002 108.756 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.65 -173.86 23.26 Favored Glycine 0 CA--C 1.482 -2.025 0 C-N-CA 120.492 -0.861 . . . . 54.240000000000002 111.365 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.7 m -120.51 137.16 54.52 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.501 -0.926 . . . . 71.099999999999994 108.501 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 22.0 t -96.56 123.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.929 -1.137 . . . . 72.129999999999995 107.929 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.446 HG22 ' CE2' ' A' ' 406' ' ' PHE . 16.2 t -103.66 109.6 27.58 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-O 121.389 0.614 . . . . 74.219999999999999 111.047 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 404' ' ' THR . 55.7 m-85 -94.14 100.02 12.19 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.699 -0.682 . . . . 74.219999999999999 111.064 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.8 mttt -94.53 172.1 5.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 114.263 -1.335 . . . . 75.209999999999994 110.343 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 44.5 Cg_exo -58.73 126.17 20.44 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.868 2.379 . . . . 75.319999999999993 112.173 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.84 -2.04 87.07 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.601 -0.809 . . . . 61.329999999999998 114.359 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.24 -70.16 0.38 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 117.654 0.727 . . . . 72.010000000000005 110.447 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 54.5 m 71.26 -35.33 0.33 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.686 0.795 . . . . 63.509999999999998 112.122 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -125.95 140.1 52.9 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.515 -1.291 . . . . 74.120000000000005 107.515 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -132.93 143.67 49.64 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.417 -0.356 . . . . 62.509999999999998 110.322 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 392' ' ' LEU . 36.8 tt0 -106.0 134.64 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.495 -0.928 . . . . 65.219999999999999 108.495 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.4 pt -123.14 148.54 26.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.437 -1.32 . . . . 71.430000000000007 107.437 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 75.5 mtt180 -129.0 138.18 51.78 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.363 0.602 . . . . 71.409999999999997 111.93 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.661 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 52.1 t -109.62 119.0 58.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.732 -1.122 . . . . 72.209999999999994 108.628 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.419 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -66.03 132.55 33.83 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 124.192 0.933 . . . . 61.020000000000003 112.236 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 31.8 mm -97.71 135.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.169 -1.419 . . . . 70.040000000000006 107.169 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 76.0 mt -101.72 150.57 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 106.948 -1.501 . . . . 72.049999999999997 106.948 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.23 95.47 6.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.365 -0.534 . . . . 71.040000000000006 111.317 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -122.61 128.1 50.25 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 103.539 -2.763 . . . . 72.420000000000002 103.539 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -126.54 99.85 5.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 C-N-CA 116.999 -1.881 . . . . 75.040000000000006 110.149 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.761 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -131.04 158.27 43.3 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.118 0 CA-C-N 111.077 -2.783 . . . . 72.219999999999999 105.03 -171.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -53.16 114.82 1.6 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 116.721 -1.992 . . . . 70.239999999999995 106.397 166.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.761 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.6 mt-10 -125.23 97.17 5.11 Favored 'General case' 0 CA--C 1.458 -2.571 0 N-CA-C 107.856 -1.164 . . . . 74.129999999999995 107.856 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -117.84 113.47 21.83 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 108.192 -1.04 . . . . 75.230000000000004 108.192 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 31.38 20.41 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.114 0.884 . . . . 71.230000000000004 111.366 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.492 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.0 tt0 -65.32 106.57 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.27 -1.381 . . . . 65.140000000000001 107.27 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -141.2 169.68 17.15 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.65 -0.704 . . . . 63.219999999999999 109.846 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.661 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 22.5 p90 -143.35 170.44 15.76 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.749 -0.834 . . . . 63.109999999999999 108.749 173.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.74 136.5 50.92 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.058 -1.46 . . . . 73.230000000000004 107.058 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.58 124.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 106.806 -1.553 . . . . 71.109999999999999 106.806 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -120.37 142.8 48.84 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.652 -0.704 . . . . 74.109999999999999 109.242 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.5 138.13 33.61 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.931 -1.878 . . . . 73.219999999999999 105.931 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 26.0 m -148.09 155.1 41.06 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.89 -0.781 . . . . 54.130000000000003 108.89 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.5 t30 57.56 92.38 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 O-C-N 124.543 1.152 . . . . 62.43 111.95 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.75 142.46 14.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.391 -0.966 . . . . 73.230000000000004 108.391 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 464' ' ' LYS . 32.6 ttmt . . . . . 0 N--CA 1.429 -1.52 0 N-CA-C 109.3 -0.63 . . . . 71.409999999999997 109.3 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.425 -1.687 0 N-CA-C 109.25 -0.648 . . . . 50.25 109.25 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -107.59 118.66 37.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.331 -0.989 . . . . 73.150000000000006 108.331 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 23.6 m -88.25 119.51 28.73 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.814 0.34 . . . . 60.109999999999999 110.47 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 390' ' ' VAL . 68.4 t -104.61 106.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.424 -0.954 . . . . 72.040000000000006 108.424 176.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 27.6 m -95.53 114.23 25.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.131 -1.063 . . . . 72.140000000000001 108.131 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.712 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -92.21 117.59 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 C-N-CA 120.326 -0.55 . . . . 70.319999999999993 110.411 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.43 ' O ' HD13 ' A' ' 384' ' ' LEU . 18.3 m-85 -78.42 103.06 8.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 107.621 -1.252 . . . . 63.43 107.621 170.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 385' ' ' GLU . 0.0 OUTLIER -63.06 -30.81 71.89 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.283 -1.781 . . . . 74.209999999999994 109.459 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 125.521 1.528 . . . . 72.140000000000001 110.849 174.808 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 120.798 0.333 . . . . 74.329999999999998 110.216 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.46 HD13 ' HG3' ' A' ' 396' ' ' ARG . 44.7 mm -109.38 112.62 41.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.162 -1.421 . . . . 44.340000000000003 107.162 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -145.53 160.44 41.62 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.836 -0.746 . . . . 73.530000000000001 112.609 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.06 142.76 39.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.31 -0.626 . . . . 75.129999999999995 109.31 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.21 -48.69 80.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.806 0.842 . . . . 74.519999999999996 110.093 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.554 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 16.2 mm100 -106.25 172.4 6.83 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.816 0.817 . . . . 64.030000000000001 110.649 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.11 -34.04 4.99 Favored Glycine 0 C--N 1.284 -2.327 0 CA-C-N 114.129 -1.396 . . . . 62.310000000000002 110.167 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 42.2 m -132.93 128.43 36.47 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.226 -1.028 . . . . 51.210000000000001 108.226 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 37.3 m-85 -112.06 136.84 50.91 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 495' ' ' THR . 18.8 mt-30 -126.61 142.49 51.52 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.178 -1.045 . . . . 72.219999999999999 108.178 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 19.5 t -153.68 165.1 37.01 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.278 -1.378 . . . . 73.219999999999999 107.278 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -86.18 141.99 28.94 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.584 -0.525 . . . . 74.319999999999993 109.584 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -55.55 -38.2 69.0 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.378 1.071 . . . . 61.200000000000003 110.128 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -84.83 7.03 22.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.04 -0.982 . . . . 71.230000000000004 111.999 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.5 t -90.45 -1.03 57.89 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 122.02 -0.425 . . . . 75.140000000000001 111.213 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.27 4.5 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 64.329999999999998 113.117 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 22.1 p -142.91 174.26 10.82 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.314 0.578 . . . . 71.230000000000004 110.843 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 494' ' ' VAL . 4.6 p -125.61 125.9 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 106.802 -1.555 . . . . 74.230000000000004 106.802 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.33 122.69 41.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.996 0.427 . . . . 73.0 110.118 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.546 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.3 mp -112.45 146.42 38.43 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.05 -1.092 . . . . 74.239999999999995 108.05 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.2 m -112.46 128.53 56.35 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.448 0.467 . . . . 74.549999999999997 109.748 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 62.2 mt -100.45 121.74 51.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.17 -1.419 . . . . 74.409999999999997 107.17 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.2 mm -99.2 132.3 44.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.754 -0.832 . . . . 64.510000000000005 108.754 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.46 ' HG3' HD13 ' A' ' 374' ' ' ILE . 3.3 ttp85 -107.52 122.83 47.44 Favored 'General case' 0 N--CA 1.406 -2.666 0 C-N-CA 119.702 -0.799 . . . . 75.019999999999996 110.549 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 . . . . . 0 C--N 1.284 -2.266 0 CA-C-N 115.363 -0.835 . . . . 74.439999999999998 108.965 176.262 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 50.7 m . . . . . 0 N--CA 1.439 -0.998 0 CA-C-O 121.492 0.663 . . . . 62.329999999999998 111.512 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.6 t -112.26 146.92 16.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.047 -0.524 . . . . 74.310000000000002 109.83 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.604 ' CE1' HG13 ' A' ' 430' ' ' VAL . 3.7 m-85 -120.59 129.14 53.63 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.11 0.564 . . . . 73.239999999999995 110.66 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.81 135.95 52.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.589 -1.263 . . . . 61.439999999999998 107.589 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 18.2 t70 -102.52 148.73 25.18 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.061 -0.718 . . . . 72.439999999999998 109.061 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -143.94 159.36 42.71 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.038 -0.665 . . . . 74.140000000000001 110.868 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -163.17 160.91 24.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.37 -1.715 . . . . 75.299999999999997 106.37 173.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.633 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 34.9 p -96.95 164.81 12.38 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.426 0.631 . . . . 73.120000000000005 110.581 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.4 tp10 -106.53 152.59 23.48 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.214 -1.402 . . . . 64.200000000000003 107.214 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.486 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 4.8 m-20 -60.01 -40.51 89.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.915 0.864 . . . . 71.519999999999996 110.493 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . 0.428 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . 67.69 -86.51 0.16 Allowed Glycine 0 C--N 1.299 -1.495 0 CA-C-N 114.355 -1.293 . . . . 73.209999999999994 112.964 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.1 t -135.71 11.5 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.657 -0.868 . . . . 64.129999999999995 108.657 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -141.3 -162.87 1.45 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.698 -1.593 . . . . 65.329999999999998 106.698 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.486 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 7.3 m120 -129.29 116.35 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.583 0.706 . . . . 74.019999999999996 112.141 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -78.03 124.5 28.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.903 -1.044 . . . . 64.409999999999997 108.898 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.35 -12.25 30.94 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 109.668 -1.373 . . . . 74.299999999999997 109.668 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 16.3 t -126.87 -54.84 1.4 Allowed 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.917 -0.313 . . . . 74.209999999999994 110.993 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.611 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -73.06 -58.46 3.3 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 122.4 1.095 . . . . 70.430000000000007 108.074 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.72 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.21 161.78 36.58 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.126 -1.397 . . . . 74.25 107.631 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.6 157.33 32.04 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.566 0.541 . . . . 75.099999999999994 109.649 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.633 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 15.6 p90 -90.6 -9.69 46.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.215 0.45 . . . . 64.409999999999997 112.215 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.478 HG21 HG22 ' A' ' 442' ' ' VAL . 12.7 t 37.34 68.67 0.27 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.052 1.741 . . . . 72.5 113.728 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -80.3 134.79 36.11 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.023 -1.071 . . . . 70.349999999999994 109.128 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -175.03 -178.54 44.97 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.677 -0.969 . . . . 65.219999999999999 110.677 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 18.3 m -125.73 139.97 53.08 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.789 -1.189 . . . . 73.420000000000002 107.789 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.1 t -99.42 119.43 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.922 -0.769 . . . . 55.420000000000002 108.922 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 406' ' ' PHE . 53.6 t -100.71 106.65 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.575 -0.898 . . . . 54.43 108.575 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 404' ' ' THR . 58.9 m-85 -79.17 95.0 5.49 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.736 -0.665 . . . . 74.349999999999994 110.075 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.443 ' HD2' HG12 ' A' ' 430' ' ' VAL . 5.3 mptp? -69.46 164.58 48.36 Favored Pre-proline 0 C--N 1.316 -0.852 0 O-C-N 123.58 0.55 . . . . 75.219999999999999 111.549 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.41 113.51 1.16 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.739 2.293 . . . . 75.349999999999994 111.797 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.1 67.5 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.742 -0.742 . . . . 60.100000000000001 113.399 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -88.25 62.02 6.51 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.558 0.694 . . . . 74.030000000000001 110.691 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 m -61.47 -23.31 65.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.813 -1.085 . . . . 43.539999999999999 110.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -131.38 132.26 44.28 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.58 -1.267 . . . . 75.349999999999994 107.58 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 25.8 mmmt -122.32 149.8 43.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.484 0.55 . . . . 61.539999999999999 112.484 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -114.51 125.59 53.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.381 -0.827 . . . . 64.230000000000004 111.122 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.8 pt -116.84 146.57 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.043 -1.095 . . . . 62.240000000000002 108.043 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 71.2 mtt180 -126.01 141.45 51.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.374 -0.53 . . . . 74.010000000000005 110.8 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -106.22 121.2 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.442 -0.947 . . . . 54.32 108.442 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -62.07 125.01 35.31 Favored Glycine 0 N--CA 1.435 -1.423 0 O-C-N 124.134 0.896 . . . . 70.109999999999999 112.068 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.437 HD12 HG12 ' A' ' 496' ' ' ILE . 49.5 mm -94.92 135.27 29.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.988 -1.486 . . . . 65.439999999999998 106.988 175.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.9 mt -103.19 151.08 6.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.169 -1.419 . . . . 74.219999999999999 107.169 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.98 101.31 8.57 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 121.3 0.571 . . . . 75.329999999999998 110.536 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 123.15 29.57 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 103.771 -2.677 . . . . 62.32 103.771 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.256 19.6 t70 -119.78 97.58 5.7 Favored 'General case' 0 CA--C 1.459 -2.553 0 C-N-CA 116.393 -2.123 . . . . 74.019999999999996 111.932 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.701 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -121.45 156.49 25.36 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.439 0 CA-C-N 111.282 -2.69 . . . . 74.510000000000005 104.727 -174.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -53.87 115.32 1.95 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.862 -1.903 . . . . 75.450000000000003 105.862 168.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.701 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 33.1 mt-10 -123.38 90.71 3.33 Favored 'General case' 0 CA--C 1.483 -1.605 0 CA-C-O 122.069 0.937 . . . . 42.420000000000002 111.104 -170.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -93.58 104.94 17.03 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.005 -1.452 . . . . 63.039999999999999 107.738 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.308 7.9 p-10 42.28 60.34 2.35 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 125.095 1.497 . . . . 61.340000000000003 112.9 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.564 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 33.1 tt0 -74.45 113.96 12.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.683 -1.599 . . . . 64.420000000000002 106.683 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -137.13 171.35 14.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.57 0.7 . . . . 74.409999999999997 112.729 -174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 28.5 p90 -146.62 -177.78 5.82 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.861 -1.063 . . . . 71.319999999999993 109.665 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 412' ' ' GLU . 26.6 mt -123.32 141.57 51.85 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.015 -1.106 . . . . 63.240000000000002 108.015 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 411' ' ' THR . 25.7 t -110.56 130.85 63.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.199 -1.408 . . . . 53.030000000000001 107.199 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -124.17 134.2 53.37 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.498 0.499 . . . . 63.219999999999999 110.76 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.86 140.62 30.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.048 -1.093 . . . . 73.019999999999996 108.048 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 49.1 m -155.3 -177.79 6.8 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.693 -0.854 . . . . 64.239999999999995 108.693 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 6.9 t30 51.11 83.84 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.651 1.18 . . . . 54.509999999999998 111.599 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.61 126.4 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.581 -0.848 . . . . 53.32 109.178 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 116.049 -0.523 . . . . 64.239999999999995 110.123 -178.547 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 63.4 m . . . . . 0 N--CA 1.423 -1.776 0 CA-C-O 120.832 0.348 . . . . 60.439999999999998 110.554 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -126.82 135.4 50.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.118 -1.438 . . . . 74.099999999999994 107.118 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 88.1 m -96.12 129.99 43.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.656 -0.498 . . . . 75.530000000000001 109.656 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 390' ' ' VAL . 69.0 t -115.31 109.37 28.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.587 -0.894 . . . . 74.140000000000001 108.587 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 35.6 m -101.55 117.12 34.27 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.457 -0.942 . . . . 74.540000000000006 108.457 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.72 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.4 125.08 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.267 0 CA-C-N 115.957 -0.565 . . . . 62.130000000000003 109.693 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.489 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.0 m-85 -84.69 104.26 14.51 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-O 121.799 0.809 . . . . 74.310000000000002 111.693 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 451' ' ' GLU . 6.2 t70 -49.01 -58.52 4.76 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.721 -2.491 . . . . 73.349999999999994 109.475 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.8 t0 . . . . . 0 C--N 1.311 -1.068 0 C-N-CA 125.852 1.661 . . . . 73.530000000000001 111.043 177.077 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 94.3 mttt . . . . . 0 N--CA 1.418 -2.036 0 CA-C-O 121.545 0.688 . . . . 72.109999999999999 111.293 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 21.8 mm -104.73 121.45 56.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.725 -1.58 . . . . 62.109999999999999 108.41 -173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -157.51 155.16 29.83 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 117.612 0.187 . . . . 64.109999999999999 110.658 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -73.87 152.44 40.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.841 0.353 . . . . 50.140000000000001 110.981 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.02 -30.1 70.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.649 -0.705 . . . . 74.019999999999996 110.768 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -127.71 176.93 7.15 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.76 -0.654 . . . . 63.240000000000002 111.464 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.94 -36.38 3.96 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.941 -0.863 . . . . 74.530000000000001 110.941 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 49.9 m -129.46 131.81 46.8 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.338 -0.615 . . . . 73.030000000000001 109.338 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 49.9 m-85 -114.48 135.97 53.53 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.316 -0.994 . . . . 65.310000000000002 108.316 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.411 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 18.1 mt-30 -125.54 138.91 53.97 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.919 -0.771 . . . . 72.409999999999997 108.919 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.2 p -145.82 155.37 42.87 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.525 -0.546 . . . . 75.239999999999995 109.525 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -74.67 141.98 44.52 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.243 -0.651 . . . . 51.030000000000001 109.243 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -55.41 -45.76 76.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.927 0.87 . . . . 72.209999999999994 109.165 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.414 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.6 p-10 -82.37 21.54 0.93 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.968 -1.015 . . . . 71.439999999999998 112.813 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.28 0.64 46.03 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 121.621 -0.674 . . . . 74.120000000000005 112.035 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.82 -71.63 2.57 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.497 -0.859 . . . . 23.329999999999998 112.794 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.571 HG22 ' HA2' ' A' ' 443' ' ' GLY . 17.6 p -137.25 159.4 42.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.766 0.283 . . . . 70.420000000000002 110.784 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.647 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 5.4 p -112.59 125.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.524 -1.287 . . . . 61.219999999999999 107.524 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.55 127.8 43.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.149 -0.478 . . . . 73.200000000000003 110.074 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.3 mp -121.22 138.38 54.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.922 -1.51 . . . . 74.010000000000005 106.922 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.4 m -109.8 127.29 54.56 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.408 0.443 . . . . 71.430000000000007 110.27 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.22 125.5 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.908 -1.145 . . . . 72.430000000000007 107.908 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.503 HG22 ' HG2' ' A' ' 397' ' ' ARG . 30.5 mm -102.38 140.95 19.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 107.68 -1.23 . . . . 73.430000000000007 107.68 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 47.5 ttp85 -120.89 109.29 14.94 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.789 -0.449 . . . . 74.430000000000007 109.789 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . 0.503 ' HG2' HG22 ' A' ' 395' ' ' ILE . 31.7 mmm180 . . . . . 0 CA--C 1.511 -0.529 0 CA-C-N 115.861 -0.608 . . . . 73.209999999999994 110.528 -175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.398 -3.049 0 CA-C-O 121.408 0.623 . . . . 64.310000000000002 111.443 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.66 139.55 21.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.389 -0.823 . . . . 72.430000000000007 109.12 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 3.0 m-85 -121.81 123.23 41.3 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 123.667 0.787 . . . . 73.530000000000001 110.048 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.78 128.69 72.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.292 -1.373 . . . . 74.519999999999996 107.292 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 15.7 t70 -98.73 140.33 33.09 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.092 -0.38 . . . . 74.420000000000002 110.434 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -134.85 162.73 31.57 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.683 0.278 . . . . 63.32 110.514 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 42.9 ttt180 -166.82 162.71 16.18 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.591 -1.633 . . . . 55.130000000000003 106.591 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.613 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 59.8 p -95.6 172.12 8.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.65 -0.87 . . . . 71.230000000000004 108.65 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.34 145.92 50.63 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.7 -0.482 . . . . 74.099999999999994 109.7 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.1 4.2 5.9 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.124 1.37 . . . . 73.150000000000006 113.697 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -17.97 -88.92 0.01 OUTLIER Glycine 0 N--CA 1.479 1.541 0 C-N-CA 126.141 1.829 . . . . 71.209999999999994 117.113 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 13.9 t -109.79 5.31 22.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 117.89 0.845 . . . . 64.150000000000006 110.532 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.11 28.15 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.204 -1.776 . . . . 75.420000000000002 106.204 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.08 127.98 53.97 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.202 -1.399 . . . . 64.25 113.205 -164.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -69.32 126.36 29.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.289 -0.869 . . . . 61.240000000000002 110.181 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.62 -25.03 29.85 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.769 -0.932 . . . . 72.420000000000002 110.769 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.4 m -100.27 -57.04 2.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.98 -0.748 . . . . 64.209999999999994 108.98 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.58 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.2 m-20 -84.91 -58.45 2.7 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-O 121.364 0.602 . . . . 55.350000000000001 110.499 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.555 ' CZ ' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -136.19 166.59 23.05 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 108.915 -0.772 . . . . 74.420000000000002 108.915 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.43 155.69 39.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.987 0.805 . . . . 73.340000000000003 109.716 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.613 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 3.2 p90 -91.04 -17.9 25.47 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.971 -0.559 . . . . 73.340000000000003 111.709 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.546 HG21 HG22 ' A' ' 442' ' ' VAL . 9.2 t 34.07 59.2 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 125.144 1.527 . . . . 75.310000000000002 113.024 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.1 pt-20 -79.88 119.3 22.56 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.421 -0.809 . . . . 72.409999999999997 109.656 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.74 -174.13 34.95 Favored Glycine 0 N--CA 1.419 -2.455 0 C-N-CA 120.552 -0.832 . . . . 70.5 111.426 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 4.6 m -128.8 138.56 52.14 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.321 -0.992 . . . . 74.409999999999997 108.321 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 49.1 t -95.64 123.37 47.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.971 -0.752 . . . . 62.450000000000003 108.971 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 87.9 t -100.58 107.33 20.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.874 -1.057 . . . . 72.409999999999997 109.147 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -82.52 94.37 7.46 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.071 -0.513 . . . . 63.020000000000003 110.463 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.62 160.49 58.78 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.172 -0.922 . . . . 44.030000000000001 110.476 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.799 2.333 . . . . 72.540000000000006 111.183 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.34 -0.86 57.16 Favored Glycine 0 C--N 1.31 -0.875 0 C-N-CA 120.972 -0.632 . . . . 72.040000000000006 113.831 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.01 -66.66 0.9 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.172 0.486 . . . . 74.310000000000002 110.756 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 m 71.64 -49.58 0.69 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.123 0.969 . . . . 70.540000000000006 110.571 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -107.85 136.05 48.22 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.235 -1.394 . . . . 74.430000000000007 107.235 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -129.32 140.17 51.49 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.979 0.419 . . . . 74.409999999999997 110.993 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.58 139.6 44.39 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.564 -0.743 . . . . 72.230000000000004 110.739 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.4 pt -121.71 150.44 24.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.887 -1.153 . . . . 72.219999999999999 107.887 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.2 mtt180 -131.27 139.37 49.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 110.106 -0.331 . . . . 72.519999999999996 110.106 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.546 HG22 HG21 ' A' ' 425' ' ' THR . 52.2 t -110.77 122.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.579 -1.267 . . . . 75.219999999999999 107.579 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.19 138.7 26.99 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 63.299999999999997 111.507 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.8 mm -96.6 132.61 40.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 107.089 -1.449 . . . . 70.200000000000003 107.089 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -95.7 147.08 6.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.358 -1.719 . . . . 65.040000000000006 106.358 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.18 88.0 3.05 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.312 0.577 . . . . 63.530000000000001 111.694 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.75 113.29 22.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.587 -2.375 . . . . 72.030000000000001 104.587 172.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -120.29 94.85 4.51 Favored 'General case' 0 C--N 1.274 -2.717 0 C-N-CA 116.917 -1.913 . . . . 54.310000000000002 110.547 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.4 mm -121.34 156.64 25.12 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.042 0 CA-C-N 111.172 -2.74 . . . . 73.129999999999995 105.109 -174.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -53.13 114.78 1.58 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.139 -1.424 . . . . 71.310000000000002 107.578 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 37.1 mt-10 -129.19 123.85 33.09 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-N 115.691 -0.686 . . . . 63.43 110.202 -170.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -134.06 105.95 6.97 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.893 -1.049 . . . . 51.340000000000003 109.302 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.03 61.6 3.13 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 124.376 1.048 . . . . 65.329999999999998 113.316 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.85 124.27 39.79 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.509 -0.876 . . . . 73.5 111.125 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.6 171.85 8.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.822 -1.081 . . . . 72.409999999999997 108.37 -175.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.567 ' CE2' HD11 ' A' ' 496' ' ' ILE . 13.8 p90 -147.73 171.98 14.81 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.972 -1.122 . . . . 73.030000000000001 107.972 168.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.9 mt -117.56 142.85 46.71 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.908 -0.775 . . . . 74.420000000000002 108.908 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.28 122.23 66.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.753 -1.573 . . . . 44.210000000000001 106.753 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -111.37 139.55 46.69 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.349 0.405 . . . . 75.230000000000004 110.322 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.9 mt -101.25 128.19 47.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.869 -1.16 . . . . 71.340000000000003 107.869 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.2 m -151.05 -175.3 5.1 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.668 -0.864 . . . . 61.340000000000003 108.668 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.2 t30 50.86 83.41 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.694 1.198 . . . . 71.120000000000005 111.248 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.27 119.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.774 -0.825 . . . . 54.100000000000001 108.774 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? . . . . . 0 C--N 1.291 -1.971 0 N-CA-C 108.794 -0.817 . . . . 32.200000000000003 108.794 -179.075 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 65.4 m . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 120.841 0.353 . . . . 63.219999999999999 111.939 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.45 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.848 -1.167 . . . . 64.129999999999995 107.848 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 30.7 m -103.37 128.62 50.42 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.57 -0.452 . . . . 64.129999999999995 110.298 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.471 HG11 HG11 ' A' ' 390' ' ' VAL . 69.9 t -113.36 119.19 60.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.255 -1.017 . . . . 74.340000000000003 108.255 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.411 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 7.3 m -107.75 118.2 36.11 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.366 -0.976 . . . . 71.129999999999995 108.366 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.567 HD11 ' CE2' ' A' ' 456' ' ' PHE . 4.9 mp -97.74 120.75 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.596 0.712 . . . . 75.420000000000002 110.067 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.446 ' O ' HD13 ' A' ' 384' ' ' LEU 0.265 29.3 m-85 -88.0 104.46 16.67 Favored 'General case' 0 N--CA 1.388 -3.537 0 CA-C-O 122.355 1.074 . . . . 72.349999999999994 113.262 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.5 -55.89 16.43 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 111.748 -2.478 . . . . 71.129999999999995 109.064 172.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 C--N 1.313 -0.995 0 C-N-CA 125.633 1.573 . . . . 53.200000000000003 111.135 177.627 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 N--CA 1.415 -2.203 0 CA-C-O 121.275 0.559 . . . . 64.129999999999995 111.12 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 31.8 mm -114.93 119.14 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.282 -1.747 . . . . 72.209999999999994 106.282 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -155.85 164.42 38.54 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.934 -0.306 . . . . 74.439999999999998 111.024 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -82.35 153.9 25.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.616 -0.513 . . . . 75.120000000000005 109.616 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -62.57 -38.95 92.08 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.226 -0.657 . . . . 75.510000000000005 109.226 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -125.37 175.66 7.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.967 -1.015 . . . . 64.030000000000001 112.089 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.02 -21.58 10.86 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 115.05 -0.977 . . . . 71.420000000000002 111.657 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 30.1 m -135.85 132.4 36.56 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.67 -0.493 . . . . 64.239999999999995 109.67 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 46.1 m-85 -122.92 136.79 54.99 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.25 -1.019 . . . . 65.299999999999997 108.25 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 495' ' ' THR . 75.1 mt-30 -130.02 143.32 50.73 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.241 -1.022 . . . . 73.150000000000006 108.241 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 33.9 t -153.34 165.27 36.28 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.428 -0.952 . . . . 71.099999999999994 108.428 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.24 143.0 30.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 122.589 0.356 . . . . 60.409999999999997 111.23 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -59.72 -37.27 78.43 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.876 -0.602 . . . . 71.239999999999995 109.672 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -83.44 8.31 14.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.968 -0.56 . . . . 73.120000000000005 112.371 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 32.2 t -89.91 -11.96 40.29 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 119.962 -0.695 . . . . 51.240000000000002 110.924 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.38 -53.61 2.43 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.628 -0.796 . . . . 75.140000000000001 113.708 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 7.8 p -141.37 164.93 28.91 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.803 0.301 . . . . 64.219999999999999 110.697 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.645 HG11 HG11 ' A' ' 494' ' ' VAL . 4.8 p -120.1 127.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.103 -1.073 . . . . 72.109999999999999 108.103 172.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.99 124.2 42.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 71.329999999999998 110.799 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.448 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.1 mp -116.54 146.74 42.41 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.142 -1.429 . . . . 75.310000000000002 107.142 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.6 m -116.59 129.22 56.04 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.309 -0.556 . . . . 43.130000000000003 110.624 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.414 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 73.1 mt -98.41 120.54 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 107.675 -1.232 . . . . 74.420000000000002 107.675 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 397' ' ' ARG . 49.3 mm -98.62 129.01 49.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 107.436 -1.32 . . . . 73.430000000000007 107.436 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -108.64 107.7 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.464 -0.939 . . . . 72.450000000000003 108.464 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . 0.508 ' HG3' HG22 ' A' ' 395' ' ' ILE . 59.2 mtt180 . . . . . 0 CA--C 1.501 -0.917 0 CA-C-O 121.041 0.448 . . . . 74.049999999999997 111.997 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 19.3 m . . . . . 0 N--CA 1.41 -2.428 0 CA-C-O 121.767 0.794 . . . . 74.030000000000001 110.102 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.61 146.29 16.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.198 -1.365 . . . . 73.540000000000006 107.857 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 33.6 m-85 -126.4 127.32 45.29 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.125 -0.694 . . . . 65.409999999999997 109.125 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.55 129.75 68.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.695 -1.224 . . . . 64.129999999999995 107.695 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 13.7 t70 -96.99 140.6 31.28 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.606 0.241 . . . . 60.409999999999997 110.588 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -137.1 152.34 49.9 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.751 -0.379 . . . . 72.519999999999996 111.645 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.89 172.86 14.98 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.265 1.426 . . . . 74.030000000000001 108.078 174.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.9 p -106.44 161.03 14.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.971 -0.381 . . . . 65.430000000000007 109.971 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.2 tp10 -107.65 155.29 20.31 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 122.704 0.401 . . . . 43.310000000000002 110.151 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 6.8 m-20 -84.63 1.87 44.21 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 124.021 0.928 . . . . 72.219999999999999 112.333 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -11.06 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.499 2.836 0 N-CA-C 117.413 1.725 . . . . 73.25 117.413 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 14.8 t -126.93 17.71 7.28 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 117.73 0.765 . . . . 63.009999999999998 110.445 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.88 -162.81 1.63 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.155 -0.475 . . . . 60.200000000000003 110.164 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.417 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 3.6 m120 -135.73 119.72 17.52 Favored 'General case' 0 CA--C 1.485 -1.546 0 CA-C-O 121.344 0.592 . . . . 74.299999999999997 111.215 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.91 124.48 27.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.447 -0.946 . . . . 74.310000000000002 108.447 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.25 -15.28 43.2 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 110.663 -0.975 . . . . 53.109999999999999 110.663 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 18.3 t -114.31 -50.55 2.8 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.17 -0.678 . . . . 54.409999999999997 109.17 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 20.6 m-20 -85.66 -59.66 2.25 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 122.307 1.051 . . . . 63.43 110.354 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.683 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -138.83 162.83 33.82 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.826 -1.079 . . . . 73.450000000000003 108.894 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.558 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.9 tt0 -73.82 156.87 37.33 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 124.165 0.915 . . . . 73.140000000000001 110.788 -173.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.642 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.2 p90 -89.97 -14.33 34.28 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.175 -0.92 . . . . 74.140000000000001 111.448 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.558 ' H ' ' HG2' ' A' ' 423' ' ' GLU . 15.2 t 33.24 66.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.455 1.902 . . . . 74.040000000000006 113.127 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.23 111.77 15.79 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.049 0.928 . . . . 72.140000000000001 109.592 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -151.76 173.93 30.94 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 120.061 -1.066 . . . . 22.350000000000001 111.61 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 9.2 m -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 106.913 -1.514 . . . . 50.229999999999997 106.913 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 32.7 t -95.74 120.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.24 -1.022 . . . . 64.239999999999995 108.24 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.68 106.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 115.255 -0.884 . . . . 75.400000000000006 109.037 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.3 m-85 -82.03 94.21 7.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.153 -0.684 . . . . 72.140000000000001 109.153 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.05 167.34 30.03 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 115.048 -0.978 . . . . 63.149999999999999 110.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.79 110.52 0.64 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.497 2.131 . . . . 64.129999999999995 111.569 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 113.56 -18.7 19.95 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.716 -0.675 . . . . 72.420000000000002 112.078 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -83.92 62.37 6.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.305 0.574 . . . . 75.420000000000002 111.974 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 m -65.64 -20.94 66.5 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.857 0.836 . . . . 53.32 109.486 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -132.01 135.07 46.26 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.066 -1.457 . . . . 64.299999999999997 107.066 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -122.99 147.8 46.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 111.565 0.209 . . . . 74.209999999999994 111.565 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -118.41 131.4 56.28 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.299 -0.63 . . . . 61.210000000000001 109.299 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.7 pt -120.96 149.4 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.099 -1.074 . . . . 74.310000000000002 108.099 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.1 mtt180 -129.49 138.53 51.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-O 120.899 0.381 . . . . 74.019999999999996 110.854 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.609 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 63.7 t -104.92 126.57 59.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.667 -0.864 . . . . 74.129999999999995 108.667 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -68.29 127.31 23.79 Favored Glycine 0 N--CA 1.433 -1.542 0 O-C-N 124.115 0.884 . . . . 73.25 111.953 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.456 HD12 HG12 ' A' ' 496' ' ' ILE . 43.5 mm -94.6 134.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 106.07 -1.826 . . . . 72.140000000000001 106.07 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.3 mt -98.57 144.99 10.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 106.982 -1.488 . . . . 74.400000000000006 106.982 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.2 88.3 4.28 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.667 -0.813 . . . . 72.519999999999996 111.632 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.74 97.83 5.82 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.875 -2.269 . . . . 52.210000000000001 104.875 169.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.59 87.05 2.61 Favored 'General case' 0 CA--C 1.46 -2.511 0 CA-C-O 122.905 1.336 . . . . 74.099999999999994 109.856 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.425 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 26.5 mm -116.1 154.48 17.61 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.948 0 CA-C-N 111.688 -2.506 . . . . 75.319999999999993 104.575 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -63.97 114.82 4.35 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.386 -1.726 . . . . 71.439999999999998 108.62 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.428 ' HB2' ' OD1' ' A' ' 498' ' ' ASP . 19.5 mt-10 -135.49 151.93 50.85 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.646 -1.161 . . . . 62.219999999999999 108.485 -170.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -131.55 102.1 5.78 Favored 'General case' 0 N--CA 1.411 -2.393 0 C-N-CA 119.583 -0.847 . . . . 72.319999999999993 111.165 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 14.3 t70 63.86 61.55 0.95 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 124.704 1.252 . . . . 54.409999999999997 111.018 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.41 130.77 40.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.965 -0.562 . . . . 74.200000000000003 109.576 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.94 161.86 39.11 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.885 -0.726 . . . . 72.549999999999997 109.831 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.609 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 25.1 p90 -140.91 -178.99 5.81 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.98 -0.555 . . . . 70.310000000000002 109.711 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.3 mt -120.92 138.9 53.88 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.359 -1.349 . . . . 75.239999999999995 107.359 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 491' ' ' THR . 61.1 t -106.33 121.95 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.069 -1.456 . . . . 75.310000000000002 107.069 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 412' ' ' GLU . 63.5 m-70 -110.68 128.36 55.67 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.503 0.502 . . . . 73.400000000000006 111.023 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.99 131.7 42.09 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.031 -1.1 . . . . 74.239999999999995 108.031 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 12.4 p -155.7 -176.81 6.15 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.843 -0.799 . . . . 51.140000000000001 108.843 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 2.4 t-20 49.67 81.96 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.176 0.922 . . . . 70.129999999999995 112.694 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.12 128.36 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 115.332 -0.849 . . . . 64.129999999999995 108.772 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 72.0 tttt . . . . . 0 N--CA 1.403 -2.776 0 N-CA-C 106.381 -1.711 . . . . 65.209999999999994 106.381 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 36.0 m . . . . . 0 N--CA 1.42 -1.955 0 CA-C-O 120.672 0.272 . . . . 54.140000000000001 111.057 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -125.27 136.68 53.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.441 -1.318 . . . . 75.540000000000006 107.441 172.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 28.0 m -89.94 125.82 35.51 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.715 -0.476 . . . . 75.510000000000005 109.715 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.645 HG11 HG11 ' A' ' 390' ' ' VAL . 79.2 t -111.83 109.35 28.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.065 -0.717 . . . . 61.43 109.065 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 29.5 m -99.99 122.27 42.63 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.126 -1.064 . . . . 75.549999999999997 108.126 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.683 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -101.79 124.23 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 N-CA-C 108.561 -0.903 . . . . 71.340000000000003 108.561 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . 0.277 42.0 m-85 -87.8 111.3 21.22 Favored 'General case' 0 N--CA 1.393 -3.3 0 CA-C-O 122.124 0.964 . . . . 64.25 112.514 178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 451' ' ' GLU . 7.6 m-20 -51.8 -52.41 49.27 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-N 111.882 -2.417 . . . . 72.25 112.364 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 N--CA 1.472 0.641 0 O-C-N 125.171 1.544 . . . . 74.409999999999997 107.956 -173.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp . . . . . 0 C--O 1.24 0.576 0 N-CA-C 108.986 -0.746 . . . . 53.210000000000001 108.986 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.44 115.75 50.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.695 -1.594 . . . . 73.239999999999995 106.695 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -146.54 158.58 43.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 119.012 0.824 . . . . 71.25 112.752 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -70.47 143.1 51.84 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.542 -0.54 . . . . 73.430000000000007 109.542 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.71 -39.44 80.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.533 0.683 . . . . 74.5 109.171 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 12.7 mt-30 -122.58 153.71 38.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.432 -0.804 . . . . 71.200000000000003 111.34 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.2 -22.82 26.31 Favored Glycine 0 C--N 1.304 -1.24 0 C-N-CA 120.98 -0.629 . . . . 41.399999999999999 111.644 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 85.7 m -137.0 135.72 37.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.144 -0.687 . . . . 55.5 109.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 72.0 m-85 -124.96 138.85 54.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.264 -1.013 . . . . 71.230000000000004 108.264 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 495' ' ' THR . 39.3 mt-30 -128.93 124.86 36.21 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.888 -0.782 . . . . 73.340000000000003 108.888 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . 0.573 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -136.49 156.73 48.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.509 -0.552 . . . . 72.400000000000006 109.509 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -75.24 144.63 42.48 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 110.174 -0.306 . . . . 63.100000000000001 110.174 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 498' ' ' ASP . 51.8 tt0 -61.66 -31.56 71.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.831 0.824 . . . . 70.239999999999995 109.92 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.521 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.9 p-10 -84.52 1.74 44.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.891 -1.049 . . . . 73.540000000000006 112.698 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 45.8 t -77.0 -19.09 57.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.133 -0.354 . . . . 54.43 111.476 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.13 -61.86 2.19 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.748 -0.739 . . . . 75.109999999999999 112.208 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.3 p -136.96 148.97 47.25 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.54 0.17 . . . . 54.310000000000002 110.566 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.2 p -106.35 134.06 49.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.1 -1.445 . . . . 63.219999999999999 107.1 174.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.13 112.32 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.547 0.689 . . . . 63.409999999999997 110.835 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.499 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.9 mp -101.87 153.88 19.44 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.485 -1.302 . . . . 64.340000000000003 107.485 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -116.52 132.35 56.7 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.513 -0.475 . . . . 54.210000000000001 110.025 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 79.2 mt -104.91 122.86 58.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.186 -1.042 . . . . 73.219999999999999 108.186 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.72 127.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.54 -0.911 . . . . 54.439999999999998 108.54 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 54.7 ttt180 -113.75 110.1 19.63 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.3 -0.864 . . . . 63.240000000000002 109.157 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 . . . . . 0 C--N 1.304 -1.412 0 N-CA-C 109.439 -0.578 . . . . 71.109999999999999 109.439 -178.846 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.9 m . . . . . 0 N--CA 1.437 -1.107 0 CA-C-O 121.629 0.728 . . . . 63.43 110.749 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.09 149.68 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.085 -0.961 . . . . 71.540000000000006 108.663 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.423 ' CZ ' HG13 ' A' ' 430' ' ' VAL . 22.1 m-85 -127.31 129.38 47.55 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.942 0.497 . . . . 73.150000000000006 110.19 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.66 131.1 62.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.897 -0.779 . . . . 75.219999999999999 108.897 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 21.5 t70 -99.91 135.43 41.34 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 110.066 -0.346 . . . . 75.109999999999999 110.066 -175.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -134.98 165.66 24.82 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 122.093 -0.379 . . . . 72.450000000000003 111.158 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.515 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 21.6 ttm180 -166.02 160.19 16.28 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.115 -1.068 . . . . 73.420000000000002 108.115 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 72.5 p -96.71 154.96 16.98 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.905 -0.776 . . . . 72.540000000000006 108.905 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -115.65 148.49 39.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.734 1.013 . . . . 72.450000000000003 113.734 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.79 2.61 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.885 0 C-N-CA 130.722 3.609 . . . . 72.329999999999998 114.102 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -20.19 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 125.741 1.638 . . . . 73.420000000000002 117.156 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.1 t -136.24 16.19 3.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.117 0.958 . . . . 75.430000000000007 109.857 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.32 -164.14 1.52 Allowed 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.103 -1.073 . . . . 41.340000000000003 108.103 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -138.98 121.84 16.57 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.212 -0.995 . . . . 74.150000000000006 111.527 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -80.82 124.71 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.232 -0.655 . . . . 44.130000000000003 109.232 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.18 -27.8 7.56 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.552 -1.819 . . . . 73.109999999999999 108.552 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.3 t -106.78 -55.71 2.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.945 -0.627 . . . . 74.209999999999994 109.518 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.615 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -80.98 -60.28 2.35 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 111.112 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.701 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -136.75 166.95 22.39 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.545 -0.909 . . . . 71.25 108.545 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.3 tm-20 -77.72 154.42 32.07 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.638 -0.875 . . . . 74.420000000000002 108.638 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.504 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.9 p90 -95.52 -13.23 24.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.97 0.73 . . . . 64.219999999999999 112.97 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.502 HG21 HG22 ' A' ' 442' ' ' VAL . 10.1 t 36.01 57.77 0.97 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.364 1.866 . . . . 74.230000000000004 113.791 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 10.5 pt-20 -78.51 116.44 18.9 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.741 0.781 . . . . 72.219999999999999 108.945 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -157.08 -173.61 25.73 Favored Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 115.313 -0.858 . . . . 71.129999999999995 111.194 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 17.9 m -128.54 136.59 50.97 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.327 -1.36 . . . . 61.020000000000003 107.327 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.42 127.64 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.745 -1.205 . . . . 62.210000000000001 107.745 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.423 HG13 ' CZ ' ' A' ' 406' ' ' PHE . 22.7 t -105.04 106.69 20.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.831 -0.803 . . . . 55.109999999999999 108.831 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.9 m-85 -85.3 95.64 9.27 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.707 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 175.08 4.46 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 114.818 -1.083 . . . . 64.319999999999993 110.238 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.83 135.2 50.69 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.444 1.43 . . . . 73.420000000000002 109.603 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 91.85 -20.09 44.5 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.084 -0.579 . . . . 44.130000000000003 112.506 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.45 63.45 4.91 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.294 0.637 . . . . 75.450000000000003 110.821 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 m -70.69 -24.92 62.75 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.972 -1.013 . . . . 74.239999999999995 108.441 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.68 135.39 42.0 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.18 -0.674 . . . . 74.099999999999994 109.18 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -123.05 153.62 39.62 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.945 0.402 . . . . 51.240000000000002 111.864 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -113.08 129.82 56.38 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.058 -0.974 . . . . 74.019999999999996 109.49 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.403 ' CG1' ' HB2' ' A' ' 392' ' ' LEU . 40.7 pt -117.37 137.28 51.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.294 -1.002 . . . . 61.539999999999999 108.294 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 47.0 mtt180 -121.97 136.37 54.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.28 0.562 . . . . 72.219999999999999 112.134 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.627 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.6 t -111.12 123.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.299 -1.371 . . . . 74.439999999999998 107.299 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -78.68 135.79 16.42 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.856 -0.688 . . . . 62.130000000000003 111.996 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.455 HD12 HG12 ' A' ' 496' ' ' ILE . 38.4 mm -94.75 131.29 42.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.602 -1.258 . . . . 73.409999999999997 107.602 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.6 mt -93.52 143.17 12.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.322 -2.103 . . . . 75.409999999999997 105.322 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.47 86.22 7.31 Favored 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 119.036 -1.065 . . . . 62.310000000000002 111.314 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.85 98.44 8.13 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 103.25 -2.87 . . . . 72.329999999999998 103.25 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.84 89.29 3.61 Favored 'General case' 0 C--N 1.271 -2.841 0 C-N-CA 117.2 -1.8 . . . . 72.319999999999993 110.911 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.426 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -123.2 153.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.449 0 N-CA-C 104.265 -2.494 . . . . 74.519999999999996 104.265 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -60.12 114.64 2.97 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.658 -1.217 . . . . 73.230000000000004 108.845 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 21.3 mt-10 -128.46 140.99 51.53 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.717 -0.674 . . . . 74.409999999999997 109.555 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -121.15 99.67 6.62 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.313 -0.858 . . . . 75.420000000000002 109.546 -173.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.303 4.3 p-10 47.28 61.15 3.03 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.413 1.485 . . . . 64.540000000000006 112.794 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.559 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.7 tt0 -74.56 127.93 34.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.817 -1.083 . . . . 63.329999999999998 108.684 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.433 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.2 p-10 -145.56 169.09 19.08 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.811 -0.555 . . . . 73.140000000000001 111.905 -173.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.627 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 26.2 p90 -143.83 179.48 7.14 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.269 -0.423 . . . . 65.439999999999998 110.582 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 37.9 mt -118.08 138.68 52.08 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.724 -1.213 . . . . 74.510000000000005 107.724 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 491' ' ' THR . 41.1 t -112.43 126.47 69.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.216 -1.402 . . . . 72.540000000000006 107.216 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -119.66 157.07 29.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.407 0.442 . . . . 72.329999999999998 110.662 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.73 138.63 50.49 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.456 -0.572 . . . . 70.430000000000007 109.456 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.9 p -153.44 -174.3 4.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.023 0.529 . . . . 70.540000000000006 109.691 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.7 t30 34.79 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 126.201 1.8 . . . . 65.209999999999994 112.85 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.33 127.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 C-N-CA 119.9 -0.72 . . . . 65.450000000000003 109.692 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 108.993 -0.743 . . . . 73.409999999999997 108.993 -177.553 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 17.8 m . . . . . 0 N--CA 1.414 -2.265 0 N-CA-C 109.686 -0.487 . . . . 64.430000000000007 109.686 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -122.75 117.39 25.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.525 -1.657 . . . . 64.010000000000005 106.525 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 89.8 m -86.09 119.77 26.75 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.237 0.542 . . . . 61.229999999999997 110.573 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.557 HG11 HG11 ' A' ' 390' ' ' VAL . 80.2 t -104.08 108.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.603 -0.888 . . . . 55.039999999999999 108.603 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 90.2 m -96.58 121.01 37.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.629 -0.878 . . . . 73.420000000000002 108.629 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.94 126.88 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.179 0 CA-C-O 121.502 0.668 . . . . 73.340000000000003 109.535 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.59 ' O ' HD13 ' A' ' 384' ' ' LEU . 9.3 m-85 -93.0 104.16 16.4 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-O 121.854 0.835 . . . . 73.430000000000007 110.433 173.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 385' ' ' GLU . 8.3 m-20 -56.01 -54.02 49.9 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 112.882 -1.963 . . . . 73.420000000000002 113.283 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 N--CA 1.48 1.039 0 C-N-CA 126.174 1.79 . . . . 71.239999999999995 107.863 -170.129 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp . . . . . 0 N--CA 1.444 -0.766 0 N-CA-C 109.569 -0.53 . . . . 72.099999999999994 109.569 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 39.0 mm -107.16 115.87 49.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.909 -1.886 . . . . 72.540000000000006 105.909 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.46 167.11 23.76 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 118.794 0.725 . . . . 60.130000000000003 112.487 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -78.68 147.61 33.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.107 -0.701 . . . . 73.0 109.107 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.13 -53.3 39.51 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.569 -0.9 . . . . 71.109999999999999 108.569 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -109.8 174.15 6.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.074 -0.512 . . . . 65.310000000000002 110.751 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.48 -35.49 2.85 Favored Glycine 0 C--N 1.298 -1.559 0 CA-C-N 115.264 -0.88 . . . . 62.450000000000003 111.148 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 23.1 m -121.05 134.74 55.29 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.915 -1.142 . . . . 62.240000000000002 107.915 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 61.6 m-85 -124.19 136.34 54.11 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.673 -1.232 . . . . 71.349999999999994 107.673 175.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.39 123.59 36.56 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.507 -0.923 . . . . 71.239999999999995 108.507 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.2 p -134.33 152.9 52.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.667 -0.494 . . . . 71.140000000000001 109.667 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -75.02 152.74 38.68 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.256 -0.646 . . . . 75.400000000000006 109.256 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 498' ' ' ASP . 29.1 tt0 -65.52 -38.73 90.51 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.06 0.933 . . . . 64.530000000000001 109.5 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.464 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.5 p-10 -83.89 16.36 2.85 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.875 -1.057 . . . . 72.200000000000003 111.661 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.9 t -84.63 -20.59 31.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.188 0.518 . . . . 61.130000000000003 109.632 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.85 -60.37 3.15 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.913 -0.66 . . . . 72.109999999999999 111.883 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.53 HG22 ' HA2' ' A' ' 443' ' ' GLY . 9.0 p -143.57 155.97 44.45 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 122.662 0.385 . . . . 50.25 110.209 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -112.82 132.43 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.522 -1.288 . . . . 62.020000000000003 107.522 173.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.52 120.14 40.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.197 0.522 . . . . 51.130000000000003 110.141 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.8 mp -112.2 142.25 44.9 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.588 -1.264 . . . . 63.409999999999997 107.588 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.2 m -106.8 131.14 54.25 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.565 -0.531 . . . . 70.319999999999993 109.565 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.3 122.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.869 -1.16 . . . . 64.430000000000007 107.869 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.6 mm -98.02 123.95 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.319 -0.993 . . . . 54.229999999999997 108.319 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.505 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 51.4 ttt180 -111.02 110.89 21.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.383 -0.826 . . . . 71.319999999999993 109.639 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 . . . . . 0 C--N 1.308 -1.215 0 CA-C-N 115.968 -0.56 . . . . 64.219999999999999 109.578 -179.327 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 4.3 m . . . . . 0 N--CA 1.42 -1.959 0 CA-C-O 121.47 0.652 . . . . 43.009999999999998 111.687 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.65 142.96 22.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.042 -1.095 . . . . 72.25 108.042 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 464' ' ' LYS . 26.0 m-85 -127.24 129.91 48.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.349 -0.612 . . . . 72.230000000000004 109.349 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.27 132.39 66.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.006 -1.109 . . . . 73.420000000000002 108.006 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 19.2 t70 -93.3 134.53 35.41 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.75 -0.833 . . . . 71.019999999999996 108.75 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -123.06 148.12 45.95 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.923 -0.769 . . . . 74.150000000000006 108.923 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 410' ' ' ARG . 6.6 ttm180 -162.93 163.9 26.05 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.292 -1.003 . . . . 61.030000000000001 108.292 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 22.1 p -96.69 172.89 7.62 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.903 0.382 . . . . 73.310000000000002 111.035 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 4.8 tp10 -133.93 153.96 51.4 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.092 -2.188 . . . . 71.409999999999997 105.092 173.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -58.18 -45.02 88.28 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.185 0.809 . . . . 72.409999999999997 113.185 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.95 -93.73 0.16 Allowed Glycine 0 C--N 1.293 -1.857 0 CA-C-N 115.667 -0.697 . . . . 53.229999999999997 112.03 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.0 t -132.28 9.62 4.42 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.137 0.97 . . . . 72.349999999999994 109.007 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -132.14 -159.75 0.99 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.185 -1.783 . . . . 72.200000000000003 106.185 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -150.34 113.84 4.95 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.465 -0.894 . . . . 71.140000000000001 112.255 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.91 128.82 37.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.265 -0.643 . . . . 34.030000000000001 109.265 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.03 -31.63 6.18 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 109.102 -1.599 . . . . 42.43 109.102 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.2 m -110.18 -51.89 2.83 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.106 0.479 . . . . 61.399999999999999 109.859 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.625 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.1 m-20 -82.9 -61.43 1.87 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.531 0.682 . . . . 74.230000000000004 110.927 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.554 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.2 OUTLIER -132.31 173.42 11.28 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 107.228 -1.397 . . . . 75.209999999999994 107.228 -178.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.462 ' HG2' ' H ' ' A' ' 425' ' ' THR . 30.2 tt0 -79.11 148.0 32.54 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.361 -0.607 . . . . 72.239999999999995 109.361 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -82.36 -16.93 47.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 113.133 0.79 . . . . 63.210000000000001 113.133 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.581 HG21 HG22 ' A' ' 442' ' ' VAL 0.251 14.0 t 35.95 73.11 0.09 Allowed 'General case' 0 CA--C 1.556 1.198 0 O-C-N 125.513 1.758 . . . . 73.340000000000003 113.279 -178.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.5 130.93 35.76 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.591 -1.186 . . . . 75.230000000000004 109.273 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.78 48.53 Favored Glycine 0 CA--C 1.476 -2.35 0 C-N-CA 119.784 -1.198 . . . . 52.409999999999997 111.86 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 60.6 m -123.68 138.63 54.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.524 -0.917 . . . . 71.030000000000001 108.524 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.39 124.8 49.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.927 -0.768 . . . . 65.219999999999999 108.927 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 432' ' ' LYS . 23.4 t -95.3 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.25 109.232 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.505 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 60.5 m-85 -88.78 95.67 10.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.095 0.474 . . . . 73.409999999999997 111.236 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 57.3 mtmt -92.7 176.81 2.36 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 114.918 -1.037 . . . . 72.319999999999993 110.456 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.5 Cg_exo -56.62 131.71 47.3 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 122.479 2.119 . . . . 72.209999999999994 112.353 175.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 98.34 -33.08 6.27 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.845 -0.616 . . . . 70.109999999999999 111.985 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.458 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 33.4 mt-10 -82.54 64.15 7.04 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.803 1.241 . . . . 74.340000000000003 113.086 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 9.2 t -75.81 -13.01 60.28 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.49 -1.232 . . . . 62.219999999999999 109.816 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -135.79 137.12 41.28 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.867 -1.16 . . . . 71.25 107.867 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -130.81 157.87 41.69 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.572 0.225 . . . . 72.430000000000007 111.367 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -122.59 137.29 54.94 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 110.498 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -121.35 145.72 27.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 75.230000000000004 108.772 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 60.2 mtm180 -120.42 141.64 49.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.032 0.444 . . . . 71.530000000000001 111.097 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.581 HG22 HG21 ' A' ' 425' ' ' THR . 42.0 t -110.72 121.54 63.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.392 -1.336 . . . . 55.219999999999999 107.392 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.53 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.15 140.67 30.17 Favored Glycine 0 N--CA 1.433 -1.544 0 O-C-N 123.895 0.747 . . . . 61.520000000000003 112.113 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.406 HG23 ' HD1' ' A' ' 422' ' ' TYR . 37.8 mm -101.15 132.56 46.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 106.74 -1.578 . . . . 73.400000000000006 106.74 175.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.625 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.9 mt -99.22 151.49 4.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 106.536 -1.653 . . . . 71.439999999999998 106.536 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -82.38 86.23 6.76 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.223 -0.991 . . . . 71.040000000000006 112.136 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.41 107.59 18.55 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.76 -2.682 . . . . 71.329999999999998 103.76 169.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -109.69 84.86 2.0 Allowed 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 117.864 -1.534 . . . . 71.340000000000003 109.921 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 47.6 mm -124.37 154.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 111.966 -2.379 . . . . 72.299999999999997 105.81 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.19 115.38 4.45 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.428 -1.309 . . . . 62.299999999999997 109.018 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 24.0 mt-10 -126.98 135.75 51.29 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 114.371 -1.286 . . . . 75.010000000000005 109.516 -170.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -138.0 117.16 12.61 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.972 -1.013 . . . . 70.25 108.903 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 56.8 29.99 16.98 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.227 1.011 . . . . 72.109999999999999 110.97 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -75.38 118.24 18.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.906 -1.146 . . . . 70.129999999999995 107.906 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 2.7 p-10 -144.03 167.72 21.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.313 0.578 . . . . 70.5 110.775 -174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.546 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.9 p90 -139.12 -177.49 4.92 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.443 -0.799 . . . . 72.510000000000005 109.242 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 30.1 mt -122.13 139.64 53.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.401 -0.963 . . . . 54.329999999999998 108.401 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.81 126.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.821 -1.548 . . . . 71.510000000000005 106.821 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.62 149.62 41.66 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.164 -0.471 . . . . 53.509999999999998 110.672 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.08 124.84 50.25 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.275 -1.75 . . . . 65.349999999999994 106.275 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.8 m -144.25 170.91 15.08 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.212 -0.662 . . . . 74.109999999999999 109.212 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.13 86.53 0.04 OUTLIER 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.708 1.203 . . . . 63.399999999999999 112.525 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 61.9 t -80.14 128.82 38.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 119.698 -0.801 . . . . 61.420000000000002 108.897 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 406' ' ' PHE . 39.9 ttmt . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 107.088 -1.449 . . . . 72.409999999999997 107.088 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.413 -2.324 0 N-CA-C 108.381 -0.97 . . . . 73.439999999999998 108.381 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -104.78 131.82 51.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.618 -1.252 . . . . 50.229999999999997 107.618 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.7 m -98.86 121.86 41.35 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 120.481 -0.488 . . . . 70.109999999999999 110.338 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 86.9 t -109.01 106.06 19.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.798 -0.816 . . . . 70.439999999999998 108.798 177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 93.9 m -95.83 115.3 27.22 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.861 -1.162 . . . . 72.329999999999998 107.861 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.541 HD13 ' CZ ' ' A' ' 422' ' ' TYR . 4.9 mp -88.6 107.88 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 C-N-CA 119.896 -0.722 . . . . 52.439999999999998 109.867 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 38.2 m-85 -78.01 92.4 4.34 Favored 'General case' 0 CA--C 1.446 -3.044 0 N-CA-C 106.37 -1.715 . . . . 75.439999999999998 106.37 169.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 385' ' ' GLU . 1.1 p-10 -82.79 -19.87 36.91 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 114.241 -1.345 . . . . 71.219999999999999 108.905 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 N--CA 1.428 -1.552 0 CA-C-N 112.985 -1.916 . . . . 71.109999999999999 110.565 179.288 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.0 mmtp . . . . . 0 CA--C 1.505 -0.783 0 N-CA-C 109.899 -0.408 . . . . 73.340000000000003 109.899 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 35.6 mm -110.04 119.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.313 -1.366 . . . . 63.299999999999997 107.313 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -156.43 161.68 40.06 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 118.443 0.565 . . . . 64.439999999999998 112.305 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.17 145.04 40.17 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.133 -0.321 . . . . 73.200000000000003 110.133 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.89 -44.28 90.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.395 0.617 . . . . 72.299999999999997 109.359 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 14.4 mm100 -107.17 171.11 7.56 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.412 -0.813 . . . . 51.399999999999999 111.236 177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -105.62 -25.66 6.49 Favored Glycine 0 C--N 1.289 -2.063 0 N-CA-C 109.63 -1.388 . . . . 73.319999999999993 109.63 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 493' ' ' THR . 24.0 m -135.94 140.22 43.84 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.694 -1.225 . . . . 65.439999999999998 107.694 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 91.7 m-85 -129.13 136.69 50.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.31 -0.996 . . . . 74.430000000000007 108.31 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.66 134.45 53.74 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.131 -0.692 . . . . 74.310000000000002 109.131 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 31.7 t -148.69 165.03 32.57 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.486 -1.301 . . . . 72.349999999999994 107.486 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -84.4 143.54 29.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.627 0.603 . . . . 72.150000000000006 112.627 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.182 -0.917 . . . . 61.009999999999998 109.975 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -90.64 14.19 13.98 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.351 0.5 . . . . 71.310000000000002 112.351 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.78 -16.32 34.49 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.994 -0.441 . . . . 64.049999999999997 111.268 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.21 -68.77 0.37 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.527 -0.844 . . . . 74.329999999999998 112.405 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.522 HG22 ' HA2' ' A' ' 443' ' ' GLY . 16.7 p -135.18 161.68 34.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.094 0.473 . . . . 65.310000000000002 110.714 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 494' ' ' VAL . 5.7 p -112.5 129.13 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 107.842 -1.17 . . . . 71.040000000000006 107.842 172.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.78 120.85 40.39 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.603 0.564 . . . . 74.219999999999999 110.306 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.09 141.8 45.32 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.647 -1.242 . . . . 70.040000000000006 107.647 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -105.3 129.01 53.74 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.81 -0.441 . . . . 63.130000000000003 109.81 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.8 122.64 55.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.164 -1.05 . . . . 73.439999999999998 108.164 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.2 mm -94.43 132.36 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 C-N-CA 124.259 1.024 . . . . 70.439999999999998 108.456 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 60.6 ttt180 -115.6 111.23 20.36 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.293 -0.867 . . . . 70.409999999999997 109.788 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 . . . . . 0 C--N 1.299 -1.616 0 CA-C-N 115.129 -0.941 . . . . 72.010000000000005 109.044 179.473 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 25.3 m . . . . . 0 N--CA 1.403 -2.812 0 CA-C-O 121.561 0.696 . . . . 74.219999999999999 110.684 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 55.8 t -104.68 143.2 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 114.428 -1.26 . . . . 71.140000000000001 108.618 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 47.4 m-85 -126.22 112.77 16.14 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.544 -0.909 . . . . 64.340000000000003 108.544 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.6 124.66 71.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.1 -0.704 . . . . 73.540000000000006 109.1 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -87.41 140.49 29.48 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.094 -0.706 . . . . 73.219999999999999 109.094 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -142.83 154.66 44.38 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.44 -0.788 . . . . 74.120000000000005 111.69 -175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 426' ' ' GLU . 56.0 mtt85 -154.6 165.58 36.05 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 125.144 1.378 . . . . 63.439999999999998 109.27 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.607 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 58.5 p -100.97 158.05 16.29 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.647 -0.706 . . . . 70.340000000000003 109.262 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 8.2 tp10 -106.02 163.92 12.38 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.006 -1.85 . . . . 75.530000000000001 106.006 176.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.8 p-10 -60.29 -40.1 89.25 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.626 0.726 . . . . 70.150000000000006 110.559 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.76 -89.26 0.3 Allowed Glycine 0 C--N 1.299 -1.514 0 CA-C-N 114.737 -1.119 . . . . 73.439999999999998 110.456 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.433 ' CG2' ' H ' ' A' ' 455' ' ' ASN . 9.6 t -131.57 -1.09 3.9 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 122.093 0.949 . . . . 43.340000000000003 109.212 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -129.5 -154.84 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.254 -1.017 . . . . 73.120000000000005 108.254 -173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.41 125.6 20.06 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.101 0.477 . . . . 54.539999999999999 110.822 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -73.32 128.45 35.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.237 -0.653 . . . . 40.32 109.237 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.27 -13.08 48.34 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 110.522 -1.031 . . . . 24.239999999999998 110.522 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.4 m -117.64 -56.49 2.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.17 0.51 . . . . 72.340000000000003 109.67 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 38.1 m-20 -85.23 -57.64 3.0 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 122.174 0.988 . . . . 74.409999999999997 109.663 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.635 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -139.95 165.01 28.47 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.275 -0.875 . . . . 74.049999999999997 110.638 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.3 tt0 -73.82 149.16 41.82 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 124.057 0.848 . . . . 62.020000000000003 110.836 -173.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.607 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.3 OUTLIER -79.85 -16.29 55.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 73.5 111.818 176.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.608 HG21 HG22 ' A' ' 442' ' ' VAL 0.259 8.9 t 35.05 63.91 0.46 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 126.412 1.885 . . . . 72.239999999999995 113.622 -177.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' A' ' 410' ' ' ARG . 21.5 pt-20 -79.2 126.36 30.65 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.427 -0.806 . . . . 74.150000000000006 109.084 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -170.14 -173.2 37.32 Favored Glycine 0 N--CA 1.41 -3.065 0 N-CA-C 110.672 -0.971 . . . . 60.520000000000003 110.672 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 40.8 m -127.22 139.98 52.55 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.382 -0.97 . . . . 70.510000000000005 108.382 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.76 117.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.051 -1.092 . . . . 71.409999999999997 108.051 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.0 t -92.75 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.525 -0.761 . . . . 53.409999999999997 110.009 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.9 m-85 -91.82 94.46 9.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 110.053 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.2 mttm -82.79 174.93 5.31 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.073 -0.967 . . . . 64.329999999999998 110.296 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.2 Cg_exo -59.75 133.45 51.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 70.140000000000001 109.639 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.8 -18.8 48.88 Favored Glycine 0 C--N 1.305 -1.175 0 C-N-CA 120.564 -0.827 . . . . 44.109999999999999 113.199 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.83 63.99 7.22 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.24 0.616 . . . . 63.539999999999999 112.275 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 7.6 m -68.46 -19.27 64.55 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.182 -0.917 . . . . 73.239999999999995 109.113 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -138.28 137.78 37.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.294 -1.002 . . . . 72.329999999999998 108.294 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -124.48 151.66 44.32 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.485 -0.325 . . . . 74.019999999999996 111.028 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.76 138.99 48.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.964 -0.562 . . . . 64.109999999999999 109.946 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.51 133.9 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.445 -0.576 . . . . 74.299999999999997 109.445 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 24.5 mmt180 -104.55 133.02 50.12 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.636 -0.711 . . . . 73.040000000000006 111.123 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.685 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -110.55 124.21 67.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.14 -1.43 . . . . 64.310000000000002 107.14 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.7 133.86 19.77 Favored Glycine 0 N--CA 1.428 -1.841 0 O-C-N 123.903 0.752 . . . . 35.409999999999997 112.343 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 496' ' ' ILE . 34.7 mm -95.19 134.31 33.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 105.966 -1.865 . . . . 74.340000000000003 105.966 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 78.2 mt -97.03 143.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 107.732 -1.21 . . . . 64.319999999999993 107.732 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.87 95.03 0.66 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.544 0.688 . . . . 72.230000000000004 110.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.06 102.84 7.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 104.774 -2.306 . . . . 63.240000000000002 104.774 169.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -106.55 89.85 3.16 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.116 -1.434 . . . . 62.310000000000002 109.697 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.2 mm -129.63 155.57 41.43 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.28 0 CA-C-N 112.108 -2.315 . . . . 44.420000000000002 105.244 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.25 115.22 4.34 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 117.713 -1.595 . . . . 75.019999999999996 106.963 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 20.5 mt-10 -126.1 136.55 53.04 Favored 'General case' 0 CA--C 1.468 -2.178 0 CA-C-N 114.843 -1.071 . . . . 73.129999999999995 108.653 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -128.94 106.56 8.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.31 0.576 . . . . 63.299999999999997 110.35 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 54.74 60.67 3.36 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 125.316 1.446 . . . . 62.100000000000001 114.004 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.47 117.44 17.27 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.7 -0.852 . . . . 71.420000000000002 108.7 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.433 ' H ' ' CG2' ' A' ' 415' ' ' THR . 8.5 p30 -140.48 145.48 36.97 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.665 0.745 . . . . 74.340000000000003 110.115 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.685 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 22.3 p90 -123.81 174.3 7.61 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.612 -1.176 . . . . 74.150000000000006 109.124 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.3 mt -120.7 136.14 54.94 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 107.072 -1.455 . . . . 75.230000000000004 107.072 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.65 126.17 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.625 -1.25 . . . . 75.299999999999997 107.625 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -121.56 140.98 51.53 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.617 0.573 . . . . 74.230000000000004 110.007 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.92 138.8 33.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.973 -1.121 . . . . 74.430000000000007 107.973 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 14.9 m -146.55 177.16 9.27 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.16 -1.052 . . . . 72.109999999999999 108.16 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 40.8 83.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.727 0 C-N-CA 125.112 1.365 . . . . 54.530000000000001 113.42 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.37 134.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.688 -0.687 . . . . 72.439999999999998 109.16 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 23.3 ttmm . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 108.016 -1.105 . . . . 74.439999999999998 108.016 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 110.002 -0.37 . . . . 73.129999999999995 110.002 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.37 27.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.244 -1.021 . . . . 71.120000000000005 108.244 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 380' ' ' THR . 30.8 m -86.0 121.26 28.37 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.876 0.37 . . . . 65.319999999999993 110.486 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 390' ' ' VAL . 73.6 t -107.25 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.411 -0.959 . . . . 65.329999999999998 108.411 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 24.5 m -98.14 112.85 24.67 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.815 -1.18 . . . . 75.209999999999994 107.815 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.635 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.59 121.63 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 N-CA-C 109.212 -0.662 . . . . 72.239999999999995 109.212 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.436 ' O ' HD13 ' A' ' 384' ' ' LEU 0.29 23.3 m-85 -81.87 99.95 9.33 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-O 122.652 1.215 . . . . 71.209999999999994 112.459 177.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -49.89 -52.11 35.46 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 111.042 -2.799 . . . . 64.310000000000002 109.862 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 N--CA 1.479 0.983 0 C-N-CA 126.018 1.727 . . . . 61.149999999999999 111.317 177.561 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 51.7 mttm . . . . . 0 N--CA 1.427 -1.621 0 CA-C-O 120.533 0.206 . . . . 72.420000000000002 110.509 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 25.5 mm -115.36 124.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 107.421 -1.325 . . . . 64.209999999999994 107.421 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -155.64 -177.8 6.82 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 110.025 -0.361 . . . . 64.450000000000003 110.025 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -94.33 162.37 13.86 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.146 0.498 . . . . 63.020000000000003 112.054 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.11 -35.47 56.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.239 -0.891 . . . . 70.109999999999999 109.854 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 23.1 mm-40 -122.38 172.31 8.42 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.386 -0.825 . . . . 70.349999999999994 111.966 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -103.01 -37.18 3.21 Favored Glycine 0 C--N 1.293 -1.845 0 CA-C-N 114.465 -1.243 . . . . 65.349999999999994 110.025 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . 0.456 HG23 ' HB ' ' A' ' 493' ' ' THR . 26.0 m -133.02 130.98 40.15 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.452 0.644 . . . . 74.319999999999993 109.439 176.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 74.7 m-85 -113.43 143.9 43.71 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.112 -1.07 . . . . 71.120000000000005 108.112 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 495' ' ' THR . 15.7 mp0 -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.705 -0.85 . . . . 71.340000000000003 108.705 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 30.3 t -148.13 165.11 31.84 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.686 -0.857 . . . . 71.319999999999993 108.686 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.7 mm? -89.07 141.46 28.48 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 122.457 0.303 . . . . 60.149999999999999 110.617 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -56.88 -35.73 69.27 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 122.163 0.982 . . . . 74.519999999999996 109.605 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -74.26 -7.83 54.12 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.897 -1.502 . . . . 73.299999999999997 111.4 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.57 -22.85 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.011 0.434 . . . . 54.25 111.239 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.14 -51.48 2.48 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.177 -1.011 . . . . 44.219999999999999 112.493 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 17.2 p -138.12 160.75 38.58 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.073 0.463 . . . . 54.219999999999999 111.175 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.6 p -116.5 132.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.126 -1.435 . . . . 71.349999999999994 107.126 172.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -104.06 115.54 30.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.405 0.621 . . . . 54.350000000000001 110.36 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.1 mp -105.65 147.43 28.49 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.825 -1.176 . . . . 71.549999999999997 107.825 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.7 m -108.76 129.45 55.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.489 -0.559 . . . . 75.230000000000004 109.489 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.1 mt -97.98 119.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.465 -1.309 . . . . 74.319999999999993 107.465 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.17 121.6 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.473 -0.785 . . . . 55.240000000000002 109.324 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.44 129.93 55.87 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.222 -1.399 . . . . 73.540000000000006 107.222 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 . . . . . 0 C--N 1.285 -2.209 0 N-CA-C 109.389 -0.597 . . . . 74.109999999999999 109.389 177.661 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 33.4 m . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 121.336 0.588 . . . . 73.430000000000007 110.14 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.98 148.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.675 -0.693 . . . . 70.329999999999998 109.501 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.465 ' CE1' HG13 ' A' ' 430' ' ' VAL . 4.1 m-85 -123.55 132.62 53.95 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.821 0.849 . . . . 64.540000000000006 110.137 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.23 134.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.563 -1.273 . . . . 70.409999999999997 107.563 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.509 ' CB ' ' HB3' ' A' ' 462' ' ' ASN . 11.6 t70 -105.58 146.21 29.94 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.924 -0.485 . . . . 65.239999999999995 109.998 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -143.35 164.0 31.48 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.748 0.309 . . . . 62.240000000000002 110.257 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 17.2 ttp180 -166.42 169.28 14.12 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.693 -1.965 . . . . 73.129999999999995 105.693 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 68.5 p -96.72 145.9 25.37 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.303 0.573 . . . . 72.420000000000002 110.537 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 12.1 tp10 -108.67 133.75 52.33 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.929 -1.878 . . . . 73.129999999999995 105.929 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 64.2 m-20 -42.69 -52.66 4.82 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.112 1.365 . . . . 63.450000000000003 114.24 -173.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 74.57 -90.9 0.75 Allowed Glycine 0 C--N 1.285 -2.28 0 CA-C-N 114.975 -1.011 . . . . 63.450000000000003 110.918 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 455' ' ' ASN . 9.4 t -124.86 -13.86 6.82 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.703 -0.851 . . . . 72.010000000000005 108.703 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -105.86 -165.98 1.16 Allowed 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.288 -1.375 . . . . 74.510000000000005 107.288 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.52 115.87 10.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.116 -0.634 . . . . 60.409999999999997 110.62 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -72.56 138.51 46.92 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.809 -0.812 . . . . 73.120000000000005 108.809 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 97.85 -10.84 64.38 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.252 -1.139 . . . . 53.299999999999997 110.252 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 35.0 t -126.45 -56.09 1.42 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.792 -0.447 . . . . 64.409999999999997 109.792 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.593 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 13.6 m-20 -78.61 -54.88 5.66 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-O 121.541 0.686 . . . . 63.219999999999999 109.406 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.613 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -138.61 171.55 14.18 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 108.41 -0.959 . . . . 75.25 108.41 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.1 tm-20 -77.83 161.41 27.66 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.88 -1.156 . . . . 65.519999999999996 107.88 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.483 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 8.0 p90 -99.49 -12.98 19.69 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 112.451 0.538 . . . . 73.239999999999995 112.451 -174.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.485 HG21 HG22 ' A' ' 442' ' ' VAL 0.273 11.5 t 37.27 73.84 0.09 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.227 1.811 . . . . 65.409999999999997 113.449 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 0.6 OUTLIER -79.71 138.31 37.29 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.397 -1.274 . . . . 64.140000000000001 108.755 177.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 179.66 169.31 39.81 Favored Glycine 0 N--CA 1.413 -2.863 0 C-N-CA 118.777 -1.678 . . . . 70.129999999999995 112.205 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 5.9 m -117.41 133.67 55.71 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 106.69 -1.596 . . . . 63.340000000000003 106.69 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.2 t -96.14 119.85 44.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.745 -0.835 . . . . 70.129999999999995 108.745 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.465 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.0 t -95.73 117.44 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 71.219999999999999 108.941 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.9 m-85 -89.77 110.32 21.24 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 116.056 -0.52 . . . . 63.350000000000001 111.291 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 164.82 23.31 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.476 -0.784 . . . . 71.420000000000002 110.359 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -52.28 113.57 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.664 2.243 . . . . 72.150000000000006 112.236 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.58 25.29 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 111.134 -0.787 . . . . 73.109999999999999 111.134 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -81.85 63.23 6.01 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 123.533 0.733 . . . . 63.140000000000001 110.514 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 11.3 t -79.19 -7.69 58.43 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.874 -1.158 . . . . 71.519999999999996 107.874 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -136.92 137.09 39.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.905 -1.517 . . . . 75.540000000000006 106.905 172.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -125.98 153.23 44.62 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 111.596 0.221 . . . . 70.420000000000002 111.596 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -112.48 132.5 55.04 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.475 -0.565 . . . . 53.219999999999999 109.475 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 41.1 pt -127.07 146.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.255 -1.017 . . . . 64.420000000000002 108.255 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 52.5 mtt180 -125.8 145.56 50.16 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.133 0.492 . . . . 71.25 111.886 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 425' ' ' THR . 48.9 t -113.42 124.05 69.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.269 -1.382 . . . . 74.209999999999994 107.269 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -76.05 137.05 20.78 Favored Glycine 0 N--CA 1.435 -1.428 0 O-C-N 123.816 0.698 . . . . 73.519999999999996 111.866 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.507 HD12 HG12 ' A' ' 496' ' ' ILE . 36.8 mm -96.8 132.28 41.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.014 -0.735 . . . . 65.329999999999998 109.014 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.5 mt -94.53 149.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.541 -1.651 . . . . 34.229999999999997 106.541 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 86.9 5.38 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.471 -0.491 . . . . 75.109999999999999 111.868 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.64 120.99 43.43 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 104.717 -2.327 . . . . 73.010000000000005 104.717 172.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.289 4.0 t70 -118.35 90.2 3.28 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 116.046 -2.262 . . . . 72.319999999999993 112.398 178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.731 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.2 mm -120.21 155.62 23.24 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 110.747 -2.933 . . . . 74.519999999999996 104.041 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -54.26 114.84 1.78 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.602 -1.629 . . . . 71.010000000000005 106.602 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 47.4 mt-10 -107.42 98.34 7.97 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.564 1.173 . . . . 71.209999999999994 112.676 -171.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -112.58 108.47 17.57 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.673 -2.058 . . . . 71.030000000000001 107.681 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 42.07 60.56 2.23 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.99 1.431 . . . . 52.109999999999999 111.256 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.407 ' OE2' ' HG2' ' A' ' 451' ' ' GLU . 12.0 tt0 -89.15 107.22 18.93 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.914 -1.513 . . . . 63.509999999999998 106.914 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.3 OUTLIER -136.92 159.98 40.27 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 114.684 1.364 . . . . 55.020000000000003 114.684 -175.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 412' ' ' GLU . 34.0 p90 -132.97 177.61 7.52 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.359 -1.291 . . . . 74.439999999999998 108.613 174.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.47 136.99 54.58 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.82 -0.808 . . . . 75.420000000000002 108.82 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 41.0 t -108.84 125.87 65.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.277 -1.009 . . . . 73.409999999999997 108.277 176.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -120.68 152.98 37.54 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.923 -0.581 . . . . 72.319999999999993 109.561 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 72.9 mt -109.19 140.61 42.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.465 -0.569 . . . . 70.329999999999998 109.465 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.7 m -152.54 -173.13 4.45 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.592 0.757 . . . . 43.130000000000003 108.961 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.509 ' HB3' ' CB ' ' A' ' 408' ' ' ASP . 3.0 t30 48.89 81.28 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.95 1.3 . . . . 65.430000000000007 111.267 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.09 128.0 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.879 -1.156 . . . . 72.239999999999995 107.879 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 88.0 tttt . . . . . 0 N--CA 1.42 -1.956 0 CA-C-O 121.163 0.506 . . . . 75.0 111.185 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 25.7 m . . . . . 0 N--CA 1.419 -1.998 0 CA-C-O 120.588 0.232 . . . . 64.319999999999993 110.704 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -104.22 100.46 10.19 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.277 -1.379 . . . . 42.229999999999997 107.277 171.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . 0.456 ' HB ' HG23 ' A' ' 380' ' ' THR . 29.9 m -78.06 129.6 35.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.948 -0.76 . . . . 72.420000000000002 108.948 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 390' ' ' VAL . 92.4 t -117.25 109.23 27.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.398 -0.593 . . . . 73.010000000000005 109.398 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 26.8 m -98.28 115.67 28.89 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.987 -0.746 . . . . 73.209999999999994 108.987 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.613 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -95.81 124.46 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 CA-C-O 122.075 0.941 . . . . 73.329999999999998 110.002 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 71.7 m-85 -108.04 126.05 52.28 Favored 'General case' 0 N--CA 1.396 -3.156 0 CA-C-N 114.588 -1.187 . . . . 71.5 109.06 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -91.28 -19.7 22.7 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 104.431 -2.433 . . . . 73.430000000000007 104.431 166.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 111.795 -2.457 . . . . 73.340000000000003 111.677 178.443 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 53.0 mttp . . . . . 0 CA--C 1.477 -1.846 0 CA-C-O 121.242 0.544 . . . . 72.239999999999995 112.026 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 37.9 mm -114.49 106.86 21.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.252 -1.34 . . . . 70.329999999999998 108.728 -170.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.55 155.84 43.86 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 119.81 -0.756 . . . . 61.530000000000001 111.515 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -76.49 150.88 36.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.407 -0.361 . . . . 73.230000000000004 110.132 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.8 -42.27 86.21 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.532 -0.914 . . . . 71.219999999999999 108.532 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.543 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.4 mm100 -106.29 -171.75 1.96 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.869 -1.059 . . . . 62.340000000000003 110.221 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -123.02 -32.67 0.9 Allowed Glycine 0 C--N 1.289 -2.04 0 N-CA-C 109.233 -1.547 . . . . 71.239999999999995 109.233 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.2 m -127.84 141.4 51.58 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.907 -1.145 . . . . 72.310000000000002 107.907 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 64.5 m-85 -127.88 136.27 51.16 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.361 -0.978 . . . . 75.299999999999997 108.361 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.24 129.35 54.89 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.537 -1.283 . . . . 70.519999999999996 107.537 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 48.6 t -146.16 163.11 36.41 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.243 -0.651 . . . . 71.049999999999997 109.243 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -81.64 146.5 30.03 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.219 0.608 . . . . 71.340000000000003 111.917 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -58.12 -49.63 76.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.283 -1.006 . . . . 72.209999999999994 108.283 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.487 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.8 p-10 -73.55 16.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.911 -1.041 . . . . 71.150000000000006 113.706 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.1 t -86.71 -26.65 24.15 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.184 0.516 . . . . 62.210000000000001 109.725 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 96.78 -49.92 1.57 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.762 -0.732 . . . . 75.239999999999995 111.486 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.424 HG22 ' HA2' ' A' ' 443' ' ' GLY . 11.4 p -143.31 152.36 41.57 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.855 0.462 . . . . 71.129999999999995 109.943 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.52 HG12 ' HB ' ' A' ' 442' ' ' VAL . 5.7 p -107.42 133.88 50.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.146 -1.427 . . . . 65.319999999999993 107.146 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.18 126.43 50.35 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 123.299 0.375 . . . . 62.240000000000002 110.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.4 mp -119.59 145.94 45.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.961 -1.496 . . . . 72.430000000000007 106.961 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 56.7 m -113.14 127.65 56.26 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.438 -0.505 . . . . 74.299999999999997 110.831 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 70.1 mt -98.43 126.22 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 107.828 -1.175 . . . . 75.209999999999994 107.828 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 397' ' ' ARG . 43.7 mm -102.24 125.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.398 -1.334 . . . . 75.010000000000005 107.398 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 16.8 ttp180 -109.38 108.49 19.06 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.464 -0.335 . . . . 63.399999999999999 110.373 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 395' ' ' ILE . 80.2 mtp180 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 116.281 -0.418 . . . . 55.340000000000003 111.495 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.7 m . . . . . 0 N--CA 1.419 -2.016 0 CA-C-O 121.625 0.726 . . . . 65.109999999999999 109.739 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.49 133.82 51.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.599 -1.182 . . . . 65.510000000000005 109.259 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.496 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 21.8 m-85 -113.62 123.61 50.36 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.599 -0.728 . . . . 73.5 109.234 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.56 128.94 74.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.721 -0.844 . . . . 60.43 108.721 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 26.8 t70 -94.4 139.38 31.18 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.848 0.356 . . . . 62.539999999999999 110.725 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -132.56 153.98 50.46 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.858 -0.526 . . . . 71.129999999999995 111.108 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -159.39 163.64 35.33 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.433 -0.951 . . . . 75.430000000000007 108.433 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 77.2 p -101.01 171.85 7.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.667 0.27 . . . . 72.340000000000003 111.139 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.3 151.1 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.06 -0.719 . . . . 73.219999999999999 109.06 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.11 1.63 35.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 118.345 -0.836 . . . . 62.25 113.054 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -4.49 -97.08 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 C-N-CA 125.842 1.687 . . . . 71.439999999999998 115.185 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.9 t -105.47 -18.66 14.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.296 -0.631 . . . . 74.219999999999999 109.296 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.471 ' HB2' ' HG2' ' A' ' 454' ' ' GLU . . . -118.52 143.56 46.66 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.955 -0.758 . . . . 63.109999999999999 108.955 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -108.02 113.83 27.29 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 121.487 0.66 . . . . 71.540000000000006 111.59 -166.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -74.78 124.39 26.72 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.335 -0.848 . . . . 64.439999999999998 109.685 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.35 -28.35 6.05 Favored Glycine 0 C--N 1.294 -1.756 0 N-CA-C 109.19 -1.564 . . . . 65.400000000000006 109.19 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 32.6 t -117.03 -52.64 2.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.474 -0.363 . . . . 71.430000000000007 110.205 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.624 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 6.4 m-20 -75.63 -59.94 2.53 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.865 0.84 . . . . 41.240000000000002 110.24 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.525 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.1 OUTLIER -136.93 176.48 8.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.714 -1.587 . . . . 72.030000000000001 106.714 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -83.76 157.67 22.03 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.014 -0.736 . . . . 50.310000000000002 109.014 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -91.52 -8.93 46.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.068 -0.515 . . . . 74.140000000000001 112.337 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 442' ' ' VAL . 15.1 t 37.9 63.73 0.76 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.681 1.593 . . . . 74.439999999999998 113.252 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.56 110.98 15.39 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.216 -0.902 . . . . 63.520000000000003 109.576 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.0 174.24 33.24 Favored Glycine 0 N--CA 1.41 -3.046 0 CA-C-N 115.079 -0.964 . . . . 54.409999999999997 111.119 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 69.6 m -125.49 133.45 52.38 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 107.139 -1.43 . . . . 74.25 107.139 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.44 129.47 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.358 -0.978 . . . . 54.009999999999998 108.358 -176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.11 104.87 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.342 -0.845 . . . . 73.040000000000006 108.873 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.7 m-85 -84.8 108.39 17.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.867 -0.606 . . . . 73.329999999999998 111.325 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.441 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -90.1 165.04 25.63 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.773 -0.649 . . . . 60.409999999999997 110.093 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -50.92 127.73 22.4 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.991 2.461 . . . . 71.430000000000007 112.184 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 93.66 -17.65 58.13 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 115.839 -0.619 . . . . 70.340000000000003 113.426 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 71.2 mt-10 -84.24 63.88 7.97 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.866 0.841 . . . . 71.319999999999993 112.957 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 39.2 m -60.36 -24.06 64.77 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.009 -1.45 . . . . 55.100000000000001 110.707 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -128.57 138.88 52.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.7 -0.625 . . . . 75.239999999999995 110.36 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 438' ' ' LYS . 20.1 mmmt -134.87 145.65 48.48 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 120.941 0.401 . . . . 71.150000000000006 111.498 173.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -109.04 134.43 51.68 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.522 -0.763 . . . . 65.129999999999995 110.259 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.7 pt -116.34 137.05 51.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.826 -0.625 . . . . 60.43 109.514 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 17.5 mmt180 -109.05 132.84 53.73 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.297 -0.865 . . . . 74.030000000000001 111.286 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 425' ' ' THR . 47.9 t -108.23 116.79 52.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.674 -1.232 . . . . 73.5 107.674 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -61.2 130.79 47.52 Favored Glycine 0 N--CA 1.44 -1.096 0 O-C-N 124.482 1.114 . . . . 71.430000000000007 113.083 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.429 ' HA ' ' HB3' ' A' ' 422' ' ' TYR . 33.3 mm -101.45 130.66 50.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.393 -1.336 . . . . 74.409999999999997 107.393 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 68.7 mt -98.38 150.04 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 105.485 -2.042 . . . . 75.140000000000001 105.485 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -84.64 86.13 7.35 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.405 -0.918 . . . . 72.239999999999995 111.564 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.39 124.27 51.4 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 103.269 -2.863 . . . . 51.119999999999997 103.269 169.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -119.38 94.73 4.52 Favored 'General case' 0 CA--C 1.456 -2.658 0 C-N-CA 116.836 -1.945 . . . . 62.119999999999997 110.841 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . . . . . . . . . 39.9 mm -118.29 155.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.816 0 CA-C-N 111.752 -2.476 . . . . 74.150000000000006 105.379 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.43 115.06 2.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.114 -1.81 . . . . 73.329999999999998 106.114 170.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 498' ' ' ASP . 29.5 mt-10 -129.37 94.28 3.75 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.847 1.308 . . . . 74.230000000000004 110.442 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.74 106.29 18.56 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 113.703 -1.59 . . . . 72.420000000000002 108.747 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.28 4.4 p30 42.39 60.16 2.44 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.86 1.35 . . . . 73.219999999999999 112.971 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 416' ' ' ALA . 36.4 tt0 -87.29 135.22 33.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.252 -1.388 . . . . 70.310000000000002 107.252 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -149.55 161.45 42.13 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.238 0.542 . . . . 75.549999999999997 111.941 -172.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.495 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.4 p90 -137.91 -177.98 5.05 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.71 -0.677 . . . . 73.109999999999999 110.225 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -119.82 145.04 47.0 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.274 -1.01 . . . . 72.5 108.274 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.24 132.16 67.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 106.828 -1.545 . . . . 51.119999999999997 106.828 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -123.06 139.43 54.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.423 0.452 . . . . 52.25 111.033 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.2 mt -100.07 136.69 39.59 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.31 -1.367 . . . . 73.140000000000001 107.31 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 44.5 m -157.77 174.3 15.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.425 -0.583 . . . . 53.43 109.425 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.4 t30 54.18 90.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.858 1.263 . . . . 73.329999999999998 112.596 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.2 123.19 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.644 -0.707 . . . . 52.439999999999998 109.688 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 37.2 ttmt . . . . . 0 C--N 1.281 -2.392 0 N-CA-C 107.362 -1.347 . . . . 74.200000000000003 107.362 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 109.413 -0.588 . . . . 61.130000000000003 109.413 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.18 130.4 53.35 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.845 -1.168 . . . . 72.219999999999999 107.845 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 123.37 41.19 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.523 -0.471 . . . . 74.329999999999998 109.9 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.502 HG11 HG11 ' A' ' 390' ' ' VAL . 76.5 t -108.3 107.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.248 -0.649 . . . . 61.140000000000001 109.248 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 10.2 m -91.03 116.54 28.88 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.069 -1.086 . . . . 54.43 108.069 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 50.1 mt -101.97 114.64 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.218 1.009 . . . . 73.400000000000006 110.902 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.504 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -84.05 102.36 12.46 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.24 -1.346 . . . . 74.010000000000005 110.777 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 451' ' ' GLU . 23.5 t70 -52.28 -54.87 25.86 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 112.418 -2.174 . . . . 71.209999999999994 108.518 172.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.474 0.769 0 CA-C-N 113.23 -1.804 . . . . 44.509999999999998 112.003 176.519 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 32.9 mmtp . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 108.199 -1.037 . . . . 74.219999999999999 108.199 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 42.7 mm -105.67 114.6 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.52 -0.919 . . . . 73.349999999999994 108.52 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -149.33 174.61 12.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.488 0.585 . . . . 72.209999999999994 111.319 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.28 146.76 26.89 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.01 -0.366 . . . . 71.299999999999997 110.01 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.668 -1.604 . . . . 73.310000000000002 106.668 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.512 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 4.8 mt-30 -102.31 144.14 31.19 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.288 -0.869 . . . . 62.420000000000002 110.201 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.13 -12.4 57.59 Favored Glycine 0 C--N 1.284 -2.341 0 CA-C-N 115.699 -0.682 . . . . 72.030000000000001 111.553 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 25.6 m -140.37 131.37 26.18 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.644 -0.873 . . . . 65.219999999999999 108.644 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 72.5 m-85 -127.42 136.59 52.04 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.709 -0.848 . . . . 75.319999999999993 108.709 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -121.84 123.15 41.08 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.549 -1.278 . . . . 71.140000000000001 107.549 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 43.9 t -134.9 165.38 25.45 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.512 -0.551 . . . . 74.030000000000001 109.512 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 3.3 mm? -95.38 141.64 28.7 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.478 -0.783 . . . . 73.430000000000007 109.722 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.9 -36.93 78.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.822 -0.807 . . . . 61.43 108.822 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -65.53 -14.26 60.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.621 -1.172 . . . . 73.530000000000001 112.689 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 76.6 m -72.52 -19.22 61.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.769 0.285 . . . . 75.129999999999995 111.769 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.83 -48.48 3.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.309 -0.716 . . . . 64.200000000000003 111.309 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.1 p -141.51 161.34 38.16 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.605 0.762 . . . . 51.32 109.807 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.4 p -114.14 130.0 69.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.832 -1.173 . . . . 71.140000000000001 107.832 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.98 128.3 46.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 123.558 0.536 . . . . 72.420000000000002 110.174 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.52 151.04 41.76 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.677 -1.231 . . . . 53.549999999999997 107.677 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -112.03 128.83 56.3 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.336 0.588 . . . . 73.120000000000005 111.656 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 73.3 mt -101.53 126.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 107.913 -1.143 . . . . 62.329999999999998 107.913 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.2 mm -100.0 128.23 52.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.56 -0.904 . . . . 73.140000000000001 108.56 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.498 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 59.9 ttt180 -112.58 107.65 16.45 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.527 -0.916 . . . . 65.540000000000006 108.527 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 . . . . . 0 C--N 1.293 -1.874 0 CA-C-N 115.708 -0.678 . . . . 72.109999999999999 111.405 -178.885 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.437 -1.112 0 CA-C-O 121.798 0.808 . . . . 65.530000000000001 111.085 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 67.2 t -115.49 149.1 17.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.702 -1.136 . . . . 55.200000000000003 109.18 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 11.8 m-85 -126.69 147.42 49.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.338 0.59 . . . . 74.450000000000003 110.015 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.1 p -143.82 130.49 16.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.557 -0.535 . . . . 75.319999999999993 109.557 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -93.41 128.56 39.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.476 -0.565 . . . . 72.329999999999998 109.476 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -123.77 153.11 41.41 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.536 -0.912 . . . . 72.099999999999994 108.536 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -161.23 161.1 30.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.6 -1.259 . . . . 63.350000000000001 107.6 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 71.2 p -96.62 172.03 8.17 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.36 0.6 . . . . 63.039999999999999 109.859 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 6.8 tp10 -127.37 153.95 45.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.517 -2.031 . . . . 75.230000000000004 105.517 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.3 p-10 -58.2 -41.94 85.05 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.626 0.579 . . . . 64.049999999999997 112.425 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.62 -94.43 0.16 Allowed Glycine 0 C--N 1.294 -1.77 0 CA-C-N 115.478 -0.783 . . . . 53.240000000000002 111.696 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.9 t -127.74 7.83 6.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.655 0.741 . . . . 53.420000000000002 109.495 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -130.94 -159.48 0.97 Allowed 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.043 -1.466 . . . . 55.409999999999997 107.043 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -141.68 116.67 9.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.072 0.463 . . . . 75.109999999999999 110.546 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -71.44 128.72 36.78 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.905 -0.589 . . . . 75.329999999999998 109.557 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.45 -24.38 15.78 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.445 -1.462 . . . . 71.340000000000003 109.445 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 21.2 t -111.93 -55.76 2.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 109.632 -0.507 . . . . 63.039999999999999 109.632 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 11.1 m-20 -80.09 -56.72 4.03 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.844 0.83 . . . . 62.310000000000002 110.055 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.5 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.0 OUTLIER -136.95 167.78 20.84 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.191 -1.411 . . . . 74.129999999999995 107.191 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -74.96 152.05 38.81 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.308 -0.627 . . . . 74.019999999999996 109.308 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.461 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -85.76 -13.17 49.1 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.93 -0.577 . . . . 75.439999999999998 111.547 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 442' ' ' VAL 0.253 14.7 t 35.5 63.11 0.55 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 126.1 1.76 . . . . 73.019999999999996 113.152 179.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.35 107.55 12.2 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.981 -1.008 . . . . 73.439999999999998 109.097 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -147.49 171.51 28.08 Favored Glycine 1 N--CA 1.394 -4.126 0 C-N-CA 119.125 -1.512 . . . . 71.5 112.07 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 25.5 m -124.27 136.13 53.91 Favored 'General case' 0 N--CA 1.388 -3.558 0 N-CA-C 106.652 -1.61 . . . . 51.329999999999998 106.652 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.7 t -95.77 126.89 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.371 -0.974 . . . . 61.509999999999998 108.371 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.502 HG22 ' CE2' ' A' ' 406' ' ' PHE . 19.3 t -100.52 100.59 10.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.188 -1.041 . . . . 73.200000000000003 108.188 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.498 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 54.6 m-85 -80.91 104.51 11.46 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.32 -0.4 . . . . 75.049999999999997 111.006 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -84.53 169.47 16.6 Favored Pre-proline 0 C--O 1.256 1.432 0 CA-C-N 115.785 -0.643 . . . . 75.310000000000002 110.169 177.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.08 132.74 49.17 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.79 2.327 . . . . 73.409999999999997 111.868 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.44 -25.57 17.63 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.851 -0.613 . . . . 75.109999999999999 113.224 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.48 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 44.9 mt-10 -75.57 64.47 1.66 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.86 0.864 . . . . 60.409999999999997 113.168 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 22.4 m -61.42 -23.64 65.96 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.437 -1.256 . . . . 73.420000000000002 109.149 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -132.8 143.25 49.44 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.192 -0.67 . . . . 71.299999999999997 109.192 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -131.31 149.82 52.4 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.049 -0.523 . . . . 73.400000000000006 110.457 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.1 135.51 51.51 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.798 -0.816 . . . . 54.009999999999998 108.798 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.8 pt -120.77 146.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.999 -1.111 . . . . 75.109999999999999 107.999 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 87.8 mtt180 -125.41 146.18 49.73 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.207 0.527 . . . . 73.310000000000002 110.651 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 425' ' ' THR . 51.1 t -113.37 120.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.863 -1.162 . . . . 73.409999999999997 107.863 178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -64.3 131.36 38.59 Favored Glycine 0 N--CA 1.439 -1.153 0 O-C-N 124.072 0.858 . . . . 74.340000000000003 111.897 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.51 133.52 39.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.563 -1.273 . . . . 75.030000000000001 107.563 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 75.6 mt -98.77 150.43 4.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.049 -1.093 . . . . 63.420000000000002 108.049 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.9 86.8 5.39 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.224 0.535 . . . . 70.140000000000001 111.421 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -112.9 101.66 9.71 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 104.579 -2.378 . . . . 75.420000000000002 104.579 171.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.285 11.3 t70 -106.61 84.44 2.01 Favored 'General case' 0 CA--C 1.458 -2.572 0 C-N-CA 115.613 -2.435 . . . . 70.150000000000006 112.025 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 46.1 mm -117.06 154.0 18.77 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.75 0 N-CA-C 103.388 -2.819 . . . . 65.329999999999998 103.388 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -52.09 116.15 2.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.32 0.964 . . . . 63.539999999999999 110.158 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 27.2 mt-10 -122.48 119.0 29.66 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.436 1.113 . . . . 72.540000000000006 113.258 -171.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.07 110.92 11.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.563 -1.653 . . . . 74.030000000000001 106.847 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 48.63 60.52 3.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.72 1.378 . . . . 53.329999999999998 114.72 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.2 pt-20 -99.5 134.6 42.14 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.781 -1.168 . . . . 74.140000000000001 108.253 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.7 p-10 -149.25 166.19 29.65 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.372 0.606 . . . . 71.319999999999993 111.534 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.561 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 30.7 p90 -137.35 -177.73 4.91 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.248 -0.887 . . . . 73.409999999999997 109.404 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.95 137.05 54.68 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.621 -1.251 . . . . 72.209999999999994 107.621 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 42.3 t -108.79 128.23 64.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.482 -1.303 . . . . 65.439999999999998 107.482 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -122.68 163.07 20.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.075 -0.511 . . . . 72.099999999999994 109.718 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 82.4 mt -118.2 134.04 55.36 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.252 -1.388 . . . . 64.239999999999995 107.252 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.0 m -150.43 161.46 42.46 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 109.222 -0.659 . . . . 52.520000000000003 109.222 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . 0.433 ' C ' HD22 ' A' ' 462' ' ' ASN . 0.2 OUTLIER 59.73 87.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.257 0.973 . . . . 72.299999999999997 110.918 178.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.16 137.94 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.681 -1.229 . . . . 65.420000000000002 107.681 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 C--N 1.301 -1.51 0 N-CA-C 109.114 -0.698 . . . . 65.219999999999999 109.114 -176.65 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 110.024 -0.361 . . . . 71.340000000000003 110.024 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -102.93 103.02 13.12 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.383 -1.339 . . . . 72.049999999999997 107.383 172.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 53.3 m -83.26 118.74 23.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.133 0.492 . . . . 60.310000000000002 110.986 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.584 HG11 HG11 ' A' ' 390' ' ' VAL . 80.4 t -106.21 110.68 32.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.782 -0.822 . . . . 63.439999999999998 108.782 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 46.9 m -98.85 121.57 40.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.36 -0.978 . . . . 63.549999999999997 108.36 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.549 HD11 ' CE2' ' A' ' 456' ' ' PHE . 5.2 mp -97.9 117.52 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 121.835 0.826 . . . . 74.510000000000005 110.764 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.716 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 55.6 m-85 -98.07 122.98 41.87 Favored 'General case' 0 N--CA 1.399 -3.005 0 N-CA-C 105.709 -1.96 . . . . 74.310000000000002 105.709 170.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.12 -3.0 23.58 Favored 'General case' 0 C--N 1.258 -3.402 0 C-N-CA 119.33 -0.948 . . . . 74.430000000000007 109.114 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.312 -1.058 0 C-N-CA 126.754 2.021 . . . . 63.119999999999997 113.191 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 93.0 mttt . . . . . 0 CA--C 1.494 -1.183 0 N-CA-C 112.917 0.71 . . . . 71.140000000000001 112.917 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 31.5 mm -102.19 127.86 55.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.054 -1.462 . . . . 71.219999999999999 107.054 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 397' ' ' ARG . 39.3 p90 -159.85 168.73 25.13 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 117.994 0.361 . . . . 70.230000000000004 111.655 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -88.55 142.31 27.81 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 110.021 -0.363 . . . . 70.319999999999993 110.021 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 395' ' ' ILE . 41.4 tt0 -62.87 -51.08 68.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.518 0.675 . . . . 73.230000000000004 109.444 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 378' ' ' GLN . 2.8 mm100 -108.94 146.61 33.53 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 114.972 -1.013 . . . . 72.019999999999996 110.425 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.47 -25.43 33.19 Favored Glycine 0 C--N 1.294 -1.801 0 N-CA-C 110.686 -0.965 . . . . 42.030000000000001 110.686 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 12.9 m -127.34 136.04 51.36 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.406 -0.961 . . . . 62.509999999999998 108.406 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -127.13 137.32 52.96 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.355 -0.98 . . . . 73.430000000000007 108.355 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -127.34 129.66 48.05 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.83 -1.544 . . . . 72.450000000000003 106.83 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 11.9 t -148.72 160.3 43.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.054 -1.091 . . . . 61.030000000000001 108.054 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.556 HD12 ' OD1' ' A' ' 386' ' ' ASN . 2.6 mm? -78.43 144.76 35.55 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.294 0.569 . . . . 72.349999999999994 112.202 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -59.48 -41.82 90.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.315 -0.857 . . . . 63.039999999999999 108.742 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.556 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.4 p-10 -78.25 9.81 3.52 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.436 -0.802 . . . . 74.109999999999999 113.065 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.3 t -83.97 -28.5 27.74 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.728 -0.608 . . . . 72.030000000000001 110.524 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.81 -58.39 0.56 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.175 -0.536 . . . . 53.439999999999998 112.209 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 5.6 p -141.95 151.41 42.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.024 0.412 . . . . 43.439999999999998 110.447 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 494' ' ' VAL . 5.7 p -109.14 133.41 54.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 107.755 -1.202 . . . . 74.219999999999999 107.755 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.98 128.83 48.24 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.153 0.501 . . . . 73.329999999999998 110.39 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -120.62 145.28 47.56 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.311 -1.366 . . . . 75.209999999999994 107.311 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 29.4 m -113.67 127.06 55.9 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 121.43 0.633 . . . . 73.510000000000005 111.298 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 76.5 mt -95.05 121.34 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 N-CA-C 108.02 -1.104 . . . . 73.540000000000006 108.02 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 377' ' ' GLU . 42.8 mm -99.14 119.4 47.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.48 -1.304 . . . . 74.120000000000005 107.48 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.416 ' NH1' HG21 ' A' ' 405' ' ' VAL . 23.6 ttt85 -100.48 121.36 41.42 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-O 121.482 0.658 . . . . 61.409999999999997 110.576 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 375' ' ' PHE . 22.0 mmm180 . . . . . 0 C--N 1.295 -1.788 0 CA-C-N 115.449 -0.796 . . . . 75.430000000000007 109.094 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.434 -1.251 0 CA-C-O 121.183 0.516 . . . . 75.310000000000002 111.681 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 66.6 t -103.44 136.5 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.046 -0.524 . . . . 71.549999999999997 109.707 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.95 121.41 34.37 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.601 0.361 . . . . 72.230000000000004 110.582 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 463' ' ' VAL . 5.9 p -120.8 127.62 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.354 -0.98 . . . . 61.25 108.354 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.6 143.53 27.61 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.539 -0.912 . . . . 74.230000000000004 108.539 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -142.42 158.39 43.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.941 -0.474 . . . . 75.439999999999998 110.124 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -165.68 158.01 15.0 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.548 -1.279 . . . . 72.329999999999998 107.548 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.646 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 36.5 p -96.73 156.13 16.48 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.373 -0.603 . . . . 74.510000000000005 109.373 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.2 tp10 -106.35 151.26 25.1 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.96 -1.496 . . . . 70.329999999999998 106.96 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 417' ' ' ASN . 11.2 m-20 -55.96 -39.02 71.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.698 0.799 . . . . 61.32 112.38 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 62.93 -95.56 0.13 Allowed Glycine 0 C--N 1.297 -1.614 0 CA-C-N 114.938 -1.028 . . . . 34.240000000000002 112.63 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.9 t -121.37 8.92 10.26 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.296 -0.631 . . . . 62.020000000000003 109.296 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -137.9 -160.49 1.06 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.537 -0.912 . . . . 73.510000000000005 108.537 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.589 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 6.5 m120 -137.25 122.55 19.37 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.708 0.766 . . . . 72.530000000000001 112.021 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -68.62 129.31 39.56 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.561 -1.199 . . . . 72.519999999999996 109.394 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.95 -32.66 6.87 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 111.305 -0.718 . . . . 64.299999999999997 111.305 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 t -102.24 -44.52 5.4 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.695 -0.483 . . . . 60.340000000000003 109.695 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.551 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 23.7 m-20 -87.3 -64.27 1.17 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.049 0.928 . . . . 63.140000000000001 109.659 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.714 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.16 167.0 23.24 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.147 -0.933 . . . . 65.219999999999999 110.217 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 425' ' ' THR . 23.1 tt0 -75.47 153.52 37.53 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.632 0.583 . . . . 43.43 110.333 -174.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.646 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.2 p90 -88.93 -15.34 34.56 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.717 -0.674 . . . . 65.329999999999998 112.126 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.439 ' CG2' HG22 ' A' ' 442' ' ' VAL 0.296 13.5 t 32.49 66.87 0.18 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.897 1.679 . . . . 74.530000000000001 114.414 -176.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.76 131.12 34.94 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.592 -0.892 . . . . 71.0 108.592 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -173.38 -175.74 41.36 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 120.099 -1.048 . . . . 72.430000000000007 110.957 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.3 m -116.89 138.35 51.59 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 108.159 -1.052 . . . . 75.239999999999995 108.159 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.2 t -96.12 116.42 37.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.085 -1.45 . . . . 72.040000000000006 107.085 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.17 105.69 17.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.533 -0.758 . . . . 64.049999999999997 109.749 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 78.7 m-85 -82.57 98.36 8.94 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.226 -1.028 . . . . 50.030000000000001 108.226 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.1 mttm -80.58 170.18 16.66 Favored Pre-proline 0 C--N 1.296 -1.747 0 CA-C-N 114.065 -1.425 . . . . 63.43 109.948 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.7 Cg_exo -52.24 109.91 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.55 2.167 . . . . 54.039999999999999 113.339 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.47 -0.34 61.47 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.126 -0.943 . . . . 44.119999999999997 114.825 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.406 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 34.6 mm-40 -76.59 64.23 2.2 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.852 0.826 . . . . 74.209999999999994 113.062 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.9 m -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 121.374 0.607 . . . . 74.340000000000003 110.381 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -131.4 139.81 49.52 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.08 -0.711 . . . . 74.120000000000005 109.08 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -130.63 151.41 51.12 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.594 -0.275 . . . . 63.43 111.65 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.85 137.3 52.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.849 -0.614 . . . . 73.409999999999997 109.644 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.28 147.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.936 -1.135 . . . . 71.439999999999998 107.936 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 49.4 mtt180 -129.57 135.07 48.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 120.996 0.426 . . . . 61.520000000000003 111.215 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.6 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 61.9 t -105.34 127.3 60.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.431 -0.804 . . . . 34.219999999999999 109.409 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -70.97 130.31 19.45 Favored Glycine 0 N--CA 1.439 -1.115 0 O-C-N 124.192 0.933 . . . . 62.229999999999997 112.37 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.489 HD12 HG12 ' A' ' 496' ' ' ILE . 38.7 mm -94.9 134.78 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 106.916 -1.512 . . . . 73.310000000000002 106.916 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 66.6 mt -101.7 151.19 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 108.063 -1.088 . . . . 71.450000000000003 108.063 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.96 97.6 2.33 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.995 0.426 . . . . 42.530000000000001 110.234 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.45 124.75 27.63 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 103.63 -2.73 . . . . 73.099999999999994 103.63 170.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.2 97.13 4.81 Favored 'General case' 0 CA--C 1.462 -2.436 0 C-N-CA 117.733 -1.587 . . . . 54.229999999999997 110.042 174.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.733 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 28.9 mm -123.35 156.64 29.53 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.55 0 CA-C-N 111.308 -2.678 . . . . 75.5 104.171 -173.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -56.86 113.49 1.69 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 116.652 -2.019 . . . . 72.340000000000003 105.777 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.733 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.7 mt-10 -120.93 121.86 38.96 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 108.986 -0.746 . . . . 70.540000000000006 108.986 -170.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -132.34 109.48 9.9 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 115.176 -0.92 . . . . 63.219999999999999 108.691 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.37 35.72 26.34 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.469 1.106 . . . . 70.319999999999993 111.18 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.434 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.3 tt0 -64.02 106.63 1.08 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.318 -1.364 . . . . 63.409999999999997 107.318 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.476 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 35.2 p30 -138.57 166.15 25.07 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.449 0.643 . . . . 75.420000000000002 112.078 -175.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.605 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 21.2 p90 -140.2 -179.24 5.87 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.182 -0.917 . . . . 60.119999999999997 109.764 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 31.9 mt -123.79 136.74 54.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.134 -1.062 . . . . 60.520000000000003 108.134 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.3 124.9 60.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.418 -1.327 . . . . 63.409999999999997 107.418 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -117.71 156.34 28.4 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.572 0.545 . . . . 41.109999999999999 109.839 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 86.5 mt -113.42 140.61 47.93 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.563 -0.903 . . . . 73.299999999999997 108.563 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.7 m -146.84 173.56 12.29 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.787 -0.449 . . . . 71.040000000000006 109.787 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.4 t30 34.65 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 126.145 1.778 . . . . 75.409999999999997 113.854 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 407' ' ' VAL . 24.7 t -98.77 132.54 43.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.142 -1.023 . . . . 73.010000000000005 108.564 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.2 tptp . . . . . 0 C--N 1.296 -1.74 0 N-CA-C 108.237 -1.023 . . . . 72.310000000000002 108.237 -179.55 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 N--CA 1.409 -2.51 0 N-CA-C 108.024 -1.102 . . . . 73.239999999999995 108.024 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -101.84 120.6 40.64 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.131 -1.063 . . . . 73.239999999999995 108.131 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 40.8 m -89.38 119.19 29.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.235 -0.586 . . . . 40.119999999999997 109.834 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 390' ' ' VAL . 76.6 t -106.89 107.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 108.177 -1.046 . . . . 73.450000000000003 108.177 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.476 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 85.2 m -97.45 114.32 26.15 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.72 -0.844 . . . . 74.120000000000005 108.72 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.714 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.09 116.96 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.367 -0.833 . . . . 72.310000000000002 109.169 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.554 ' O ' HD13 ' A' ' 384' ' ' LEU . 24.2 m-85 -80.26 97.79 7.11 Favored 'General case' 0 N--CA 1.382 -3.868 0 CA-C-O 122.324 1.059 . . . . 74.540000000000006 112.366 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 451' ' ' GLU . 3.3 t70 -50.17 -54.87 17.85 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 111.749 -2.478 . . . . 55.409999999999997 108.493 170.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.476 0.853 0 CA-C-N 113.797 -1.547 . . . . 45.439999999999998 110.965 176.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 107.411 -1.329 . . . . 71.409999999999997 107.411 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.0 120.74 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 60.229999999999997 107.98 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -152.95 173.32 15.54 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 118.455 0.57 . . . . 73.129999999999995 110.361 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -87.41 154.68 20.47 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.209999999999994 110.873 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.12 -40.68 86.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.958 -0.756 . . . . 73.329999999999998 108.958 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -126.36 162.74 24.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.492 -0.777 . . . . 72.109999999999999 111.835 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -94.46 -19.69 31.8 Favored Glycine 0 C--N 1.3 -1.436 0 CA-C-N 115.045 -0.979 . . . . 60.329999999999998 111.712 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 62.6 m -141.86 128.51 20.33 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.967 -0.753 . . . . 74.219999999999999 108.967 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.457 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 39.8 m-85 -114.56 136.82 52.61 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 124.261 1.024 . . . . 75.329999999999998 108.792 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 495' ' ' THR . 43.7 mt-30 -129.51 123.92 32.68 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.429 -1.323 . . . . 74.540000000000006 107.429 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 46.6 t -139.96 165.18 28.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.356 -0.979 . . . . 72.430000000000007 108.356 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.671 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 3.8 mm? -87.13 140.56 29.43 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 123.32 0.388 . . . . 73.420000000000002 111.552 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -58.76 -42.28 88.54 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.009 -0.737 . . . . 73.120000000000005 109.009 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -73.19 -5.42 39.17 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.354 0.872 . . . . 53.409999999999997 113.354 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 57.7 m -80.73 -7.28 59.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.8 -0.562 . . . . 72.140000000000001 111.91 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.78 -56.01 3.38 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.467 -0.873 . . . . 74.340000000000003 112.819 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.473 HG22 ' HA2' ' A' ' 443' ' ' GLY . 21.6 p -137.58 166.77 23.09 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.979 0.419 . . . . 74.319999999999993 111.203 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 494' ' ' VAL . 3.8 p -116.93 128.84 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 106.932 -1.507 . . . . 64.010000000000005 106.932 170.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.95 118.48 37.0 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.307 0.575 . . . . 71.120000000000005 110.418 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.0 mp -109.82 139.89 44.37 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.52 -1.289 . . . . 71.209999999999994 107.52 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.9 m -109.55 127.92 54.82 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 109.391 -0.596 . . . . 71.040000000000006 109.391 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 64.1 mt -99.37 125.6 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.52 -1.289 . . . . 75.530000000000001 107.52 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.458 HG22 ' HG3' ' A' ' 397' ' ' ARG . 43.6 mm -101.48 129.04 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 115.09 -0.959 . . . . 50.009999999999998 108.421 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -115.92 108.88 16.84 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.928 -1.033 . . . . 74.140000000000001 109.226 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 395' ' ' ILE . 32.4 mtp180 . . . . . 0 C--N 1.301 -1.53 0 CA-C-N 115.72 -0.673 . . . . 64.129999999999995 110.292 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 9.4 m . . . . . 0 N--CA 1.411 -2.382 0 N-CA-C 109.38 -0.6 . . . . 65.310000000000002 109.38 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 57.5 t -100.37 141.86 16.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.404 -0.962 . . . . 72.430000000000007 108.404 -177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 54.2 m-85 -128.38 119.77 25.67 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 122.735 0.414 . . . . 62.310000000000002 109.948 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.07 124.45 72.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.532 -0.914 . . . . 73.450000000000003 108.532 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 14.7 t70 -90.05 140.46 29.62 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 110.1 -0.333 . . . . 71.310000000000002 110.1 -177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.95 169.1 18.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.179 -0.304 . . . . 74.540000000000006 110.179 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 411' ' ' THR . 63.5 ttt-85 -167.52 167.22 13.77 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 105.825 -1.917 . . . . 71.409999999999997 105.825 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.632 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 62.2 p -95.55 168.2 10.84 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.692 -0.855 . . . . 75.120000000000005 108.692 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.594 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.7 tp10 -106.51 150.74 25.81 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.613 0.721 . . . . 71.319999999999993 109.29 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.53 5.39 51.01 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 125.915 1.686 . . . . 44.549999999999997 110.679 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . 0.594 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -28.73 -93.39 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.74 2.114 . . . . 61.140000000000001 116.953 -174.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 455' ' ' ASN . 5.2 t -93.74 -7.06 44.68 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.848 0.832 . . . . 74.030000000000001 110.56 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.779 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . . . -151.89 153.22 33.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.409 -1.7 . . . . 60.229999999999997 106.409 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.19 145.86 33.61 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.617 0.722 . . . . 72.430000000000007 112.138 -164.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -82.93 148.71 27.48 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.072 -0.967 . . . . 71.420000000000002 108.534 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.94 79.05 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.454 -1.058 . . . . 60.119999999999997 110.454 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 38.3 m -149.44 -58.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.697 -0.483 . . . . 54.219999999999999 109.697 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.505 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 8.0 m-20 -86.23 -55.0 4.12 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.408 1.099 . . . . 71.239999999999995 108.934 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.779 ' OH ' ' HB3' ' A' ' 416' ' ' ALA . 0.1 OUTLIER -141.67 164.79 29.26 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.948 -1.024 . . . . 75.420000000000002 111.07 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 425' ' ' THR . 0.9 OUTLIER -74.07 160.56 31.08 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.352 -0.84 . . . . 71.230000000000004 108.842 -177.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.632 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -100.07 -20.14 16.17 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 122.936 0.495 . . . . 72.420000000000002 112.152 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.49 ' CG2' HG22 ' A' ' 442' ' ' VAL 0.323 10.1 t 39.04 64.55 0.78 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.351 1.861 . . . . 72.5 114.239 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.67 112.33 15.67 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.589 -1.187 . . . . 61.409999999999997 109.274 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -158.25 -178.62 32.46 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 110.443 -1.063 . . . . 73.140000000000001 110.443 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 17.5 m -122.63 139.72 53.62 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.358 -1.349 . . . . 73.099999999999994 107.358 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 45.0 t -95.56 118.8 42.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.8 -0.815 . . . . 73.120000000000005 108.8 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 406' ' ' PHE . 26.0 t -91.11 112.18 24.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.654 -1.157 . . . . 71.25 108.511 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 60.5 m-85 -97.61 101.75 13.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.69 -0.485 . . . . 71.510000000000005 109.69 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.3 mttm -85.21 172.5 8.68 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.071 -0.513 . . . . 74.430000000000007 109.979 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.9 Cg_exo -56.09 131.83 48.3 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.467 2.111 . . . . 74.349999999999994 111.649 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 87.33 -14.89 56.66 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 116.027 -0.533 . . . . 73.299999999999997 113.77 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -81.07 63.57 5.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.607 0.717 . . . . 71.140000000000001 112.391 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.1 m -60.9 -22.22 64.12 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.273 -1.33 . . . . 75.010000000000005 110.366 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -131.17 139.64 49.79 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.951 -1.129 . . . . 65.109999999999999 107.951 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -131.46 154.35 48.8 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 122.793 0.437 . . . . 73.140000000000001 110.068 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.27 132.48 50.33 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.787 -0.765 . . . . 74.010000000000005 111.076 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.5 pt -119.39 146.72 23.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.594 -0.891 . . . . 74.319999999999993 108.594 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 90.2 mtt180 -130.27 132.88 46.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.343 -0.543 . . . . 75.239999999999995 111.788 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.49 HG22 ' CG2' ' A' ' 425' ' ' THR . 62.1 t -104.71 120.56 55.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.041 -0.981 . . . . 72.299999999999997 108.451 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -71.98 136.52 24.2 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 121.134 -0.555 . . . . 71.420000000000002 112.241 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.464 HD12 HG12 ' A' ' 496' ' ' ILE . 35.5 mm -97.93 132.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.83 -1.174 . . . . 71.120000000000005 107.83 177.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 92.4 mt -91.57 151.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.477 -0.934 . . . . 74.430000000000007 108.477 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.29 92.54 5.15 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 120.981 0.419 . . . . 73.219999999999999 110.015 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.07 96.49 6.35 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.498 -2.778 . . . . 60.43 103.498 166.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -99.59 81.3 2.48 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 116.687 -2.005 . . . . 63.530000000000001 110.454 -173.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.6 mm -127.37 155.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.09 0 CA-C-N 110.383 -3.099 . . . . 73.140000000000001 103.993 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -56.36 114.36 1.96 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.925 -1.509 . . . . 62.229999999999997 106.925 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.7 mt-10 -111.89 128.12 56.05 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 108.259 -1.015 . . . . 73.109999999999999 108.259 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -124.27 103.85 8.47 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 115.599 -0.728 . . . . 72.450000000000003 110.086 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.82 60.38 3.58 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 125.076 1.485 . . . . 74.310000000000002 113.078 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.21 114.55 20.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.693 0.758 . . . . 75.099999999999994 109.516 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.469 ' O ' HG22 ' A' ' 415' ' ' THR . 3.4 p-10 -136.74 153.44 50.86 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 114.949 -1.023 . . . . 70.5 109.799 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 422' ' ' TYR . 20.9 p90 -136.78 -177.94 4.96 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.861 -0.609 . . . . 74.299999999999997 110.195 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.457 ' H ' ' HB3' ' A' ' 412' ' ' GLU . 57.2 mt -121.17 139.71 52.98 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.983 -1.117 . . . . 72.200000000000003 107.983 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 491' ' ' THR . 47.5 t -107.65 110.77 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.579 -1.267 . . . . 73.219999999999999 107.579 174.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -102.78 137.83 40.47 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.591 -0.522 . . . . 63.049999999999997 109.591 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.83 126.66 42.14 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.592 -0.892 . . . . 73.230000000000004 108.592 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 408' ' ' ASP . 17.4 m -147.04 148.52 31.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.933 -0.765 . . . . 63.109999999999999 108.933 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.5 93.6 0.06 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.974 1.31 . . . . 61.200000000000003 110.575 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.15 137.07 39.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.378 -1.341 . . . . 72.040000000000006 107.378 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt . . . . . 0 C--N 1.286 -2.155 0 C-N-CA 123.609 0.764 . . . . 75.0 108.991 -175.547 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 45.5 m . . . . . 0 N--CA 1.426 -1.663 0 CA-C-O 120.88 0.371 . . . . 64.239999999999995 110.692 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.27 131.44 52.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.035 -0.728 . . . . 52.43 109.035 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 77.1 m -86.42 126.91 34.72 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.592 -0.892 . . . . 71.549999999999997 108.592 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 390' ' ' VAL . 77.0 t -111.94 107.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.674 -0.862 . . . . 73.200000000000003 108.674 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 23.6 m -101.21 111.22 23.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.13 -1.063 . . . . 71.019999999999996 108.13 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.625 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -88.49 123.68 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.595 0.712 . . . . 72.329999999999998 111.06 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -82.75 107.2 15.2 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-O 122.344 1.069 . . . . 71.510000000000005 110.209 173.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -40.42 84.03 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 112.288 -2.233 . . . . 43.140000000000001 112.766 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.549 ' HB2' ' CD1' ' A' ' 384' ' ' LEU . 20.4 t70 . . . . . 0 N--CA 1.501 2.099 0 C-N-CA 124.63 1.172 . . . . 75.239999999999995 112.454 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 96.4 mttt . . . . . 0 N--CA 1.423 -1.783 0 CA-C-O 120.56 0.219 . . . . 71.140000000000001 110.853 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.476 HG21 HG11 ' A' ' 407' ' ' VAL . 38.8 mm -125.12 109.16 21.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.572 -0.899 . . . . 73.439999999999998 108.572 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -145.71 162.78 36.79 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.425 -0.51 . . . . 71.430000000000007 110.85 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.1 151.42 28.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 110.122 -0.325 . . . . 71.439999999999998 110.122 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -59.77 4.52 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.902 -1.518 . . . . 72.5 106.902 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 15.3 mm100 -102.55 173.11 6.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.604 -0.726 . . . . 74.439999999999998 111.007 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.26 -40.36 1.95 Allowed Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.943 -1.026 . . . . 71.140000000000001 110.651 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.0 m -122.68 126.11 46.94 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.876 -0.787 . . . . 72.030000000000001 108.876 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 77.5 m-85 -115.81 142.79 46.29 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.48 -0.933 . . . . 72.209999999999994 108.48 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 495' ' ' THR . 14.0 mp0 -123.53 146.14 48.33 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.251 -1.388 . . . . 73.420000000000002 107.251 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . 0.569 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -149.77 151.29 33.35 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.982 -1.118 . . . . 63.439999999999998 107.982 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.4 OUTLIER -80.91 145.03 31.5 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.607 -0.886 . . . . 73.120000000000005 108.607 176.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -58.97 -29.95 67.57 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.55 0.69 . . . . 61.229999999999997 110.064 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 384' ' ' LEU . 34.5 p30 -80.94 -1.44 43.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.455 -0.793 . . . . 65.230000000000004 112.558 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.45 -22.04 48.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.261 0.553 . . . . 64.010000000000005 111.182 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 91.6 -59.7 2.92 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.781 -0.723 . . . . 74.319999999999993 111.522 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.4 p -136.27 155.24 50.37 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.615 0.245 . . . . 74.409999999999997 110.793 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 N-CA-C 107.888 -1.153 . . . . 63.009999999999998 107.888 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.44 124.42 40.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.125 0.488 . . . . 64.109999999999999 110.592 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.74 137.41 53.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.248 -1.389 . . . . 52.439999999999998 107.248 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.9 m -104.49 134.4 47.74 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.703 -0.48 . . . . 72.299999999999997 109.703 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 80.1 mt -103.85 126.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.57 -1.27 . . . . 72.409999999999997 107.57 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 44.9 mm -103.93 121.53 55.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.323 -0.991 . . . . 60.240000000000002 108.323 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 55.7 ttt180 -105.71 122.17 45.51 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.492 -0.777 . . . . 74.150000000000006 109.557 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.822 -0.626 . . . . 64.239999999999995 110.762 -178.276 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.419 -2.007 0 CA-C-O 121.497 0.665 . . . . 64.400000000000006 110.296 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.78 132.62 51.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.793 -0.817 . . . . 64.140000000000001 108.793 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 36.8 m-85 -115.62 129.3 56.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.192 0.52 . . . . 72.420000000000002 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.476 HG11 HG21 ' A' ' 374' ' ' ILE . 7.6 p -129.78 133.86 64.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.197 -1.409 . . . . 63.119999999999997 107.197 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -99.77 124.64 45.24 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.086 -0.709 . . . . 51.109999999999999 109.086 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 11.6 p90 -110.64 147.47 34.22 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.172 -0.677 . . . . 63.329999999999998 109.172 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 48.6 ttp180 -157.21 150.44 23.83 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.825 -1.176 . . . . 72.099999999999994 107.825 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 63.7 p -96.87 171.0 8.78 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.552 -0.459 . . . . 73.049999999999997 110.24 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 9.4 tp10 -137.57 158.21 44.88 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.166 -0.679 . . . . 74.430000000000007 109.166 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -31.14 -62.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.712 2.405 . . . . 72.319999999999993 113.147 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.29 -74.52 0.39 Allowed Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.069 -0.968 . . . . 51.200000000000003 111.019 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 8.8 t -154.87 16.72 0.44 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.122 -1.066 . . . . 71.019999999999996 108.122 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.8 -169.44 3.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.539 -0.755 . . . . 64.25 110.371 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.85 120.98 27.25 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.325 -0.621 . . . . 71.019999999999996 109.325 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.47 124.55 29.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.714 0.769 . . . . 71.140000000000001 110.553 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.49 32.0 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 109.43 -1.468 . . . . 31.329999999999998 109.43 -173.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 14.9 m -110.54 -58.55 2.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.985 -0.746 . . . . 62.32 108.985 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.561 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 14.3 m-20 -82.71 -58.26 2.97 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 122.011 0.91 . . . . 74.299999999999997 109.677 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.701 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.34 158.99 43.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.635 -0.876 . . . . 71.129999999999995 108.635 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.82 144.88 45.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.879 -0.785 . . . . 73.319999999999993 108.879 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.538 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 17.7 p90 -79.4 -18.45 52.28 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 113.054 0.761 . . . . 74.099999999999994 113.054 -173.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 442' ' ' VAL 0.268 11.0 t 40.06 55.99 2.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 127.198 2.199 . . . . 74.420000000000002 115.311 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 1.5 pp20? -78.41 131.15 36.81 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 118.952 -1.099 . . . . 75.019999999999996 108.944 173.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -164.4 170.13 39.46 Favored Glycine 0 CA--C 1.46 -3.365 0 N-CA-C 109.93 -1.268 . . . . 72.349999999999994 109.93 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.5 m -111.35 131.63 55.02 Favored 'General case' 0 N--CA 1.394 -3.242 0 C-N-CA 119.739 -0.784 . . . . 72.140000000000001 108.888 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.67 125.49 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.941 -1.503 . . . . 71.230000000000004 106.941 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . 0.44 HG22 ' CE2' ' A' ' 406' ' ' PHE . 19.5 t -103.72 117.11 48.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.614 -0.884 . . . . 62.130000000000003 108.614 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.473 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 65.1 m-85 -94.91 105.02 16.91 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.188 0.518 . . . . 72.299999999999997 110.689 177.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 0.2 OUTLIER -90.12 167.64 16.47 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 114.652 -1.158 . . . . 71.5 110.315 -176.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 32.0 Cg_exo -57.03 115.09 2.24 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.872 2.381 . . . . 73.409999999999997 108.989 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.02 -38.04 3.32 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 111.523 -0.631 . . . . 62.299999999999997 111.523 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -85.97 62.37 7.4 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.717 0.77 . . . . 74.420000000000002 110.595 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 14.1 t -84.08 9.58 12.21 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 115.134 -0.939 . . . . 71.549999999999997 109.878 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -140.55 137.05 33.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.116 -1.809 . . . . 74.129999999999995 106.116 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -135.47 153.29 51.8 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.358 0.411 . . . . 75.349999999999994 111.193 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.26 128.54 55.67 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.537 -0.912 . . . . 71.510000000000005 108.537 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.91 149.56 19.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.857 -1.164 . . . . 73.209999999999994 107.857 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 79.9 mtm180 -133.28 143.36 49.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.174 0.511 . . . . 71.319999999999993 111.265 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 425' ' ' THR . 48.7 t -109.92 124.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.394 -0.965 . . . . 63.100000000000001 108.394 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -77.28 127.09 8.17 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.559 -0.616 . . . . 63.32 111.559 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.498 HD12 HG12 ' A' ' 496' ' ' ILE . 35.7 mm -89.97 134.74 28.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.162 -1.051 . . . . 63.439999999999998 108.162 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.2 mt -96.77 147.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.274 -1.38 . . . . 74.230000000000004 107.274 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -78.97 86.68 4.82 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.416 -0.513 . . . . 75.200000000000003 111.925 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.38 126.81 55.69 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 103.338 -2.838 . . . . 73.409999999999997 103.338 169.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.18 93.26 3.54 Favored 'General case' 0 CA--C 1.463 -2.366 0 CA-C-O 123.438 1.59 . . . . 64.230000000000004 109.785 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.756 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 51.8 mm -125.25 158.22 33.59 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.161 0 CA-C-N 111.283 -2.689 . . . . 42.329999999999998 104.608 -171.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -51.23 114.39 1.19 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.784 -1.932 . . . . 74.540000000000006 105.784 166.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.756 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 36.2 mt-10 -121.74 94.74 4.41 Favored 'General case' 0 CA--C 1.468 -2.21 0 CA-C-O 122.117 0.961 . . . . 71.439999999999998 111.476 -169.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.01 102.06 13.76 Favored 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 114.26 -1.336 . . . . 64.340000000000003 110.146 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.82 57.56 5.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.787 -1.552 . . . . 75.219999999999999 112.953 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . 85.2 mt-10 -71.01 113.22 7.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.379 0.609 . . . . 64.430000000000007 109.836 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -137.47 160.36 39.34 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.874 -0.603 . . . . 74.019999999999996 110.401 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.589 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.3 p90 -140.37 177.25 8.13 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.489 -0.778 . . . . 73.140000000000001 109.735 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -117.69 138.07 52.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.335 -0.987 . . . . 71.430000000000007 108.335 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.28 120.58 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.896 -1.52 . . . . 74.439999999999998 106.896 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -114.3 149.12 36.45 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.641 0.588 . . . . 74.430000000000007 109.683 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.72 127.45 53.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.0 -0.741 . . . . 73.400000000000006 109.0 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 20.3 m -142.01 178.71 7.34 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.373 -0.602 . . . . 72.219999999999999 109.373 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.8 t30 50.37 86.11 0.03 OUTLIER 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.778 1.231 . . . . 75.040000000000006 113.238 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 53.4 t -84.89 116.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.55 -0.907 . . . . 75.5 108.55 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 26.3 tptp . . . . . 0 C--N 1.293 -1.872 0 N-CA-C 105.605 -1.998 . . . . 74.540000000000006 105.605 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.419 -2.009 0 N-CA-C 109.105 -0.702 . . . . 71.409999999999997 109.105 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.92 33.56 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.19 -1.041 . . . . 61.299999999999997 108.19 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 24.3 m -105.94 120.5 41.92 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.676 -0.41 . . . . 71.430000000000007 109.972 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 390' ' ' VAL . 73.0 t -107.12 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.93 -0.767 . . . . 52.329999999999998 108.93 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 37.7 m -104.36 117.98 35.51 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.813 -0.81 . . . . 73.219999999999999 108.813 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -97.08 118.9 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 109.341 -0.614 . . . . 63.329999999999998 109.341 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.577 ' O ' HD13 ' A' ' 384' ' ' LEU . 6.1 m-85 -83.25 105.22 14.04 Favored 'General case' 0 N--CA 1.389 -3.494 0 CA-C-N 115.513 -0.767 . . . . 62.409999999999997 110.963 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.6 -57.51 12.07 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 113.088 -1.869 . . . . 75.010000000000005 109.348 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.49 1.562 0 C-N-CA 124.922 1.289 . . . . 72.209999999999994 111.246 176.821 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.3 mmtp . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 108.251 -1.018 . . . . 72.030000000000001 108.251 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.482 HG21 HG11 ' A' ' 407' ' ' VAL . 25.9 mm -95.18 119.12 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.588 -1.187 . . . . 52.509999999999998 108.434 -176.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 160.93 42.49 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.925 0.33 . . . . 64.140000000000001 110.503 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.78 148.64 29.95 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.609 -0.515 . . . . 74.439999999999998 109.609 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.3 -43.83 85.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.586 -0.524 . . . . 60.539999999999999 109.586 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -115.22 176.29 5.13 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.885 -0.598 . . . . 64.329999999999998 110.676 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -110.36 -19.17 8.11 Favored Glycine 0 C--N 1.291 -1.964 0 CA-C-N 115.063 -0.971 . . . . 21.210000000000001 110.801 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 59.8 m -140.06 135.24 32.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.117 -1.068 . . . . 74.010000000000005 108.117 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 49.8 m-85 -125.41 141.2 52.2 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.076 -1.083 . . . . 70.530000000000001 108.076 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.61 132.67 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.505 -1.294 . . . . 74.319999999999993 107.505 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 15.2 t -151.81 165.52 34.23 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.149 -1.056 . . . . 72.140000000000001 108.149 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 2.4 mm? -81.03 143.33 32.57 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.216 0.531 . . . . 71.140000000000001 111.095 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.94 -39.4 85.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.339 -0.846 . . . . 71.230000000000004 109.784 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -73.65 -4.4 34.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.534 -0.757 . . . . 75.129999999999995 112.474 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 89.1 m -71.11 -22.33 62.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 122.109 -0.369 . . . . 51.100000000000001 111.953 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 94.68 -50.11 2.04 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.706 -0.759 . . . . 43.43 111.565 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.464 HG22 ' HA2' ' A' ' 443' ' ' GLY . 18.9 p -139.28 160.4 39.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.911 -0.403 . . . . 51.25 109.911 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 494' ' ' VAL . 6.0 p -114.83 133.8 59.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.281 -1.377 . . . . 74.200000000000003 107.281 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.41 125.83 48.11 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.201 0.524 . . . . 44.119999999999997 110.187 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.5 mp -116.52 153.68 31.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.121 -1.437 . . . . 72.230000000000004 107.121 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 28.1 m -120.6 126.93 51.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.335 0.588 . . . . 72.219999999999999 110.816 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.7 mt -100.69 120.27 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 108.204 -1.035 . . . . 44.420000000000002 108.204 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.481 HG22 ' HG2' ' A' ' 397' ' ' ARG . 46.2 mm -97.89 114.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.892 -1.049 . . . . 73.430000000000007 108.273 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.705 ' HB3' ' O ' ' A' ' 436' ' ' THR . 56.0 ttt180 -100.68 112.15 24.5 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 108.232 -1.025 . . . . 72.140000000000001 108.232 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' A' ' 397' ' ' ARG . 4.3 mmp_? . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 109.518 -0.549 . . . . 75.349999999999994 109.518 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 31.9 m . . . . . 0 N--CA 1.422 -1.844 0 CA-C-O 121.757 0.789 . . . . 71.310000000000002 111.282 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.23 144.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.065 -0.97 . . . . 62.130000000000003 108.48 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 14.7 m-85 -119.7 132.08 55.57 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.905 0.383 . . . . 74.109999999999999 110.027 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 374' ' ' ILE . 3.7 p -132.78 131.68 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.834 -1.543 . . . . 63.009999999999998 106.834 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 11.3 t70 -98.97 136.68 38.6 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.802 -0.561 . . . . 74.129999999999995 111.492 -173.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -135.83 165.78 24.83 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.982 0.42 . . . . 72.420000000000002 110.536 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -167.12 155.53 9.78 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.579 -1.637 . . . . 73.299999999999997 106.579 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.681 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 26.1 p -96.62 160.81 14.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.437 -0.579 . . . . 54.310000000000002 109.437 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 16.0 tp10 -106.76 169.86 8.28 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.523 -1.288 . . . . 70.219999999999999 107.523 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 8.6 p-10 -63.03 -39.43 94.73 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.992 0.901 . . . . 64.420000000000002 110.255 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 72.21 -98.86 0.84 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.397 -1.274 . . . . 65.150000000000006 110.475 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 455' ' ' ASN . 10.8 t -122.34 -2.27 9.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.339 1.066 . . . . 74.340000000000003 108.65 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . . . -124.72 -153.28 0.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.816 -1.179 . . . . 31.43 107.816 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -133.93 116.11 15.2 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 118.199 0.454 . . . . 72.019999999999996 110.019 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.69 24.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.819 -0.808 . . . . 62.32 108.819 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.13 -19.27 25.13 Favored Glycine 0 C--N 1.288 -2.099 0 N-CA-C 110.539 -1.024 . . . . 64.409999999999997 110.539 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 m -115.84 -51.05 2.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.82 0.343 . . . . 64.099999999999994 110.568 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.613 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 16.3 m-20 -79.98 -64.57 1.16 Allowed 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 122.369 1.081 . . . . 72.430000000000007 108.819 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.652 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -134.29 162.6 31.73 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.19 -1.368 . . . . 74.439999999999998 107.899 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 425' ' ' THR . 5.9 tp10 -82.82 154.38 24.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.486 0.66 . . . . 64.319999999999993 111.792 -172.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.681 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.5 OUTLIER -79.1 -12.11 60.0 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.16 -0.927 . . . . 72.219999999999999 113.014 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.528 HG21 HG22 ' A' ' 442' ' ' VAL 0.253 13.3 t 33.64 69.47 0.14 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.734 1.614 . . . . 70.030000000000001 113.29 -177.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.26 129.48 34.5 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.254 -0.884 . . . . 73.219999999999999 109.647 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -174.11 175.59 46.57 Favored Glycine 0 N--CA 1.405 -3.425 0 C-N-CA 119.783 -1.199 . . . . 63.219999999999999 111.025 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 7.9 m -112.81 142.26 45.66 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.247 -1.39 . . . . 72.209999999999994 107.247 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 407' ' ' VAL . 22.4 t -95.16 111.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.528 -1.656 . . . . 74.219999999999999 106.528 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.3 106.51 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 115.036 -0.984 . . . . 75.439999999999998 109.093 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' ' 404' ' ' THR . 70.7 m-85 -77.61 94.26 4.34 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.268 -0.878 . . . . 74.430000000000007 109.887 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -73.98 163.77 65.99 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.971 -0.559 . . . . 44.200000000000003 111.021 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -51.28 113.84 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.47 2.113 . . . . 72.030000000000001 112.686 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.74 -24.0 32.95 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.832 -0.699 . . . . 53.130000000000003 111.488 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . 0.443 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 9.7 mm-40 -86.06 61.28 6.74 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.754 -0.832 . . . . 74.230000000000004 108.754 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.705 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 12.4 m -67.45 -33.73 75.74 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 107.613 -1.254 . . . . 73.349999999999994 107.613 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.26 132.8 50.13 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 106.607 -1.627 . . . . 63.310000000000002 106.607 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -118.73 147.53 43.75 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.118 0.485 . . . . 73.140000000000001 111.481 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.99 132.29 54.29 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 115.075 -0.966 . . . . 74.510000000000005 108.512 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.0 pt -119.24 146.78 23.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.435 -0.95 . . . . 71.319999999999993 108.435 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 85.9 mtt180 -126.82 141.16 51.9 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-O 121.698 0.761 . . . . 73.349999999999994 111.942 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.661 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 57.6 t -109.08 126.37 66.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.384 -1.339 . . . . 74.530000000000001 107.384 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -76.49 123.53 6.79 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.948 -0.861 . . . . 42.509999999999998 110.948 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.508 HD12 HG12 ' A' ' 496' ' ' ILE . 42.1 mm -86.57 132.92 31.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.051 -1.833 . . . . 75.219999999999999 106.051 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.613 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -94.32 149.27 4.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 105.134 -2.172 . . . . 63.329999999999998 105.134 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.66 85.79 4.67 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.801 -0.76 . . . . 65.129999999999995 110.733 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.25 112.92 23.9 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.075 -2.195 . . . . 73.109999999999999 105.075 172.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -118.0 93.61 4.2 Favored 'General case' 0 C--N 1.275 -2.671 0 C-N-CA 117.274 -1.771 . . . . 74.109999999999999 109.538 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.636 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 44.6 mm -125.9 156.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.86 0 CA-C-N 111.693 -2.503 . . . . 62.439999999999998 105.423 -172.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -49.45 115.03 1.18 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.458 -1.682 . . . . 75.400000000000006 106.458 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.2 mt-10 -129.35 121.42 27.42 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 109.621 -0.511 . . . . 74.129999999999995 109.621 -172.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -134.01 113.9 12.64 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.661 -1.237 . . . . 73.420000000000002 107.661 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 20.8 t70 56.74 54.88 6.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.518 1.127 . . . . 54.350000000000001 110.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -86.58 98.63 11.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.332 -1.358 . . . . 72.219999999999999 107.332 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.584 ' O ' HG22 ' A' ' 415' ' ' THR . 0.0 OUTLIER -131.85 143.4 50.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 122.108 0.956 . . . . 71.010000000000005 113.274 -176.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.661 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.9 p90 -116.74 177.04 4.84 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.742 -1.117 . . . . 74.0 109.453 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -121.94 136.4 54.92 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.647 -1.242 . . . . 74.340000000000003 107.647 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 15.6 t -108.25 131.24 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.616 -1.253 . . . . 62.240000000000002 107.616 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -123.46 164.44 18.91 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.769 0.668 . . . . 74.239999999999995 109.769 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 91.3 mt -126.51 139.27 53.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.834 -0.432 . . . . 62.130000000000003 109.834 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 50.2 m -156.94 178.5 10.29 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.536 -0.912 . . . . 75.239999999999995 108.536 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 8.3 t30 42.75 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.653 1.581 . . . . 73.120000000000005 114.731 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.37 139.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 115.834 -0.621 . . . . 73.019999999999996 109.651 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 24.4 ttmm . . . . . 0 C--N 1.297 -1.705 0 N-CA-C 107.922 -1.14 . . . . 71.430000000000007 107.922 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.405 -2.697 0 N-CA-C 109.081 -0.711 . . . . 70.010000000000005 109.081 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -99.47 99.74 10.69 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.603 -1.628 . . . . 74.219999999999999 106.603 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 36.9 m -79.98 120.32 24.01 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.566 -0.531 . . . . 61.130000000000003 109.566 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 390' ' ' VAL . 72.2 t -107.0 105.48 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 109.759 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 86.7 m -88.69 111.5 22.02 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.533 -0.914 . . . . 73.409999999999997 108.533 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.652 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -87.1 117.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 108.998 -0.742 . . . . 73.209999999999994 108.998 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.452 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.9 m-85 -83.47 97.58 9.06 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-O 122.182 0.991 . . . . 74.409999999999997 112.169 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -51.58 -56.24 14.64 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.212 -2.267 . . . . 62.100000000000001 108.312 170.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 125.72 1.608 . . . . 50.32 111.306 175.551 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 28.7 mmtp . . . . . 0 CA--C 1.491 -1.309 0 N-CA-C 109.128 -0.693 . . . . 44.25 109.128 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 31.7 mm -98.81 118.27 45.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.813 -1.54 . . . . 71.239999999999995 108.49 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -154.87 174.15 15.51 Favored 'General case' 0 C--O 1.196 -1.718 0 CA-C-N 117.728 0.24 . . . . 74.219999999999999 110.364 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -92.74 153.0 19.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.345 -0.542 . . . . 74.340000000000003 112.268 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -54.53 37.68 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.659 -1.238 . . . . 73.510000000000005 107.659 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -106.51 160.86 15.1 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.559 -0.746 . . . . 74.329999999999998 110.693 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -96.31 -18.72 30.16 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 110.057 -1.217 . . . . 35.119999999999997 110.057 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 493' ' ' THR . 73.8 m -143.07 125.54 15.72 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 109.038 -0.727 . . . . 70.209999999999994 109.038 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 45.2 m-85 -109.84 136.23 49.48 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.289 -1.004 . . . . 74.030000000000001 108.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -130.28 122.82 28.71 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.616 -0.883 . . . . 74.230000000000004 108.616 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 390' ' ' VAL . 94.6 m -145.14 165.4 28.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.993 -0.743 . . . . 74.099999999999994 108.993 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' LEU . . . . . 0.755 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -78.19 149.66 33.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.967 0.413 . . . . 75.109999999999999 111.357 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . 0.459 ' HA ' HG21 ' A' ' 444' ' ' ILE . 13.9 tt0 -60.76 -28.29 68.61 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.642 1.211 . . . . 73.129999999999995 107.833 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -81.91 -4.72 57.25 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.327 -1.761 . . . . 51.030000000000001 111.833 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 78.7 m -77.23 -14.53 59.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 122.234 -0.291 . . . . 65.310000000000002 110.811 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.19 -53.6 3.9 Favored Glycine 0 CA--C 1.5 -0.882 0 N-CA-C 111.309 -0.717 . . . . 53.020000000000003 111.309 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . 0.548 HG22 ' HA2' ' A' ' 443' ' ' GLY . 11.1 p -139.03 164.31 30.09 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.674 . . . . 52.030000000000001 109.179 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 494' ' ' VAL . 7.3 p -117.82 129.37 74.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.564 -1.273 . . . . 63.100000000000001 107.564 173.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 440' ' ' ILE . . . -96.53 135.31 38.6 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.873 0.368 . . . . 75.0 110.291 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.436 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -126.19 145.37 50.4 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.839 -1.171 . . . . 64.129999999999995 107.839 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.3 m -112.85 124.2 52.05 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.226 0.536 . . . . 62.509999999999998 110.362 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.21 120.03 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.883 -1.154 . . . . 73.239999999999995 107.883 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.4 mm -99.13 116.04 41.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.469 -1.241 . . . . 64.530000000000001 108.417 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 44.3 ttt180 -102.62 113.05 26.1 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.522 -1.288 . . . . 74.510000000000005 107.522 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 112.681 0.623 . . . . 75.329999999999998 112.681 -178.511 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 60.9 m . . . . . 0 N--CA 1.432 -1.343 0 CA-C-O 122.014 0.912 . . . . 63.100000000000001 111.896 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.91 140.26 35.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 113.887 -1.506 . . . . 44.039999999999999 108.292 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 16.5 m-85 -120.07 129.27 54.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.582 -0.895 . . . . 73.319999999999993 108.582 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.22 132.69 70.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.887 -1.153 . . . . 64.239999999999995 107.887 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.05 147.09 27.4 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.805 -0.442 . . . . 60.420000000000002 109.805 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -141.72 163.99 31.41 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.868 -0.52 . . . . 74.540000000000006 111.792 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -158.13 168.93 25.72 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 125.313 1.445 . . . . 73.439999999999998 109.006 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 69.0 p -96.89 162.06 13.57 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.527 -1.286 . . . . 72.129999999999995 107.527 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -126.32 151.41 47.59 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.105 -0.638 . . . . 75.409999999999997 111.032 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 416' ' ' ALA . 2.5 p30 -65.71 2.77 0.9 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.795 2.038 . . . . 71.239999999999995 115.957 -176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.48 -73.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 124.92 1.247 . . . . 74.030000000000001 116.007 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.8 t -122.37 6.62 9.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 117.716 0.758 . . . . 54.32 110.304 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 413' ' ' ASP . . . -158.76 171.89 19.25 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 109.241 -0.652 . . . . 70.209999999999994 109.241 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -120.23 131.97 55.17 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.619 0.723 . . . . 71.310000000000002 112.073 -172.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -78.67 138.66 38.4 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.879 -1.055 . . . . 55.100000000000001 108.945 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.76 65.72 Favored Glycine 0 C--N 1.3 -1.467 0 N-CA-C 109.983 -1.247 . . . . 73.140000000000001 109.983 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 49.0 m -141.28 -59.02 0.49 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 122.546 0.339 . . . . 71.439999999999998 110.215 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.639 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 12.8 m-20 -77.82 -57.91 3.55 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-O 122.038 0.923 . . . . 73.430000000000007 108.744 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' TYR . . . . . 0.758 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -140.3 168.85 18.85 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.642 -1.163 . . . . 64.329999999999998 108.14 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.12 169.71 17.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.9 -0.408 . . . . 73.319999999999993 109.9 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.596 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.7 p90 -101.56 -17.21 16.49 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.265 0.469 . . . . 74.319999999999993 112.265 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' THR . . . . . 0.536 HG21 HG22 ' A' ' 442' ' ' VAL . 9.6 t 40.54 65.36 0.78 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.096 1.758 . . . . 53.020000000000003 113.108 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.09 114.92 18.42 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.665 -0.698 . . . . 70.510000000000005 110.124 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.71 172.92 33.8 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 110.948 -0.861 . . . . 71.530000000000001 110.948 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.1 m -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.585 -0.895 . . . . 63.43 108.585 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 33.5 t -96.52 128.36 47.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.901 -0.778 . . . . 65.129999999999995 108.901 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.16 112.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.53 -0.544 . . . . 75.329999999999998 109.53 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.6 m-85 -93.56 94.42 8.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.984 0.421 . . . . 74.409999999999997 110.603 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.0 mttt -89.08 176.17 3.41 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.137 -0.938 . . . . 75.239999999999995 110.212 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 31.1 Cg_exo -62.22 119.57 6.74 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.055 1.837 . . . . 70.209999999999994 110.431 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.12 -21.81 34.73 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.14 -0.784 . . . . 52.229999999999997 111.14 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -88.3 62.27 6.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.639 -0.874 . . . . 62.149999999999999 108.639 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 5.1 m -69.74 -28.15 65.55 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.428 -1.26 . . . . 73.129999999999995 108.537 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.23 145.62 49.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.184 -1.413 . . . . 74.319999999999993 107.184 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -132.89 148.27 52.29 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.539 0.209 . . . . 65.040000000000006 110.938 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.5 131.54 54.77 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.073 -0.512 . . . . 72.129999999999995 109.851 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 391' ' ' ALA . 44.5 pt -124.11 152.13 29.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.063 -0.717 . . . . 73.010000000000005 109.063 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 67.0 mtm180 -127.01 143.61 51.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.534 0.207 . . . . 72.430000000000007 110.65 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.548 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 93.6 t -109.9 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.44 -0.948 . . . . 62.210000000000001 108.44 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -66.65 122.42 19.98 Favored Glycine 0 N--CA 1.437 -1.258 0 O-C-N 123.984 0.802 . . . . 51.109999999999999 111.614 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.502 HD12 HG12 ' A' ' 496' ' ' ILE . 50.4 mm -95.63 134.13 34.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.452 -0.944 . . . . 63.009999999999998 108.452 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.3 mt -99.02 148.12 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 106.019 -1.845 . . . . 74.140000000000001 106.019 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.5 89.56 7.26 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 121.767 0.794 . . . . 54.119999999999997 111.777 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.37 117.37 34.42 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.266 -1.383 . . . . 64.219999999999999 107.266 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.439 33.1 m-20 -102.43 85.02 2.53 Favored 'General case' 0 CA--C 1.446 -3.025 0 CA-C-O 123.736 1.732 . . . . 75.420000000000002 114.346 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' ILE . . . . . 0.741 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.8 mm -122.44 153.42 27.04 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 0 N-CA-C 102.368 -3.197 . . . . 74.209999999999994 102.368 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -56.86 116.37 3.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.528 -1.286 . . . . 74.319999999999993 107.528 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.741 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 45.6 mt-10 -112.3 118.66 35.87 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 121.191 0.52 . . . . 72.329999999999998 111.793 -172.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -136.41 111.62 9.05 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.095 -1.411 . . . . 74.450000000000003 107.97 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.54 26.96 14.98 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.364 0.876 . . . . 53.210000000000001 113.364 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . 0.532 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 24.4 tt0 -66.22 109.69 2.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.223 -1.028 . . . . 74.420000000000002 108.223 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.41 168.67 19.19 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.039 -0.528 . . . . 73.340000000000003 110.475 -175.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . 0.586 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 18.6 p90 -140.11 171.5 14.09 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.221 -0.659 . . . . 72.0 109.221 173.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 38.2 mt -114.4 136.34 53.1 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.532 -1.284 . . . . 71.329999999999998 107.532 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 56.7 t -102.06 113.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.415 -1.328 . . . . 74.209999999999994 107.415 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.39 136.3 48.26 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 123.571 0.545 . . . . 71.430000000000007 110.837 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.6 mt -96.86 132.18 42.87 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.001 -0.74 . . . . 64.540000000000006 109.001 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.4 m -151.07 176.26 11.32 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.704 -0.851 . . . . 74.329999999999998 108.704 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.95 81.16 0.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.192 0.997 . . . . 72.349999999999994 112.297 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 58.5 t -87.7 123.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 115.401 -0.818 . . . . 61.130000000000003 109.283 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 39.6 ttmt . . . . . 0 C--N 1.286 -2.182 0 N-CA-C 108.111 -1.07 . . . . 72.209999999999994 108.111 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.416 -2.143 0 CA-C-O 121.171 0.51 . . . . 74.150000000000006 110.164 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -109.82 118.28 36.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.115 -1.439 . . . . 72.409999999999997 107.115 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 380' ' ' THR . 41.2 m -87.67 131.66 34.38 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 120.837 0.351 . . . . 62.530000000000001 110.23 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 390' ' ' VAL . 78.5 t -116.64 106.51 20.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.668 -1.234 . . . . 73.329999999999998 107.668 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 47.9 m -97.78 112.84 24.58 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.303 -0.999 . . . . 52.310000000000002 108.303 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.758 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -89.79 115.57 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 122.144 0.973 . . . . 72.109999999999999 110.409 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . 0.755 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 83.7 m-85 -99.8 120.86 40.41 Favored 'General case' 0 N--CA 1.396 -3.129 0 CA-C-N 114.796 -1.093 . . . . 74.310000000000002 108.176 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -99.92 -7.55 25.08 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-O 122.603 1.192 . . . . 74.049999999999997 107.97 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.483 1.217 0 CA-C-N 113.276 -1.784 . . . . 64.209999999999994 106.297 -172.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 479' ' ' HIS . 83.4 t . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 108.235 -1.024 . . . . 65.230000000000004 108.235 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 480' ' ' VAL . 75.7 m -147.28 120.13 8.69 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.706 -0.225 . . . . 64.230000000000004 110.684 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.463 ' HA ' HG13 ' A' ' 480' ' ' VAL . 96.5 mttt -93.43 121.12 34.5 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.195 -0.668 . . . . 74.219999999999999 109.195 174.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.455 HG21 HG11 ' A' ' 407' ' ' VAL . 30.9 mm -94.71 136.31 26.3 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 105.374 -2.084 . . . . 73.200000000000003 105.374 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.4 ' HA ' HD11 ' A' ' 486' ' ' LEU . 35.2 p90 -165.6 160.53 17.65 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 118.278 0.49 . . . . 72.409999999999997 111.697 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -79.22 141.01 37.51 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.674 -0.491 . . . . 75.439999999999998 109.674 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -65.18 -44.99 86.68 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.592 -0.892 . . . . 65.439999999999998 108.592 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -114.44 161.68 17.66 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-N 115.401 -0.818 . . . . 74.329999999999998 111.053 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.93 -19.11 18.16 Favored Glycine 0 C--N 1.278 -2.67 0 CA-C-N 114.425 -1.261 . . . . 73.140000000000001 110.406 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.7 m -138.6 134.21 33.47 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.992 -0.744 . . . . 72.219999999999999 108.992 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 72.5 m-85 -124.5 140.38 53.0 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.704 -1.221 . . . . 74.420000000000002 107.704 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.459 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 19.2 mt-30 -129.82 140.4 51.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.576 -0.898 . . . . 43.200000000000003 108.576 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.8 p -151.88 159.86 43.71 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.737 -0.838 . . . . 62.329999999999998 108.737 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.1 mm? -74.98 148.72 39.69 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.45 0.469 . . . . 64.140000000000001 109.906 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.652 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 4.5 tt0 -62.83 -36.83 84.5 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.697 0.761 . . . . 74.510000000000005 109.425 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.459 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.7 p-10 -81.15 6.21 14.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.461 -0.791 . . . . 74.209999999999994 112.283 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 54.1 t -70.95 -32.66 69.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.395 0.617 . . . . 61.210000000000001 110.402 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.17 -61.42 0.53 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.769 -0.932 . . . . 60.5 110.769 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 6.2 p -137.71 152.57 49.39 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.708 0.29 . . . . 75.340000000000003 111.143 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.638 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 7.7 p -109.97 127.43 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 107.976 -1.12 . . . . 74.310000000000002 107.976 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.71 120.64 38.46 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.141 0.496 . . . . 54.149999999999999 110.482 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -111.1 152.86 26.47 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.269 -1.382 . . . . 61.229999999999997 107.269 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.0 m -123.93 128.47 49.48 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.27 0.557 . . . . 71.450000000000003 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.89 125.56 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.796 -1.187 . . . . 52.219999999999999 107.796 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.54 144.95 11.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.645 -1.243 . . . . 72.420000000000002 107.645 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.506 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 55.8 ttt180 -127.28 121.06 30.1 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 116.068 -0.515 . . . . 73.209999999999994 109.94 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -118.84 167.51 11.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.761 -0.654 . . . . 71.109999999999999 111.028 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 136.15 14.6 0.95 Allowed Glycine 0 C--N 1.303 -1.263 0 N-CA-C 111.287 -0.725 . . . . 75.510000000000005 111.287 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 92.65 -106.01 3.36 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 110.306 -1.118 . . . . 42.240000000000002 110.306 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -135.28 137.9 42.97 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.861 -0.792 . . . . 75.340000000000003 108.861 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.467 HD13 ' H ' ' A' ' 403' ' ' ASN . 0.7 OUTLIER -160.35 111.87 1.93 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.2 -1.037 . . . . 72.120000000000005 108.2 -176.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 3.9 p -98.87 -8.3 25.94 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.531 0.567 . . . . 71.540000000000006 112.531 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.467 ' H ' HD13 ' A' ' 401' ' ' LEU . 2.2 m-20 -67.81 146.39 53.75 Favored 'General case' 0 C--O 1.249 1.065 0 N-CA-C 108.246 -1.02 . . . . 53.340000000000003 108.246 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 14.0 m -83.68 114.0 21.26 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.616 0.722 . . . . 65.25 111.75 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.38 133.89 43.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.231 -0.895 . . . . 55.439999999999998 108.737 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -115.94 126.97 54.59 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.75 0.42 . . . . 71.439999999999998 109.948 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.455 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -125.29 135.36 64.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.294 -1.743 . . . . 72.230000000000004 106.294 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 140.45 35.05 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.24 -0.652 . . . . 60.240000000000002 109.24 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -135.25 160.59 37.9 Favored 'General case' 0 C--O 1.254 1.305 0 C-N-CA 120.676 -0.41 . . . . 65.219999999999999 110.646 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 30.6 ttt180 -164.03 158.02 19.02 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.263 -1.754 . . . . 52.25 106.263 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.723 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 43.2 p -96.3 150.39 20.62 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.863 -0.791 . . . . 63.340000000000003 108.863 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.9 tp10 -105.64 139.8 39.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.735 -1.209 . . . . 74.409999999999997 107.735 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.423 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 3.7 m-20 -52.39 -39.03 60.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.512 1.125 . . . . 64.400000000000006 112.651 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 57.96 -94.99 0.05 OUTLIER Glycine 0 C--N 1.295 -1.708 0 CA-C-N 114.755 -1.111 . . . . 72.129999999999995 113.717 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -124.18 17.83 9.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.498 1.142 . . . . 63.43 108.889 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -148.27 -160.52 1.18 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.678 -1.23 . . . . 53.229999999999997 107.678 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 417' ' ' ASN . 2.8 m120 -132.71 126.71 33.16 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 113.028 0.751 . . . . 72.310000000000002 113.028 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.43 124.37 28.85 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.914 -1.143 . . . . 62.32 107.914 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.48 -5.69 54.99 Favored Glycine 0 C--N 1.3 -1.465 0 N-CA-C 110.69 -0.964 . . . . 74.349999999999994 110.69 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 19.9 m -126.13 -51.83 1.53 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.877 0.37 . . . . 61.409999999999997 110.114 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.489 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 7.6 m-20 -86.46 -57.14 3.11 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-O 122.205 1.002 . . . . 72.319999999999993 109.726 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.689 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.47 165.03 28.61 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 115.116 -0.947 . . . . 62.530000000000001 109.683 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -69.69 162.15 28.3 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.936 0.773 . . . . 71.439999999999998 111.788 -173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.723 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 2.4 p90 -97.93 -17.87 18.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.124 -0.943 . . . . 65.239999999999995 111.875 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.495 HG21 HG22 ' A' ' 442' ' ' VAL . 6.9 t 32.93 56.37 0.44 Allowed 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.594 1.558 . . . . 45.140000000000001 113.844 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.546 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.3 pt-20 -79.89 119.28 22.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.624 0.726 . . . . 73.129999999999995 111.614 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -162.51 -167.51 23.04 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.617 -0.993 . . . . 55.119999999999997 110.617 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.8 m -127.78 137.51 52.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 70.109999999999999 108.514 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.23 118.49 42.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.532 -0.914 . . . . 74.140000000000001 108.532 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.36 107.42 19.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.854 -1.066 . . . . 72.239999999999995 109.324 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 404' ' ' THR . 71.1 m-85 -90.38 94.35 9.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.255 0.55 . . . . 72.519999999999996 110.784 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.476 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 67.3 mttm -84.54 175.71 4.39 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.637 -1.165 . . . . 65.530000000000001 111.022 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 34.3 Cg_exo -60.87 117.75 4.55 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.324 2.016 . . . . 73.510000000000005 110.27 172.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.93 -11.4 41.16 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.454 -0.658 . . . . 43.329999999999998 111.454 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -90.58 63.45 5.48 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.714 0.768 . . . . 72.200000000000003 110.765 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 16.9 m -67.52 -22.46 65.43 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.23 -1.35 . . . . 63.350000000000001 108.474 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -136.15 149.2 48.54 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 107.284 -1.376 . . . . 72.019999999999996 107.284 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 24.3 mmmt -133.07 151.72 52.01 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 120.778 0.323 . . . . 63.140000000000001 111.078 172.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -121.46 132.93 55.01 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.725 -0.67 . . . . 74.5 109.509 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.7 150.46 26.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.513 -0.921 . . . . 65.420000000000002 108.513 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 23.1 mtm180 -131.53 134.69 46.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.141 0.496 . . . . 72.129999999999995 111.663 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.56 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -107.66 125.56 64.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.437 -0.949 . . . . 53.310000000000002 108.437 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -74.82 138.35 23.65 Favored Glycine 0 N--CA 1.439 -1.127 0 O-C-N 123.667 0.604 . . . . 75.140000000000001 112.06 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.441 HD12 HG12 ' A' ' 496' ' ' ILE . 43.3 mm -97.37 130.71 45.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.597 -1.26 . . . . 72.420000000000002 107.597 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 84.4 mt -92.03 151.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 108.202 -1.036 . . . . 75.530000000000001 108.202 -176.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.03 86.67 6.09 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.708 0.289 . . . . 72.150000000000006 110.822 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.8 129.57 54.51 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.521 -2.4 . . . . 55.130000000000003 104.521 171.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.256 8.2 t0 -125.61 89.45 3.04 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 116.577 -2.049 . . . . 73.239999999999995 111.518 178.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.623 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.6 mm -115.21 156.4 16.21 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.034 0 CA-C-N 111.058 -2.792 . . . . 62.420000000000002 105.587 -174.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -59.79 115.1 3.13 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 105.76 -1.941 . . . . 72.219999999999999 105.76 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.623 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 34.9 mt-10 -122.22 110.78 16.15 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.044 0.926 . . . . 75.340000000000003 110.338 -169.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 504' ' ' ILE . 33.0 mt-10 -115.44 111.93 21.53 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.146 -1.388 . . . . 73.120000000000005 108.713 -175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 49.34 30.38 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.914 1.686 . . . . 72.150000000000006 112.548 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.542 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.5 tt0 -60.8 112.55 2.08 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.538 -1.21 . . . . 74.239999999999995 108.809 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -139.84 168.51 19.64 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.472 -0.786 . . . . 74.120000000000005 110.168 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.585 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 31.3 p90 -139.07 175.1 9.84 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.956 -0.566 . . . . 72.230000000000004 109.552 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 27.1 mt -120.36 136.79 54.59 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.976 -1.12 . . . . 60.130000000000003 107.976 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.0 t -106.43 123.55 61.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.934 -1.136 . . . . 73.519999999999996 107.934 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -114.54 150.87 34.26 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 123.852 0.72 . . . . 75.530000000000001 109.917 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 486' ' ' LEU . 65.5 mt -116.36 140.01 49.79 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.414 -0.958 . . . . 70.310000000000002 108.414 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 11.8 p -153.37 -179.97 8.23 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.749 -0.834 . . . . 44.43 108.749 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 49.6 86.91 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.307 1.043 . . . . 74.040000000000006 112.505 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.57 HG11 HG23 ' A' ' 480' ' ' VAL . 83.8 t -102.03 125.87 56.13 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.89 -0.782 . . . . 34.229999999999997 108.89 176.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 464' ' ' LYS . 38.5 ttmt -134.87 141.47 46.36 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.977 -1.49 . . . . 74.340000000000003 106.977 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.5 132.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.341 0.591 . . . . 61.009999999999998 111.469 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.48 ' HB3' ' HB ' ' A' ' 404' ' ' THR . 16.7 t -97.44 109.11 21.93 Favored 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 107.313 -1.366 . . . . 54.420000000000002 107.313 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 12.8 t -128.72 -48.08 1.26 Allowed 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.937 -1.875 . . . . 71.049999999999997 105.937 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -84.5 166.73 17.01 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.177 -1.416 . . . . 74.120000000000005 107.177 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.85 0.87 22.26 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.3 0.571 . . . . 73.099999999999994 111.691 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 8.5 t -98.23 151.58 20.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.395 -1.335 . . . . 74.219999999999999 107.395 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.51 -34.16 76.54 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.976 0.417 . . . . 64.140000000000001 111.865 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.26 93.12 8.93 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.139 -0.482 . . . . 72.239999999999995 109.733 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -77.9 105.88 2.19 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.953 -1.659 . . . . 73.349999999999994 108.953 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 49.3 mt -68.7 89.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.688 0.625 . . . . 54.340000000000003 112.688 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 68.5 mt 59.16 22.22 10.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.836 1.254 . . . . 72.420000000000002 112.406 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.36 135.06 57.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.293 0.568 . . . . 73.129999999999995 112.529 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . 0.446 ' HA ' ' CE1' ' A' ' 479' ' ' HIS . . . -73.07 22.72 0.07 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.125 1.528 . . . . 61.409999999999997 115.125 -169.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -109.14 25.65 11.55 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.702 -1.222 . . . . 71.430000000000007 107.702 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' A' ' 483' ' ' LEU . 5.7 p-80 -88.71 -173.09 3.98 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.736 -1.575 . . . . 71.040000000000006 113.318 -173.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.57 HG23 HG11 ' A' ' 463' ' ' VAL . 90.7 t -79.85 -70.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.513 -0.767 . . . . 61.140000000000001 110.702 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 70.6 m -154.4 118.73 4.79 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.043 -0.725 . . . . 55.030000000000001 109.043 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . 70.41 -55.77 0.61 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.322 1.449 . . . . 61.210000000000001 109.086 -173.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 479' ' ' HIS . 2.0 tm? -156.13 -58.23 0.09 Allowed 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 104.419 -2.438 . . . . 72.519999999999996 104.419 170.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.447 ' HB2' ' HB ' ' A' ' 463' ' ' VAL . . . -143.72 149.45 37.18 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 112.632 0.604 . . . . 64.439999999999998 112.632 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 38.5 t -175.53 -173.94 0.67 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 102.972 -2.973 . . . . 73.340000000000003 102.972 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 460' ' ' LEU . 1.0 OUTLIER -148.59 143.43 26.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.238 -1.393 . . . . 61.210000000000001 107.238 176.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.517 ' N ' HD13 ' A' ' 486' ' ' LEU . . . -82.09 35.63 2.56 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 122.052 -0.118 . . . . 70.439999999999998 113.314 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.541 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 20.1 m -147.77 173.65 4.03 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 107.835 -1.172 . . . . 74.010000000000005 107.835 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 488' ' ' SER . 4.9 Cg_exo -44.4 -39.84 12.79 Favored 'Trans proline' 0 CA--C 1.575 2.564 0 N-CA-C 119.268 2.757 . . . . 71.329999999999998 119.268 176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.472 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 20.1 m -101.65 109.16 20.89 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 128.645 2.778 . . . . 42.299999999999997 108.149 1.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.479 ' H ' ' HG2' ' A' ' 489' ' ' PRO . 57.6 m -140.88 106.0 5.0 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-O 120.727 0.298 . . . . 65.310000000000002 110.458 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.82 102.72 14.24 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.394 -1.706 . . . . 74.450000000000003 106.394 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 29.5 m -80.29 121.28 25.46 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.754 -0.657 . . . . 72.109999999999999 109.747 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.575 HG11 HG11 ' A' ' 390' ' ' VAL . 99.5 t -105.68 103.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 108.391 -0.966 . . . . 64.420000000000002 108.391 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 19.7 m -93.17 108.42 20.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.137 -1.06 . . . . 73.530000000000001 108.137 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.689 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -85.87 121.66 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-O 122.015 0.912 . . . . 74.439999999999998 110.992 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.459 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -83.55 95.91 8.46 Favored 'General case' 0 N--CA 1.388 -3.541 0 CA-C-N 114.896 -1.047 . . . . 64.430000000000007 110.498 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.654 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.7 t70 -51.06 -54.04 28.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 113.149 -1.841 . . . . 73.299999999999997 108.344 170.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 13.6 t70 68.91 -7.1 0.79 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.141 1.776 . . . . 74.109999999999999 111.683 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -82.48 -51.69 7.57 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.638 0.775 . . . . 63.43 109.492 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -128.83 18.61 6.15 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.307 -1.368 . . . . 75.0 107.307 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -79.56 73.82 6.23 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.819 -1.082 . . . . 43.140000000000001 113.293 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -92.72 61.74 2.34 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 107.059 -2.416 . . . . 71.310000000000002 107.059 171.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 452' ' ' GLU . 0.2 OUTLIER -74.6 164.14 3.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 113.722 1.008 . . . . 63.149999999999999 113.722 -169.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -125.31 142.23 51.62 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 106.021 -1.844 . . . . 61.539999999999999 106.021 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 98.8 m -81.07 100.2 8.88 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-O 121.228 0.537 . . . . 72.129999999999995 111.535 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -100.91 122.76 44.04 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.231 -1.396 . . . . 72.129999999999995 107.231 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.94 138.21 40.85 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 113.142 0.793 . . . . 60.520000000000003 113.142 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--N 1.307 -1.273 0 CA-C-N 114.968 -1.015 . . . . 74.319999999999993 109.684 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.654 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.583 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.245 0.867 0 N-CA-C 108.643 -0.873 . . . . 62.210000000000001 108.643 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 49.8 m -160.16 149.42 17.57 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.069 0.395 . . . . 75.299999999999997 110.922 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 373' ' ' LYS . 25.8 mmtp -104.94 136.35 44.59 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.312 -0.625 . . . . 62.149999999999999 109.312 171.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.573 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 28.4 mm -110.4 124.61 67.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.28 -1.378 . . . . 63.420000000000002 107.28 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.495 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 45.8 p90 -154.82 169.54 23.74 Favored 'General case' 0 C--O 1.201 -1.458 0 CA-C-N 118.335 0.516 . . . . 72.439999999999998 111.633 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -85.12 148.13 26.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.3 -0.63 . . . . 63.350000000000001 109.3 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -64.51 -46.19 84.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.367 0.604 . . . . 74.530000000000001 109.459 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -109.29 -173.89 2.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.334 -0.848 . . . . 74.310000000000002 110.414 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.43 -37.22 1.02 Allowed Glycine 0 C--N 1.285 -2.297 0 N-CA-C 109.769 -1.333 . . . . 75.310000000000002 109.769 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 35.2 m -121.19 134.36 55.21 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.456 -0.942 . . . . 71.409999999999997 108.456 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.459 ' HB2' HG22 ' A' ' 494' ' ' VAL . 58.3 m-85 -122.19 136.62 54.93 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.814 -1.18 . . . . 64.530000000000001 107.814 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -130.43 134.76 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.867 -1.16 . . . . 54.409999999999997 107.867 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 21.2 t -154.42 164.09 39.17 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.992 -1.114 . . . . 64.120000000000005 107.992 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 497' ' ' PHE . 1.8 mm? -79.96 142.88 34.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.279 0.562 . . . . 65.200000000000003 111.826 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.6 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 13.9 tt0 -57.45 -41.61 80.86 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.438 1.095 . . . . 72.25 109.745 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -70.38 -7.76 45.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.424 -0.807 . . . . 73.310000000000002 113.169 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 49.7 t -68.11 -35.61 78.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.903 0.382 . . . . 72.420000000000002 110.837 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.54 -47.5 1.13 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.725 -0.75 . . . . 72.109999999999999 111.474 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 16.6 p -142.58 152.6 42.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.692 0.246 . . . . 73.519999999999996 110.636 175.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.2 p -111.42 133.15 57.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.471 -1.307 . . . . 72.400000000000006 107.471 174.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.49 120.57 41.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.114 0.483 . . . . 72.109999999999999 110.833 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -111.45 146.64 36.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.374 -0.973 . . . . 75.0 108.374 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.3 m -107.73 123.81 49.09 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.607 -0.516 . . . . 33.539999999999999 109.607 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 61.0 mt -98.83 124.42 52.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.869 -1.16 . . . . 70.299999999999997 107.869 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 52.2 mm -99.46 127.8 51.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.409 -0.96 . . . . 64.099999999999994 108.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -113.56 114.58 26.68 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.541 -0.911 . . . . 75.239999999999995 108.541 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -111.53 151.06 29.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.367 -0.379 . . . . 74.109999999999999 110.092 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 162.61 36.73 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.796 -0.638 . . . . 73.400000000000006 111.811 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 71.93 -98.94 0.82 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.438 -0.665 . . . . 54.229999999999997 111.438 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -150.84 121.96 7.73 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 124.192 0.997 . . . . 73.219999999999999 108.91 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.514 ' HB3' ' OD1' ' A' ' 403' ' ' ASN . 0.1 OUTLIER -157.21 136.08 11.65 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.356 -1.72 . . . . 40.399999999999999 106.356 175.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 20.3 p -86.25 7.89 23.43 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 120.975 0.417 . . . . 43.409999999999997 110.988 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 401' ' ' LEU . 19.5 p-10 -50.22 129.45 21.31 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.658 1.183 . . . . 43.350000000000001 113.471 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 7.5 m -92.96 117.72 30.36 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.783 -0.821 . . . . 74.349999999999994 108.783 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.79 143.83 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.257 -0.883 . . . . 72.530000000000001 110.074 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CE1' HG13 ' A' ' 430' ' ' VAL . 3.5 m-85 -118.43 125.18 49.41 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.422 0.689 . . . . 72.140000000000001 109.317 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -125.62 135.62 63.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.63 -1.248 . . . . 73.239999999999995 107.63 176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.45 145.43 27.44 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.099 -0.704 . . . . 65.540000000000006 109.099 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 17.4 p90 -142.89 157.78 44.25 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.06 -0.4 . . . . 73.409999999999997 110.461 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -161.28 163.92 30.59 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.843 -1.169 . . . . 72.310000000000002 107.843 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.678 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.5 p -95.66 172.58 7.96 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.003 -0.74 . . . . 55.039999999999999 109.003 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -115.42 157.72 23.53 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 120.991 0.424 . . . . 63.009999999999998 111.995 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -85.95 4.01 39.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.184 1.794 . . . . 72.219999999999999 110.571 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -23.36 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.48 1.593 0 C-N-CA 125.912 1.72 . . . . 73.349999999999994 116.579 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 455' ' ' ASN . 11.3 t -99.66 -16.48 18.18 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.564 0.697 . . . . 74.319999999999993 109.653 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -140.22 170.32 16.05 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 108.583 -0.895 . . . . 65.450000000000003 108.583 -175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -110.83 113.99 26.99 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 112.93 0.715 . . . . 72.099999999999994 112.93 -167.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -68.27 124.09 22.51 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.986 -1.116 . . . . 63.439999999999998 107.986 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 116.14 -26.79 8.52 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.391 -1.084 . . . . 54.350000000000001 110.391 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 43.2 m -116.38 -47.78 2.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.685 0.279 . . . . 53.0 111.338 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.0 m-20 -80.39 -57.77 3.44 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 122.174 0.987 . . . . 63.240000000000002 109.403 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.733 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.647 -1.161 . . . . 72.530000000000001 108.716 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -75.12 160.38 30.53 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.748 0.785 . . . . 74.299999999999997 110.702 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.678 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.3 p90 -94.69 -17.95 21.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.402 -0.817 . . . . 52.100000000000001 112.268 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 442' ' ' VAL . 10.1 t 37.08 58.12 1.19 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.413 1.485 . . . . 52.130000000000003 113.688 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 13.6 pt-20 -80.92 111.86 17.77 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.997 0.903 . . . . 72.129999999999995 110.399 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.6 -173.61 22.96 Favored Glycine 0 N--CA 1.415 -2.76 0 CA-C-N 114.799 -1.091 . . . . 63.140000000000001 111.446 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.8 m -126.52 133.19 51.2 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.781 -0.822 . . . . 74.340000000000003 108.781 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 17.8 t -96.91 123.55 49.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.527 -0.916 . . . . 42.409999999999997 108.527 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.5 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.2 t -99.29 109.96 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.051 -0.722 . . . . 63.32 109.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 404' ' ' THR . 65.6 m-85 -86.07 114.94 23.34 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.693 -0.685 . . . . 63.509999999999998 109.731 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 95.5 mttt -108.73 171.56 4.4 Favored Pre-proline 0 C--N 1.291 -1.935 0 CA-C-N 114.944 -1.025 . . . . 75.109999999999999 110.296 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 52.4 Cg_exo -57.26 121.6 10.35 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.784 2.322 . . . . 71.340000000000003 111.205 175.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.81 -16.8 60.38 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.711 -0.677 . . . . 14.24 111.938 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -87.99 62.25 6.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.217 0.532 . . . . 43.549999999999997 110.143 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.4 t -70.48 -17.26 62.97 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.643 -0.708 . . . . 73.209999999999994 109.561 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -130.86 141.89 50.34 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.245 -1.391 . . . . 72.340000000000003 107.245 174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -128.94 147.86 50.88 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 120.612 0.244 . . . . 55.009999999999998 111.235 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.74 127.7 54.79 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.724 -0.671 . . . . 71.430000000000007 109.599 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.5 pt -118.95 149.29 21.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.037 -1.098 . . . . 72.319999999999993 108.037 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 62.2 mtt180 -130.6 140.12 50.42 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 120.63 -0.428 . . . . 72.310000000000002 111.418 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.603 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.1 t -108.09 127.65 64.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.11 -0.95 . . . . 73.340000000000003 108.442 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -70.82 138.82 28.99 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 124.002 0.814 . . . . 72.549999999999997 111.857 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.409 HD12 HG12 ' A' ' 496' ' ' ILE . 38.4 mm -104.16 128.73 57.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.298 -1.371 . . . . 60.340000000000003 107.298 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 77.5 mt -94.65 151.14 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 106.705 -1.591 . . . . 74.209999999999994 106.705 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -81.51 86.29 6.36 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.489 0.662 . . . . 70.319999999999993 110.652 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.99 124.67 52.71 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 103.338 -2.838 . . . . 70.310000000000002 103.338 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -125.89 98.45 5.53 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 117.297 -1.761 . . . . 75.019999999999996 110.027 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.667 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -122.0 156.37 26.54 Favored 'Isoleucine or valine' 1 C--N 1.237 -4.304 0 CA-C-N 111.411 -2.631 . . . . 73.25 104.669 -174.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -56.19 113.48 1.57 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.174 -2.158 . . . . 72.120000000000005 105.174 168.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.2 mt-10 -119.37 107.91 13.93 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-O 121.963 0.887 . . . . 71.519999999999996 110.568 -169.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -113.6 107.98 16.53 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 114.432 -1.258 . . . . 64.329999999999998 108.059 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 35.3 t70 51.88 61.03 3.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.097 0.873 . . . . 73.120000000000005 110.69 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.453 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 32.9 tt0 -89.52 112.68 23.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.52 -1.659 . . . . 52.219999999999999 106.52 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 415' ' ' THR . 3.2 p-10 -143.98 164.93 29.18 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.179 0.514 . . . . 72.510000000000005 110.77 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.7 p90 -136.68 178.48 7.04 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.948 -0.76 . . . . 74.329999999999998 108.948 173.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.08 136.71 54.92 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.149 -1.426 . . . . 73.430000000000007 107.149 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 25.9 t -103.49 122.88 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.333 -1.358 . . . . 72.040000000000006 107.333 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -119.96 148.58 43.35 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.862 -0.608 . . . . 70.030000000000001 109.849 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.96 147.29 28.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.912 -0.585 . . . . 52.539999999999999 109.559 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.8 m -156.11 179.82 8.86 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.514 0.726 . . . . 72.439999999999998 109.527 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.0 t30 47.75 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.335 1.454 . . . . 61.219999999999999 114.267 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 98.5 t -91.67 127.36 44.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 C-N-CA 119.713 -0.795 . . . . 74.439999999999998 109.091 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -133.99 143.55 48.21 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.232 -1.395 . . . . 65.349999999999994 107.232 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 29.9 t -107.77 156.71 8.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.434 -0.951 . . . . 71.5 108.434 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 48.9 m -71.82 127.61 33.1 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.992 0.901 . . . . 63.130000000000003 111.341 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' A' ' 471' ' ' GLU . 29.2 m -86.32 93.14 9.01 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.383 -1.281 . . . . 63.25 109.358 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -124.05 -60.64 1.42 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.68 -0.859 . . . . 73.230000000000004 108.68 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -72.57 -55.19 7.3 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.814 -0.81 . . . . 74.340000000000003 108.814 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 35.4 p -121.63 132.05 54.45 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.876 -0.602 . . . . 44.520000000000003 109.727 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 467' ' ' SER . 44.8 tt0 -105.06 -62.28 1.36 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.119 -1.437 . . . . 73.420000000000002 107.119 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -87.22 177.8 7.06 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.256 -1.016 . . . . 73.120000000000005 108.256 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 91.25 -71.14 1.91 Allowed Glycine 0 N--CA 1.423 -2.227 0 C-N-CA 120.224 -0.989 . . . . 44.140000000000001 111.123 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -165.42 132.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 121.283 0.564 . . . . 74.420000000000002 110.85 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 77.2 mt -119.58 129.37 54.61 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.333 -1.728 . . . . 52.130000000000003 106.333 171.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.54 95.36 3.88 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.332 0.493 . . . . 75.010000000000005 112.332 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -69.26 -36.05 76.73 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 108.621 -0.881 . . . . 72.25 108.621 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 481' ' ' SER . 48.6 t30 -74.86 72.08 2.05 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.621 1.2 . . . . 71.430000000000007 108.798 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -140.32 -36.06 0.49 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 113.657 -1.611 . . . . 73.409999999999997 108.135 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 485' ' ' CYS . 86.0 t -96.22 -42.23 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 119.688 -0.805 . . . . 64.239999999999995 109.25 172.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 478' ' ' ASN . 25.9 t -153.08 -171.24 3.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.893 -1.521 . . . . 61.140000000000001 106.893 173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -51.98 -43.61 63.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.132 0.973 . . . . 70.319999999999993 111.083 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.67 -76.32 0.57 Allowed 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 104.477 -2.416 . . . . 65.109999999999999 104.477 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -165.65 114.51 1.0 Allowed 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.306 -0.628 . . . . 65.420000000000002 109.306 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . 0.437 ' O ' HG12 ' A' ' 480' ' ' VAL . 37.7 t -155.94 132.48 10.29 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 104.944 -2.243 . . . . 72.120000000000005 104.944 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.573 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 1.7 mm? -89.7 -163.81 1.06 Allowed 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 109.179 -0.674 . . . . 74.530000000000001 109.179 -172.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 375' ' ' PHE . . . -63.69 137.32 41.84 Favored Glycine 0 CA--C 1.484 -1.887 0 N-CA-C 104.313 -3.515 . . . . 73.239999999999995 104.313 169.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.496 ' HA ' ' OG ' ' A' ' 490' ' ' SER . 15.1 m -110.81 75.27 1.03 Allowed Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 118.999 2.962 . . . . 63.25 118.999 -165.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.569 ' HB2' ' H ' ' A' ' 491' ' ' THR . 3.0 Cg_exo -70.76 -59.58 0.07 OUTLIER 'Trans proline' 1 N--CA 1.396 -4.225 0 N-CA-C 108.307 -1.459 . . . . 64.450000000000003 108.307 153.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.546 ' HA ' ' CD ' ' A' ' 489' ' ' PRO . 20.4 m -115.79 89.54 3.13 Favored 'General case' 0 C--N 1.389 2.294 0 C-N-CA 128.564 2.746 . . . . 71.150000000000006 105.483 -7.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.569 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 34.4 m -145.03 124.55 13.17 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 116.029 -0.532 . . . . 74.519999999999996 109.885 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -109.39 108.39 18.91 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.435 -1.32 . . . . 61.049999999999997 107.435 170.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 74.4 m -83.2 111.71 19.19 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.282 -0.636 . . . . 73.239999999999995 109.282 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.559 HG11 HG11 ' A' ' 390' ' ' VAL . 71.4 t -100.62 106.62 19.64 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 108.262 -1.014 . . . . 60.100000000000001 108.262 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 25.1 m -93.47 112.16 24.0 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 107.158 -1.423 . . . . 63.149999999999999 107.158 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.733 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.7 mp -86.56 119.66 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 CA-C-O 121.831 0.824 . . . . 64.150000000000006 109.616 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.486 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.5 m-85 -82.79 98.08 8.94 Favored 'General case' 1 N--CA 1.378 -4.068 0 CA-C-N 115.041 -0.981 . . . . 73.329999999999998 112.34 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 451' ' ' GLU . 2.9 t70 -50.09 -60.52 2.87 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 112.019 -2.355 . . . . 71.010000000000005 108.518 170.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.518 ' H ' ' HB3' ' A' ' 502' ' ' ALA . 33.4 t70 67.05 -8.98 0.4 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 113.767 -1.56 . . . . 51.219999999999999 112.363 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 498' ' ' ASP . 27.3 m-20 -69.86 -53.86 16.16 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.713 -1.217 . . . . 74.230000000000004 107.713 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -107.31 -32.89 7.58 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.63 -1.168 . . . . 62.240000000000002 108.198 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.518 ' HB3' ' H ' ' A' ' 499' ' ' ASP . . . -60.23 -47.69 84.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.985 -1.007 . . . . 74.540000000000006 112.113 -177.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 65.06 27.92 72.89 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.572 -0.346 . . . . 54.109999999999999 113.11 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.473 HG12 ' OD1' ' A' ' 499' ' ' ASP . 23.8 mm 54.06 85.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.855 1.262 . . . . 73.230000000000004 111.675 -174.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -124.6 146.81 48.86 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.648 -0.871 . . . . 74.230000000000004 108.648 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.0 t -119.09 125.4 49.21 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 106.913 -1.514 . . . . 61.229999999999997 106.913 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -107.17 115.5 30.29 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.133 0.419 . . . . 74.439999999999998 112.133 -171.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -155.12 118.31 4.41 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.487 -1.301 . . . . 74.319999999999993 107.487 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.459 0 N-CA-C 112.437 0.532 . . . . 74.530000000000001 112.437 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.6 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.628 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.466 ' HA ' ' C ' ' A' ' 478' ' ' ASN . 76.0 t . . . . . 0 N--CA 1.445 -0.675 0 N-CA-C 109.556 -0.535 . . . . 60.130000000000003 109.556 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 480' ' ' VAL . 50.4 m -60.97 114.7 3.23 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.898 0.749 . . . . 53.439999999999998 110.42 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -100.71 143.28 31.06 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 107.873 -1.158 . . . . 72.420000000000002 107.873 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 407' ' ' VAL . 37.4 mm -110.08 112.73 41.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 107.092 -1.448 . . . . 74.299999999999997 107.092 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -145.76 161.41 39.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.471 -0.492 . . . . 73.129999999999995 111.87 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -79.51 150.46 31.16 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.17 -0.468 . . . . 74.430000000000007 110.86 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.14 -50.0 62.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.741 -1.207 . . . . 73.310000000000002 107.741 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 27.6 mm-40 -103.57 -177.69 3.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.609 -0.723 . . . . 73.109999999999999 111.494 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -116.44 -38.4 0.93 Allowed Glycine 0 C--N 1.293 -1.847 0 N-CA-C 109.836 -1.306 . . . . 73.129999999999995 109.836 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.8 m -123.55 131.86 53.74 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 107.582 -1.266 . . . . 70.140000000000001 107.582 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 86.1 m-85 -119.78 140.87 50.08 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.483 -1.303 . . . . 75.430000000000007 107.483 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 495' ' ' THR . 21.3 mt-30 -130.14 127.39 39.66 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.312 -0.625 . . . . 73.540000000000006 109.312 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . 0.652 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.5 p -133.83 165.06 25.85 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.488 -0.93 . . . . 62.539999999999999 108.488 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.79 146.09 24.72 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.023 0.439 . . . . 73.019999999999996 111.125 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.644 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 20.1 tt0 -62.72 -28.94 70.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.84 0.828 . . . . 65.200000000000003 109.138 175.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -86.45 2.4 47.91 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.868 -1.06 . . . . 71.239999999999995 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.76 -32.24 31.54 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 112.611 0.597 . . . . 35.049999999999997 112.611 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.71 -65.47 0.4 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.284 -0.96 . . . . 55.420000000000002 111.21 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.477 HG22 ' HA2' ' A' ' 443' ' ' GLY . 30.3 p -133.01 159.45 39.99 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.478 0.639 . . . . 54.25 111.01 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.652 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 3.6 p -111.87 129.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 107.431 -1.322 . . . . 72.019999999999996 107.431 171.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.39 128.24 44.69 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.661 -0.866 . . . . 52.119999999999997 108.661 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.28 142.82 47.74 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.456 -1.313 . . . . 74.120000000000005 107.456 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.4 m -105.64 131.43 53.03 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.188 0.518 . . . . 72.409999999999997 110.371 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.459 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 84.4 mt -106.54 128.79 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.915 -1.143 . . . . 64.530000000000001 107.915 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.41 HG22 ' HG2' ' A' ' 397' ' ' ARG . 46.4 mm -105.52 127.71 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.121 0 N-CA-C 108.198 -1.038 . . . . 74.409999999999997 108.198 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -110.41 112.06 23.73 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 116.118 -0.492 . . . . 65.25 109.792 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.559 ' HA ' ' HE ' ' A' ' 397' ' ' ARG . 0.6 OUTLIER -127.79 152.56 47.63 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.874 -0.788 . . . . 73.230000000000004 108.874 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 122.46 78.39 0.45 Allowed Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.849 -0.901 . . . . 50.310000000000002 110.849 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 79.24 -163.73 49.1 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.908 -0.663 . . . . 41.240000000000002 112.077 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -135.35 121.08 19.56 Favored 'General case' 0 CA--C 1.468 -2.176 0 N-CA-C 107.618 -1.253 . . . . 70.040000000000006 107.618 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 84.1 mt -146.91 132.96 19.23 Favored 'General case' 0 C--N 1.287 -2.115 0 O-C-N 123.618 0.573 . . . . 73.329999999999998 109.558 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 25.4 p -91.62 2.85 56.18 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.389 0.614 . . . . 64.540000000000006 110.108 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -61.09 132.5 53.97 Favored 'General case' 0 C--O 1.257 1.457 0 CA-C-N 115.236 -0.893 . . . . 73.230000000000004 109.108 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 10.0 m -80.65 112.07 17.67 Favored 'General case' 0 N--CA 1.414 -2.248 0 O-C-N 123.877 0.736 . . . . 71.340000000000003 109.253 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.71 140.22 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.813 -1.085 . . . . 74.219999999999999 108.207 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 50.2 m-85 -123.09 128.01 49.52 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.756 -0.831 . . . . 74.530000000000001 108.756 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 374' ' ' ILE . 7.4 p -128.92 134.57 64.01 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 106.339 -1.726 . . . . 73.140000000000001 106.339 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.47 122.43 42.54 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.497 -0.481 . . . . 70.439999999999998 110.01 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -109.57 154.17 23.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.695 -0.483 . . . . 54.200000000000003 109.695 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -163.78 164.73 23.56 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.078 -1.452 . . . . 63.409999999999997 107.078 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 80.0 p -95.89 172.51 7.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.801 0.334 . . . . 71.030000000000001 110.268 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 8.7 tp10 -118.6 147.97 43.17 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.286 0.565 . . . . 73.329999999999998 110.257 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.72 4.02 26.77 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 127.039 2.136 . . . . 75.340000000000003 109.514 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . 0.563 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -20.35 -74.26 0.01 OUTLIER Glycine 0 N--CA 1.482 1.744 0 C-N-CA 126.113 1.816 . . . . 44.210000000000001 115.686 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.7 t -118.47 -5.46 10.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.347 0.594 . . . . 70.420000000000002 110.63 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -134.23 -179.65 5.7 Favored 'General case' 0 C--O 1.195 -1.774 0 CA-C-N 116.357 -0.383 . . . . 74.409999999999997 110.223 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -123.16 118.96 28.86 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.409 0.623 . . . . 74.299999999999997 110.065 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -71.23 137.89 49.02 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.177 -0.675 . . . . 74.329999999999998 109.177 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.24 -4.92 81.09 Favored Glycine 0 C--N 1.303 -1.303 0 N-CA-C 110.721 -0.952 . . . . 72.329999999999998 110.721 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.1 t -123.73 -57.83 1.61 Allowed 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.25 -1.018 . . . . 50.210000000000001 108.25 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.534 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 17.6 m-20 -82.45 -59.39 2.55 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-O 122.19 0.995 . . . . 61.530000000000001 109.097 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.728 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.23 158.92 43.32 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.267 -0.879 . . . . 74.150000000000006 109.99 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.4 142.87 46.95 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.106 -0.701 . . . . 73.129999999999995 109.106 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.51 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 8.7 p90 -73.68 -24.13 59.92 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 123.304 0.642 . . . . 65.120000000000005 112.632 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.559 HG21 HG22 ' A' ' 442' ' ' VAL 0.291 10.9 t 41.6 62.42 1.56 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.37 1.868 . . . . 75.430000000000007 113.185 178.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.44 107.38 12.16 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.691 -1.141 . . . . 73.150000000000006 108.854 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -144.42 168.38 26.72 Favored Glycine 0 CA--C 1.46 -3.385 0 C-N-CA 120.073 -1.06 . . . . 54.130000000000003 111.49 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.6 m -112.7 138.1 50.01 Favored 'General case' 0 N--CA 1.393 -3.292 0 N-CA-C 107.652 -1.24 . . . . 45.100000000000001 107.652 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.3 t -95.4 117.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.759 -1.201 . . . . 62.119999999999997 107.759 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.74 105.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.496 -0.774 . . . . 62.420000000000002 109.755 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 404' ' ' THR . 57.7 m-85 -89.25 94.53 9.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.054 -0.521 . . . . 71.239999999999995 110.786 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.28 167.51 16.63 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.234 -0.894 . . . . 74.140000000000001 110.568 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.01 119.65 7.05 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 122.742 2.295 . . . . 50.229999999999997 110.881 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.24 -14.75 60.93 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.073 -0.584 . . . . 72.299999999999997 112.457 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -93.91 61.16 2.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.748 0.785 . . . . 70.0 109.381 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 8.0 m -66.09 -25.77 67.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.624 -1.171 . . . . 71.319999999999993 109.625 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.41 132.36 54.32 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.415 -1.328 . . . . 72.430000000000007 107.415 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -120.73 149.69 42.13 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.93 0.395 . . . . 62.399999999999999 111.994 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -113.73 131.91 56.02 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.223 -0.899 . . . . 63.5 109.435 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.57 149.75 26.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.929 -1.137 . . . . 64.129999999999995 107.929 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 51.4 mtt180 -131.62 144.01 50.74 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.253 0.549 . . . . 63.530000000000001 111.972 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 425' ' ' THR . 49.2 t -117.51 121.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.708 -1.219 . . . . 63.130000000000003 107.708 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -78.45 134.1 13.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.07 -0.586 . . . . 75.230000000000004 111.985 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 496' ' ' ILE . 28.9 mm -90.42 139.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.693 -1.225 . . . . 72.230000000000004 107.693 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 81.3 mt -99.29 150.98 4.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.236 -1.394 . . . . 63.520000000000003 107.236 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -76.19 88.03 3.05 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.113 0.482 . . . . 63.420000000000002 111.344 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.95 113.4 20.94 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.029 -2.211 . . . . 54.119999999999997 105.029 171.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.644 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 13.5 t70 -115.88 96.2 5.48 Favored 'General case' 0 CA--C 1.457 -2.629 0 C-N-CA 116.802 -1.959 . . . . 61.049999999999997 110.054 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.627 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 31.7 mm -121.68 155.63 25.93 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.097 0 N-CA-C 103.589 -2.745 . . . . 74.409999999999997 103.589 -175.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -58.49 114.65 2.56 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.602 -1.639 . . . . 74.400000000000006 107.55 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.627 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 24.4 mt-10 -128.65 130.32 47.08 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-N 115.518 -0.764 . . . . 60.43 109.693 -169.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.69 108.04 8.78 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.057 -0.974 . . . . 64.040000000000006 108.508 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.81 49.72 15.57 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 124.537 1.148 . . . . 73.319999999999993 110.238 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.556 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 37.2 tt0 -72.15 116.75 12.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.548 -1.649 . . . . 63.039999999999999 106.548 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 36.5 p30 -141.29 166.05 25.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.938 0.718 . . . . 74.319999999999993 112.938 -172.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.574 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 23.5 p90 -144.39 175.75 9.88 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.241 -0.891 . . . . 74.129999999999995 108.665 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.13 136.64 52.84 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.558 -1.275 . . . . 73.439999999999998 107.558 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.84 123.52 52.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.865 -1.532 . . . . 75.129999999999995 106.865 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 490' ' ' SER . 98.9 m-70 -112.66 135.03 53.86 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 123.803 0.689 . . . . 75.120000000000005 111.492 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.9 129.15 45.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.967 -1.494 . . . . 72.129999999999995 106.967 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.1 t -154.69 -176.82 6.1 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.982 -1.488 . . . . 60.100000000000001 106.982 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 50.86 81.77 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 O-C-N 124.488 1.118 . . . . 74.340000000000003 112.216 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 41.2 t -82.05 131.55 33.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 114.916 -1.038 . . . . 71.420000000000002 109.026 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 4.2 tppp? -132.46 135.74 46.24 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.18 -1.415 . . . . 74.109999999999999 107.18 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.2 135.91 60.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.383 -0.599 . . . . 74.439999999999998 109.383 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.6 t -116.04 116.57 28.13 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 108.681 -0.859 . . . . 64.200000000000003 108.681 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 46.6 t -74.58 -42.76 58.15 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.409 -1.33 . . . . 71.530000000000001 107.409 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 67.87 -49.36 0.52 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.708 2.003 . . . . 75.230000000000004 111.777 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -66.9 -46.79 73.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.381 -1.34 . . . . 71.010000000000005 107.381 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 15.5 t 56.57 36.01 26.93 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.749 -1.114 . . . . 74.420000000000002 111.591 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -83.68 -6.26 59.39 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.683 -0.689 . . . . 72.109999999999999 110.492 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 12.2 t70 66.44 174.95 0.24 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.046 1.338 . . . . 75.129999999999995 110.28 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 78.14 18.62 76.22 Favored Glycine 0 C--O 1.242 0.652 0 N-CA-C 110.579 -1.009 . . . . 64.299999999999997 110.579 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 44.6 mm -76.53 112.14 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.774 -0.824 . . . . 61.109999999999999 108.774 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.38 -3.95 24.8 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.236 -1.024 . . . . 71.340000000000003 108.236 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.87 44.29 0.91 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.147 -1.388 . . . . 65.450000000000003 109.846 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -83.11 23.6 0.85 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.744 0.783 . . . . 73.329999999999998 110.407 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . 0.466 ' C ' ' HA ' ' A' ' 371' ' ' VAL . 8.3 m120 -81.6 53.91 2.24 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 124.969 1.308 . . . . 63.109999999999999 108.217 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -155.24 161.05 41.25 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.619 -0.882 . . . . 63.140000000000001 108.619 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 372' ' ' SER . 28.8 m -69.42 148.18 11.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 123.402 0.439 . . . . 74.409999999999997 110.142 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 49.9 m -151.25 176.27 11.38 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.388 -1.338 . . . . 55.229999999999997 107.388 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 483' ' ' LEU . . . -69.59 85.28 0.45 Allowed 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.638 0.586 . . . . 41.539999999999999 109.792 177.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 482' ' ' ALA . 1.2 tm? 171.36 -39.94 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 104.509 -2.404 . . . . 60.520000000000003 104.509 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -92.42 -178.11 4.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.766 -1.561 . . . . 64.430000000000007 110.724 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 75.7 m -127.61 170.88 12.17 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.392 -0.966 . . . . 61.310000000000002 108.392 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.513 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.1 mm? -84.58 179.53 7.37 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.809 -0.441 . . . . 74.209999999999994 109.809 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -87.06 27.72 5.93 Favored Glycine 0 C--O 1.239 0.458 0 C-N-CA 120.935 -0.65 . . . . 72.329999999999998 112.323 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.408 ' C ' ' HA ' ' A' ' 490' ' ' SER . 20.2 m -155.23 173.23 5.04 Favored Pre-proline 0 C--N 1.288 -2.082 0 N-CA-C 105.386 -2.079 . . . . 50.210000000000001 105.386 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.639 ' N ' ' HA ' ' A' ' 490' ' ' SER . 35.8 Cg_exo -56.26 -31.99 86.29 Favored 'Trans proline' 0 CA--C 1.585 3.039 0 N-CA-C 119.582 2.878 . . . . 61.229999999999997 119.582 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.639 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 33.4 t -107.56 115.2 29.72 Favored 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 127.883 2.473 . . . . 53.329999999999998 108.881 3.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.404 ' H ' ' HD2' ' A' ' 489' ' ' PRO . 24.4 m -126.27 128.13 46.69 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.8 -0.637 . . . . 64.129999999999995 110.171 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -129.15 122.39 29.71 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.397 -1.334 . . . . 74.349999999999994 107.397 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.9 m -89.43 121.46 31.69 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.7 -0.4 . . . . 75.140000000000001 110.394 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 390' ' ' VAL . 74.5 t -109.54 110.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.918 -0.771 . . . . 61.219999999999999 108.918 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 91.1 m -101.49 121.61 42.29 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 108.882 -0.784 . . . . 71.310000000000002 108.882 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.728 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -95.36 117.1 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.099 0 CA-C-N 115.336 -0.847 . . . . 63.240000000000002 109.218 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.42 104.21 5.07 Favored 'General case' 0 N--CA 1.389 -3.507 0 CA-C-N 114.693 -1.14 . . . . 73.109999999999999 110.499 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.647 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 4.0 t70 -55.01 -40.92 70.67 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 112.811 -1.995 . . . . 74.549999999999997 110.803 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 498' ' ' ASP . 8.8 t70 78.01 -38.19 0.25 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.953 1.301 . . . . 72.219999999999999 112.117 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -65.67 -62.41 1.53 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 123.553 0.741 . . . . 62.350000000000001 111.421 -171.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -102.38 -0.19 33.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.912 0.863 . . . . 75.439999999999998 108.724 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.74 66.29 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.1 -0.955 . . . . 71.120000000000005 112.399 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 110.16 -19.11 27.7 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 120.122 -1.037 . . . . 74.25 112.517 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 48.3 pt -90.77 169.52 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.906 -0.776 . . . . 71.409999999999997 108.906 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -137.32 101.22 4.46 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.88 -0.415 . . . . 60.32 109.88 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 32.3 p -93.64 173.69 7.56 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.45 -0.574 . . . . 64.120000000000005 109.45 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -106.47 113.78 27.5 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.381 -0.527 . . . . 75.530000000000001 111.615 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.84 148.54 19.19 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.704 -1.591 . . . . 71.230000000000004 106.704 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--N 1.304 -1.41 0 C-N-CA 120.768 -0.373 . . . . 74.150000000000006 110.848 -177.417 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.647 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.619 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 372' ' ' SER . 12.5 t . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 106.803 -1.555 . . . . 75.219999999999999 106.803 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.501 ' H ' HG12 ' A' ' 371' ' ' VAL . 36.1 m -46.76 116.14 1.25 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 116.021 1.859 . . . . 70.040000000000006 116.021 -173.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 30.7 mmtp -99.45 132.62 44.65 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 114.009 -1.45 . . . . 74.030000000000001 107.255 171.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.494 ' HB ' HD12 ' A' ' 486' ' ' LEU . 44.6 mm -106.9 129.36 60.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 108.065 -1.087 . . . . 74.109999999999999 108.065 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.548 ' HB2' ' OG ' ' A' ' 488' ' ' SER . 43.8 p90 -159.27 167.8 28.04 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 117.907 0.321 . . . . 74.420000000000002 110.924 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -82.52 153.4 25.59 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.828 -0.349 . . . . 64.140000000000001 110.124 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.29 -38.72 81.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.333 0.587 . . . . 73.120000000000005 109.816 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.401 ' NE2' ' HA ' ' A' ' 378' ' ' GLN . 17.5 mm-40 -130.5 174.21 10.11 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.59 -0.732 . . . . 72.540000000000006 112.304 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -104.12 -25.66 7.0 Favored Glycine 0 C--N 1.304 -1.245 0 CA-C-N 115.37 -0.832 . . . . 63.520000000000003 111.857 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.6 m -129.38 133.33 47.33 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.252 -0.648 . . . . 45.149999999999999 109.252 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 66.2 m-85 -124.62 136.35 53.86 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.996 -1.113 . . . . 71.349999999999994 107.996 176.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.473 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 87.4 mt-30 -129.46 135.34 48.53 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.221 -1.029 . . . . 73.239999999999995 108.221 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 37.8 t -148.81 165.0 32.79 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.446 -0.946 . . . . 55.219999999999999 108.446 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -79.23 141.17 37.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.417 0.448 . . . . 75.349999999999994 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.635 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 10.5 tt0 -56.93 -50.34 72.89 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.755 0.822 . . . . 61.020000000000003 110.764 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -77.25 2.56 15.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.519 0.563 . . . . 72.109999999999999 112.519 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.14 -20.6 59.31 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.236 0.541 . . . . 71.200000000000003 111.017 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.28 -57.14 0.63 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.258 -0.972 . . . . 70.349999999999994 113.105 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 14.8 p -139.33 165.35 27.44 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 117.189 0.495 . . . . 72.519999999999996 111.566 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.606 HG11 HG11 ' A' ' 494' ' ' VAL . 6.8 p -122.51 125.72 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 169.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.39 129.29 43.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.197 0.522 . . . . 73.25 110.4 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.21 140.91 51.39 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 107.876 -1.157 . . . . 71.299999999999997 107.876 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.2 m -108.33 131.52 54.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.92 -0.582 . . . . 72.200000000000003 109.511 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.09 125.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.923 -1.139 . . . . 62.149999999999999 107.923 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.8 mm -99.73 133.63 41.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.766 -0.828 . . . . 73.209999999999994 108.766 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 436' ' ' THR . 58.4 ttt180 -117.53 120.17 37.28 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.316 -0.856 . . . . 75.209999999999994 108.773 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 372' ' ' SER . 35.0 mmt180 -122.87 168.87 11.74 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.732 -1.211 . . . . 75.519999999999996 107.732 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 99.68 44.98 2.19 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 110.249 -1.14 . . . . 61.350000000000001 110.249 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 80.0 -161.35 45.53 Favored Glycine 0 N--CA 1.413 -2.849 0 N-CA-C 110.373 -1.091 . . . . 53.030000000000001 110.373 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -153.91 146.66 24.28 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.114 -1.809 . . . . 72.209999999999994 106.114 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.62 154.23 31.3 Favored 'General case' 0 C--N 1.274 -2.698 0 O-C-N 123.546 0.529 . . . . 73.040000000000006 109.932 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 49.3 p -80.62 -0.64 38.84 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.729 0.776 . . . . 71.310000000000002 111.206 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.38 129.36 38.63 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.022 -1.103 . . . . 74.030000000000001 108.022 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 41.9 m -82.68 116.9 22.26 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.557 -0.747 . . . . 63.109999999999999 111.517 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.64 146.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.578 -0.737 . . . . 75.400000000000006 109.351 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -122.12 125.53 46.38 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.074 0.549 . . . . 61.219999999999999 110.292 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.49 130.83 70.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.208 -1.404 . . . . 71.409999999999997 107.208 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 15.1 t70 -100.25 135.0 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.688 -0.486 . . . . 71.140000000000001 109.688 -174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.02 153.99 48.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.45 -0.5 . . . . 74.349999999999994 110.363 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 426' ' ' GLU . 33.6 ttp180 -163.43 154.57 16.67 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.752 -1.573 . . . . 71.239999999999995 106.752 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.607 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 30.8 p -96.46 162.55 13.43 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.279 0.562 . . . . 72.230000000000004 110.4 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 3.6 mm-40 -105.11 160.58 14.95 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.586 -0.734 . . . . 75.230000000000004 109.378 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.31 -37.65 63.56 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.131 -0.94 . . . . 75.200000000000003 110.035 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 48.57 -107.74 0.3 Allowed Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.228 -1.351 . . . . 40.0 114.215 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -101.53 5.03 41.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.739 0.781 . . . . 62.350000000000001 110.237 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -135.57 -159.53 0.97 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.942 0.897 . . . . 34.130000000000003 109.067 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 417' ' ' ASN . 1.2 m120 -136.17 126.2 26.06 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 121.089 0.471 . . . . 73.030000000000001 111.616 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -82.18 124.52 29.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.513 -0.921 . . . . 75.420000000000002 108.513 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.44 -19.42 36.79 Favored Glycine 0 C--N 1.296 -1.659 0 N-CA-C 110.123 -1.191 . . . . 60.130000000000003 110.123 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.6 m -106.94 -56.88 2.14 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.66 -0.496 . . . . 64.209999999999994 109.66 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 2.2 m-20 -84.68 -57.34 3.17 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 122.106 0.955 . . . . 74.439999999999998 110.205 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.686 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -140.01 159.78 41.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.24 -0.891 . . . . 74.519999999999996 109.002 -178.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.4 tm-20 -76.26 157.88 32.14 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 123.873 0.733 . . . . 70.120000000000005 109.794 -173.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.607 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 13.7 p90 -94.21 -16.68 23.44 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.288 0.635 . . . . 61.420000000000002 112.669 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.508 HG21 HG22 ' A' ' 442' ' ' VAL 0.303 9.9 t 37.59 67.12 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.66 1.984 . . . . 70.239999999999995 114.303 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.423 ' HB3' ' HD3' ' A' ' 410' ' ' ARG . 9.5 pt-20 -79.1 121.16 24.65 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.003 -0.998 . . . . 64.420000000000002 109.481 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -163.0 176.73 39.23 Favored Glycine 0 CA--C 1.476 -2.349 0 C-N-CA 120.372 -0.918 . . . . 61.140000000000001 111.386 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 32.4 m -120.52 136.73 54.69 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.881 -1.155 . . . . 72.150000000000006 107.881 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.9 t -95.57 119.17 43.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.902 -1.147 . . . . 75.150000000000006 107.902 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 99.6 t -95.83 107.04 19.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 114.704 -1.134 . . . . 71.040000000000006 108.798 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 404' ' ' THR . 51.1 m-85 -84.55 95.08 8.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.971 -0.559 . . . . 73.540000000000006 110.586 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.478 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 10.4 mtmp? -80.52 167.83 29.94 Favored Pre-proline 0 N--CA 1.432 -1.373 0 CA-C-N 115.487 -0.778 . . . . 71.349999999999994 110.156 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 54.9 Cg_exo -52.66 131.61 42.2 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.371 2.047 . . . . 74.230000000000004 111.803 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.66 -21.49 32.67 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.851 -0.613 . . . . 51.109999999999999 113.37 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 38.0 mt-10 -81.17 63.9 5.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.171 0.986 . . . . 71.150000000000006 112.647 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 21.4 m -67.49 -11.33 57.68 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.2 -1.364 . . . . 62.149999999999999 110.069 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -139.14 136.55 35.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.497 -0.927 . . . . 73.439999999999998 108.497 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -126.14 155.12 42.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.294 0.092 . . . . 71.530000000000001 111.05 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.22 138.04 54.12 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.807 -0.357 . . . . 64.109999999999999 110.801 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 39.9 pt -125.68 153.97 34.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.635 -0.876 . . . . 51.0 108.635 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 56.5 mtm180 -130.4 138.32 50.29 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.911 0.386 . . . . 64.430000000000007 110.865 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.516 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 58.6 t -106.54 122.25 60.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.838 -1.171 . . . . 60.399999999999999 107.838 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -76.88 130.7 10.71 Favored Glycine 0 N--CA 1.434 -1.453 0 O-C-N 123.583 0.552 . . . . 71.099999999999994 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 496' ' ' ILE . 38.0 mm -88.98 143.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.527 -1.657 . . . . 74.540000000000006 106.527 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.2 mt -102.04 145.94 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 N-CA-C 107.368 -1.345 . . . . 61.399999999999999 107.368 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.26 85.99 1.43 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.508 0.67 . . . . 73.5 111.497 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.55 120.22 36.1 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 105.175 -2.158 . . . . 72.540000000000006 105.175 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 20.2 t70 -122.57 95.3 4.58 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 116.951 -1.9 . . . . 74.349999999999994 110.554 173.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.647 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 34.3 mm -118.62 155.9 20.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.348 0 N-CA-C 103.61 -2.737 . . . . 63.340000000000003 103.61 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -56.89 114.6 2.16 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.058 -1.457 . . . . 73.120000000000005 107.119 171.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 29.0 mt-10 -127.19 133.94 50.22 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-N 116.06 -0.518 . . . . 73.540000000000006 109.7 -169.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.48 112.48 7.66 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.475 -0.935 . . . . 74.219999999999999 108.475 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 33.5 t70 50.56 61.53 3.17 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.855 0.862 . . . . 64.239999999999995 112.8 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.32 123.47 41.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 118.729 -1.188 . . . . 71.400000000000006 110.932 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.28 174.36 10.64 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.87 -1.059 . . . . 73.310000000000002 110.54 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.554 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 26.0 p90 -148.0 -178.54 6.34 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.746 -1.115 . . . . 71.409999999999997 108.042 172.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -123.79 136.72 54.58 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.284 -1.006 . . . . 64.299999999999997 108.284 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.4 122.03 59.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.903 -1.517 . . . . 55.43 106.903 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.82 152.86 31.43 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.712 0.632 . . . . 75.140000000000001 110.005 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.48 121.43 44.95 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.893 -0.78 . . . . 74.019999999999996 108.893 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 46.8 m -131.1 -178.11 4.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.429 -0.952 . . . . 60.25 108.429 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 39.45 82.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.143 1.377 . . . . 74.019999999999996 112.348 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.2 t -92.75 123.02 44.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 119.168 -1.013 . . . . 73.409999999999997 108.911 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -134.7 174.28 10.74 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.926 -1.034 . . . . 75.209999999999994 109.453 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 69.3 t -142.18 150.72 18.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 103.974 -2.602 . . . . 72.329999999999998 103.974 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 8.5 t -74.2 109.95 8.1 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.616 -0.883 . . . . 52.509999999999998 108.616 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 470' ' ' SER . 20.1 m -81.35 105.62 12.68 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.691 -1.14 . . . . 75.329999999999998 110.364 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.54 -65.4 0.94 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 105.35 -2.093 . . . . 70.150000000000006 105.35 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -102.13 -79.16 0.52 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.429 -1.323 . . . . 74.239999999999995 107.429 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 467' ' ' SER . 12.2 m 54.3 10.19 0.29 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.09 1.515 . . . . 51.200000000000003 115.09 174.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -70.95 -49.44 45.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.928 0.394 . . . . 75.409999999999997 110.671 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -153.57 170.05 21.74 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.046 -1.094 . . . . 74.239999999999995 108.046 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 84.02 -65.61 4.06 Favored Glycine 0 CA--C 1.502 -0.72 0 N-CA-C 110.429 -1.068 . . . . 62.340000000000003 110.429 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 75.5 mt -73.99 109.71 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 108.61 -0.885 . . . . 65.109999999999999 108.61 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 70.1 mt -88.08 -30.52 19.82 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.369 -0.604 . . . . 41.409999999999997 109.369 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -83.74 80.12 9.24 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.539 -0.755 . . . . 74.209999999999994 109.778 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -84.61 -49.18 8.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.073 -1.454 . . . . 73.209999999999994 107.073 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -88.31 132.26 34.47 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.272 -1.381 . . . . 54.219999999999999 107.272 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -105.53 -6.17 19.6 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.819 -0.628 . . . . 74.409999999999997 112.53 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.54 -48.36 18.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 120.036 -0.666 . . . . 75.400000000000006 112.364 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 22.8 t -146.91 -168.35 3.01 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.869 -0.732 . . . . 73.219999999999999 109.258 177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.26 86.08 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.549 -0.908 . . . . 70.030000000000001 108.549 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -120.78 -79.68 0.61 Allowed 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 103.887 -2.634 . . . . 54.409999999999997 103.887 167.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -164.97 134.74 3.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.614 -0.513 . . . . 70.519999999999996 109.614 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 51.9 t -166.38 133.22 2.56 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.193 -1.41 . . . . 52.140000000000001 107.193 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.494 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.4 mm? -87.82 174.2 8.51 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 123.185 0.303 . . . . 63.32 110.221 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -75.73 -39.59 33.78 Favored Glycine 0 C--N 1.317 -0.479 0 N-CA-C 110.434 -1.067 . . . . 62.399999999999999 110.434 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.548 ' OG ' ' HB2' ' A' ' 375' ' ' PHE . 14.7 m -87.99 171.78 8.94 Favored Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 107.545 -1.279 . . . . 62.439999999999998 107.545 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.487 ' N ' ' HA ' ' A' ' 490' ' ' SER . 2.5 Cg_endo -45.53 -47.44 13.28 Favored 'Trans proline' 0 CA--C 1.584 2.983 0 C-N-CA 122.493 2.129 . . . . 64.0 117.554 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.487 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 20.6 m -109.66 138.76 45.56 Favored 'General case' 0 N--CA 1.412 -2.361 0 C-N-CA 127.912 2.485 . . . . 70.230000000000004 108.435 3.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 62.9 m -143.56 104.6 4.24 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 109.174 -0.676 . . . . 74.019999999999996 109.174 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -102.22 115.06 29.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.944 -1.132 . . . . 61.509999999999998 107.944 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 20.7 m -89.2 121.08 31.16 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.1 -0.704 . . . . 61.109999999999999 109.1 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.606 HG11 HG11 ' A' ' 390' ' ' VAL . 92.6 t -108.81 106.03 19.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 115.987 -0.551 . . . . 61.119999999999997 109.727 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 88.2 m -92.9 118.85 31.59 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.348 -0.982 . . . . 62.240000000000002 108.348 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.686 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -95.17 120.36 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 N-CA-C 108.946 -0.761 . . . . 71.109999999999999 108.946 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.458 ' CZ ' HD13 ' A' ' 504' ' ' ILE 0.316 26.1 m-85 -84.37 102.7 12.94 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-O 122.233 1.016 . . . . 53.240000000000002 113.624 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.64 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.7 t70 -51.02 -54.11 27.49 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 111.779 -2.464 . . . . 61.439999999999998 109.435 173.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 28.5 t70 69.1 5.35 5.03 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.578 -1.192 . . . . 72.340000000000003 111.507 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -95.8 -63.38 1.16 Allowed 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.52 -0.919 . . . . 71.230000000000004 108.52 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -102.72 -30.36 10.94 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.779 -1.563 . . . . 74.049999999999997 106.779 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 498' ' ' ASP . . . -82.07 70.9 9.08 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.504 -0.771 . . . . 52.149999999999999 110.04 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -93.02 93.02 1.71 Allowed Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.85 -1.3 . . . . 54.5 109.85 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.458 HD13 ' CZ ' ' A' ' 497' ' ' PHE . 46.4 pt -85.6 167.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 121.306 0.574 . . . . 70.530000000000001 110.631 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -131.49 129.07 40.64 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 104.923 -2.251 . . . . 75.340000000000003 104.923 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 49.8 m -71.12 98.04 1.6 Allowed 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.694 -0.484 . . . . 64.010000000000005 109.694 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -72.86 113.93 10.43 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.903 -1.517 . . . . 72.409999999999997 106.903 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.01 157.13 38.37 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.854 0.835 . . . . 52.119999999999997 112.5 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 . . . . . 0 C--N 1.292 -1.932 0 CA-C-N 114.537 -1.211 . . . . 72.310000000000002 109.265 -178.881 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.64 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.625 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 108.198 -1.038 . . . . 61.049999999999997 108.198 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 397' ' ' ARG . 15.3 m -79.42 124.05 28.08 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 109.145 -0.687 . . . . 72.209999999999994 109.145 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 97.0 mttt -112.08 146.58 37.72 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 116.153 -0.476 . . . . 74.25 112.046 -174.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.634 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 18.6 mm -104.36 121.12 55.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.027 -1.101 . . . . 63.409999999999997 108.027 -176.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.447 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 21.4 p90 -150.49 168.34 24.5 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.153 -0.619 . . . . 52.240000000000002 112.235 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -80.91 145.72 31.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.588 -0.523 . . . . 74.209999999999994 109.588 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.543 ' HB3' ' OH ' ' A' ' 381' ' ' TYR . 37.2 tt0 -58.4 -59.03 5.99 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.847 0.859 . . . . 72.400000000000006 109.746 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.521 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.8 mm100 -104.87 179.98 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.343 -0.844 . . . . 65.439999999999998 110.332 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -109.13 -22.2 6.98 Favored Glycine 0 C--N 1.287 -2.173 0 N-CA-C 109.687 -1.365 . . . . 61.030000000000001 109.687 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 493' ' ' THR . 38.5 m -143.23 132.16 22.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 115.059 -0.571 . . . . 50.350000000000001 109.607 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.543 ' OH ' ' HB3' ' A' ' 377' ' ' GLU . 48.7 m-85 -118.98 147.83 43.64 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.159 -1.052 . . . . 65.030000000000001 108.159 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 495' ' ' THR . 40.1 mt-30 -130.74 133.55 46.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.041 -1.096 . . . . 71.129999999999995 108.041 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.6 p -140.06 157.39 45.72 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 109.123 -0.695 . . . . 72.120000000000005 109.123 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -81.15 143.7 32.2 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.02 -0.733 . . . . 74.019999999999996 109.02 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.88 -31.18 70.67 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 123.355 0.662 . . . . 72.340000000000003 110.833 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.485 ' C ' HD22 ' A' ' 386' ' ' ASN . 0.2 OUTLIER -80.94 -2.26 46.98 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-N 115.831 -0.622 . . . . 61.43 112.496 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 48.7 t -68.9 -33.2 73.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.808 0.337 . . . . 72.319999999999993 111.685 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 100.78 -58.04 0.71 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.886 -0.886 . . . . 61.130000000000003 110.886 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.8 p -137.79 154.35 49.57 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.003 -0.369 . . . . 73.430000000000007 110.003 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 4.9 p -110.22 130.52 63.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.042 -1.096 . . . . 62.329999999999998 108.042 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -100.54 119.34 38.37 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.997 0.427 . . . . 75.340000000000003 110.26 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.449 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.7 mp -113.14 157.14 22.03 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.862 -1.532 . . . . 71.329999999999998 106.862 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.1 m -120.54 137.01 54.61 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.232 -0.587 . . . . 70.439999999999998 110.5 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.8 mt -101.56 121.43 52.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.386 -1.338 . . . . 74.340000000000003 107.386 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.55 115.38 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 N-CA-C 108.248 -1.019 . . . . 71.530000000000001 108.248 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 436' ' ' THR . 52.7 ttt-85 -105.84 129.27 54.05 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 107.726 -1.212 . . . . 71.430000000000007 107.726 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 372' ' ' SER . 28.7 mmm180 -118.26 141.54 48.4 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.084 -0.709 . . . . 75.150000000000006 109.084 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 144.33 -9.21 1.93 Allowed Glycine 0 C--O 1.24 0.482 0 C-N-CA 120.651 -0.785 . . . . 63.130000000000003 112.959 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 126.12 179.72 15.88 Favored Glycine 0 N--CA 1.433 -1.525 0 C-N-CA 120.823 -0.703 . . . . 62.149999999999999 111.834 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -112.1 165.95 11.67 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.624 -0.88 . . . . 72.109999999999999 108.624 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.453 HD13 ' CB ' ' A' ' 478' ' ' ASN . 2.1 pt? -166.18 162.58 17.67 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.724 -0.843 . . . . 64.340000000000003 108.724 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 433' ' ' PRO . 12.2 p -102.5 7.16 40.25 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.209 0.528 . . . . 64.129999999999995 111.965 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 401' ' ' LEU . 20.4 t-20 -81.47 179.24 7.92 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.654 -1.239 . . . . 64.439999999999998 107.654 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 24.5 m -125.42 114.26 18.6 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.373 0.606 . . . . 73.540000000000006 110.967 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 52.6 t -106.68 148.89 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.062 -0.972 . . . . 61.109999999999999 108.67 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.605 ' CE2' HG22 ' A' ' 430' ' ' VAL . 25.8 m-85 -131.41 142.55 50.05 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.037 0.446 . . . . 61.109999999999999 110.706 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.89 137.82 24.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.017 -1.475 . . . . 62.310000000000002 107.017 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.3 t70 -101.36 138.5 38.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.189 -0.671 . . . . 72.219999999999999 109.189 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.42 150.5 45.56 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.325 -0.991 . . . . 70.109999999999999 108.325 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 10.0 ttm180 -157.85 150.42 22.63 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.446 -0.946 . . . . 65.239999999999995 108.446 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 31.9 p -96.75 156.86 16.17 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.183 -0.607 . . . . 44.229999999999997 110.319 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 11.5 tp10 -114.36 150.19 34.96 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.475 -1.676 . . . . 65.349999999999994 106.475 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 24.4 m-20 -53.86 -44.77 70.66 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.829 0.823 . . . . 71.439999999999998 112.2 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.97 3.55 Favored Glycine 0 N--CA 1.42 -2.408 0 CA-C-N 114.299 -1.319 . . . . 55.200000000000003 110.351 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 455' ' ' ASN . 9.9 t -104.99 -9.32 17.98 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.83 -0.804 . . . . 73.530000000000001 108.83 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -117.72 -159.22 0.74 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.302 -0.999 . . . . 61.149999999999999 108.302 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.402 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 3.4 m120 -131.38 127.68 38.06 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 112.878 0.696 . . . . 70.430000000000007 112.878 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.05 124.93 29.59 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.105 -1.072 . . . . 73.129999999999995 108.105 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.75 56.95 Favored Glycine 0 C--N 1.295 -1.728 0 N-CA-C 110.513 -1.035 . . . . 60.109999999999999 110.513 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.1 m -128.88 -54.79 1.21 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.155 -0.313 . . . . 74.209999999999994 110.155 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.51 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 18.2 m-20 -84.25 -53.05 5.76 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.814 0.816 . . . . 72.530000000000001 108.977 177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -139.93 166.09 25.57 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.699 -0.852 . . . . 75.140000000000001 108.699 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.54 159.68 30.13 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.662 -0.866 . . . . 70.439999999999998 108.662 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.558 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 6.6 p90 -97.44 -17.69 19.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 123.01 0.524 . . . . 71.239999999999995 111.853 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.531 HG21 HG22 ' A' ' 442' ' ' VAL . 6.4 t 40.92 56.44 2.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.576 1.95 . . . . 73.239999999999995 113.24 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 9.4 pt-20 -77.55 108.96 11.1 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 122.225 1.012 . . . . 73.0 109.213 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -146.6 163.71 28.49 Favored Glycine 0 N--CA 1.411 -2.998 0 CA-C-N 114.905 -1.043 . . . . 71.049999999999997 110.904 -176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 11.0 m -108.71 134.23 51.71 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 108.049 -1.093 . . . . 63.25 108.049 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 48.8 t -94.78 125.24 47.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.399 -0.963 . . . . 53.219999999999999 108.399 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.605 HG22 ' CE2' ' A' ' 406' ' ' PHE . 37.2 t -99.42 112.28 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 CA-C-N 114.761 -1.109 . . . . 75.439999999999998 108.392 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -83.48 105.54 14.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.3 -1.0 . . . . 53.240000000000002 108.3 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 1.0 OUTLIER -79.58 163.94 56.26 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.913 -1.039 . . . . 53.450000000000003 111.465 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.0 Cg_exo -51.41 118.1 4.06 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 123.247 2.631 . . . . 72.409999999999997 111.303 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.87 -15.96 49.66 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.924 -0.58 . . . . 73.310000000000002 113.88 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.8 63.65 7.56 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.393 0.886 . . . . 64.430000000000007 113.393 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.506 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 19.3 m -53.86 -24.78 16.93 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 114.496 -1.229 . . . . 74.099999999999994 112.092 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -116.23 145.27 43.26 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.763 -0.828 . . . . 61.109999999999999 108.763 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -134.48 147.55 50.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 112.02 0.378 . . . . 70.430000000000007 112.02 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.29 141.01 37.56 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.683 -0.689 . . . . 74.510000000000005 109.543 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.1 pt -128.42 148.44 32.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.709 -0.849 . . . . 63.439999999999998 108.709 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 73.9 mtm180 -129.02 142.66 50.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.361 0.601 . . . . 63.140000000000001 111.191 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 46.1 t -116.42 124.37 72.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.503 -1.295 . . . . 74.099999999999994 107.503 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -75.71 141.67 27.77 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.989 -0.624 . . . . 55.310000000000002 112.368 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.452 HD12 HG12 ' A' ' 496' ' ' ILE . 36.6 mm -99.47 136.91 28.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.892 -1.151 . . . . 73.450000000000003 107.892 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.3 mt -98.19 148.36 5.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.48 -1.674 . . . . 73.120000000000005 106.48 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.47 86.59 5.77 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.287 -0.565 . . . . 73.030000000000001 110.707 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.0 118.66 37.03 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 103.936 -2.616 . . . . 63.509999999999998 103.936 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.605 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.258 10.7 t70 -121.21 92.5 3.77 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.493 -2.083 . . . . 75.219999999999999 110.966 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.723 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.6 mm -120.23 156.62 23.1 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.357 0 CA-C-N 111.018 -2.81 . . . . 71.510000000000005 103.825 -175.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -53.62 114.0 1.38 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.625 -1.62 . . . . 73.0 106.625 169.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.723 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 35.5 mt-10 -121.18 113.04 19.42 Favored 'General case' 0 CA--C 1.468 -2.208 0 CA-C-O 121.56 0.695 . . . . 60.520000000000003 110.532 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -117.81 100.55 7.66 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.691 -1.14 . . . . 75.109999999999999 109.767 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 51.75 40.89 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.447 -1.251 . . . . 74.329999999999998 113.393 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.431 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.7 pt-20 -70.12 131.84 44.91 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 119.945 -0.702 . . . . 62.549999999999997 109.81 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.634 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.2 OUTLIER -150.13 161.22 42.8 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.446 0.535 . . . . 63.229999999999997 112.446 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 35.3 p90 -131.96 -179.56 5.48 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.377 -0.374 . . . . 75.340000000000003 110.611 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 47.4 mt -121.34 138.49 54.23 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.457 -0.942 . . . . 75.099999999999994 108.457 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 23.0 t -111.06 129.59 66.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.34 -1.356 . . . . 54.200000000000003 107.34 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -122.67 165.75 16.01 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 123.574 0.546 . . . . 64.239999999999995 109.712 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.52 139.36 51.58 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.198 0.523 . . . . 74.530000000000001 110.536 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 37.3 m -150.57 -179.28 7.1 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.271 -1.011 . . . . 65.150000000000006 108.271 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.8 t30 45.7 88.39 0.02 OUTLIER 'General case' 0 C--O 1.248 1.02 0 C-N-CA 124.815 1.246 . . . . 72.329999999999998 113.856 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.493 HG11 HG23 ' A' ' 480' ' ' VAL . 45.3 t -90.3 123.8 42.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.219 -0.992 . . . . 73.439999999999998 108.779 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -127.35 173.5 9.73 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 121.501 0.667 . . . . 72.540000000000006 110.421 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 42.3 t -143.96 159.14 16.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 102.888 -3.005 . . . . 65.340000000000003 102.888 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.2 m -69.34 108.92 3.9 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 122.657 1.218 . . . . 63.509999999999998 108.333 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 3.5 p -82.12 82.88 7.52 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-N 112.92 -1.945 . . . . 61.119999999999997 113.319 -172.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -93.6 -44.25 8.29 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.249 -1.342 . . . . 73.109999999999999 107.801 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -103.18 -50.01 3.6 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.049 -0.978 . . . . 62.25 108.928 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 22.4 m -160.05 153.75 22.67 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.092 -1.077 . . . . 75.040000000000006 108.092 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -85.99 -39.63 16.68 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.311 -0.996 . . . . 62.240000000000002 108.311 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -120.35 110.82 16.99 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.942 -1.133 . . . . 74.540000000000006 107.942 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 147.78 -40.67 0.96 Allowed Glycine 0 C--N 1.29 -2.009 0 N-CA-C 108.78 -1.728 . . . . 70.25 108.78 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 50.5 mm -85.32 95.98 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 104.983 -2.229 . . . . 73.150000000000006 104.983 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.563 ' HA ' ' NE2' ' A' ' 479' ' ' HIS . 2.4 pp -119.38 138.65 52.94 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 113.844 1.053 . . . . 61.130000000000003 113.844 -173.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.44 162.54 35.22 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.676 -0.861 . . . . 72.439999999999998 108.676 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -69.11 -6.86 31.11 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.632 0.605 . . . . 72.200000000000003 112.632 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . 0.499 ' HA ' ' OG ' ' A' ' 372' ' ' SER . 53.6 m-80 -86.21 -0.01 54.76 Favored 'General case' 0 C--O 1.253 1.242 0 N-CA-C 113.509 0.929 . . . . 75.530000000000001 113.509 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.563 ' NE2' ' HA ' ' A' ' 475' ' ' LEU . 2.4 p-80 -139.77 173.23 11.74 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.513 0.673 . . . . 73.310000000000002 112.079 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.493 HG23 HG11 ' A' ' 463' ' ' VAL . 18.5 m -113.45 -169.45 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 114.104 -1.407 . . . . 61.439999999999998 108.111 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 33.6 p -162.84 -151.49 0.19 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 118.372 0.533 . . . . 61.130000000000003 110.155 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -94.58 8.62 41.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.706 -0.85 . . . . 74.219999999999999 108.706 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -118.54 -52.12 2.37 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.226 -1.768 . . . . 73.219999999999999 106.226 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.09 131.11 36.13 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.513 -2.032 . . . . 71.299999999999997 105.513 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 70.2 m -104.21 176.76 5.05 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 120.815 -0.354 . . . . 65.319999999999993 110.245 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.634 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 1.2 mm? -68.98 -164.41 0.05 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 123.743 0.652 . . . . 55.130000000000003 109.615 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.479 ' C ' ' HD3' ' A' ' 489' ' ' PRO . . . -66.81 -169.96 3.89 Favored Glycine 0 C--O 1.24 0.519 0 N-CA-C 110.133 -1.187 . . . . 63.420000000000002 110.133 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.0 m -113.28 65.34 1.03 Allowed Pre-proline 0 C--N 1.298 -1.667 0 C-N-CA 116.551 -2.06 . . . . 62.009999999999998 116.306 -176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.589 ' CG ' ' HA ' ' A' ' 490' ' ' SER . 10.8 Cg_endo -98.15 -80.55 0.0 OUTLIER 'Trans proline' 1 CA--C 1.61 4.318 0 C-N-CA 121.341 1.36 . . . . 75.219999999999999 111.711 161.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.589 ' HA ' ' CG ' ' A' ' 489' ' ' PRO . 22.6 m -118.88 86.49 2.55 Favored 'General case' 0 C--N 1.388 2.28 0 CA-C-N 123.591 2.905 . . . . 71.540000000000006 106.886 -5.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.509 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 53.0 m -147.55 128.7 14.66 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 109.166 -0.679 . . . . 62.219999999999999 109.166 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -112.06 106.78 15.51 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.714 -1.217 . . . . 53.439999999999998 107.714 170.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 380' ' ' THR . 27.0 m -82.0 121.9 27.11 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.69 -0.485 . . . . 74.400000000000006 109.69 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.517 HG11 HG11 ' A' ' 390' ' ' VAL . 86.6 t -107.75 107.89 23.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.492 -0.929 . . . . 62.219999999999999 108.492 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.634 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 66.9 m -98.39 113.44 25.42 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.895 -0.779 . . . . 72.099999999999994 108.895 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.617 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.0 mp -91.3 120.5 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.556 0.693 . . . . 75.109999999999999 110.767 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.01 101.63 13.09 Favored 'General case' 0 N--CA 1.394 -3.273 0 CA-C-N 115.013 -0.994 . . . . 72.400000000000006 110.999 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.601 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 2.1 t70 -53.6 -53.42 52.05 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.547 -2.115 . . . . 63.509999999999998 108.974 172.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.468 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 31.8 t70 69.29 -5.74 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.571 1.548 . . . . 74.120000000000005 112.1 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -78.06 -35.49 49.52 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.832 -1.173 . . . . 73.010000000000005 107.832 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -95.35 -35.45 11.76 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.322 -0.854 . . . . 53.329999999999998 110.257 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 499' ' ' ASP . . . -72.38 -73.95 0.18 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.273 0.842 . . . . 64.310000000000002 113.273 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.14 60.7 1.9 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.12 -1.192 . . . . 72.310000000000002 110.12 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 49.3 pt -97.96 178.47 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 110.337 -0.245 . . . . 74.329999999999998 110.337 -176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -85.72 125.87 33.54 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.392 -0.966 . . . . 70.400000000000006 108.392 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 2.2 p -81.44 176.15 9.94 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.005 -0.543 . . . . 65.310000000000002 111.236 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -74.29 135.89 42.61 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.567 -0.531 . . . . 63.219999999999999 109.567 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -78.74 95.43 5.31 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.273 -0.64 . . . . 74.109999999999999 109.273 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 115.244 -0.889 . . . . 72.019999999999996 108.687 -176.695 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.605 'CA ' ' OD1' ' A' ' 448' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.619 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 478' ' ' ASN . 47.0 t . . . . . 0 N--CA 1.444 -0.739 0 N-CA-C 109.275 -0.639 . . . . 74.150000000000006 109.275 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.419 ' HA ' ' HA3' ' A' ' 398' ' ' GLY . 44.9 m -126.4 150.68 48.47 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 116.259 -0.428 . . . . 41.32 110.233 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 95.6 mttt -126.85 159.17 34.69 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.095 0.558 . . . . 73.319999999999993 111.445 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.611 ' HB ' HD12 ' A' ' 486' ' ' LEU . 33.4 mm -116.23 121.41 67.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.143 -1.058 . . . . 70.409999999999997 108.143 -175.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.436 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 21.0 p90 -154.1 172.12 18.04 Favored 'General case' 0 C--O 1.193 -1.894 0 N-CA-C 112.195 0.443 . . . . 64.409999999999997 112.195 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -85.49 153.36 22.51 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.594 -0.442 . . . . 71.109999999999999 110.491 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.46 -36.79 81.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.46 0.648 . . . . 72.129999999999995 109.582 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -128.59 172.3 11.32 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.227 -0.897 . . . . 70.319999999999993 111.792 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.41 -32.3 4.93 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 114.881 -1.054 . . . . 63.25 110.966 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 26.3 m -130.39 125.5 34.7 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.389 -0.597 . . . . 72.430000000000007 109.389 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.17 140.69 48.33 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.449 -0.945 . . . . 71.549999999999997 108.449 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 495' ' ' THR . 37.9 mt-30 -123.96 135.52 53.71 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.404 -1.332 . . . . 75.109999999999999 107.404 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 29.7 t -146.48 165.86 28.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.279 -1.008 . . . . 74.0 108.279 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -91.14 145.54 24.59 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.634 -0.506 . . . . 70.409999999999997 109.634 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.699 ' HB2' ' HA ' ' A' ' 498' ' ' ASP . 18.1 tt0 -55.66 -54.86 39.05 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.778 0.831 . . . . 75.439999999999998 110.723 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.418 ' C ' HD22 ' A' ' 386' ' ' ASN . 0.2 OUTLIER -74.37 8.34 2.29 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.765 1.024 . . . . 65.310000000000002 113.765 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.8 t -69.89 -31.05 68.64 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 109.538 -0.541 . . . . 65.019999999999996 109.538 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.64 -60.38 0.52 Allowed Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 120.425 -0.893 . . . . 62.310000000000002 111.245 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 12.7 p -138.02 152.1 48.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 110.348 -0.242 . . . . 74.040000000000006 110.348 176.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 494' ' ' VAL . 3.6 p -108.15 124.22 64.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.559 -1.274 . . . . 74.530000000000001 107.559 174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.16 118.92 34.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.309 0.576 . . . . 71.349999999999994 110.815 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 392' ' ' LEU . 3.2 mp -110.93 149.99 29.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.511 -1.292 . . . . 51.450000000000003 107.511 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.4 m -116.37 125.45 52.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 121.235 0.54 . . . . 71.540000000000006 110.462 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 77.6 mt -97.24 123.98 49.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.346 -1.353 . . . . 71.140000000000001 107.346 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.7 mm -102.16 129.93 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.303 0 CA-C-N 115.205 -0.907 . . . . 74.329999999999998 108.775 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 35.9 ttt180 -112.06 108.62 17.99 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.424 -0.807 . . . . 71.209999999999994 108.873 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -111.45 158.47 19.08 Favored 'General case' 0 CA--C 1.487 -1.462 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 109.755 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 372' ' ' SER . . . 150.28 -40.13 0.84 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.405 -1.078 . . . . 70.299999999999997 110.405 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 156.51 -125.19 1.57 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 110.273 -1.131 . . . . 70.439999999999998 110.273 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -133.15 119.94 20.56 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.526 -0.916 . . . . 61.43 108.526 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 80.5 mt -143.43 138.01 29.03 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.166 -1.05 . . . . 63.210000000000001 108.166 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.44 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 48.4 p -98.41 6.27 47.4 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 122.165 0.983 . . . . 74.010000000000005 109.859 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.65 138.16 50.48 Favored 'General case' 0 C--O 1.258 1.516 0 CA-C-N 114.135 -1.393 . . . . 75.040000000000006 108.994 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 466' ' ' SER . 7.0 m -90.78 124.76 35.39 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 121.623 0.725 . . . . 72.209999999999994 109.832 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.87 137.25 56.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.307 -0.86 . . . . 72.109999999999999 109.132 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.446 ' CE2' HG22 ' A' ' 430' ' ' VAL . 17.9 m-85 -119.93 137.1 54.24 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.582 -0.896 . . . . 72.510000000000005 108.582 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.18 128.76 49.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 107.619 -1.252 . . . . 73.349999999999994 107.619 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.5 153.68 20.96 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.714 -0.476 . . . . 63.109999999999999 109.714 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -146.95 161.54 40.55 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.232 -0.293 . . . . 65.310000000000002 110.435 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -161.03 163.0 31.91 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 107.311 -1.366 . . . . 75.230000000000004 107.311 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 49.4 p -95.71 172.54 7.98 Favored 'General case' 0 C--O 1.26 1.656 0 N-CA-C 108.34 -0.985 . . . . 64.510000000000005 108.34 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -121.72 151.61 40.32 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 120.218 -0.593 . . . . 63.020000000000003 111.339 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.21 3.49 8.68 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 125.734 1.613 . . . . 71.329999999999998 113.045 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.85 -92.02 0.01 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 116.917 1.527 . . . . 71.430000000000007 116.917 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.3 t -101.85 9.58 40.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.212 1.006 . . . . 73.420000000000002 111.096 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -147.03 -157.58 0.82 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.492 -0.929 . . . . 34.409999999999997 108.492 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -145.17 124.37 12.94 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.95 -1.1 . . . . 41.340000000000003 111.768 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -72.28 124.65 25.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.255 -0.884 . . . . 74.099999999999994 108.889 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.48 -16.02 41.53 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.963 -1.255 . . . . 73.329999999999998 109.963 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 48.1 t -110.48 -58.71 2.04 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.379 -0.6 . . . . 32.43 109.379 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 15.4 m-20 -86.28 -58.39 2.65 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-O 122.261 1.029 . . . . 73.109999999999999 109.418 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.712 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.11 163.43 32.45 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.086 -0.961 . . . . 75.219999999999999 109.48 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -72.94 151.94 41.63 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 123.879 0.737 . . . . 73.040000000000006 110.735 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.619 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.1 p90 -80.54 -21.62 41.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.747 -0.661 . . . . 70.319999999999993 112.654 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 442' ' ' VAL 0.255 13.8 t 36.69 67.16 0.35 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.647 1.579 . . . . 74.129999999999995 113.754 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -87.86 113.15 23.24 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.098 -0.956 . . . . 65.420000000000002 108.756 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -153.65 -173.86 23.26 Favored Glycine 0 CA--C 1.482 -2.025 0 C-N-CA 120.492 -0.861 . . . . 54.240000000000002 111.365 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.7 m -120.51 137.16 54.52 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.501 -0.926 . . . . 71.099999999999994 108.501 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 22.0 t -96.56 123.51 48.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.929 -1.137 . . . . 72.129999999999995 107.929 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.446 HG22 ' CE2' ' A' ' 406' ' ' PHE . 16.2 t -103.66 109.6 27.58 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-O 121.389 0.614 . . . . 74.219999999999999 111.047 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 404' ' ' THR . 55.7 m-85 -94.14 100.02 12.19 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.699 -0.682 . . . . 74.219999999999999 111.064 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.8 mttt -94.53 172.1 5.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 114.263 -1.335 . . . . 75.209999999999994 110.343 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 44.5 Cg_exo -58.73 126.17 20.44 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.868 2.379 . . . . 75.319999999999993 112.173 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 86.84 -2.04 87.07 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.601 -0.809 . . . . 61.329999999999998 114.359 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.24 -70.16 0.38 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 117.654 0.727 . . . . 72.010000000000005 110.447 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 54.5 m 71.26 -35.33 0.33 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.686 0.795 . . . . 63.509999999999998 112.122 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -125.95 140.1 52.9 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.515 -1.291 . . . . 74.120000000000005 107.515 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -132.93 143.67 49.64 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.417 -0.356 . . . . 62.509999999999998 110.322 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 392' ' ' LEU . 36.8 tt0 -106.0 134.64 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.495 -0.928 . . . . 65.219999999999999 108.495 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.4 pt -123.14 148.54 26.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.437 -1.32 . . . . 71.430000000000007 107.437 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 75.5 mtt180 -129.0 138.18 51.78 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.363 0.602 . . . . 71.409999999999997 111.93 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.661 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 52.1 t -109.62 119.0 58.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.732 -1.122 . . . . 72.209999999999994 108.628 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.419 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -66.03 132.55 33.83 Favored Glycine 0 N--CA 1.432 -1.589 0 O-C-N 124.192 0.933 . . . . 61.020000000000003 112.236 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 31.8 mm -97.71 135.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.169 -1.419 . . . . 70.040000000000006 107.169 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 76.0 mt -101.72 150.57 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 106.948 -1.501 . . . . 72.049999999999997 106.948 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.23 95.47 6.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.365 -0.534 . . . . 71.040000000000006 111.317 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -122.61 128.1 50.25 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 103.539 -2.763 . . . . 72.420000000000002 103.539 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -126.54 99.85 5.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 C-N-CA 116.999 -1.881 . . . . 75.040000000000006 110.149 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.761 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 37.1 mm -131.04 158.27 43.3 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.118 0 CA-C-N 111.077 -2.783 . . . . 72.219999999999999 105.03 -171.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -53.16 114.82 1.6 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 116.721 -1.992 . . . . 70.239999999999995 106.397 166.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.761 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.6 mt-10 -125.23 97.17 5.11 Favored 'General case' 0 CA--C 1.458 -2.571 0 N-CA-C 107.856 -1.164 . . . . 74.129999999999995 107.856 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -117.84 113.47 21.83 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 108.192 -1.04 . . . . 75.230000000000004 108.192 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 31.38 20.41 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.114 0.884 . . . . 71.230000000000004 111.366 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.492 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.0 tt0 -65.32 106.57 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.27 -1.381 . . . . 65.140000000000001 107.27 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -141.2 169.68 17.15 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.65 -0.704 . . . . 63.219999999999999 109.846 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.661 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 22.5 p90 -143.35 170.44 15.76 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.749 -0.834 . . . . 63.109999999999999 108.749 173.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.74 136.5 50.92 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.058 -1.46 . . . . 73.230000000000004 107.058 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.58 124.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 106.806 -1.553 . . . . 71.109999999999999 106.806 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -120.37 142.8 48.84 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.652 -0.704 . . . . 74.109999999999999 109.242 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.5 138.13 33.61 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.931 -1.878 . . . . 73.219999999999999 105.931 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 26.0 m -148.09 155.1 41.06 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.89 -0.781 . . . . 54.130000000000003 108.89 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.5 t30 57.56 92.38 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 O-C-N 124.543 1.152 . . . . 62.43 111.95 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.75 142.46 14.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 108.391 -0.966 . . . . 73.230000000000004 108.391 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 464' ' ' LYS . 32.6 ttmt -140.76 120.18 13.12 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.3 -0.63 . . . . 71.409999999999997 109.3 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 50.4 t -102.74 140.51 20.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.388 -0.967 . . . . 75.340000000000003 108.388 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.54 ' O ' ' HB ' ' A' ' 404' ' ' THR . 71.0 m -138.89 109.54 6.63 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.465 0.65 . . . . 71.230000000000004 112.665 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 15.7 m -95.16 98.34 10.57 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 105.743 -1.947 . . . . 74.329999999999998 105.743 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.28 -8.29 52.64 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.706 1.373 . . . . 74.109999999999999 114.706 -172.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.03 -32.86 57.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.651 -1.24 . . . . 73.420000000000002 107.651 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 48.9 m 54.95 34.78 23.04 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.129 -1.396 . . . . 61.140000000000001 113.835 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.6 -32.28 65.84 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.927 0.87 . . . . 64.120000000000005 108.99 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -155.66 139.76 16.47 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.085 -0.961 . . . . 65.409999999999997 108.479 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -82.14 67.45 3.68 Favored Glycine 0 C--N 1.301 -1.365 0 N-CA-C 110.201 -1.16 . . . . 73.140000000000001 110.201 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 13.9 tt -74.56 141.15 16.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.162 0.506 . . . . 61.439999999999998 110.067 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 475' ' ' LEU . 2.5 pt? -76.42 134.46 39.59 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.456 -0.793 . . . . 64.439999999999998 110.005 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -103.32 110.48 22.49 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.291 0.567 . . . . 75.530000000000001 111.871 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -93.96 -6.06 46.3 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 122.245 1.021 . . . . 73.209999999999994 108.273 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 371' ' ' VAL . 3.4 p-10 -86.23 1.34 51.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.119 -1.401 . . . . 65.25 109.524 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -139.56 175.61 9.42 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-N 115.759 -0.655 . . . . 75.5 110.289 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 25.8 m -79.43 145.39 9.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.292 -0.867 . . . . 75.010000000000005 110.918 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 28.5 t 177.75 -78.34 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.059 1.343 . . . . 60.020000000000003 108.507 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.73 -0.35 1.93 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.332 . . . . 75.420000000000002 111.674 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -108.94 -45.14 3.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 104.54 -2.393 . . . . 75.409999999999997 104.54 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -113.32 147.95 36.62 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 106.89 -1.522 . . . . 71.209999999999994 106.89 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 77.7 m -122.32 177.89 5.18 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 108.119 -1.067 . . . . 72.310000000000002 108.119 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.611 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.5 mm? -65.51 154.48 38.48 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.521 -0.472 . . . . 70.219999999999999 109.979 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 375' ' ' PHE . . . -72.83 -30.45 63.65 Favored Glycine 0 C--O 1.227 -0.344 0 C-N-CA 120.972 -0.632 . . . . 63.509999999999998 112.647 -176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 9.4 m -97.55 167.45 11.81 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 107.602 -1.259 . . . . 70.430000000000007 107.602 175.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.606 ' N ' ' HA ' ' A' ' 490' ' ' SER . 38.7 Cg_exo -57.37 -29.84 85.72 Favored 'Trans proline' 0 CA--C 1.586 3.109 0 N-CA-C 120.127 3.087 . . . . 62.409999999999997 120.127 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.606 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 14.5 m -111.61 117.63 33.48 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 128.245 2.618 . . . . 63.509999999999998 108.642 2.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 23.2 m -127.92 104.86 8.04 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.25 -0.648 . . . . 50.25 109.25 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -107.59 118.66 37.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.331 -0.989 . . . . 73.150000000000006 108.331 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 23.6 m -88.25 119.51 28.73 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.814 0.34 . . . . 60.109999999999999 110.47 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 390' ' ' VAL . 68.4 t -104.61 106.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.424 -0.954 . . . . 72.040000000000006 108.424 176.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 27.6 m -95.53 114.23 25.97 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.131 -1.063 . . . . 72.140000000000001 108.131 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.712 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -92.21 117.59 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 C-N-CA 120.326 -0.55 . . . . 70.319999999999993 110.411 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.43 ' O ' HD13 ' A' ' 384' ' ' LEU . 18.3 m-85 -78.42 103.06 8.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 107.621 -1.252 . . . . 63.43 107.621 170.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 385' ' ' GLU . 0.0 OUTLIER -63.06 -30.81 71.89 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.283 -1.781 . . . . 74.209999999999994 109.459 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.9 t70 64.49 18.76 11.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.521 1.528 . . . . 72.140000000000001 110.849 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . 0.4 ' HB2' ' OD2' ' A' ' 498' ' ' ASP . 35.6 m-20 -112.4 -52.12 2.8 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.198 -1.408 . . . . 73.310000000000002 107.198 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.44 ' HB2' ' H ' ' A' ' 451' ' ' GLU . 32.7 m80 -130.32 -14.8 3.75 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.875 -1.057 . . . . 75.420000000000002 111.003 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -67.63 100.52 0.9 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.341 0.867 . . . . 73.299999999999997 113.341 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 77.9 -61.99 3.66 Favored Glycine 0 CA--C 1.497 -1.044 0 CA-C-N 115.733 -0.667 . . . . 75.099999999999994 111.638 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.93 160.92 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 C-N-CA 123.398 0.679 . . . . 71.109999999999999 110.036 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -114.46 124.44 51.92 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.611 -0.436 . . . . 72.329999999999998 111.588 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 18.3 m -136.44 149.37 48.22 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.826 -1.546 . . . . 74.209999999999994 106.826 173.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -75.16 138.77 42.23 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.701 0.4 . . . . 74.310000000000002 111.139 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.66 125.44 31.85 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.873 -0.788 . . . . 65.340000000000003 108.873 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 112.283 0.475 . . . . 64.299999999999997 112.283 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.608 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.634 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.433 ' O ' ' HA3' ' A' ' 398' ' ' GLY . 13.5 p . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 121.159 0.505 . . . . 63.25 109.879 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 479' ' ' HIS . 23.6 m -74.65 135.03 41.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.951 -0.568 . . . . 75.409999999999997 111.22 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -138.39 142.54 39.61 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 122.775 0.43 . . . . 74.329999999999998 110.216 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.645 ' HB ' HD12 ' A' ' 486' ' ' LEU . 44.7 mm -109.38 112.62 41.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.162 -1.421 . . . . 44.340000000000003 107.162 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -145.53 160.44 41.62 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.836 -0.746 . . . . 73.530000000000001 112.609 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.06 142.76 39.69 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.31 -0.626 . . . . 75.129999999999995 109.31 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.21 -48.69 80.66 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.806 0.842 . . . . 74.519999999999996 110.093 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.554 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 16.2 mm100 -106.25 172.4 6.83 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.816 0.817 . . . . 64.030000000000001 110.649 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.11 -34.04 4.99 Favored Glycine 0 C--N 1.284 -2.327 0 CA-C-N 114.129 -1.396 . . . . 62.310000000000002 110.167 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 42.2 m -132.93 128.43 36.47 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.226 -1.028 . . . . 51.210000000000001 108.226 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 37.3 m-85 -112.06 136.84 50.91 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.761 -0.829 . . . . 63.32 108.761 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 495' ' ' THR . 18.8 mt-30 -126.61 142.49 51.52 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.178 -1.045 . . . . 72.219999999999999 108.178 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 19.5 t -153.68 165.1 37.01 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.278 -1.378 . . . . 73.219999999999999 107.278 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.2 OUTLIER -86.18 141.99 28.94 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.584 -0.525 . . . . 74.319999999999993 109.584 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.601 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 24.9 tt0 -55.55 -38.2 69.0 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.378 1.071 . . . . 61.200000000000003 110.128 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 509' ' ' GLU . 41.7 m-80 -84.83 7.03 22.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.04 -0.982 . . . . 71.230000000000004 111.999 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.5 t -90.45 -1.03 57.89 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 122.02 -0.425 . . . . 75.140000000000001 111.213 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.27 4.5 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 64.329999999999998 113.117 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 22.1 p -142.91 174.26 10.82 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.314 0.578 . . . . 71.230000000000004 110.843 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 494' ' ' VAL . 4.6 p -125.61 125.9 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 106.802 -1.555 . . . . 74.230000000000004 106.802 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -98.33 122.69 41.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.996 0.427 . . . . 73.0 110.118 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.546 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.3 mp -112.45 146.42 38.43 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.05 -1.092 . . . . 74.239999999999995 108.05 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.2 m -112.46 128.53 56.35 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.448 0.467 . . . . 74.549999999999997 109.748 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 62.2 mt -100.45 121.74 51.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.17 -1.419 . . . . 74.409999999999997 107.17 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 42.2 mm -99.2 132.3 44.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.754 -0.832 . . . . 64.510000000000005 108.754 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.46 ' HG3' HD13 ' A' ' 374' ' ' ILE . 3.3 ttp85 -107.52 122.83 47.44 Favored 'General case' 0 N--CA 1.406 -2.666 0 C-N-CA 119.702 -0.799 . . . . 75.019999999999996 110.549 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -119.6 157.62 28.05 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.363 -0.835 . . . . 74.439999999999998 108.965 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 371' ' ' VAL . . . 91.39 49.41 3.02 Favored Glycine 0 N--CA 1.418 -2.503 0 O-C-N 124.037 0.836 . . . . 73.25 111.739 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 115.07 115.08 3.01 Favored Glycine 0 N--CA 1.415 -2.726 0 C-N-CA 120.122 -1.037 . . . . 73.239999999999995 112.735 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -100.78 121.37 41.57 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 105.766 -1.939 . . . . 65.299999999999997 105.766 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 403' ' ' ASN . 2.0 pt? -157.08 -173.14 4.31 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 120.609 -0.437 . . . . 65.319999999999993 111.252 -173.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.8 p -102.49 -4.11 25.86 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.53 0.937 . . . . 73.230000000000004 113.53 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.421 ' H ' ' HG ' ' A' ' 401' ' ' LEU . 94.6 m-20 -69.88 138.67 52.69 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.955 -0.466 . . . . 72.140000000000001 110.575 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 50.7 m -93.9 124.55 37.98 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 123.93 0.892 . . . . 62.329999999999998 111.512 -176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 50.6 t -112.26 146.92 16.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.047 -0.524 . . . . 74.310000000000002 109.83 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.604 ' CE1' HG13 ' A' ' 430' ' ' VAL . 3.7 m-85 -120.59 129.14 53.63 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.11 0.564 . . . . 73.239999999999995 110.66 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.81 135.95 52.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.589 -1.263 . . . . 61.439999999999998 107.589 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 18.2 t70 -102.52 148.73 25.18 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.061 -0.718 . . . . 72.439999999999998 109.061 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -143.94 159.36 42.71 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.038 -0.665 . . . . 74.140000000000001 110.868 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -163.17 160.91 24.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.37 -1.715 . . . . 75.299999999999997 106.37 173.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.633 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 34.9 p -96.95 164.81 12.38 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.426 0.631 . . . . 73.120000000000005 110.581 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.4 tp10 -106.53 152.59 23.48 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.214 -1.402 . . . . 64.200000000000003 107.214 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.486 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 4.8 m-20 -60.01 -40.51 89.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.915 0.864 . . . . 71.519999999999996 110.493 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . 0.428 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . 67.69 -86.51 0.16 Allowed Glycine 0 C--N 1.299 -1.495 0 CA-C-N 114.355 -1.293 . . . . 73.209999999999994 112.964 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.1 t -135.71 11.5 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.657 -0.868 . . . . 64.129999999999995 108.657 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -141.3 -162.87 1.45 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.698 -1.593 . . . . 65.329999999999998 106.698 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.486 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 7.3 m120 -129.29 116.35 18.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.583 0.706 . . . . 74.019999999999996 112.141 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -78.03 124.5 28.1 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.903 -1.044 . . . . 64.409999999999997 108.898 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.35 -12.25 30.94 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 109.668 -1.373 . . . . 74.299999999999997 109.668 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 16.3 t -126.87 -54.84 1.4 Allowed 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.917 -0.313 . . . . 74.209999999999994 110.993 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.611 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -73.06 -58.46 3.3 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 122.4 1.095 . . . . 70.430000000000007 108.074 176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.72 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.21 161.78 36.58 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.126 -1.397 . . . . 74.25 107.631 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.6 157.33 32.04 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 123.566 0.541 . . . . 75.099999999999994 109.649 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.633 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 15.6 p90 -90.6 -9.69 46.12 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.215 0.45 . . . . 64.409999999999997 112.215 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.478 HG21 HG22 ' A' ' 442' ' ' VAL . 12.7 t 37.34 68.67 0.27 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.052 1.741 . . . . 72.5 113.728 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -80.3 134.79 36.11 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.023 -1.071 . . . . 70.349999999999994 109.128 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -175.03 -178.54 44.97 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.677 -0.969 . . . . 65.219999999999999 110.677 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 18.3 m -125.73 139.97 53.08 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.789 -1.189 . . . . 73.420000000000002 107.789 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.1 t -99.42 119.43 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.922 -0.769 . . . . 55.420000000000002 108.922 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 406' ' ' PHE . 53.6 t -100.71 106.65 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.575 -0.898 . . . . 54.43 108.575 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 404' ' ' THR . 58.9 m-85 -79.17 95.0 5.49 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.736 -0.665 . . . . 74.349999999999994 110.075 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.443 ' HD2' HG12 ' A' ' 430' ' ' VAL . 5.3 mptp? -69.46 164.58 48.36 Favored Pre-proline 0 C--N 1.316 -0.852 0 O-C-N 123.58 0.55 . . . . 75.219999999999999 111.549 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.41 113.51 1.16 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.739 2.293 . . . . 75.349999999999994 111.797 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.1 67.5 Favored Glycine 0 C--N 1.309 -0.957 0 C-N-CA 120.742 -0.742 . . . . 60.100000000000001 113.399 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -88.25 62.02 6.51 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.558 0.694 . . . . 74.030000000000001 110.691 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 m -61.47 -23.31 65.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.813 -1.085 . . . . 43.539999999999999 110.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -131.38 132.26 44.28 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.58 -1.267 . . . . 75.349999999999994 107.58 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 438' ' ' LYS . 25.8 mmmt -122.32 149.8 43.24 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.484 0.55 . . . . 61.539999999999999 112.484 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -114.51 125.59 53.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.381 -0.827 . . . . 64.230000000000004 111.122 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.8 pt -116.84 146.57 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.043 -1.095 . . . . 62.240000000000002 108.043 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 71.2 mtt180 -126.01 141.45 51.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.374 -0.53 . . . . 74.010000000000005 110.8 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.597 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -106.22 121.2 58.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.442 -0.947 . . . . 54.32 108.442 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -62.07 125.01 35.31 Favored Glycine 0 N--CA 1.435 -1.423 0 O-C-N 124.134 0.896 . . . . 70.109999999999999 112.068 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.437 HD12 HG12 ' A' ' 496' ' ' ILE . 49.5 mm -94.92 135.27 29.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.988 -1.486 . . . . 65.439999999999998 106.988 175.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.9 mt -103.19 151.08 6.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.169 -1.419 . . . . 74.219999999999999 107.169 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.98 101.31 8.57 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 121.3 0.571 . . . . 75.329999999999998 110.536 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 123.15 29.57 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 103.771 -2.677 . . . . 62.32 103.771 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . 0.256 19.6 t70 -119.78 97.58 5.7 Favored 'General case' 0 CA--C 1.459 -2.553 0 C-N-CA 116.393 -2.123 . . . . 74.019999999999996 111.932 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.701 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -121.45 156.49 25.36 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.439 0 CA-C-N 111.282 -2.69 . . . . 74.510000000000005 104.727 -174.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -53.87 115.32 1.95 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.862 -1.903 . . . . 75.450000000000003 105.862 168.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.701 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 33.1 mt-10 -123.38 90.71 3.33 Favored 'General case' 0 CA--C 1.483 -1.605 0 CA-C-O 122.069 0.937 . . . . 42.420000000000002 111.104 -170.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -93.58 104.94 17.03 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.005 -1.452 . . . . 63.039999999999999 107.738 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.308 7.9 p-10 42.28 60.34 2.35 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 125.095 1.497 . . . . 61.340000000000003 112.9 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.564 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 33.1 tt0 -74.45 113.96 12.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.683 -1.599 . . . . 64.420000000000002 106.683 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -137.13 171.35 14.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.57 0.7 . . . . 74.409999999999997 112.729 -174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 28.5 p90 -146.62 -177.78 5.82 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.861 -1.063 . . . . 71.319999999999993 109.665 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 412' ' ' GLU . 26.6 mt -123.32 141.57 51.85 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.015 -1.106 . . . . 63.240000000000002 108.015 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 411' ' ' THR . 25.7 t -110.56 130.85 63.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.199 -1.408 . . . . 53.030000000000001 107.199 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -124.17 134.2 53.37 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.498 0.499 . . . . 63.219999999999999 110.76 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.405 ' HB2' ' HG ' ' A' ' 486' ' ' LEU . 91.0 mt -95.86 140.62 30.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.048 -1.093 . . . . 73.019999999999996 108.048 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 49.1 m -155.3 -177.79 6.8 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.693 -0.854 . . . . 64.239999999999995 108.693 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 6.9 t30 51.11 83.84 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.651 1.18 . . . . 54.509999999999998 111.599 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.61 126.4 43.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.581 -0.848 . . . . 53.32 109.178 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -133.72 155.9 48.92 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.049 -0.523 . . . . 64.239999999999995 110.123 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.44 133.83 67.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.351 -0.981 . . . . 72.230000000000004 108.351 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.488 ' HB2' ' CE1' ' A' ' 406' ' ' PHE . 35.1 t -76.99 136.67 38.73 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.021 0.439 . . . . 75.209999999999994 110.534 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 470' ' ' SER . 5.4 m -65.41 116.35 6.62 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.057 -0.974 . . . . 50.009999999999998 109.595 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -77.54 -68.59 0.61 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.824 1.046 . . . . 71.239999999999995 113.824 -176.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -103.83 -57.78 1.98 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.558 0.694 . . . . 64.349999999999994 109.313 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 467' ' ' SER . 47.0 t -90.88 169.79 10.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.956 -1.127 . . . . 71.230000000000004 107.956 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.64 -22.35 62.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.009 0.433 . . . . 74.140000000000001 110.011 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.08 98.83 9.51 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.59 -0.522 . . . . 74.230000000000004 109.59 172.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -131.29 41.4 1.52 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.507 -1.037 . . . . 73.109999999999999 110.507 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 64.9 mt -92.73 102.74 13.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.125 -1.065 . . . . 72.349999999999994 108.125 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 475' ' ' LEU . 1.3 pt? -104.45 90.62 3.59 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.719 0.771 . . . . 74.030000000000001 112.614 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.48 69.43 10.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 122.157 0.979 . . . . 73.040000000000006 109.807 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -104.8 -69.98 0.79 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.515 -1.221 . . . . 45.32 109.935 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -134.5 15.65 3.71 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.713 0.768 . . . . 71.340000000000003 109.191 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 372' ' ' SER . 28.6 m-70 -110.16 169.03 9.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.865 -0.607 . . . . 62.109999999999999 110.512 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 22.8 m -77.34 138.46 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.636 -0.505 . . . . 62.539999999999999 109.636 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 10.8 p 170.63 -87.32 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.488 1.515 . . . . 75.030000000000001 108.847 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -127.42 18.54 6.93 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.69 -1.226 . . . . 74.510000000000005 107.69 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -119.38 -64.1 1.31 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.747 -2.316 . . . . 74.540000000000006 104.747 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -113.62 161.41 17.47 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 114.639 -1.164 . . . . 33.109999999999999 108.753 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 83.7 m -121.63 -168.99 1.79 Allowed 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.176 -1.416 . . . . 73.510000000000005 107.176 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.645 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.4 mm? -70.63 152.61 43.71 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.333 0.515 . . . . 74.439999999999998 110.189 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -75.72 -30.4 57.98 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 111.257 -0.737 . . . . 71.530000000000001 111.257 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.534 ' C ' ' HA ' ' A' ' 490' ' ' SER . 12.9 m -78.68 166.25 43.92 Favored Pre-proline 0 N--CA 1.429 -1.497 0 N-CA-C 108.733 -0.839 . . . . 62.200000000000003 108.733 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.61 ' N ' ' HA ' ' A' ' 490' ' ' SER . 34.0 Cg_exo -58.46 -23.81 65.89 Favored 'Trans proline' 0 CA--C 1.59 3.309 0 N-CA-C 120.582 3.262 . . . . 53.119999999999997 120.582 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.61 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 35.5 t -105.29 114.28 28.36 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 123.184 2.72 . . . . 73.209999999999994 108.168 1.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.486 ' H ' ' HD2' ' A' ' 489' ' ' PRO . 63.4 m -143.75 128.02 17.76 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.876 -0.602 . . . . 60.439999999999998 110.554 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -126.82 135.4 50.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.118 -1.438 . . . . 74.099999999999994 107.118 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 88.1 m -96.12 129.99 43.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.656 -0.498 . . . . 75.530000000000001 109.656 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 390' ' ' VAL . 69.0 t -115.31 109.37 28.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.587 -0.894 . . . . 74.140000000000001 108.587 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 35.6 m -101.55 117.12 34.27 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.457 -0.942 . . . . 74.540000000000006 108.457 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.72 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.4 125.08 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.267 0 CA-C-N 115.957 -0.565 . . . . 62.130000000000003 109.693 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.489 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.0 m-85 -84.69 104.26 14.51 Favored 'General case' 0 N--CA 1.397 -3.112 0 CA-C-O 121.799 0.809 . . . . 74.310000000000002 111.693 175.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.619 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 6.2 t70 -49.01 -58.52 4.76 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.721 -2.491 . . . . 73.349999999999994 109.475 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.551 ' HA ' ' CA ' ' A' ' 503' ' ' GLY . 11.8 t0 68.99 7.92 6.53 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 125.852 1.661 . . . . 73.530000000000001 111.043 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -93.52 -56.38 2.94 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.702 -1.221 . . . . 72.030000000000001 107.702 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -104.45 -54.24 2.56 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.606 -1.179 . . . . 74.140000000000001 108.412 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -108.39 108.63 19.67 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 108.017 -1.105 . . . . 74.230000000000004 108.017 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 499' ' ' ASP . . . -139.72 179.93 18.34 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 118.718 -1.706 . . . . 72.200000000000003 115.65 -173.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.62 -4.63 3.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 113.46 -1.37 . . . . 74.25 108.96 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 72.82 83.84 0.12 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 125.464 1.506 . . . . 75.439999999999998 111.816 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 42.0 m -150.43 65.75 0.95 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.242 -1.392 . . . . 75.439999999999998 107.242 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.21 83.25 6.11 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.668 -1.151 . . . . 75.0 111.205 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.97 129.07 22.07 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.658 -1.156 . . . . 72.239999999999995 108.442 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 386' ' ' ASN . 43.6 tt0 . . . . . 0 C--N 1.291 -1.977 0 CA-C-N 115.634 -0.712 . . . . 72.540000000000006 110.293 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.619 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.633 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 121.951 0.881 . . . . 64.230000000000004 109.413 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 480' ' ' VAL . 49.3 m -77.3 104.53 7.87 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.03 -0.986 . . . . 44.409999999999997 109.618 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.16 140.85 29.07 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-O 121.545 0.688 . . . . 72.109999999999999 111.293 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.584 ' HB ' HD12 ' A' ' 486' ' ' LEU . 21.8 mm -104.73 121.45 56.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.725 -1.58 . . . . 62.109999999999999 108.41 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -157.51 155.16 29.83 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 117.612 0.187 . . . . 64.109999999999999 110.658 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -73.87 152.44 40.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.841 0.353 . . . . 50.140000000000001 110.981 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.02 -30.1 70.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.649 -0.705 . . . . 74.019999999999996 110.768 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -127.71 176.93 7.15 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.76 -0.654 . . . . 63.240000000000002 111.464 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.94 -36.38 3.96 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.941 -0.863 . . . . 74.530000000000001 110.941 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 49.9 m -129.46 131.81 46.8 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.338 -0.615 . . . . 73.030000000000001 109.338 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 49.9 m-85 -114.48 135.97 53.53 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.316 -0.994 . . . . 65.310000000000002 108.316 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.411 ' HG2' ' HB ' ' A' ' 495' ' ' THR . 18.1 mt-30 -125.54 138.91 53.97 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.919 -0.771 . . . . 72.409999999999997 108.919 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 26.2 p -145.82 155.37 42.87 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.525 -0.546 . . . . 75.239999999999995 109.525 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -74.67 141.98 44.52 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.243 -0.651 . . . . 51.030000000000001 109.243 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.64 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 20.9 tt0 -55.41 -45.76 76.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.927 0.87 . . . . 72.209999999999994 109.165 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.414 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.6 p-10 -82.37 21.54 0.93 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.968 -1.015 . . . . 71.439999999999998 112.813 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.28 0.64 46.03 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 121.621 -0.674 . . . . 74.120000000000005 112.035 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 87.82 -71.63 2.57 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.497 -0.859 . . . . 23.329999999999998 112.794 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.571 HG22 ' HA2' ' A' ' 443' ' ' GLY . 17.6 p -137.25 159.4 42.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.766 0.283 . . . . 70.420000000000002 110.784 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.647 ' HB ' ' SG ' ' A' ' 383' ' ' CYS . 5.4 p -112.59 125.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.524 -1.287 . . . . 61.219999999999999 107.524 172.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.55 127.8 43.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.149 -0.478 . . . . 73.200000000000003 110.074 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.3 mp -121.22 138.38 54.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.922 -1.51 . . . . 74.010000000000005 106.922 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.4 m -109.8 127.29 54.56 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.408 0.443 . . . . 71.430000000000007 110.27 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.22 125.5 47.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.908 -1.145 . . . . 72.430000000000007 107.908 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.503 HG22 ' HG2' ' A' ' 397' ' ' ARG . 30.5 mm -102.38 140.95 19.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 107.68 -1.23 . . . . 73.430000000000007 107.68 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.502 HH12 HD23 ' A' ' 401' ' ' LEU . 47.5 ttp85 -120.89 109.29 14.94 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.789 -0.449 . . . . 74.430000000000007 109.789 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.503 ' HG2' HG22 ' A' ' 395' ' ' ILE . 31.7 mmm180 -128.75 158.86 37.46 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.861 -0.608 . . . . 73.209999999999994 110.528 -175.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 116.79 -25.07 9.18 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.087 -1.605 . . . . 71.140000000000001 109.087 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 158.4 -172.63 35.41 Favored Glycine 0 N--CA 1.404 -3.493 0 N-CA-C 108.175 -1.97 . . . . 75.530000000000001 108.175 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.404 ' HA ' ' NH1' ' A' ' 396' ' ' ARG . 2.5 p-10 -146.55 171.98 14.26 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.545 -0.909 . . . . 72.0 108.545 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.502 HD23 HH12 ' A' ' 396' ' ' ARG . 2.3 pt? -166.04 151.18 8.47 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.575 -2.009 . . . . 73.319999999999993 105.575 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 36.6 p -90.32 3.59 53.23 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.682 0.754 . . . . 73.340000000000003 110.558 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -74.45 151.28 39.62 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 105.7 -1.963 . . . . 51.030000000000001 105.7 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 466' ' ' SER . 4.1 m -92.83 119.23 31.96 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-O 121.408 0.623 . . . . 64.310000000000002 111.443 -171.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.66 139.55 21.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.389 -0.823 . . . . 72.430000000000007 109.12 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 3.0 m-85 -121.81 123.23 41.3 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 123.667 0.787 . . . . 73.530000000000001 110.048 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.78 128.69 72.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.292 -1.373 . . . . 74.519999999999996 107.292 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 15.7 t70 -98.73 140.33 33.09 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.092 -0.38 . . . . 74.420000000000002 110.434 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -134.85 162.73 31.57 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.683 0.278 . . . . 63.32 110.514 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 42.9 ttt180 -166.82 162.71 16.18 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.591 -1.633 . . . . 55.130000000000003 106.591 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.613 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 59.8 p -95.6 172.12 8.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.65 -0.87 . . . . 71.230000000000004 108.65 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.34 145.92 50.63 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.7 -0.482 . . . . 74.099999999999994 109.7 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.1 4.2 5.9 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.124 1.37 . . . . 73.150000000000006 113.697 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -17.97 -88.92 0.01 OUTLIER Glycine 0 N--CA 1.479 1.541 0 C-N-CA 126.141 1.829 . . . . 71.209999999999994 117.113 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 13.9 t -109.79 5.31 22.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 117.89 0.845 . . . . 64.150000000000006 110.532 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -155.73 152.11 28.15 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.204 -1.776 . . . . 75.420000000000002 106.204 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.08 127.98 53.97 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.202 -1.399 . . . . 64.25 113.205 -164.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -69.32 126.36 29.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.289 -0.869 . . . . 61.240000000000002 110.181 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 99.62 -25.03 29.85 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.769 -0.932 . . . . 72.420000000000002 110.769 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.4 m -100.27 -57.04 2.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.98 -0.748 . . . . 64.209999999999994 108.98 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.58 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.2 m-20 -84.91 -58.45 2.7 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-O 121.364 0.602 . . . . 55.350000000000001 110.499 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.555 ' CZ ' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -136.19 166.59 23.05 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 108.915 -0.772 . . . . 74.420000000000002 108.915 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -68.43 155.69 39.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.987 0.805 . . . . 73.340000000000003 109.716 -176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.613 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 3.2 p90 -91.04 -17.9 25.47 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.971 -0.559 . . . . 73.340000000000003 111.709 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.546 HG21 HG22 ' A' ' 442' ' ' VAL . 9.2 t 34.07 59.2 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 125.144 1.527 . . . . 75.310000000000002 113.024 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 12.1 pt-20 -79.88 119.3 22.56 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.421 -0.809 . . . . 72.409999999999997 109.656 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -165.74 -174.13 34.95 Favored Glycine 0 N--CA 1.419 -2.455 0 C-N-CA 120.552 -0.832 . . . . 70.5 111.426 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 4.6 m -128.8 138.56 52.14 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.321 -0.992 . . . . 74.409999999999997 108.321 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 49.1 t -95.64 123.37 47.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.971 -0.752 . . . . 62.450000000000003 108.971 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 87.9 t -100.58 107.33 20.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.874 -1.057 . . . . 72.409999999999997 109.147 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -82.52 94.37 7.46 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.071 -0.513 . . . . 63.020000000000003 110.463 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.62 160.49 58.78 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.172 -0.922 . . . . 44.030000000000001 110.476 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.449 ' HG3' ' O ' ' A' ' 402' ' ' THR . 35.2 Cg_exo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.799 2.333 . . . . 72.540000000000006 111.183 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 99.34 -0.86 57.16 Favored Glycine 0 C--N 1.31 -0.875 0 C-N-CA 120.972 -0.632 . . . . 72.040000000000006 113.831 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.01 -66.66 0.9 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 117.172 0.486 . . . . 74.310000000000002 110.756 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 m 71.64 -49.58 0.69 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.123 0.969 . . . . 70.540000000000006 110.571 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -107.85 136.05 48.22 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.235 -1.394 . . . . 74.430000000000007 107.235 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -129.32 140.17 51.49 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.979 0.419 . . . . 74.409999999999997 110.993 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.58 139.6 44.39 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.564 -0.743 . . . . 72.230000000000004 110.739 -175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.4 pt -121.71 150.44 24.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.887 -1.153 . . . . 72.219999999999999 107.887 173.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.2 mtt180 -131.27 139.37 49.61 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 110.106 -0.331 . . . . 72.519999999999996 110.106 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.546 HG22 HG21 ' A' ' 425' ' ' THR . 52.2 t -110.77 122.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.579 -1.267 . . . . 75.219999999999999 107.579 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.19 138.7 26.99 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.498 -0.858 . . . . 63.299999999999997 111.507 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 38.8 mm -96.6 132.61 40.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 107.089 -1.449 . . . . 70.200000000000003 107.089 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -95.7 147.08 6.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.358 -1.719 . . . . 65.040000000000006 106.358 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.18 88.0 3.05 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.312 0.577 . . . . 63.530000000000001 111.694 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.75 113.29 22.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.587 -2.375 . . . . 72.030000000000001 104.587 172.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.639 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 22.7 t70 -120.29 94.85 4.51 Favored 'General case' 0 C--N 1.274 -2.717 0 C-N-CA 116.917 -1.913 . . . . 54.310000000000002 110.547 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.68 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.4 mm -121.34 156.64 25.12 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.042 0 CA-C-N 111.172 -2.74 . . . . 73.129999999999995 105.109 -174.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -53.13 114.78 1.58 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.139 -1.424 . . . . 71.310000000000002 107.578 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 37.1 mt-10 -129.19 123.85 33.09 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-N 115.691 -0.686 . . . . 63.43 110.202 -170.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 31.2 mt-10 -134.06 105.95 6.97 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.893 -1.049 . . . . 51.340000000000003 109.302 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.03 61.6 3.13 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 124.376 1.048 . . . . 65.329999999999998 113.316 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.85 124.27 39.79 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.509 -0.876 . . . . 73.5 111.125 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.6 171.85 8.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.822 -1.081 . . . . 72.409999999999997 108.37 -175.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.567 ' CE2' HD11 ' A' ' 496' ' ' ILE . 13.8 p90 -147.73 171.98 14.81 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.972 -1.122 . . . . 73.030000000000001 107.972 168.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 55.9 mt -117.56 142.85 46.71 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.908 -0.775 . . . . 74.420000000000002 108.908 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.28 122.23 66.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.753 -1.573 . . . . 44.210000000000001 106.753 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 490' ' ' SER . 92.9 m-70 -111.37 139.55 46.69 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.349 0.405 . . . . 75.230000000000004 110.322 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.9 mt -101.25 128.19 47.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.869 -1.16 . . . . 71.340000000000003 107.869 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.2 m -151.05 -175.3 5.1 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.668 -0.864 . . . . 61.340000000000003 108.668 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.2 t30 50.86 83.41 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.694 1.198 . . . . 71.120000000000005 111.248 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.27 119.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.774 -0.825 . . . . 54.100000000000001 108.774 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -129.14 145.41 51.31 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.794 -0.817 . . . . 32.200000000000003 108.794 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.08 134.55 60.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.372 -1.344 . . . . 72.140000000000001 107.372 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.484 ' HB3' ' HB ' ' A' ' 404' ' ' THR . 34.1 t -74.41 109.98 8.34 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 109.408 -0.59 . . . . 74.409999999999997 109.408 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 14.5 m -91.24 139.38 30.8 Favored 'General case' 0 N--CA 1.409 -2.506 0 N-CA-C 106.353 -1.721 . . . . 71.5 106.353 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.76 157.68 35.87 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.459 -0.496 . . . . 74.319999999999993 110.596 -176.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.15 -6.5 53.13 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.269 0.556 . . . . 74.420000000000002 110.742 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.9 t -80.78 163.08 23.74 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.612 -1.255 . . . . 72.109999999999999 107.612 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -61.72 -55.9 25.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.743 0.306 . . . . 73.230000000000004 111.383 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -88.9 86.67 7.0 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 120.527 -0.469 . . . . 71.400000000000006 110.069 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -98.2 83.55 0.67 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.724 -0.951 . . . . 32.5 110.724 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.65 126.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 123.074 0.55 . . . . 72.430000000000007 110.738 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 84.5 mt -109.65 103.25 12.06 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 107.435 -1.32 . . . . 70.319999999999993 107.435 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . 0.505 ' O ' ' HD2' ' A' ' 479' ' ' HIS . 9.6 mp0 -59.39 125.06 22.1 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.444 -0.947 . . . . 74.319999999999993 108.444 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -71.08 38.56 0.05 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.485 1.114 . . . . 62.140000000000001 112.485 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 476' ' ' GLU . 17.6 m120 -110.15 17.94 20.48 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.906 -1.146 . . . . 64.439999999999998 107.906 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.505 ' HD2' ' O ' ' A' ' 476' ' ' GLU . 30.1 p80 -112.09 175.34 5.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.257 -0.883 . . . . 73.319999999999993 110.433 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 372' ' ' SER . 16.2 m -101.86 159.04 4.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.855 -0.795 . . . . 72.040000000000006 108.855 173.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 35.8 t -172.4 -89.65 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.344 0.658 . . . . 52.030000000000001 109.89 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -122.3 -11.22 8.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.975 0.417 . . . . 51.329999999999998 111.405 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -94.88 -60.76 1.62 Allowed 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 104.928 -2.249 . . . . 73.430000000000007 104.928 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -97.94 128.35 44.46 Favored 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.583 -1.265 . . . . 71.349999999999994 107.583 172.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 83.7 m -106.75 -169.67 1.59 Allowed 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 107.819 -1.178 . . . . 73.200000000000003 107.819 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.584 HD12 ' HB ' ' A' ' 374' ' ' ILE . 0.6 OUTLIER -70.13 163.9 25.29 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.197 -1.038 . . . . 72.439999999999998 108.197 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -82.31 25.04 4.49 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 120.896 -0.668 . . . . 70.439999999999998 113.422 -173.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 34.5 m -155.31 177.1 2.17 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.791 -1.189 . . . . 62.149999999999999 107.791 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.575 ' N ' ' HA ' ' A' ' 490' ' ' SER . 10.4 Cg_exo -69.91 -22.3 31.59 Favored 'Trans proline' 0 CA--C 1.581 2.864 0 N-CA-C 119.395 2.806 . . . . 54.350000000000001 119.395 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.575 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 16.1 m -118.93 123.73 45.33 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 129.544 3.138 . . . . 62.530000000000001 106.528 1.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 65.4 m -133.85 106.9 7.55 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.841 0.353 . . . . 63.219999999999999 111.939 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.45 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.848 -1.167 . . . . 64.129999999999995 107.848 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 30.7 m -103.37 128.62 50.42 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.57 -0.452 . . . . 64.129999999999995 110.298 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.471 HG11 HG11 ' A' ' 390' ' ' VAL . 69.9 t -113.36 119.19 60.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.255 -1.017 . . . . 74.340000000000003 108.255 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.411 ' HB ' ' HG2' ' A' ' 382' ' ' GLN . 7.3 m -107.75 118.2 36.11 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.366 -0.976 . . . . 71.129999999999995 108.366 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.567 HD11 ' CE2' ' A' ' 456' ' ' PHE . 4.9 mp -97.74 120.75 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.596 0.712 . . . . 75.420000000000002 110.067 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.446 ' O ' HD13 ' A' ' 384' ' ' LEU 0.265 29.3 m-85 -88.0 104.46 16.67 Favored 'General case' 0 N--CA 1.388 -3.537 0 CA-C-O 122.355 1.074 . . . . 72.349999999999994 113.262 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.636 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 10.5 t70 -51.5 -55.89 16.43 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 111.748 -2.478 . . . . 71.129999999999995 109.064 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.431 ' HA ' ' CA ' ' A' ' 503' ' ' GLY . 32.5 t70 64.98 15.98 10.29 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 125.633 1.573 . . . . 53.200000000000003 111.135 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -97.1 -58.61 1.98 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.927 -1.509 . . . . 74.040000000000006 106.927 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -97.01 -51.15 4.34 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.748 -1.204 . . . . 72.329999999999998 107.748 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 452' ' ' GLU . . . -121.45 124.07 43.58 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.807 -0.633 . . . . 72.540000000000006 109.835 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 499' ' ' ASP . . . -138.29 -158.06 7.64 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.31 -0.947 . . . . 61.210000000000001 113.012 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.2 pp -150.95 176.5 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 124.142 0.977 . . . . 73.120000000000005 110.272 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -71.53 107.32 4.36 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.254 -1.758 . . . . 72.150000000000006 106.254 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 8.2 m -83.35 106.85 15.45 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 116.118 -0.492 . . . . 75.109999999999999 111.767 -172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -79.64 103.08 9.31 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 104.483 -2.414 . . . . 65.040000000000006 104.483 170.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -50.7 132.01 25.93 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 124.315 1.046 . . . . 75.349999999999994 113.36 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 115.145 -0.934 . . . . 72.319999999999993 110.468 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.64 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.593 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 C--O 1.241 0.638 0 N-CA-C 109.509 -0.552 . . . . 71.209999999999994 109.509 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.409 ' HA ' ' HA3' ' A' ' 398' ' ' GLY . 19.5 m -76.01 123.97 26.62 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 108.328 -0.989 . . . . 63.43 108.328 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -112.55 155.89 23.58 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 115.831 -0.622 . . . . 64.129999999999995 111.12 -172.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.621 ' HB ' HD12 ' A' ' 486' ' ' LEU . 31.8 mm -114.93 119.14 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.282 -1.747 . . . . 72.209999999999994 106.282 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -155.85 164.42 38.54 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.934 -0.306 . . . . 74.439999999999998 111.024 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -82.35 153.9 25.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.616 -0.513 . . . . 75.120000000000005 109.616 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -62.57 -38.95 92.08 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.226 -0.657 . . . . 75.510000000000005 109.226 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -125.37 175.66 7.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.967 -1.015 . . . . 64.030000000000001 112.089 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -102.02 -21.58 10.86 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 115.05 -0.977 . . . . 71.420000000000002 111.657 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 30.1 m -135.85 132.4 36.56 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.67 -0.493 . . . . 64.239999999999995 109.67 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 46.1 m-85 -122.92 136.79 54.99 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.25 -1.019 . . . . 65.299999999999997 108.25 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 495' ' ' THR . 75.1 mt-30 -130.02 143.32 50.73 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.241 -1.022 . . . . 73.150000000000006 108.241 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 33.9 t -153.34 165.27 36.28 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.428 -0.952 . . . . 71.099999999999994 108.428 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.24 143.0 30.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 122.589 0.356 . . . . 60.409999999999997 111.23 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.624 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 12.0 tt0 -59.72 -37.27 78.43 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.876 -0.602 . . . . 71.239999999999995 109.672 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -83.44 8.31 14.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.968 -0.56 . . . . 73.120000000000005 112.371 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 32.2 t -89.91 -11.96 40.29 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 119.962 -0.695 . . . . 51.240000000000002 110.924 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.38 -53.61 2.43 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.628 -0.796 . . . . 75.140000000000001 113.708 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 7.8 p -141.37 164.93 28.91 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.803 0.301 . . . . 64.219999999999999 110.697 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.645 HG11 HG11 ' A' ' 494' ' ' VAL . 4.8 p -120.1 127.88 75.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.103 -1.073 . . . . 72.109999999999999 108.103 172.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -97.99 124.2 42.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 71.329999999999998 110.799 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.448 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.1 mp -116.54 146.74 42.41 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.142 -1.429 . . . . 75.310000000000002 107.142 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 21.6 m -116.59 129.22 56.04 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 120.309 -0.556 . . . . 43.130000000000003 110.624 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.414 ' CG2' ' HZ ' ' A' ' 431' ' ' PHE . 73.1 mt -98.41 120.54 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 107.675 -1.232 . . . . 74.420000000000002 107.675 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 397' ' ' ARG . 49.3 mm -98.62 129.01 49.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 107.436 -1.32 . . . . 73.430000000000007 107.436 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -108.64 107.7 18.29 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.464 -0.939 . . . . 72.450000000000003 108.464 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.508 ' HG3' HG22 ' A' ' 395' ' ' ILE . 59.2 mtt180 -123.84 157.74 33.43 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.041 0.448 . . . . 74.049999999999997 111.997 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 372' ' ' SER . . . 124.93 -46.78 1.06 Allowed Glycine 0 CA--C 1.49 -1.5 0 N-CA-C 108.735 -1.746 . . . . 73.120000000000005 108.735 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -166.18 162.72 36.27 Favored Glycine 0 N--CA 1.415 -2.713 0 N-CA-C 107.208 -2.357 . . . . 62.409999999999997 107.208 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -146.18 121.55 10.29 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 117.842 0.821 . . . . 73.439999999999998 109.963 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -147.25 172.57 13.63 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.909 -1.041 . . . . 74.319999999999993 109.168 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 24.3 p -71.08 5.23 2.18 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.625 0.972 . . . . 73.540000000000006 113.625 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.48 HD22 ' CD ' ' A' ' 476' ' ' GLU . 6.7 m-20 -67.24 132.34 47.56 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.67 0.748 . . . . 64.219999999999999 111.376 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.706 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 19.3 m -92.99 112.38 24.33 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.924 -1.489 . . . . 74.030000000000001 110.102 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.61 146.29 16.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.198 -1.365 . . . . 73.540000000000006 107.857 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 33.6 m-85 -126.4 127.32 45.29 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.125 -0.694 . . . . 65.409999999999997 109.125 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.55 129.75 68.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.695 -1.224 . . . . 64.129999999999995 107.695 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 13.7 t70 -96.99 140.6 31.28 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.606 0.241 . . . . 60.409999999999997 110.588 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -137.1 152.34 49.9 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.751 -0.379 . . . . 72.519999999999996 111.645 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.89 172.86 14.98 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 125.265 1.426 . . . . 74.030000000000001 108.078 174.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 44.9 p -106.44 161.03 14.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.971 -0.381 . . . . 65.430000000000007 109.971 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.2 tp10 -107.65 155.29 20.31 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 122.704 0.401 . . . . 43.310000000000002 110.151 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 417' ' ' ASN . 6.8 m-20 -84.63 1.87 44.21 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 124.021 0.928 . . . . 72.219999999999999 112.333 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -11.06 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.499 2.836 0 N-CA-C 117.413 1.725 . . . . 73.25 117.413 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 14.8 t -126.93 17.71 7.28 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 117.73 0.765 . . . . 63.009999999999998 110.445 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -149.88 -162.81 1.63 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.155 -0.475 . . . . 60.200000000000003 110.164 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.417 ' HA ' ' OD2' ' A' ' 413' ' ' ASP . 3.6 m120 -135.73 119.72 17.52 Favored 'General case' 0 CA--C 1.485 -1.546 0 CA-C-O 121.344 0.592 . . . . 74.299999999999997 111.215 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.91 124.48 27.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.447 -0.946 . . . . 74.310000000000002 108.447 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.25 -15.28 43.2 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 110.663 -0.975 . . . . 53.109999999999999 110.663 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 18.3 t -114.31 -50.55 2.8 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.17 -0.678 . . . . 54.409999999999997 109.17 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.586 ' OD1' 'CA ' ' A' ' 650' ' ' ' CA' . 20.6 m-20 -85.66 -59.66 2.25 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 122.307 1.051 . . . . 63.43 110.354 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.683 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -138.83 162.83 33.82 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.826 -1.079 . . . . 73.450000000000003 108.894 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.558 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.9 tt0 -73.82 156.87 37.33 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 124.165 0.915 . . . . 73.140000000000001 110.788 -173.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.642 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.2 p90 -89.97 -14.33 34.28 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.175 -0.92 . . . . 74.140000000000001 111.448 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.558 ' H ' ' HG2' ' A' ' 423' ' ' GLU . 15.2 t 33.24 66.81 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.455 1.902 . . . . 74.040000000000006 113.127 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.23 111.77 15.79 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.049 0.928 . . . . 72.140000000000001 109.592 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -151.76 173.93 30.94 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 120.061 -1.066 . . . . 22.350000000000001 111.61 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 9.2 m -119.39 136.46 54.27 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 106.913 -1.514 . . . . 50.229999999999997 106.913 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 32.7 t -95.74 120.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.24 -1.022 . . . . 64.239999999999995 108.24 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.68 106.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 115.255 -0.884 . . . . 75.400000000000006 109.037 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.3 m-85 -82.03 94.21 7.13 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.153 -0.684 . . . . 72.140000000000001 109.153 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.05 167.34 30.03 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 115.048 -0.978 . . . . 63.149999999999999 110.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.79 110.52 0.64 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.497 2.131 . . . . 64.129999999999995 111.569 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 113.56 -18.7 19.95 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.716 -0.675 . . . . 72.420000000000002 112.078 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -83.92 62.37 6.95 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.305 0.574 . . . . 75.420000000000002 111.974 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 m -65.64 -20.94 66.5 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.857 0.836 . . . . 53.32 109.486 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -132.01 135.07 46.26 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.066 -1.457 . . . . 64.299999999999997 107.066 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -122.99 147.8 46.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 111.565 0.209 . . . . 74.209999999999994 111.565 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -118.41 131.4 56.28 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.299 -0.63 . . . . 61.210000000000001 109.299 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 46.7 pt -120.96 149.4 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.099 -1.074 . . . . 74.310000000000002 108.099 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 91.1 mtt180 -129.49 138.53 51.44 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-O 120.899 0.381 . . . . 74.019999999999996 110.854 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.609 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 63.7 t -104.92 126.57 59.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.667 -0.864 . . . . 74.129999999999995 108.667 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -68.29 127.31 23.79 Favored Glycine 0 N--CA 1.433 -1.542 0 O-C-N 124.115 0.884 . . . . 73.25 111.953 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.456 HD12 HG12 ' A' ' 496' ' ' ILE . 43.5 mm -94.6 134.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 106.07 -1.826 . . . . 72.140000000000001 106.07 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 71.3 mt -98.57 144.99 10.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 106.982 -1.488 . . . . 74.400000000000006 106.982 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -78.2 88.3 4.28 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.667 -0.813 . . . . 72.519999999999996 111.632 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.74 97.83 5.82 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.875 -2.269 . . . . 52.210000000000001 104.875 169.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.59 87.05 2.61 Favored 'General case' 0 CA--C 1.46 -2.511 0 CA-C-O 122.905 1.336 . . . . 74.099999999999994 109.856 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.425 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 26.5 mm -116.1 154.48 17.61 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.948 0 CA-C-N 111.688 -2.506 . . . . 75.319999999999993 104.575 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -63.97 114.82 4.35 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.386 -1.726 . . . . 71.439999999999998 108.62 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.647 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 19.5 mt-10 -135.49 151.93 50.85 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.646 -1.161 . . . . 62.219999999999999 108.485 -170.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 502' ' ' ALA . 31.4 mt-10 -131.55 102.1 5.78 Favored 'General case' 0 N--CA 1.411 -2.393 0 C-N-CA 119.583 -0.847 . . . . 72.319999999999993 111.165 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 14.3 t70 63.86 61.55 0.95 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 124.704 1.252 . . . . 54.409999999999997 111.018 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -73.41 130.77 40.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.965 -0.562 . . . . 74.200000000000003 109.576 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.94 161.86 39.11 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.885 -0.726 . . . . 72.549999999999997 109.831 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.609 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 25.1 p90 -140.91 -178.99 5.81 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.98 -0.555 . . . . 70.310000000000002 109.711 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 50.3 mt -120.92 138.9 53.88 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.359 -1.349 . . . . 75.239999999999995 107.359 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 491' ' ' THR . 61.1 t -106.33 121.95 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.069 -1.456 . . . . 75.310000000000002 107.069 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . 0.42 ' NE2' ' HB2' ' A' ' 412' ' ' GLU . 63.5 m-70 -110.68 128.36 55.67 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.503 0.502 . . . . 73.400000000000006 111.023 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.99 131.7 42.09 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.031 -1.1 . . . . 74.239999999999995 108.031 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 12.4 p -155.7 -176.81 6.15 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.843 -0.799 . . . . 51.140000000000001 108.843 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 2.4 t-20 49.67 81.96 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.176 0.922 . . . . 70.129999999999995 112.694 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.516 HG11 HG23 ' A' ' 480' ' ' VAL . 61.8 t -82.12 128.36 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 115.332 -0.849 . . . . 64.129999999999995 108.772 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 72.0 tttt -133.32 148.08 51.89 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 106.381 -1.711 . . . . 65.209999999999994 106.381 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 474' ' ' ILE . 91.4 t -130.03 154.0 39.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 N-CA-C 107.97 -1.122 . . . . 73.209999999999994 107.97 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 32.7 t -74.57 111.85 10.17 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.382 -0.97 . . . . 62.299999999999997 108.382 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . 0.485 ' HA ' ' HB ' ' A' ' 474' ' ' ILE . 18.7 m -76.1 111.24 11.3 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 116.273 -0.422 . . . . 73.409999999999997 110.674 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -50.4 -50.16 52.45 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.844 1.053 . . . . 74.219999999999999 113.844 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -95.74 -18.99 20.02 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.862 -0.735 . . . . 74.349999999999994 111.087 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 49.8 m 62.38 23.24 13.76 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.887 0.875 . . . . 75.219999999999999 111.041 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -67.94 -45.27 74.73 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.282 -1.377 . . . . 71.439999999999998 107.282 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -148.58 -166.49 2.56 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 104.421 -2.437 . . . . 71.219999999999999 104.421 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -84.09 134.13 12.46 Favored Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 110.914 -0.874 . . . . 72.120000000000005 110.914 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.598 ' O ' ' HB ' ' A' ' 465' ' ' VAL . 28.0 mm -107.47 132.56 54.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.477 -0.564 . . . . 62.140000000000001 109.477 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 99.0 mt -125.24 145.21 50.09 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.764 -1.569 . . . . 74.109999999999999 106.764 172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . 0.491 ' HG3' HG11 ' A' ' 465' ' ' VAL . 50.7 mt-10 -91.07 152.59 20.57 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.559 0.578 . . . . 74.109999999999999 112.559 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -99.26 -18.58 17.52 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.725 -1.125 . . . . 62.030000000000001 108.3 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -75.82 -53.41 8.51 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.77 -1.196 . . . . 71.319999999999993 107.77 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -89.72 -171.83 3.33 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.044 -0.98 . . . . 74.319999999999993 109.4 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.516 HG23 HG11 ' A' ' 463' ' ' VAL . 34.0 m -77.38 168.5 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 115.603 -0.726 . . . . 75.230000000000004 111.164 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 33.2 p -153.83 -149.5 0.29 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.434 -0.58 . . . . 34.109999999999999 109.434 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -100.01 16.7 23.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.047 -1.094 . . . . 73.400000000000006 108.047 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.68 -55.42 1.52 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 105.84 -1.911 . . . . 70.450000000000003 105.84 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.61 131.86 36.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.646 -1.242 . . . . 70.319999999999993 107.646 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.8 -178.46 3.66 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 116.032 -0.531 . . . . 75.25 110.521 -172.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.646 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 0.5 OUTLIER -74.52 -167.17 0.51 Allowed 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 109.807 -0.442 . . . . 54.520000000000003 109.807 -176.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -71.97 -130.15 0.11 Allowed Glycine 0 CA--C 1.534 1.263 0 N-CA-C 114.396 0.518 . . . . 54.509999999999998 114.396 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.763 ' O ' ' HA ' ' A' ' 490' ' ' SER . 7.0 m -78.01 140.64 62.28 Favored Pre-proline 0 C--N 1.311 -1.087 0 O-C-N 122.174 -0.604 . . . . 63.520000000000003 109.931 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.589 ' HA ' ' N ' ' A' ' 491' ' ' THR 2.367 83.7 Cg_exo 90.39 -83.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.531 1 N-CA-C 123.432 4.358 . . . . 65.099999999999994 123.432 -174.037 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.763 ' HA ' ' O ' ' A' ' 488' ' ' SER . 6.1 m -86.41 99.31 11.54 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 124.769 1.227 . . . . 74.230000000000004 108.754 0.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.589 ' N ' ' HA ' ' A' ' 489' ' ' PRO . 36.0 m -142.84 139.07 30.74 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 115.367 -0.833 . . . . 54.140000000000001 111.057 -172.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -125.27 136.68 53.77 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.441 -1.318 . . . . 75.540000000000006 107.441 172.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 28.0 m -89.94 125.82 35.51 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.715 -0.476 . . . . 75.510000000000005 109.715 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.645 HG11 HG11 ' A' ' 390' ' ' VAL . 79.2 t -111.83 109.35 28.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.065 -0.717 . . . . 61.43 109.065 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 29.5 m -99.99 122.27 42.63 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.126 -1.064 . . . . 75.549999999999997 108.126 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.683 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.9 mp -101.79 124.23 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 N-CA-C 108.561 -0.903 . . . . 71.340000000000003 108.561 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.508 ' CE1' HG13 ' A' ' 504' ' ' ILE 0.277 42.0 m-85 -87.8 111.3 21.22 Favored 'General case' 0 N--CA 1.393 -3.3 0 CA-C-O 122.124 0.964 . . . . 64.25 112.514 178.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.606 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 7.6 m-20 -51.8 -52.41 49.27 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-N 111.882 -2.417 . . . . 72.25 112.364 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 26.7 t70 76.2 3.82 3.67 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 125.171 1.544 . . . . 74.409999999999997 107.956 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . 0.616 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' 0.28 2.6 p30 -93.84 -89.02 0.22 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.632 -1.167 . . . . 74.209999999999994 111.533 -177.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -81.59 -43.28 18.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.753 -1.573 . . . . 65.120000000000005 106.753 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 452' ' ' GLU . . . -82.94 90.0 6.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.151 -0.931 . . . . 40.439999999999998 108.756 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -97.98 69.89 0.69 Allowed Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.69 -0.686 . . . . 71.140000000000001 113.368 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.508 HG13 ' CE1' ' A' ' 497' ' ' PHE . 47.3 mm -77.66 123.7 34.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.157 -1.053 . . . . 54.539999999999999 108.157 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -88.26 134.06 33.89 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.382 0.61 . . . . 41.109999999999999 112.139 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.3 t -128.65 152.76 48.01 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.306 -1.368 . . . . 52.119999999999997 107.306 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -95.69 113.4 25.04 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.095 -0.705 . . . . 73.400000000000006 109.095 -177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.8 99.29 9.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.898 -0.592 . . . . 71.439999999999998 110.248 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.308 -1.201 0 N-CA-C 107.113 -1.439 . . . . 75.120000000000005 107.113 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.637 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.647 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.487 ' N ' ' HD1' ' A' ' 479' ' ' HIS . 46.5 t . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 108.76 -0.83 . . . . 55.140000000000001 108.76 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 44.3 m -152.17 -173.51 4.57 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.95 -1.13 . . . . 70.219999999999999 107.95 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -138.86 141.59 38.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.986 -0.746 . . . . 53.210000000000001 108.986 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.605 ' HB ' HD12 ' A' ' 486' ' ' LEU . 46.1 mm -114.44 115.75 50.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.695 -1.594 . . . . 73.239999999999995 106.695 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.502 ' HB3' ' HA3' ' A' ' 487' ' ' GLY . 35.4 p90 -146.54 158.58 43.92 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 119.012 0.824 . . . . 71.25 112.752 -177.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -70.47 143.1 51.84 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.542 -0.54 . . . . 73.430000000000007 109.542 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.71 -39.44 80.47 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.533 0.683 . . . . 74.5 109.171 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 12.7 mt-30 -122.58 153.71 38.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.432 -0.804 . . . . 71.200000000000003 111.34 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.2 -22.82 26.31 Favored Glycine 0 C--N 1.304 -1.24 0 C-N-CA 120.98 -0.629 . . . . 41.399999999999999 111.644 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 85.7 m -137.0 135.72 37.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.144 -0.687 . . . . 55.5 109.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 72.0 m-85 -124.96 138.85 54.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.264 -1.013 . . . . 71.230000000000004 108.264 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 495' ' ' THR . 39.3 mt-30 -128.93 124.86 36.21 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.888 -0.782 . . . . 73.340000000000003 108.888 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . 0.573 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -136.49 156.73 48.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.509 -0.552 . . . . 72.400000000000006 109.509 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -75.24 144.63 42.48 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 110.174 -0.306 . . . . 63.100000000000001 110.174 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 498' ' ' ASP . 51.8 tt0 -61.66 -31.56 71.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.831 0.824 . . . . 70.239999999999995 109.92 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.521 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.9 p-10 -84.52 1.74 44.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.891 -1.049 . . . . 73.540000000000006 112.698 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 45.8 t -77.0 -19.09 57.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.133 -0.354 . . . . 54.43 111.476 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.13 -61.86 2.19 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.748 -0.739 . . . . 75.109999999999999 112.208 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.3 p -136.96 148.97 47.25 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.54 0.17 . . . . 54.310000000000002 110.566 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 6.2 p -106.35 134.06 49.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.1 -1.445 . . . . 63.219999999999999 107.1 174.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.13 112.32 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.547 0.689 . . . . 63.409999999999997 110.835 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.499 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 2.9 mp -101.87 153.88 19.44 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.485 -1.302 . . . . 64.340000000000003 107.485 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -116.52 132.35 56.7 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.513 -0.475 . . . . 54.210000000000001 110.025 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 79.2 mt -104.91 122.86 58.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.186 -1.042 . . . . 73.219999999999999 108.186 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.7 mm -98.72 127.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.54 -0.911 . . . . 54.439999999999998 108.54 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 54.7 ttt180 -113.75 110.1 19.63 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.3 -0.864 . . . . 63.240000000000002 109.157 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -116.43 145.13 43.49 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.439 -0.578 . . . . 71.109999999999999 109.439 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 170.32 -35.2 0.17 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.383 -0.687 . . . . 60.409999999999997 111.383 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 152.36 -136.91 5.63 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 111.001 -0.84 . . . . 72.239999999999995 111.001 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.13 120.55 37.7 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 103.612 -2.736 . . . . 75.409999999999997 103.612 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 84.4 mt -135.23 98.61 4.02 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 113.318 0.859 . . . . 73.150000000000006 113.318 -166.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 40.8 p -93.21 -12.45 30.22 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.147 -0.933 . . . . 71.219999999999999 109.367 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -65.06 155.48 34.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.903 -1.044 . . . . 74.109999999999999 111.626 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.9 m -105.88 118.13 35.82 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.629 0.728 . . . . 63.43 110.749 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.09 149.68 17.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.085 -0.961 . . . . 71.540000000000006 108.663 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.423 ' CZ ' HG13 ' A' ' 430' ' ' VAL . 22.1 m-85 -127.31 129.38 47.55 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.942 0.497 . . . . 73.150000000000006 110.19 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.66 131.1 62.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.897 -0.779 . . . . 75.219999999999999 108.897 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 462' ' ' ASN . 21.5 t70 -99.91 135.43 41.34 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 110.066 -0.346 . . . . 75.109999999999999 110.066 -175.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -134.98 165.66 24.82 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 122.093 -0.379 . . . . 72.450000000000003 111.158 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.515 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 21.6 ttm180 -166.02 160.19 16.28 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 108.115 -1.068 . . . . 73.420000000000002 108.115 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 72.5 p -96.71 154.96 16.98 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.905 -0.776 . . . . 72.540000000000006 108.905 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -115.65 148.49 39.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.734 1.013 . . . . 72.450000000000003 113.734 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.79 2.61 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.885 0 C-N-CA 130.722 3.609 . . . . 72.329999999999998 114.102 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -20.19 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 125.741 1.638 . . . . 73.420000000000002 117.156 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.1 t -136.24 16.19 3.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 118.117 0.958 . . . . 75.430000000000007 109.857 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.32 -164.14 1.52 Allowed 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.103 -1.073 . . . . 41.340000000000003 108.103 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -138.98 121.84 16.57 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.212 -0.995 . . . . 74.150000000000006 111.527 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -80.82 124.71 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.232 -0.655 . . . . 44.130000000000003 109.232 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.18 -27.8 7.56 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 108.552 -1.819 . . . . 73.109999999999999 108.552 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.3 t -106.78 -55.71 2.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.945 -0.627 . . . . 74.209999999999994 109.518 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.615 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 9.8 m-20 -80.98 -60.28 2.35 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 111.112 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.701 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -136.75 166.95 22.39 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.545 -0.909 . . . . 71.25 108.545 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.3 tm-20 -77.72 154.42 32.07 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.638 -0.875 . . . . 74.420000000000002 108.638 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.504 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.9 p90 -95.52 -13.23 24.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.97 0.73 . . . . 64.219999999999999 112.97 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.502 HG21 HG22 ' A' ' 442' ' ' VAL . 10.1 t 36.01 57.77 0.97 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.364 1.866 . . . . 74.230000000000004 113.791 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 10.5 pt-20 -78.51 116.44 18.9 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.741 0.781 . . . . 72.219999999999999 108.945 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -157.08 -173.61 25.73 Favored Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 115.313 -0.858 . . . . 71.129999999999995 111.194 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 17.9 m -128.54 136.59 50.97 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.327 -1.36 . . . . 61.020000000000003 107.327 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.42 127.64 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.745 -1.205 . . . . 62.210000000000001 107.745 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.423 HG13 ' CZ ' ' A' ' 406' ' ' PHE . 22.7 t -105.04 106.69 20.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.831 -0.803 . . . . 55.109999999999999 108.831 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.9 m-85 -85.3 95.64 9.27 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.707 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 175.08 4.46 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 114.818 -1.083 . . . . 64.319999999999993 110.238 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.83 135.2 50.69 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.444 1.43 . . . . 73.420000000000002 109.603 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 91.85 -20.09 44.5 Favored Glycine 0 C--N 1.306 -1.128 0 C-N-CA 121.084 -0.579 . . . . 44.130000000000003 112.506 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -80.45 63.45 4.91 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.294 0.637 . . . . 75.450000000000003 110.821 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.9 m -70.69 -24.92 62.75 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.972 -1.013 . . . . 74.239999999999995 108.441 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -134.68 135.39 42.0 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.18 -0.674 . . . . 74.099999999999994 109.18 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -123.05 153.62 39.62 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.945 0.402 . . . . 51.240000000000002 111.864 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -113.08 129.82 56.38 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.058 -0.974 . . . . 74.019999999999996 109.49 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.403 ' CG1' ' HB2' ' A' ' 392' ' ' LEU . 40.7 pt -117.37 137.28 51.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.294 -1.002 . . . . 61.539999999999999 108.294 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 47.0 mtt180 -121.97 136.37 54.92 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.28 0.562 . . . . 72.219999999999999 112.134 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.627 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.6 t -111.12 123.24 66.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.299 -1.371 . . . . 74.439999999999998 107.299 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -78.68 135.79 16.42 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.856 -0.688 . . . . 62.130000000000003 111.996 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.455 HD12 HG12 ' A' ' 496' ' ' ILE . 38.4 mm -94.75 131.29 42.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 107.602 -1.258 . . . . 73.409999999999997 107.602 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.6 mt -93.52 143.17 12.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.322 -2.103 . . . . 75.409999999999997 105.322 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -84.47 86.22 7.31 Favored 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 119.036 -1.065 . . . . 62.310000000000002 111.314 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.85 98.44 8.13 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 103.25 -2.87 . . . . 72.329999999999998 103.25 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.84 89.29 3.61 Favored 'General case' 0 C--N 1.271 -2.841 0 C-N-CA 117.2 -1.8 . . . . 72.319999999999993 110.911 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.426 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 39.8 mm -123.2 153.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.449 0 N-CA-C 104.265 -2.494 . . . . 74.519999999999996 104.265 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -60.12 114.64 2.97 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.658 -1.217 . . . . 73.230000000000004 108.845 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.632 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 21.3 mt-10 -128.46 140.99 51.53 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.717 -0.674 . . . . 74.409999999999997 109.555 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -121.15 99.67 6.62 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.313 -0.858 . . . . 75.420000000000002 109.546 -173.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.303 4.3 p-10 47.28 61.15 3.03 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.413 1.485 . . . . 64.540000000000006 112.794 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.559 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.7 tt0 -74.56 127.93 34.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.817 -1.083 . . . . 63.329999999999998 108.684 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.433 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.2 p-10 -145.56 169.09 19.08 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.811 -0.555 . . . . 73.140000000000001 111.905 -173.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.627 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 26.2 p90 -143.83 179.48 7.14 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.269 -0.423 . . . . 65.439999999999998 110.582 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 37.9 mt -118.08 138.68 52.08 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.724 -1.213 . . . . 74.510000000000005 107.724 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 491' ' ' THR . 41.1 t -112.43 126.47 69.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.216 -1.402 . . . . 72.540000000000006 107.216 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -119.66 157.07 29.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.407 0.442 . . . . 72.329999999999998 110.662 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.0 mt -114.73 138.63 50.49 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.456 -0.572 . . . . 70.430000000000007 109.456 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.9 p -153.44 -174.3 4.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.023 0.529 . . . . 70.540000000000006 109.691 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 408' ' ' ASP . 5.7 t30 34.79 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 126.201 1.8 . . . . 65.209999999999994 112.85 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.33 127.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 C-N-CA 119.9 -0.72 . . . . 65.450000000000003 109.692 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -129.28 150.28 50.72 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.993 -0.743 . . . . 73.409999999999997 108.993 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.06 149.39 13.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 106.701 -1.592 . . . . 73.540000000000006 106.701 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.47 ' CB ' ' HB ' ' A' ' 404' ' ' THR . 22.7 t -74.2 128.1 34.66 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.472 0.653 . . . . 45.350000000000001 112.397 -174.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 21.9 m -81.37 172.02 14.07 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.817 -1.92 . . . . 72.010000000000005 105.817 169.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 72.68 -58.42 0.6 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.076 0.95 . . . . 74.439999999999998 111.564 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -67.6 -27.58 67.03 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.089 0.947 . . . . 35.25 109.099 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.2 p -145.35 94.87 2.58 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 113.776 -1.556 . . . . 74.25 107.608 172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -89.44 -20.69 23.61 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.955 -1.02 . . . . 71.409999999999997 112.402 -172.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -108.05 -179.83 4.01 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.039 -0.726 . . . . 72.150000000000006 109.039 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -83.75 50.94 4.49 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 121.221 0.345 . . . . 61.210000000000001 112.624 -174.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.43 109.37 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.991 -1.115 . . . . 64.099999999999994 107.991 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.6 mt -82.51 3.27 29.09 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.505 0.669 . . . . 72.099999999999994 111.71 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -93.28 -2.53 54.88 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.473 -0.936 . . . . 70.349999999999994 108.473 172.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -105.15 -34.31 7.98 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.246 -0.888 . . . . 73.150000000000006 108.907 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -83.66 86.11 7.17 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.767 -1.197 . . . . 54.229999999999997 107.767 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.487 ' HD1' ' N ' ' A' ' 371' ' ' VAL . 70.2 m-70 -80.59 -66.39 0.89 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.06 0.934 . . . . 72.340000000000003 108.837 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.17 130.51 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.443 0 CA-C-N 114.431 -1.259 . . . . 61.310000000000002 108.514 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 32.2 t 149.78 -68.04 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.137 2.175 . . . . 53.549999999999997 108.413 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -111.7 14.54 21.17 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.18 -0.464 . . . . 74.549999999999997 111.876 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -141.34 -72.05 0.34 Allowed 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 106.074 -1.825 . . . . 75.030000000000001 106.074 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -98.1 171.05 8.49 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 109.144 -0.687 . . . . 51.509999999999998 109.144 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 45.7 t -125.58 -173.45 2.83 Favored 'General case' 0 C--N 1.27 -2.876 0 N-CA-C 106.086 -1.82 . . . . 64.120000000000005 106.086 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.605 HD12 ' HB ' ' A' ' 374' ' ' ILE . 0.5 OUTLIER -75.15 175.6 8.1 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.105 -1.442 . . . . 62.439999999999998 107.105 178.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 375' ' ' PHE . . . -63.72 127.46 36.53 Favored Glycine 0 C--O 1.253 1.314 0 N-CA-C 104.179 -3.568 . . . . 72.299999999999997 104.179 169.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.591 ' HA ' ' OG ' ' A' ' 490' ' ' SER . 15.4 m -109.15 70.98 0.45 Allowed Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 119.489 3.144 . . . . 41.399999999999999 119.489 -164.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.558 ' CD ' ' HA ' ' A' ' 490' ' ' SER . 3.1 Cg_exo -70.09 -61.05 0.06 OUTLIER 'Trans proline' 0 N--CA 1.404 -3.757 0 N-CA-C 109.693 -0.926 . . . . 73.439999999999998 109.693 155.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 488' ' ' SER . 49.3 m -119.15 91.66 3.61 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 128.418 2.687 . . . . 72.140000000000001 108.117 -2.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.504 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 17.8 m -141.76 138.41 32.29 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 109.686 -0.487 . . . . 64.430000000000007 109.686 -175.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -122.75 117.39 25.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.525 -1.657 . . . . 64.010000000000005 106.525 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 89.8 m -86.09 119.77 26.75 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.237 0.542 . . . . 61.229999999999997 110.573 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.557 HG11 HG11 ' A' ' 390' ' ' VAL . 80.2 t -104.08 108.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.603 -0.888 . . . . 55.039999999999999 108.603 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 90.2 m -96.58 121.01 37.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.629 -0.878 . . . . 73.420000000000002 108.629 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -93.94 126.88 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.179 0 CA-C-O 121.502 0.668 . . . . 73.340000000000003 109.535 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.59 ' O ' HD13 ' A' ' 384' ' ' LEU . 9.3 m-85 -93.0 104.16 16.4 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-O 121.854 0.835 . . . . 73.430000000000007 110.433 173.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.47 ' HB3' ' CG ' ' A' ' 500' ' ' ASP . 8.3 m-20 -56.01 -54.02 49.9 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 112.882 -1.963 . . . . 73.420000000000002 113.283 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.7 t70 84.59 -10.98 0.83 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.174 1.79 . . . . 71.239999999999995 107.863 -170.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . 0.59 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 3.4 p30 -76.29 -70.25 0.46 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.093 -0.958 . . . . 75.109999999999999 110.491 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -114.64 -14.43 12.05 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.0 -0.741 . . . . 71.129999999999995 109.0 172.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -68.93 104.26 2.03 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.971 -0.752 . . . . 61.310000000000002 108.971 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -75.23 72.45 1.65 Allowed Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 118.449 2.14 . . . . 34.539999999999999 118.449 -166.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.61 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -91.15 -37.59 9.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 106.253 -1.758 . . . . 74.430000000000007 106.253 163.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 50.6 p90 179.31 173.49 0.82 Allowed 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 128.66 2.784 . . . . 62.009999999999998 105.162 173.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 6.2 m -126.95 105.3 8.52 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.279 -1.008 . . . . 54.539999999999999 108.279 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -151.75 98.88 2.53 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 120.087 -0.645 . . . . 74.510000000000005 111.844 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 72.37 -37.8 0.4 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.237 1.569 . . . . 62.130000000000003 115.237 173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 . . . . . 0 C--N 1.304 -1.395 0 CA-C-N 117.903 0.319 . . . . 64.420000000000002 111.36 -175.309 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.618 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.632 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 108.731 -0.84 . . . . 72.540000000000006 108.731 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 64.6 m -151.3 160.6 43.71 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.838 -1.171 . . . . 72.120000000000005 107.838 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -140.37 130.79 25.31 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 123.614 0.571 . . . . 72.099999999999994 109.569 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.522 ' HB ' HD12 ' A' ' 486' ' ' LEU . 39.0 mm -107.16 115.87 49.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 105.909 -1.886 . . . . 72.540000000000006 105.909 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.46 167.11 23.76 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 118.794 0.725 . . . . 60.130000000000003 112.487 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -78.68 147.61 33.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.107 -0.701 . . . . 73.0 109.107 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.13 -53.3 39.51 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.569 -0.9 . . . . 71.109999999999999 108.569 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -109.8 174.15 6.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.074 -0.512 . . . . 65.310000000000002 110.751 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.48 -35.49 2.85 Favored Glycine 0 C--N 1.298 -1.559 0 CA-C-N 115.264 -0.88 . . . . 62.450000000000003 111.148 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 23.1 m -121.05 134.74 55.29 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.915 -1.142 . . . . 62.240000000000002 107.915 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 494' ' ' VAL . 61.6 m-85 -124.19 136.34 54.11 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.673 -1.232 . . . . 71.349999999999994 107.673 175.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -127.39 123.59 36.56 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.507 -0.923 . . . . 71.239999999999995 108.507 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 24.2 p -134.33 152.9 52.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.667 -0.494 . . . . 71.140000000000001 109.667 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 1.1 mm? -75.02 152.74 38.68 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.256 -0.646 . . . . 75.400000000000006 109.256 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.638 ' OE2' 'CA ' ' A' ' 600' ' ' ' CA' . 29.1 tt0 -65.52 -38.73 90.51 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.06 0.933 . . . . 64.530000000000001 109.5 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.464 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.5 p-10 -83.89 16.36 2.85 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.875 -1.057 . . . . 72.200000000000003 111.661 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 52.9 t -84.63 -20.59 31.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.188 0.518 . . . . 61.130000000000003 109.632 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.85 -60.37 3.15 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.913 -0.66 . . . . 72.109999999999999 111.883 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.53 HG22 ' HA2' ' A' ' 443' ' ' GLY . 9.0 p -143.57 155.97 44.45 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 122.662 0.385 . . . . 50.25 110.209 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -112.82 132.43 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.522 -1.288 . . . . 62.020000000000003 107.522 173.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.52 120.14 40.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.197 0.522 . . . . 51.130000000000003 110.141 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 392' ' ' LEU . 2.8 mp -112.2 142.25 44.9 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.588 -1.264 . . . . 63.409999999999997 107.588 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.2 m -106.8 131.14 54.25 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.565 -0.531 . . . . 70.319999999999993 109.565 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.3 122.48 54.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.869 -1.16 . . . . 64.430000000000007 107.869 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 45.6 mm -98.02 123.95 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.319 -0.993 . . . . 54.229999999999997 108.319 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.505 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 51.4 ttt180 -111.02 110.89 21.63 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.383 -0.826 . . . . 71.319999999999993 109.639 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -115.09 168.47 9.91 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.968 -0.56 . . . . 64.219999999999999 109.578 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 145.62 -19.09 1.84 Allowed Glycine 0 C--N 1.311 -0.816 0 N-CA-C 111.443 -0.663 . . . . 74.120000000000005 111.443 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 139.95 -103.85 0.39 Allowed Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 108.836 -1.705 . . . . 75.040000000000006 108.836 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -153.09 120.25 5.83 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 107.387 -1.338 . . . . 71.219999999999999 107.387 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 52.6 mt -128.44 121.72 29.64 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.272 -0.571 . . . . 63.25 110.842 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 19.0 p -95.62 0.49 52.87 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-O 122.302 1.049 . . . . 72.420000000000002 108.405 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -74.79 159.99 31.27 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.42 -1.326 . . . . 73.310000000000002 107.42 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 4.3 m -102.12 121.01 41.39 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.47 0.652 . . . . 43.009999999999998 111.687 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.65 142.96 22.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.042 -1.095 . . . . 72.25 108.042 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 464' ' ' LYS . 26.0 m-85 -127.24 129.91 48.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.349 -0.612 . . . . 72.230000000000004 109.349 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.27 132.39 66.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.006 -1.109 . . . . 73.420000000000002 108.006 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 19.2 t70 -93.3 134.53 35.41 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.75 -0.833 . . . . 71.019999999999996 108.75 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -123.06 148.12 45.95 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.923 -0.769 . . . . 74.150000000000006 108.923 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 410' ' ' ARG . 6.6 ttm180 -162.93 163.9 26.05 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.292 -1.003 . . . . 61.030000000000001 108.292 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 22.1 p -96.69 172.89 7.62 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.903 0.382 . . . . 73.310000000000002 111.035 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 4.8 tp10 -133.93 153.96 51.4 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.092 -2.188 . . . . 71.409999999999997 105.092 173.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -58.18 -45.02 88.28 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.185 0.809 . . . . 72.409999999999997 113.185 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.95 -93.73 0.16 Allowed Glycine 0 C--N 1.293 -1.857 0 CA-C-N 115.667 -0.697 . . . . 53.229999999999997 112.03 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.0 t -132.28 9.62 4.42 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.137 0.97 . . . . 72.349999999999994 109.007 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -132.14 -159.75 0.99 Allowed 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.185 -1.783 . . . . 72.200000000000003 106.185 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -150.34 113.84 4.95 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.465 -0.894 . . . . 71.140000000000001 112.255 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.91 128.82 37.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.265 -0.643 . . . . 34.030000000000001 109.265 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.03 -31.63 6.18 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 109.102 -1.599 . . . . 42.43 109.102 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 15.2 m -110.18 -51.89 2.83 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.106 0.479 . . . . 61.399999999999999 109.859 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.625 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 4.1 m-20 -82.9 -61.43 1.87 Allowed 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.531 0.682 . . . . 74.230000000000004 110.927 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.554 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.2 OUTLIER -132.31 173.42 11.28 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 107.228 -1.397 . . . . 75.209999999999994 107.228 -178.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.462 ' HG2' ' H ' ' A' ' 425' ' ' THR . 30.2 tt0 -79.11 148.0 32.54 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.361 -0.607 . . . . 72.239999999999995 109.361 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -82.36 -16.93 47.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 113.133 0.79 . . . . 63.210000000000001 113.133 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.581 HG21 HG22 ' A' ' 442' ' ' VAL 0.251 14.0 t 35.95 73.11 0.09 Allowed 'General case' 0 CA--C 1.556 1.198 0 O-C-N 125.513 1.758 . . . . 73.340000000000003 113.279 -178.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.5 130.93 35.76 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.591 -1.186 . . . . 75.230000000000004 109.273 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -177.97 178.78 48.53 Favored Glycine 0 CA--C 1.476 -2.35 0 C-N-CA 119.784 -1.198 . . . . 52.409999999999997 111.86 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 60.6 m -123.68 138.63 54.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.524 -0.917 . . . . 71.030000000000001 108.524 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.39 124.8 49.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.927 -0.768 . . . . 65.219999999999999 108.927 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 432' ' ' LYS . 23.4 t -95.3 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.616 -0.72 . . . . 73.25 109.232 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.505 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 60.5 m-85 -88.78 95.67 10.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.095 0.474 . . . . 73.409999999999997 111.236 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 57.3 mtmt -92.7 176.81 2.36 Favored Pre-proline 0 C--N 1.306 -1.306 0 CA-C-N 114.918 -1.037 . . . . 72.319999999999993 110.456 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.5 Cg_exo -56.62 131.71 47.3 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 122.479 2.119 . . . . 72.209999999999994 112.353 175.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 98.34 -33.08 6.27 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 115.845 -0.616 . . . . 70.109999999999999 111.985 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.458 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 33.4 mt-10 -82.54 64.15 7.04 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.803 1.241 . . . . 74.340000000000003 113.086 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 9.2 t -75.81 -13.01 60.28 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.49 -1.232 . . . . 62.219999999999999 109.816 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -135.79 137.12 41.28 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.867 -1.16 . . . . 71.25 107.867 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -130.81 157.87 41.69 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.572 0.225 . . . . 72.430000000000007 111.367 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -122.59 137.29 54.94 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 110.498 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -121.35 145.72 27.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.772 -0.825 . . . . 75.230000000000004 108.772 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 60.2 mtm180 -120.42 141.64 49.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.032 0.444 . . . . 71.530000000000001 111.097 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.581 HG22 HG21 ' A' ' 425' ' ' THR . 42.0 t -110.72 121.54 63.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.392 -1.336 . . . . 55.219999999999999 107.392 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.53 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.15 140.67 30.17 Favored Glycine 0 N--CA 1.433 -1.544 0 O-C-N 123.895 0.747 . . . . 61.520000000000003 112.113 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.406 HG23 ' HD1' ' A' ' 422' ' ' TYR . 37.8 mm -101.15 132.56 46.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 106.74 -1.578 . . . . 73.400000000000006 106.74 175.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.625 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.9 mt -99.22 151.49 4.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 106.536 -1.653 . . . . 71.439999999999998 106.536 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -82.38 86.23 6.76 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.223 -0.991 . . . . 71.040000000000006 112.136 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.41 107.59 18.55 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.76 -2.682 . . . . 71.329999999999998 103.76 169.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -109.69 84.86 2.0 Allowed 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 117.864 -1.534 . . . . 71.340000000000003 109.921 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 47.6 mm -124.37 154.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 111.966 -2.379 . . . . 72.299999999999997 105.81 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.19 115.38 4.45 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.428 -1.309 . . . . 62.299999999999997 109.018 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.626 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 24.0 mt-10 -126.98 135.75 51.29 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 114.371 -1.286 . . . . 75.010000000000005 109.516 -170.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 501' ' ' HIS . 32.8 mt-10 -138.0 117.16 12.61 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.972 -1.013 . . . . 70.25 108.903 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 56.8 29.99 16.98 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.227 1.011 . . . . 72.109999999999999 110.97 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -75.38 118.24 18.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.906 -1.146 . . . . 70.129999999999995 107.906 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 2.7 p-10 -144.03 167.72 21.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.313 0.578 . . . . 70.5 110.775 -174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.546 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.9 p90 -139.12 -177.49 4.92 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.443 -0.799 . . . . 72.510000000000005 109.242 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 30.1 mt -122.13 139.64 53.5 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.401 -0.963 . . . . 54.329999999999998 108.401 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.81 126.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.821 -1.548 . . . . 71.510000000000005 106.821 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -119.62 149.62 41.66 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.164 -0.471 . . . . 53.509999999999998 110.672 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.08 124.84 50.25 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.275 -1.75 . . . . 65.349999999999994 106.275 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.8 m -144.25 170.91 15.08 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.212 -0.662 . . . . 74.109999999999999 109.212 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.13 86.53 0.04 OUTLIER 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.708 1.203 . . . . 63.399999999999999 112.525 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.485 HG11 HG23 ' A' ' 480' ' ' VAL . 61.9 t -80.14 128.82 38.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 119.698 -0.801 . . . . 61.420000000000002 108.897 177.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 406' ' ' PHE . 39.9 ttmt -118.54 134.34 55.17 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.088 -1.449 . . . . 72.409999999999997 107.088 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 476' ' ' GLU . 13.4 t -125.55 138.22 55.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 119.748 -0.781 . . . . 74.439999999999998 109.124 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.8 t -103.39 124.56 48.93 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 116.455 -0.339 . . . . 71.530000000000001 110.537 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 23.8 m -84.76 89.7 7.58 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.68 -1.23 . . . . 73.219999999999999 107.68 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -97.06 -22.1 16.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.109 -0.496 . . . . 75.109999999999999 110.593 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -75.48 -27.4 58.82 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.407 -0.517 . . . . 74.299999999999997 111.106 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 34.9 t -164.04 143.52 7.88 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.189 -1.041 . . . . 61.25 108.189 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -95.47 -24.36 16.69 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.085 -1.08 . . . . 62.030000000000001 108.085 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -81.96 -50.15 9.47 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.16 -0.927 . . . . 65.319999999999993 110.013 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -98.57 137.98 13.6 Favored Glycine 0 N--CA 1.412 -2.966 0 N-CA-C 108.876 -1.689 . . . . 60.140000000000001 108.876 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 13.1 tt -75.48 89.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 122.406 1.098 . . . . 74.310000000000002 110.106 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 97.0 mt -115.41 96.28 5.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.696 -1.138 . . . . 75.310000000000002 108.386 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . 0.522 ' HB2' HG12 ' A' ' 465' ' ' VAL . 0.0 OUTLIER -146.17 -173.21 4.11 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.452 -1.249 . . . . 72.120000000000005 111.206 -175.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.92 69.84 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.985 0.735 . . . . 61.310000000000002 112.985 -175.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . 0.281 9.0 p30 51.84 -20.88 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 118.049 2.611 . . . . 73.219999999999999 118.049 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' A' ' 484' ' ' ALA . 58.3 m170 -51.35 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.538 0.735 . . . . 74.329999999999998 112.441 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.485 HG23 HG11 ' A' ' 463' ' ' VAL . 34.1 m -76.77 120.04 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 118.586 -1.246 . . . . 62.210000000000001 109.313 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 8.9 p -161.31 -47.83 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.992 -1.003 . . . . 74.439999999999998 112.12 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.5 -66.27 0.31 Allowed 'General case' 0 C--O 1.242 0.676 0 N-CA-C 112.563 0.579 . . . . 70.439999999999998 112.563 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -81.81 -43.31 18.47 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 105.735 -1.95 . . . . 71.439999999999998 105.735 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 479' ' ' HIS . . . -91.18 114.7 27.29 Favored 'General case' 0 N--CA 1.387 -3.615 0 N-CA-C 103.465 -2.791 . . . . 64.129999999999995 103.465 166.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 37.0 t -134.81 -167.67 2.02 Favored 'General case' 0 C--N 1.249 -3.773 0 N-CA-C 105.203 -2.147 . . . . 54.549999999999997 105.203 -173.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.557 HD22 ' H ' ' A' ' 486' ' ' LEU . 1.6 mm? -60.47 145.26 48.99 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.883 -1.155 . . . . 71.040000000000006 107.883 175.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -65.31 -43.39 95.22 Favored Glycine 0 CA--C 1.505 -0.583 0 C-N-CA 120.808 -0.71 . . . . 61.119999999999997 111.793 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 8.2 m -80.56 167.67 31.13 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 107.976 -1.12 . . . . 62.509999999999998 107.976 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.58 ' N ' ' HA ' ' A' ' 490' ' ' SER . 1.6 Cg_endo -43.3 -41.54 10.1 Favored 'Trans proline' 0 CA--C 1.591 3.342 0 N-CA-C 119.294 2.767 . . . . 52.420000000000002 119.294 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.58 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 50.6 m -107.22 124.5 49.84 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 127.04 2.136 . . . . 74.319999999999993 109.215 2.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 29.4 m -133.45 105.72 7.07 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 108.381 -0.97 . . . . 73.439999999999998 108.381 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -104.78 131.82 51.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.618 -1.252 . . . . 50.229999999999997 107.618 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 26.7 m -98.86 121.86 41.35 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 120.481 -0.488 . . . . 70.109999999999999 110.338 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 381' ' ' TYR . 86.9 t -109.01 106.06 19.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.798 -0.816 . . . . 70.439999999999998 108.798 177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 93.9 m -95.83 115.3 27.22 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.861 -1.162 . . . . 72.329999999999998 107.861 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.541 HD13 ' CZ ' ' A' ' 422' ' ' TYR . 4.9 mp -88.6 107.88 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 C-N-CA 119.896 -0.722 . . . . 52.439999999999998 109.867 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 38.2 m-85 -78.01 92.4 4.34 Favored 'General case' 0 CA--C 1.446 -3.044 0 N-CA-C 106.37 -1.715 . . . . 75.439999999999998 106.37 169.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.601 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 1.1 p-10 -82.79 -19.87 36.91 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 114.241 -1.345 . . . . 71.219999999999999 108.905 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 31.8 t70 63.75 37.82 9.65 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 112.985 -1.916 . . . . 71.109999999999999 110.565 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . 0.62 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 2.2 m-20 -81.9 -50.33 9.3 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 118.373 -1.331 . . . . 72.230000000000004 108.659 172.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.477 ' HB3' ' HG2' ' A' ' 452' ' ' GLU . 23.9 t-80 -139.27 84.34 1.99 Allowed 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.761 -1.199 . . . . 74.209999999999994 107.761 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -143.37 -47.04 0.29 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.439 -0.8 . . . . 74.319999999999993 111.019 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 98.22 44.85 2.49 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.502 -0.856 . . . . 71.430000000000007 112.236 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 49.5 mm -89.34 140.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.466 -0.938 . . . . 72.219999999999999 108.466 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 74.08 18.71 3.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.843 1.257 . . . . 75.230000000000004 110.178 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.3 t -156.66 -159.9 0.92 Allowed 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.781 -1.192 . . . . 72.230000000000004 107.781 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -54.96 126.34 24.11 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.691 0.997 . . . . 73.420000000000002 113.691 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.87 160.67 33.78 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.161 -1.052 . . . . 73.120000000000005 108.161 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--N 1.292 -1.912 0 O-C-N 123.409 0.443 . . . . 52.020000000000003 109.922 177.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.638 'CA ' ' OE2' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.616 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 108.472 -0.936 . . . . 73.510000000000005 108.472 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 20.6 m -78.63 141.27 38.14 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.689 -0.486 . . . . 70.310000000000002 109.689 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.0 mmtp -132.76 128.67 37.35 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.899 -0.408 . . . . 73.340000000000003 109.899 176.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.554 ' HB ' HD12 ' A' ' 486' ' ' LEU . 35.6 mm -110.04 119.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.313 -1.366 . . . . 63.299999999999997 107.313 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.412 ' HB3' ' CA ' ' A' ' 487' ' ' GLY . 32.6 p90 -156.43 161.68 40.06 Favored 'General case' 0 C--O 1.197 -1.705 0 CA-C-N 118.443 0.565 . . . . 64.439999999999998 112.305 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.17 145.04 40.17 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 110.133 -0.321 . . . . 73.200000000000003 110.133 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.89 -44.28 90.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.395 0.617 . . . . 72.299999999999997 109.359 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 14.4 mm100 -107.17 171.11 7.56 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.412 -0.813 . . . . 51.399999999999999 111.236 177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -105.62 -25.66 6.49 Favored Glycine 0 C--N 1.289 -2.063 0 N-CA-C 109.63 -1.388 . . . . 73.319999999999993 109.63 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 493' ' ' THR . 24.0 m -135.94 140.22 43.84 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.694 -1.225 . . . . 65.439999999999998 107.694 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 91.7 m-85 -129.13 136.69 50.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.31 -0.996 . . . . 74.430000000000007 108.31 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.66 134.45 53.74 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.131 -0.692 . . . . 74.310000000000002 109.131 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 31.7 t -148.69 165.03 32.57 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.486 -1.301 . . . . 72.349999999999994 107.486 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.0 mm? -84.4 143.54 29.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.627 0.603 . . . . 72.150000000000006 112.627 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.626 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 15.7 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.182 -0.917 . . . . 61.009999999999998 109.975 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -90.64 14.19 13.98 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.351 0.5 . . . . 71.310000000000002 112.351 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 41.7 t -87.78 -16.32 34.49 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.994 -0.441 . . . . 64.049999999999997 111.268 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.21 -68.77 0.37 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.527 -0.844 . . . . 74.329999999999998 112.405 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.522 HG22 ' HA2' ' A' ' 443' ' ' GLY . 16.7 p -135.18 161.68 34.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.094 0.473 . . . . 65.310000000000002 110.714 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 494' ' ' VAL . 5.7 p -112.5 129.13 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 107.842 -1.17 . . . . 71.040000000000006 107.842 172.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.78 120.85 40.39 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.603 0.564 . . . . 74.219999999999999 110.306 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.09 141.8 45.32 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.647 -1.242 . . . . 70.040000000000006 107.647 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 17.7 m -105.3 129.01 53.74 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.81 -0.441 . . . . 63.130000000000003 109.81 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.8 122.64 55.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.164 -1.05 . . . . 73.439999999999998 108.164 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 40.2 mm -94.43 132.36 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 C-N-CA 124.259 1.024 . . . . 70.439999999999998 108.456 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 60.6 ttt180 -115.6 111.23 20.36 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.293 -0.867 . . . . 70.409999999999997 109.788 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -101.63 167.46 10.1 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.129 -0.941 . . . . 72.010000000000005 109.044 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 123.13 -17.01 8.09 Favored Glycine 0 C--N 1.303 -1.299 0 N-CA-C 110.715 -0.954 . . . . 70.310000000000002 110.715 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 117.15 -141.84 16.94 Favored Glycine 0 N--CA 1.419 -2.474 0 N-CA-C 111.335 -0.706 . . . . 54.5 111.335 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.03 120.97 34.91 Favored 'General case' 0 CA--C 1.471 -2.092 0 N-CA-C 108.83 -0.804 . . . . 73.230000000000004 108.83 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 74.3 mt -143.27 136.11 27.69 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 114.486 -1.233 . . . . 72.349999999999994 108.009 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 58.7 p -82.42 6.25 17.82 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.498 0.666 . . . . 54.43 110.291 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -58.59 152.56 18.15 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.578 1.151 . . . . 74.209999999999994 109.03 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 25.3 m -118.59 111.95 19.24 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-O 121.561 0.696 . . . . 74.219999999999999 110.684 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 55.8 t -104.68 143.2 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 114.428 -1.26 . . . . 71.140000000000001 108.618 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 47.4 m-85 -126.22 112.77 16.14 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.544 -0.909 . . . . 64.340000000000003 108.544 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.6 124.66 71.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.1 -0.704 . . . . 73.540000000000006 109.1 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -87.41 140.49 29.48 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.094 -0.706 . . . . 73.219999999999999 109.094 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -142.83 154.66 44.38 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.44 -0.788 . . . . 74.120000000000005 111.69 -175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 426' ' ' GLU . 56.0 mtt85 -154.6 165.58 36.05 Favored 'General case' 0 CA--C 1.486 -1.491 0 C-N-CA 125.144 1.378 . . . . 63.439999999999998 109.27 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.607 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 58.5 p -100.97 158.05 16.29 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.647 -0.706 . . . . 70.340000000000003 109.262 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 8.2 tp10 -106.02 163.92 12.38 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.006 -1.85 . . . . 75.530000000000001 106.006 176.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.8 p-10 -60.29 -40.1 89.25 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.626 0.726 . . . . 70.150000000000006 110.559 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.76 -89.26 0.3 Allowed Glycine 0 C--N 1.299 -1.514 0 CA-C-N 114.737 -1.119 . . . . 73.439999999999998 110.456 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.433 ' CG2' ' H ' ' A' ' 455' ' ' ASN . 9.6 t -131.57 -1.09 3.9 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 122.093 0.949 . . . . 43.340000000000003 109.212 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -129.5 -154.84 0.66 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.254 -1.017 . . . . 73.120000000000005 108.254 -173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.41 125.6 20.06 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 121.101 0.477 . . . . 54.539999999999999 110.822 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -73.32 128.45 35.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.237 -0.653 . . . . 40.32 109.237 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.27 -13.08 48.34 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 110.522 -1.031 . . . . 24.239999999999998 110.522 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 20.4 m -117.64 -56.49 2.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.17 0.51 . . . . 72.340000000000003 109.67 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 38.1 m-20 -85.23 -57.64 3.0 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 122.174 0.988 . . . . 74.409999999999997 109.663 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.635 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -139.95 165.01 28.47 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.275 -0.875 . . . . 74.049999999999997 110.638 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' A' ' 425' ' ' THR . 26.3 tt0 -73.82 149.16 41.82 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 124.057 0.848 . . . . 62.020000000000003 110.836 -173.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.607 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.3 OUTLIER -79.85 -16.29 55.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 73.5 111.818 176.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.608 HG21 HG22 ' A' ' 442' ' ' VAL 0.259 8.9 t 35.05 63.91 0.46 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 126.412 1.885 . . . . 72.239999999999995 113.622 -177.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' A' ' 410' ' ' ARG . 21.5 pt-20 -79.2 126.36 30.65 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.427 -0.806 . . . . 74.150000000000006 109.084 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -170.14 -173.2 37.32 Favored Glycine 0 N--CA 1.41 -3.065 0 N-CA-C 110.672 -0.971 . . . . 60.520000000000003 110.672 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 40.8 m -127.22 139.98 52.55 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.382 -0.97 . . . . 70.510000000000005 108.382 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.76 117.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.051 -1.092 . . . . 71.409999999999997 108.051 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 26.0 t -92.75 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.525 -0.761 . . . . 53.409999999999997 110.009 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.9 m-85 -91.82 94.46 9.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 110.053 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.2 mttm -82.79 174.93 5.31 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.073 -0.967 . . . . 64.329999999999998 110.296 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 51.2 Cg_exo -59.75 133.45 51.27 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.984 1.79 . . . . 70.140000000000001 109.639 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 90.8 -18.8 48.88 Favored Glycine 0 C--N 1.305 -1.175 0 C-N-CA 120.564 -0.827 . . . . 44.109999999999999 113.199 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.83 63.99 7.22 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.24 0.616 . . . . 63.539999999999999 112.275 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 7.6 m -68.46 -19.27 64.55 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.182 -0.917 . . . . 73.239999999999995 109.113 176.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -138.28 137.78 37.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.294 -1.002 . . . . 72.329999999999998 108.294 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -124.48 151.66 44.32 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.485 -0.325 . . . . 74.019999999999996 111.028 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.76 138.99 48.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.964 -0.562 . . . . 64.109999999999999 109.946 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.51 133.9 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.445 -0.576 . . . . 74.299999999999997 109.445 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 24.5 mmt180 -104.55 133.02 50.12 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.636 -0.711 . . . . 73.040000000000006 111.123 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.685 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 48.7 t -110.55 124.21 67.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.14 -1.43 . . . . 64.310000000000002 107.14 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -72.7 133.86 19.77 Favored Glycine 0 N--CA 1.428 -1.841 0 O-C-N 123.903 0.752 . . . . 35.409999999999997 112.343 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 496' ' ' ILE . 34.7 mm -95.19 134.31 33.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 105.966 -1.865 . . . . 74.340000000000003 105.966 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 78.2 mt -97.03 143.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 107.732 -1.21 . . . . 64.319999999999993 107.732 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.87 95.03 0.66 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.544 0.688 . . . . 72.230000000000004 110.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.06 102.84 7.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 104.774 -2.306 . . . . 63.240000000000002 104.774 169.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -106.55 89.85 3.16 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.116 -1.434 . . . . 62.310000000000002 109.697 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 43.2 mm -129.63 155.57 41.43 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.28 0 CA-C-N 112.108 -2.315 . . . . 44.420000000000002 105.244 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.25 115.22 4.34 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 117.713 -1.595 . . . . 75.019999999999996 106.963 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.637 ' OE1' 'CA ' ' A' ' 650' ' ' ' CA' . 20.5 mt-10 -126.1 136.55 53.04 Favored 'General case' 0 CA--C 1.468 -2.178 0 CA-C-N 114.843 -1.071 . . . . 73.129999999999995 108.653 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 502' ' ' ALA . 30.4 mt-10 -128.94 106.56 8.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.31 0.576 . . . . 63.299999999999997 110.35 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 54.74 60.67 3.36 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 125.316 1.446 . . . . 62.100000000000001 114.004 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.47 117.44 17.27 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.7 -0.852 . . . . 71.420000000000002 108.7 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.433 ' H ' ' CG2' ' A' ' 415' ' ' THR . 8.5 p30 -140.48 145.48 36.97 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.665 0.745 . . . . 74.340000000000003 110.115 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.685 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 22.3 p90 -123.81 174.3 7.61 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.612 -1.176 . . . . 74.150000000000006 109.124 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.3 mt -120.7 136.14 54.94 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 107.072 -1.455 . . . . 75.230000000000004 107.072 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 29.7 t -104.65 126.17 59.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.625 -1.25 . . . . 75.299999999999997 107.625 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -121.56 140.98 51.53 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 123.617 0.573 . . . . 74.230000000000004 110.007 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.92 138.8 33.04 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.973 -1.121 . . . . 74.430000000000007 107.973 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 14.9 m -146.55 177.16 9.27 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.16 -1.052 . . . . 72.109999999999999 108.16 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 40.8 83.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.727 0 C-N-CA 125.112 1.365 . . . . 54.530000000000001 113.42 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.37 134.75 27.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 115.688 -0.687 . . . . 72.439999999999998 109.16 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 23.3 ttmm -139.75 157.96 44.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.016 -1.105 . . . . 74.439999999999998 108.016 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 69.9 t -141.84 155.6 19.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.67 -1.604 . . . . 75.450000000000003 106.67 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.485 ' HG ' ' HE1' ' A' ' 406' ' ' PHE . 70.6 m -72.52 109.77 6.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.683 -1.229 . . . . 74.420000000000002 107.683 175.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 32.8 m -62.68 116.69 5.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.698 -1.137 . . . . 34.420000000000002 112.289 -173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -122.75 135.92 54.71 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.509 -1.663 . . . . 73.310000000000002 106.509 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -60.89 -20.41 61.94 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.132 0.492 . . . . 72.439999999999998 112.174 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 27.5 t -81.1 82.38 7.05 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 108.073 -1.084 . . . . 42.329999999999998 108.073 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -100.77 -19.68 15.89 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.855 -0.612 . . . . 75.349999999999994 110.694 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 13.4 t70 78.26 -39.43 0.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.038 1.335 . . . . 62.100000000000001 110.872 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 177.32 160.28 23.85 Favored Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 106.678 -2.569 . . . . 54.240000000000002 106.678 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 49.4 mm -78.29 76.38 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 118.865 1.333 . . . . 64.120000000000005 109.614 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 95.1 mt -155.75 99.51 2.01 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 126.678 1.991 . . . . 75.200000000000003 106.078 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . 0.427 ' HB2' ' OG ' ' A' ' 481' ' ' SER . 35.5 mt-10 -91.81 75.95 5.64 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.411 0.624 . . . . 70.439999999999998 109.334 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -103.98 -24.11 13.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.454 -0.794 . . . . 73.030000000000001 110.826 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -65.62 -42.36 91.63 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.817 0.818 . . . . 75.230000000000004 109.448 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -123.05 153.6 39.65 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.265 -1.334 . . . . 75.25 108.779 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.56 ' HA ' ' HB3' ' A' ' 484' ' ' ALA . 31.4 m -64.95 150.29 10.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.975 0.416 . . . . 63.25 112.015 -177.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 476' ' ' GLU . 35.5 p -165.65 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.494 -0.776 . . . . 70.120000000000005 109.954 -177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.61 6.31 2.48 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.292 -1.373 . . . . 73.540000000000006 107.292 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.12 -62.86 1.29 Allowed 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 103.1 -2.926 . . . . 54.32 103.1 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 480' ' ' VAL . . . -93.92 142.39 27.43 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 106.219 -1.771 . . . . 42.030000000000001 106.219 170.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 15.2 p -128.47 -170.52 2.27 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 122.392 0.277 . . . . 63.509999999999998 111.087 -174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.554 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.8 mm? -77.37 151.94 34.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.006 0.431 . . . . 74.319999999999993 110.271 -177.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.412 ' CA ' ' HB3' ' A' ' 375' ' ' PHE . . . -77.95 -25.13 62.82 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 110.986 -0.846 . . . . 73.400000000000006 110.986 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.474 ' C ' ' HA ' ' A' ' 490' ' ' SER . 37.8 m -78.97 157.15 76.55 Favored Pre-proline 0 N--CA 1.429 -1.492 0 N-CA-C 108.031 -1.1 . . . . 71.230000000000004 108.031 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.648 ' N ' ' HA ' ' A' ' 490' ' ' SER . 72.6 Cg_endo -73.19 -10.71 24.57 Favored 'Trans proline' 0 CA--C 1.594 3.5 0 N-CA-C 120.683 3.301 . . . . 61.509999999999998 120.683 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.648 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 19.6 m -116.4 104.04 11.06 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 123.742 2.974 . . . . 72.209999999999994 108.137 -0.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 48.8 m -135.14 115.95 13.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 110.002 -0.37 . . . . 73.129999999999995 110.002 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -114.46 115.37 27.16 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.244 -1.021 . . . . 71.120000000000005 108.244 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 380' ' ' THR . 30.8 m -86.0 121.26 28.37 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.876 0.37 . . . . 65.319999999999993 110.486 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 390' ' ' VAL . 73.6 t -107.25 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.411 -0.959 . . . . 65.329999999999998 108.411 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 24.5 m -98.14 112.85 24.67 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.815 -1.18 . . . . 75.209999999999994 107.815 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.635 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.59 121.63 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 0 N-CA-C 109.212 -0.662 . . . . 72.239999999999995 109.212 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.436 ' O ' HD13 ' A' ' 384' ' ' LEU 0.29 23.3 m-85 -81.87 99.95 9.33 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-O 122.652 1.215 . . . . 71.209999999999994 112.459 177.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 4.7 t70 -49.89 -52.11 35.46 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 111.042 -2.799 . . . . 64.310000000000002 109.862 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.1 t70 65.94 6.47 4.06 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.018 1.727 . . . . 61.149999999999999 111.317 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . 0.615 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 58.4 m-20 -92.28 -56.0 3.21 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.911 -1.515 . . . . 75.099999999999994 106.911 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -116.75 -31.77 5.36 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.658 -1.156 . . . . 74.340000000000003 108.051 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 452' ' ' GLU . . . -118.12 104.15 10.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.318 -0.553 . . . . 70.340000000000003 111.736 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -105.81 179.83 23.44 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 111.5 -0.64 . . . . 71.219999999999999 111.5 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 58.4 mt -67.22 141.62 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 122.988 0.515 . . . . 72.329999999999998 109.939 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -90.21 93.67 9.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 110.001 -0.37 . . . . 61.439999999999998 110.001 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 90.8 m 63.76 95.98 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.21 1.189 . . . . 74.109999999999999 114.21 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -160.78 113.51 1.98 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.587 -0.733 . . . . 72.549999999999997 109.25 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -147.69 162.16 39.74 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.104 -1.072 . . . . 73.409999999999997 108.104 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.295 -1.785 0 O-C-N 123.14 0.275 . . . . 73.120000000000005 110.407 -177.741 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.635 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.637 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.387 0.613 . . . . 72.329999999999998 110.668 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 479' ' ' HIS . 15.4 m -84.41 94.54 8.53 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.488 0.661 . . . . 51.25 112.76 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.432 ' HD3' ' HA2' ' A' ' 487' ' ' GLY . 51.7 mttm -130.55 166.02 21.48 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.965 -0.561 . . . . 72.420000000000002 110.509 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 25.5 mm -115.36 124.55 72.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 107.421 -1.325 . . . . 64.209999999999994 107.421 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -155.64 -177.8 6.82 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 110.025 -0.361 . . . . 64.450000000000003 110.025 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -94.33 162.37 13.86 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.146 0.498 . . . . 63.020000000000003 112.054 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.11 -35.47 56.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.239 -0.891 . . . . 70.109999999999999 109.854 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 23.1 mm-40 -122.38 172.31 8.42 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.386 -0.825 . . . . 70.349999999999994 111.966 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -103.01 -37.18 3.21 Favored Glycine 0 C--N 1.293 -1.845 0 CA-C-N 114.465 -1.243 . . . . 65.349999999999994 110.025 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . 0.456 HG23 ' HB ' ' A' ' 493' ' ' THR . 26.0 m -133.02 130.98 40.15 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.452 0.644 . . . . 74.319999999999993 109.439 176.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 74.7 m-85 -113.43 143.9 43.71 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.112 -1.07 . . . . 71.120000000000005 108.112 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 495' ' ' THR . 15.7 mp0 -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.705 -0.85 . . . . 71.340000000000003 108.705 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 30.3 t -148.13 165.11 31.84 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.686 -0.857 . . . . 71.319999999999993 108.686 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.7 mm? -89.07 141.46 28.48 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 122.457 0.303 . . . . 60.149999999999999 110.617 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.627 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 9.6 tt0 -56.88 -35.73 69.27 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 122.163 0.982 . . . . 74.519999999999996 109.605 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -74.26 -7.83 54.12 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.897 -1.502 . . . . 73.299999999999997 111.4 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.57 -22.85 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.011 0.434 . . . . 54.25 111.239 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 93.14 -51.48 2.48 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.177 -1.011 . . . . 44.219999999999999 112.493 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 17.2 p -138.12 160.75 38.58 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.073 0.463 . . . . 54.219999999999999 111.175 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 5.6 p -116.5 132.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.126 -1.435 . . . . 71.349999999999994 107.126 172.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -104.06 115.54 30.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.405 0.621 . . . . 54.350000000000001 110.36 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.1 mp -105.65 147.43 28.49 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.825 -1.176 . . . . 71.549999999999997 107.825 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 19.7 m -108.76 129.45 55.37 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.489 -0.559 . . . . 75.230000000000004 109.489 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 72.1 mt -97.98 119.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.465 -1.309 . . . . 74.319999999999993 107.465 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.17 121.6 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 115.473 -0.785 . . . . 55.240000000000002 109.324 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.44 129.93 55.87 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.222 -1.399 . . . . 73.540000000000006 107.222 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -106.7 167.28 9.97 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.389 -0.597 . . . . 74.109999999999999 109.389 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 142.58 -16.93 2.44 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.765 -0.731 . . . . 62.219999999999999 112.1 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 94.19 -95.12 1.89 Allowed Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 109.766 -1.334 . . . . 45.439999999999998 109.766 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -129.56 119.7 24.1 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 108.752 -0.833 . . . . 74.239999999999995 108.752 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 79.7 mt -146.21 103.49 3.72 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.431 -0.951 . . . . 64.120000000000005 108.431 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 35.0 p -83.59 -1.09 53.08 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.635 0.731 . . . . 52.100000000000001 110.469 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -61.63 136.1 57.88 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 125.51 1.524 . . . . 64.329999999999998 108.681 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 33.4 m -85.04 113.72 21.66 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.336 0.588 . . . . 73.430000000000007 110.14 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 479' ' ' HIS . 57.7 t -112.98 148.04 16.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.675 -0.693 . . . . 70.329999999999998 109.501 -177.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.465 ' CE1' HG13 ' A' ' 430' ' ' VAL . 4.1 m-85 -123.55 132.62 53.95 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.821 0.849 . . . . 64.540000000000006 110.137 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.23 134.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.563 -1.273 . . . . 70.409999999999997 107.563 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.509 ' CB ' ' HB3' ' A' ' 462' ' ' ASN . 11.6 t70 -105.58 146.21 29.94 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.924 -0.485 . . . . 65.239999999999995 109.998 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -143.35 164.0 31.48 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.748 0.309 . . . . 62.240000000000002 110.257 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 17.2 ttp180 -166.42 169.28 14.12 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.693 -1.965 . . . . 73.129999999999995 105.693 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 68.5 p -96.72 145.9 25.37 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.303 0.573 . . . . 72.420000000000002 110.537 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 12.1 tp10 -108.67 133.75 52.33 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.929 -1.878 . . . . 73.129999999999995 105.929 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 416' ' ' ALA . 64.2 m-20 -42.69 -52.66 4.82 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.112 1.365 . . . . 63.450000000000003 114.24 -173.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 74.57 -90.9 0.75 Allowed Glycine 0 C--N 1.285 -2.28 0 CA-C-N 114.975 -1.011 . . . . 63.450000000000003 110.918 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 455' ' ' ASN . 9.4 t -124.86 -13.86 6.82 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.703 -0.851 . . . . 72.010000000000005 108.703 176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -105.86 -165.98 1.16 Allowed 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.288 -1.375 . . . . 74.510000000000005 107.288 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.52 115.87 10.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.116 -0.634 . . . . 60.409999999999997 110.62 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -72.56 138.51 46.92 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.809 -0.812 . . . . 73.120000000000005 108.809 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 97.85 -10.84 64.38 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.252 -1.139 . . . . 53.299999999999997 110.252 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 35.0 t -126.45 -56.09 1.42 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.792 -0.447 . . . . 64.409999999999997 109.792 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.593 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 13.6 m-20 -78.61 -54.88 5.66 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-O 121.541 0.686 . . . . 63.219999999999999 109.406 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.613 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -138.61 171.55 14.18 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 108.41 -0.959 . . . . 75.25 108.41 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 425' ' ' THR . 1.1 tm-20 -77.83 161.41 27.66 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.88 -1.156 . . . . 65.519999999999996 107.88 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.483 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 8.0 p90 -99.49 -12.98 19.69 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 112.451 0.538 . . . . 73.239999999999995 112.451 -174.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.485 HG21 HG22 ' A' ' 442' ' ' VAL 0.273 11.5 t 37.27 73.84 0.09 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.227 1.811 . . . . 65.409999999999997 113.449 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 410' ' ' ARG . 0.6 OUTLIER -79.71 138.31 37.29 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.397 -1.274 . . . . 64.140000000000001 108.755 177.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 179.66 169.31 39.81 Favored Glycine 0 N--CA 1.413 -2.863 0 C-N-CA 118.777 -1.678 . . . . 70.129999999999995 112.205 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 5.9 m -117.41 133.67 55.71 Favored 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 106.69 -1.596 . . . . 63.340000000000003 106.69 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 39.2 t -96.14 119.85 44.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.745 -0.835 . . . . 70.129999999999995 108.745 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.465 HG13 ' CE1' ' A' ' 406' ' ' PHE . 44.0 t -95.73 117.44 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.941 -0.763 . . . . 71.219999999999999 108.941 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 404' ' ' THR . 59.9 m-85 -89.77 110.32 21.24 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 116.056 -0.52 . . . . 63.350000000000001 111.291 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.32 164.82 23.31 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.476 -0.784 . . . . 71.420000000000002 110.359 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -52.28 113.57 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.664 2.243 . . . . 72.150000000000006 112.236 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.58 25.29 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 111.134 -0.787 . . . . 73.109999999999999 111.134 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -81.85 63.23 6.01 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 123.533 0.733 . . . . 63.140000000000001 110.514 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 11.3 t -79.19 -7.69 58.43 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.874 -1.158 . . . . 71.519999999999996 107.874 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -136.92 137.09 39.2 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.905 -1.517 . . . . 75.540000000000006 106.905 172.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -125.98 153.23 44.62 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 111.596 0.221 . . . . 70.420000000000002 111.596 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -112.48 132.5 55.04 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.475 -0.565 . . . . 53.219999999999999 109.475 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 41.1 pt -127.07 146.01 33.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.255 -1.017 . . . . 64.420000000000002 108.255 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 52.5 mtt180 -125.8 145.56 50.16 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.133 0.492 . . . . 71.25 111.886 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 425' ' ' THR . 48.9 t -113.42 124.05 69.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.269 -1.382 . . . . 74.209999999999994 107.269 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -76.05 137.05 20.78 Favored Glycine 0 N--CA 1.435 -1.428 0 O-C-N 123.816 0.698 . . . . 73.519999999999996 111.866 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.507 HD12 HG12 ' A' ' 496' ' ' ILE . 36.8 mm -96.8 132.28 41.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.014 -0.735 . . . . 65.329999999999998 109.014 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 80.5 mt -94.53 149.91 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.541 -1.651 . . . . 34.229999999999997 106.541 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.92 86.9 5.38 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.471 -0.491 . . . . 75.109999999999999 111.868 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.64 120.99 43.43 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 104.717 -2.327 . . . . 73.010000000000005 104.717 172.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.605 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.289 4.0 t70 -118.35 90.2 3.28 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 116.046 -2.262 . . . . 72.319999999999993 112.398 178.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.731 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.2 mm -120.21 155.62 23.24 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 110.747 -2.933 . . . . 74.519999999999996 104.041 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -54.26 114.84 1.78 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.602 -1.629 . . . . 71.010000000000005 106.602 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 47.4 mt-10 -107.42 98.34 7.97 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.564 1.173 . . . . 71.209999999999994 112.676 -171.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -112.58 108.47 17.57 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.673 -2.058 . . . . 71.030000000000001 107.681 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 42.07 60.56 2.23 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.99 1.431 . . . . 52.109999999999999 111.256 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.407 ' OE2' ' HG2' ' A' ' 451' ' ' GLU . 12.0 tt0 -89.15 107.22 18.93 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.914 -1.513 . . . . 63.509999999999998 106.914 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 0.3 OUTLIER -136.92 159.98 40.27 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 114.684 1.364 . . . . 55.020000000000003 114.684 -175.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 412' ' ' GLU . 34.0 p90 -132.97 177.61 7.52 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.359 -1.291 . . . . 74.439999999999998 108.613 174.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.3 mt -120.47 136.99 54.58 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.82 -0.808 . . . . 75.420000000000002 108.82 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 41.0 t -108.84 125.87 65.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.277 -1.009 . . . . 73.409999999999997 108.277 176.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -120.68 152.98 37.54 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.923 -0.581 . . . . 72.319999999999993 109.561 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 72.9 mt -109.19 140.61 42.57 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.465 -0.569 . . . . 70.329999999999998 109.465 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.7 m -152.54 -173.13 4.45 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.592 0.757 . . . . 43.130000000000003 108.961 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.509 ' HB3' ' CB ' ' A' ' 408' ' ' ASP . 3.0 t30 48.89 81.28 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.95 1.3 . . . . 65.430000000000007 111.267 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.09 128.0 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.879 -1.156 . . . . 72.239999999999995 107.879 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 88.0 tttt -144.51 141.97 29.9 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-O 121.163 0.506 . . . . 75.0 111.185 -174.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 29.2 t -110.39 146.69 15.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 105.542 -2.022 . . . . 61.539999999999999 105.542 175.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.4 t -103.06 120.61 40.98 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.611 -0.835 . . . . 63.140000000000001 112.249 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 48.0 t -129.28 132.89 47.26 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.347 -2.464 . . . . 74.129999999999995 104.347 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.51 -33.7 18.88 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.366 -0.534 . . . . 63.520000000000003 112.128 -172.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -103.14 -39.81 6.71 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.446 0.535 . . . . 62.210000000000001 112.446 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 47.2 t -96.48 128.02 43.02 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.167 0.508 . . . . 74.439999999999998 111.48 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -71.0 -28.6 64.54 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.847 -0.798 . . . . 73.109999999999999 108.847 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -101.16 15.89 27.25 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 115.424 -0.807 . . . . 52.149999999999999 112.226 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . -81.79 44.97 3.2 Favored Glycine 0 C--N 1.315 -0.596 0 N-CA-C 110.8 -0.92 . . . . 71.129999999999995 110.8 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.482 HG22 ' OG ' ' A' ' 481' ' ' SER . 14.9 mm -126.26 30.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 106.255 -1.758 . . . . 75.319999999999993 106.255 -174.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 76.1 mt -82.28 -20.62 37.14 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.918 -1.037 . . . . 42.229999999999997 111.944 -173.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -72.6 87.73 1.23 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 122.432 1.11 . . . . 71.140000000000001 112.254 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -87.81 -11.91 46.57 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.862 -1.063 . . . . 62.509999999999998 108.902 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -52.2 -45.82 65.35 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.666 -1.152 . . . . 74.030000000000001 110.65 176.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 372' ' ' SER . 0.9 OUTLIER -82.5 -97.04 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.151 -1.426 . . . . 74.340000000000003 107.151 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.48 145.71 18.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 104.483 -2.414 . . . . 72.430000000000007 104.483 171.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.503 ' H ' ' HB3' ' A' ' 484' ' ' ALA . 37.4 t -146.48 176.75 9.57 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.517 -0.92 . . . . 41.210000000000001 108.517 -175.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -77.1 72.38 3.64 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 121.365 0.602 . . . . 73.329999999999998 110.136 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 179.13 -38.74 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 104.902 -2.259 . . . . 72.530000000000001 104.902 -176.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.503 ' HB3' ' H ' ' A' ' 481' ' ' SER . . . -90.59 -178.59 5.34 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.006 -1.452 . . . . 73.420000000000002 109.563 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 69.1 m -131.52 -177.62 4.49 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.864 -1.161 . . . . 73.299999999999997 107.864 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.496 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 1.6 mm? -87.98 -159.53 0.55 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.252 -0.648 . . . . 73.019999999999996 109.252 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.432 ' HA2' ' HD3' ' A' ' 373' ' ' LYS . . . -70.76 134.59 23.99 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 104.838 -3.305 . . . . 73.430000000000007 104.838 170.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.613 ' HA ' ' OG ' ' A' ' 490' ' ' SER . 14.5 m -115.56 77.56 6.11 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 118.075 2.62 . . . . 63.439999999999998 118.075 -168.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 490' ' ' SER . 17.1 Cg_exo -70.59 -61.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.401 -3.938 0 N-CA-C 109.199 -1.116 . . . . 74.099999999999994 109.199 155.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.613 ' OG ' ' HA ' ' A' ' 488' ' ' SER . 44.8 m -125.79 89.89 3.11 Favored 'General case' 0 C--N 1.387 2.208 0 C-N-CA 129.323 3.049 . . . . 75.530000000000001 106.283 -3.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 25.7 m -143.05 113.47 7.35 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 120.381 -0.528 . . . . 64.319999999999993 110.704 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -104.22 100.46 10.19 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.277 -1.379 . . . . 42.229999999999997 107.277 171.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . 0.456 ' HB ' HG23 ' A' ' 380' ' ' THR . 29.9 m -78.06 129.6 35.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.948 -0.76 . . . . 72.420000000000002 108.948 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 390' ' ' VAL . 92.4 t -117.25 109.23 27.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.398 -0.593 . . . . 73.010000000000005 109.398 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 26.8 m -98.28 115.67 28.89 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.987 -0.746 . . . . 73.209999999999994 108.987 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.613 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -95.81 124.46 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 CA-C-O 122.075 0.941 . . . . 73.329999999999998 110.002 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 71.7 m-85 -108.04 126.05 52.28 Favored 'General case' 0 N--CA 1.396 -3.156 0 CA-C-N 114.588 -1.187 . . . . 71.5 109.06 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.603 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 50.4 t0 -91.28 -19.7 22.7 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 104.431 -2.433 . . . . 73.430000000000007 104.431 166.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 38.3 t70 74.45 4.15 4.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 111.795 -2.457 . . . . 73.340000000000003 111.677 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -55.24 -65.98 0.49 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.935 -1.029 . . . . 72.430000000000007 113.362 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -95.14 -0.36 53.45 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.203 0.525 . . . . 75.040000000000006 110.231 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 499' ' ' ASP . . . -80.67 -74.21 0.33 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.962 -0.563 . . . . 71.129999999999995 110.298 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.28 44.57 5.87 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 121.029 -0.605 . . . . 60.340000000000003 112.24 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 46.6 pt -108.88 -13.42 10.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.762 0.792 . . . . 54.409999999999997 109.762 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -134.9 -167.91 2.07 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 105.411 -2.07 . . . . 73.140000000000001 105.411 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.5 t -140.1 108.99 5.98 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 108.052 -1.092 . . . . 63.219999999999999 108.052 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -87.76 108.67 19.24 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 108.419 -0.956 . . . . 75.120000000000005 108.419 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.28 -67.54 0.79 Allowed 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.009 -0.996 . . . . 74.25 110.624 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 C--O 1.247 0.935 0 N-CA-C 108.792 -0.818 . . . . 64.519999999999996 108.792 -175.275 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.637 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.608 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.235 0.337 0 N-CA-C 109.832 -0.433 . . . . 44.039999999999999 109.832 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.403 ' OG ' HD21 ' A' ' 401' ' ' LEU . 13.3 m -112.6 117.27 31.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.357 -0.979 . . . . 45.520000000000003 108.357 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.693 ' HA ' HG13 ' A' ' 480' ' ' VAL . 53.0 mttp -93.76 137.25 33.2 Favored 'General case' 0 CA--C 1.477 -1.846 0 C-N-CA 120.182 -0.607 . . . . 72.239999999999995 112.026 176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.657 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 37.9 mm -114.49 106.86 21.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.252 -1.34 . . . . 70.329999999999998 108.728 -170.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.55 155.84 43.86 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 119.81 -0.756 . . . . 61.530000000000001 111.515 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -76.49 150.88 36.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.407 -0.361 . . . . 73.230000000000004 110.132 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.8 -42.27 86.21 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.532 -0.914 . . . . 71.219999999999999 108.532 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.543 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 15.4 mm100 -106.29 -171.75 1.96 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.869 -1.059 . . . . 62.340000000000003 110.221 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -123.02 -32.67 0.9 Allowed Glycine 0 C--N 1.289 -2.04 0 N-CA-C 109.233 -1.547 . . . . 71.239999999999995 109.233 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.2 m -127.84 141.4 51.58 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 107.907 -1.145 . . . . 72.310000000000002 107.907 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 64.5 m-85 -127.88 136.27 51.16 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.361 -0.978 . . . . 75.299999999999997 108.361 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.24 129.35 54.89 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.537 -1.283 . . . . 70.519999999999996 107.537 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 48.6 t -146.16 163.11 36.41 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.243 -0.651 . . . . 71.049999999999997 109.243 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -81.64 146.5 30.03 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.219 0.608 . . . . 71.340000000000003 111.917 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.642 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 11.5 tt0 -58.12 -49.63 76.29 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.283 -1.006 . . . . 72.209999999999994 108.283 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.487 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.8 p-10 -73.55 16.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.911 -1.041 . . . . 71.150000000000006 113.706 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.1 t -86.71 -26.65 24.15 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.184 0.516 . . . . 62.210000000000001 109.725 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 96.78 -49.92 1.57 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.762 -0.732 . . . . 75.239999999999995 111.486 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.424 HG22 ' HA2' ' A' ' 443' ' ' GLY . 11.4 p -143.31 152.36 41.57 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.855 0.462 . . . . 71.129999999999995 109.943 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.52 HG12 ' HB ' ' A' ' 442' ' ' VAL . 5.7 p -107.42 133.88 50.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.146 -1.427 . . . . 65.319999999999993 107.146 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -103.18 126.43 50.35 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 123.299 0.375 . . . . 62.240000000000002 110.142 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.4 mp -119.59 145.94 45.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.961 -1.496 . . . . 72.430000000000007 106.961 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 56.7 m -113.14 127.65 56.26 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.438 -0.505 . . . . 74.299999999999997 110.831 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 70.1 mt -98.43 126.22 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 107.828 -1.175 . . . . 75.209999999999994 107.828 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 397' ' ' ARG . 43.7 mm -102.24 125.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.398 -1.334 . . . . 75.010000000000005 107.398 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 16.8 ttp180 -109.38 108.49 19.06 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.464 -0.335 . . . . 63.399999999999999 110.373 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 395' ' ' ILE . 80.2 mtp180 -129.34 168.24 16.55 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.281 -0.418 . . . . 55.340000000000003 111.495 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 133.78 -6.0 4.8 Favored Glycine 0 C--N 1.31 -0.869 0 N-CA-C 110.311 -1.116 . . . . 62.509999999999998 110.311 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 135.74 175.83 14.04 Favored Glycine 0 N--CA 1.424 -2.157 0 N-CA-C 108.189 -1.964 . . . . 65.230000000000004 108.189 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -118.15 120.98 39.36 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.813 -1.155 . . . . 63.329999999999998 110.75 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.403 HD21 ' OG ' ' A' ' 372' ' ' SER . 1.7 pt? -139.94 158.41 44.12 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.914 -1.513 . . . . 73.329999999999998 106.914 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 77.2 p -91.02 6.78 43.43 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.961 0.41 . . . . 71.340000000000003 111.932 -175.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -66.26 134.65 53.1 Favored 'General case' 0 C--O 1.255 1.394 0 CA-C-O 121.662 0.744 . . . . 64.450000000000003 112.232 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 18.7 m -86.13 113.76 22.43 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.131 -1.395 . . . . 65.109999999999999 109.739 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.49 133.82 51.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 114.599 -1.182 . . . . 65.510000000000005 109.259 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.496 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 21.8 m-85 -113.62 123.61 50.36 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.599 -0.728 . . . . 73.5 109.234 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.56 128.94 74.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.721 -0.844 . . . . 60.43 108.721 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 26.8 t70 -94.4 139.38 31.18 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 120.848 0.356 . . . . 62.539999999999999 110.725 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -132.56 153.98 50.46 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.858 -0.526 . . . . 71.129999999999995 111.108 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -159.39 163.64 35.33 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.433 -0.951 . . . . 75.430000000000007 108.433 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 77.2 p -101.01 171.85 7.38 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 120.667 0.27 . . . . 72.340000000000003 111.139 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.3 151.1 37.66 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.06 -0.719 . . . . 73.219999999999999 109.06 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.11 1.63 35.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 118.345 -0.836 . . . . 62.25 113.054 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -4.49 -97.08 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 0 C-N-CA 125.842 1.687 . . . . 71.439999999999998 115.185 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 10.9 t -105.47 -18.66 14.03 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.296 -0.631 . . . . 74.219999999999999 109.296 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.471 ' HB2' ' HG2' ' A' ' 454' ' ' GLU . . . -118.52 143.56 46.66 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.955 -0.758 . . . . 63.109999999999999 108.955 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -108.02 113.83 27.29 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 121.487 0.66 . . . . 71.540000000000006 111.59 -166.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -74.78 124.39 26.72 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.335 -0.848 . . . . 64.439999999999998 109.685 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.35 -28.35 6.05 Favored Glycine 0 C--N 1.294 -1.756 0 N-CA-C 109.19 -1.564 . . . . 65.400000000000006 109.19 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 32.6 t -117.03 -52.64 2.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.474 -0.363 . . . . 71.430000000000007 110.205 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.624 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 6.4 m-20 -75.63 -59.94 2.53 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.865 0.84 . . . . 41.240000000000002 110.24 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.525 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.1 OUTLIER -136.93 176.48 8.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.714 -1.587 . . . . 72.030000000000001 106.714 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -83.76 157.67 22.03 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.014 -0.736 . . . . 50.310000000000002 109.014 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -91.52 -8.93 46.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.068 -0.515 . . . . 74.140000000000001 112.337 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.555 HG21 HG22 ' A' ' 442' ' ' VAL . 15.1 t 37.9 63.73 0.76 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.681 1.593 . . . . 74.439999999999998 113.252 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.56 110.98 15.39 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.216 -0.902 . . . . 63.520000000000003 109.576 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.0 174.24 33.24 Favored Glycine 0 N--CA 1.41 -3.046 0 CA-C-N 115.079 -0.964 . . . . 54.409999999999997 111.119 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 69.6 m -125.49 133.45 52.38 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 107.139 -1.43 . . . . 74.25 107.139 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.44 129.47 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.358 -0.978 . . . . 54.009999999999998 108.358 -176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.11 104.87 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.342 -0.845 . . . . 73.040000000000006 108.873 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 404' ' ' THR . 67.7 m-85 -84.8 108.39 17.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.867 -0.606 . . . . 73.329999999999998 111.325 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.441 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -90.1 165.04 25.63 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.773 -0.649 . . . . 60.409999999999997 110.093 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -50.92 127.73 22.4 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.991 2.461 . . . . 71.430000000000007 112.184 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 93.66 -17.65 58.13 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 115.839 -0.619 . . . . 70.340000000000003 113.426 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 71.2 mt-10 -84.24 63.88 7.97 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.866 0.841 . . . . 71.319999999999993 112.957 -176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 39.2 m -60.36 -24.06 64.77 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.009 -1.45 . . . . 55.100000000000001 110.707 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -128.57 138.88 52.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.7 -0.625 . . . . 75.239999999999995 110.36 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 438' ' ' LYS . 20.1 mmmt -134.87 145.65 48.48 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 120.941 0.401 . . . . 71.150000000000006 111.498 173.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -109.04 134.43 51.68 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.522 -0.763 . . . . 65.129999999999995 110.259 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 47.7 pt -116.34 137.05 51.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.826 -0.625 . . . . 60.43 109.514 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 17.5 mmt180 -109.05 132.84 53.73 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.297 -0.865 . . . . 74.030000000000001 111.286 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 425' ' ' THR . 47.9 t -108.23 116.79 52.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.674 -1.232 . . . . 73.5 107.674 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -61.2 130.79 47.52 Favored Glycine 0 N--CA 1.44 -1.096 0 O-C-N 124.482 1.114 . . . . 71.430000000000007 113.083 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.429 ' HA ' ' HB3' ' A' ' 422' ' ' TYR . 33.3 mm -101.45 130.66 50.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.393 -1.336 . . . . 74.409999999999997 107.393 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 68.7 mt -98.38 150.04 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 105.485 -2.042 . . . . 75.140000000000001 105.485 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -84.64 86.13 7.35 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.405 -0.918 . . . . 72.239999999999995 111.564 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.39 124.27 51.4 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 103.269 -2.863 . . . . 51.119999999999997 103.269 169.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.625 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 25.1 t70 -119.38 94.73 4.52 Favored 'General case' 0 CA--C 1.456 -2.658 0 C-N-CA 116.836 -1.945 . . . . 62.119999999999997 110.841 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . . . . . . . . . 39.9 mm -118.29 155.47 20.28 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.816 0 CA-C-N 111.752 -2.476 . . . . 74.150000000000006 105.379 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.43 115.06 2.75 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.114 -1.81 . . . . 73.329999999999998 106.114 170.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.64 ' OE2' 'CA ' ' A' ' 650' ' ' ' CA' . 29.5 mt-10 -129.37 94.28 3.75 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.847 1.308 . . . . 74.230000000000004 110.442 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.74 106.29 18.56 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 113.703 -1.59 . . . . 72.420000000000002 108.747 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . 0.28 4.4 p30 42.39 60.16 2.44 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.86 1.35 . . . . 73.219999999999999 112.971 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 416' ' ' ALA . 36.4 tt0 -87.29 135.22 33.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.252 -1.388 . . . . 70.310000000000002 107.252 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -149.55 161.45 42.13 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.238 0.542 . . . . 75.549999999999997 111.941 -172.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.495 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 17.4 p90 -137.91 -177.98 5.05 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.71 -0.677 . . . . 73.109999999999999 110.225 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -119.82 145.04 47.0 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.274 -1.01 . . . . 72.5 108.274 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.24 132.16 67.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 106.828 -1.545 . . . . 51.119999999999997 106.828 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -123.06 139.43 54.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.423 0.452 . . . . 52.25 111.033 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 85.2 mt -100.07 136.69 39.59 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.31 -1.367 . . . . 73.140000000000001 107.31 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 44.5 m -157.77 174.3 15.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.425 -0.583 . . . . 53.43 109.425 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.4 t30 54.18 90.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.858 1.263 . . . . 73.329999999999998 112.596 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.531 HG11 HG23 ' A' ' 480' ' ' VAL . 99.1 t -90.2 123.19 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.644 -0.707 . . . . 52.439999999999998 109.688 176.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 37.2 ttmt -116.86 129.45 56.08 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.362 -1.347 . . . . 74.200000000000003 107.362 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 31.3 t -103.41 151.56 6.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.77 -1.567 . . . . 73.230000000000004 106.77 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 404' ' ' THR . 17.6 t -73.81 111.68 9.19 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.215 -1.031 . . . . 73.349999999999994 108.215 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 14.9 m -82.34 157.31 23.83 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.936 -1.029 . . . . 70.450000000000003 110.272 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 67.15 25.61 9.0 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.556 1.142 . . . . 62.109999999999999 110.037 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.85 75.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 114.912 -1.04 . . . . 61.020000000000003 109.996 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . 0.462 ' HB2' ' HB ' ' A' ' 474' ' ' ILE . 40.3 m -146.24 99.96 3.31 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.519 -1.66 . . . . 74.319999999999993 106.519 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -57.27 -24.99 58.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.211 -0.904 . . . . 73.129999999999995 112.614 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -107.08 113.42 26.87 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.537 -1.283 . . . . 73.430000000000007 107.537 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 99.42 -49.41 1.21 Allowed Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.686 -0.768 . . . . 64.129999999999995 114.473 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 470' ' ' SER . 38.7 mm -107.72 75.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 118.249 1.024 . . . . 72.120000000000005 112.671 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 92.2 mt -121.56 20.35 11.11 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.973 -1.862 . . . . 72.209999999999994 105.973 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.37 167.75 21.04 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 113.04 -1.891 . . . . 62.420000000000002 110.736 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -68.2 -64.11 0.93 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.825 -0.625 . . . . 62.32 110.995 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . 0.296 0.2 OUTLIER 35.45 55.59 0.86 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.548 1.139 . . . . 70.420000000000002 113.87 -178.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 481' ' ' SER . 39.0 m80 -87.19 -172.95 4.18 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.004 -0.998 . . . . 72.530000000000001 109.581 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.693 HG13 ' HA ' ' A' ' 373' ' ' LYS . 59.7 t -70.68 -41.46 77.69 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 CA-C-O 121.805 0.812 . . . . 62.43 108.944 176.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 479' ' ' HIS . 34.0 t -130.11 -153.46 0.57 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.99 -1.856 . . . . 73.010000000000005 105.99 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.36 -46.58 86.04 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.211 -1.033 . . . . 72.239999999999995 108.211 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -123.87 -68.97 0.84 Allowed 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.097 -1.816 . . . . 74.140000000000001 106.097 171.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -161.24 114.86 1.97 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 113.675 0.991 . . . . 62.520000000000003 113.675 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 40.4 t -151.38 115.12 4.91 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 102.131 -3.285 . . . . 74.150000000000006 102.131 171.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.657 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 2.8 mm? -69.39 -56.58 7.04 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 115.026 1.491 . . . . 74.230000000000004 115.026 -166.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 155.05 -43.11 0.57 Allowed Glycine 0 C--N 1.292 -1.893 0 N-CA-C 107.369 -2.292 . . . . 71.209999999999994 107.369 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 13.1 m -85.93 173.43 6.91 Favored Pre-proline 0 C--N 1.307 -1.263 0 N-CA-C 106.503 -1.666 . . . . 71.450000000000003 106.503 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.616 ' N ' ' HA ' ' A' ' 490' ' ' SER . 32.0 Cg_exo -51.88 -35.43 59.69 Favored 'Trans proline' 0 CA--C 1.588 3.202 0 N-CA-C 119.684 2.917 . . . . 63.520000000000003 119.684 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.616 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 29.7 t -105.32 112.39 25.48 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 127.156 2.182 . . . . 74.120000000000005 108.921 0.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 55.4 m -133.25 110.29 10.0 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.638 -0.71 . . . . 61.130000000000003 109.413 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.18 130.4 53.35 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.845 -1.168 . . . . 72.219999999999999 107.845 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 123.37 41.19 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.523 -0.471 . . . . 74.329999999999998 109.9 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.502 HG11 HG11 ' A' ' 390' ' ' VAL . 76.5 t -108.3 107.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.248 -0.649 . . . . 61.140000000000001 109.248 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 10.2 m -91.03 116.54 28.88 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.069 -1.086 . . . . 54.43 108.069 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 50.1 mt -101.97 114.64 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.218 1.009 . . . . 73.400000000000006 110.902 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.504 ' O ' HD13 ' A' ' 384' ' ' LEU . 5.3 m-85 -84.05 102.36 12.46 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 114.24 -1.346 . . . . 74.010000000000005 110.777 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 451' ' ' GLU . 23.5 t70 -52.28 -54.87 25.86 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 112.418 -2.174 . . . . 71.209999999999994 108.518 172.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.1 t70 71.63 -10.88 0.78 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.23 -1.804 . . . . 44.509999999999998 112.003 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -73.57 -44.07 58.24 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.215 -1.772 . . . . 63.350000000000001 106.215 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -124.04 85.44 2.42 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.556 -1.202 . . . . 70.430000000000007 108.512 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -150.09 -49.97 0.14 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.764 -0.653 . . . . 73.129999999999995 110.44 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 75.09 32.42 56.36 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.869 -0.605 . . . . 55.0 111.921 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 50.5 pt -93.42 162.54 2.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 120.964 0.411 . . . . 70.450000000000003 110.533 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.51 163.39 16.14 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.432 -1.321 . . . . 73.209999999999994 107.432 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 7.3 p -79.29 82.15 5.48 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.72 0.771 . . . . 74.140000000000001 110.99 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -147.45 142.11 26.65 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 105.449 -2.056 . . . . 71.150000000000006 105.449 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.71 155.3 39.57 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.5 0.667 . . . . 62.520000000000003 112.473 -175.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 . . . . . 0 C--N 1.306 -1.298 0 CA-C-N 115.738 -0.665 . . . . 72.319999999999993 109.528 -179.581 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.642 'CA ' ' OE1' ' A' ' 385' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.64 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 477' ' ' ALA . 13.2 p . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 108.682 -0.859 . . . . 71.349999999999994 108.682 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 48.0 m -118.7 140.57 49.72 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.048 -1.093 . . . . 71.230000000000004 108.048 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 32.9 mmtp -137.33 119.64 15.73 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.199 -1.037 . . . . 74.219999999999999 108.199 169.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.571 ' HB ' HD12 ' A' ' 486' ' ' LEU . 42.7 mm -105.67 114.6 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.52 -0.919 . . . . 73.349999999999994 108.52 -175.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -149.33 174.61 12.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 118.488 0.585 . . . . 72.209999999999994 111.319 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.28 146.76 26.89 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.01 -0.366 . . . . 71.299999999999997 110.01 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.668 -1.604 . . . . 73.310000000000002 106.668 175.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.512 ' HB2' ' CE1' ' A' ' 381' ' ' TYR . 4.8 mt-30 -102.31 144.14 31.19 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.288 -0.869 . . . . 62.420000000000002 110.201 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -93.13 -12.4 57.59 Favored Glycine 0 C--N 1.284 -2.341 0 CA-C-N 115.699 -0.682 . . . . 72.030000000000001 111.553 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 25.6 m -140.37 131.37 26.18 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.644 -0.873 . . . . 65.219999999999999 108.644 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' A' ' 378' ' ' GLN . 72.5 m-85 -127.42 136.59 52.04 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.709 -0.848 . . . . 75.319999999999993 108.709 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -121.84 123.15 41.08 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.549 -1.278 . . . . 71.140000000000001 107.549 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 43.9 t -134.9 165.38 25.45 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.512 -0.551 . . . . 74.030000000000001 109.512 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 3.3 mm? -95.38 141.64 28.7 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.478 -0.783 . . . . 73.430000000000007 109.722 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.9 -36.93 78.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.822 -0.807 . . . . 61.43 108.822 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -65.53 -14.26 60.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.621 -1.172 . . . . 73.530000000000001 112.689 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 76.6 m -72.52 -19.22 61.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.769 0.285 . . . . 75.129999999999995 111.769 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.83 -48.48 3.03 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.309 -0.716 . . . . 64.200000000000003 111.309 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 13.1 p -141.51 161.34 38.16 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.605 0.762 . . . . 51.32 109.807 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 3.4 p -114.14 130.0 69.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.832 -1.173 . . . . 71.140000000000001 107.832 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -99.98 128.3 46.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 123.558 0.536 . . . . 72.420000000000002 110.174 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -122.52 151.04 41.76 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.677 -1.231 . . . . 53.549999999999997 107.677 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -112.03 128.83 56.3 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.336 0.588 . . . . 73.120000000000005 111.656 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 73.3 mt -101.53 126.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 107.913 -1.143 . . . . 62.329999999999998 107.913 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.2 mm -100.0 128.23 52.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.56 -0.904 . . . . 73.140000000000001 108.56 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.498 ' NH1' ' HB3' ' A' ' 431' ' ' PHE . 59.9 ttt180 -112.58 107.65 16.45 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.527 -0.916 . . . . 65.540000000000006 108.527 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -98.69 164.35 12.27 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.708 -0.678 . . . . 72.109999999999999 111.405 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 371' ' ' VAL . . . 130.45 -11.01 5.81 Favored Glycine 0 N--CA 1.435 -1.369 0 O-C-N 124.351 1.032 . . . . 75.430000000000007 110.869 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 123.34 -127.9 6.79 Favored Glycine 0 N--CA 1.426 -1.98 0 N-CA-C 111.279 -0.729 . . . . 62.149999999999999 111.279 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -124.58 123.98 41.25 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 106.625 -1.62 . . . . 52.229999999999997 106.625 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.08 134.38 47.33 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 113.609 0.966 . . . . 75.329999999999998 113.609 -166.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 433' ' ' PRO . 6.9 p -105.64 -2.61 23.21 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 114.523 -1.217 . . . . 73.230000000000004 110.935 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -75.07 161.62 29.26 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.722 -0.672 . . . . 74.109999999999999 110.425 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m -112.69 112.91 24.76 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.798 0.808 . . . . 65.530000000000001 111.085 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 67.2 t -115.49 149.1 17.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.702 -1.136 . . . . 55.200000000000003 109.18 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 11.8 m-85 -126.69 147.42 49.95 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.338 0.59 . . . . 74.450000000000003 110.015 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.1 p -143.82 130.49 16.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.557 -0.535 . . . . 75.319999999999993 109.557 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -93.41 128.56 39.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.476 -0.565 . . . . 72.329999999999998 109.476 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -123.77 153.11 41.41 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.536 -0.912 . . . . 72.099999999999994 108.536 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -161.23 161.1 30.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.6 -1.259 . . . . 63.350000000000001 107.6 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.461 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 71.2 p -96.62 172.03 8.17 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.36 0.6 . . . . 63.039999999999999 109.859 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 6.8 tp10 -127.37 153.95 45.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.517 -2.031 . . . . 75.230000000000004 105.517 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 7.3 p-10 -58.2 -41.94 85.05 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.626 0.579 . . . . 64.049999999999997 112.425 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 64.62 -94.43 0.16 Allowed Glycine 0 C--N 1.294 -1.77 0 CA-C-N 115.478 -0.783 . . . . 53.240000000000002 111.696 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.9 t -127.74 7.83 6.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.655 0.741 . . . . 53.420000000000002 109.495 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 413' ' ' ASP . . . -130.94 -159.48 0.97 Allowed 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.043 -1.466 . . . . 55.409999999999997 107.043 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -141.68 116.67 9.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.072 0.463 . . . . 75.109999999999999 110.546 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -71.44 128.72 36.78 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.905 -0.589 . . . . 75.329999999999998 109.557 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.45 -24.38 15.78 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.445 -1.462 . . . . 71.340000000000003 109.445 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 21.2 t -111.93 -55.76 2.47 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 109.632 -0.507 . . . . 63.039999999999999 109.632 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 11.1 m-20 -80.09 -56.72 4.03 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.844 0.83 . . . . 62.310000000000002 110.055 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.5 ' HA ' ' H ' ' A' ' 445' ' ' ILE . 0.0 OUTLIER -136.95 167.78 20.84 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.191 -1.411 . . . . 74.129999999999995 107.191 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -74.96 152.05 38.81 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.308 -0.627 . . . . 74.019999999999996 109.308 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.461 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -85.76 -13.17 49.1 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.93 -0.577 . . . . 75.439999999999998 111.547 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 442' ' ' VAL 0.253 14.7 t 35.5 63.11 0.55 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 126.1 1.76 . . . . 73.019999999999996 113.152 179.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.35 107.55 12.2 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 114.981 -1.008 . . . . 73.439999999999998 109.097 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -147.49 171.51 28.08 Favored Glycine 1 N--CA 1.394 -4.126 0 C-N-CA 119.125 -1.512 . . . . 71.5 112.07 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 25.5 m -124.27 136.13 53.91 Favored 'General case' 0 N--CA 1.388 -3.558 0 N-CA-C 106.652 -1.61 . . . . 51.329999999999998 106.652 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 21.7 t -95.77 126.89 48.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.371 -0.974 . . . . 61.509999999999998 108.371 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.502 HG22 ' CE2' ' A' ' 406' ' ' PHE . 19.3 t -100.52 100.59 10.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.188 -1.041 . . . . 73.200000000000003 108.188 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.498 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 54.6 m-85 -80.91 104.51 11.46 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.32 -0.4 . . . . 75.049999999999997 111.006 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 435' ' ' GLU . 0.1 OUTLIER -84.53 169.47 16.6 Favored Pre-proline 0 C--O 1.256 1.432 0 CA-C-N 115.785 -0.643 . . . . 75.310000000000002 110.169 177.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 402' ' ' THR . 9.3 Cg_endo -53.08 132.74 49.17 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.79 2.327 . . . . 73.409999999999997 111.868 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 92.44 -25.57 17.63 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.851 -0.613 . . . . 75.109999999999999 113.224 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.48 ' OE1' ' HB2' ' A' ' 432' ' ' LYS . 44.9 mt-10 -75.57 64.47 1.66 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.86 0.864 . . . . 60.409999999999997 113.168 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 22.4 m -61.42 -23.64 65.96 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.437 -1.256 . . . . 73.420000000000002 109.149 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -132.8 143.25 49.44 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.192 -0.67 . . . . 71.299999999999997 109.192 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -131.31 149.82 52.4 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.049 -0.523 . . . . 73.400000000000006 110.457 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.1 135.51 51.51 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.798 -0.816 . . . . 54.009999999999998 108.798 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.8 pt -120.77 146.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.999 -1.111 . . . . 75.109999999999999 107.999 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 87.8 mtt180 -125.41 146.18 49.73 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.207 0.527 . . . . 73.310000000000002 110.651 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 425' ' ' THR . 51.1 t -113.37 120.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.863 -1.162 . . . . 73.409999999999997 107.863 178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -64.3 131.36 38.59 Favored Glycine 0 N--CA 1.439 -1.153 0 O-C-N 124.072 0.858 . . . . 74.340000000000003 111.897 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 43.3 mm -97.51 133.52 39.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.563 -1.273 . . . . 75.030000000000001 107.563 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 75.6 mt -98.77 150.43 4.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.049 -1.093 . . . . 63.420000000000002 108.049 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.9 86.8 5.39 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.224 0.535 . . . . 70.140000000000001 111.421 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -112.9 101.66 9.71 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 104.579 -2.378 . . . . 75.420000000000002 104.579 171.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.629 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.285 11.3 t70 -106.61 84.44 2.01 Favored 'General case' 0 CA--C 1.458 -2.572 0 C-N-CA 115.613 -2.435 . . . . 70.150000000000006 112.025 -177.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 46.1 mm -117.06 154.0 18.77 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.75 0 N-CA-C 103.388 -2.819 . . . . 65.329999999999998 103.388 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -52.09 116.15 2.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.32 0.964 . . . . 63.539999999999999 110.158 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 27.2 mt-10 -122.48 119.0 29.66 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.436 1.113 . . . . 72.540000000000006 113.258 -171.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 501' ' ' HIS . 34.4 mt-10 -131.07 110.92 11.55 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.563 -1.653 . . . . 74.030000000000001 106.847 177.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 48.63 60.52 3.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.72 1.378 . . . . 53.329999999999998 114.72 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' A' ' 451' ' ' GLU . 8.2 pt-20 -99.5 134.6 42.14 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.781 -1.168 . . . . 74.140000000000001 108.253 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 495' ' ' THR . 3.7 p-10 -149.25 166.19 29.65 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.372 0.606 . . . . 71.319999999999993 111.534 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.561 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 30.7 p90 -137.35 -177.73 4.91 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.248 -0.887 . . . . 73.409999999999997 109.404 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.8 mt -123.95 137.05 54.68 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.621 -1.251 . . . . 72.209999999999994 107.621 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 42.3 t -108.79 128.23 64.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.482 -1.303 . . . . 65.439999999999998 107.482 175.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -122.68 163.07 20.76 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.075 -0.511 . . . . 72.099999999999994 109.718 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 82.4 mt -118.2 134.04 55.36 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.252 -1.388 . . . . 64.239999999999995 107.252 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.0 m -150.43 161.46 42.46 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 109.222 -0.659 . . . . 52.520000000000003 109.222 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . 0.433 ' C ' HD22 ' A' ' 462' ' ' ASN . 0.2 OUTLIER 59.73 87.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.257 0.973 . . . . 72.299999999999997 110.918 178.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.16 137.94 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.681 -1.229 . . . . 65.420000000000002 107.681 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -135.02 146.21 48.8 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.114 -0.698 . . . . 65.219999999999999 109.114 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 11.1 t -127.49 157.7 39.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.006 -1.479 . . . . 72.129999999999995 107.006 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 49.0 m -72.16 110.28 6.51 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.402 -0.592 . . . . 61.340000000000003 109.402 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 17.6 m -55.89 123.56 14.68 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.487 -1.233 . . . . 65.340000000000003 112.2 -174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.68 168.16 9.26 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.283 -1.006 . . . . 65.329999999999998 108.283 174.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -74.02 -15.29 61.09 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.719 0.295 . . . . 60.530000000000001 111.527 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 18.4 t 68.83 24.51 6.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.403 1.081 . . . . 60.439999999999998 109.384 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -78.71 -50.31 11.62 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.603 -1.999 . . . . 62.229999999999997 105.603 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -107.33 -176.29 3.03 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.704 -2.332 . . . . 71.219999999999999 104.704 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 176.8 141.4 3.94 Favored Glycine 0 C--N 1.29 -2.01 0 C-N-CA 119.572 -1.299 . . . . 73.540000000000006 112.986 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 16.2 tt -147.87 83.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.561 1.172 . . . . 71.120000000000005 109.164 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.4 mt -84.73 110.45 18.79 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.644 -1.162 . . . . 71.099999999999994 110.72 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.29 177.49 6.91 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.683 -1.228 . . . . 73.230000000000004 107.683 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 371' ' ' VAL . . . -84.65 4.47 32.29 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.031 0.443 . . . . 71.329999999999998 110.148 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -64.15 -12.86 43.91 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.687 -0.688 . . . . 73.409999999999997 112.119 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -131.19 138.79 49.57 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.289 -0.634 . . . . 72.409999999999997 109.289 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 11.7 m -66.05 132.95 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 108.737 -0.838 . . . . 74.439999999999998 108.737 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 4.3 p -159.05 -76.48 0.07 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.131 0.491 . . . . 65.310000000000002 109.774 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -133.28 142.57 48.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.264 -1.754 . . . . 53.32 106.264 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 73.35 -55.04 0.68 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.504 1.521 . . . . 62.310000000000002 107.812 -174.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.49 114.06 26.16 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 106.724 -1.584 . . . . 34.240000000000002 106.724 172.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 78.1 m -133.83 -168.74 2.17 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 107.721 -1.214 . . . . 70.439999999999998 107.721 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.571 HD12 ' HB ' ' A' ' 374' ' ' ILE . 0.4 OUTLIER -60.28 151.17 28.19 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 109.839 -0.43 . . . . 73.329999999999998 109.839 -176.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.528 ' O ' ' HD3' ' A' ' 489' ' ' PRO . . . -67.37 118.08 9.68 Favored Glycine 0 CA--C 1.483 -1.919 0 N-CA-C 103.847 -3.701 . . . . 34.140000000000001 103.847 172.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.9 m -106.5 103.39 45.95 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 115.144 1.535 . . . . 64.349999999999994 115.144 -165.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 487' ' ' GLY . 2.9 Cg_exo -71.66 -63.12 0.04 OUTLIER 'Trans proline' 0 CA--C 1.586 3.119 0 C-N-CA 120.491 0.794 . . . . 64.140000000000001 110.897 162.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.514 ' HA ' ' CD ' ' A' ' 489' ' ' PRO . 19.0 m -126.34 88.5 2.85 Favored 'General case' 0 C--N 1.38 1.895 0 C-N-CA 127.362 2.265 . . . . 71.409999999999997 108.806 -3.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 97.7 m -144.51 110.98 5.6 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 110.024 -0.361 . . . . 71.340000000000003 110.024 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -102.93 103.02 13.12 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.383 -1.339 . . . . 72.049999999999997 107.383 172.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 53.3 m -83.26 118.74 23.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.133 0.492 . . . . 60.310000000000002 110.986 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.584 HG11 HG11 ' A' ' 390' ' ' VAL . 80.4 t -106.21 110.68 32.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.782 -0.822 . . . . 63.439999999999998 108.782 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 455' ' ' ASN . 46.9 m -98.85 121.57 40.97 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.36 -0.978 . . . . 63.549999999999997 108.36 177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.549 HD11 ' CE2' ' A' ' 456' ' ' PHE . 5.2 mp -97.9 117.52 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 121.835 0.826 . . . . 74.510000000000005 110.764 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.716 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 55.6 m-85 -98.07 122.98 41.87 Favored 'General case' 0 N--CA 1.399 -3.005 0 N-CA-C 105.709 -1.96 . . . . 74.310000000000002 105.709 170.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.12 -3.0 23.58 Favored 'General case' 0 C--N 1.258 -3.402 0 C-N-CA 119.33 -0.948 . . . . 74.430000000000007 109.114 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.29 17.77 9.24 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 126.754 2.021 . . . . 63.119999999999997 113.191 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . 0.626 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' 0.269 2.2 p30 -85.19 -47.33 10.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 118.034 -1.466 . . . . 60.109999999999999 112.885 -178.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.47 ' O ' ' HG2' ' A' ' 452' ' ' GLU . 2.7 t-80 -133.14 17.99 4.09 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.797 -1.186 . . . . 71.319999999999993 107.797 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -82.41 148.82 28.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.541 -1.209 . . . . 62.299999999999997 111.105 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -85.42 65.31 4.01 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 115.823 -0.626 . . . . 73.109999999999999 112.333 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 43.7 pt -142.05 -179.66 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.728 -1.212 . . . . 74.349999999999994 107.728 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -72.68 107.97 5.44 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.287 -1.005 . . . . 63.009999999999998 108.287 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 17.6 p -75.99 151.27 37.26 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.87 -1.059 . . . . 74.329999999999998 112.594 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -109.0 -39.72 5.22 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.563 -1.273 . . . . 71.430000000000007 107.563 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -83.26 158.78 22.12 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.297 -1.371 . . . . 72.450000000000003 107.297 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--N 1.307 -1.264 0 C-N-CA 120.136 -0.626 . . . . 65.430000000000007 110.203 -179.183 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.638 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.647 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 109.339 -0.615 . . . . 72.349999999999994 109.339 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 480' ' ' VAL . 60.9 m -139.18 109.58 6.54 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.92 -1.141 . . . . 60.039999999999999 107.92 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 480' ' ' VAL . 93.0 mttt -121.27 120.67 35.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 112.917 0.71 . . . . 71.140000000000001 112.917 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.521 ' HB ' HD12 ' A' ' 486' ' ' LEU . 31.5 mm -102.19 127.86 55.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.054 -1.462 . . . . 71.219999999999999 107.054 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.518 ' HB2' ' OG ' ' A' ' 488' ' ' SER . 39.3 p90 -159.85 168.73 25.13 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 117.994 0.361 . . . . 70.230000000000004 111.655 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -88.55 142.31 27.81 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 110.021 -0.363 . . . . 70.319999999999993 110.021 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 395' ' ' ILE . 41.4 tt0 -62.87 -51.08 68.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.518 0.675 . . . . 73.230000000000004 109.444 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 378' ' ' GLN . 2.8 mm100 -108.94 146.61 33.53 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 114.972 -1.013 . . . . 72.019999999999996 110.425 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.47 -25.43 33.19 Favored Glycine 0 C--N 1.294 -1.801 0 N-CA-C 110.686 -0.965 . . . . 42.030000000000001 110.686 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 12.9 m -127.34 136.04 51.36 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.406 -0.961 . . . . 62.509999999999998 108.406 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -127.13 137.32 52.96 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.355 -0.98 . . . . 73.430000000000007 108.355 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -127.34 129.66 48.05 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.83 -1.544 . . . . 72.450000000000003 106.83 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 11.9 t -148.72 160.3 43.31 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.054 -1.091 . . . . 61.030000000000001 108.054 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.556 HD12 ' OD1' ' A' ' 386' ' ' ASN . 2.6 mm? -78.43 144.76 35.55 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.294 0.569 . . . . 72.349999999999994 112.202 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.596 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 5.9 tt0 -59.48 -41.82 90.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.315 -0.857 . . . . 63.039999999999999 108.742 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.556 ' OD1' HD12 ' A' ' 384' ' ' LEU . 2.4 p-10 -78.25 9.81 3.52 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.436 -0.802 . . . . 74.109999999999999 113.065 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 35.3 t -83.97 -28.5 27.74 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.728 -0.608 . . . . 72.030000000000001 110.524 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 102.81 -58.39 0.56 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.175 -0.536 . . . . 53.439999999999998 112.209 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 441' ' ' ARG . 5.6 p -141.95 151.41 42.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.024 0.412 . . . . 43.439999999999998 110.447 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 494' ' ' VAL . 5.7 p -109.14 133.41 54.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 107.755 -1.202 . . . . 74.219999999999999 107.755 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.98 128.83 48.24 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.153 0.501 . . . . 73.329999999999998 110.39 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 mp -120.62 145.28 47.56 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.311 -1.366 . . . . 75.209999999999994 107.311 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 29.4 m -113.67 127.06 55.9 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 121.43 0.633 . . . . 73.510000000000005 111.298 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 76.5 mt -95.05 121.34 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 N-CA-C 108.02 -1.104 . . . . 73.540000000000006 108.02 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 377' ' ' GLU . 42.8 mm -99.14 119.4 47.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.48 -1.304 . . . . 74.120000000000005 107.48 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.416 ' NH1' HG21 ' A' ' 405' ' ' VAL . 23.6 ttt85 -100.48 121.36 41.42 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-O 121.482 0.658 . . . . 61.409999999999997 110.576 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 375' ' ' PHE . 22.0 mmm180 -106.59 168.07 9.42 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.449 -0.796 . . . . 75.430000000000007 109.094 175.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 105.9 -30.83 9.11 Favored Glycine 0 C--N 1.292 -1.862 0 N-CA-C 108.151 -1.98 . . . . 64.310000000000002 108.151 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 125.61 -176.08 17.36 Favored Glycine 0 N--CA 1.408 -3.23 0 CA-C-N 114.136 -1.032 . . . . 72.019999999999996 111.523 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.67 178.02 4.83 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.831 -1.544 . . . . 75.319999999999993 106.831 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 403' ' ' ASN . 1.1 pt? -171.53 161.35 6.21 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.264 -1.384 . . . . 73.329999999999998 107.264 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 46.2 p -94.94 -4.2 47.21 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 122.027 0.918 . . . . 75.340000000000003 109.905 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.424 ' HB2' HD12 ' A' ' 401' ' ' LEU . 4.9 m-20 -78.59 146.39 34.2 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.725 -1.213 . . . . 71.540000000000006 107.725 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 466' ' ' SER . 9.4 m -92.06 116.55 29.03 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.183 0.516 . . . . 75.310000000000002 111.681 -171.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 66.6 t -103.44 136.5 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.046 -0.524 . . . . 71.549999999999997 109.707 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -124.95 121.41 34.37 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.601 0.361 . . . . 72.230000000000004 110.582 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 463' ' ' VAL . 5.9 p -120.8 127.62 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.354 -0.98 . . . . 61.25 108.354 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.6 143.53 27.61 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.539 -0.912 . . . . 74.230000000000004 108.539 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -142.42 158.39 43.74 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.941 -0.474 . . . . 75.439999999999998 110.124 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -165.68 158.01 15.0 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.548 -1.279 . . . . 72.329999999999998 107.548 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.646 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 36.5 p -96.73 156.13 16.48 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.373 -0.603 . . . . 74.510000000000005 109.373 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 10.2 tp10 -106.35 151.26 25.1 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.96 -1.496 . . . . 70.329999999999998 106.96 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 417' ' ' ASN . 11.2 m-20 -55.96 -39.02 71.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.698 0.799 . . . . 61.32 112.38 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 62.93 -95.56 0.13 Allowed Glycine 0 C--N 1.297 -1.614 0 CA-C-N 114.938 -1.028 . . . . 34.240000000000002 112.63 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.9 t -121.37 8.92 10.26 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.296 -0.631 . . . . 62.020000000000003 109.296 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 413' ' ' ASP . . . -137.9 -160.49 1.06 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.537 -0.912 . . . . 73.510000000000005 108.537 -175.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.589 ' HA ' ' OD1' ' A' ' 413' ' ' ASP . 6.5 m120 -137.25 122.55 19.37 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.708 0.766 . . . . 72.530000000000001 112.021 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -68.62 129.31 39.56 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.561 -1.199 . . . . 72.519999999999996 109.394 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.95 -32.66 6.87 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 111.305 -0.718 . . . . 64.299999999999997 111.305 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 t -102.24 -44.52 5.4 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.695 -0.483 . . . . 60.340000000000003 109.695 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.551 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 23.7 m-20 -87.3 -64.27 1.17 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.049 0.928 . . . . 63.140000000000001 109.659 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.714 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -141.16 167.0 23.24 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.147 -0.933 . . . . 65.219999999999999 110.217 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 425' ' ' THR . 23.1 tt0 -75.47 153.52 37.53 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.632 0.583 . . . . 43.43 110.333 -174.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.646 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 5.2 p90 -88.93 -15.34 34.56 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.717 -0.674 . . . . 65.329999999999998 112.126 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.439 ' CG2' HG22 ' A' ' 442' ' ' VAL 0.296 13.5 t 32.49 66.87 0.18 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.897 1.679 . . . . 74.530000000000001 114.414 -176.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.76 131.12 34.94 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.592 -0.892 . . . . 71.0 108.592 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -173.38 -175.74 41.36 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 120.099 -1.048 . . . . 72.430000000000007 110.957 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.3 m -116.89 138.35 51.59 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 108.159 -1.052 . . . . 75.239999999999995 108.159 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 44.2 t -96.12 116.42 37.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.085 -1.45 . . . . 72.040000000000006 107.085 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.17 105.69 17.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.533 -0.758 . . . . 64.049999999999997 109.749 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 78.7 m-85 -82.57 98.36 8.94 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.226 -1.028 . . . . 50.030000000000001 108.226 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.1 mttm -80.58 170.18 16.66 Favored Pre-proline 0 C--N 1.296 -1.747 0 CA-C-N 114.065 -1.425 . . . . 63.43 109.948 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.7 Cg_exo -52.24 109.91 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.55 2.167 . . . . 54.039999999999999 113.339 -178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 96.47 -0.34 61.47 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.126 -0.943 . . . . 44.119999999999997 114.825 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.406 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 34.6 mm-40 -76.59 64.23 2.2 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.852 0.826 . . . . 74.209999999999994 113.062 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 24.9 m -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 121.374 0.607 . . . . 74.340000000000003 110.381 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -131.4 139.81 49.52 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.08 -0.711 . . . . 74.120000000000005 109.08 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -130.63 151.41 51.12 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.594 -0.275 . . . . 63.43 111.65 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.85 137.3 52.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.849 -0.614 . . . . 73.409999999999997 109.644 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.28 147.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.936 -1.135 . . . . 71.439999999999998 107.936 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 49.4 mtt180 -129.57 135.07 48.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 120.996 0.426 . . . . 61.520000000000003 111.215 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.6 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 61.9 t -105.34 127.3 60.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.431 -0.804 . . . . 34.219999999999999 109.409 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -70.97 130.31 19.45 Favored Glycine 0 N--CA 1.439 -1.115 0 O-C-N 124.192 0.933 . . . . 62.229999999999997 112.37 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.489 HD12 HG12 ' A' ' 496' ' ' ILE . 38.7 mm -94.9 134.78 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 106.916 -1.512 . . . . 73.310000000000002 106.916 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 66.6 mt -101.7 151.19 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 108.063 -1.088 . . . . 71.450000000000003 108.063 -177.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.96 97.6 2.33 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.995 0.426 . . . . 42.530000000000001 110.234 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.45 124.75 27.63 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 103.63 -2.73 . . . . 73.099999999999994 103.63 170.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.2 97.13 4.81 Favored 'General case' 0 CA--C 1.462 -2.436 0 C-N-CA 117.733 -1.587 . . . . 54.229999999999997 110.042 174.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.733 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 28.9 mm -123.35 156.64 29.53 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.55 0 CA-C-N 111.308 -2.678 . . . . 75.5 104.171 -173.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -56.86 113.49 1.69 Allowed 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 116.652 -2.019 . . . . 72.340000000000003 105.777 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.733 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.7 mt-10 -120.93 121.86 38.96 Favored 'General case' 0 CA--C 1.465 -2.313 0 N-CA-C 108.986 -0.746 . . . . 70.540000000000006 108.986 -170.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -132.34 109.48 9.9 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 115.176 -0.92 . . . . 63.219999999999999 108.691 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.37 35.72 26.34 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.469 1.106 . . . . 70.319999999999993 111.18 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.434 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 31.3 tt0 -64.02 106.63 1.08 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.318 -1.364 . . . . 63.409999999999997 107.318 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.476 ' HB3' ' HA ' ' A' ' 495' ' ' THR . 35.2 p30 -138.57 166.15 25.07 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.449 0.643 . . . . 75.420000000000002 112.078 -175.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.605 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 21.2 p90 -140.2 -179.24 5.87 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.182 -0.917 . . . . 60.119999999999997 109.764 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 31.9 mt -123.79 136.74 54.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.134 -1.062 . . . . 60.520000000000003 108.134 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.3 124.9 60.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.418 -1.327 . . . . 63.409999999999997 107.418 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -117.71 156.34 28.4 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.572 0.545 . . . . 41.109999999999999 109.839 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 86.5 mt -113.42 140.61 47.93 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.563 -0.903 . . . . 73.299999999999997 108.563 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.7 m -146.84 173.56 12.29 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.787 -0.449 . . . . 71.040000000000006 109.787 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.4 t30 34.65 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 126.145 1.778 . . . . 75.409999999999997 113.854 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.49 HG11 HG23 ' A' ' 480' ' ' VAL . 24.7 t -98.77 132.54 43.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.142 -1.023 . . . . 73.010000000000005 108.564 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -133.53 148.23 51.65 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.237 -1.023 . . . . 72.310000000000002 108.237 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 90.9 t -127.65 129.65 70.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 120.851 0.358 . . . . 60.439999999999998 110.471 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 404' ' ' THR . 58.1 m -95.63 109.27 21.55 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 106.88 -1.526 . . . . 73.219999999999999 106.88 173.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 11.0 p -92.84 -57.2 2.73 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 112.174 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -116.94 166.6 11.98 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.872 -0.603 . . . . 65.319999999999993 110.508 -175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.42 50.61 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.301 -0.629 . . . . 74.129999999999995 109.301 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 16.3 m -55.57 127.71 31.1 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.675 -1.148 . . . . 60.409999999999997 110.021 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.45 -47.15 57.54 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.646 -0.872 . . . . 75.010000000000005 108.646 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.41 142.71 29.7 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.02 -0.733 . . . . 61.149999999999999 109.02 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 100.29 47.29 1.72 Allowed Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.032 -1.08 . . . . 51.340000000000003 111.439 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.35 117.2 45.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.901 -0.407 . . . . 74.019999999999996 109.901 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.23 93.03 9.18 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.1 -0.704 . . . . 71.25 109.1 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -106.55 72.25 0.9 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.876 0.846 . . . . 74.329999999999998 110.72 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -91.79 -16.28 27.04 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.219 -0.901 . . . . 54.210000000000001 110.219 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 481' ' ' SER . 5.9 p-10 -163.78 131.8 3.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.268 -0.878 . . . . 64.129999999999995 109.022 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -107.24 -45.14 4.18 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.915 -1.513 . . . . 73.329999999999998 106.915 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.49 HG23 HG11 ' A' ' 463' ' ' VAL . 44.7 t -138.17 -49.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 104.039 -2.578 . . . . 75.25 104.039 174.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 478' ' ' ASN . 15.1 m -127.03 -164.7 1.38 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.52 -2.4 . . . . 62.43 104.52 171.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -51.21 -52.53 43.65 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.801 0.728 . . . . 51.229999999999997 109.927 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -107.53 -79.37 0.58 Allowed 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.239 -1.763 . . . . 70.420000000000002 106.239 171.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -163.79 114.29 1.32 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.002 0.43 . . . . 74.510000000000005 111.919 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . 0.404 ' HB3' ' OG ' ' A' ' 481' ' ' SER . 42.7 t -141.88 125.4 16.73 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 104.246 -2.501 . . . . 43.450000000000003 104.246 172.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.521 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.7 mm? -92.0 176.04 6.65 Favored 'General case' 0 C--N 1.278 -2.516 0 C-N-CA 119.75 -0.78 . . . . 63.350000000000001 111.96 -170.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -70.42 -38.6 70.03 Favored Glycine 0 CA--C 1.506 -0.5 0 N-CA-C 110.397 -1.081 . . . . 74.209999999999994 110.397 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 375' ' ' PHE . 16.2 m -93.18 170.3 8.96 Favored Pre-proline 0 N--CA 1.426 -1.626 0 N-CA-C 107.239 -1.393 . . . . 70.239999999999995 107.239 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.469 ' N ' ' HA ' ' A' ' 490' ' ' SER . 2.5 Cg_endo -40.28 -48.41 4.07 Favored 'Trans proline' 0 CA--C 1.578 2.689 0 C-N-CA 123.1 2.533 . . . . 74.329999999999998 118.511 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.469 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 31.6 m -107.8 129.06 55.09 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 127.433 2.293 . . . . 63.340000000000003 108.966 2.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 90.4 m -137.08 103.97 5.29 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.024 -1.102 . . . . 73.239999999999995 108.024 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -101.84 120.6 40.64 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.131 -1.063 . . . . 73.239999999999995 108.131 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 40.8 m -89.38 119.19 29.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.235 -0.586 . . . . 40.119999999999997 109.834 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 390' ' ' VAL . 76.6 t -106.89 107.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 108.177 -1.046 . . . . 73.450000000000003 108.177 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.476 ' HA ' ' HB3' ' A' ' 455' ' ' ASN . 85.2 m -97.45 114.32 26.15 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.72 -0.844 . . . . 74.120000000000005 108.72 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.714 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -89.09 116.96 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.367 -0.833 . . . . 72.310000000000002 109.169 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.554 ' O ' HD13 ' A' ' 384' ' ' LEU . 24.2 m-85 -80.26 97.79 7.11 Favored 'General case' 0 N--CA 1.382 -3.868 0 CA-C-O 122.324 1.059 . . . . 74.540000000000006 112.366 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.3 t70 -50.17 -54.87 17.85 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 111.749 -2.478 . . . . 55.409999999999997 108.493 170.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.46 ' H ' ' HB3' ' A' ' 502' ' ' ALA . 25.8 t70 61.35 12.64 4.4 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 113.797 -1.547 . . . . 45.439999999999998 110.965 176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -95.86 -59.69 1.8 Allowed 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.992 -1.485 . . . . 75.109999999999999 106.992 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -110.41 -24.8 10.41 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.072 -1.422 . . . . 72.510000000000005 107.979 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.46 ' HB3' ' H ' ' A' ' 499' ' ' ASP . . . -64.48 115.5 5.2 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 114.828 -1.078 . . . . 75.040000000000006 111.535 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -118.43 134.68 11.07 Favored Glycine 0 N--CA 1.422 -2.286 0 N-CA-C 108.843 -1.703 . . . . 70.510000000000005 108.843 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 27.1 pt -132.81 176.65 8.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 117.413 0.606 . . . . 73.349999999999994 111.473 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 507' ' ' PHE . 24.5 p90 -113.18 179.32 3.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.299 -1.371 . . . . 74.519999999999996 107.299 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.4 m -87.04 117.67 25.92 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.36 -0.607 . . . . 74.219999999999999 109.36 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.46 ' HB3' ' CE2' ' A' ' 505' ' ' PHE . 55.0 p90 -145.05 166.57 24.98 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.316 0.579 . . . . 74.439999999999998 112.547 -176.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -139.88 109.66 6.35 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.817 -1.549 . . . . 72.349999999999994 106.817 174.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 . . . . . 0 C--N 1.308 -1.23 0 N-CA-C 109.516 -0.55 . . . . 62.149999999999999 109.516 -177.85 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.616 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.631 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 C--O 1.239 0.545 0 CA-C-O 121.639 0.733 . . . . 52.200000000000003 110.741 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 10.1 m -97.78 175.51 6.14 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.968 -1.014 . . . . 65.450000000000003 109.646 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -141.82 130.74 23.07 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.411 -1.329 . . . . 71.409999999999997 107.411 171.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 486' ' ' LEU . 45.3 mm -110.0 120.74 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 60.229999999999997 107.98 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -152.95 173.32 15.54 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 118.455 0.57 . . . . 73.129999999999995 110.361 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -87.41 154.68 20.47 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.709 -0.396 . . . . 65.209999999999994 110.873 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.12 -40.68 86.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.958 -0.756 . . . . 73.329999999999998 108.958 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -126.36 162.74 24.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.492 -0.777 . . . . 72.109999999999999 111.835 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -94.46 -19.69 31.8 Favored Glycine 0 C--N 1.3 -1.436 0 CA-C-N 115.045 -0.979 . . . . 60.329999999999998 111.712 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 62.6 m -141.86 128.51 20.33 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.967 -0.753 . . . . 74.219999999999999 108.967 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.457 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 39.8 m-85 -114.56 136.82 52.61 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 124.261 1.024 . . . . 75.329999999999998 108.792 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 495' ' ' THR . 43.7 mt-30 -129.51 123.92 32.68 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.429 -1.323 . . . . 74.540000000000006 107.429 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 46.6 t -139.96 165.18 28.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.356 -0.979 . . . . 72.430000000000007 108.356 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.671 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 3.8 mm? -87.13 140.56 29.43 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 123.32 0.388 . . . . 73.420000000000002 111.552 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.621 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 9.1 tt0 -58.76 -42.28 88.54 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.009 -0.737 . . . . 73.120000000000005 109.009 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -73.19 -5.42 39.17 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.354 0.872 . . . . 53.409999999999997 113.354 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 57.7 m -80.73 -7.28 59.31 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.8 -0.562 . . . . 72.140000000000001 111.91 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 90.78 -56.01 3.38 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.467 -0.873 . . . . 74.340000000000003 112.819 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.473 HG22 ' HA2' ' A' ' 443' ' ' GLY . 21.6 p -137.58 166.77 23.09 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.979 0.419 . . . . 74.319999999999993 111.203 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 494' ' ' VAL . 3.8 p -116.93 128.84 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 106.932 -1.507 . . . . 64.010000000000005 106.932 170.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.95 118.48 37.0 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.307 0.575 . . . . 71.120000000000005 110.418 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.0 mp -109.82 139.89 44.37 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.52 -1.289 . . . . 71.209999999999994 107.52 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.9 m -109.55 127.92 54.82 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 109.391 -0.596 . . . . 71.040000000000006 109.391 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 64.1 mt -99.37 125.6 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.52 -1.289 . . . . 75.530000000000001 107.52 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.458 HG22 ' HG3' ' A' ' 397' ' ' ARG . 43.6 mm -101.48 129.04 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 115.09 -0.959 . . . . 50.009999999999998 108.421 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -115.92 108.88 16.84 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.928 -1.033 . . . . 74.140000000000001 109.226 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 395' ' ' ILE . 32.4 mtp180 -123.44 168.41 12.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.72 -0.673 . . . . 64.129999999999995 110.292 -177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 111.88 -146.99 18.06 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 109.395 -1.482 . . . . 42.420000000000002 109.395 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -78.27 139.24 22.28 Favored Glycine 0 N--CA 1.422 -2.275 0 N-CA-C 108.691 -1.764 . . . . 64.140000000000001 108.691 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -111.87 140.84 46.19 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.72 0.771 . . . . 72.329999999999998 109.742 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 401' ' ' LEU . 2.2 pt? -140.49 152.18 45.41 Favored 'General case' 0 C--N 1.267 -2.982 0 N-CA-C 105.949 -1.871 . . . . 70.219999999999999 105.949 -177.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 44.4 p -81.9 6.12 16.83 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.406 0.521 . . . . 74.439999999999998 112.406 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -68.9 143.41 54.49 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.177 -0.675 . . . . 71.129999999999995 109.177 175.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 9.4 m -82.37 119.34 24.03 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.751 -0.659 . . . . 65.310000000000002 109.38 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 431' ' ' PHE . 57.5 t -100.37 141.86 16.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.404 -0.962 . . . . 72.430000000000007 108.404 -177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 429' ' ' VAL . 54.2 m-85 -128.38 119.77 25.67 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 122.735 0.414 . . . . 62.310000000000002 109.948 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.07 124.45 72.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.532 -0.914 . . . . 73.450000000000003 108.532 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 14.7 t70 -90.05 140.46 29.62 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 110.1 -0.333 . . . . 71.310000000000002 110.1 -177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -139.95 169.1 18.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.179 -0.304 . . . . 74.540000000000006 110.179 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 411' ' ' THR . 63.5 ttt-85 -167.52 167.22 13.77 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 105.825 -1.917 . . . . 71.409999999999997 105.825 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.632 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 62.2 p -95.55 168.2 10.84 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.692 -0.855 . . . . 75.120000000000005 108.692 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.594 ' HG3' ' H ' ' A' ' 414' ' ' GLY . 9.7 tp10 -106.51 150.74 25.81 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.613 0.721 . . . . 71.319999999999993 109.29 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.53 5.39 51.01 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 125.915 1.686 . . . . 44.549999999999997 110.679 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . 0.594 ' H ' ' HG3' ' A' ' 412' ' ' GLU . . . -28.73 -93.39 0.01 OUTLIER Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.74 2.114 . . . . 61.140000000000001 116.953 -174.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 455' ' ' ASN . 5.2 t -93.74 -7.06 44.68 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.848 0.832 . . . . 74.030000000000001 110.56 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.779 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . . . -151.89 153.22 33.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.409 -1.7 . . . . 60.229999999999997 106.409 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.19 145.86 33.61 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.617 0.722 . . . . 72.430000000000007 112.138 -164.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -82.93 148.71 27.48 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.072 -0.967 . . . . 71.420000000000002 108.534 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 77.13 17.94 79.05 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.454 -1.058 . . . . 60.119999999999997 110.454 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 38.3 m -149.44 -58.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.697 -0.483 . . . . 54.219999999999999 109.697 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.505 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 8.0 m-20 -86.23 -55.0 4.12 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 122.408 1.099 . . . . 71.239999999999995 108.934 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.779 ' OH ' ' HB3' ' A' ' 416' ' ' ALA . 0.1 OUTLIER -141.67 164.79 29.26 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.948 -1.024 . . . . 75.420000000000002 111.07 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 425' ' ' THR . 0.9 OUTLIER -74.07 160.56 31.08 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.352 -0.84 . . . . 71.230000000000004 108.842 -177.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.632 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 6.6 p90 -100.07 -20.14 16.17 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 122.936 0.495 . . . . 72.420000000000002 112.152 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.49 ' CG2' HG22 ' A' ' 442' ' ' VAL 0.323 10.1 t 39.04 64.55 0.78 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.351 1.861 . . . . 72.5 114.239 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.67 112.33 15.67 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.589 -1.187 . . . . 61.409999999999997 109.274 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -158.25 -178.62 32.46 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 110.443 -1.063 . . . . 73.140000000000001 110.443 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 17.5 m -122.63 139.72 53.62 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.358 -1.349 . . . . 73.099999999999994 107.358 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 406' ' ' PHE . 45.0 t -95.56 118.8 42.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.8 -0.815 . . . . 73.120000000000005 108.8 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 406' ' ' PHE . 26.0 t -91.11 112.18 24.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.654 -1.157 . . . . 71.25 108.511 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 405' ' ' VAL . 60.5 m-85 -97.61 101.75 13.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.69 -0.485 . . . . 71.510000000000005 109.69 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 68.3 mttm -85.21 172.5 8.68 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.071 -0.513 . . . . 74.430000000000007 109.979 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 50.9 Cg_exo -56.09 131.83 48.3 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.467 2.111 . . . . 74.349999999999994 111.649 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 87.33 -14.89 56.66 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 116.027 -0.533 . . . . 73.299999999999997 113.77 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -81.07 63.57 5.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.607 0.717 . . . . 71.140000000000001 112.391 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.1 m -60.9 -22.22 64.12 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.273 -1.33 . . . . 75.010000000000005 110.366 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -131.17 139.64 49.79 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.951 -1.129 . . . . 65.109999999999999 107.951 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -131.46 154.35 48.8 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 122.793 0.437 . . . . 73.140000000000001 110.068 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.27 132.48 50.33 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.787 -0.765 . . . . 74.010000000000005 111.076 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 45.5 pt -119.39 146.72 23.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.594 -0.891 . . . . 74.319999999999993 108.594 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 90.2 mtt180 -130.27 132.88 46.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.343 -0.543 . . . . 75.239999999999995 111.788 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.49 HG22 ' CG2' ' A' ' 425' ' ' THR . 62.1 t -104.71 120.56 55.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.041 -0.981 . . . . 72.299999999999997 108.451 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -71.98 136.52 24.2 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 121.134 -0.555 . . . . 71.420000000000002 112.241 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.464 HD12 HG12 ' A' ' 496' ' ' ILE . 35.5 mm -97.93 132.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 107.83 -1.174 . . . . 71.120000000000005 107.83 177.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 92.4 mt -91.57 151.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.477 -0.934 . . . . 74.430000000000007 108.477 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.29 92.54 5.15 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 120.981 0.419 . . . . 73.219999999999999 110.015 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.07 96.49 6.35 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.498 -2.778 . . . . 60.43 103.498 166.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -99.59 81.3 2.48 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 116.687 -2.005 . . . . 63.530000000000001 110.454 -173.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.69 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 41.6 mm -127.37 155.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.09 0 CA-C-N 110.383 -3.099 . . . . 73.140000000000001 103.993 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -56.36 114.36 1.96 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.925 -1.509 . . . . 62.229999999999997 106.925 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 32.7 mt-10 -111.89 128.12 56.05 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 108.259 -1.015 . . . . 73.109999999999999 108.259 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -124.27 103.85 8.47 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 115.599 -0.728 . . . . 72.450000000000003 110.086 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.82 60.38 3.58 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 125.076 1.485 . . . . 74.310000000000002 113.078 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.21 114.55 20.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.693 0.758 . . . . 75.099999999999994 109.516 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.469 ' O ' HG22 ' A' ' 415' ' ' THR . 3.4 p-10 -136.74 153.44 50.86 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 114.949 -1.023 . . . . 70.5 109.799 -176.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 422' ' ' TYR . 20.9 p90 -136.78 -177.94 4.96 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 115.861 -0.609 . . . . 74.299999999999997 110.195 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.457 ' H ' ' HB3' ' A' ' 412' ' ' GLU . 57.2 mt -121.17 139.71 52.98 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.983 -1.117 . . . . 72.200000000000003 107.983 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 491' ' ' THR . 47.5 t -107.65 110.77 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.579 -1.267 . . . . 73.219999999999999 107.579 174.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -102.78 137.83 40.47 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.591 -0.522 . . . . 63.049999999999997 109.591 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.83 126.66 42.14 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.592 -0.892 . . . . 73.230000000000004 108.592 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 408' ' ' ASP . 17.4 m -147.04 148.52 31.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.933 -0.765 . . . . 63.109999999999999 108.933 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.5 93.6 0.06 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.974 1.31 . . . . 61.200000000000003 110.575 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.15 137.07 39.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.378 -1.341 . . . . 72.040000000000006 107.378 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -131.96 150.25 52.21 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 123.609 0.764 . . . . 75.0 108.991 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.55 131.25 68.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.957 -1.498 . . . . 71.540000000000006 106.957 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 11.6 t -86.93 126.04 34.43 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.129 -0.693 . . . . 71.219999999999999 109.129 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 477' ' ' ALA . 13.0 t -90.98 -146.21 0.19 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.286 -1.005 . . . . 72.329999999999998 108.286 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -68.28 177.55 2.27 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 123.592 0.757 . . . . 64.340000000000003 109.631 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -71.49 -22.45 61.8 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 122.122 -0.361 . . . . 71.140000000000001 111.928 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 14.5 m -70.29 106.41 3.34 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 121.234 0.54 . . . . 74.129999999999995 109.546 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -103.71 3.98 34.83 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.754 -0.657 . . . . 62.350000000000001 110.697 -176.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -81.39 132.26 35.32 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.974 -0.75 . . . . 70.109999999999999 108.974 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 80.76 -170.37 53.08 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.563 -1.015 . . . . 54.43 110.563 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 43.0 mm -119.11 125.13 74.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.616 -0.883 . . . . 70.519999999999996 108.616 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -136.21 104.5 5.67 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.527 0.679 . . . . 74.319999999999993 109.305 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -54.87 108.66 0.42 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.13 -1.395 . . . . 74.510000000000005 113.104 -176.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 467' ' ' SER . . . -106.02 12.52 30.35 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.969 -1.014 . . . . 62.409999999999997 108.355 175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' A' ' 481' ' ' SER . 30.4 t30 -54.95 93.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.307 1.443 . . . . 73.200000000000003 113.344 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -102.45 -80.25 0.51 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.689 -1.967 . . . . 52.109999999999999 105.689 169.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 28.8 m -94.62 116.37 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.853 -0.795 . . . . 71.319999999999993 108.853 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . 0.437 ' HB3' ' OD1' ' A' ' 478' ' ' ASN . 32.7 t 170.73 -74.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 125.838 1.655 . . . . 73.239999999999995 107.823 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -120.36 -2.6 10.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.309 -0.405 . . . . 52.039999999999999 111.868 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -110.0 -69.06 0.88 Allowed 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 104.981 -2.229 . . . . 75.010000000000005 104.981 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -94.81 161.53 14.13 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 105.543 -2.021 . . . . 40.229999999999997 105.543 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 61.7 m -137.26 -169.24 2.46 Favored 'General case' 0 C--N 1.255 -3.513 0 N-CA-C 107.32 -1.363 . . . . 44.32 107.32 -175.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.513 HD12 ' HB ' ' A' ' 374' ' ' ILE . 2.0 mm? -68.9 157.42 36.64 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.549 -0.86 . . . . 74.109999999999999 108.903 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -65.49 -30.79 78.35 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-O 121.477 0.487 . . . . 72.150000000000006 111.953 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.576 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 14.6 m -124.06 -173.53 0.29 Allowed Pre-proline 0 C--N 1.281 -2.401 0 N-CA-C 104.377 -2.453 . . . . 51.439999999999998 104.377 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 488' ' ' SER . 4.1 Cg_exo -34.63 -51.9 0.66 Allowed 'Trans proline' 0 CA--C 1.585 3.028 0 C-N-CA 122.977 2.452 . . . . 63.549999999999997 117.865 172.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 42.3 m -113.7 136.48 52.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.82 2.448 . . . . 64.340000000000003 107.246 1.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 458' ' ' VAL . 45.5 m -131.94 117.48 18.51 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 116.22 -0.445 . . . . 64.239999999999995 110.692 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -105.27 131.44 52.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.035 -0.728 . . . . 52.43 109.035 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 77.1 m -86.42 126.91 34.72 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.592 -0.892 . . . . 71.549999999999997 108.592 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 390' ' ' VAL . 77.0 t -111.94 107.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.674 -0.862 . . . . 73.200000000000003 108.674 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 23.6 m -101.21 111.22 23.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.13 -1.063 . . . . 71.019999999999996 108.13 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.625 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -88.49 123.68 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.595 0.712 . . . . 72.329999999999998 111.06 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -82.75 107.2 15.2 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-O 122.344 1.069 . . . . 71.510000000000005 110.209 173.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.61 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 0.1 OUTLIER -58.8 -40.42 84.03 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 112.288 -2.233 . . . . 43.140000000000001 112.766 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.549 ' HB2' ' CD1' ' A' ' 384' ' ' LEU . 20.4 t70 71.24 -2.06 2.51 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 124.63 1.172 . . . . 75.239999999999995 112.454 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . 0.622 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 48.3 m-20 -101.86 -40.6 6.84 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.461 -0.57 . . . . 74.540000000000006 109.461 -174.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -145.57 -26.13 0.46 Allowed 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.857 0.863 . . . . 73.510000000000005 111.583 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 451' ' ' GLU . . . -71.77 89.69 1.05 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.015 0.746 . . . . 63.32 113.015 -176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 76.09 -68.31 2.32 Favored Glycine 0 CA--C 1.502 -0.777 0 N-CA-C 110.874 -0.89 . . . . 61.049999999999997 110.874 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 499' ' ' ASP . 6.4 pt -89.33 137.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.2 -1.407 . . . . 72.420000000000002 107.2 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -146.95 155.15 42.05 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 121.043 -0.263 . . . . 72.519999999999996 110.849 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.5 t -155.43 -170.87 3.59 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.756 -1.201 . . . . 61.329999999999998 107.756 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.445 ' CD2' ' HG3' ' A' ' 508' ' ' GLU . 19.1 p90 -73.62 157.53 36.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.146 -0.687 . . . . 72.019999999999996 109.146 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' CD2' ' A' ' 507' ' ' PHE . 36.6 mt-10 70.81 96.08 0.07 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.293 0.996 . . . . 73.109999999999999 109.22 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--N 1.307 -1.246 0 CA-C-N 116.413 -0.358 . . . . 71.209999999999994 110.353 -178.11 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.622 'CA ' ' OD2' ' A' ' 500' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.615 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 122.424 1.107 . . . . 70.129999999999995 112.34 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 480' ' ' VAL . 69.9 m -156.84 107.49 2.34 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.057 -0.974 . . . . 54.229999999999997 109.405 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 96.4 mttt -92.91 148.64 21.84 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 123.392 0.432 . . . . 71.140000000000001 110.853 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.701 ' O ' ' HB3' ' A' ' 486' ' ' LEU . 38.8 mm -125.12 109.16 21.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.572 -0.899 . . . . 73.439999999999998 108.572 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -145.71 162.78 36.79 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.425 -0.51 . . . . 71.430000000000007 110.85 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.1 151.42 28.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 110.122 -0.325 . . . . 71.439999999999998 110.122 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -59.77 4.52 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.902 -1.518 . . . . 72.5 106.902 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 381' ' ' TYR . 15.3 mm100 -102.55 173.11 6.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.604 -0.726 . . . . 74.439999999999998 111.007 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -106.26 -40.36 1.95 Allowed Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.943 -1.026 . . . . 71.140000000000001 110.651 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.0 m -122.68 126.11 46.94 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.876 -0.787 . . . . 72.030000000000001 108.876 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 378' ' ' GLN . 77.5 m-85 -115.81 142.79 46.29 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.48 -0.933 . . . . 72.209999999999994 108.48 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 495' ' ' THR . 14.0 mp0 -123.53 146.14 48.33 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.251 -1.388 . . . . 73.420000000000002 107.251 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . 0.569 ' SG ' ' HB ' ' A' ' 390' ' ' VAL . 25.1 p -149.77 151.29 33.35 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.982 -1.118 . . . . 63.439999999999998 107.982 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 497' ' ' PHE . 0.4 OUTLIER -80.91 145.03 31.5 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.607 -0.886 . . . . 73.120000000000005 108.607 176.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.634 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 15.0 tt0 -58.97 -29.95 67.57 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.55 0.69 . . . . 61.229999999999997 110.064 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 384' ' ' LEU . 34.5 p30 -80.94 -1.44 43.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.455 -0.793 . . . . 65.230000000000004 112.558 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.45 -22.04 48.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.261 0.553 . . . . 64.010000000000005 111.182 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 91.6 -59.7 2.92 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.781 -0.723 . . . . 74.319999999999993 111.522 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 442' ' ' VAL . 15.4 p -136.27 155.24 50.37 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.615 0.245 . . . . 74.409999999999997 110.793 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 441' ' ' ARG . 7.7 p -111.1 126.71 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 N-CA-C 107.888 -1.153 . . . . 63.009999999999998 107.888 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -96.44 124.42 40.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.125 0.488 . . . . 64.109999999999999 110.592 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.74 137.41 53.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.248 -1.389 . . . . 52.439999999999998 107.248 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 24.9 m -104.49 134.4 47.74 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.703 -0.48 . . . . 72.299999999999997 109.703 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 80.1 mt -103.85 126.03 58.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.57 -1.27 . . . . 72.409999999999997 107.57 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 44.9 mm -103.93 121.53 55.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.323 -0.991 . . . . 60.240000000000002 108.323 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 55.7 ttt180 -105.71 122.17 45.51 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.492 -0.777 . . . . 74.150000000000006 109.557 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -139.12 167.53 21.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.822 -0.626 . . . . 64.239999999999995 110.762 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 142.43 -28.56 2.19 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.687 -0.768 . . . . 63.450000000000003 111.845 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 167.02 -132.9 2.74 Favored Glycine 0 C--N 1.298 -1.577 0 N-CA-C 109.599 -1.4 . . . . 71.25 109.599 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . 0.482 ' O ' HD23 ' A' ' 401' ' ' LEU . 2.3 p-10 -139.98 121.98 15.66 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 108.671 -0.863 . . . . 74.019999999999996 108.671 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 400' ' ' ASP . 35.1 mt -146.12 125.47 13.09 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.214 -0.903 . . . . 62.420000000000002 109.351 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 5.6 p -87.44 -0.27 56.56 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.025 0.917 . . . . 74.299999999999997 109.11 174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.38 138.12 58.25 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.275 -1.33 . . . . 65.230000000000004 109.606 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 466' ' ' SER . 0.8 OUTLIER -80.77 112.33 18.05 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 124.073 0.858 . . . . 64.400000000000006 110.296 -176.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 57.6 t -104.78 132.62 51.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.793 -0.817 . . . . 64.140000000000001 108.793 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 36.8 m-85 -115.62 129.3 56.45 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.192 0.52 . . . . 72.420000000000002 109.853 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.476 HG11 HG21 ' A' ' 374' ' ' ILE . 7.6 p -129.78 133.86 64.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.197 -1.409 . . . . 63.119999999999997 107.197 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -99.77 124.64 45.24 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.086 -0.709 . . . . 51.109999999999999 109.086 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 426' ' ' GLU . 11.6 p90 -110.64 147.47 34.22 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.172 -0.677 . . . . 63.329999999999998 109.172 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 426' ' ' GLU . 48.6 ttp180 -157.21 150.44 23.83 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.825 -1.176 . . . . 72.099999999999994 107.825 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 63.7 p -96.87 171.0 8.78 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.552 -0.459 . . . . 73.049999999999997 110.24 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 9.4 tp10 -137.57 158.21 44.88 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.166 -0.679 . . . . 74.430000000000007 109.166 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -31.14 -62.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.712 2.405 . . . . 72.319999999999993 113.147 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 69.29 -74.52 0.39 Allowed Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.069 -0.968 . . . . 51.200000000000003 111.019 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 8.8 t -154.87 16.72 0.44 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.122 -1.066 . . . . 71.019999999999996 108.122 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -146.8 -169.44 3.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.539 -0.755 . . . . 64.25 110.371 -171.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.85 120.98 27.25 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.325 -0.621 . . . . 71.019999999999996 109.325 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 424' ' ' PHE . . . -81.47 124.55 29.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.714 0.769 . . . . 71.140000000000001 110.553 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.49 32.0 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 109.43 -1.468 . . . . 31.329999999999998 109.43 -173.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 14.9 m -110.54 -58.55 2.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.985 -0.746 . . . . 62.32 108.985 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.561 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 14.3 m-20 -82.71 -58.26 2.97 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 122.011 0.91 . . . . 74.299999999999997 109.677 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.701 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.1 OUTLIER -139.34 158.99 43.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.635 -0.876 . . . . 71.129999999999995 108.635 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.82 144.88 45.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.879 -0.785 . . . . 73.319999999999993 108.879 -175.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.538 ' HB3' ' HB1' ' A' ' 418' ' ' ALA . 17.7 p90 -79.4 -18.45 52.28 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 113.054 0.761 . . . . 74.099999999999994 113.054 -173.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 442' ' ' VAL 0.268 11.0 t 40.06 55.99 2.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 127.198 2.199 . . . . 74.420000000000002 115.311 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 409' ' ' PHE . 1.5 pp20? -78.41 131.15 36.81 Favored 'General case' 0 N--CA 1.432 -1.375 0 C-N-CA 118.952 -1.099 . . . . 75.019999999999996 108.944 173.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -164.4 170.13 39.46 Favored Glycine 0 CA--C 1.46 -3.365 0 N-CA-C 109.93 -1.268 . . . . 72.349999999999994 109.93 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.5 m -111.35 131.63 55.02 Favored 'General case' 0 N--CA 1.394 -3.242 0 C-N-CA 119.739 -0.784 . . . . 72.140000000000001 108.888 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.67 125.49 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.941 -1.503 . . . . 71.230000000000004 106.941 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . 0.44 HG22 ' CE2' ' A' ' 406' ' ' PHE . 19.5 t -103.72 117.11 48.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.614 -0.884 . . . . 62.130000000000003 108.614 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.473 ' HB3' ' NH1' ' A' ' 396' ' ' ARG . 65.1 m-85 -94.91 105.02 16.91 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.188 0.518 . . . . 72.299999999999997 110.689 177.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 0.2 OUTLIER -90.12 167.64 16.47 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 114.652 -1.158 . . . . 71.5 110.315 -176.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 432' ' ' LYS . 32.0 Cg_exo -57.03 115.09 2.24 Favored 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.872 2.381 . . . . 73.409999999999997 108.989 170.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.02 -38.04 3.32 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 111.523 -0.631 . . . . 62.299999999999997 111.523 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -85.97 62.37 7.4 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.717 0.77 . . . . 74.420000000000002 110.595 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 14.1 t -84.08 9.58 12.21 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 115.134 -0.939 . . . . 71.549999999999997 109.878 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -140.55 137.05 33.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.116 -1.809 . . . . 74.129999999999995 106.116 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -135.47 153.29 51.8 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.358 0.411 . . . . 75.349999999999994 111.193 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.26 128.54 55.67 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.537 -0.912 . . . . 71.510000000000005 108.537 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.91 149.56 19.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.857 -1.164 . . . . 73.209999999999994 107.857 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 79.9 mtm180 -133.28 143.36 49.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.174 0.511 . . . . 71.319999999999993 111.265 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 425' ' ' THR . 48.7 t -109.92 124.01 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.394 -0.965 . . . . 63.100000000000001 108.394 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -77.28 127.09 8.17 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.559 -0.616 . . . . 63.32 111.559 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.498 HD12 HG12 ' A' ' 496' ' ' ILE . 35.7 mm -89.97 134.74 28.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.162 -1.051 . . . . 63.439999999999998 108.162 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 82.2 mt -96.77 147.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.274 -1.38 . . . . 74.230000000000004 107.274 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -78.97 86.68 4.82 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.416 -0.513 . . . . 75.200000000000003 111.925 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.38 126.81 55.69 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 103.338 -2.838 . . . . 73.409999999999997 103.338 169.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 9.2 t70 -129.18 93.26 3.54 Favored 'General case' 0 CA--C 1.463 -2.366 0 CA-C-O 123.438 1.59 . . . . 64.230000000000004 109.785 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.756 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 51.8 mm -125.25 158.22 33.59 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.161 0 CA-C-N 111.283 -2.689 . . . . 42.329999999999998 104.608 -171.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . 0.469 ' HA ' ' CB ' ' A' ' 501' ' ' HIS . 98.2 m-85 -51.23 114.39 1.19 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.784 -1.932 . . . . 74.540000000000006 105.784 166.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.756 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 36.2 mt-10 -121.74 94.74 4.41 Favored 'General case' 0 CA--C 1.468 -2.21 0 CA-C-O 122.117 0.961 . . . . 71.439999999999998 111.476 -169.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.01 102.06 13.76 Favored 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 114.26 -1.336 . . . . 64.340000000000003 110.146 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.82 57.56 5.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.787 -1.552 . . . . 75.219999999999999 112.953 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.422 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . 85.2 mt-10 -71.01 113.22 7.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.379 0.609 . . . . 64.430000000000007 109.836 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -137.47 160.36 39.34 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.874 -0.603 . . . . 74.019999999999996 110.401 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.589 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.3 p90 -140.37 177.25 8.13 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.489 -0.778 . . . . 73.140000000000001 109.735 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 33.5 mt -117.69 138.07 52.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.335 -0.987 . . . . 71.430000000000007 108.335 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.28 120.58 60.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.896 -1.52 . . . . 74.439999999999998 106.896 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -114.3 149.12 36.45 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.641 0.588 . . . . 74.430000000000007 109.683 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.72 127.45 53.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.0 -0.741 . . . . 73.400000000000006 109.0 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 20.3 m -142.01 178.71 7.34 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.373 -0.602 . . . . 72.219999999999999 109.373 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 5.8 t30 50.37 86.11 0.03 OUTLIER 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.778 1.231 . . . . 75.040000000000006 113.238 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 53.4 t -84.89 116.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.55 -0.907 . . . . 75.5 108.55 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 26.3 tptp -116.89 133.33 56.14 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.605 -1.998 . . . . 74.540000000000006 105.605 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.39 138.65 51.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.439 -0.904 . . . . 74.439999999999998 111.514 -173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.473 ' HB3' ' HB ' ' A' ' 404' ' ' THR . 33.9 t -137.64 150.62 47.54 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-O 121.348 0.594 . . . . 55.310000000000002 109.725 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 70.1 m -122.19 19.91 10.65 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.483 -0.932 . . . . 53.439999999999998 108.483 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.31 9.04 0.5 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.065 0.946 . . . . 70.430000000000007 112.797 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -77.27 -7.08 55.38 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.803 -0.814 . . . . 75.430000000000007 108.803 173.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 32.6 t -149.64 150.29 31.95 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 104.99 -2.226 . . . . 74.439999999999998 104.99 175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.87 -23.68 25.17 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.753 -0.779 . . . . 62.009999999999998 111.509 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -109.67 114.42 28.01 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.624 -0.51 . . . . 63.340000000000003 109.624 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 134.07 42.81 0.14 Allowed Glycine 0 C--N 1.299 -1.485 0 C-N-CA 120.992 -0.623 . . . . 54.119999999999997 111.657 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 41.5 mm -77.82 87.89 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.354 -0.98 . . . . 73.5 108.354 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 54.1 mt -86.84 -54.9 4.1 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.41 -0.814 . . . . 75.129999999999995 111.635 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 65.82 10.29 6.73 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.862 1.265 . . . . 63.43 112.1 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -104.91 21.28 17.3 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.228 1.013 . . . . 63.119999999999997 108.435 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -88.52 36.84 0.8 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.204 -1.406 . . . . 62.299999999999997 107.204 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -65.03 154.86 36.53 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 122.106 0.955 . . . . 72.549999999999997 113.312 -172.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 372' ' ' SER . 38.2 t -68.03 -45.42 83.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 113.058 -1.883 . . . . 65.230000000000004 109.955 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 43.6 t -128.47 -158.07 0.86 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.661 -1.607 . . . . 34.240000000000002 106.661 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -52.53 -54.8 27.87 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.264 -1.013 . . . . 41.149999999999999 108.264 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.27 -69.96 0.83 Allowed 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 105.7 -1.963 . . . . 71.430000000000007 105.7 171.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -162.24 128.76 3.64 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.724 0.773 . . . . 73.239999999999995 111.299 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 36.8 t -174.4 129.25 0.35 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 102.619 -3.104 . . . . 73.109999999999999 102.619 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.701 ' HB3' ' O ' ' A' ' 374' ' ' ILE . 2.6 mm? -72.44 -45.25 60.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 113.715 1.005 . . . . 73.010000000000005 113.715 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 144.77 -38.26 1.29 Allowed Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 107.0 -2.44 . . . . 74.299999999999997 107.0 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.489 ' HB3' ' HD2' ' A' ' 489' ' ' PRO . 15.6 m -118.32 175.05 2.26 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 103.603 -2.74 . . . . 73.530000000000001 103.603 169.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 488' ' ' SER . 3.6 Cg_exo -36.37 -52.83 1.11 Allowed 'Trans proline' 0 CA--C 1.583 2.949 0 C-N-CA 123.38 2.72 . . . . 70.109999999999999 118.491 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 27.8 m -111.8 125.72 54.3 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 126.983 2.113 . . . . 74.450000000000003 107.863 1.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . . . . . . . . . 40.1 m -124.09 114.28 19.49 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 115.625 -0.716 . . . . 71.409999999999997 109.105 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.92 33.56 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.19 -1.041 . . . . 61.299999999999997 108.19 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 24.3 m -105.94 120.5 41.92 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.676 -0.41 . . . . 71.430000000000007 109.972 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 390' ' ' VAL . 73.0 t -107.12 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.93 -0.767 . . . . 52.329999999999998 108.93 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 382' ' ' GLN . 37.7 m -104.36 117.98 35.51 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.813 -0.81 . . . . 73.219999999999999 108.813 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.701 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.1 mp -97.08 118.9 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 109.341 -0.614 . . . . 63.329999999999998 109.341 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.577 ' O ' HD13 ' A' ' 384' ' ' LEU . 6.1 m-85 -83.25 105.22 14.04 Favored 'General case' 0 N--CA 1.389 -3.494 0 CA-C-N 115.513 -0.767 . . . . 62.409999999999997 110.963 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.667 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.2 t70 -56.6 -57.51 12.07 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 113.088 -1.869 . . . . 75.010000000000005 109.348 173.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.7 t70 69.87 0.82 3.19 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.922 1.289 . . . . 72.209999999999994 111.246 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.28 -62.64 1.36 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.834 0.826 . . . . 60.299999999999997 109.469 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.469 ' CB ' ' HA ' ' A' ' 450' ' ' PHE . 88.5 m-70 -130.77 25.81 5.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.423 -1.262 . . . . 73.409999999999997 107.878 -176.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 451' ' ' GLU . . . -67.85 -18.92 64.97 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 114.924 -1.034 . . . . 63.109999999999999 111.309 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 74.94 36.36 47.19 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 110.044 -1.222 . . . . 54.340000000000003 110.044 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.38 161.19 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 121.315 0.579 . . . . 61.210000000000001 109.568 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.25 -171.43 2.45 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 103.799 -2.667 . . . . 74.310000000000002 103.799 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 38.0 m -74.66 92.01 2.4 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 119.33 0.968 . . . . 55.219999999999999 110.208 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.42 138.87 40.18 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.612 -1.255 . . . . 74.200000000000003 107.612 177.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -90.7 125.35 35.65 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.028 -0.73 . . . . 74.430000000000007 109.028 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.507 0 N-CA-C 108.168 -1.049 . . . . 74.150000000000006 108.168 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.667 'CA ' ' OD1' ' A' ' 498' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.626 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.413 ' O ' ' HA3' ' A' ' 398' ' ' GLY . 59.5 t . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.707 -0.849 . . . . 72.049999999999997 108.707 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 66.9 m -73.14 104.46 4.22 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 123.613 0.571 . . . . 53.420000000000002 110.755 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 33.3 mmtp -92.79 119.35 32.06 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.251 -1.018 . . . . 72.030000000000001 108.251 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.563 ' HB ' HD12 ' A' ' 486' ' ' LEU . 25.9 mm -95.18 119.12 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.588 -1.187 . . . . 52.509999999999998 108.434 -176.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -153.7 160.93 42.49 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.925 0.33 . . . . 64.140000000000001 110.503 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.78 148.64 29.95 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.609 -0.515 . . . . 74.439999999999998 109.609 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.3 -43.83 85.18 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.586 -0.524 . . . . 60.539999999999999 109.586 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -115.22 176.29 5.13 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.885 -0.598 . . . . 64.329999999999998 110.676 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -110.36 -19.17 8.11 Favored Glycine 0 C--N 1.291 -1.964 0 CA-C-N 115.063 -0.971 . . . . 21.210000000000001 110.801 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 59.8 m -140.06 135.24 32.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.117 -1.068 . . . . 74.010000000000005 108.117 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 49.8 m-85 -125.41 141.2 52.2 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.076 -1.083 . . . . 70.530000000000001 108.076 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.61 132.67 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.505 -1.294 . . . . 74.319999999999993 107.505 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . . . . . . . . . 15.2 t -151.81 165.52 34.23 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.149 -1.056 . . . . 72.140000000000001 108.149 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 387' ' ' CYS . 2.4 mm? -81.03 143.33 32.57 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.216 0.531 . . . . 71.140000000000001 111.095 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.627 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 16.2 tt0 -59.94 -39.4 85.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.339 -0.846 . . . . 71.230000000000004 109.784 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -73.65 -4.4 34.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.534 -0.757 . . . . 75.129999999999995 112.474 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 89.1 m -71.11 -22.33 62.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 122.109 -0.369 . . . . 51.100000000000001 111.953 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 94.68 -50.11 2.04 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.706 -0.759 . . . . 43.43 111.565 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.464 HG22 ' HA2' ' A' ' 443' ' ' GLY . 18.9 p -139.28 160.4 39.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.911 -0.403 . . . . 51.25 109.911 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 494' ' ' VAL . 6.0 p -114.83 133.8 59.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.281 -1.377 . . . . 74.200000000000003 107.281 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.41 125.83 48.11 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.201 0.524 . . . . 44.119999999999997 110.187 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.5 mp -116.52 153.68 31.74 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.121 -1.437 . . . . 72.230000000000004 107.121 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 28.1 m -120.6 126.93 51.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.335 0.588 . . . . 72.219999999999999 110.816 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 74.7 mt -100.69 120.27 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 108.204 -1.035 . . . . 44.420000000000002 108.204 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.481 HG22 ' HG2' ' A' ' 397' ' ' ARG . 46.2 mm -97.89 114.25 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 114.892 -1.049 . . . . 73.430000000000007 108.273 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.705 ' HB3' ' O ' ' A' ' 436' ' ' THR . 56.0 ttt180 -100.68 112.15 24.5 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 108.232 -1.025 . . . . 72.140000000000001 108.232 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' A' ' 397' ' ' ARG . 4.3 mmp_? -113.55 161.64 17.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.518 -0.549 . . . . 75.349999999999994 109.518 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 371' ' ' VAL . . . 106.89 2.09 36.54 Favored Glycine 0 C--N 1.304 -1.21 0 C-N-CA 120.262 -0.971 . . . . 73.239999999999995 111.8 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . 158.6 105.07 0.21 Allowed Glycine 0 N--CA 1.424 -2.117 0 C-N-CA 121.025 -0.607 . . . . 51.43 112.165 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -81.55 119.67 24.06 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 104.837 -2.283 . . . . 41.409999999999997 104.837 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 53.0 mt -148.45 159.34 44.13 Favored 'General case' 0 C--N 1.269 -2.892 0 C-N-CA 119.848 -0.741 . . . . 75.150000000000006 111.745 -167.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 433' ' ' PRO . 3.0 p -88.29 -3.98 58.76 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 114.455 -1.248 . . . . 72.239999999999995 110.159 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.412 ' HB3' ' OE1' ' A' ' 476' ' ' GLU . 2.3 m-20 -70.02 135.81 49.72 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.667 -1.152 . . . . 74.319999999999993 110.57 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 31.9 m -89.9 112.71 24.16 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.218 -0.901 . . . . 71.310000000000002 111.282 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.23 144.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.065 -0.97 . . . . 62.130000000000003 108.48 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 14.7 m-85 -119.7 132.08 55.57 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.905 0.383 . . . . 74.109999999999999 110.027 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 374' ' ' ILE . 3.7 p -132.78 131.68 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.834 -1.543 . . . . 63.009999999999998 106.834 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 11.3 t70 -98.97 136.68 38.6 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.802 -0.561 . . . . 74.129999999999995 111.492 -173.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -135.83 165.78 24.83 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.982 0.42 . . . . 72.420000000000002 110.536 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -167.12 155.53 9.78 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.579 -1.637 . . . . 73.299999999999997 106.579 176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.681 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 26.1 p -96.62 160.81 14.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.437 -0.579 . . . . 54.310000000000002 109.437 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 456' ' ' PHE . 16.0 tp10 -106.76 169.86 8.28 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.523 -1.288 . . . . 70.219999999999999 107.523 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 8.6 p-10 -63.03 -39.43 94.73 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.992 0.901 . . . . 64.420000000000002 110.255 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . 72.21 -98.86 0.84 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.397 -1.274 . . . . 65.150000000000006 110.475 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 455' ' ' ASN . 10.8 t -122.34 -2.27 9.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.339 1.066 . . . . 74.340000000000003 108.65 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 422' ' ' TYR . . . -124.72 -153.28 0.55 Allowed 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 107.816 -1.179 . . . . 31.43 107.816 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -133.93 116.11 15.2 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 118.199 0.454 . . . . 72.019999999999996 110.019 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.69 24.96 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.819 -0.808 . . . . 62.32 108.819 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 111.13 -19.27 25.13 Favored Glycine 0 C--N 1.288 -2.099 0 N-CA-C 110.539 -1.024 . . . . 64.409999999999997 110.539 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 23.1 m -115.84 -51.05 2.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.82 0.343 . . . . 64.099999999999994 110.568 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.613 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 16.3 m-20 -79.98 -64.57 1.16 Allowed 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 122.369 1.081 . . . . 72.430000000000007 108.819 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.652 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -134.29 162.6 31.73 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.19 -1.368 . . . . 74.439999999999998 107.899 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 425' ' ' THR . 5.9 tp10 -82.82 154.38 24.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.486 0.66 . . . . 64.319999999999993 111.792 -172.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.681 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 0.5 OUTLIER -79.1 -12.11 60.0 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.16 -0.927 . . . . 72.219999999999999 113.014 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.528 HG21 HG22 ' A' ' 442' ' ' VAL 0.253 13.3 t 33.64 69.47 0.14 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.734 1.614 . . . . 70.030000000000001 113.29 -177.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.26 129.48 34.5 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.254 -0.884 . . . . 73.219999999999999 109.647 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -174.11 175.59 46.57 Favored Glycine 0 N--CA 1.405 -3.425 0 C-N-CA 119.783 -1.199 . . . . 63.219999999999999 111.025 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 408' ' ' ASP . 7.9 m -112.81 142.26 45.66 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.247 -1.39 . . . . 72.209999999999994 107.247 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 407' ' ' VAL . 22.4 t -95.16 111.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.528 -1.656 . . . . 74.219999999999999 106.528 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.3 106.51 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 115.036 -0.984 . . . . 75.439999999999998 109.093 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' ' 404' ' ' THR . 70.7 m-85 -77.61 94.26 4.34 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.268 -0.878 . . . . 74.430000000000007 109.887 178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -73.98 163.77 65.99 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.971 -0.559 . . . . 44.200000000000003 111.021 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 402' ' ' THR . 48.1 Cg_exo -51.28 113.84 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.47 2.113 . . . . 72.030000000000001 112.686 175.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 101.74 -24.0 32.95 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.832 -0.699 . . . . 53.130000000000003 111.488 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.443 ' O ' ' HD1' ' A' ' 431' ' ' PHE . 9.7 mm-40 -86.06 61.28 6.74 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.754 -0.832 . . . . 74.230000000000004 108.754 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.705 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 12.4 m -67.45 -33.73 75.74 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 107.613 -1.254 . . . . 73.349999999999994 107.613 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.26 132.8 50.13 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 106.607 -1.627 . . . . 63.310000000000002 106.607 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -118.73 147.53 43.75 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.118 0.485 . . . . 73.140000000000001 111.481 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.99 132.29 54.29 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 115.075 -0.966 . . . . 74.510000000000005 108.512 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 44.0 pt -119.24 146.78 23.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.435 -0.95 . . . . 71.319999999999993 108.435 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 85.9 mtt180 -126.82 141.16 51.9 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-O 121.698 0.761 . . . . 73.349999999999994 111.942 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.661 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 57.6 t -109.08 126.37 66.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.384 -1.339 . . . . 74.530000000000001 107.384 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -76.49 123.53 6.79 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.948 -0.861 . . . . 42.509999999999998 110.948 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.508 HD12 HG12 ' A' ' 496' ' ' ILE . 42.1 mm -86.57 132.92 31.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.051 -1.833 . . . . 75.219999999999999 106.051 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.613 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 74.4 mt -94.32 149.27 4.45 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 105.134 -2.172 . . . . 63.329999999999998 105.134 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -78.66 85.79 4.67 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.801 -0.76 . . . . 65.129999999999995 110.733 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.25 112.92 23.9 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 105.075 -2.195 . . . . 73.109999999999999 105.075 172.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.638 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 14.4 t0 -118.0 93.61 4.2 Favored 'General case' 0 C--N 1.275 -2.671 0 C-N-CA 117.274 -1.771 . . . . 74.109999999999999 109.538 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.636 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 44.6 mm -125.9 156.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.86 0 CA-C-N 111.693 -2.503 . . . . 62.439999999999998 105.423 -172.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -49.45 115.03 1.18 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.458 -1.682 . . . . 75.400000000000006 106.458 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 30.2 mt-10 -129.35 121.42 27.42 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 109.621 -0.511 . . . . 74.129999999999995 109.621 -172.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -134.01 113.9 12.64 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.661 -1.237 . . . . 73.420000000000002 107.661 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 20.8 t70 56.74 54.88 6.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.518 1.127 . . . . 54.350000000000001 110.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -86.58 98.63 11.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.332 -1.358 . . . . 72.219999999999999 107.332 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.584 ' O ' HG22 ' A' ' 415' ' ' THR . 0.0 OUTLIER -131.85 143.4 50.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 122.108 0.956 . . . . 71.010000000000005 113.274 -176.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.661 ' CZ ' HG11 ' A' ' 442' ' ' VAL . 23.9 p90 -116.74 177.04 4.84 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.742 -1.117 . . . . 74.0 109.453 175.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -121.94 136.4 54.92 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.647 -1.242 . . . . 74.340000000000003 107.647 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 492' ' ' ALA . 15.6 t -108.25 131.24 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.616 -1.253 . . . . 62.240000000000002 107.616 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -123.46 164.44 18.91 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.769 0.668 . . . . 74.239999999999995 109.769 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 91.3 mt -126.51 139.27 53.35 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.834 -0.432 . . . . 62.130000000000003 109.834 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 50.2 m -156.94 178.5 10.29 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.536 -0.912 . . . . 75.239999999999995 108.536 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 8.3 t30 42.75 91.19 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.653 1.581 . . . . 73.120000000000005 114.731 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 36.4 t -90.37 139.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 115.834 -0.621 . . . . 73.019999999999996 109.651 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 24.4 ttmm -132.67 154.32 50.24 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.922 -1.14 . . . . 71.430000000000007 107.922 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 14.9 t -114.27 154.87 15.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 106.368 -1.715 . . . . 75.209999999999994 106.368 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.7 t -73.71 109.41 7.2 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.526 -1.657 . . . . 71.340000000000003 106.526 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 6.9 m -104.49 78.43 1.47 Allowed 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.84 -1.17 . . . . 71.420000000000002 107.84 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -99.49 -53.35 3.23 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.383 -0.826 . . . . 65.010000000000005 109.654 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -68.6 -47.06 67.67 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.359 -0.837 . . . . 73.239999999999995 109.644 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 50.6 m -133.8 134.94 43.46 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 108.113 -1.069 . . . . 50.439999999999998 108.113 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.56 -37.4 36.48 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.273 -0.64 . . . . 74.129999999999995 109.273 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -120.44 137.91 54.07 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.103 -1.073 . . . . 63.409999999999997 108.103 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 101.7 84.18 1.78 Allowed Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 108.224 -1.95 . . . . 75.450000000000003 108.224 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.28 110.92 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-O 121.528 0.68 . . . . 75.120000000000005 109.475 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 49.7 mt -67.06 -29.18 68.89 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.575 -1.193 . . . . 70.430000000000007 112.05 -174.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . 0.412 ' OE1' ' HB3' ' A' ' 403' ' ' ASN . 13.8 pt-20 -112.16 135.93 52.21 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.177 -0.465 . . . . 74.129999999999995 111.06 -175.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -105.08 19.5 20.5 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 112.283 0.475 . . . . 73.25 112.283 -176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.28 5.7 49.53 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.869 -0.52 . . . . 73.420000000000002 111.288 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -87.86 150.29 23.61 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.1 0.476 . . . . 74.349999999999994 111.924 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.82 110.24 20.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.566 -0.743 . . . . 71.200000000000003 109.813 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 49.4 m -162.95 156.78 20.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 122.154 -0.341 . . . . 74.120000000000005 110.117 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . 68.28 -53.95 0.53 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.687 1.595 . . . . 73.319999999999993 114.676 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -124.61 -37.9 2.45 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.878 -1.527 . . . . 55.140000000000001 106.878 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -90.42 123.93 34.55 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.378 -0.828 . . . . 71.450000000000003 109.383 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 20.0 p -107.51 -171.18 1.83 Allowed 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.834 -1.173 . . . . 72.299999999999997 107.834 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.0 OUTLIER -69.54 171.98 8.03 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.324 -0.621 . . . . 72.420000000000002 109.324 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.666 ' O ' ' HD3' ' A' ' 489' ' ' PRO . . . -77.82 79.24 1.44 Allowed Glycine 0 C--O 1.209 -1.451 0 N-CA-C 105.223 -3.151 . . . . 54.219999999999999 105.223 171.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.5 m -78.89 110.55 14.84 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 116.545 2.054 . . . . 74.200000000000003 116.545 -160.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 487' ' ' GLY . 4.6 Cg_exo -71.37 -60.92 0.05 OUTLIER 'Trans proline' 0 CA--C 1.589 3.234 0 CA-C-O 118.096 -0.877 . . . . 75.129999999999995 111.017 163.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.561 ' HA ' ' CD ' ' A' ' 489' ' ' PRO . 48.7 m -121.63 88.05 2.87 Favored 'General case' 0 C--N 1.385 2.137 0 CA-C-N 121.61 2.005 . . . . 71.439999999999998 107.921 -6.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 489' ' ' PRO . 39.0 m -145.21 105.19 4.03 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 109.081 -0.711 . . . . 70.010000000000005 109.081 177.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 458' ' ' VAL . . . -99.47 99.74 10.69 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.603 -1.628 . . . . 74.219999999999999 106.603 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . . . . . . . . . 36.9 m -79.98 120.32 24.01 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.566 -0.531 . . . . 61.130000000000003 109.566 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.637 HG11 HG11 ' A' ' 390' ' ' VAL . 72.2 t -107.0 105.48 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 109.759 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 86.7 m -88.69 111.5 22.02 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.533 -0.914 . . . . 73.409999999999997 108.533 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.652 HD13 ' CE2' ' A' ' 422' ' ' TYR . 4.8 mp -87.1 117.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 108.998 -0.742 . . . . 73.209999999999994 108.998 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.452 ' O ' HD13 ' A' ' 384' ' ' LEU . 12.9 m-85 -83.47 97.58 9.06 Favored 'General case' 0 N--CA 1.387 -3.595 0 CA-C-O 122.182 0.991 . . . . 74.409999999999997 112.169 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' . 3.8 t70 -51.58 -56.24 14.64 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 112.212 -2.267 . . . . 62.100000000000001 108.312 170.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.0 t70 66.71 3.01 2.79 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.72 1.608 . . . . 50.32 111.306 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -92.15 -58.62 2.33 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.735 -1.209 . . . . 74.340000000000003 107.735 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -107.24 -18.43 13.88 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.245 -1.343 . . . . 54.43 108.999 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -69.55 100.12 1.38 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.278 -1.008 . . . . 61.530000000000001 108.278 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -85.87 54.88 4.8 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 116.369 -0.378 . . . . 62.039999999999999 113.536 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.54 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -84.14 -28.03 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.555 0.693 . . . . 63.549999999999997 109.79 177.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.405 ' CD2' HG12 ' A' ' 504' ' ' ILE . 75.4 m-85 -143.78 -85.25 0.14 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.281 -1.378 . . . . 73.109999999999999 107.281 175.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 25.9 m 46.18 87.64 0.02 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.508 1.523 . . . . 62.210000000000001 114.171 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.95 88.4 2.86 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.411 -1.7 . . . . 70.530000000000001 106.411 173.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -168.15 168.23 11.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.924 -1.509 . . . . 74.230000000000004 106.924 -171.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.195 0 C-N-CA 122.772 0.429 . . . . 75.200000000000003 111.11 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.638 'CA ' ' OD1' ' A' ' 448' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.631 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.526 -0.546 . . . . 72.439999999999998 109.526 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 480' ' ' VAL . 20.1 m -73.24 99.23 2.81 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.256 -0.646 . . . . 63.43 109.256 177.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 396' ' ' ARG . 28.7 mmtp -92.01 117.72 30.09 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.431 -0.908 . . . . 44.25 109.128 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.651 ' HB ' HD12 ' A' ' 486' ' ' LEU . 31.7 mm -98.81 118.27 45.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.813 -1.54 . . . . 71.239999999999995 108.49 -175.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -154.87 174.15 15.51 Favored 'General case' 0 C--O 1.196 -1.718 0 CA-C-N 117.728 0.24 . . . . 74.219999999999999 110.364 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -92.74 153.0 19.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.345 -0.542 . . . . 74.340000000000003 112.268 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -54.53 37.68 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.659 -1.238 . . . . 73.510000000000005 107.659 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -106.51 160.86 15.1 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.559 -0.746 . . . . 74.329999999999998 110.693 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -96.31 -18.72 30.16 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 110.057 -1.217 . . . . 35.119999999999997 110.057 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 493' ' ' THR . 73.8 m -143.07 125.54 15.72 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 109.038 -0.727 . . . . 70.209999999999994 109.038 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 392' ' ' LEU . 45.2 m-85 -109.84 136.23 49.48 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.289 -1.004 . . . . 74.030000000000001 108.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -130.28 122.82 28.71 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.616 -0.883 . . . . 74.230000000000004 108.616 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 390' ' ' VAL . 94.6 m -145.14 165.4 28.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.993 -0.743 . . . . 74.099999999999994 108.993 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' LEU . . . . . 0.755 ' HA ' ' O ' ' A' ' 497' ' ' PHE . 2.5 mm? -78.19 149.66 33.68 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.967 0.413 . . . . 75.109999999999999 111.357 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.606 ' OE1' 'CA ' ' A' ' 600' ' ' ' CA' . 13.9 tt0 -60.76 -28.29 68.61 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.642 1.211 . . . . 73.129999999999995 107.833 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.439 HD22 ' HG3' ' A' ' 508' ' ' GLU . 76.4 m-20 -81.91 -4.72 57.25 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.327 -1.761 . . . . 51.030000000000001 111.833 -175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 384' ' ' LEU . 78.7 m -77.23 -14.53 59.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 122.234 -0.291 . . . . 65.310000000000002 110.811 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.19 -53.6 3.9 Favored Glycine 0 CA--C 1.5 -0.882 0 N-CA-C 111.309 -0.717 . . . . 53.020000000000003 111.309 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . 0.548 HG22 ' HA2' ' A' ' 443' ' ' GLY . 11.1 p -139.03 164.31 30.09 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.179 -0.674 . . . . 52.030000000000001 109.179 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 494' ' ' VAL . 7.3 p -117.82 129.37 74.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.564 -1.273 . . . . 63.100000000000001 107.564 173.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 440' ' ' ILE . . . -96.53 135.31 38.6 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.873 0.368 . . . . 75.0 110.291 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.436 ' HA ' ' CE2' ' A' ' 381' ' ' TYR . 3.8 mp -126.19 145.37 50.4 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.839 -1.171 . . . . 64.129999999999995 107.839 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 32.3 m -112.85 124.2 52.05 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.226 0.536 . . . . 62.509999999999998 110.362 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.21 120.03 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.883 -1.154 . . . . 73.239999999999995 107.883 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 51.4 mm -99.13 116.04 41.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.469 -1.241 . . . . 64.530000000000001 108.417 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 373' ' ' LYS . 44.3 ttt180 -102.62 113.05 26.1 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.522 -1.288 . . . . 74.510000000000005 107.522 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -104.93 149.76 25.45 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.681 0.623 . . . . 75.329999999999998 112.681 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 167.1 -179.59 40.7 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 107.52 -2.232 . . . . 63.539999999999999 107.52 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -76.85 -64.81 2.07 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 110.88 -0.888 . . . . 61.520000000000003 110.88 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -144.26 121.4 11.48 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 107.015 -1.476 . . . . 74.099999999999994 107.015 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' LEU . . . . . . . . . . . . . 87.3 mt -130.65 99.92 5.13 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.588 0.709 . . . . 50.439999999999998 111.47 -174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' ' 433' ' ' PRO . 49.3 p -102.41 1.93 35.96 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.477 -0.783 . . . . 74.530000000000001 109.429 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -70.91 171.95 9.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.46 -0.791 . . . . 64.319999999999993 109.941 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 431' ' ' PHE . 60.9 m -124.29 113.45 18.27 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.014 0.912 . . . . 63.100000000000001 111.896 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.91 140.26 35.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 113.887 -1.506 . . . . 44.039999999999999 108.292 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . 16.5 m-85 -120.07 129.27 54.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.582 -0.895 . . . . 73.319999999999993 108.582 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.5 p -126.22 132.69 70.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.887 -1.153 . . . . 64.239999999999995 107.887 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.05 147.09 27.4 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.805 -0.442 . . . . 60.420000000000002 109.805 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -141.72 163.99 31.41 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.868 -0.52 . . . . 74.540000000000006 111.792 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -158.13 168.93 25.72 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 125.313 1.445 . . . . 73.439999999999998 109.006 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 424' ' ' PHE . 69.0 p -96.89 162.06 13.57 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.527 -1.286 . . . . 72.129999999999995 107.527 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -126.32 151.41 47.59 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.105 -0.638 . . . . 75.409999999999997 111.032 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 416' ' ' ALA . 2.5 p30 -65.71 2.77 0.9 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.795 2.038 . . . . 71.239999999999995 115.957 -176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' GLY . . . . . . . . . . . . . . . -21.48 -73.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 124.92 1.247 . . . . 74.030000000000001 116.007 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 11.8 t -122.37 6.62 9.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 117.716 0.758 . . . . 54.32 110.304 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 413' ' ' ASP . . . -158.76 171.89 19.25 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 109.241 -0.652 . . . . 70.209999999999994 109.241 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -120.23 131.97 55.17 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.619 0.723 . . . . 71.310000000000002 112.073 -172.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 422' ' ' TYR . . . -78.67 138.66 38.4 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.879 -1.055 . . . . 55.100000000000001 108.945 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.76 65.72 Favored Glycine 0 C--N 1.3 -1.467 0 N-CA-C 109.983 -1.247 . . . . 73.140000000000001 109.983 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 49.0 m -141.28 -59.02 0.49 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 122.546 0.339 . . . . 71.439999999999998 110.215 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.639 ' O ' ' HB ' ' A' ' 445' ' ' ILE . 12.8 m-20 -77.82 -57.91 3.55 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-O 122.038 0.923 . . . . 73.430000000000007 108.744 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' TYR . . . . . 0.758 ' CE2' HD13 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -140.3 168.85 18.85 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.642 -1.163 . . . . 64.329999999999998 108.14 178.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.12 169.71 17.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.9 -0.408 . . . . 73.319999999999993 109.9 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.596 ' HA ' ' OG1' ' A' ' 411' ' ' THR . 9.7 p90 -101.56 -17.21 16.49 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.265 0.469 . . . . 74.319999999999993 112.265 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' THR . . . . . 0.536 HG21 HG22 ' A' ' 442' ' ' VAL . 9.6 t 40.54 65.36 0.78 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.096 1.758 . . . . 53.020000000000003 113.108 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -79.09 114.92 18.42 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.665 -0.698 . . . . 70.510000000000005 110.124 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -155.71 172.92 33.8 Favored Glycine 0 N--CA 1.413 -2.848 0 N-CA-C 110.948 -0.861 . . . . 71.530000000000001 110.948 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.1 m -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.585 -0.895 . . . . 63.43 108.585 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 33.5 t -96.52 128.36 47.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.901 -0.778 . . . . 65.129999999999995 108.901 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.16 112.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.53 -0.544 . . . . 75.329999999999998 109.53 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 404' ' ' THR . 63.6 m-85 -93.56 94.42 8.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.984 0.421 . . . . 74.409999999999997 110.603 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 433' ' ' PRO . 98.0 mttt -89.08 176.17 3.41 Favored Pre-proline 0 C--N 1.303 -1.438 0 CA-C-N 115.137 -0.938 . . . . 75.239999999999995 110.212 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.546 ' HG3' ' O ' ' A' ' 402' ' ' THR . 31.1 Cg_exo -62.22 119.57 6.74 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.055 1.837 . . . . 70.209999999999994 110.431 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.12 -21.81 34.73 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.14 -0.784 . . . . 52.229999999999997 111.14 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -88.3 62.27 6.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.639 -0.874 . . . . 62.149999999999999 108.639 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 396' ' ' ARG . 5.1 m -69.74 -28.15 65.55 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.428 -1.26 . . . . 73.129999999999995 108.537 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -125.23 145.62 49.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.184 -1.413 . . . . 74.319999999999993 107.184 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -132.89 148.27 52.29 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.539 0.209 . . . . 65.040000000000006 110.938 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.5 131.54 54.77 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.073 -0.512 . . . . 72.129999999999995 109.851 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 391' ' ' ALA . 44.5 pt -124.11 152.13 29.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.063 -0.717 . . . . 73.010000000000005 109.063 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 390' ' ' VAL . 67.0 mtm180 -127.01 143.61 51.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.534 0.207 . . . . 72.430000000000007 110.65 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.548 HG11 ' CZ ' ' A' ' 456' ' ' PHE . 93.6 t -109.9 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.44 -0.948 . . . . 62.210000000000001 108.44 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 389' ' ' THR . . . -66.65 122.42 19.98 Favored Glycine 0 N--CA 1.437 -1.258 0 O-C-N 123.984 0.802 . . . . 51.109999999999999 111.614 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.502 HD12 HG12 ' A' ' 496' ' ' ILE . 50.4 mm -95.63 134.13 34.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.452 -0.944 . . . . 63.009999999999998 108.452 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 421' ' ' ASP . 69.3 mt -99.02 148.12 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 106.019 -1.845 . . . . 74.140000000000001 106.019 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.5 89.56 7.26 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 121.767 0.794 . . . . 54.119999999999997 111.777 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.37 117.37 34.42 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.266 -1.383 . . . . 64.219999999999999 107.266 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 600' ' ' ' CA' 0.439 33.1 m-20 -102.43 85.02 2.53 Favored 'General case' 0 CA--C 1.446 -3.025 0 CA-C-O 123.736 1.732 . . . . 75.420000000000002 114.346 177.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' ILE . . . . . 0.741 ' O ' ' HG3' ' A' ' 451' ' ' GLU . 32.8 mm -122.44 153.42 27.04 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 0 N-CA-C 102.368 -3.197 . . . . 74.209999999999994 102.368 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -56.86 116.37 3.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.528 -1.286 . . . . 74.319999999999993 107.528 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.741 ' HG3' ' O ' ' A' ' 449' ' ' ILE . 45.6 mt-10 -112.3 118.66 35.87 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 121.191 0.52 . . . . 72.329999999999998 111.793 -172.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -136.41 111.62 9.05 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.095 -1.411 . . . . 74.450000000000003 107.97 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.54 26.96 14.98 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.364 0.876 . . . . 53.210000000000001 113.364 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . 0.532 ' HG2' ' OH ' ' A' ' 422' ' ' TYR . 24.4 tt0 -66.22 109.69 2.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.223 -1.028 . . . . 74.420000000000002 108.223 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.41 168.67 19.19 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.039 -0.528 . . . . 73.340000000000003 110.475 -175.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . 0.586 ' HD2' ' CE1' ' A' ' 422' ' ' TYR . 18.6 p90 -140.11 171.5 14.09 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.221 -0.659 . . . . 72.0 109.221 173.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 38.2 mt -114.4 136.34 53.1 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.532 -1.284 . . . . 71.329999999999998 107.532 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 56.7 t -102.06 113.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.415 -1.328 . . . . 74.209999999999994 107.415 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.39 136.3 48.26 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 123.571 0.545 . . . . 71.430000000000007 110.837 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.6 mt -96.86 132.18 42.87 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.001 -0.74 . . . . 64.540000000000006 109.001 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.4 m -151.07 176.26 11.32 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.704 -0.851 . . . . 74.329999999999998 108.704 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 51.95 81.16 0.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.192 0.997 . . . . 72.349999999999994 112.297 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.453 HG11 ' O ' ' A' ' 480' ' ' VAL . 58.5 t -87.7 123.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 115.401 -0.818 . . . . 61.130000000000003 109.283 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 406' ' ' PHE . 39.6 ttmt -116.46 131.69 56.88 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.111 -1.07 . . . . 72.209999999999994 108.111 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.24 151.49 7.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 108.089 -1.078 . . . . 71.319999999999993 108.089 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 35.5 t -74.18 131.29 41.12 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.49 0.662 . . . . 73.400000000000006 111.72 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 11.9 t -113.13 94.84 5.08 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 105.74 -1.948 . . . . 71.209999999999994 105.74 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.38 -167.48 1.61 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.629 -0.714 . . . . 75.329999999999998 111.242 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ALA . . . . . . . . . . . . . . . -66.19 -13.17 59.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.992 -0.549 . . . . 65.230000000000004 111.474 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 33.3 t -74.82 77.65 2.11 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.099 0.952 . . . . 65.120000000000005 108.446 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -86.39 -2.08 58.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.299 1.047 . . . . 70.340000000000003 109.363 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -72.38 -17.18 61.84 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.702 -1.136 . . . . 71.420000000000002 108.895 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 127.18 79.85 0.3 Allowed Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.602 -0.809 . . . . 54.340000000000003 113.066 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.58 98.04 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 107.421 -1.326 . . . . 72.310000000000002 107.421 174.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 85.4 mt -132.45 96.04 3.76 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.294 -1.321 . . . . 73.109999999999999 107.913 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.94 154.1 18.32 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.342 -0.844 . . . . 73.25 110.556 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' ALA . . . . . . . . . . . . . . . -104.9 24.32 12.1 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.011 0.434 . . . . 71.219999999999999 111.139 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -108.76 31.09 5.91 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.254 -0.43 . . . . 72.430000000000007 111.013 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -129.7 176.72 7.79 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.802 -0.561 . . . . 70.310000000000002 111.483 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 372' ' ' SER . 12.7 m -102.05 148.47 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 116.069 -0.514 . . . . 72.439999999999998 110.12 175.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' SER . . . . . . . . . . . . . 68.0 m -161.07 -92.55 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.88 1.272 . . . . 64.430000000000007 109.778 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -124.53 -11.33 7.34 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 122.107 -0.371 . . . . 51.420000000000002 111.552 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -89.85 -56.14 3.35 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 104.322 -2.473 . . . . 74.299999999999997 104.322 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -107.63 134.12 51.08 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 106.465 -1.68 . . . . 63.340000000000003 106.465 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' CYS . . . . . . . . . . . . . 74.1 m -120.01 -170.05 1.89 Allowed 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 109.288 -0.634 . . . . 74.519999999999996 109.288 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.651 HD12 ' HB ' ' A' ' 374' ' ' ILE . 1.3 mm? -64.23 155.74 30.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.299 -0.26 . . . . 75.200000000000003 110.299 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -71.69 -30.09 66.72 Favored Glycine 0 C--N 1.32 -0.34 0 N-CA-C 111.774 -0.53 . . . . 41.149999999999999 111.774 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.507 ' C ' ' HA ' ' A' ' 490' ' ' SER . 15.0 m -89.85 166.84 18.97 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 108.615 -0.883 . . . . 54.229999999999997 108.615 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.662 ' N ' ' HA ' ' A' ' 490' ' ' SER . 24.6 Cg_exo -58.29 -25.09 70.99 Favored 'Trans proline' 0 CA--C 1.592 3.417 0 N-CA-C 120.237 3.13 . . . . 64.150000000000006 120.237 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.662 ' HA ' ' N ' ' A' ' 489' ' ' PRO . 15.3 m -106.48 108.04 19.35 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 122.684 2.493 . . . . 72.439999999999998 109.055 0.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.453 ' H ' ' HD2' ' A' ' 489' ' ' PRO . 31.8 m -121.8 105.34 10.29 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-O 121.171 0.51 . . . . 74.150000000000006 110.164 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -109.82 118.28 36.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.115 -1.439 . . . . 72.409999999999997 107.115 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 380' ' ' THR . 41.2 m -87.67 131.66 34.38 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 120.837 0.351 . . . . 62.530000000000001 110.23 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' VAL . . . . . 0.671 HG11 HG11 ' A' ' 390' ' ' VAL . 78.5 t -116.64 106.51 20.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.668 -1.234 . . . . 73.329999999999998 107.668 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 47.9 m -97.78 112.84 24.58 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.303 -0.999 . . . . 52.310000000000002 108.303 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.758 HD13 ' CE2' ' A' ' 422' ' ' TYR . 5.2 mp -89.79 115.57 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 122.144 0.973 . . . . 72.109999999999999 110.409 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.755 ' O ' ' HA ' ' A' ' 384' ' ' LEU . 83.7 m-85 -99.8 120.86 40.41 Favored 'General case' 0 N--CA 1.396 -3.129 0 CA-C-N 114.796 -1.093 . . . . 74.310000000000002 108.176 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' ASP . . . . . 0.616 ' OD2' 'CA ' ' A' ' 600' ' ' ' CA' . 31.8 t0 -99.92 -7.55 25.08 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-O 122.603 1.192 . . . . 74.049999999999997 107.97 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 502' ' ' ALA . 16.9 t70 60.53 30.45 19.77 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 113.276 -1.784 . . . . 64.209999999999994 106.297 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 498' ' ' ASP . 13.6 t70 -71.04 -76.88 0.1 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.532 -2.122 . . . . 65.010000000000005 109.534 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -105.93 -35.93 7.14 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.588 -1.264 . . . . 75.409999999999997 107.588 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 499' ' ' ASP . . . -82.25 107.96 15.33 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.908 -1.042 . . . . 51.420000000000002 108.575 175.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -89.49 128.68 9.31 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 111.333 -0.707 . . . . 52.549999999999997 111.333 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 40.1 pt -127.36 -173.22 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 120.994 0.426 . . . . 74.209999999999994 110.651 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.9 83.71 2.14 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-O 122.491 1.139 . . . . 54.210000000000001 110.247 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 33.1 m -151.05 145.37 25.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 104.34 -2.467 . . . . 71.150000000000006 104.34 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.78 156.86 24.73 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 118.739 0.7 . . . . 71.030000000000001 111.72 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.439 ' HG3' HD22 ' A' ' 386' ' ' ASN . 38.7 tt0 -95.57 110.42 22.51 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.983 -0.553 . . . . 75.030000000000001 110.324 -177.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--N 1.298 -1.655 0 N-CA-C 109.361 -0.607 . . . . 72.409999999999997 109.361 178.881 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . 0.644 'CA ' ' OE1' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' ' CA' . . . . . 0.628 'CA ' ' OE2' ' A' ' 451' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_